data_2mx6_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mx6 _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.258 -0.275 . . . . 1.7 110.258 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.7 mt -102.64 122.3 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.293 -0.262 . . . . 1.03 110.293 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 27.0 mm -120.13 124.21 72.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 1.1 110.832 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -110.36 111.86 23.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.769 -0.456 . . . . 1.06 109.769 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.87 156.21 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.77 111.434 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -124.85 113.91 18.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.218 -1.03 . . . . 1.19 108.218 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 288' ' ' ALA . 76.5 mt -97.82 137.97 35.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.622 0.601 . . . . 0.72 112.622 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.16 110.73 14.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.088 -0.96 . . . . 0.7 109.962 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 71.6 mmm -94.87 21.04 8.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.268 -0.424 . . . . 0.87 111.338 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -93.14 -51.06 5.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.21 -0.663 . . . . 1.27 109.21 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -87.24 1.88 51.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.627 -0.715 . . . . 1.23 110.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -128.38 154.96 45.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.878 -0.601 . . . . 0.93 109.464 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -124.89 7.82 8.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 1.35 111.023 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.7 164.7 23.77 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.286 -0.416 . . . . 0.82 110.659 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.52 -56.38 4.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.469 -0.567 . . . . 0.43 109.469 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.77 43.18 4.25 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.664 -0.698 . . . . 0.14 112.681 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.77 150.34 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.55 112.186 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 22.7 t -98.99 131.36 45.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.751 -1.113 . . . . 1.57 108.198 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 6.7 mm -98.09 115.79 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.967 0.413 . . . . 0.44 110.752 -179.144 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 278' ' ' ILE . 62.1 t -86.84 126.07 40.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.5 110.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.84 88.64 0.86 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.972 -0.632 . . . . 0.37 112.337 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 120.852 0.358 . . . . 2.46 110.266 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 120.953 0.196 . . . . 0.38 112.613 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 8.3 pt -103.53 123.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.177 0.513 . . . . 0.51 110.432 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.7 156.84 21.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.964 -0.562 . . . . 1.07 111.354 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.97 118.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.57 109.998 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -88.74 -112.69 1.21 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.675 -0.774 . . . . 0.42 111.973 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.62 139.31 31.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.872 0.368 . . . . 1.26 111.445 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.19 132.59 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.16 -0.681 . . . . 0.87 109.16 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 33.9 mmt -95.1 134.83 37.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.517 -0.311 . . . . 0.96 110.994 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.47 133.14 46.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.45 110.199 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.79 -17.81 44.89 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.665 -0.778 . . . . 0.42 111.647 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.6 167.11 54.76 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.019 -0.61 . . . . 0.27 112.131 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 254' ' ' LEU . . . -63.75 -35.25 79.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.723 0.297 . . . . 0.53 111.387 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.67 -42.56 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.58 110.804 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.96 -17.64 64.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.5 111.496 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.66 -21.27 44.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.55 111.135 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.69 -82.21 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.214 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 122.02 -21.45 7.85 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.25 -0.976 . . . . 0.39 113.764 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -66.43 -31.12 71.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.466 0.633 . . . . 0.81 111.277 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 51.3 mt -89.35 132.85 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.337 -0.616 . . . . 0.74 109.337 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.81 165.12 36.23 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.69 110.42 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.51 119.68 7.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.022 1.815 . . . . 0.41 111.47 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 121.99 -21.31 7.9 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.585 -0.817 . . . . 0.37 112.273 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.49 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 91.3 m-20 -65.79 141.31 58.35 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.318 -0.253 . . . . 0.34 110.318 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.6 ttp -100.86 132.4 46.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.059 -0.256 . . . . 1.93 110.553 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 34.3 mt -82.09 123.07 28.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.561 -0.29 . . . . 1.16 110.554 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.69 -72.54 0.69 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.626 0.726 . . . . 1.07 110.137 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -116.52 134.25 55.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.103 -0.953 . . . . 0.92 110.971 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.22 96.97 4.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.8 109.34 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.2 t-20 60.47 73.87 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.71 111.461 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.7 m-20 75.86 -50.03 0.61 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.734 1.013 . . . . 1.11 113.734 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.36 130.02 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.57 . . . . 1.02 112.405 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.64 123.14 46.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.92 110.269 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -95.69 6.77 48.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.4 111.598 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.46 -12.36 30.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.319 0.489 . . . . 1.21 112.319 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -126.42 26.89 6.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.218 0.532 . . . . 1.71 110.63 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.2 mtp -125.5 163.02 23.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.259 -0.428 . . . . 0.94 109.987 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 17.9 p -72.08 157.81 37.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.584 0.23 . . . . 0.97 110.646 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 318' ' ' VAL . 70.4 m-20 -54.94 -43.49 73.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.6 111.168 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -63.84 -52.82 58.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 1.4 110.878 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.99 -39.2 77.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.897 -0.592 . . . . 0.88 111.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.36 -54.33 47.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.4 111.892 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 314' ' ' ASN . 3.0 t -70.58 -30.89 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.002 -0.279 . . . . 0.93 111.123 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 58.8 mtt180 -55.77 -52.39 64.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.001 -0.37 . . . . 1.08 110.001 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.27 -37.48 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.42 110.453 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 325' ' ' VAL . 20.7 tp -55.99 -49.33 73.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.073 0.463 . . . . 0.78 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.537 ' HA ' HG13 ' B' ' 3' ' ' VAL . 42.8 mtp180 -62.34 -35.59 79.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.764 -0.653 . . . . 2.1 111.106 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 17.3 mm-40 -64.84 -36.32 83.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.8 0.333 . . . . 1.87 110.868 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.1 mt -73.61 -40.77 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.416 . . . . 0.58 110.502 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 321' ' ' LEU . 47.3 t -70.32 -21.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.46 110.397 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.8 m -90.21 33.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -144.13 170.9 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 1.16 109.704 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.46 149.43 22.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.393 . . . . 1.31 111.503 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.14 158.64 10.17 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.117 -0.563 . . . . 0.66 112.332 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 133.71 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.871 2.381 . . . . 0.84 111.837 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.4 mt -103.5 120.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.967 0.413 . . . . 0.58 111.553 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.86 108.65 20.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.833 -0.621 . . . . 1.49 110.093 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.88 122.97 45.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.268 -0.423 . . . . 0.74 111.652 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.9 m -108.04 104.52 13.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.642 . . . . 0.89 109.265 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.4 153.65 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.88 112.136 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -108.53 111.17 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.06 110.176 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.49 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.432 -0.794 . . . . 0.7 109.347 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 17.4 m95 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 110.147 -0.316 . . . . 0.5 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.537 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.458 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.089 0.471 . . . . 1.7 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 83.0 mt -79.76 129.59 37.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.185 -0.461 . . . . 1.03 110.135 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.7 mt -128.77 131.83 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 1.1 110.789 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 m -106.2 112.5 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.585 -0.524 . . . . 1.06 109.585 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.57 150.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.902 0.382 . . . . 0.77 111.045 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -116.78 117.29 29.35 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.79 -0.819 . . . . 1.19 108.79 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 69.9 mt -106.53 152.53 23.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.167 0.508 . . . . 0.72 111.952 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -100.27 126.19 46.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.451 -0.795 . . . . 0.7 110.36 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 79.7 mmm -104.58 22.69 14.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.87 111.752 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -95.46 -52.08 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.386 -0.598 . . . . 1.27 109.386 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -79.81 -26.63 40.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 1.23 109.495 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -110.42 150.7 28.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.93 109.151 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -123.66 12.6 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.461 -0.495 . . . . 1.35 111.105 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -161.24 162.37 31.1 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.077 -0.51 . . . . 0.82 110.099 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . 0.406 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.9 mt -77.88 -52.21 9.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.43 110.07 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.91 43.01 6.14 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.85 -0.614 . . . . 0.14 112.394 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 262' ' ' LEU . 9.1 pt -136.94 154.02 30.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.441 0.639 . . . . 0.55 112.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 21.5 t -106.49 121.43 44.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.93 -1.032 . . . . 1.57 108.786 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 9.0 mm -91.25 132.49 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.709 0.29 . . . . 0.44 110.844 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.05 124.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.412 . . . . 0.5 110.032 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.12 113.63 4.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.816 -0.706 . . . . 0.37 112.102 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 2.46 110.557 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 111.848 -0.501 . . . . 0.38 111.848 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 7.6 pt -100.5 126.4 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.171 0.51 . . . . 0.51 111.103 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 84.9 m-85 -117.68 159.27 23.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 1.07 110.871 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.99 112.14 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.296 -0.631 . . . . 0.57 109.296 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.55 -56.68 3.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.888 -0.672 . . . . 0.42 112.88 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.17 161.41 38.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.627 -0.138 . . . . 1.26 110.627 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 31.1 mt -122.35 131.35 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.87 110.335 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.8 mmt -96.08 115.56 27.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.406 -0.361 . . . . 0.96 110.456 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -64.04 109.77 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.472 . . . . 1.45 110.015 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 142.45 -23.06 2.37 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.877 -0.889 . . . . 0.42 110.877 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.73 177.81 53.88 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.155 -0.545 . . . . 0.27 112.216 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.47 73.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.656 0.243 . . . . 0.53 111.656 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.11 -41.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.58 111.358 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.7 -18.62 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.5 111.68 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.22 -14.37 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.215 -0.448 . . . . 0.55 111.143 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -88.27 -72.52 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.775 0.321 . . . . 0.55 110.523 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.35 -19.98 26.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.453 -0.879 . . . . 0.39 113.853 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -69.9 -37.49 76.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.418 0.609 . . . . 0.81 110.976 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.6 mt -78.83 135.14 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.743 -0.465 . . . . 0.74 109.743 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.99 161.07 61.8 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.414 . . . . 0.69 110.119 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.21 124.08 15.33 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.195 1.93 . . . . 0.41 111.178 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.14 -16.0 18.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.662 -0.78 . . . . 0.37 111.938 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 90.7 m-20 -67.43 142.79 56.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.813 -0.44 . . . . 0.34 109.813 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 300' ' ' MET . . . . . 0.401 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 28.0 ttt -101.61 136.31 41.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.664 0.268 . . . . 1.93 110.766 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.3 124.99 34.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.373 . . . . 1.16 110.032 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 68.8 mt -105.47 -72.47 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.42 . . . . 1.07 110.453 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.8 135.14 54.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.935 -0.575 . . . . 0.92 110.744 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.33 106.44 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.882 -0.599 . . . . 0.8 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.5 m-20 61.4 62.93 1.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.987 -0.551 . . . . 1.71 111.455 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 29.0 m-20 75.12 -45.94 0.58 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.339 1.237 . . . . 1.11 114.339 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.1 m -71.11 130.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.199 0.523 . . . . 1.02 111.467 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -103.42 140.33 37.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.92 110.319 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.8 5.46 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.321 . . . . 0.4 111.729 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.25 -26.38 66.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.975 0.361 . . . . 1.21 111.975 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -116.74 26.39 9.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.263 0.554 . . . . 1.71 110.904 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 97.3 mtp -118.79 165.77 13.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.314 -0.403 . . . . 0.94 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 27.4 p -75.84 164.8 25.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.97 109.855 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.43 ' O ' HG23 ' A' ' 318' ' ' VAL . 86.7 m-20 -63.78 -36.65 84.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.249 0.547 . . . . 0.6 109.666 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 5.6 t70 -71.29 -53.77 13.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 1.4 110.992 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.24 -35.82 72.28 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.818 -0.628 . . . . 0.88 111.743 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.49 69.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.134 -0.484 . . . . 0.4 112.002 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 314' ' ' ASN . 0.9 OUTLIER -69.82 -29.02 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.926 -0.31 . . . . 0.93 111.003 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 82.8 mtt180 -55.82 -48.06 76.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.281 0.562 . . . . 1.08 110.068 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.3 -41.61 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.42 110.5 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.05 -50.2 67.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.78 111.456 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' B' ' 3' ' ' VAL . 63.4 mtp180 -62.41 -36.84 83.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 2.1 111.005 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -63.16 -44.0 96.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 1.87 110.478 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.59 -47.94 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.078 -0.51 . . . . 0.58 111.159 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 -15.19 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.133 0.492 . . . . 0.46 111.347 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 68.8 m -86.06 -5.73 59.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.818 0.342 . . . . 0.44 110.865 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.4 148.72 24.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.236 -0.438 . . . . 1.16 110.528 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 88.21 7.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.066 -0.515 . . . . 1.31 111.356 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -166.26 173.63 41.76 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.959 -0.639 . . . . 0.66 112.187 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.03 141.05 62.45 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.685 2.257 . . . . 0.84 112.371 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 72.2 mt -119.83 123.85 71.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.172 0.51 . . . . 0.58 111.442 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.8 m -112.35 102.61 10.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.554 -0.748 . . . . 1.49 109.435 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.73 121.03 33.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.74 111.801 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.9 m -103.53 98.91 8.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.826 -0.805 . . . . 0.89 108.826 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.42 152.48 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.503 0.557 . . . . 0.88 112.503 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -109.49 108.27 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 1.06 110.012 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.8 mtpp . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.092 -0.956 . . . . 0.7 109.74 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.9 m95 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.463 0.173 . . . . 0.5 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.848 -0.596 . . . . 1.0 109.69 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.905 -0.406 . . . . 1.7 109.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.15 126.01 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.283 -0.417 . . . . 1.03 110.659 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 23.5 mt -123.46 126.37 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 1.1 111.484 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 103.57 15.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.27 -0.641 . . . . 1.06 109.27 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 13.4 m -102.15 160.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 0.77 111.509 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.8 t -122.86 142.52 50.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.514 -0.921 . . . . 1.19 108.514 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 288' ' ' ALA . 80.7 mt -123.85 136.36 54.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.209 0.528 . . . . 0.72 112.101 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.45 111.85 14.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.393 -0.821 . . . . 0.7 109.832 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.3 mmm -96.21 17.85 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.87 110.911 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.7 -50.53 6.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.507 0.67 . . . . 1.27 109.229 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -88.95 0.05 56.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.92 -1.036 . . . . 1.23 110.186 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -130.28 133.18 46.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.93 110.276 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.61 15.39 25.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.567 -0.288 . . . . 1.35 110.783 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -166.54 166.64 16.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.24 -0.436 . . . . 0.82 110.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.5 mt -82.77 -52.54 6.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.189 -0.46 . . . . 0.43 109.988 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.74 43.11 5.54 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.891 -0.595 . . . . 0.14 112.98 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.83 150.6 20.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.656 0.741 . . . . 0.55 111.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 12.1 t -100.46 124.51 46.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.874 -1.057 . . . . 1.57 108.691 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 6.5 mm -91.1 114.81 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.44 110.854 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.01 112.31 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.5 110.254 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.15 101.79 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.939 -0.648 . . . . 0.37 112.156 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 110.122 -0.325 . . . . 2.46 110.122 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 111.834 -0.507 . . . . 0.38 111.834 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.5 pt -98.9 123.62 51.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.273 0.559 . . . . 0.51 110.557 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -111.21 156.22 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.716 -0.675 . . . . 1.07 110.604 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.99 118.46 30.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.12 -0.491 . . . . 0.57 109.866 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -89.76 -101.95 1.1 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.519 -0.848 . . . . 0.42 112.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.18 138.88 31.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.663 0.268 . . . . 1.26 111.094 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 69.8 mt -105.28 129.79 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.353 -0.61 . . . . 0.87 109.353 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 26.1 mmt -95.54 123.69 39.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.934 0.397 . . . . 0.96 111.202 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -67.37 122.56 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 1.45 109.809 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 122.73 -20.78 7.68 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.469 -0.652 . . . . 0.42 111.469 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.55 172.65 55.27 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.803 -0.713 . . . . 0.27 112.104 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -36.18 82.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.754 0.312 . . . . 0.53 111.099 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.14 -35.34 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.575 . . . . 0.58 111.115 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.86 -11.52 60.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.5 111.776 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -94.71 -10.17 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.104 0.478 . . . . 0.55 110.462 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.83 -77.12 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.55 110.239 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.0 -16.34 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.653 -0.784 . . . . 0.39 113.699 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -81.39 -36.1 29.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.417 0.608 . . . . 0.81 111.433 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.5 mt -80.04 134.29 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.421 -0.354 . . . . 0.74 110.307 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.51 168.11 16.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.69 110.292 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.75 128.23 25.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.984 1.789 . . . . 0.41 111.49 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.88 -14.6 31.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.821 -0.704 . . . . 0.37 112.299 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.95 141.97 52.95 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.647 -0.501 . . . . 0.34 109.647 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 35.9 ttp -101.36 132.14 47.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.643 0.259 . . . . 1.93 110.859 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.64 120.62 29.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.393 -0.367 . . . . 1.16 110.027 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 43.3 mt -101.29 -69.09 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.132 0.492 . . . . 1.07 110.359 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -111.9 133.82 53.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.744 -0.662 . . . . 0.92 110.563 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.64 94.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.8 109.964 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.1 t30 58.83 72.9 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.472 -0.786 . . . . 1.71 111.761 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 73.3 m-20 78.3 -48.4 0.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.422 0.897 . . . . 1.11 113.422 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.66 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.229 0.538 . . . . 1.02 111.657 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -103.08 137.51 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.698 -0.683 . . . . 0.92 110.413 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.59 13.0 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.477 -0.329 . . . . 0.4 111.06 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.73 6.11 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.115 0.413 . . . . 1.21 112.115 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.25 33.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.348 0.594 . . . . 1.71 110.068 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.7 mtp -134.31 159.17 41.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.94 110.498 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.06 153.36 43.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.97 110.746 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -54.18 -46.34 72.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.6 110.961 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.1 t70 -62.06 -48.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.881 -0.599 . . . . 1.4 110.779 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.87 -38.59 76.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.74 -0.664 . . . . 0.88 111.331 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.37 70.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.997 -0.547 . . . . 0.4 111.645 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.403 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.3 t -69.88 -27.73 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.956 -0.298 . . . . 0.93 111.298 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 88.3 mtt180 -58.23 -46.06 86.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.447 . . . . 1.08 110.202 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.59 -38.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.83 -0.623 . . . . 0.42 110.109 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 325' ' ' VAL . 19.0 tp -53.57 -53.25 54.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.87 -0.605 . . . . 0.78 111.34 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.1 mtp180 -62.09 -34.64 76.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 2.1 111.338 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 mm-40 -66.84 -40.3 87.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.89 0.376 . . . . 1.87 110.44 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -68.58 -44.64 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.58 110.939 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.9 t -64.74 -21.78 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.16 0.505 . . . . 0.46 111.152 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.5 m -84.69 -0.36 53.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.499 -0.319 . . . . 0.44 110.825 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 80.4 mm-40 -98.19 163.11 12.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 1.16 110.596 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 15.4 p -99.12 118.68 36.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.224 -0.444 . . . . 1.31 111.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 154.02 165.72 14.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.835 -0.697 . . . . 0.66 111.985 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.92 128.23 14.7 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.337 2.024 . . . . 0.84 111.503 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 34.6 mt -108.22 130.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.922 0.391 . . . . 0.58 111.354 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 18.5 t -104.8 129.73 53.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 1.49 109.258 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.4 mt -114.92 125.76 54.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 0.74 111.287 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -100.65 97.54 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.853 -0.795 . . . . 0.89 108.853 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.3 151.55 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.341 0.591 . . . . 0.88 112.247 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -111.57 113.07 25.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.234 -0.894 . . . . 1.06 109.146 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.274 -0.869 . . . . 0.7 110.391 -179.535 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.0 m95 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 110.527 -0.175 . . . . 0.5 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.887 -0.577 . . . . 1.0 109.879 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.868 0.366 . . . . 1.7 110.309 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -98.08 129.51 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.359 -0.382 . . . . 1.03 110.436 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.11 128.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.944 0.402 . . . . 1.1 111.152 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.71 119.81 39.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.055 -0.52 . . . . 1.06 109.691 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.95 144.17 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.912 0.387 . . . . 0.77 111.524 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.3 t -107.63 131.59 54.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.426 -0.953 . . . . 1.19 108.426 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 42.7 mt -114.8 140.17 49.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.72 111.737 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.31 116.79 21.33 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.475 -0.784 . . . . 0.7 110.285 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.6 mmm -98.69 12.62 34.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.87 111.654 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.92 -46.96 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.099 0.476 . . . . 1.27 109.803 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.06 -18.94 29.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 1.23 110.409 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -112.44 137.95 49.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.111 -0.495 . . . . 0.93 109.716 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -102.02 3.52 38.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.022 -0.271 . . . . 1.35 111.572 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -159.72 166.27 30.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.602 0.239 . . . . 0.82 111.05 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.04 -53.0 9.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.43 109.735 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.69 40.59 6.27 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 116.049 -0.523 . . . . 0.14 113.052 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.07 149.2 24.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.346 0.593 . . . . 0.55 111.623 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.86 129.79 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.284 -0.871 . . . . 1.57 109.264 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 10.1 mm -93.78 119.76 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.938 0.399 . . . . 0.44 110.483 -179.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.01 113.66 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.369 -0.378 . . . . 0.5 110.583 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.33 124.09 8.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.859 -0.686 . . . . 0.37 111.67 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 2.46 110.783 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 112.22 -0.352 . . . . 0.38 112.22 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.4 pt -113.96 130.63 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.51 110.925 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -115.59 163.65 15.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.0 -0.546 . . . . 1.07 110.827 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.34 118.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.059 -0.519 . . . . 0.57 109.883 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.32 -66.94 1.68 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.729 -0.748 . . . . 0.42 112.147 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -145.26 155.62 43.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.537 0.208 . . . . 1.26 110.554 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 30.2 mt -106.88 134.33 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.246 -0.434 . . . . 0.87 109.995 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.9 mmt -95.48 122.53 38.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.288 -0.414 . . . . 0.96 110.832 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.88 118.04 5.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 1.45 110.148 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.63 9.05 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.352 -0.699 . . . . 0.42 111.352 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.96 170.62 54.69 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.008 -0.615 . . . . 0.27 112.104 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.92 85.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.751 0.31 . . . . 0.53 111.363 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.01 -35.9 71.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.119 -0.492 . . . . 0.58 111.274 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.99 66.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.115 -0.493 . . . . 0.5 111.691 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.2 46.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.55 111.524 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.33 -72.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.799 0.333 . . . . 0.55 110.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.16 -17.8 34.27 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.393 -0.908 . . . . 0.39 114.3 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -73.21 -28.72 62.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.822 0.811 . . . . 0.81 111.278 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.7 mt -88.1 140.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.114 -0.698 . . . . 0.74 109.114 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.63 167.67 12.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.579 -0.282 . . . . 0.69 110.242 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.04 133.56 58.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.215 1.943 . . . . 0.41 111.061 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.14 -20.91 32.35 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.37 112.151 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.9 137.87 55.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.925 -0.398 . . . . 0.34 109.925 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.5 ttp -97.5 134.23 41.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.726 0.298 . . . . 1.93 110.729 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.75 124.71 32.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.314 -0.403 . . . . 1.16 109.974 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.8 -71.22 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.074 0.464 . . . . 1.07 110.606 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.93 136.96 53.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.92 111.162 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.02 94.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.8 109.919 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.4 m-20 59.09 75.4 0.4 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.211 -0.45 . . . . 1.71 111.407 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 3.3 m-20 76.72 -58.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.149 0.796 . . . . 1.11 113.149 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.43 121.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.379 0.609 . . . . 1.02 111.898 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -101.15 128.81 47.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.316 -0.856 . . . . 0.92 109.389 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -102.38 20.38 17.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.739 0.304 . . . . 0.4 111.477 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.45 -27.3 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.205 0.446 . . . . 1.21 112.205 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -125.58 37.45 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.633 0.254 . . . . 1.71 111.279 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 86.7 mtp -125.36 168.83 13.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.433 -0.349 . . . . 0.94 110.364 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.9 p -75.33 157.13 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.97 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.6 m-20 -62.27 -33.98 75.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.6 109.799 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -69.53 -54.03 16.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.575 -0.738 . . . . 1.4 111.118 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -59.58 -34.16 72.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.88 111.072 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.34 69.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.984 -0.553 . . . . 0.4 111.031 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.1 t -74.25 -27.96 22.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 121.041 -0.264 . . . . 0.93 110.725 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 66.8 mtt180 -58.35 -51.59 69.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.07 0.462 . . . . 1.08 109.864 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.78 -35.36 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.517 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 41.0 tp -54.67 -50.83 67.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.076 -0.511 . . . . 0.78 110.82 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.417 ' HA ' HG13 ' B' ' 3' ' ' VAL . 22.7 mtp-105 -61.32 -34.28 74.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.979 -0.555 . . . . 2.1 111.396 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.03 -40.63 96.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 1.87 110.54 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.89 -43.83 76.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.58 110.749 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.413 HG11 ' HB ' ' B' ' 3' ' ' VAL . 65.4 t -64.93 -32.1 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 0.46 110.753 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 13.7 m -87.31 10.3 17.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.928 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -110.98 151.41 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 1.16 110.081 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.62 134.57 37.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.563 -0.29 . . . . 1.31 110.617 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 135.71 156.14 7.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.852 -0.689 . . . . 0.66 112.339 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.3 139.82 46.87 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.851 2.368 . . . . 0.84 112.044 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.79 126.92 66.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.151 -0.477 . . . . 0.58 111.539 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 108.24 19.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.972 -0.751 . . . . 1.49 108.972 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 99.0 mt -93.65 128.93 40.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.237 -0.438 . . . . 0.74 111.756 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.5 m -108.34 97.39 7.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.442 -0.947 . . . . 0.89 108.442 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.85 159.17 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.88 112.154 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.83 116.62 27.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.334 -0.848 . . . . 1.06 109.718 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.488 -0.768 . . . . 0.7 110.271 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 30.4 m95 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 110.243 -0.28 . . . . 0.5 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.417 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.678 -0.677 . . . . 1.0 110.418 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.879 0.371 . . . . 1.7 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 56.0 mt -90.32 111.8 23.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.015 0.436 . . . . 1.03 110.251 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.55 128.73 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 1.1 110.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 m -98.74 112.35 24.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.273 -0.422 . . . . 1.06 109.867 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 332' ' ' SER . 6.0 m -100.87 163.34 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.436 -0.347 . . . . 0.77 110.67 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 14.8 t -131.11 134.66 46.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.309 -0.626 . . . . 1.19 109.309 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 72.4 mt -121.96 135.79 54.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.72 111.735 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -85.22 115.62 23.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.459 -0.792 . . . . 0.7 109.973 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.0 mmm -95.8 32.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.952 0.406 . . . . 0.87 111.327 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -102.8 -53.82 2.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.27 109.703 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -70.48 -41.28 72.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.483 -0.562 . . . . 1.23 109.483 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -107.34 157.26 18.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.69 -0.855 . . . . 0.93 108.69 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -124.07 22.56 8.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.625 -0.43 . . . . 1.35 112.03 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.5 158.75 27.01 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.736 0.303 . . . . 0.82 110.778 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.8 mt -76.35 -56.01 5.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.43 109.734 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.8 42.95 5.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.644 -0.707 . . . . 0.14 112.632 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -143.95 153.84 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.277 0.561 . . . . 0.55 111.866 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.465 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -100.85 131.59 46.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 1.57 109.48 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.5 mm -96.44 110.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.942 0.401 . . . . 0.44 110.385 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.09 110.78 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.504 -0.316 . . . . 0.5 111.486 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.61 113.7 3.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.092 -0.803 . . . . 0.37 111.092 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 120.99 0.424 . . . . 2.46 111.043 -178.801 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.269 -0.332 . . . . 0.38 112.269 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -105.88 129.36 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.031 0.443 . . . . 0.51 110.696 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.45 158.8 23.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 1.07 110.805 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.79 117.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.534 . . . . 0.57 110.393 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.76 -71.42 1.14 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.701 -0.761 . . . . 0.42 112.15 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.0 p -142.58 155.51 44.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.182 -0.303 . . . . 1.26 110.182 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 43.0 mt -106.43 125.53 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.87 110.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.3 mmt -86.36 126.72 34.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.07 -0.513 . . . . 0.96 110.668 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -67.88 110.6 3.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.662 -0.496 . . . . 1.45 109.662 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 132.84 -19.9 4.37 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.885 -0.886 . . . . 0.42 110.885 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.28 54.64 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.713 . . . . 0.27 111.969 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.19 73.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.812 0.339 . . . . 0.53 111.0 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.23 -33.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.58 110.734 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.08 -15.7 62.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.5 111.273 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.1 -27.79 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.55 110.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 16.5 t70 -76.05 -69.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.55 110.681 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.24 57.32 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.448 -0.882 . . . . 0.39 114.714 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 79.3 mtm180 -82.9 -19.65 36.96 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.019 0.91 . . . . 0.81 111.351 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.1 mt -96.78 138.51 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.206 -0.452 . . . . 0.74 109.959 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.1 157.9 76.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.43 -0.35 . . . . 0.69 110.409 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 33.4 Cg_exo -61.44 94.34 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.611 2.207 . . . . 0.41 111.793 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 150.52 -19.56 1.03 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.37 111.963 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -64.06 151.17 43.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.736 0.303 . . . . 0.34 110.842 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 300' ' ' MET . . . . . 0.411 ' HE2' HD23 ' A' ' 302' ' ' LEU . 50.6 ttp -104.02 130.1 51.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 1.93 110.683 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.84 115.23 22.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.382 -0.372 . . . . 1.16 110.103 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . 0.417 HD12 ' HB1' ' A' ' 336' ' ' ALA . 51.7 mt -97.9 -73.31 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.27 0.557 . . . . 1.07 110.844 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -115.11 130.74 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.594 -0.73 . . . . 0.92 110.625 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 96.5 t -126.91 106.44 15.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.201 -0.454 . . . . 0.8 109.972 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 11.4 t-20 61.34 65.98 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 1.5 m-20 74.87 -52.9 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.715 1.006 . . . . 1.11 113.715 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 134.74 29.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.063 0.458 . . . . 1.02 111.542 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -107.32 126.73 52.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.92 110.701 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -96.58 3.79 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.4 111.839 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.62 -28.08 65.3 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.828 0.307 . . . . 1.21 111.828 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.75 31.53 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 1.71 110.796 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 89.6 mtp -128.69 154.36 46.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.159 -0.473 . . . . 0.94 110.773 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.95 150.11 48.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.97 110.993 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -51.9 -47.98 64.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.343 . . . . 0.6 111.348 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.42 -46.39 88.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.4 111.672 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.505 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.1 m-20 -64.32 -30.72 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.294 -0.412 . . . . 0.88 110.8 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.42 85.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.4 110.786 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 -31.55 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.664 0.268 . . . . 0.93 110.535 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 90.1 mtt180 -56.74 -53.92 52.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 1.08 110.263 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.8 -37.19 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.42 110.366 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 325' ' ' VAL . 15.1 tp -55.79 -51.02 68.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.932 -0.577 . . . . 0.78 111.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.417 ' HA ' HG11 ' B' ' 3' ' ' VAL . 36.5 mtp180 -61.83 -35.14 77.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 2.1 111.091 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -64.53 -40.69 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.152 0.501 . . . . 1.87 109.959 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.59 -42.47 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.634 -0.712 . . . . 0.58 110.828 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 321' ' ' LEU . 62.6 t -66.29 -23.95 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.46 110.31 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 6.76 26.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.852 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -105.75 135.54 46.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.349 -0.387 . . . . 1.16 110.002 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 92.18 4.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.438 . . . . 1.31 111.569 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -173.74 171.92 44.86 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.461 -0.656 . . . . 0.66 111.461 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 126.04 13.18 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.361 2.041 . . . . 0.84 111.584 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 58.5 mt -102.95 122.75 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.93 0.395 . . . . 0.58 111.457 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.5 OUTLIER -106.66 121.78 45.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.564 . . . . 1.49 109.615 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.1 mt -108.1 120.95 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.525 . . . . 0.74 110.99 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.82 95.94 7.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.627 -0.879 . . . . 0.89 108.627 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.53 0.681 . . . . 0.88 112.399 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 302' ' ' LEU . . . -102.52 94.76 5.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.951 -1.022 . . . . 1.06 108.868 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.628 -0.701 . . . . 0.7 110.725 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.465 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 9.8 m95 . . . . . 0 C--O 1.234 0.244 0 N-CA-C 110.366 -0.235 . . . . 0.5 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.428 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.637 -0.696 . . . . 1.0 110.22 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.61 0.243 . . . . 1.7 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 95.1 mt -103.78 127.02 58.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.453 -0.34 . . . . 1.03 110.188 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.21 135.44 59.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.827 0.346 . . . . 1.1 111.358 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 62.9 m -107.01 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.648 -0.501 . . . . 1.06 109.648 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 332' ' ' SER . 4.0 m -102.26 143.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.789 0.328 . . . . 0.77 111.122 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.9 t -114.19 109.78 18.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 1.19 109.5 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 58.4 mt -100.31 145.27 28.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.72 112.016 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -91.72 119.79 31.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.7 109.732 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 89.5 mmm -99.0 21.52 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.026 0.441 . . . . 0.87 111.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -87.71 -49.91 6.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.768 -0.456 . . . . 1.27 109.768 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.16 -35.81 19.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 1.23 109.355 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -86.87 145.71 26.48 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.695 -0.684 . . . . 0.93 109.464 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.85 -2.33 13.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.545 -0.462 . . . . 1.35 112.024 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -157.58 162.54 38.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.498 0.19 . . . . 0.82 110.677 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.4 mt -77.55 -52.04 9.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.727 -0.472 . . . . 0.43 109.727 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.44 4.61 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.577 -0.738 . . . . 0.14 112.999 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.0 pt -144.84 144.1 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.213 0.53 . . . . 0.55 111.563 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.565 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 1.1 p -96.49 126.87 41.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.208 -0.664 . . . . 1.57 109.208 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 9.2 mm -91.75 115.84 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.825 0.345 . . . . 0.44 110.776 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.22 119.01 48.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.5 110.251 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.26 122.51 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.002 -0.618 . . . . 0.37 112.072 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 2.46 110.1 179.831 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.192 -0.363 . . . . 0.38 112.192 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.03 128.41 73.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.068 0.461 . . . . 0.51 110.839 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -113.99 157.46 22.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.772 -0.649 . . . . 1.07 110.803 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.59 115.02 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.57 110.014 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.72 -58.16 4.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.42 112.698 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.6 p -151.54 161.97 41.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.187 -0.301 . . . . 1.26 110.187 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.18 134.8 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.87 110.46 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -95.7 125.17 40.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.96 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.05 124.47 20.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.883 -0.599 . . . . 1.45 110.056 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.58 18.12 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.29 -0.724 . . . . 0.42 111.29 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -80.52 166.03 48.88 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.875 -0.679 . . . . 0.27 111.875 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.83 87.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.662 0.268 . . . . 0.53 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.69 -31.3 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.58 110.907 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.83 -20.29 61.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.5 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.02 -11.7 43.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.272 -0.422 . . . . 0.55 111.73 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.11 -72.61 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.15 -0.22 . . . . 0.55 111.218 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 113.74 -17.08 20.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.381 -0.914 . . . . 0.39 113.902 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -89.93 -49.32 6.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.32 0.56 . . . . 0.81 111.064 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.24 136.93 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.74 110.206 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.8 164.2 31.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.69 110.308 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.5 Cg_exo -60.24 112.54 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.329 2.019 . . . . 0.41 111.27 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 132.45 -19.86 4.48 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.241 -0.744 . . . . 0.37 111.241 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.0 m-20 -70.84 146.14 49.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.732 0.301 . . . . 0.34 110.245 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.1 ttt -103.76 136.44 43.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.309 -0.405 . . . . 1.93 110.656 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.99 123.39 32.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 1.16 110.109 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 90.6 mt -106.25 -69.07 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.048 0.451 . . . . 1.07 110.818 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -121.1 124.7 45.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.92 110.484 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 307' ' ' VAL . 59.5 t -125.62 101.57 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.8 110.23 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.88 65.69 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.998 -0.546 . . . . 1.71 111.244 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 74.69 -43.67 0.53 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.922 1.082 . . . . 1.11 113.922 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 304' ' ' VAL . 33.6 m -69.51 137.47 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 118.261 0.482 . . . . 1.02 111.329 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -111.06 133.16 53.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.771 -0.65 . . . . 0.92 109.645 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.13 12.44 30.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.909 0.337 . . . . 0.4 111.909 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -66.32 -30.56 70.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.723 0.297 . . . . 1.21 111.715 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.56 36.96 4.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 1.71 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 84.1 mtp -125.05 154.96 40.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.324 -0.621 . . . . 0.94 109.324 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 97.0 p -69.17 153.56 43.51 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.147 -0.316 . . . . 0.97 110.147 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -59.6 -26.38 65.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.6 109.842 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -71.48 -56.3 6.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.279 -0.873 . . . . 1.4 110.588 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.422 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 10.6 m-20 -63.64 -30.98 72.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.84 -0.618 . . . . 0.88 111.683 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.15 67.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.929 -0.578 . . . . 0.4 112.011 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.33 -27.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.931 -0.308 . . . . 0.93 111.024 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 81.4 mtt180 -58.53 -53.31 59.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 1.08 110.11 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.6 -40.49 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.871 -0.604 . . . . 0.42 110.274 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 325' ' ' VAL . 20.6 tp -55.12 -50.98 67.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.938 -0.574 . . . . 0.78 111.229 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.431 ' HA ' HG13 ' B' ' 3' ' ' VAL . 9.0 mtp180 -61.0 -41.86 97.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.404 . . . . 2.1 111.359 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -61.42 -43.52 98.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.52 0.2 . . . . 1.87 110.55 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.01 -43.25 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.58 110.508 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 321' ' ' LEU . 59.3 t -70.01 -19.68 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.277 -0.42 . . . . 0.46 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 66.7 m -77.86 -18.38 56.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.44 110.789 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.09 162.39 12.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.228 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.39 172.07 13.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.359 -0.382 . . . . 1.31 111.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 116.19 168.08 15.04 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.925 -0.655 . . . . 0.66 112.572 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -79.56 104.52 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.699 2.266 . . . . 0.84 111.733 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 50.0 mt -74.06 114.13 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.58 110.691 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 8.1 m -97.31 102.74 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 1.49 109.75 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.89 119.05 37.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.023 -0.535 . . . . 0.74 111.319 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 26.8 m -98.54 101.12 12.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.779 -0.822 . . . . 0.89 108.779 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.64 156.23 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 0.88 112.204 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -110.07 111.43 22.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.113 -0.949 . . . . 1.06 109.894 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.7 mtpp . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.511 -0.757 . . . . 0.7 109.796 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.565 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 22.4 m95 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.126 -0.324 . . . . 0.5 110.126 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.71 -0.662 . . . . 1.0 109.973 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.74 0.305 . . . . 1.7 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.61 128.38 49.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.128 -0.323 . . . . 1.03 110.128 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 42.2 mt -126.53 130.51 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.339 . . . . 1.1 111.151 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.8 m -101.62 111.11 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.52 -0.548 . . . . 1.06 109.52 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.91 147.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.688 0.28 . . . . 0.77 111.566 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.2 t -110.16 136.8 48.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.642 -0.503 . . . . 1.19 109.642 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.2 mt -114.71 138.41 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.905 0.383 . . . . 0.72 111.469 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -83.91 117.96 23.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.704 . . . . 0.7 110.155 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 92.2 mmm -98.35 14.05 29.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.374 -0.375 . . . . 0.87 111.584 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.14 -38.39 15.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 1.27 110.342 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -96.34 0.66 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.575 -0.739 . . . . 1.23 110.255 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -131.03 162.52 29.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.93 109.709 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -120.32 -8.23 9.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.827 0.346 . . . . 1.35 111.283 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -154.62 175.95 13.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.509 -0.314 . . . . 0.82 110.707 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.08 -52.46 6.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.43 109.971 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.68 43.18 5.54 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.806 -0.634 . . . . 0.14 112.879 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.02 154.35 31.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.538 0.685 . . . . 0.55 112.37 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 282' ' ' SER . 42.5 t -101.8 118.03 36.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.612 -1.176 . . . . 1.57 109.043 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.1 mm -88.63 118.5 34.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.776 0.322 . . . . 0.44 110.138 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.99 109.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.007 0.432 . . . . 0.5 110.759 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.1 124.38 7.54 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.247 -0.741 . . . . 0.37 111.247 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 . . . . . 0 C--N 1.323 -0.543 0 CA-C-O 120.938 0.399 . . . . 2.46 110.635 -179.839 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.305 -0.318 . . . . 0.38 112.305 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.44 114.26 45.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.297 0.57 . . . . 0.51 110.212 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -107.32 154.57 21.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.893 -0.594 . . . . 1.07 110.692 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.23 114.18 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.57 109.782 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.12 -57.7 3.62 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.746 -0.74 . . . . 0.42 112.333 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 282' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 265' ' ' SER . 1.8 p -145.16 158.25 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.144 -0.317 . . . . 1.26 110.144 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 50.4 mt -118.24 131.62 70.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.58 -0.526 . . . . 0.87 109.58 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 34.1 mmt -92.77 124.32 36.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.415 -0.357 . . . . 0.96 110.619 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -58.56 130.18 45.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 1.45 110.997 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.12 -24.55 20.78 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.894 -0.67 . . . . 0.42 112.034 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.19 45.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.058 -0.591 . . . . 0.27 112.424 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.01 -37.32 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.53 111.056 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.54 -39.27 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.58 110.781 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.27 -18.15 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.5 111.254 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -85.67 -11.03 54.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.55 110.955 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.49 -67.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.839 -0.43 . . . . 0.55 109.839 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 103.47 -14.96 54.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 0.39 114.435 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -79.96 -33.13 39.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.738 0.769 . . . . 0.81 111.137 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -82.57 140.65 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.651 -0.5 . . . . 0.74 109.651 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.13 164.3 32.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.765 -0.198 . . . . 0.69 110.88 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.37 116.94 3.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.41 111.823 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 125.82 -21.81 6.19 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.917 -0.658 . . . . 0.37 111.509 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.457 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.5 m-20 -69.44 143.23 53.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 43.7 ttp -103.36 135.3 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.702 0.287 . . . . 1.93 110.813 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 70.4 mt -83.39 123.97 30.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 1.16 110.182 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 46.7 mt -105.15 -72.57 0.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.245 0.545 . . . . 1.07 110.835 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -109.75 135.32 50.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.754 . . . . 0.92 111.034 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.98 93.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.8 110.149 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 59.21 76.61 0.35 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.798 -0.637 . . . . 1.71 111.737 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.8 OUTLIER 75.21 -53.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.053 -0.976 . . . . 1.11 113.455 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.5 139.66 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.349 0.595 . . . . 1.02 111.864 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.99 130.8 55.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.442 -0.799 . . . . 0.92 110.409 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.481 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 23.7 m-85 -102.02 6.53 41.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.867 0.321 . . . . 0.4 111.867 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.92 -31.61 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 1.21 111.696 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -119.44 53.35 1.04 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.2 0.524 . . . . 1.71 110.301 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 312' ' ' MET . . . . . 0.481 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 84.1 mtp -141.11 160.37 40.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.94 110.182 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 148.14 51.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.242 -0.435 . . . . 0.97 110.75 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -49.7 -50.97 41.69 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.484 0.49 . . . . 0.6 111.638 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.22 -47.3 80.22 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.446 . . . . 1.4 111.833 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.58 -35.1 75.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.886 -0.597 . . . . 0.88 111.815 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.02 93.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.452 -0.34 . . . . 0.4 110.865 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -73.82 -32.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.93 110.623 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -54.98 -50.33 69.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.864 0.364 . . . . 1.08 110.627 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.6 t -70.49 -39.93 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.75 -0.659 . . . . 0.42 110.249 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 325' ' ' VAL . 56.6 tp -55.36 -50.44 69.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.053 -0.521 . . . . 0.78 111.373 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.523 ' HA ' HG13 ' B' ' 3' ' ' VAL . 27.0 mtp180 -63.69 -30.13 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 2.1 111.462 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.7 -40.37 80.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.136 0.493 . . . . 1.87 109.804 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.92 -42.67 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.73 . . . . 0.58 111.209 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 321' ' ' LEU . 43.8 t -69.23 -16.94 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.46 110.802 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 23.57 6.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.092 0.473 . . . . 0.44 110.161 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.26 -179.31 4.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 1.16 110.102 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.99 146.24 32.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.71 0.29 . . . . 1.31 110.607 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.37 169.59 13.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.707 -0.759 . . . . 0.66 112.269 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 137.09 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 0.84 112.166 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 84.4 mt -115.34 121.57 67.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.142 -0.481 . . . . 0.58 110.414 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.8 m -106.11 121.06 43.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.138 0.494 . . . . 1.49 109.95 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 84.0 mt -105.5 130.52 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.74 111.538 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.7 m -104.04 103.23 13.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.89 108.802 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.28 142.68 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.343 0.592 . . . . 0.88 112.35 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -108.22 111.95 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.186 -0.916 . . . . 1.06 109.582 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.457 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.0 mtpp . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.613 -0.708 . . . . 0.7 109.942 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 28.9 m95 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.547 0.213 . . . . 0.5 110.62 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 119.038 -0.506 . . . . 1.0 109.949 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.917 0.389 . . . . 1.7 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 57.2 mt -92.3 128.78 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 1.03 110.731 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 33.8 mt -129.67 123.7 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 1.1 110.875 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.1 m -95.39 102.39 14.19 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.424 -0.584 . . . . 1.06 109.424 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.27 148.4 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.954 0.407 . . . . 0.77 111.751 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -114.87 129.95 56.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.802 -0.814 . . . . 1.19 108.802 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.2 mt -110.89 149.66 30.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.463 . . . . 0.72 111.606 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.27 118.04 30.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.507 -0.77 . . . . 0.7 110.901 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 67.0 mmm -99.46 16.26 23.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.863 -0.608 . . . . 0.87 111.304 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -86.47 -49.41 7.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.35 -0.611 . . . . 1.27 109.35 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -86.44 -22.8 26.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.583 -0.735 . . . . 1.23 110.193 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -106.92 154.76 20.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 0.93 110.472 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.76 -2.39 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.519 0.2 . . . . 1.35 111.304 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -157.56 171.92 19.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.348 . . . . 0.82 110.959 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.21 -51.31 10.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.887 -0.597 . . . . 0.43 110.016 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.05 47.34 5.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.776 -0.647 . . . . 0.14 112.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.73 150.45 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.55 112.023 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.26 120.61 40.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.991 -1.004 . . . . 1.57 108.81 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.3 mm -89.56 116.11 30.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.919 0.39 . . . . 0.44 111.036 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.69 118.77 48.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.877 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.51 127.82 9.36 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.511 -0.852 . . . . 0.37 112.013 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.114 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.511 -0.236 . . . . 0.38 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.67 138.43 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.898 0.38 . . . . 0.51 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -125.69 158.24 35.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.996 -0.547 . . . . 1.07 110.661 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.3 mm -75.92 109.5 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.067 -0.515 . . . . 0.57 109.698 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.29 -60.13 3.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.754 -0.736 . . . . 0.42 112.273 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 m -145.17 157.97 43.94 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.708 -0.289 . . . . 1.26 110.355 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.2 mt -113.52 130.22 67.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.211 -0.45 . . . . 0.87 110.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.97 119.33 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.96 110.335 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -61.72 116.99 5.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.955 -0.566 . . . . 1.45 110.023 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.1 -17.58 9.12 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.477 -0.649 . . . . 0.42 111.477 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.8 174.03 55.26 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.863 -0.684 . . . . 0.27 111.912 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.87 84.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.769 0.318 . . . . 0.53 111.218 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.98 -37.37 77.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.58 111.169 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.41 -17.88 64.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.5 111.828 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.92 -3.66 57.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.828 0.347 . . . . 0.55 111.192 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.63 -80.25 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.745 -0.465 . . . . 0.55 109.745 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 118.33 -21.53 9.97 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.274 -0.965 . . . . 0.39 113.908 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -76.84 -19.59 57.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.568 0.684 . . . . 0.81 111.751 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.8 mt -95.18 136.36 26.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.646 -0.501 . . . . 0.74 109.646 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.63 163.77 47.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.742 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.47 109.04 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.368 2.045 . . . . 0.41 111.452 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.96 -17.14 5.21 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.37 112.09 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 97.7 m-20 -65.11 140.39 58.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.634 0.254 . . . . 0.34 110.348 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.6 ttt -93.76 135.2 35.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.322 . . . . 1.93 111.02 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.6 mt -90.07 118.14 29.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.193 -0.458 . . . . 1.16 109.936 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 59.4 mt -103.54 -77.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.098 0.475 . . . . 1.07 110.837 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -106.01 134.42 49.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.92 110.996 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 321' ' ' LEU . 84.7 t -131.31 102.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.782 -0.645 . . . . 0.8 109.83 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.2 m-20 58.35 70.53 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.566 -0.743 . . . . 1.71 111.568 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.5 OUTLIER 76.51 -53.36 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.585 0.957 . . . . 1.11 113.585 178.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.09 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 1.02 112.122 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -103.32 131.39 50.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.521 -0.763 . . . . 0.92 109.782 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -97.17 3.98 51.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.984 0.364 . . . . 0.4 111.984 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.4 -32.8 67.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.965 0.412 . . . . 1.21 111.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -105.78 39.88 1.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.71 111.47 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 34.1 mtp -141.78 165.77 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.514 -0.312 . . . . 0.94 110.263 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.5 p -79.25 162.8 25.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.97 109.899 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 318' ' ' VAL . 42.7 m-20 -57.26 -40.06 76.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.6 110.037 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 23.9 t0 -63.08 -55.09 28.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.182 -0.917 . . . . 1.4 110.514 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -60.13 -36.18 76.94 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.826 -0.625 . . . . 0.88 111.34 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.29 -56.02 27.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.4 112.157 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.9 t -69.62 -26.71 31.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.963 -0.295 . . . . 0.93 111.358 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 69.4 mtt180 -57.11 -52.28 65.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 1.08 110.072 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.22 -38.26 74.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.976 -0.556 . . . . 0.42 110.4 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 325' ' ' VAL . 23.9 tp -56.09 -51.58 67.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.923 -0.581 . . . . 0.78 110.942 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.531 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.7 mtp180 -61.15 -38.41 86.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.945 -0.571 . . . . 2.1 111.082 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.3 -45.38 88.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.595 -0.275 . . . . 1.87 110.682 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.78 -44.37 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 0.58 110.9 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 321' ' ' LEU . 26.1 t -72.22 -15.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.46 111.424 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 71.7 m -81.74 -16.6 50.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.83 0.348 . . . . 0.44 110.838 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.65 160.7 14.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 1.16 110.357 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 130.82 41.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.97 0.414 . . . . 1.31 111.075 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.31 176.1 27.1 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.523 -0.631 . . . . 0.66 111.523 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.38 135.95 35.46 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.539 2.159 . . . . 0.84 112.151 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.43 129.64 72.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.145 0.497 . . . . 0.58 110.732 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 126.81 52.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.347 -0.842 . . . . 1.49 109.403 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.12 115.91 26.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.74 111.586 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -93.37 90.13 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.599 -0.889 . . . . 0.89 108.599 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.11 146.47 6.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.912 -0.585 . . . . 0.88 111.996 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -111.04 107.75 17.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.333 -0.849 . . . . 1.06 110.018 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 22.7 mtpp . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.432 -0.795 . . . . 0.7 109.692 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.881 -0.414 . . . . 0.5 109.881 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.164 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.74 0.305 . . . . 1.7 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.61 122.16 61.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 1.03 110.629 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 18.3 mt -126.31 131.42 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 1.1 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 88.8 m -104.96 113.24 26.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.943 -0.762 . . . . 1.06 108.943 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 10.2 m -103.56 155.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.283 -0.417 . . . . 0.77 111.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.5 t -108.23 135.35 49.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.05 -0.722 . . . . 1.19 109.05 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.9 mt -119.04 136.14 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.947 0.403 . . . . 0.72 111.524 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -83.46 114.85 21.76 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.547 -0.751 . . . . 0.7 109.924 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 93.8 mmm -98.89 14.77 27.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.87 111.159 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -88.93 -47.54 8.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.27 109.819 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.71 -21.63 32.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 1.23 110.048 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -111.67 159.04 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.93 109.867 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -128.24 14.76 6.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.899 0.38 . . . . 1.35 110.443 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -164.72 169.0 17.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.82 110.163 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.28 -57.68 3.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.828 0.347 . . . . 0.43 110.27 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.6 36.35 5.89 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.14 112.578 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.1 pt -137.16 156.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.42 0.629 . . . . 0.55 111.894 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.485 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -102.71 129.15 49.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.993 -1.003 . . . . 1.57 110.006 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.6 mm -97.37 113.33 31.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.953 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.5 t -114.88 115.24 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.5 110.709 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.64 134.23 12.26 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.97 -0.633 . . . . 0.37 112.393 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 120.623 0.249 . . . . 2.46 110.539 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.679 0 N-CA-C 112.025 -0.43 . . . . 0.38 112.025 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.6 130.44 56.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.174 0.511 . . . . 0.51 111.07 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 45.4 m-85 -117.71 159.17 23.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 1.07 110.687 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.0 mm -79.88 120.2 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.919 -0.582 . . . . 0.57 110.227 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.29 -53.41 5.17 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.704 -0.76 . . . . 0.42 112.073 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -155.59 163.76 39.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.841 -0.429 . . . . 1.26 109.841 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.49 128.61 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.95 -0.389 . . . . 0.87 109.95 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -90.86 126.45 36.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 0.96 110.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.57 127.57 31.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 1.45 110.03 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 112.4 -14.37 25.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.42 111.572 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.39 175.1 54.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.982 -0.628 . . . . 0.27 111.778 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.85 79.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.69 0.281 . . . . 0.53 111.027 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.22 -36.93 78.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.58 111.054 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.33 -7.27 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.5 111.703 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.91 37.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.327 -0.397 . . . . 0.55 111.155 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -91.8 -80.2 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.55 110.333 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.22 -18.62 9.53 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.521 -0.847 . . . . 0.39 114.024 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -76.69 -33.38 58.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.55 0.675 . . . . 0.81 111.338 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.0 139.43 17.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.173 -0.467 . . . . 0.74 109.892 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.78 160.63 60.21 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.107 -0.331 . . . . 0.69 110.107 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.45 122.97 12.56 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.386 2.057 . . . . 0.41 111.023 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.82 9.82 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.298 -0.721 . . . . 0.37 111.298 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 93.6 m-20 -69.09 144.23 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.666 0.269 . . . . 0.34 110.504 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 300' ' ' MET . . . . . 0.453 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 27.3 ttt -100.36 135.38 41.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.381 -0.372 . . . . 1.93 111.1 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.41 123.4 32.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.902 -0.407 . . . . 1.16 109.902 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 75.3 mt -102.12 -64.67 1.04 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 1.07 110.887 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -125.11 136.17 53.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.733 -0.667 . . . . 0.92 110.672 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 307' ' ' VAL . 98.5 t -132.66 103.38 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.8 110.134 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.5 m-20 59.81 65.14 1.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 1.71 111.444 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 58.0 m-20 76.31 -51.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.034 0.934 . . . . 1.11 113.451 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 304' ' ' VAL . 0.0 OUTLIER -63.66 124.35 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.387 0.613 . . . . 1.02 111.852 -178.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.59 129.61 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.34 -0.845 . . . . 0.92 109.67 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.131 0.419 . . . . 0.4 112.131 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -63.25 -26.19 68.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.643 0.259 . . . . 1.21 111.637 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -117.14 24.37 11.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.68 0.252 . . . . 1.71 111.68 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.8 mtp -122.23 156.49 33.65 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.788 -0.365 . . . . 0.94 111.501 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 144.0 57.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.724 -0.671 . . . . 0.97 110.388 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -50.86 -49.05 59.86 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.279 0.362 . . . . 0.6 111.463 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -47.18 85.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.4 111.309 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.21 -29.16 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.509 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.48 81.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.27 -0.423 . . . . 0.4 110.97 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.537 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -74.28 -23.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.81 -0.356 . . . . 0.93 110.688 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.08 -45.9 79.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.016 0.436 . . . . 1.08 110.168 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.02 -36.37 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.879 -0.601 . . . . 0.42 110.256 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.444 ' CD1' HG13 ' A' ' 304' ' ' VAL . 32.3 tp -56.76 -50.6 71.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.841 -0.618 . . . . 0.78 111.398 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.544 ' HA ' HG11 ' B' ' 3' ' ' VAL . 31.3 mtp180 -61.61 -33.16 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 2.1 111.258 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.71 -45.46 86.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 1.87 109.948 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.48 -42.78 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.58 111.624 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.451 HG11 ' HB ' ' B' ' 3' ' ' VAL . 57.5 t -66.32 -26.83 38.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.93 0.395 . . . . 0.46 111.264 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 15.8 m -86.71 -2.21 58.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.253 0.549 . . . . 0.44 110.474 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 163.86 12.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.411 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.13 144.61 25.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.487 -0.324 . . . . 1.31 110.842 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.21 152.8 8.46 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.677 -0.773 . . . . 0.66 111.994 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.36 139.7 72.74 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.947 2.431 . . . . 0.84 112.15 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 57.9 mt -114.52 134.39 57.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.079 -0.51 . . . . 0.58 111.301 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.5 m -108.63 126.16 52.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.59 -0.522 . . . . 1.49 109.59 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 63.8 mt -110.51 118.2 35.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.075 0.398 . . . . 0.74 112.075 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 89.1 m -98.78 100.28 11.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.767 -0.827 . . . . 0.89 108.767 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.92 155.48 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 0.88 112.005 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -113.61 114.89 27.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.263 -0.88 . . . . 1.06 110.111 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.6 mtpp . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.477 -0.773 . . . . 0.7 109.604 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.485 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 58.2 m95 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.368 0.128 . . . . 0.5 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.72 -0.657 . . . . 1.0 109.801 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.26 -0.274 . . . . 1.7 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.36 128.99 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.814 -0.439 . . . . 1.03 109.814 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.36 132.5 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.1 110.99 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 13.2 m -109.01 111.4 23.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.414 -0.587 . . . . 1.06 109.414 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.19 149.47 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.77 111.469 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.4 t -115.35 106.84 14.47 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.148 -0.686 . . . . 1.19 109.148 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 57.9 mt -87.91 134.96 33.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.72 111.618 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -79.22 115.9 19.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 0.7 110.508 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 60.9 mmm -99.33 19.59 15.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.073 0.463 . . . . 0.87 110.937 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.22 -52.77 4.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.617 -0.512 . . . . 1.27 109.617 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -82.89 -25.67 32.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 1.23 109.62 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -98.86 160.21 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.93 109.561 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -130.21 12.69 5.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.967 0.413 . . . . 1.35 110.562 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -168.6 165.8 12.13 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.791 -0.641 . . . . 0.82 110.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.1 -51.51 8.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.639 -0.504 . . . . 0.43 109.639 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.4 43.45 5.55 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.14 112.653 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -144.86 152.16 15.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.489 0.662 . . . . 0.55 111.66 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.407 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 21.5 p -104.22 128.82 52.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.202 -0.908 . . . . 1.57 108.842 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.6 mm -95.26 123.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.899 0.38 . . . . 0.44 110.551 -178.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 63.1 t -104.08 113.43 40.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.419 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.08 105.65 2.8 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.268 -0.733 . . . . 0.37 111.268 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 2.46 110.768 -179.284 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.28 -0.328 . . . . 0.38 112.28 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.83 124.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.045 0.45 . . . . 0.51 110.741 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -116.38 154.95 29.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 1.07 110.536 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 43.7 mm -74.23 114.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.57 109.869 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -72.93 -58.71 4.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.946 -0.645 . . . . 0.42 112.512 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.8 p -152.98 161.36 42.63 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.215 -0.291 . . . . 1.26 110.215 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 41.2 mt -111.02 135.45 50.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.87 110.273 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.0 mmt -98.54 131.61 44.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 0.96 110.152 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -63.85 131.58 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.45 110.668 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.05 50.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.763 -0.732 . . . . 0.42 111.888 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.16 165.22 54.61 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.972 -0.632 . . . . 0.27 112.264 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.62 72.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.616 0.246 . . . . 0.53 111.089 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.42 -42.52 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.58 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.03 -17.91 65.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.54 . . . . 0.5 111.214 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.87 55.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 0.55 111.212 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.14 -75.98 0.46 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.515 -0.311 . . . . 0.55 110.755 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.35 -19.96 16.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.374 -0.917 . . . . 0.39 113.813 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -76.88 -27.72 55.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.568 0.684 . . . . 0.81 111.245 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.17 136.99 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.74 109.934 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.04 161.01 62.06 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.407 -0.36 . . . . 0.69 110.543 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.57 114.11 1.99 Allowed 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.266 1.977 . . . . 0.41 110.896 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.27 -20.07 5.33 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.603 -0.599 . . . . 0.37 111.603 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.45 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 92.2 m-20 -65.9 143.86 57.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.967 -0.383 . . . . 0.34 109.967 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 39.9 ttp -101.85 135.85 42.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.632 0.254 . . . . 1.93 110.334 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 52.7 mt -86.64 121.02 28.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 1.16 110.423 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.14 -77.88 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 1.07 110.269 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -114.58 129.43 56.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.636 -0.711 . . . . 0.92 110.404 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 321' ' ' LEU . 90.6 t -123.21 97.06 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.367 -0.605 . . . . 0.8 109.367 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.43 HD22 HG21 ' A' ' 331' ' ' ILE . 61.6 m-80 63.05 72.24 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.641 0.588 . . . . 1.71 111.315 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 21.1 m-20 73.92 -48.12 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.8 1.037 . . . . 1.11 113.8 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.44 125.6 32.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.253 0.549 . . . . 1.02 111.83 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -103.17 123.76 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.627 -0.715 . . . . 0.92 109.744 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.06 8.02 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.441 0.534 . . . . 0.4 112.441 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.16 -22.97 63.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.24 0.459 . . . . 1.21 112.24 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -123.82 37.65 4.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.802 0.334 . . . . 1.71 111.152 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.6 mtp -132.03 164.04 27.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.85 -0.426 . . . . 0.94 109.85 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 p -77.99 155.55 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.286 -0.264 . . . . 0.97 110.286 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 318' ' ' VAL . 93.6 m-20 -52.15 -46.18 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.6 111.086 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -61.28 -51.34 69.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 1.4 111.604 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 7.4 m-20 -64.77 -34.85 79.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.772 0.286 . . . . 0.88 111.772 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.8 81.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.4 110.943 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.5 t -79.47 -24.42 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.776 -0.369 . . . . 0.93 110.885 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 71.3 mtt180 -57.94 -48.63 79.38 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.437 -0.579 . . . . 1.08 109.437 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -73.36 -36.1 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.792 -0.64 . . . . 0.42 110.158 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 325' ' ' VAL . 20.9 tp -56.13 -51.23 68.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.066 -0.516 . . . . 0.78 110.881 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.486 ' HA ' HG11 ' B' ' 3' ' ' VAL . 16.6 mtp-105 -62.6 -34.4 76.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 2.1 110.93 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.75 -46.95 83.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.561 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.58 111.125 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 321' ' ' LEU . 30.8 t -68.74 -12.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.186 0.517 . . . . 0.46 110.951 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -84.6 -4.41 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.85 0.357 . . . . 0.44 110.696 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 176.45 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.16 110.132 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 112.89 24.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 1.31 110.964 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 167.01 169.74 30.99 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.67 -0.776 . . . . 0.66 112.452 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.71 123.13 11.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.62 2.213 . . . . 0.84 111.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . 0.43 HG21 HD22 ' A' ' 305' ' ' ASN . 66.3 mt -98.5 114.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.207 -0.451 . . . . 0.58 111.098 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.35 111.18 22.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 1.49 110.123 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.03 120.3 41.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.117 -0.492 . . . . 0.74 111.114 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -105.12 98.65 8.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.136 -0.69 . . . . 0.89 109.136 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.13 149.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.88 111.978 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -110.77 109.21 19.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.275 -0.875 . . . . 1.06 109.764 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.45 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.267 -0.873 . . . . 0.7 109.958 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 18.0 m95 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.425 -0.213 . . . . 0.5 110.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.741 -0.647 . . . . 1.0 109.924 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.975 -0.38 . . . . 1.7 109.975 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.0 mt -104.26 130.71 54.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.738 0.304 . . . . 1.03 111.232 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.6 mt -131.62 138.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 1.1 110.905 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.06 109.91 21.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.118 -0.697 . . . . 1.06 109.118 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.28 158.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.422 . . . . 0.77 111.519 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -123.91 129.35 50.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.893 -0.781 . . . . 1.19 108.893 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.41 141.39 46.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.72 111.862 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -82.21 107.93 15.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.7 110.628 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 94.0 mmm -93.86 22.48 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.87 110.905 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -94.74 -47.61 6.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.144 -0.688 . . . . 1.27 109.144 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -86.15 -27.7 24.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.288 -0.869 . . . . 1.23 109.55 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -108.76 135.31 50.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.93 109.806 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -102.63 -0.82 31.3 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.028 -0.269 . . . . 1.35 111.398 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -150.26 162.13 41.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.318 . . . . 0.82 110.956 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.3 mt -75.85 -50.96 13.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.43 109.541 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.23 49.54 4.41 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.659 -0.7 . . . . 0.14 112.589 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.6 pt -145.48 149.71 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.321 0.582 . . . . 0.55 111.722 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.36 121.53 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.57 108.871 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.0 mm -88.56 123.3 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.949 0.404 . . . . 0.44 110.623 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.33 113.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.358 -0.383 . . . . 0.5 110.246 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -85.72 103.79 2.78 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.728 -0.749 . . . . 0.37 111.81 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 109.612 -0.514 . . . . 2.46 109.612 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.55 -0.22 . . . . 0.38 112.55 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.34 129.4 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.102 0.477 . . . . 0.51 111.008 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -117.69 162.47 18.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 1.07 110.771 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.78 113.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.57 109.999 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.37 -65.09 2.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.42 112.478 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.87 152.73 45.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.759 0.314 . . . . 1.26 110.637 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.78 131.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.079 -0.51 . . . . 0.87 109.912 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -92.86 126.2 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.851 0.358 . . . . 0.96 110.642 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -65.3 128.43 35.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 1.45 109.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.21 -12.85 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.968 -0.634 . . . . 0.42 111.519 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.5 171.08 47.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.934 -0.65 . . . . 0.27 111.73 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.52 86.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.53 111.259 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.29 -34.2 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.58 111.039 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.67 -20.78 64.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 0.5 111.619 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.7 -6.58 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.457 -0.338 . . . . 0.55 111.057 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 15.0 t70 -90.97 -76.4 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.938 -0.393 . . . . 0.55 109.938 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.92 32.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.377 -0.916 . . . . 0.39 114.177 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.404 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 22.8 mtm180 -76.83 -34.99 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.571 0.685 . . . . 0.81 110.937 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.76 136.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.678 -0.49 . . . . 0.74 109.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.52 158.65 75.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.522 -0.308 . . . . 0.69 110.697 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.48 99.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.497 2.131 . . . . 0.41 111.434 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 141.66 -15.82 2.66 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.59 -0.604 . . . . 0.37 111.59 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.0 146.41 54.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.732 0.301 . . . . 0.34 110.321 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.3 ttt -99.88 135.27 41.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.266 -0.424 . . . . 1.93 110.75 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.1 mt -90.82 117.46 29.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.246 -0.434 . . . . 1.16 109.933 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.85 -62.83 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.163 0.506 . . . . 1.07 110.735 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -127.33 133.15 50.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.92 110.912 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.5 HG11 ' CD1' ' A' ' 321' ' ' LEU . 44.4 t -119.62 87.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.173 -0.467 . . . . 0.8 109.76 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.4 t30 62.96 82.97 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.786 . . . . 1.71 111.437 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 4.6 m-20 74.8 -59.78 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.427 -0.806 . . . . 1.11 113.11 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.0 m -64.34 124.91 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.589 . . . . 1.02 112.456 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.52 130.02 47.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.466 -0.788 . . . . 0.92 109.628 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.421 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 44.0 m-85 -106.89 15.99 24.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.944 0.349 . . . . 0.4 111.944 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -62.64 -32.8 73.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.122 0.415 . . . . 1.21 112.122 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -117.6 35.81 4.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.392 . . . . 1.71 111.209 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 312' ' ' MET . . . . . 0.421 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 95.3 mtp -123.09 167.67 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.02 -0.363 . . . . 0.94 110.02 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 38.9 p -75.96 154.59 35.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.447 -0.342 . . . . 0.97 110.133 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -58.37 -32.67 68.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.6 111.109 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -49.82 19.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.207 -0.452 . . . . 1.4 111.063 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.59 -35.16 77.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.257 -0.429 . . . . 0.88 110.974 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.4 73.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.018 -0.537 . . . . 0.4 111.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.53 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 4.0 t -73.5 -31.96 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.3 . . . . 0.93 110.811 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 78.7 mtt180 -55.45 -50.49 69.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.748 0.309 . . . . 1.08 110.339 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.88 -41.01 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.246 -0.433 . . . . 0.42 110.093 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.5 ' CD1' HG11 ' A' ' 304' ' ' VAL . 17.3 tp -52.5 -48.51 65.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.964 -0.562 . . . . 0.78 111.22 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 18.3 mtp-105 -62.42 -39.14 92.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.012 -0.54 . . . . 2.1 111.743 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 5.9 mm-40 -65.91 -34.6 78.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.87 110.439 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.3 mt -70.65 -43.93 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.557 . . . . 0.58 110.142 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 321' ' ' LEU . 47.8 t -70.78 -18.75 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.246 0.546 . . . . 0.46 110.507 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 56.5 m -87.05 4.77 40.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.037 0.446 . . . . 0.44 110.204 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.35 158.53 18.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 1.16 109.989 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.91 120.48 35.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.662 0.268 . . . . 1.31 111.066 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.59 169.09 19.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.655 -0.783 . . . . 0.66 112.0 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.05 125.4 10.88 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.913 2.408 . . . . 0.84 111.714 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 60.0 mt -100.36 117.69 45.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.282 -0.417 . . . . 0.58 110.922 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 m -90.97 102.23 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.49 110.093 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 24.7 mt -92.93 123.37 36.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.872 0.367 . . . . 0.74 111.886 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.4 m -107.3 99.23 8.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.543 -0.91 . . . . 0.89 108.543 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.68 155.71 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.88 112.194 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.72 111.06 21.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.227 -0.897 . . . . 1.06 109.829 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.311 -0.852 . . . . 0.7 110.144 -179.346 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 43.4 m95 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 110.665 -0.124 . . . . 0.5 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.679 -0.677 . . . . 1.0 110.003 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.673 0.273 . . . . 1.7 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.45 109.67 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.608 -0.516 . . . . 1.03 109.608 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.63 127.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.362 -0.381 . . . . 1.1 110.799 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -104.21 103.46 13.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 1.06 110.118 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.38 144.06 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.067 0.46 . . . . 0.77 111.276 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.3 t -114.5 113.68 24.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.087 -0.708 . . . . 1.19 109.087 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 24.0 mt -95.79 152.74 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.359 0.599 . . . . 0.72 112.038 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.29 122.18 34.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.84 . . . . 0.7 110.017 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 90.7 mmm -102.51 25.07 9.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.87 111.752 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -100.37 -45.38 5.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -92.95 11.43 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.385 0.612 . . . . 1.23 110.178 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.52 155.69 50.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 0.93 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -111.98 -11.94 13.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.627 0.251 . . . . 1.35 110.833 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' B' ' 3' ' ' VAL . 30.0 p90 -157.31 173.07 17.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.542 -0.299 . . . . 0.82 111.066 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.93 -50.95 13.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.584 . . . . 0.43 109.422 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.9 41.58 5.9 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.517 -0.765 . . . . 0.14 112.823 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.65 146.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.441 0.639 . . . . 0.55 111.767 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.04 115.44 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.0 -1.0 . . . . 1.57 108.704 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.6 mm -85.44 126.65 40.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.44 110.239 -179.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.76 115.84 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.5 110.326 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.32 113.79 4.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.868 -0.682 . . . . 0.37 111.73 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.909 0.385 . . . . 2.46 110.455 -179.837 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 112.116 -0.394 . . . . 0.38 112.116 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.0 pt -102.24 128.85 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.193 0.521 . . . . 0.51 110.809 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -118.19 163.97 15.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 1.07 111.12 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.3 mm -85.74 110.68 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.867 -0.606 . . . . 0.57 109.448 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.79 8.87 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.737 -0.744 . . . . 0.42 112.689 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 163.9 39.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.549 0.214 . . . . 1.26 110.579 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 32.8 mt -114.24 134.32 57.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.87 109.991 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.9 mmt -96.13 128.42 43.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.375 -0.375 . . . . 0.96 110.277 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.26 131.86 49.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.522 . . . . 1.45 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 101.49 -6.85 55.68 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.963 -0.637 . . . . 0.42 112.176 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.15 171.28 46.09 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.872 -0.68 . . . . 0.27 112.419 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.41 80.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.311 . . . . 0.53 111.057 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.89 -35.63 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.58 110.662 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.57 65.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.5 111.182 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -78.89 -16.61 56.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.55 111.069 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.59 -76.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.641 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.89 -18.35 26.62 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.481 -0.866 . . . . 0.39 114.199 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -69.2 -40.05 78.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.568 0.684 . . . . 0.81 111.468 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.3 137.09 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.739 -0.467 . . . . 0.74 109.739 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.87 159.05 68.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.504 -0.316 . . . . 0.69 110.616 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 118.75 5.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.358 2.039 . . . . 0.41 111.629 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 122.12 -19.72 8.18 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.469 -0.653 . . . . 0.37 111.469 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.424 ' CG ' ' HZ3' ' A' ' 337' ' ' LYS . 84.1 m-20 -65.46 145.49 56.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.656 0.265 . . . . 0.34 110.331 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.3 ttp -101.1 133.84 45.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.443 -0.344 . . . . 1.93 110.516 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.456 HD22 HG13 ' A' ' 335' ' ' VAL . 73.3 mt -88.46 130.19 35.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 1.16 110.205 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 71.4 mt -111.16 -76.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.199 0.523 . . . . 1.07 110.899 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -115.79 140.61 49.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.92 111.136 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.12 101.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.798 -0.637 . . . . 0.8 109.52 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 7.1 m120 62.3 68.16 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.064 -0.516 . . . . 1.71 111.428 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.93 -51.33 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.251 -0.886 . . . . 1.11 113.373 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.3 m -67.78 130.89 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.27 0.557 . . . . 1.02 111.528 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -105.56 135.61 46.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.421 -0.809 . . . . 0.92 109.767 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . 0.402 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 21.9 m-85 -106.2 11.01 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.951 0.352 . . . . 0.4 111.951 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.5 -32.47 71.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.233 0.457 . . . . 1.21 112.233 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -112.33 32.14 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.022 0.439 . . . . 1.71 111.002 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 312' ' ' MET . . . . . 0.402 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 86.5 mtp -123.81 163.72 20.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.181 -0.463 . . . . 0.94 110.371 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 75.5 p -74.39 156.6 36.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.97 110.274 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 318' ' ' VAL . 90.5 m-20 -55.5 -40.64 72.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.86 0.362 . . . . 0.6 110.483 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.0 m-20 -68.61 -51.47 42.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 1.4 111.28 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.425 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 28.6 m-20 -61.01 -36.8 80.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.88 111.684 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.28 -48.94 78.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.4 111.245 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 6.2 t -73.51 -31.87 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.93 110.771 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 93.1 mtt180 -55.48 -46.52 76.88 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.03 -0.359 . . . . 1.08 110.03 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.51 -38.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.42 110.276 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 325' ' ' VAL . 40.1 tp -54.61 -50.66 67.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.102 -0.499 . . . . 0.78 110.581 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 27.9 mtp-105 -61.34 -36.43 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.892 -0.595 . . . . 2.1 110.877 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.96 -46.69 89.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.491 . . . . 1.87 110.016 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.11 -41.71 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.788 -0.642 . . . . 0.58 110.878 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 321' ' ' LEU . 65.1 t -65.53 -15.92 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.282 0.563 . . . . 0.46 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 19.8 m -89.96 0.41 57.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.894 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.23 147.5 26.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 1.16 110.417 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.77 103.8 16.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.761 0.315 . . . . 1.31 111.148 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 176.86 -175.4 47.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.661 -0.78 . . . . 0.66 112.049 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.62 112.05 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.025 2.484 . . . . 0.84 112.077 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.81 121.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.58 110.389 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.34 103.17 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.904 -0.589 . . . . 1.49 110.243 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.8 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.74 111.217 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.6 m -96.78 97.42 9.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.763 -0.828 . . . . 0.89 108.763 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . 0.456 HG13 HD22 ' A' ' 301' ' ' LEU . 26.3 m -100.81 154.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.223 0.535 . . . . 0.88 112.228 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -111.56 110.6 21.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.172 -0.922 . . . . 1.06 109.54 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.424 ' HZ3' ' CG ' ' A' ' 299' ' ' ASP . 26.3 mtpp . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.083 -0.96 . . . . 0.7 110.129 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 120.587 0.232 . . . . 0.5 110.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 261' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.762 -0.637 . . . . 1.0 109.799 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.094 0.473 . . . . 1.7 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.35 115.35 28.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.877 -0.602 . . . . 1.03 110.134 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.88 130.94 74.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 1.1 111.132 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.7 m -104.62 102.66 12.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.704 -0.68 . . . . 1.06 109.434 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 332' ' ' SER . 21.5 m -90.42 152.38 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.77 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -113.5 125.15 53.89 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.317 -0.623 . . . . 1.19 109.317 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.33 136.97 52.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 0.72 111.791 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -90.94 117.3 29.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.855 . . . . 0.7 109.971 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.9 mmm -94.16 26.78 3.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.87 111.624 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -99.74 -50.42 4.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.538 -0.541 . . . . 1.27 109.538 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -81.83 -20.6 38.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.495 -0.775 . . . . 1.23 109.992 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -119.74 134.0 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.93 110.033 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -93.17 -8.5 42.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.499 0.555 . . . . 1.35 112.499 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -151.76 170.85 18.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.82 111.116 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.4 mt -78.67 -53.82 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.886 -0.597 . . . . 0.43 110.466 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.06 5.73 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.14 112.729 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.9 pt -135.14 152.23 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.525 0.678 . . . . 0.55 111.802 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.91 126.5 47.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.993 -1.003 . . . . 1.57 108.812 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.0 mm -96.34 114.92 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.65 -0.42 . . . . 0.44 110.461 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.6 t -110.53 106.42 20.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.205 -0.452 . . . . 0.5 110.153 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.96 120.71 5.3 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.734 -0.746 . . . . 0.37 111.813 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.982 -0.377 . . . . 2.46 109.982 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 111.981 -0.448 . . . . 0.38 111.981 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.9 pt -102.37 118.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.51 110.37 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.84 150.48 28.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.865 -0.607 . . . . 1.07 110.777 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.2 mm -76.51 115.5 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.271 -0.422 . . . . 0.57 110.001 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -69.89 -58.82 5.96 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.814 -0.708 . . . . 0.42 112.139 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.47 165.08 36.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.152 -0.314 . . . . 1.26 110.152 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.96 138.88 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.707 -0.479 . . . . 0.87 109.707 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 35.2 mmt -102.39 132.17 48.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.817 0.342 . . . . 0.96 110.675 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -70.07 108.25 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 1.45 110.451 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 136.06 -13.08 4.13 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.382 -0.687 . . . . 0.42 111.382 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.3 170.63 39.3 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.27 111.965 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.15 83.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.53 111.382 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.84 -33.34 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.58 111.132 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.56 -15.35 62.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.5 111.541 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.26 -20.09 25.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.288 -0.415 . . . . 0.55 110.942 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.4 -73.35 0.35 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.55 110.351 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.31 -20.56 30.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.48 -0.867 . . . . 0.39 113.57 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -73.37 -35.79 65.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.743 0.771 . . . . 0.81 111.048 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.86 137.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.591 -0.522 . . . . 0.74 109.591 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -135.83 158.65 73.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.44 -0.345 . . . . 0.69 110.369 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.34 112.69 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.505 2.137 . . . . 0.41 111.429 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.92 -21.09 5.02 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.101 -0.571 . . . . 0.37 111.94 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.86 146.67 54.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.758 0.313 . . . . 0.34 110.92 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 59.4 ttp -105.9 132.41 52.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.288 -0.414 . . . . 1.93 110.363 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.46 129.92 34.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.347 -0.388 . . . . 1.16 110.491 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 19.3 mt -104.78 -76.6 0.6 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 1.07 110.221 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -112.1 128.79 56.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.584 -0.734 . . . . 0.92 110.569 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.99 97.68 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.135 -0.484 . . . . 0.8 110.121 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 57.23 77.22 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.71 111.647 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 75.3 -52.83 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.763 1.023 . . . . 1.11 113.763 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.21 132.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.437 0.637 . . . . 1.02 112.349 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -105.67 132.53 51.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.577 -0.738 . . . . 0.92 109.586 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -99.53 3.7 45.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.845 0.313 . . . . 0.4 111.845 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.53 -22.57 65.26 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.654 0.242 . . . . 1.21 111.654 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -118.06 38.24 3.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.71 110.55 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -138.83 159.34 42.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.94 110.397 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 157.34 37.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.537 -0.301 . . . . 0.97 110.549 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.455 ' O ' HG21 ' A' ' 318' ' ' VAL . 83.1 m-20 -54.78 -48.17 73.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.35 -0.387 . . . . 0.6 111.179 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.21 -50.79 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.849 -0.614 . . . . 1.4 111.386 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -65.05 -33.79 76.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.88 111.469 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.07 83.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.319 -0.401 . . . . 0.4 111.307 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.598 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 2.3 t -71.97 -31.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.607 -0.437 . . . . 0.93 110.917 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -56.25 -54.57 43.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.891 0.377 . . . . 1.08 110.613 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.83 -36.4 77.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.42 110.526 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 325' ' ' VAL . 25.3 tp -56.03 -50.83 69.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.78 110.817 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 30.8 mtp180 -63.74 -31.96 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.745 -0.661 . . . . 2.1 111.292 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -66.13 -45.17 82.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.029 0.442 . . . . 1.87 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.0 mt -67.08 -41.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.899 -0.591 . . . . 0.58 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 321' ' ' LEU . 99.0 t -66.77 -19.48 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.159 0.504 . . . . 0.46 110.992 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 55.3 m -87.25 -5.62 58.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.809 0.337 . . . . 0.44 110.406 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.6 133.69 41.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 1.16 110.393 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.97 130.43 39.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.176 -0.465 . . . . 1.31 110.656 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 146.86 -174.57 26.64 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.83 -0.7 . . . . 0.66 112.286 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 127.67 8.12 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.079 2.519 . . . . 0.84 112.129 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.69 123.92 71.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.103 -0.499 . . . . 0.58 110.564 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 332' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.9 OUTLIER -105.59 117.25 33.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.825 -0.625 . . . . 1.49 110.335 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 78.3 mt -102.05 120.8 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.07 -0.513 . . . . 0.74 111.002 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.1 m -100.54 103.91 15.25 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.336 -0.616 . . . . 0.89 109.336 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.33 145.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.88 112.023 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -94.79 92.95 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.526 -0.761 . . . . 1.06 109.316 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.49 -0.766 . . . . 0.7 111.196 -178.447 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 110.162 -0.311 . . . . 0.5 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.73 -0.653 . . . . 1.0 110.012 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.991 0.424 . . . . 1.7 110.284 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.34 121.4 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.907 -0.588 . . . . 1.03 110.727 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.9 127.11 67.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.477 -0.328 . . . . 1.1 111.221 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 86.8 m -103.63 118.9 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.157 -0.683 . . . . 1.06 109.157 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.48 143.4 22.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 0.77 111.399 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 t -101.33 137.85 39.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.046 -1.094 . . . . 1.19 108.046 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 85.7 mt -119.15 131.24 55.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.107 0.479 . . . . 0.72 111.668 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.07 108.32 13.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.437 -0.801 . . . . 0.7 110.353 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 95.4 mmm -96.0 13.92 25.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.87 110.981 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -85.27 -40.7 16.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 1.27 109.941 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -93.88 -17.13 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.434 0.635 . . . . 1.23 109.898 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -108.01 161.45 14.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.714 -0.676 . . . . 0.93 110.108 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -124.87 -0.66 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.839 -0.344 . . . . 1.35 111.515 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -159.71 164.04 34.25 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.571 -0.286 . . . . 0.82 110.918 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.39 -49.22 15.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.863 -0.608 . . . . 0.43 109.711 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 81.27 50.85 4.92 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.68 -0.691 . . . . 0.14 112.339 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.56 146.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.517 0.675 . . . . 0.55 111.767 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.29 120.25 38.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.974 . . . . 1.57 108.761 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.3 mm -88.33 127.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.567 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.81 115.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.331 -0.395 . . . . 0.5 110.714 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.63 111.62 4.29 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.201 -0.759 . . . . 0.37 111.201 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.46 110.215 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.354 -0.298 . . . . 0.38 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.86 123.34 58.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.365 0.602 . . . . 0.51 110.601 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.0 159.43 19.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.611 -0.722 . . . . 1.07 110.681 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.62 108.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.379 -0.6 . . . . 0.57 109.379 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -68.57 -58.34 7.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.063 -0.589 . . . . 0.42 112.71 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.63 156.22 39.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.673 0.273 . . . . 1.26 110.545 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.23 134.8 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.87 109.915 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 31.3 mmt -96.38 125.06 40.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.337 -0.392 . . . . 0.96 110.166 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.93 120.75 11.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 1.45 110.364 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.82 -12.56 13.29 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.813 -0.708 . . . . 0.42 111.635 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.48 171.66 47.87 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.712 -0.756 . . . . 0.27 111.641 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.47 80.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.836 0.351 . . . . 0.53 111.382 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.41 -35.12 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.58 110.806 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.58 -11.1 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.5 111.958 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -97.19 -5.43 37.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.775 0.322 . . . . 0.55 110.94 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -95.82 -73.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.55 110.04 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.7 -11.54 42.11 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.556 -0.831 . . . . 0.39 114.174 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -81.2 -29.01 34.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.962 0.881 . . . . 0.81 111.289 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.38 138.06 19.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.603 -0.518 . . . . 0.74 109.603 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.19 158.88 71.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.333 -0.247 . . . . 0.69 110.333 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.3 Cg_exo -59.3 114.07 1.87 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.385 2.057 . . . . 0.41 111.455 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.81 -21.36 5.01 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.995 -0.548 . . . . 0.37 111.954 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -70.2 148.03 49.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.611 0.243 . . . . 0.34 110.425 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 57.6 ttp -105.36 139.67 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 1.93 111.05 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.0 mt -87.16 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.377 -0.374 . . . . 1.16 110.51 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.16 -68.29 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.07 110.732 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 306' ' ' ASP . 7.7 tt0 -119.65 133.89 55.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.92 110.258 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 307' ' ' VAL . 69.5 t -127.91 116.15 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.187 -0.461 . . . . 0.8 110.935 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 1.1 m-20 50.73 46.61 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.876 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 25.6 m-20 81.27 -13.66 0.89 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.73 1.011 . . . . 1.11 113.73 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 304' ' ' VAL . 2.5 m -90.41 137.01 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.938 -0.705 . . . . 1.02 109.988 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -98.03 134.62 40.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.92 111.649 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.18 -0.34 14.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.4 110.989 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.6 -24.72 64.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.451 0.538 . . . . 1.21 112.451 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -125.71 53.95 1.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.115 0.484 . . . . 1.71 111.407 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 94.6 mtp -142.98 169.02 18.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.138 -0.483 . . . . 0.94 110.139 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.3 p -79.1 159.07 27.66 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.767 -0.457 . . . . 0.97 109.767 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.503 ' O ' HG23 ' A' ' 318' ' ' VAL . 94.1 m-20 -58.05 -42.62 85.82 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.199 0.523 . . . . 0.6 110.217 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -64.87 -55.13 21.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.209 -0.905 . . . . 1.4 111.263 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -58.58 -37.31 75.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.392 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.92 63.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.4 111.692 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -70.4 -30.74 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.839 -0.344 . . . . 0.93 110.97 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 75.4 mtt180 -57.64 -49.93 74.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.023 0.44 . . . . 1.08 110.182 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.63 -39.57 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.539 . . . . 0.42 110.128 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.505 ' O ' HG21 ' A' ' 325' ' ' VAL . 23.5 tp -56.27 -52.28 65.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.78 110.501 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.472 ' HA ' HG13 ' B' ' 3' ' ' VAL . 70.6 mtp180 -62.3 -36.33 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.759 -0.655 . . . . 2.1 111.014 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -46.12 87.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.389 -0.369 . . . . 1.87 110.153 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.84 -42.38 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.228 -0.442 . . . . 0.58 110.97 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 321' ' ' LEU . 60.3 t -67.18 -17.02 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 0.46 110.948 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.4 m -86.57 3.79 42.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.44 110.727 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 171.62 7.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.16 110.643 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 138.6 37.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.42 -0.355 . . . . 1.31 111.209 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 132.15 169.42 12.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.699 -0.762 . . . . 0.66 112.312 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.7 140.25 42.45 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.758 2.306 . . . . 0.84 112.118 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 69.2 mt -114.31 128.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.35 -0.386 . . . . 0.58 110.859 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.6 p -101.71 120.24 40.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.012 -0.54 . . . . 1.49 110.003 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.4 mt -113.12 118.74 35.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.385 -0.37 . . . . 0.74 111.53 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 85.6 m -101.94 109.62 21.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.379 -0.6 . . . . 0.89 109.379 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.28 155.16 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.34 0.59 . . . . 0.88 112.126 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -107.39 103.36 12.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.202 -0.908 . . . . 1.06 109.336 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.559 -0.734 . . . . 0.7 110.617 -179.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 120.404 0.145 . . . . 0.5 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.92 -0.4 . . . . 1.7 109.92 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.9 mt -122.84 129.73 74.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.83 0.348 . . . . 1.03 110.536 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.09 125.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.369 -0.378 . . . . 1.1 110.829 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 61.2 m -111.8 111.59 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.29 -0.633 . . . . 1.06 109.29 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.44 153.6 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.77 111.494 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.4 t -106.01 133.69 50.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 1.19 109.472 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.5 mt -109.26 132.37 54.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.026 0.441 . . . . 0.72 111.159 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.93 114.21 9.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.7 109.998 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.5 mmm -96.57 21.36 9.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.87 111.203 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -93.39 -50.3 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.224 0.535 . . . . 1.27 109.668 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -83.49 -16.92 43.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.66 . . . . 1.23 110.428 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -119.97 135.62 54.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.071 -0.714 . . . . 0.93 109.071 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -101.97 5.76 40.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.138 0.421 . . . . 1.35 112.138 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.54 166.01 31.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.651 0.263 . . . . 0.82 110.725 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.4 -52.61 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.43 109.843 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.73 42.85 5.3 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.995 -0.622 . . . . 0.14 112.56 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.0 pt -143.54 149.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.54 . . . . 0.55 111.635 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.548 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 0.3 OUTLIER -98.22 131.92 44.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 1.57 109.343 178.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.8 104.42 15.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.937 0.399 . . . . 0.44 110.673 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 90.5 t -92.32 108.31 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.884 -0.598 . . . . 0.5 110.157 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.0 106.95 3.48 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.834 -0.698 . . . . 0.37 111.994 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.249 0.547 . . . . 2.46 110.386 -179.552 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 N-CA-C 112.112 -0.395 . . . . 0.38 112.112 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.2 pt -106.12 129.14 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.218 0.532 . . . . 0.51 111.272 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -119.47 160.15 22.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.725 -0.671 . . . . 1.07 110.676 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.15 116.03 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.708 -0.678 . . . . 0.57 109.399 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -75.46 -74.47 0.9 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.42 112.44 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 152.51 50.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.221 -0.289 . . . . 1.26 110.221 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.12 128.3 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.87 110.459 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -95.04 127.24 40.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.989 -0.55 . . . . 0.96 111.032 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -64.25 128.45 35.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.45 110.161 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.34 12.91 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.16 -0.776 . . . . 0.42 111.16 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.24 166.94 51.88 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.776 -0.726 . . . . 0.27 111.926 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.84 -32.33 73.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.738 0.304 . . . . 0.53 111.509 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.22 -40.8 80.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.321 -0.4 . . . . 0.58 110.953 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.42 -13.06 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.208 -0.451 . . . . 0.5 111.081 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.34 -11.04 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.55 111.148 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 30.6 t70 -96.33 -69.89 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.393 -0.367 . . . . 0.55 110.514 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.3 -13.04 40.17 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.284 -0.96 . . . . 0.39 114.823 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.484 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 19.9 mtm180 -81.1 -33.19 33.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.342 1.071 . . . . 0.81 111.143 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.7 mt -80.43 138.42 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.285 -0.635 . . . . 0.74 109.285 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.48 162.01 49.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.351 0.119 . . . . 0.69 110.929 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 50.4 Cg_exo -56.97 118.38 5.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.335 2.023 . . . . 0.41 111.549 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.74 -26.12 5.73 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.743 -0.742 . . . . 0.37 112.119 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 87.4 m-20 -62.06 145.75 52.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.799 0.333 . . . . 0.34 110.471 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.4 ttp -103.04 135.96 43.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 1.93 110.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.1 121.4 30.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.861 -0.422 . . . . 1.16 109.861 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.01 -68.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.327 0.584 . . . . 1.07 110.07 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.53 136.32 54.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.414 -0.812 . . . . 0.92 110.768 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.461 HG13 ' CD1' ' A' ' 321' ' ' LEU . 79.5 t -128.73 107.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.427 -0.583 . . . . 0.8 109.427 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 0.9 OUTLIER 58.32 62.97 1.84 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.072 -0.513 . . . . 1.71 111.286 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 7.7 m-20 76.51 -44.02 0.47 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.94 1.089 . . . . 1.11 113.94 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 304' ' ' VAL . 35.9 m -71.59 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.265 0.555 . . . . 1.02 111.289 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 310' ' ' GLU . 52.5 t30 -105.02 128.7 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.92 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -101.11 2.86 40.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.409 -0.36 . . . . 0.4 111.712 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 308' ' ' ASN . 2.8 mt-10 -49.29 -41.69 38.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.853 0.686 . . . . 1.21 112.853 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -112.8 39.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.331 . . . . 1.71 111.299 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -121.93 179.67 4.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.761 0.315 . . . . 0.94 110.681 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 89.9 p -88.71 155.66 19.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.805 -0.443 . . . . 0.97 109.805 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 318' ' ' VAL . 97.2 m-20 -58.05 -41.14 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 0.6 110.973 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -50.92 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 1.4 111.802 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.41 -32.52 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.88 111.762 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.23 77.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.337 . . . . 0.4 110.863 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.8 t -73.58 -31.03 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.93 110.657 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.22 -51.67 65.84 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.502 . . . . 1.08 110.314 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.89 -39.74 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.42 110.37 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.461 ' CD1' HG13 ' A' ' 304' ' ' VAL . 25.5 tp -56.1 -52.53 63.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.78 110.95 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' B' ' 3' ' ' VAL . 47.4 mtp180 -62.21 -37.94 87.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 2.1 110.991 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.65 -45.28 94.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.665 0.269 . . . . 1.87 110.421 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.53 -42.79 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.58 110.537 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 321' ' ' LEU . 41.6 t -71.15 -9.92 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.279 0.562 . . . . 0.46 111.043 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -90.21 -9.26 48.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.95 0.405 . . . . 0.44 110.76 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.43 159.48 15.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 1.16 110.618 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.23 116.49 29.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.331 -0.395 . . . . 1.31 110.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 166.05 169.82 30.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.82 -0.705 . . . . 0.66 111.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.05 118.96 5.88 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.603 2.202 . . . . 0.84 111.664 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.22 119.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.032 -0.531 . . . . 0.58 110.954 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 m -97.59 112.17 24.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.797 -0.638 . . . . 1.49 110.022 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 251' ' ' THR . 96.6 mt -101.3 121.47 41.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.74 111.819 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 99.4 m -106.26 100.04 9.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.89 108.618 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.3 m -101.95 156.56 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.323 0.583 . . . . 0.88 112.335 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.4 113.29 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 1.06 109.459 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.5 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.324 -0.846 . . . . 0.7 109.969 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.548 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 30.1 m95 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 110.672 -0.121 . . . . 0.5 110.672 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.594 -0.717 . . . . 1.0 109.697 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.948 -0.39 . . . . 1.7 109.948 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.71 124.44 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 1.03 111.335 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 41.3 mt -120.88 133.22 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.146 -0.479 . . . . 1.1 110.19 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 m -107.36 109.8 21.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.091 -0.504 . . . . 1.06 109.924 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.19 152.61 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.862 0.363 . . . . 0.77 111.101 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 8.8 t -117.91 131.08 56.56 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.94 -0.763 . . . . 1.19 108.94 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.77 140.53 39.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 0.72 111.872 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.43 119.89 25.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.7 110.077 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 83.4 mmm -101.0 17.74 21.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.963 0.411 . . . . 0.87 111.33 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -88.35 -50.13 6.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.679 -0.489 . . . . 1.27 109.679 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -93.58 11.77 27.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.441 0.639 . . . . 1.23 109.922 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -133.28 159.0 41.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.93 108.964 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -128.66 0.63 5.49 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.575 -0.45 . . . . 1.35 111.615 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.84 165.5 25.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.603 0.24 . . . . 0.82 110.593 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.36 -54.77 6.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.096 -0.502 . . . . 0.43 109.757 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.1 44.1 5.46 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.894 -0.594 . . . . 0.14 112.269 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.9 pt -143.29 150.4 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.536 . . . . 0.55 111.947 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.545 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.0 OUTLIER -100.21 132.89 45.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.231 -0.895 . . . . 1.57 109.011 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.9 mm -98.99 117.7 44.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.965 0.412 . . . . 0.44 110.469 -179.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.94 106.64 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.456 -0.338 . . . . 0.5 110.536 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.12 118.15 4.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.37 111.732 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 2.46 110.431 -179.679 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 N-CA-C 111.902 -0.479 . . . . 0.38 111.902 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.5 pt -107.72 117.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.154 0.502 . . . . 0.51 110.308 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -108.08 151.11 26.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.777 -0.647 . . . . 1.07 111.152 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.83 117.63 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.222 -0.444 . . . . 0.57 110.045 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -72.63 -64.27 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.166 -0.54 . . . . 0.42 112.146 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.9 m -149.56 161.37 42.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.843 -0.429 . . . . 1.26 109.843 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 57.2 mt -112.49 128.77 68.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.011 0.434 . . . . 0.87 111.166 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.9 mmt -87.31 119.15 27.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.688 -0.687 . . . . 0.96 110.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -62.56 117.61 6.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 1.45 110.142 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 126.14 -18.69 6.53 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.131 -0.788 . . . . 0.42 111.131 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.39 175.0 53.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.972 -0.632 . . . . 0.27 111.995 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.23 86.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.799 0.333 . . . . 0.53 111.341 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.94 -37.08 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.58 111.368 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.3 66.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.083 -0.508 . . . . 0.5 111.88 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.28 -14.66 40.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.55 111.197 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.04 -74.57 0.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.441 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.86 -9.89 37.46 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.483 -0.865 . . . . 0.39 114.42 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -88.34 -35.21 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.044 0.922 . . . . 0.81 110.348 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 29.8 mt -81.81 138.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.046 -0.724 . . . . 0.74 109.046 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.6 162.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.607 -0.27 . . . . 0.69 110.755 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 52.2 Cg_exo -55.76 117.47 4.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.598 2.199 . . . . 0.41 111.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.56 -24.9 6.05 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.209 -0.757 . . . . 0.37 111.209 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.66 135.44 55.91 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.712 -0.477 . . . . 0.34 109.712 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 46.3 ttp -97.4 130.86 44.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.728 0.299 . . . . 1.93 110.815 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.8 mt -80.51 125.44 29.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 1.16 110.276 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . 0.426 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 40.2 mt -105.41 -71.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.19 0.519 . . . . 1.07 110.442 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.07 133.68 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.773 -0.649 . . . . 0.92 110.963 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.07 104.16 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.023 -0.535 . . . . 0.8 110.141 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.45 69.11 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 1.71 111.662 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 74.39 -44.68 0.56 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 1.11 114.103 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.0 m -76.87 127.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.606 0.717 . . . . 1.02 111.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -97.4 130.64 44.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.249 -0.887 . . . . 0.92 110.299 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -100.81 2.35 41.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.794 0.294 . . . . 0.4 111.794 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.08 -27.71 63.9 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.17 0.433 . . . . 1.21 112.17 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -109.22 20.3 18.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.7 0.259 . . . . 1.71 111.7 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.0 mtp -118.41 166.54 12.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.94 111.049 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 10.7 p -75.48 162.63 28.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.97 110.355 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 318' ' ' VAL . 52.5 m-20 -60.97 -43.49 98.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.6 110.697 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.53 -56.71 13.87 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.957 -0.565 . . . . 1.4 111.215 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 8.8 m-20 -58.78 -36.25 74.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.88 112.346 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.3 -47.73 80.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.4 111.374 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -73.63 -31.52 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.458 -0.337 . . . . 0.93 111.095 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 88.5 mtt180 -56.9 -46.92 81.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.86 0.362 . . . . 1.08 110.145 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.29 -38.2 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.42 110.114 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.48 ' O ' HG21 ' A' ' 325' ' ' VAL . 37.4 tp -58.32 -51.36 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.78 110.763 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.484 ' HA ' HG11 ' B' ' 3' ' ' VAL . 52.2 mtp180 -61.59 -31.94 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.1 110.706 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.78 -51.29 50.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.465 . . . . 1.87 109.743 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.42 -42.76 88.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.986 -0.552 . . . . 0.58 111.344 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 321' ' ' LEU . 61.6 t -69.12 -13.89 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.072 0.463 . . . . 0.46 111.256 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 75.2 m -87.45 -6.61 58.34 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.148 -0.345 . . . . 0.44 110.538 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.41 139.55 31.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.215 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.62 91.34 4.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.115 0.484 . . . . 1.31 111.693 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.27 172.52 44.89 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.829 -0.7 . . . . 0.66 111.694 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.37 143.94 44.51 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.498 2.132 . . . . 0.84 111.893 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 42.3 mt -122.16 125.59 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.915 0.388 . . . . 0.58 111.496 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m -107.07 120.99 43.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.119 -0.697 . . . . 1.49 109.119 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.6 mt -106.39 129.2 54.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.336 0.588 . . . . 0.74 111.903 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.09 97.3 6.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.491 -0.929 . . . . 0.89 108.491 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.99 152.34 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.398 0.618 . . . . 0.88 112.418 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 302' ' ' LEU . . . -111.15 106.79 15.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.924 . . . . 1.06 109.404 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.312 -0.852 . . . . 0.7 110.103 -179.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.545 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 21.5 m95 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 110.15 -0.315 . . . . 0.5 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.489 -0.767 . . . . 1.0 110.464 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.713 0.292 . . . . 1.7 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.2 mt -91.34 111.34 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.414 . . . . 1.03 110.496 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.29 131.94 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.007 -0.542 . . . . 1.1 110.053 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 5.0 m -121.35 105.46 10.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.036 0.446 . . . . 1.06 110.492 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.54 157.89 6.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.105 -0.498 . . . . 0.77 111.051 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.0 t -109.7 122.55 47.73 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.525 -0.546 . . . . 1.19 109.525 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 53.1 mt -94.48 120.69 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.18 -0.464 . . . . 0.72 111.158 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.51 115.39 18.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.7 110.315 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 85.2 mmm -98.12 19.12 14.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.87 111.039 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -88.66 -52.18 5.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 1.27 109.784 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -92.02 2.03 56.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 1.23 110.001 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -127.71 148.41 50.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.968 -0.56 . . . . 0.93 110.333 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.91 -8.19 14.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.367 -0.379 . . . . 1.35 111.504 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.74 169.51 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.755 0.312 . . . . 0.82 111.194 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -51.63 11.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.365 -0.605 . . . . 0.43 109.365 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.21 39.28 6.45 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.58 -0.736 . . . . 0.14 112.531 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.7 pt -142.31 149.75 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.309 0.575 . . . . 0.55 111.507 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 23.3 p -105.26 129.29 53.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.32 -0.855 . . . . 1.57 108.892 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.0 mm -89.43 127.01 42.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.786 0.327 . . . . 0.44 110.524 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 79.3 t -115.57 109.82 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.396 . . . . 0.5 110.129 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.14 145.71 18.69 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.757 -0.735 . . . . 0.37 111.933 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.895 0.379 . . . . 2.46 110.828 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 112.277 -0.329 . . . . 0.38 112.277 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.7 pt -110.78 132.88 58.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 0.51 110.552 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 163.79 16.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.534 . . . . 1.07 110.785 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.8 mm -84.04 119.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.57 109.786 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -83.69 -66.28 1.51 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.867 -0.682 . . . . 0.42 112.835 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.3 p -137.93 153.38 49.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.729 0.3 . . . . 1.26 110.959 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 70.8 mt -112.78 133.58 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.87 109.815 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.8 mmt -98.01 127.08 43.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.96 110.848 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.17 117.75 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 1.45 110.459 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.86 -16.6 8.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.821 -0.704 . . . . 0.42 111.946 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.22 168.4 53.12 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.837 -0.696 . . . . 0.27 112.021 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.72 76.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.53 111.301 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.4 -37.43 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.967 -0.56 . . . . 0.58 111.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.28 62.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.5 111.614 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -81.3 -27.88 34.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.342 -0.39 . . . . 0.55 110.939 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.29 -71.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.36 -0.382 . . . . 0.55 110.054 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.08 27.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.083 -1.056 . . . . 0.39 114.168 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -76.26 -23.93 54.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.475 0.637 . . . . 0.81 111.002 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 37.0 mt -88.52 130.06 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.427 -0.583 . . . . 0.74 109.427 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.06 162.64 47.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.725 -0.216 . . . . 0.69 110.553 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 129.75 36.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.322 2.015 . . . . 0.41 111.202 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.55 -17.5 28.23 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.533 -0.841 . . . . 0.37 111.83 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 337' ' ' LYS . 73.6 m-20 -70.55 141.58 51.86 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.702 -0.481 . . . . 0.34 109.702 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 41.0 ttp -98.97 132.62 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.451 -0.341 . . . . 1.93 111.093 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . 0.473 HD21 HG13 ' A' ' 335' ' ' VAL . 94.4 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.16 110.058 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.1 -60.72 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.537 -0.302 . . . . 1.07 111.281 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -126.91 135.33 50.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.386 -0.37 . . . . 0.92 111.076 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.7 92.26 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.376 -0.374 . . . . 0.8 110.305 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.38 79.31 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.835 -0.62 . . . . 1.71 111.312 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.67 -57.43 0.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.978 -1.01 . . . . 1.11 113.416 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.17 130.76 28.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.412 0.625 . . . . 1.02 111.641 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -108.02 135.2 49.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.53 -0.759 . . . . 0.92 111.137 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -113.85 18.7 17.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.4 111.187 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.16 -36.56 75.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.584 -0.28 . . . . 1.21 111.662 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.98 49.28 1.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.26 0.552 . . . . 1.71 110.523 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.81 152.95 48.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.94 110.435 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 155.56 40.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 0.97 110.522 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -49.19 -50.82 36.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.008 0.433 . . . . 0.6 111.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.62 -53.14 61.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.483 -0.781 . . . . 1.4 111.206 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.8 m-20 -56.3 -40.57 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.882 -0.599 . . . . 0.88 111.714 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.83 81.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.141 -0.481 . . . . 0.4 111.392 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.478 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.9 t -78.04 -29.19 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.9 -0.32 . . . . 0.93 111.176 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 81.2 mtt180 -55.17 -49.99 70.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 1.08 110.286 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.11 -36.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.093 -0.503 . . . . 0.42 110.655 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 19.6 tp -54.68 -48.29 72.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.995 -0.548 . . . . 0.78 111.801 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.504 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.5 mtp180 -64.48 -30.24 71.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.238 -0.437 . . . . 2.1 111.713 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 9.3 mm-40 -68.76 -39.38 80.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.087 0.47 . . . . 1.87 109.916 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 62.0 mt -71.13 -43.42 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.837 -0.619 . . . . 0.58 111.085 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.466 HG11 ' HB ' ' B' ' 3' ' ' VAL . 63.7 t -66.65 -19.04 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.169 0.509 . . . . 0.46 111.432 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.4 m -87.64 10.98 16.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.99 0.424 . . . . 0.44 110.853 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.64 152.41 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.377 . . . . 1.16 110.28 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.89 101.06 13.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 1.31 111.635 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.98 39.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.954 -0.641 . . . . 0.66 111.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.5 124.93 11.23 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.327 2.018 . . . . 0.84 112.152 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 78.8 mt -104.74 118.65 52.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.58 110.78 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.19 113.18 25.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.998 -0.546 . . . . 1.49 110.641 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 251' ' ' THR . 11.5 mt -96.4 119.39 34.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.159 -0.473 . . . . 0.74 111.194 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 93.68 5.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.89 108.635 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . 0.473 HG13 HD21 ' A' ' 301' ' ' LEU . 21.7 m -97.66 152.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.88 112.278 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.03 95.92 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.399 -0.819 . . . . 1.06 109.078 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HZ3' ' CG ' ' A' ' 299' ' ' ASP . 30.0 mtpp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.285 -0.864 . . . . 0.7 110.256 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 25.0 m95 . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 110.089 -0.337 . . . . 0.5 110.089 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.559 -0.734 . . . . 1.0 110.436 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.831 0.348 . . . . 1.7 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 70.7 mt -93.1 119.38 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 1.03 109.868 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.47 137.71 51.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.202 -0.453 . . . . 1.1 111.264 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.23 122.97 48.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.855 -0.612 . . . . 1.06 110.115 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.39 143.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.776 0.322 . . . . 0.77 111.019 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.43 107.4 18.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 1.19 110.014 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.16 145.18 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 0.72 111.658 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -99.73 117.95 35.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.794 . . . . 0.7 110.078 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.7 mmm -98.75 26.25 5.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.258 -0.428 . . . . 0.87 111.396 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.99 -53.69 3.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 1.27 109.723 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -83.12 -17.4 43.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.554 -0.748 . . . . 1.23 109.822 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -112.28 145.95 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.832 -0.622 . . . . 0.93 109.959 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -111.12 3.23 18.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.683 -0.235 . . . . 1.35 111.616 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -160.03 165.1 32.55 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.746 0.307 . . . . 0.82 110.734 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.43 110.0 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.96 4.26 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.791 -0.641 . . . . 0.14 112.843 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.41 151.65 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.51 0.671 . . . . 0.55 112.073 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.74 119.56 38.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.885 -1.052 . . . . 1.57 109.217 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mm -88.34 107.9 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.892 0.377 . . . . 0.44 110.717 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.86 114.2 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.19 -0.459 . . . . 0.5 110.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.66 113.36 4.46 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.782 -0.723 . . . . 0.37 111.92 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.193 0.521 . . . . 2.46 110.626 -179.753 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.791 0 N-CA-C 111.637 -0.585 . . . . 0.38 111.637 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.7 pt -103.59 123.9 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.51 110.565 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 157.05 22.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.704 . . . . 1.07 110.9 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.7 mm -78.28 114.13 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.641 -0.709 . . . . 0.57 109.974 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.91 -57.72 3.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.881 -0.676 . . . . 0.42 112.416 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.9 153.81 35.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.243 -0.281 . . . . 1.26 110.243 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.3 mt -108.88 130.18 62.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.87 110.157 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 39.3 mmt -93.85 122.72 36.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.362 -0.381 . . . . 0.96 110.93 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -61.84 120.21 10.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 1.45 109.764 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.64 -16.19 9.02 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.33 -0.708 . . . . 0.42 111.33 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.2 169.13 45.48 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.443 -0.663 . . . . 0.27 111.443 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.22 74.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.555 0.216 . . . . 0.53 111.546 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.87 -37.48 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.58 110.836 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.24 -13.28 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.5 111.249 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.16 -13.72 40.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.507 -0.315 . . . . 0.55 111.048 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.15 -70.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.55 110.534 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.44 42.14 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.386 -0.912 . . . . 0.39 114.276 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.16 -22.77 41.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.864 0.832 . . . . 0.81 111.387 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.97 137.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.226 -0.657 . . . . 0.74 109.226 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -140.86 163.34 43.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.752 -0.204 . . . . 0.69 110.864 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.32 121.58 10.3 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.216 1.944 . . . . 0.41 111.368 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.43 8.5 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.849 -0.691 . . . . 0.37 112.173 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.4 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 84.1 m-20 -61.4 139.65 58.16 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.34 110.498 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 36.3 ttp -101.12 130.45 47.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.524 -0.307 . . . . 1.93 110.429 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 31.6 mt -84.73 127.48 34.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.389 . . . . 1.16 110.154 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 62.4 mt -107.19 -73.55 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.236 0.541 . . . . 1.07 110.391 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -108.07 137.65 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.577 -0.738 . . . . 0.92 110.512 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.45 98.05 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.289 -0.634 . . . . 0.8 109.289 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.9 m120 59.97 71.94 0.55 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.666 -0.697 . . . . 1.71 111.464 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 76.69 -51.52 0.58 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.957 1.095 . . . . 1.11 113.957 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.93 131.66 34.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.571 0.582 . . . . 1.02 112.571 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -101.48 131.39 47.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.44 -0.8 . . . . 0.92 109.235 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.35 5.06 50.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.554 0.576 . . . . 0.4 112.554 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -64.44 -22.16 66.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 1.21 111.699 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -107.44 22.5 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.354 -0.384 . . . . 1.71 111.085 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.21 168.89 16.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 0.94 111.07 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.38 156.14 26.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.863 -0.608 . . . . 0.97 110.404 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -53.22 -50.19 65.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.451 -0.34 . . . . 0.6 111.819 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 10.9 t70 -60.77 -52.77 63.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 1.4 110.901 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.5 -35.56 70.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.933 -0.576 . . . . 0.88 111.123 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.4 111.417 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.416 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.8 t -70.78 -26.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.845 -0.342 . . . . 0.93 111.285 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 95.5 mtt180 -56.14 -52.36 64.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.631 -0.507 . . . . 1.08 109.631 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.33 -37.28 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.412 -0.813 . . . . 0.42 110.34 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.419 ' O ' HG21 ' A' ' 325' ' ' VAL . 13.5 tp -54.23 -52.82 60.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.78 110.725 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.46 ' HA ' HG11 ' B' ' 3' ' ' VAL . 33.7 mtp180 -64.03 -33.74 76.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 2.1 111.011 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.83 -41.23 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 1.87 110.412 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.8 mt -69.14 -43.04 81.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.937 -0.574 . . . . 0.58 110.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 321' ' ' LEU . 87.3 t -67.03 -21.98 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.068 0.461 . . . . 0.46 111.165 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -83.97 1.94 41.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.768 0.318 . . . . 0.44 110.954 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.7 141.01 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.16 110.269 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 115.13 21.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 1.31 111.659 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 169.18 -170.92 42.83 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.993 -0.622 . . . . 0.66 112.037 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.24 117.18 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.202 2.602 . . . . 0.84 111.806 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 64.8 mt -98.3 118.12 44.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.58 110.95 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.61 110.13 21.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 1.49 110.295 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.05 124.35 45.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.74 111.379 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.67 99.36 9.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.699 -0.852 . . . . 0.89 108.699 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.88 148.23 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.286 0.565 . . . . 0.88 112.232 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -105.12 102.79 12.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.33 -0.85 . . . . 1.06 109.966 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 28.2 mtpp . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.349 -0.834 . . . . 0.7 109.856 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.532 0.206 . . . . 0.5 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.853 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 43.2 t30 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.808 0.337 . . . . 1.7 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 91.9 mt -92.12 123.21 44.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 1.03 110.512 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.26 122.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.865 0.364 . . . . 1.1 111.074 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.35 120.35 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 1.06 110.104 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 24.8 m -125.49 144.98 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 0.77 111.785 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.0 t -110.99 120.94 44.05 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.582 -0.896 . . . . 1.19 108.582 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.81 135.55 44.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.083 0.468 . . . . 0.72 111.766 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.01 120.17 13.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.277 -0.874 . . . . 0.7 110.371 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 87.8 mmm -102.54 17.46 23.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.165 0.507 . . . . 0.87 110.895 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -88.65 -53.19 4.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.121 0.486 . . . . 1.27 109.801 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -80.48 -31.04 37.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.374 -0.83 . . . . 1.23 110.648 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -92.6 157.71 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.677 -0.49 . . . . 0.93 109.677 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -119.18 -7.76 10.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.915 0.388 . . . . 1.35 110.787 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -156.52 173.26 17.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.036 -0.529 . . . . 0.82 110.279 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.57 -52.93 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.43 110.029 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.55 46.27 4.37 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.975 -0.631 . . . . 0.14 112.809 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -145.86 149.58 16.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.113 0.483 . . . . 0.55 111.388 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 265' ' ' SER . . . . . 0.481 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 5.5 p -99.18 124.62 44.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.473 -0.785 . . . . 1.57 109.159 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.3 mm -89.23 111.02 22.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.04 0.448 . . . . 0.44 110.87 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.7 t -105.94 110.43 31.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.103 -0.498 . . . . 0.5 110.986 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.72 119.36 6.09 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.825 -0.702 . . . . 0.37 111.361 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 2.46 110.5 -179.677 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.989 0 N-CA-C 111.756 -0.538 . . . . 0.38 111.756 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.12 119.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.015 0.436 . . . . 0.51 110.147 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.61 159.54 17.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.783 -0.644 . . . . 1.07 111.18 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.99 112.61 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.564 -0.743 . . . . 0.57 109.397 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.18 -55.38 6.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.397 -0.906 . . . . 0.42 112.267 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.9 p -153.29 156.68 38.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.188 -0.301 . . . . 1.26 110.188 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 35.9 mt -106.71 135.73 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.201 -0.454 . . . . 0.87 110.131 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -97.55 134.65 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.224 -0.444 . . . . 0.96 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -70.25 135.84 49.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 1.45 110.006 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.76 -10.26 64.37 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.824 -0.703 . . . . 0.42 111.907 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.03 176.12 53.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.96 -0.638 . . . . 0.27 112.115 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.98 81.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.73 0.3 . . . . 0.53 111.094 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.3 -33.42 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.048 0.451 . . . . 0.58 111.283 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.13 -21.97 66.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.092 -0.504 . . . . 0.5 111.629 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -84.88 -15.01 46.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.359 -0.382 . . . . 0.55 111.419 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.34 -74.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.55 110.968 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.95 -15.94 47.33 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.604 -0.808 . . . . 0.39 114.085 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -80.29 -29.96 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.651 0.725 . . . . 0.81 110.945 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.8 mt -84.55 137.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.751 -0.462 . . . . 0.74 109.751 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -136.7 164.36 43.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.657 -0.247 . . . . 0.69 110.924 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.7 111.77 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.261 1.974 . . . . 0.41 110.615 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.81 -19.02 5.04 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.485 -0.646 . . . . 0.37 111.485 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 337' ' ' LYS . 95.4 m-20 -69.06 147.53 51.38 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.044 -0.354 . . . . 0.34 110.044 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 26.7 ttt -103.57 136.97 42.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.695 0.283 . . . . 1.93 110.811 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 19.5 mt -88.59 123.13 32.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 1.16 109.828 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.3 -77.66 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.168 0.509 . . . . 1.07 110.586 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -113.0 134.29 54.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.92 111.3 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.32 94.33 2.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.144 -0.48 . . . . 0.8 109.889 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 60.63 75.98 0.39 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.705 -0.68 . . . . 1.71 111.399 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 56.5 m-20 76.97 -61.44 0.43 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.903 0.881 . . . . 1.11 112.894 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m -63.36 125.89 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.627 0.727 . . . . 1.02 111.986 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.23 132.95 51.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.249 -0.887 . . . . 0.92 109.925 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -104.35 11.09 35.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.568 -0.287 . . . . 0.4 111.434 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.6 -38.54 66.89 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.952 0.406 . . . . 1.21 111.257 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -123.96 59.17 1.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 1.71 110.867 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 87.2 mtp -140.05 163.84 31.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.94 110.051 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.1 m -69.85 147.29 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.821 -0.437 . . . . 0.97 109.821 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -52.59 -47.07 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.744 0.306 . . . . 0.6 111.096 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -50.3 71.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.4 110.91 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.434 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 1.7 m-20 -61.1 -34.74 75.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.88 111.834 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.98 -49.09 78.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.117 -0.492 . . . . 0.4 111.1 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.76 -28.0 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.529 -0.305 . . . . 0.93 110.905 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 67.5 mtt180 -54.71 -52.04 63.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 1.08 110.571 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 15.4 t -70.42 -39.58 76.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.42 110.618 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 325' ' ' VAL . 21.7 tp -54.26 -49.24 70.01 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.163 -0.471 . . . . 0.78 111.431 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.518 ' HA ' HG11 ' B' ' 3' ' ' VAL . 14.7 mtp-105 -60.9 -37.49 82.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 2.1 111.654 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.33 -38.02 88.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 1.87 110.779 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.36 -41.64 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.091 -0.504 . . . . 0.58 110.692 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 321' ' ' LEU . 40.5 t -69.83 -19.42 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.044 0.45 . . . . 0.46 111.075 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 22.6 m -91.08 2.01 56.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.053 0.454 . . . . 0.44 110.463 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -106.92 137.78 44.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.164 -0.471 . . . . 1.16 110.572 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.81 99.37 3.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 1.31 111.814 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.59 160.3 24.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.054 -0.593 . . . . 0.66 111.757 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.82 130.32 32.56 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.824 2.349 . . . . 0.84 112.229 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 76.3 mt -112.18 121.13 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.58 111.131 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.5 m -105.99 121.33 43.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.931 -0.577 . . . . 1.49 109.893 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 36.5 mt -104.08 126.71 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.019 -0.537 . . . . 0.74 111.297 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -106.18 98.65 8.31 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.336 -0.986 . . . . 0.89 108.336 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.12 151.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.414 0.626 . . . . 0.88 112.447 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.47 112.01 23.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.174 -0.921 . . . . 1.06 109.973 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 299' ' ' ASP . 25.6 mtpp . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.393 -0.813 . . . . 0.7 109.803 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 16.8 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.58 -0.156 . . . . 0.5 110.58 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.077 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.139 0.495 . . . . 1.7 109.976 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.7 mt -95.58 127.76 47.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.202 -0.453 . . . . 1.03 110.926 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.23 129.38 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.439 -0.346 . . . . 1.1 110.681 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 6.9 m -100.08 110.17 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.149 -0.686 . . . . 1.06 109.149 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.85 154.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.121 0.486 . . . . 0.77 111.385 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.3 t -122.44 126.24 47.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.998 -0.741 . . . . 1.19 108.998 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' LEU . . . . . 0.419 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 66.7 mt -114.21 149.16 36.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.72 111.492 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.8 120.09 34.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.589 -0.732 . . . . 0.7 110.116 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 99.8 mmm -101.1 16.99 23.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.11 0.481 . . . . 0.87 111.223 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.217 -0.66 . . . . 1.27 109.217 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -91.65 -16.32 27.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.478 -0.783 . . . . 1.23 109.9 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -114.39 145.37 41.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.9 -0.591 . . . . 0.93 109.933 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -107.9 -7.94 16.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.742 0.306 . . . . 1.35 111.673 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -151.7 168.91 23.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.492 -0.322 . . . . 0.82 110.932 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.94 -55.17 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.43 109.637 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 91.24 43.79 4.56 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.726 -0.67 . . . . 0.14 112.331 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 8.1 pt -139.74 151.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.397 0.617 . . . . 0.55 111.736 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 t -103.1 128.51 49.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.841 -1.072 . . . . 1.57 108.795 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.54 113.87 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.989 0.423 . . . . 0.44 110.744 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.41 114.11 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.101 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.75 108.86 3.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.545 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.749 0.309 . . . . 2.46 110.328 -179.73 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.127 -0.389 . . . . 0.38 112.127 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -106.08 118.09 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.374 0.607 . . . . 0.51 110.629 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.0 152.73 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.743 -0.662 . . . . 1.07 110.94 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.13 113.36 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.466 . . . . 0.57 110.128 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.33 -60.05 3.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.877 -0.677 . . . . 0.42 112.33 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.07 160.96 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.54 0.209 . . . . 1.26 110.524 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.92 131.98 64.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.778 -0.453 . . . . 0.87 109.778 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.2 mmt -97.99 128.29 44.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.778 0.323 . . . . 0.96 110.759 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -66.45 132.89 49.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.45 110.308 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.86 -12.7 32.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.93 -0.653 . . . . 0.42 111.552 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -87.36 171.82 42.44 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.024 -0.608 . . . . 0.27 111.826 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 288' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.12 -36.65 83.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.53 111.518 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.76 -35.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.58 111.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.79 -14.09 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.5 111.91 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.71 -23.56 25.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 0.55 110.728 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 292' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 13.0 t70 -77.98 -68.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.55 110.215 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.46 -20.38 46.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.431 -0.89 . . . . 0.39 113.991 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 294' ' ' ARG . . . . . 0.417 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 72.7 mtm180 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.716 0.758 . . . . 0.81 110.927 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.1 mt -75.62 136.02 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.593 -0.521 . . . . 0.74 109.593 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.42 161.16 64.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.539 -0.3 . . . . 0.69 110.443 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.74 109.41 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.2 1.933 . . . . 0.41 111.041 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 131.86 -15.79 5.1 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.153 -0.546 . . . . 0.37 111.737 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -70.61 149.59 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.241 -0.281 . . . . 0.34 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 27.0 ttp -107.15 135.94 47.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.556 -0.293 . . . . 1.93 110.613 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 mt -89.3 119.22 29.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.135 -0.484 . . . . 1.16 109.829 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 67.2 mt -100.99 -64.33 1.06 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.084 0.469 . . . . 1.07 110.705 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 303' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 307' ' ' VAL . 5.1 tt0 -120.6 133.23 55.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.92 110.815 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 304' ' ' VAL . . . . . 0.425 ' O ' HG21 ' A' ' 307' ' ' VAL . 59.0 t -129.14 104.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.258 -0.428 . . . . 0.8 110.536 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 58.07 70.32 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 1.71 111.483 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.89 -44.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.994 1.109 . . . . 1.11 113.994 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 307' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 303' ' ' GLN . 32.2 m -74.15 139.22 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.354 0.597 . . . . 1.02 111.36 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -111.66 135.64 51.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.69 -0.686 . . . . 0.92 110.379 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -109.26 11.84 25.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.286 . . . . 0.4 111.661 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.98 -29.01 70.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.845 0.313 . . . . 1.21 111.845 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -117.98 36.31 4.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.792 0.33 . . . . 1.71 111.07 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.3 mtp -129.68 153.07 48.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.489 -0.323 . . . . 0.94 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 149.9 49.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.132 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -51.59 -47.67 63.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.443 -0.344 . . . . 0.6 111.602 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 315' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.1 OUTLIER -57.8 -50.03 74.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 1.4 111.009 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 316' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 29.8 m-20 -63.75 -37.44 87.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.88 111.815 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.28 -51.09 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.4 111.634 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 318' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -72.92 -30.46 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.688 -0.405 . . . . 0.93 110.992 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 80.5 mtt180 -56.11 -46.52 79.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.884 0.373 . . . . 1.08 110.499 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.47 -40.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.42 110.504 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 321' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 304' ' ' VAL . 31.5 tp -54.36 -47.77 72.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.12 -0.491 . . . . 0.78 111.417 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 322' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 25.6 mtp-105 -64.96 -29.58 70.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.955 -0.566 . . . . 2.1 111.871 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -69.07 -40.42 78.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.153 0.501 . . . . 1.87 110.003 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.66 -44.55 85.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.685 . . . . 0.58 110.718 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 325' ' ' VAL . . . . . 0.428 HG11 ' HB ' ' B' ' 3' ' ' VAL . 40.8 t -69.2 -18.65 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.483 . . . . 0.46 111.594 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -91.75 3.55 54.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.44 110.875 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 148.77 33.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 1.16 110.24 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.0 139.98 36.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.497 -0.32 . . . . 1.31 110.49 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 143.06 -173.62 24.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.662 -0.78 . . . . 0.66 112.308 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.5 117.18 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.424 2.749 . . . . 0.84 112.21 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.6 mt -96.88 119.23 44.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.58 111.258 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.59 115.2 28.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 1.49 110.169 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.45 125.36 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.87 0.367 . . . . 0.74 111.36 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 103.05 11.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.563 . . . . 0.89 109.812 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.7 m -103.96 158.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.191 -0.458 . . . . 0.88 111.691 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -118.34 108.72 15.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.488 -0.778 . . . . 1.06 110.195 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.263 -0.875 . . . . 0.7 110.223 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.377 0.132 . . . . 0.5 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.727 -0.654 . . . . 1.0 109.997 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.258 -0.275 . . . . 1.7 110.258 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.7 mt -102.64 122.3 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.293 -0.262 . . . . 1.03 110.293 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 27.0 mm -120.13 124.21 72.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 1.1 110.832 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -110.36 111.86 23.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.769 -0.456 . . . . 1.06 109.769 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.87 156.21 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.77 111.434 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -124.85 113.91 18.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.218 -1.03 . . . . 1.19 108.218 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.401 ' HB3' ' HB3' ' A' ' 288' ' ' ALA . 76.5 mt -97.82 137.97 35.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.622 0.601 . . . . 0.72 112.622 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.16 110.73 14.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.088 -0.96 . . . . 0.7 109.962 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 71.6 mmm -94.87 21.04 8.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.268 -0.424 . . . . 0.87 111.338 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -93.14 -51.06 5.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.21 -0.663 . . . . 1.27 109.21 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -87.24 1.88 51.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.627 -0.715 . . . . 1.23 110.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -128.38 154.96 45.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.878 -0.601 . . . . 0.93 109.464 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -124.89 7.82 8.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 1.35 111.023 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.7 164.7 23.77 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.286 -0.416 . . . . 0.82 110.659 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.1 mt -79.52 -56.38 4.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.469 -0.567 . . . . 0.43 109.469 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.77 43.18 4.25 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.664 -0.698 . . . . 0.14 112.681 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.77 150.34 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.55 112.186 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 22.7 t -98.99 131.36 45.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.751 -1.113 . . . . 1.57 108.198 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.704 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 6.7 mm -98.09 115.79 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.967 0.413 . . . . 0.44 110.752 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . 0.469 ' O ' ' HA ' ' A' ' 278' ' ' ILE . 62.1 t -86.84 126.07 40.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.5 110.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.84 88.64 0.86 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.972 -0.632 . . . . 0.37 112.337 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -72.72 118.87 16.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.852 0.358 . . . . 2.46 110.266 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.2 m -129.0 112.82 14.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.341 -0.39 . . . . 1.34 110.916 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.484 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 6.6 t30 -91.76 -152.06 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.97 -0.559 . . . . 2.95 109.937 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.484 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 12.7 p-10 -59.23 -46.35 88.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.292 . . . . 2.08 111.076 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.2 mtm105 -75.78 -55.21 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.126 0.488 . . . . 2.98 110.377 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 137.79 -35.43 2.05 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.607 -0.724 . . . . 1.1 111.913 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.08 92.92 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.819 0.819 . . . . 1.75 110.71 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -113.24 -30.81 2.59 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.501 -0.772 . . . . 1.0 112.091 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.6 158.12 20.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.654 -0.784 . . . . 0.38 112.613 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . 0.469 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 8.3 pt -103.53 123.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.177 0.513 . . . . 0.51 110.432 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.7 156.84 21.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.964 -0.562 . . . . 1.07 111.354 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.97 118.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.57 109.998 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -88.74 -112.69 1.21 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.675 -0.774 . . . . 0.42 111.973 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.62 139.31 31.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.872 0.368 . . . . 1.26 111.445 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.19 132.59 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.16 -0.681 . . . . 0.87 109.16 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 33.9 mmt -95.1 134.83 37.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.517 -0.311 . . . . 0.96 110.994 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.47 133.14 46.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.45 110.199 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.79 -17.81 44.89 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.665 -0.778 . . . . 0.42 111.647 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.6 167.11 54.76 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.019 -0.61 . . . . 0.27 112.131 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.401 ' HB3' ' HB3' ' A' ' 254' ' ' LEU . . . -63.75 -35.25 79.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.723 0.297 . . . . 0.53 111.387 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.67 -42.56 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.58 110.804 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.96 -17.64 64.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.5 111.496 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.66 -21.27 44.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.55 111.135 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.69 -82.21 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.214 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 122.02 -21.45 7.85 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.25 -0.976 . . . . 0.39 113.764 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -66.43 -31.12 71.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.466 0.633 . . . . 0.81 111.277 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 51.3 mt -89.35 132.85 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.337 -0.616 . . . . 0.74 109.337 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.81 165.12 36.23 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.69 110.42 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.51 119.68 7.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.022 1.815 . . . . 0.41 111.47 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 121.99 -21.31 7.9 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.585 -0.817 . . . . 0.37 112.273 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.49 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 91.3 m-20 -65.79 141.31 58.35 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.318 -0.253 . . . . 0.34 110.318 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.6 ttp -100.86 132.4 46.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.059 -0.256 . . . . 1.93 110.553 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 34.3 mt -82.09 123.07 28.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.561 -0.29 . . . . 1.16 110.554 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 63.9 mt -102.69 -72.54 0.69 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.626 0.726 . . . . 1.07 110.137 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -116.52 134.25 55.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.103 -0.953 . . . . 0.92 110.971 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 94.7 t -124.22 96.97 4.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.8 109.34 178.754 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.2 t-20 60.47 73.87 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.71 111.461 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.7 m-20 75.86 -50.03 0.61 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.734 1.013 . . . . 1.11 113.734 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.36 130.02 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.57 . . . . 1.02 112.405 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.64 123.14 46.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.92 110.269 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -95.69 6.77 48.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.4 111.598 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.46 -12.36 30.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.319 0.489 . . . . 1.21 112.319 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -126.42 26.89 6.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.218 0.532 . . . . 1.71 110.63 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.2 mtp -125.5 163.02 23.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.259 -0.428 . . . . 0.94 109.987 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 17.9 p -72.08 157.81 37.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.584 0.23 . . . . 0.97 110.646 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.418 ' O ' HG23 ' A' ' 318' ' ' VAL . 70.4 m-20 -54.94 -43.49 73.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.6 111.168 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -63.84 -52.82 58.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 1.4 110.878 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.99 -39.2 77.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.897 -0.592 . . . . 0.88 111.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.36 -54.33 47.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.4 111.892 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.418 HG23 ' O ' ' A' ' 314' ' ' ASN . 3.0 t -70.58 -30.89 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.002 -0.279 . . . . 0.93 111.123 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.531 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 58.8 mtt180 -55.77 -52.39 64.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.001 -0.37 . . . . 1.08 110.001 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.27 -37.48 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.42 110.453 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.443 ' O ' HG21 ' A' ' 325' ' ' VAL . 20.7 tp -55.99 -49.33 73.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.073 0.463 . . . . 0.78 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.537 ' HA ' HG13 ' B' ' 3' ' ' VAL . 42.8 mtp180 -62.34 -35.59 79.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.764 -0.653 . . . . 2.1 111.106 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.531 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 17.3 mm-40 -64.84 -36.32 83.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.8 0.333 . . . . 1.87 110.868 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.1 mt -73.61 -40.77 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.416 . . . . 0.58 110.502 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.443 HG21 ' O ' ' A' ' 321' ' ' LEU . 47.3 t -70.32 -21.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.46 110.397 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.8 m -90.21 33.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -144.13 170.9 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 1.16 109.704 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.46 149.43 22.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.393 . . . . 1.31 111.503 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.14 158.64 10.17 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.117 -0.563 . . . . 0.66 112.332 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 133.71 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.871 2.381 . . . . 0.84 111.837 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.4 mt -103.5 120.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.967 0.413 . . . . 0.58 111.553 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.86 108.65 20.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.833 -0.621 . . . . 1.49 110.093 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.88 122.97 45.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.268 -0.423 . . . . 0.74 111.652 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.9 m -108.04 104.52 13.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.642 . . . . 0.89 109.265 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.4 153.65 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.88 112.136 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -108.53 111.17 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.06 110.176 179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.49 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.432 -0.794 . . . . 0.7 109.347 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.704 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 17.4 m95 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 110.147 -0.316 . . . . 0.5 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.537 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.741 -0.647 . . . . 1.0 110.458 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.089 0.471 . . . . 1.7 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 83.0 mt -79.76 129.59 37.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.185 -0.461 . . . . 1.03 110.135 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 39.7 mt -128.77 131.83 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 1.1 110.789 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 m -106.2 112.5 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.585 -0.524 . . . . 1.06 109.585 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.57 150.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.902 0.382 . . . . 0.77 111.045 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -116.78 117.29 29.35 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.79 -0.819 . . . . 1.19 108.79 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 69.9 mt -106.53 152.53 23.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.167 0.508 . . . . 0.72 111.952 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -100.27 126.19 46.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.451 -0.795 . . . . 0.7 110.36 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 79.7 mmm -104.58 22.69 14.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.87 111.752 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -95.46 -52.08 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.386 -0.598 . . . . 1.27 109.386 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -79.81 -26.63 40.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 1.23 109.495 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -110.42 150.7 28.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.93 109.151 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -123.66 12.6 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.461 -0.495 . . . . 1.35 111.105 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -161.24 162.37 31.1 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.077 -0.51 . . . . 0.82 110.099 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . 0.406 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.9 mt -77.88 -52.21 9.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.43 110.07 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.91 43.01 6.14 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.85 -0.614 . . . . 0.14 112.394 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . 0.406 HG12 ' HB3' ' A' ' 262' ' ' LEU . 9.1 pt -136.94 154.02 30.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.441 0.639 . . . . 0.55 112.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 21.5 t -106.49 121.43 44.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.93 -1.032 . . . . 1.57 108.786 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.68 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 9.0 mm -91.25 132.49 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.709 0.29 . . . . 0.44 110.844 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.05 124.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.412 . . . . 0.5 110.032 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.12 113.63 4.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.816 -0.706 . . . . 0.37 112.102 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.11 109.15 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 2.46 110.557 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.3 m -109.4 142.53 40.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.977 -0.556 . . . . 1.34 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -161.8 -170.34 2.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.615 -0.513 . . . . 2.95 109.615 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -56.39 -41.47 76.33 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.347 0.404 . . . . 2.08 110.796 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -40.0 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 2.98 110.36 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 97.47 -46.18 1.68 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.861 -0.685 . . . . 1.1 113.098 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.59 78.16 2.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.742 0.782 . . . . 1.75 111.141 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -95.36 -45.46 3.0 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.716 -0.754 . . . . 1.0 112.3 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 114.19 164.92 15.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.701 -0.761 . . . . 0.38 111.848 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 7.6 pt -100.5 126.4 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.171 0.51 . . . . 0.51 111.103 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.401 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 84.9 m-85 -117.68 159.27 23.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 1.07 110.871 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.99 112.14 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.296 -0.631 . . . . 0.57 109.296 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.55 -56.68 3.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.888 -0.672 . . . . 0.42 112.88 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.17 161.41 38.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.627 -0.138 . . . . 1.26 110.627 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 31.1 mt -122.35 131.35 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.87 110.335 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.8 mmt -96.08 115.56 27.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.406 -0.361 . . . . 0.96 110.456 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -64.04 109.77 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.472 . . . . 1.45 110.015 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 142.45 -23.06 2.37 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.877 -0.889 . . . . 0.42 110.877 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.73 177.81 53.88 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.155 -0.545 . . . . 0.27 112.216 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.47 73.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.656 0.243 . . . . 0.53 111.656 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 84.7 t -71.11 -41.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.58 111.358 -179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.7 -18.62 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.5 111.68 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.22 -14.37 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.215 -0.448 . . . . 0.55 111.143 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -88.27 -72.52 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.775 0.321 . . . . 0.55 110.523 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.35 -19.98 26.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.453 -0.879 . . . . 0.39 113.853 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -69.9 -37.49 76.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.418 0.609 . . . . 0.81 110.976 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 59.6 mt -78.83 135.14 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.743 -0.465 . . . . 0.74 109.743 179.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.99 161.07 61.8 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.414 . . . . 0.69 110.119 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.21 124.08 15.33 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.195 1.93 . . . . 0.41 111.178 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.14 -16.0 18.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.662 -0.78 . . . . 0.37 111.938 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 90.7 m-20 -67.43 142.79 56.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.813 -0.44 . . . . 0.34 109.813 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 300' ' ' MET . . . . . 0.401 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 28.0 ttt -101.61 136.31 41.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.664 0.268 . . . . 1.93 110.766 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.3 124.99 34.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.373 . . . . 1.16 110.032 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 68.8 mt -105.47 -72.47 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.42 . . . . 1.07 110.453 -179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.8 135.14 54.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.935 -0.575 . . . . 0.92 110.744 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.33 106.44 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.882 -0.599 . . . . 0.8 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.5 m-20 61.4 62.93 1.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.987 -0.551 . . . . 1.71 111.455 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 29.0 m-20 75.12 -45.94 0.58 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.339 1.237 . . . . 1.11 114.339 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.1 m -71.11 130.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.199 0.523 . . . . 1.02 111.467 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -103.42 140.33 37.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.92 110.319 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.8 5.46 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.321 . . . . 0.4 111.729 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.25 -26.38 66.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.975 0.361 . . . . 1.21 111.975 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -116.74 26.39 9.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.263 0.554 . . . . 1.71 110.904 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 97.3 mtp -118.79 165.77 13.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.314 -0.403 . . . . 0.94 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 27.4 p -75.84 164.8 25.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.97 109.855 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.43 ' O ' HG23 ' A' ' 318' ' ' VAL . 86.7 m-20 -63.78 -36.65 84.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.249 0.547 . . . . 0.6 109.666 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.481 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 5.6 t70 -71.29 -53.77 13.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 1.4 110.992 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.24 -35.82 72.28 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.818 -0.628 . . . . 0.88 111.743 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.49 69.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.134 -0.484 . . . . 0.4 112.002 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.43 HG23 ' O ' ' A' ' 314' ' ' ASN . 0.9 OUTLIER -69.82 -29.02 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.926 -0.31 . . . . 0.93 111.003 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.481 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 82.8 mtt180 -55.82 -48.06 76.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.281 0.562 . . . . 1.08 110.068 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.3 -41.61 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.42 110.5 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 22.6 tp -54.05 -50.2 67.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.78 111.456 -179.694 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.518 ' HA ' HG12 ' B' ' 3' ' ' VAL . 63.4 mtp180 -62.41 -36.84 83.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 2.1 111.005 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -63.16 -44.0 96.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 1.87 110.478 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.59 -47.94 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.078 -0.51 . . . . 0.58 111.159 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . . . . . . . . . 24.8 t -69.06 -15.19 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.133 0.492 . . . . 0.46 111.347 -179.227 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 68.8 m -86.06 -5.73 59.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.818 0.342 . . . . 0.44 110.865 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.4 148.72 24.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.236 -0.438 . . . . 1.16 110.528 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 88.21 7.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.066 -0.515 . . . . 1.31 111.356 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -166.26 173.63 41.76 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.959 -0.639 . . . . 0.66 112.187 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.03 141.05 62.45 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.685 2.257 . . . . 0.84 112.371 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 72.2 mt -119.83 123.85 71.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.172 0.51 . . . . 0.58 111.442 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.8 m -112.35 102.61 10.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.554 -0.748 . . . . 1.49 109.435 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.73 121.03 33.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.74 111.801 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.9 m -103.53 98.91 8.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.826 -0.805 . . . . 0.89 108.826 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.42 152.48 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.503 0.557 . . . . 0.88 112.503 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -109.49 108.27 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 1.06 110.012 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.8 mtpp . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.092 -0.956 . . . . 0.7 109.74 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.68 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.9 m95 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.463 0.173 . . . . 0.5 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.518 HG12 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.848 -0.596 . . . . 1.0 109.69 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.905 -0.406 . . . . 1.7 109.905 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.15 126.01 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.283 -0.417 . . . . 1.03 110.659 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 23.5 mt -123.46 126.37 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 1.1 111.484 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 103.57 15.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.27 -0.641 . . . . 1.06 109.27 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 13.4 m -102.15 160.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 0.77 111.509 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.8 t -122.86 142.52 50.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.514 -0.921 . . . . 1.19 108.514 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.412 ' HB3' ' HB3' ' A' ' 288' ' ' ALA . 80.7 mt -123.85 136.36 54.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.209 0.528 . . . . 0.72 112.101 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.45 111.85 14.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.393 -0.821 . . . . 0.7 109.832 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.3 mmm -96.21 17.85 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.87 110.911 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.7 -50.53 6.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.507 0.67 . . . . 1.27 109.229 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -88.95 0.05 56.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.92 -1.036 . . . . 1.23 110.186 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -130.28 133.18 46.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.93 110.276 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.61 15.39 25.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.567 -0.288 . . . . 1.35 110.783 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -166.54 166.64 16.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.24 -0.436 . . . . 0.82 110.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.5 mt -82.77 -52.54 6.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.189 -0.46 . . . . 0.43 109.988 -179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.74 43.11 5.54 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.891 -0.595 . . . . 0.14 112.98 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.83 150.6 20.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.656 0.741 . . . . 0.55 111.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 12.1 t -100.46 124.51 46.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.874 -1.057 . . . . 1.57 108.691 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.678 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 6.5 mm -91.1 114.81 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.44 110.854 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.01 112.31 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.5 110.254 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.15 101.79 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.939 -0.648 . . . . 0.37 112.156 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . 0.439 ' O ' ' HA3' ' A' ' 276' ' ' GLY . 28.3 tt0 -78.5 109.42 12.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.122 -0.325 . . . . 2.46 110.122 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.6 m -111.16 113.11 25.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.465 -0.334 . . . . 1.34 111.082 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -77.57 -163.43 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 2.95 109.992 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.09 -37.49 77.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.732 0.301 . . . . 2.08 111.439 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -78.44 -30.48 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 2.98 110.226 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.51 -7.88 15.65 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.024 -0.83 . . . . 1.1 111.024 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.21 172.49 9.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.15 -0.315 . . . . 1.75 110.15 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . 0.439 ' HA3' ' O ' ' A' ' 269' ' ' GLN . . . 159.81 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.68 -0.772 . . . . 1.0 112.195 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 122.96 162.47 11.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.841 -0.695 . . . . 0.38 111.834 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.5 pt -98.9 123.62 51.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.273 0.559 . . . . 0.51 110.557 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -111.21 156.22 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.716 -0.675 . . . . 1.07 110.604 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.99 118.46 30.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.12 -0.491 . . . . 0.57 109.866 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -89.76 -101.95 1.1 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.519 -0.848 . . . . 0.42 112.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.18 138.88 31.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.663 0.268 . . . . 1.26 111.094 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 69.8 mt -105.28 129.79 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.353 -0.61 . . . . 0.87 109.353 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 26.1 mmt -95.54 123.69 39.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.934 0.397 . . . . 0.96 111.202 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -67.37 122.56 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 1.45 109.809 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 122.73 -20.78 7.68 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.469 -0.652 . . . . 0.42 111.469 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.55 172.65 55.27 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.803 -0.713 . . . . 0.27 112.104 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.412 ' HB3' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -36.18 82.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.754 0.312 . . . . 0.53 111.099 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.14 -35.34 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.575 . . . . 0.58 111.115 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.86 -11.52 60.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.5 111.776 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -94.71 -10.17 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.104 0.478 . . . . 0.55 110.462 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.83 -77.12 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.55 110.239 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.0 -16.34 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.653 -0.784 . . . . 0.39 113.699 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -81.39 -36.1 29.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.417 0.608 . . . . 0.81 111.433 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.5 mt -80.04 134.29 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.421 -0.354 . . . . 0.74 110.307 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.51 168.11 16.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.69 110.292 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.75 128.23 25.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.984 1.789 . . . . 0.41 111.49 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.88 -14.6 31.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.821 -0.704 . . . . 0.37 112.299 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.95 141.97 52.95 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.647 -0.501 . . . . 0.34 109.647 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 35.9 ttp -101.36 132.14 47.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.643 0.259 . . . . 1.93 110.859 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.64 120.62 29.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.393 -0.367 . . . . 1.16 110.027 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 43.3 mt -101.29 -69.09 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.132 0.492 . . . . 1.07 110.359 179.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -111.9 133.82 53.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.744 -0.662 . . . . 0.92 110.563 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 90.8 t -123.64 94.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.8 109.964 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.467 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.1 t30 58.83 72.9 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.472 -0.786 . . . . 1.71 111.761 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 73.3 m-20 78.3 -48.4 0.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.422 0.897 . . . . 1.11 113.422 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.66 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.229 0.538 . . . . 1.02 111.657 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -103.08 137.51 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.698 -0.683 . . . . 0.92 110.413 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.59 13.0 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.477 -0.329 . . . . 0.4 111.06 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.73 6.11 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.115 0.413 . . . . 1.21 112.115 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.25 33.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.348 0.594 . . . . 1.71 110.068 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.7 mtp -134.31 159.17 41.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.94 110.498 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.06 153.36 43.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.97 110.746 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 95.1 m-20 -54.18 -46.34 72.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.6 110.961 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.437 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.1 t70 -62.06 -48.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.881 -0.599 . . . . 1.4 110.779 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.87 -38.59 76.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.74 -0.664 . . . . 0.88 111.331 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.37 70.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.997 -0.547 . . . . 0.4 111.645 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.403 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.3 t -69.88 -27.73 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.956 -0.298 . . . . 0.93 111.298 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.437 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 88.3 mtt180 -58.23 -46.06 86.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.447 . . . . 1.08 110.202 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.59 -38.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.83 -0.623 . . . . 0.42 110.109 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.404 ' O ' HG23 ' A' ' 325' ' ' VAL . 19.0 tp -53.57 -53.25 54.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.87 -0.605 . . . . 0.78 111.34 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.1 mtp180 -62.09 -34.64 76.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 2.1 111.338 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.487 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 mm-40 -66.84 -40.3 87.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.89 0.376 . . . . 1.87 110.44 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -68.58 -44.64 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.58 110.939 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.404 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.9 t -64.74 -21.78 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.16 0.505 . . . . 0.46 111.152 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.5 m -84.69 -0.36 53.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.499 -0.319 . . . . 0.44 110.825 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . 0.487 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 80.4 mm-40 -98.19 163.11 12.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 1.16 110.596 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 15.4 p -99.12 118.68 36.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.224 -0.444 . . . . 1.31 111.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 154.02 165.72 14.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.835 -0.697 . . . . 0.66 111.985 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.92 128.23 14.7 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.337 2.024 . . . . 0.84 111.503 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 34.6 mt -108.22 130.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.922 0.391 . . . . 0.58 111.354 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 18.5 t -104.8 129.73 53.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 1.49 109.258 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.4 mt -114.92 125.76 54.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 0.74 111.287 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -100.65 97.54 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.853 -0.795 . . . . 0.89 108.853 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.3 151.55 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.341 0.591 . . . . 0.88 112.247 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -111.57 113.07 25.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.234 -0.894 . . . . 1.06 109.146 178.823 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.274 -0.869 . . . . 0.7 110.391 -179.535 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.678 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.0 m95 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 110.527 -0.175 . . . . 0.5 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.496 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.887 -0.577 . . . . 1.0 109.879 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.868 0.366 . . . . 1.7 110.309 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -98.08 129.51 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.359 -0.382 . . . . 1.03 110.436 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.11 128.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.944 0.402 . . . . 1.1 111.152 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.71 119.81 39.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.055 -0.52 . . . . 1.06 109.691 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.95 144.17 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.912 0.387 . . . . 0.77 111.524 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.3 t -107.63 131.59 54.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.426 -0.953 . . . . 1.19 108.426 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 42.7 mt -114.8 140.17 49.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.72 111.737 -178.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.31 116.79 21.33 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.475 -0.784 . . . . 0.7 110.285 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.6 mmm -98.69 12.62 34.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.87 111.654 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.92 -46.96 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.099 0.476 . . . . 1.27 109.803 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.06 -18.94 29.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 1.23 110.409 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -112.44 137.95 49.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.111 -0.495 . . . . 0.93 109.716 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -102.02 3.52 38.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.022 -0.271 . . . . 1.35 111.572 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -159.72 166.27 30.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.602 0.239 . . . . 0.82 111.05 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.6 mt -76.04 -53.0 9.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.43 109.735 -179.967 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.69 40.59 6.27 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 116.049 -0.523 . . . . 0.14 113.052 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.6 pt -138.07 149.2 24.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.346 0.593 . . . . 0.55 111.623 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.86 129.79 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.284 -0.871 . . . . 1.57 109.264 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.682 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 10.1 mm -93.78 119.76 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.938 0.399 . . . . 0.44 110.483 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.01 113.66 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.369 -0.378 . . . . 0.5 110.583 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.33 124.09 8.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.859 -0.686 . . . . 0.37 111.67 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.64 93.15 9.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 2.46 110.783 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.77 109.63 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.34 110.438 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -123.85 -46.48 1.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 2.95 110.692 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.03 -66.13 0.33 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 2.08 110.195 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -50.71 72.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.58 -0.736 . . . . 2.98 110.665 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 99.32 -37.85 3.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.607 -0.806 . . . . 1.1 112.923 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.89 57.43 1.05 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.59 0.709 . . . . 1.75 111.572 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -94.45 -28.19 10.83 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.736 -0.665 . . . . 1.0 111.699 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.55 174.2 32.42 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.896 -0.668 . . . . 0.38 112.22 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.4 pt -113.96 130.63 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.51 110.925 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -115.59 163.65 15.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.0 -0.546 . . . . 1.07 110.827 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.34 118.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.059 -0.519 . . . . 0.57 109.883 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.32 -66.94 1.68 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.729 -0.748 . . . . 0.42 112.147 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -145.26 155.62 43.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.537 0.208 . . . . 1.26 110.554 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 30.2 mt -106.88 134.33 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.246 -0.434 . . . . 0.87 109.995 179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.9 mmt -95.48 122.53 38.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.288 -0.414 . . . . 0.96 110.832 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.88 118.04 5.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 1.45 110.148 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.63 9.05 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.352 -0.699 . . . . 0.42 111.352 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.96 170.62 54.69 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.008 -0.615 . . . . 0.27 112.104 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.7 -36.92 85.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.751 0.31 . . . . 0.53 111.363 -179.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.01 -35.9 71.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.119 -0.492 . . . . 0.58 111.274 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.99 66.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.115 -0.493 . . . . 0.5 111.691 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.2 46.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.55 111.524 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.33 -72.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.799 0.333 . . . . 0.55 110.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.16 -17.8 34.27 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.393 -0.908 . . . . 0.39 114.3 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -73.21 -28.72 62.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.822 0.811 . . . . 0.81 111.278 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.7 mt -88.1 140.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.114 -0.698 . . . . 0.74 109.114 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.6 pt-20 -148.63 167.67 12.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.579 -0.282 . . . . 0.69 110.242 -179.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.04 133.56 58.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.215 1.943 . . . . 0.41 111.061 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.14 -20.91 32.35 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.37 112.151 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.9 137.87 55.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.925 -0.398 . . . . 0.34 109.925 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.5 ttp -97.5 134.23 41.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.726 0.298 . . . . 1.93 110.729 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.75 124.71 32.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.314 -0.403 . . . . 1.16 109.974 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 92.5 mt -105.8 -71.22 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.074 0.464 . . . . 1.07 110.606 179.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.93 136.96 53.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.92 111.162 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 59.7 t -128.02 94.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.8 109.919 179.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.483 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.4 m-20 59.09 75.4 0.4 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.211 -0.45 . . . . 1.71 111.407 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.483 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 3.3 m-20 76.72 -58.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.149 0.796 . . . . 1.11 113.149 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.43 121.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.379 0.609 . . . . 1.02 111.898 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -101.15 128.81 47.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.316 -0.856 . . . . 0.92 109.389 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -102.38 20.38 17.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.739 0.304 . . . . 0.4 111.477 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.45 -27.3 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.205 0.446 . . . . 1.21 112.205 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -125.58 37.45 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.633 0.254 . . . . 1.71 111.279 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 86.7 mtp -125.36 168.83 13.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.433 -0.349 . . . . 0.94 110.364 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.9 p -75.33 157.13 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.97 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.6 m-20 -62.27 -33.98 75.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.6 109.799 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -69.53 -54.03 16.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.575 -0.738 . . . . 1.4 111.118 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -59.58 -34.16 72.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.88 111.072 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.34 69.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.984 -0.553 . . . . 0.4 111.031 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.1 t -74.25 -27.96 22.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 121.041 -0.264 . . . . 0.93 110.725 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.42 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 66.8 mtt180 -58.35 -51.59 69.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.07 0.462 . . . . 1.08 109.864 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.78 -35.36 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.42 110.517 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 41.0 tp -54.67 -50.83 67.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.076 -0.511 . . . . 0.78 110.82 179.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.417 ' HA ' HG13 ' B' ' 3' ' ' VAL . 22.7 mtp-105 -61.32 -34.28 74.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.979 -0.555 . . . . 2.1 111.396 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.03 -40.63 96.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 1.87 110.54 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.89 -43.83 76.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.58 110.749 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.413 HG11 ' HB ' ' B' ' 3' ' ' VAL . 65.4 t -64.93 -32.1 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 0.46 110.753 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 13.7 m -87.31 10.3 17.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.928 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -110.98 151.41 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 1.16 110.081 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.62 134.57 37.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.563 -0.29 . . . . 1.31 110.617 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 135.71 156.14 7.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.852 -0.689 . . . . 0.66 112.339 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.3 139.82 46.87 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.851 2.368 . . . . 0.84 112.044 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.79 126.92 66.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.151 -0.477 . . . . 0.58 111.539 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 108.24 19.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.972 -0.751 . . . . 1.49 108.972 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 99.0 mt -93.65 128.93 40.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.237 -0.438 . . . . 0.74 111.756 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.5 m -108.34 97.39 7.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.442 -0.947 . . . . 0.89 108.442 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.85 159.17 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.88 112.154 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -116.83 116.62 27.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.334 -0.848 . . . . 1.06 109.718 179.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.488 -0.768 . . . . 0.7 110.271 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.682 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 30.4 m95 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 110.243 -0.28 . . . . 0.5 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.417 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.678 -0.677 . . . . 1.0 110.418 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.879 0.371 . . . . 1.7 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 56.0 mt -90.32 111.8 23.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.015 0.436 . . . . 1.03 110.251 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.55 128.73 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 1.1 110.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 m -98.74 112.35 24.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.273 -0.422 . . . . 1.06 109.867 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.467 ' O ' ' HA ' ' A' ' 332' ' ' SER . 6.0 m -100.87 163.34 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.436 -0.347 . . . . 0.77 110.67 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 14.8 t -131.11 134.66 46.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.309 -0.626 . . . . 1.19 109.309 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 72.4 mt -121.96 135.79 54.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.72 111.735 -179.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -85.22 115.62 23.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.459 -0.792 . . . . 0.7 109.973 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.0 mmm -95.8 32.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.952 0.406 . . . . 0.87 111.327 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -102.8 -53.82 2.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.27 109.703 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -70.48 -41.28 72.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.483 -0.562 . . . . 1.23 109.483 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -107.34 157.26 18.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.69 -0.855 . . . . 0.93 108.69 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -124.07 22.56 8.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.625 -0.43 . . . . 1.35 112.03 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.5 158.75 27.01 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.736 0.303 . . . . 0.82 110.778 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.8 mt -76.35 -56.01 5.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.43 109.734 -179.707 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.8 42.95 5.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.644 -0.707 . . . . 0.14 112.632 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -143.95 153.84 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.277 0.561 . . . . 0.55 111.866 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.465 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -100.85 131.59 46.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 1.57 109.48 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.595 ' HB ' ' H22' ' B' ' 1' ' ' PHQ . 11.5 mm -96.44 110.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.942 0.401 . . . . 0.44 110.385 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.09 110.78 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.504 -0.316 . . . . 0.5 111.486 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.61 113.7 3.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.092 -0.803 . . . . 0.37 111.092 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -77.81 129.72 35.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.99 0.424 . . . . 2.46 111.043 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.3 163.98 15.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.809 -0.632 . . . . 1.34 110.352 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -174.67 -158.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.297 -0.631 . . . . 2.95 109.297 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.05 -31.37 71.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.334 0.588 . . . . 2.08 110.511 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.48 -54.94 4.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.461 -0.791 . . . . 2.98 110.222 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 111.24 -34.37 5.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.772 -0.727 . . . . 1.1 112.075 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -91.91 71.65 5.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.689 0.757 . . . . 1.75 110.667 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -89.44 -17.02 56.19 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.721 -0.672 . . . . 1.0 112.791 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.14 166.86 31.52 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.672 -0.775 . . . . 0.38 112.269 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -105.88 129.36 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.031 0.443 . . . . 0.51 110.696 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.45 158.8 23.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 1.07 110.805 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.79 117.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.534 . . . . 0.57 110.393 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.47 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.76 -71.42 1.14 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.701 -0.761 . . . . 0.42 112.15 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.0 p -142.58 155.51 44.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.182 -0.303 . . . . 1.26 110.182 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 43.0 mt -106.43 125.53 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.87 110.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.3 mmt -86.36 126.72 34.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.07 -0.513 . . . . 0.96 110.668 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -67.88 110.6 3.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.662 -0.496 . . . . 1.45 109.662 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 132.84 -19.9 4.37 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.885 -0.886 . . . . 0.42 110.885 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.28 54.64 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.713 . . . . 0.27 111.969 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -66.22 -32.19 73.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.812 0.339 . . . . 0.53 111.0 -179.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.23 -33.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.58 110.734 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.08 -15.7 62.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.5 111.273 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.1 -27.79 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.55 110.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.44 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 16.5 t70 -76.05 -69.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.55 110.681 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.24 57.32 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.448 -0.882 . . . . 0.39 114.714 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.44 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 79.3 mtm180 -82.9 -19.65 36.96 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.019 0.91 . . . . 0.81 111.351 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.1 mt -96.78 138.51 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.206 -0.452 . . . . 0.74 109.959 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.1 157.9 76.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.43 -0.35 . . . . 0.69 110.409 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.47 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 33.4 Cg_exo -61.44 94.34 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.611 2.207 . . . . 0.41 111.793 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 150.52 -19.56 1.03 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.37 111.963 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -64.06 151.17 43.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.736 0.303 . . . . 0.34 110.842 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 300' ' ' MET . . . . . 0.411 ' HE2' HD23 ' A' ' 302' ' ' LEU . 50.6 ttp -104.02 130.1 51.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 1.93 110.683 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.84 115.23 22.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.382 -0.372 . . . . 1.16 110.103 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . 0.417 HD12 ' HB1' ' A' ' 336' ' ' ALA . 51.7 mt -97.9 -73.31 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.27 0.557 . . . . 1.07 110.844 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -115.11 130.74 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.594 -0.73 . . . . 0.92 110.625 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 96.5 t -126.91 106.44 15.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.201 -0.454 . . . . 0.8 109.972 179.602 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.406 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 11.4 t-20 61.34 65.98 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.406 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 1.5 m-20 74.87 -52.9 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.715 1.006 . . . . 1.11 113.715 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 134.74 29.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.063 0.458 . . . . 1.02 111.542 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -107.32 126.73 52.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.92 110.701 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -96.58 3.79 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.4 111.839 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.62 -28.08 65.3 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.828 0.307 . . . . 1.21 111.828 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.75 31.53 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 1.71 110.796 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 89.6 mtp -128.69 154.36 46.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.159 -0.473 . . . . 0.94 110.773 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.95 150.11 48.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.97 110.993 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -51.9 -47.98 64.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.343 . . . . 0.6 111.348 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.42 -46.39 88.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.4 111.672 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.505 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.1 m-20 -64.32 -30.72 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.294 -0.412 . . . . 0.88 110.8 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.42 85.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.4 110.786 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 -31.55 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.664 0.268 . . . . 0.93 110.535 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.505 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 90.1 mtt180 -56.74 -53.92 52.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 1.08 110.263 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.8 -37.19 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.42 110.366 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 325' ' ' VAL . 15.1 tp -55.79 -51.02 68.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.932 -0.577 . . . . 0.78 111.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.417 ' HA ' HG11 ' B' ' 3' ' ' VAL . 36.5 mtp180 -61.83 -35.14 77.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 2.1 111.091 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -64.53 -40.69 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.152 0.501 . . . . 1.87 109.959 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.59 -42.47 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.634 -0.712 . . . . 0.58 110.828 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 321' ' ' LEU . 62.6 t -66.29 -23.95 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.46 110.31 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 6.76 26.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.852 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -105.75 135.54 46.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.349 -0.387 . . . . 1.16 110.002 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 92.18 4.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.438 . . . . 1.31 111.569 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -173.74 171.92 44.86 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.461 -0.656 . . . . 0.66 111.461 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 126.04 13.18 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.361 2.041 . . . . 0.84 111.584 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 58.5 mt -102.95 122.75 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.93 0.395 . . . . 0.58 111.457 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.467 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.5 OUTLIER -106.66 121.78 45.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.564 . . . . 1.49 109.615 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 18.1 mt -108.1 120.95 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.525 . . . . 0.74 110.99 -179.397 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.82 95.94 7.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.627 -0.879 . . . . 0.89 108.627 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.53 0.681 . . . . 0.88 112.399 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.417 ' HB1' HD12 ' A' ' 302' ' ' LEU . . . -102.52 94.76 5.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.951 -1.022 . . . . 1.06 108.868 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.628 -0.701 . . . . 0.7 110.725 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.595 ' H22' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.465 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 9.8 m95 . . . . . 0 C--O 1.234 0.244 0 N-CA-C 110.366 -0.235 . . . . 0.5 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.428 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.637 -0.696 . . . . 1.0 110.22 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.61 0.243 . . . . 1.7 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 95.1 mt -103.78 127.02 58.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.453 -0.34 . . . . 1.03 110.188 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.21 135.44 59.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.827 0.346 . . . . 1.1 111.358 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 62.9 m -107.01 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.648 -0.501 . . . . 1.06 109.648 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.516 ' O ' ' HA ' ' A' ' 332' ' ' SER . 4.0 m -102.26 143.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.789 0.328 . . . . 0.77 111.122 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.9 t -114.19 109.78 18.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 1.19 109.5 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 58.4 mt -100.31 145.27 28.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.72 112.016 -178.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -91.72 119.79 31.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.7 109.732 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 89.5 mmm -99.0 21.52 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.026 0.441 . . . . 0.87 111.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -87.71 -49.91 6.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.768 -0.456 . . . . 1.27 109.768 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.16 -35.81 19.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 1.23 109.355 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -86.87 145.71 26.48 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.695 -0.684 . . . . 0.93 109.464 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.85 -2.33 13.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.545 -0.462 . . . . 1.35 112.024 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -157.58 162.54 38.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.498 0.19 . . . . 0.82 110.677 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.4 mt -77.55 -52.04 9.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.727 -0.472 . . . . 0.43 109.727 179.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.44 4.61 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.577 -0.738 . . . . 0.14 112.999 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.0 pt -144.84 144.1 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.213 0.53 . . . . 0.55 111.563 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.565 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 1.1 p -96.49 126.87 41.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.208 -0.664 . . . . 1.57 109.208 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.695 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 9.2 mm -91.75 115.84 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.825 0.345 . . . . 0.44 110.776 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.22 119.01 48.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.5 110.251 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.26 122.51 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.002 -0.618 . . . . 0.37 112.072 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -85.69 89.28 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 2.46 110.1 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.6 m -113.88 80.21 1.35 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.778 -0.646 . . . . 1.34 110.555 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -92.74 -151.31 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 2.95 109.963 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -61.06 -32.38 72.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.163 0.506 . . . . 2.08 110.472 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.83 -21.25 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 2.98 110.797 179.237 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 88.12 -65.42 3.44 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.313 -0.715 . . . . 1.1 111.313 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -91.48 153.04 20.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.667 -0.494 . . . . 1.75 109.667 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.81 -34.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.608 -0.806 . . . . 1.0 112.365 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 120.25 175.53 15.57 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.425 -0.893 . . . . 0.38 112.192 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.03 128.41 73.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.068 0.461 . . . . 0.51 110.839 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -113.99 157.46 22.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.772 -0.649 . . . . 1.07 110.803 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.59 115.02 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.57 110.014 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.72 -58.16 4.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.42 112.698 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.6 p -151.54 161.97 41.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.187 -0.301 . . . . 1.26 110.187 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.0 mt -115.18 134.8 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.87 110.46 -179.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -95.7 125.17 40.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.96 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.05 124.47 20.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.883 -0.599 . . . . 1.45 110.056 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.58 18.12 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.29 -0.724 . . . . 0.42 111.29 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -80.52 166.03 48.88 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.875 -0.679 . . . . 0.27 111.875 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -61.15 -38.83 87.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.662 0.268 . . . . 0.53 111.433 -179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.69 -31.3 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.58 110.907 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.83 -20.29 61.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.5 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.02 -11.7 43.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.272 -0.422 . . . . 0.55 111.73 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.11 -72.61 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.15 -0.22 . . . . 0.55 111.218 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 113.74 -17.08 20.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.381 -0.914 . . . . 0.39 113.902 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -89.93 -49.32 6.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.32 0.56 . . . . 0.81 111.064 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.24 136.93 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.74 110.206 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -143.8 164.2 31.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.69 110.308 -179.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.488 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.5 Cg_exo -60.24 112.54 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.329 2.019 . . . . 0.41 111.27 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 132.45 -19.86 4.48 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.241 -0.744 . . . . 0.37 111.241 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.432 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.0 m-20 -70.84 146.14 49.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.732 0.301 . . . . 0.34 110.245 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.1 ttt -103.76 136.44 43.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.309 -0.405 . . . . 1.93 110.656 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 18.9 mt -87.99 123.39 32.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 1.16 110.109 179.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 90.6 mt -106.25 -69.07 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.048 0.451 . . . . 1.07 110.818 179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -121.1 124.7 45.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.92 110.484 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.481 ' O ' HG21 ' A' ' 307' ' ' VAL . 59.5 t -125.62 101.57 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.8 110.23 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 62.88 65.69 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.998 -0.546 . . . . 1.71 111.244 -179.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 74.69 -43.67 0.53 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.922 1.082 . . . . 1.11 113.922 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.481 HG21 ' O ' ' A' ' 304' ' ' VAL . 33.6 m -69.51 137.47 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 118.261 0.482 . . . . 1.02 111.329 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -111.06 133.16 53.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.771 -0.65 . . . . 0.92 109.645 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.13 12.44 30.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.909 0.337 . . . . 0.4 111.909 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -66.32 -30.56 70.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.723 0.297 . . . . 1.21 111.715 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.56 36.96 4.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 1.71 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 84.1 mtp -125.05 154.96 40.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.324 -0.621 . . . . 0.94 109.324 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 97.0 p -69.17 153.56 43.51 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.147 -0.316 . . . . 0.97 110.147 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -59.6 -26.38 65.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.6 109.842 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -71.48 -56.3 6.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.279 -0.873 . . . . 1.4 110.588 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.422 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 10.6 m-20 -63.64 -30.98 72.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.84 -0.618 . . . . 0.88 111.683 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.15 67.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.929 -0.578 . . . . 0.4 112.011 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.33 -27.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.931 -0.308 . . . . 0.93 111.024 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 81.4 mtt180 -58.53 -53.31 59.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 1.08 110.11 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.6 -40.49 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.871 -0.604 . . . . 0.42 110.274 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.425 ' O ' HG21 ' A' ' 325' ' ' VAL . 20.6 tp -55.12 -50.98 67.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.938 -0.574 . . . . 0.78 111.229 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.431 ' HA ' HG13 ' B' ' 3' ' ' VAL . 9.0 mtp180 -61.0 -41.86 97.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.404 . . . . 2.1 111.359 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -61.42 -43.52 98.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.52 0.2 . . . . 1.87 110.55 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.01 -43.25 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.58 110.508 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.425 HG21 ' O ' ' A' ' 321' ' ' LEU . 59.3 t -70.01 -19.68 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.277 -0.42 . . . . 0.46 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 66.7 m -77.86 -18.38 56.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.44 110.789 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.09 162.39 12.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.228 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.39 172.07 13.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.359 -0.382 . . . . 1.31 111.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 116.19 168.08 15.04 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.925 -0.655 . . . . 0.66 112.572 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -79.56 104.52 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.699 2.266 . . . . 0.84 111.733 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 50.0 mt -74.06 114.13 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.58 110.691 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.516 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 8.1 m -97.31 102.74 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 1.49 109.75 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.89 119.05 37.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.023 -0.535 . . . . 0.74 111.319 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 26.8 m -98.54 101.12 12.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.779 -0.822 . . . . 0.89 108.779 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.8 m -101.64 156.23 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 0.88 112.204 -178.302 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -110.07 111.43 22.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.113 -0.949 . . . . 1.06 109.894 179.091 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.432 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.7 mtpp . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.511 -0.757 . . . . 0.7 109.796 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.695 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.565 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 22.4 m95 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.126 -0.324 . . . . 0.5 110.126 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.431 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.71 -0.662 . . . . 1.0 109.973 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.74 0.305 . . . . 1.7 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.61 128.38 49.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.128 -0.323 . . . . 1.03 110.128 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 42.2 mt -126.53 130.51 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.339 . . . . 1.1 111.151 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.8 m -101.62 111.11 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.52 -0.548 . . . . 1.06 109.52 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.91 147.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.688 0.28 . . . . 0.77 111.566 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.2 t -110.16 136.8 48.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.642 -0.503 . . . . 1.19 109.642 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.2 mt -114.71 138.41 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.905 0.383 . . . . 0.72 111.469 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -83.91 117.96 23.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.704 . . . . 0.7 110.155 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 92.2 mmm -98.35 14.05 29.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.374 -0.375 . . . . 0.87 111.584 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.14 -38.39 15.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 1.27 110.342 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 25.7 ttt180 -96.34 0.66 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.575 -0.739 . . . . 1.23 110.255 179.656 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -131.03 162.52 29.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.93 109.709 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -120.32 -8.23 9.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.827 0.346 . . . . 1.35 111.283 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -154.62 175.95 13.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.509 -0.314 . . . . 0.82 110.707 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.08 -52.46 6.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.43 109.971 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.68 43.18 5.54 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.806 -0.634 . . . . 0.14 112.879 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.02 154.35 31.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.538 0.685 . . . . 0.55 112.37 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.4 ' HB3' ' H ' ' A' ' 282' ' ' SER . 42.5 t -101.8 118.03 36.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.612 -1.176 . . . . 1.57 109.043 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.639 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 11.1 mm -88.63 118.5 34.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.776 0.322 . . . . 0.44 110.138 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.99 109.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.007 0.432 . . . . 0.5 110.759 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.1 124.38 7.54 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.247 -0.741 . . . . 0.37 111.247 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.18 112.39 21.28 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.938 0.399 . . . . 2.46 110.635 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -97.86 93.58 6.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.909 -0.587 . . . . 1.34 110.41 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -86.38 -176.14 5.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 2.95 110.73 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.91 -15.07 63.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.255 0.55 . . . . 2.08 110.002 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -92.97 -3.69 54.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.563 -0.744 . . . . 2.98 110.017 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 88.5 -66.41 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.787 -0.72 . . . . 1.1 112.147 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.86 152.85 29.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.082 0.468 . . . . 1.75 110.642 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.8 -36.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.812 -0.631 . . . . 1.0 111.829 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 120.67 161.21 11.37 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.642 -0.789 . . . . 0.38 112.305 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.44 114.26 45.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.297 0.57 . . . . 0.51 110.212 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -107.32 154.57 21.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.893 -0.594 . . . . 1.07 110.692 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.23 114.18 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.57 109.782 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.12 -57.7 3.62 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.746 -0.74 . . . . 0.42 112.333 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 282' ' ' SER . . . . . 0.4 ' H ' ' HB3' ' A' ' 265' ' ' SER . 1.8 p -145.16 158.25 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.144 -0.317 . . . . 1.26 110.144 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 50.4 mt -118.24 131.62 70.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.58 -0.526 . . . . 0.87 109.58 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 34.1 mmt -92.77 124.32 36.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.415 -0.357 . . . . 0.96 110.619 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -58.56 130.18 45.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 1.45 110.997 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.12 -24.55 20.78 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.894 -0.67 . . . . 0.42 112.034 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.19 45.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.058 -0.591 . . . . 0.27 112.424 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.01 -37.32 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.53 111.056 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 54.8 t -69.54 -39.27 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.58 110.781 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.27 -18.15 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.5 111.254 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -85.67 -11.03 54.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.55 110.955 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.49 -67.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.839 -0.43 . . . . 0.55 109.839 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 103.47 -14.96 54.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 0.39 114.435 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -79.96 -33.13 39.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.738 0.769 . . . . 0.81 111.137 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 63.5 mt -82.57 140.65 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.651 -0.5 . . . . 0.74 109.651 179.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.13 164.3 32.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.765 -0.198 . . . . 0.69 110.88 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.37 116.94 3.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.41 111.823 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 125.82 -21.81 6.19 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.917 -0.658 . . . . 0.37 111.509 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.457 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.5 m-20 -69.44 143.23 53.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 43.7 ttp -103.36 135.3 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.702 0.287 . . . . 1.93 110.813 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 70.4 mt -83.39 123.97 30.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 1.16 110.182 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 46.7 mt -105.15 -72.57 0.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.245 0.545 . . . . 1.07 110.835 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -109.75 135.32 50.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.754 . . . . 0.92 111.034 -178.515 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 67.3 t -131.98 93.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.8 110.149 179.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.43 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 59.21 76.61 0.35 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.798 -0.637 . . . . 1.71 111.737 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.8 OUTLIER 75.21 -53.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.053 -0.976 . . . . 1.11 113.455 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.5 139.66 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.349 0.595 . . . . 1.02 111.864 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.99 130.8 55.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.442 -0.799 . . . . 0.92 110.409 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.481 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 23.7 m-85 -102.02 6.53 41.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.867 0.321 . . . . 0.4 111.867 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.92 -31.61 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 1.21 111.696 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -119.44 53.35 1.04 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.2 0.524 . . . . 1.71 110.301 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 312' ' ' MET . . . . . 0.481 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 84.1 mtp -141.11 160.37 40.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.94 110.182 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 148.14 51.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.242 -0.435 . . . . 0.97 110.75 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -49.7 -50.97 41.69 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.484 0.49 . . . . 0.6 111.638 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.22 -47.3 80.22 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.446 . . . . 1.4 111.833 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.58 -35.1 75.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.886 -0.597 . . . . 0.88 111.815 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.02 93.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.452 -0.34 . . . . 0.4 110.865 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.516 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -73.82 -32.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.93 110.623 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -54.98 -50.33 69.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.864 0.364 . . . . 1.08 110.627 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.6 t -70.49 -39.93 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.75 -0.659 . . . . 0.42 110.249 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.468 ' O ' HG21 ' A' ' 325' ' ' VAL . 56.6 tp -55.36 -50.44 69.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.053 -0.521 . . . . 0.78 111.373 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.523 ' HA ' HG13 ' B' ' 3' ' ' VAL . 27.0 mtp180 -63.69 -30.13 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 2.1 111.462 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.7 -40.37 80.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.136 0.493 . . . . 1.87 109.804 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.92 -42.67 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.73 . . . . 0.58 111.209 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.468 HG21 ' O ' ' A' ' 321' ' ' LEU . 43.8 t -69.23 -16.94 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.46 110.802 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 23.57 6.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.092 0.473 . . . . 0.44 110.161 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.26 -179.31 4.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 1.16 110.102 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.99 146.24 32.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.71 0.29 . . . . 1.31 110.607 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.37 169.59 13.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.707 -0.759 . . . . 0.66 112.269 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 137.09 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 0.84 112.166 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 84.4 mt -115.34 121.57 67.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.142 -0.481 . . . . 0.58 110.414 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.8 m -106.11 121.06 43.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.138 0.494 . . . . 1.49 109.95 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 84.0 mt -105.5 130.52 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.74 111.538 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.7 m -104.04 103.23 13.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.89 108.802 177.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.28 142.68 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.343 0.592 . . . . 0.88 112.35 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -108.22 111.95 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.186 -0.916 . . . . 1.06 109.582 178.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.457 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.0 mtpp . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.613 -0.708 . . . . 0.7 109.942 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.639 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 28.9 m95 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.547 0.213 . . . . 0.5 110.62 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.523 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 119.038 -0.506 . . . . 1.0 109.949 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.917 0.389 . . . . 1.7 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 57.2 mt -92.3 128.78 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 1.03 110.731 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 33.8 mt -129.67 123.7 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 1.1 110.875 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.1 m -95.39 102.39 14.19 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.424 -0.584 . . . . 1.06 109.424 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.27 148.4 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.954 0.407 . . . . 0.77 111.751 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -114.87 129.95 56.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.802 -0.814 . . . . 1.19 108.802 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 80.2 mt -110.89 149.66 30.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.463 . . . . 0.72 111.606 -178.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.27 118.04 30.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.507 -0.77 . . . . 0.7 110.901 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 67.0 mmm -99.46 16.26 23.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.863 -0.608 . . . . 0.87 111.304 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -86.47 -49.41 7.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.35 -0.611 . . . . 1.27 109.35 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -86.44 -22.8 26.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.583 -0.735 . . . . 1.23 110.193 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -106.92 154.76 20.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 0.93 110.472 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.76 -2.39 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.519 0.2 . . . . 1.35 111.304 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -157.56 171.92 19.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.348 . . . . 0.82 110.959 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.21 -51.31 10.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.887 -0.597 . . . . 0.43 110.016 -179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.05 47.34 5.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.776 -0.647 . . . . 0.14 112.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.5 pt -142.73 150.45 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.55 112.023 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.26 120.61 40.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.991 -1.004 . . . . 1.57 108.81 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.753 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 5.3 mm -89.56 116.11 30.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.919 0.39 . . . . 0.44 111.036 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.69 118.77 48.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.5 109.877 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.51 127.82 9.36 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.511 -0.852 . . . . 0.37 112.013 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -79.09 69.43 5.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.186 -0.672 . . . . 2.46 109.186 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 14.9 m -86.58 92.01 8.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 1.34 111.444 -179.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -99.37 -148.51 0.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.282 -0.872 . . . . 2.95 109.387 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.4 -33.49 67.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.695 0.283 . . . . 2.08 111.297 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -102.71 -52.44 3.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.491 -0.322 . . . . 2.98 111.106 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 95.37 27.03 11.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.541 -0.838 . . . . 1.1 112.314 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -111.03 13.98 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 1.75 110.5 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -67.58 -28.31 73.57 Favored Glycine 0 C--N 1.329 0.184 0 CA-C-N 115.803 -0.635 . . . . 1.0 112.834 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 178.17 25.27 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.502 -0.856 . . . . 0.38 112.511 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.67 138.43 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.898 0.38 . . . . 0.51 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -125.69 158.24 35.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.996 -0.547 . . . . 1.07 110.661 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.3 mm -75.92 109.5 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.067 -0.515 . . . . 0.57 109.698 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.29 -60.13 3.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.754 -0.736 . . . . 0.42 112.273 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 m -145.17 157.97 43.94 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.708 -0.289 . . . . 1.26 110.355 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.2 mt -113.52 130.22 67.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.211 -0.45 . . . . 0.87 110.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.97 119.33 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.96 110.335 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -61.72 116.99 5.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.955 -0.566 . . . . 1.45 110.023 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.1 -17.58 9.12 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.477 -0.649 . . . . 0.42 111.477 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.8 174.03 55.26 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.863 -0.684 . . . . 0.27 111.912 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.93 -36.87 84.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.769 0.318 . . . . 0.53 111.218 -179.634 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.98 -37.37 77.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.58 111.169 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.41 -17.88 64.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.5 111.828 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.92 -3.66 57.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.828 0.347 . . . . 0.55 111.192 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.63 -80.25 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.745 -0.465 . . . . 0.55 109.745 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 118.33 -21.53 9.97 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.274 -0.965 . . . . 0.39 113.908 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -76.84 -19.59 57.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.568 0.684 . . . . 0.81 111.751 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.8 mt -95.18 136.36 26.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.646 -0.501 . . . . 0.74 109.646 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.63 163.77 47.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.742 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.47 109.04 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.368 2.045 . . . . 0.41 111.452 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.96 -17.14 5.21 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.37 112.09 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.428 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 97.7 m-20 -65.11 140.39 58.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.634 0.254 . . . . 0.34 110.348 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.6 ttt -93.76 135.2 35.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.322 . . . . 1.93 111.02 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.6 mt -90.07 118.14 29.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.193 -0.458 . . . . 1.16 109.936 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 59.4 mt -103.54 -77.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.098 0.475 . . . . 1.07 110.837 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -106.01 134.42 49.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.92 110.996 -178.864 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.406 HG13 ' CD1' ' A' ' 321' ' ' LEU . 84.7 t -131.31 102.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.782 -0.645 . . . . 0.8 109.83 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.433 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.2 m-20 58.35 70.53 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.566 -0.743 . . . . 1.71 111.568 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.433 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.5 OUTLIER 76.51 -53.36 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.585 0.957 . . . . 1.11 113.585 178.124 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.09 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 1.02 112.122 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -103.32 131.39 50.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.521 -0.763 . . . . 0.92 109.782 179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -97.17 3.98 51.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.984 0.364 . . . . 0.4 111.984 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.4 -32.8 67.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.965 0.412 . . . . 1.21 111.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -105.78 39.88 1.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.71 111.47 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 34.1 mtp -141.78 165.77 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.514 -0.312 . . . . 0.94 110.263 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.5 p -79.25 162.8 25.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.97 109.899 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.481 ' O ' HG23 ' A' ' 318' ' ' VAL . 42.7 m-20 -57.26 -40.06 76.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.6 110.037 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 23.9 t0 -63.08 -55.09 28.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.182 -0.917 . . . . 1.4 110.514 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -60.13 -36.18 76.94 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.826 -0.625 . . . . 0.88 111.34 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.29 -56.02 27.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.4 112.157 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.9 t -69.62 -26.71 31.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.963 -0.295 . . . . 0.93 111.358 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 69.4 mtt180 -57.11 -52.28 65.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 1.08 110.072 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.22 -38.26 74.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.976 -0.556 . . . . 0.42 110.4 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG21 ' A' ' 325' ' ' VAL . 23.9 tp -56.09 -51.58 67.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.923 -0.581 . . . . 0.78 110.942 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.531 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.7 mtp180 -61.15 -38.41 86.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.945 -0.571 . . . . 2.1 111.082 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.3 -45.38 88.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.595 -0.275 . . . . 1.87 110.682 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.78 -44.37 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 0.58 110.9 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.448 HG21 ' O ' ' A' ' 321' ' ' LEU . 26.1 t -72.22 -15.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.46 111.424 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 71.7 m -81.74 -16.6 50.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.83 0.348 . . . . 0.44 110.838 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.65 160.7 14.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 1.16 110.357 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 130.82 41.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.97 0.414 . . . . 1.31 111.075 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.31 176.1 27.1 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.523 -0.631 . . . . 0.66 111.523 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.38 135.95 35.46 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.539 2.159 . . . . 0.84 112.151 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.43 129.64 72.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.145 0.497 . . . . 0.58 110.732 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 126.81 52.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.347 -0.842 . . . . 1.49 109.403 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.12 115.91 26.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.74 111.586 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -93.37 90.13 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.599 -0.889 . . . . 0.89 108.599 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.11 146.47 6.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.912 -0.585 . . . . 0.88 111.996 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -111.04 107.75 17.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.333 -0.849 . . . . 1.06 110.018 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.428 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 22.7 mtpp . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.432 -0.795 . . . . 0.7 109.692 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.753 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.881 -0.414 . . . . 0.5 109.881 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.531 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.84 -0.6 . . . . 1.0 110.164 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.74 0.305 . . . . 1.7 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.61 122.16 61.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 1.03 110.629 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 18.3 mt -126.31 131.42 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 1.1 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 88.8 m -104.96 113.24 26.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.943 -0.762 . . . . 1.06 108.943 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 10.2 m -103.56 155.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.283 -0.417 . . . . 0.77 111.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.5 t -108.23 135.35 49.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.05 -0.722 . . . . 1.19 109.05 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.9 mt -119.04 136.14 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.947 0.403 . . . . 0.72 111.524 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -83.46 114.85 21.76 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.547 -0.751 . . . . 0.7 109.924 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 93.8 mmm -98.89 14.77 27.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.87 111.159 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -88.93 -47.54 8.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.27 109.819 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.71 -21.63 32.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 1.23 110.048 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -111.67 159.04 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.93 109.867 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -128.24 14.76 6.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.899 0.38 . . . . 1.35 110.443 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -164.72 169.0 17.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.82 110.163 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.5 mt -81.28 -57.68 3.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.828 0.347 . . . . 0.43 110.27 -179.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.6 36.35 5.89 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.14 112.578 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.1 pt -137.16 156.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.42 0.629 . . . . 0.55 111.894 -179.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.485 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -102.71 129.15 49.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.993 -1.003 . . . . 1.57 110.006 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.6 mm -97.37 113.33 31.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.44 110.953 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.5 t -114.88 115.24 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.5 110.709 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.64 134.23 12.26 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.97 -0.633 . . . . 0.37 112.393 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.35 156.68 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.623 0.249 . . . . 2.46 110.539 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.479 ' HA ' ' O ' ' A' ' 275' ' ' ASP . 69.3 m -137.2 121.07 17.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.41 -0.359 . . . . 1.34 110.513 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 -76.15 0.16 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 2.95 110.503 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.29 -16.72 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.06 -0.256 . . . . 2.08 111.551 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 -114.25 11.99 17.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.233 0.539 . . . . 2.98 110.163 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 92.69 -15.08 63.4 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.324 -0.711 . . . . 1.1 111.324 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.479 ' O ' ' HA ' ' A' ' 270' ' ' SER . 17.2 p-10 -75.05 159.44 31.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.507 . . . . 1.75 110.794 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 163.57 -47.39 0.31 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.893 -0.67 . . . . 1.0 112.156 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.39 172.62 20.8 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.38 112.025 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.6 130.44 56.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.174 0.511 . . . . 0.51 111.07 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . 0.453 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 45.4 m-85 -117.71 159.17 23.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 1.07 110.687 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.0 mm -79.88 120.2 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.919 -0.582 . . . . 0.57 110.227 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.29 -53.41 5.17 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.704 -0.76 . . . . 0.42 112.073 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -155.59 163.76 39.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.841 -0.429 . . . . 1.26 109.841 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.49 128.61 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.95 -0.389 . . . . 0.87 109.95 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -90.86 126.45 36.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 0.96 110.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.57 127.57 31.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 1.45 110.03 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 112.4 -14.37 25.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.42 111.572 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.39 175.1 54.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.982 -0.628 . . . . 0.27 111.778 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.85 79.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.69 0.281 . . . . 0.53 111.027 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.22 -36.93 78.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.58 111.054 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.33 -7.27 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.5 111.703 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.91 37.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.327 -0.397 . . . . 0.55 111.155 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -91.8 -80.2 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.55 110.333 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.22 -18.62 9.53 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.521 -0.847 . . . . 0.39 114.024 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -76.69 -33.38 58.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.55 0.675 . . . . 0.81 111.338 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.0 139.43 17.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.173 -0.467 . . . . 0.74 109.892 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.78 160.63 60.21 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.107 -0.331 . . . . 0.69 110.107 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.45 122.97 12.56 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.386 2.057 . . . . 0.41 111.023 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.82 9.82 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.298 -0.721 . . . . 0.37 111.298 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.414 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 93.6 m-20 -69.09 144.23 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.666 0.269 . . . . 0.34 110.504 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 300' ' ' MET . . . . . 0.453 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 27.3 ttt -100.36 135.38 41.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.381 -0.372 . . . . 1.93 111.1 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.41 123.4 32.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.902 -0.407 . . . . 1.16 109.902 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 75.3 mt -102.12 -64.67 1.04 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 1.07 110.887 -179.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -125.11 136.17 53.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.733 -0.667 . . . . 0.92 110.672 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.494 ' O ' HG23 ' A' ' 307' ' ' VAL . 98.5 t -132.66 103.38 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.8 110.134 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.5 m-20 59.81 65.14 1.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 1.71 111.444 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 58.0 m-20 76.31 -51.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.034 0.934 . . . . 1.11 113.451 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.494 HG23 ' O ' ' A' ' 304' ' ' VAL . 0.0 OUTLIER -63.66 124.35 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.387 0.613 . . . . 1.02 111.852 -178.896 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.59 129.61 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.34 -0.845 . . . . 0.92 109.67 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.131 0.419 . . . . 0.4 112.131 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -63.25 -26.19 68.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.643 0.259 . . . . 1.21 111.637 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -117.14 24.37 11.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.68 0.252 . . . . 1.71 111.68 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.8 mtp -122.23 156.49 33.65 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.788 -0.365 . . . . 0.94 111.501 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 144.0 57.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.724 -0.671 . . . . 0.97 110.388 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 57.5 m-20 -50.86 -49.05 59.86 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.279 0.362 . . . . 0.6 111.463 -179.184 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -47.18 85.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.4 111.309 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.21 -29.16 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.509 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.48 81.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.27 -0.423 . . . . 0.4 110.97 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.537 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -74.28 -23.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.81 -0.356 . . . . 0.93 110.688 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.08 -45.9 79.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.016 0.436 . . . . 1.08 110.168 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.02 -36.37 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.879 -0.601 . . . . 0.42 110.256 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.444 ' CD1' HG13 ' A' ' 304' ' ' VAL . 32.3 tp -56.76 -50.6 71.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.841 -0.618 . . . . 0.78 111.398 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.544 ' HA ' HG11 ' B' ' 3' ' ' VAL . 31.3 mtp180 -61.61 -33.16 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 2.1 111.258 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.71 -45.46 86.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 1.87 109.948 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.48 -42.78 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.58 111.624 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.451 HG11 ' HB ' ' B' ' 3' ' ' VAL . 57.5 t -66.32 -26.83 38.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.93 0.395 . . . . 0.46 111.264 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 15.8 m -86.71 -2.21 58.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.253 0.549 . . . . 0.44 110.474 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 163.86 12.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.411 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.13 144.61 25.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.487 -0.324 . . . . 1.31 110.842 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.21 152.8 8.46 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.677 -0.773 . . . . 0.66 111.994 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.36 139.7 72.74 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.947 2.431 . . . . 0.84 112.15 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 57.9 mt -114.52 134.39 57.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.079 -0.51 . . . . 0.58 111.301 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.5 m -108.63 126.16 52.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.59 -0.522 . . . . 1.49 109.59 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 63.8 mt -110.51 118.2 35.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.075 0.398 . . . . 0.74 112.075 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 89.1 m -98.78 100.28 11.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.767 -0.827 . . . . 0.89 108.767 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.92 155.48 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 0.88 112.005 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -113.61 114.89 27.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.263 -0.88 . . . . 1.06 110.111 179.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.414 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.6 mtpp . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.477 -0.773 . . . . 0.7 109.604 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.463 ' H22' HG11 ' A' ' 318' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.485 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 58.2 m95 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.368 0.128 . . . . 0.5 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.544 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.72 -0.657 . . . . 1.0 109.801 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.26 -0.274 . . . . 1.7 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.36 128.99 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.814 -0.439 . . . . 1.03 109.814 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.36 132.5 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 1.1 110.99 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 13.2 m -109.01 111.4 23.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.414 -0.587 . . . . 1.06 109.414 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.19 149.47 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.77 111.469 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.4 t -115.35 106.84 14.47 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.148 -0.686 . . . . 1.19 109.148 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 57.9 mt -87.91 134.96 33.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.72 111.618 -178.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -79.22 115.9 19.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 0.7 110.508 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 60.9 mmm -99.33 19.59 15.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.073 0.463 . . . . 0.87 110.937 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.22 -52.77 4.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.617 -0.512 . . . . 1.27 109.617 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -82.89 -25.67 32.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 1.23 109.62 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -98.86 160.21 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.93 109.561 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -130.21 12.69 5.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.967 0.413 . . . . 1.35 110.562 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -168.6 165.8 12.13 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.791 -0.641 . . . . 0.82 110.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.0 mt -80.1 -51.51 8.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.639 -0.504 . . . . 0.43 109.639 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.4 43.45 5.55 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.14 112.653 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -144.86 152.16 15.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.489 0.662 . . . . 0.55 111.66 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.407 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 21.5 p -104.22 128.82 52.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.202 -0.908 . . . . 1.57 108.842 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.704 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.6 mm -95.26 123.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.899 0.38 . . . . 0.44 110.551 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 63.1 t -104.08 113.43 40.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.419 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.08 105.65 2.8 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.268 -0.733 . . . . 0.37 111.268 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.75 95.95 1.97 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 2.46 110.768 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.1 m -111.91 106.66 15.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.003 -0.544 . . . . 1.34 110.147 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.458 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 7.5 t30 -104.92 -149.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.684 -0.689 . . . . 2.95 109.522 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.458 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 18.4 p-10 -56.67 -40.85 76.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 2.08 109.819 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.401 ' HB3' ' OD1' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -83.79 -53.97 5.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 2.98 110.021 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.88 0.09 41.96 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.814 -0.708 . . . . 1.1 112.889 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.401 ' OD1' ' HB3' ' A' ' 273' ' ' ARG . 37.3 p-10 -103.61 43.1 1.11 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.182 0.515 . . . . 1.75 111.173 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -76.13 -28.65 59.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.741 . . . . 1.0 112.605 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.74 173.61 25.71 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 0.38 112.28 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.83 124.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.045 0.45 . . . . 0.51 110.741 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -116.38 154.95 29.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 1.07 110.536 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 43.7 mm -74.23 114.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.57 109.869 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -72.93 -58.71 4.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.946 -0.645 . . . . 0.42 112.512 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.8 p -152.98 161.36 42.63 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.215 -0.291 . . . . 1.26 110.215 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 41.2 mt -111.02 135.45 50.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.87 110.273 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.0 mmt -98.54 131.61 44.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 0.96 110.152 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -63.85 131.58 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.45 110.668 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.05 50.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.763 -0.732 . . . . 0.42 111.888 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.16 165.22 54.61 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.972 -0.632 . . . . 0.27 112.264 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.88 -31.62 72.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.616 0.246 . . . . 0.53 111.089 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.42 -42.52 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.58 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.03 -17.91 65.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.54 . . . . 0.5 111.214 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.87 55.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 0.55 111.212 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.14 -75.98 0.46 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.515 -0.311 . . . . 0.55 110.755 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.35 -19.96 16.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.374 -0.917 . . . . 0.39 113.813 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -76.88 -27.72 55.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.568 0.684 . . . . 0.81 111.245 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.17 136.99 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.74 109.934 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.04 161.01 62.06 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.407 -0.36 . . . . 0.69 110.543 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.57 114.11 1.99 Allowed 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.266 1.977 . . . . 0.41 110.896 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.27 -20.07 5.33 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.603 -0.599 . . . . 0.37 111.603 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.45 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 92.2 m-20 -65.9 143.86 57.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.967 -0.383 . . . . 0.34 109.967 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 39.9 ttp -101.85 135.85 42.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.632 0.254 . . . . 1.93 110.334 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 52.7 mt -86.64 121.02 28.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 1.16 110.423 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 27.7 mt -97.14 -77.88 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 1.07 110.269 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -114.58 129.43 56.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.636 -0.711 . . . . 0.92 110.404 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.407 HG13 ' CD1' ' A' ' 321' ' ' LEU . 90.6 t -123.21 97.06 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.367 -0.605 . . . . 0.8 109.367 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.43 HD22 HG21 ' A' ' 331' ' ' ILE . 61.6 m-80 63.05 72.24 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.641 0.588 . . . . 1.71 111.315 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.424 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 21.1 m-20 73.92 -48.12 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.8 1.037 . . . . 1.11 113.8 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.44 125.6 32.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.253 0.549 . . . . 1.02 111.83 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -103.17 123.76 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.627 -0.715 . . . . 0.92 109.744 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.06 8.02 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.441 0.534 . . . . 0.4 112.441 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.16 -22.97 63.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.24 0.459 . . . . 1.21 112.24 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -123.82 37.65 4.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.802 0.334 . . . . 1.71 111.152 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.6 mtp -132.03 164.04 27.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.85 -0.426 . . . . 0.94 109.85 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 p -77.99 155.55 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.286 -0.264 . . . . 0.97 110.286 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 318' ' ' VAL . 93.6 m-20 -52.15 -46.18 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.6 111.086 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -61.28 -51.34 69.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 1.4 111.604 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.465 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 7.4 m-20 -64.77 -34.85 79.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.772 0.286 . . . . 0.88 111.772 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.8 81.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.4 110.943 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.5 t -79.47 -24.42 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.776 -0.369 . . . . 0.93 110.885 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 71.3 mtt180 -57.94 -48.63 79.38 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.437 -0.579 . . . . 1.08 109.437 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -73.36 -36.1 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.792 -0.64 . . . . 0.42 110.158 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.486 ' O ' HG21 ' A' ' 325' ' ' VAL . 20.9 tp -56.13 -51.23 68.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.066 -0.516 . . . . 0.78 110.881 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.486 ' HA ' HG11 ' B' ' 3' ' ' VAL . 16.6 mtp-105 -62.6 -34.4 76.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 2.1 110.93 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.75 -46.95 83.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.561 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.58 111.125 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 321' ' ' LEU . 30.8 t -68.74 -12.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.186 0.517 . . . . 0.46 110.951 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -84.6 -4.41 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.85 0.357 . . . . 0.44 110.696 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 176.45 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.16 110.132 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 112.89 24.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 1.31 110.964 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 167.01 169.74 30.99 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.67 -0.776 . . . . 0.66 112.452 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.71 123.13 11.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.62 2.213 . . . . 0.84 111.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . 0.43 HG21 HD22 ' A' ' 305' ' ' ASN . 66.3 mt -98.5 114.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.207 -0.451 . . . . 0.58 111.098 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.35 111.18 22.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 1.49 110.123 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.03 120.3 41.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.117 -0.492 . . . . 0.74 111.114 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -105.12 98.65 8.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.136 -0.69 . . . . 0.89 109.136 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.13 149.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.88 111.978 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -110.77 109.21 19.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.275 -0.875 . . . . 1.06 109.764 179.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.45 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.267 -0.873 . . . . 0.7 109.958 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.704 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.407 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 18.0 m95 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.425 -0.213 . . . . 0.5 110.425 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.486 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.741 -0.647 . . . . 1.0 109.924 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.975 -0.38 . . . . 1.7 109.975 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.0 mt -104.26 130.71 54.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.738 0.304 . . . . 1.03 111.232 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.6 mt -131.62 138.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 1.1 110.905 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.06 109.91 21.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.118 -0.697 . . . . 1.06 109.118 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.28 158.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.422 . . . . 0.77 111.519 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -123.91 129.35 50.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.893 -0.781 . . . . 1.19 108.893 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 87.1 mt -112.41 141.39 46.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.72 111.862 -178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -82.21 107.93 15.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.7 110.628 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 94.0 mmm -93.86 22.48 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.87 110.905 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -94.74 -47.61 6.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.144 -0.688 . . . . 1.27 109.144 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -86.15 -27.7 24.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.288 -0.869 . . . . 1.23 109.55 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -108.76 135.31 50.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.93 109.806 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -102.63 -0.82 31.3 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.028 -0.269 . . . . 1.35 111.398 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -150.26 162.13 41.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.318 . . . . 0.82 110.956 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.3 mt -75.85 -50.96 13.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.43 109.541 -179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.23 49.54 4.41 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.659 -0.7 . . . . 0.14 112.589 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 2.6 pt -145.48 149.71 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.321 0.582 . . . . 0.55 111.722 179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.36 121.53 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.57 108.871 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.696 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.0 mm -88.56 123.3 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.949 0.404 . . . . 0.44 110.623 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.33 113.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.358 -0.383 . . . . 0.5 110.246 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -85.72 103.79 2.78 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.728 -0.749 . . . . 0.37 111.81 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -76.33 108.41 9.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.612 -0.514 . . . . 2.46 109.612 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 270' ' ' SER . . . . . 0.439 ' HB3' ' HA2' ' A' ' 274' ' ' GLY . 19.8 m -108.5 112.2 24.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.196 -0.457 . . . . 1.34 111.106 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -84.39 -150.97 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.05 -0.523 . . . . 2.95 110.587 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.99 -24.3 66.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.478 -0.328 . . . . 2.08 111.654 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -113.45 12.37 18.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.784 0.326 . . . . 2.98 110.591 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . 0.439 ' HA2' ' HB3' ' A' ' 270' ' ' SER . . . 78.26 8.36 87.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.635 -0.793 . . . . 1.1 112.058 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -93.19 165.39 12.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.72 0.295 . . . . 1.75 110.347 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 151.23 -44.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.867 -0.683 . . . . 1.0 112.054 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.7 170.18 21.01 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.652 -0.785 . . . . 0.38 112.55 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.34 129.4 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.102 0.477 . . . . 0.51 111.008 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -117.69 162.47 18.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 1.07 110.771 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.78 113.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.57 109.999 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.37 -65.09 2.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.42 112.478 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.87 152.73 45.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.759 0.314 . . . . 1.26 110.637 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.78 131.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.079 -0.51 . . . . 0.87 109.912 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -92.86 126.2 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.851 0.358 . . . . 0.96 110.642 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -65.3 128.43 35.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 1.45 109.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.21 -12.85 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.968 -0.634 . . . . 0.42 111.519 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.5 171.08 47.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.934 -0.65 . . . . 0.27 111.73 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.55 -37.52 86.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.53 111.259 -179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.29 -34.2 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.58 111.039 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.67 -20.78 64.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 0.5 111.619 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.7 -6.58 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.457 -0.338 . . . . 0.55 111.057 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.404 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 15.0 t70 -90.97 -76.4 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.938 -0.393 . . . . 0.55 109.938 179.814 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.92 32.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.377 -0.916 . . . . 0.39 114.177 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.404 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 22.8 mtm180 -76.83 -34.99 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.571 0.685 . . . . 0.81 110.937 -179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.76 136.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.678 -0.49 . . . . 0.74 109.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.52 158.65 75.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.522 -0.308 . . . . 0.69 110.697 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.48 99.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.497 2.131 . . . . 0.41 111.434 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 141.66 -15.82 2.66 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.59 -0.604 . . . . 0.37 111.59 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.0 146.41 54.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.732 0.301 . . . . 0.34 110.321 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.3 ttt -99.88 135.27 41.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.266 -0.424 . . . . 1.93 110.75 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 30.1 mt -90.82 117.46 29.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.246 -0.434 . . . . 1.16 109.933 179.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 82.5 mt -100.85 -62.83 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.163 0.506 . . . . 1.07 110.735 -179.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -127.33 133.15 50.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.92 110.912 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.5 HG11 ' CD1' ' A' ' 321' ' ' LEU . 44.4 t -119.62 87.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.173 -0.467 . . . . 0.8 109.76 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.453 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.4 t30 62.96 82.97 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.786 . . . . 1.71 111.437 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.453 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 4.6 m-20 74.8 -59.78 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.427 -0.806 . . . . 1.11 113.11 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.0 m -64.34 124.91 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.589 . . . . 1.02 112.456 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.52 130.02 47.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.466 -0.788 . . . . 0.92 109.628 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.421 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 44.0 m-85 -106.89 15.99 24.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.944 0.349 . . . . 0.4 111.944 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -62.64 -32.8 73.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.122 0.415 . . . . 1.21 112.122 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -117.6 35.81 4.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.392 . . . . 1.71 111.209 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 312' ' ' MET . . . . . 0.421 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 95.3 mtp -123.09 167.67 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.02 -0.363 . . . . 0.94 110.02 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 38.9 p -75.96 154.59 35.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.447 -0.342 . . . . 0.97 110.133 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.46 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -58.37 -32.67 68.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.6 111.109 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -49.82 19.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.207 -0.452 . . . . 1.4 111.063 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.59 -35.16 77.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.257 -0.429 . . . . 0.88 110.974 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.4 73.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.018 -0.537 . . . . 0.4 111.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.53 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 4.0 t -73.5 -31.96 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.3 . . . . 0.93 110.811 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.453 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 78.7 mtt180 -55.45 -50.49 69.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.748 0.309 . . . . 1.08 110.339 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.88 -41.01 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.246 -0.433 . . . . 0.42 110.093 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.5 ' CD1' HG11 ' A' ' 304' ' ' VAL . 17.3 tp -52.5 -48.51 65.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.964 -0.562 . . . . 0.78 111.22 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.53 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 18.3 mtp-105 -62.42 -39.14 92.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.012 -0.54 . . . . 2.1 111.743 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 5.9 mm-40 -65.91 -34.6 78.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.87 110.439 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.3 mt -70.65 -43.93 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.557 . . . . 0.58 110.142 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.416 HG21 ' O ' ' A' ' 321' ' ' LEU . 47.8 t -70.78 -18.75 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.246 0.546 . . . . 0.46 110.507 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 56.5 m -87.05 4.77 40.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.037 0.446 . . . . 0.44 110.204 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.35 158.53 18.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 1.16 109.989 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.91 120.48 35.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.662 0.268 . . . . 1.31 111.066 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.59 169.09 19.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.655 -0.783 . . . . 0.66 112.0 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.05 125.4 10.88 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.913 2.408 . . . . 0.84 111.714 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 60.0 mt -100.36 117.69 45.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.282 -0.417 . . . . 0.58 110.922 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 m -90.97 102.23 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.49 110.093 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 24.7 mt -92.93 123.37 36.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.872 0.367 . . . . 0.74 111.886 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.4 m -107.3 99.23 8.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.543 -0.91 . . . . 0.89 108.543 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.6 m -104.68 155.71 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.88 112.194 -177.787 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.72 111.06 21.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.227 -0.897 . . . . 1.06 109.829 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.311 -0.852 . . . . 0.7 110.144 -179.346 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.696 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 43.4 m95 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 110.665 -0.124 . . . . 0.5 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.489 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.679 -0.677 . . . . 1.0 110.003 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.673 0.273 . . . . 1.7 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.45 109.67 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.608 -0.516 . . . . 1.03 109.608 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.63 127.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.362 -0.381 . . . . 1.1 110.799 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -104.21 103.46 13.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 1.06 110.118 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.38 144.06 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.067 0.46 . . . . 0.77 111.276 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.3 t -114.5 113.68 24.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.087 -0.708 . . . . 1.19 109.087 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 24.0 mt -95.79 152.74 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.359 0.599 . . . . 0.72 112.038 -178.056 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.29 122.18 34.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.84 . . . . 0.7 110.017 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 90.7 mmm -102.51 25.07 9.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.87 111.752 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -100.37 -45.38 5.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.2 ttt180 -92.95 11.43 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.385 0.612 . . . . 1.23 110.178 179.26 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.52 155.69 50.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 0.93 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -111.98 -11.94 13.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.627 0.251 . . . . 1.35 110.833 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . 0.521 ' HB2' ' O ' ' B' ' 3' ' ' VAL . 30.0 p90 -157.31 173.07 17.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.542 -0.299 . . . . 0.82 111.066 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -75.93 -50.95 13.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.584 . . . . 0.43 109.422 179.635 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.9 41.58 5.9 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.517 -0.765 . . . . 0.14 112.823 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.65 146.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.441 0.639 . . . . 0.55 111.767 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.04 115.44 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.0 -1.0 . . . . 1.57 108.704 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.727 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 4.6 mm -85.44 126.65 40.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.44 110.239 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.76 115.84 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.5 110.326 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.32 113.79 4.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.868 -0.682 . . . . 0.37 111.73 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.99 114.32 17.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.909 0.385 . . . . 2.46 110.455 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 51.2 m -119.5 101.54 8.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.079 -0.51 . . . . 1.34 110.196 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -88.34 -146.82 0.15 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.343 -0.39 . . . . 2.95 110.174 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.89 -37.76 88.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 2.08 110.854 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.402 ' HD2' ' OD1' ' A' ' 275' ' ' ASP . 21.2 ttm180 -89.76 -52.3 5.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.6 -0.519 . . . . 2.98 109.6 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.63 -18.35 6.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.497 -0.859 . . . . 1.1 113.159 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.402 ' OD1' ' HD2' ' A' ' 273' ' ' ARG . 31.9 p-10 -85.94 73.45 10.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.651 0.739 . . . . 1.75 111.379 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -101.82 -34.26 4.41 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.745 -0.741 . . . . 1.0 112.118 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.69 165.74 22.54 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.38 112.116 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.0 pt -102.24 128.85 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.193 0.521 . . . . 0.51 110.809 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -118.19 163.97 15.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 1.07 111.12 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.3 mm -85.74 110.68 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.867 -0.606 . . . . 0.57 109.448 178.257 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.79 8.87 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.737 -0.744 . . . . 0.42 112.689 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 163.9 39.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.549 0.214 . . . . 1.26 110.579 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 32.8 mt -114.24 134.32 57.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.87 109.991 179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.9 mmt -96.13 128.42 43.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.375 -0.375 . . . . 0.96 110.277 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.26 131.86 49.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.522 . . . . 1.45 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 101.49 -6.85 55.68 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.963 -0.637 . . . . 0.42 112.176 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.15 171.28 46.09 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.872 -0.68 . . . . 0.27 112.419 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -65.52 -35.41 80.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.311 . . . . 0.53 111.057 179.809 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.89 -35.63 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.58 110.662 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.57 65.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.5 111.182 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -78.89 -16.61 56.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.55 111.069 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.59 -76.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.641 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.89 -18.35 26.62 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.481 -0.866 . . . . 0.39 114.199 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -69.2 -40.05 78.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.568 0.684 . . . . 0.81 111.468 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.3 137.09 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.739 -0.467 . . . . 0.74 109.739 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -138.87 159.05 68.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.504 -0.316 . . . . 0.69 110.616 -179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 118.75 5.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.358 2.039 . . . . 0.41 111.629 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 122.12 -19.72 8.18 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.469 -0.653 . . . . 0.37 111.469 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.424 ' CG ' ' HZ3' ' A' ' 337' ' ' LYS . 84.1 m-20 -65.46 145.49 56.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.656 0.265 . . . . 0.34 110.331 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.3 ttp -101.1 133.84 45.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.443 -0.344 . . . . 1.93 110.516 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.456 HD22 HG13 ' A' ' 335' ' ' VAL . 73.3 mt -88.46 130.19 35.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 1.16 110.205 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 71.4 mt -111.16 -76.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.199 0.523 . . . . 1.07 110.899 179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -115.79 140.61 49.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.92 111.136 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 87.3 t -134.12 101.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.798 -0.637 . . . . 0.8 109.52 179.015 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 7.1 m120 62.3 68.16 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.064 -0.516 . . . . 1.71 111.428 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.93 -51.33 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.251 -0.886 . . . . 1.11 113.373 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.3 m -67.78 130.89 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.27 0.557 . . . . 1.02 111.528 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -105.56 135.61 46.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.421 -0.809 . . . . 0.92 109.767 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . 0.402 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 21.9 m-85 -106.2 11.01 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.951 0.352 . . . . 0.4 111.951 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.5 -32.47 71.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.233 0.457 . . . . 1.21 112.233 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -112.33 32.14 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.022 0.439 . . . . 1.71 111.002 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 312' ' ' MET . . . . . 0.402 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 86.5 mtp -123.81 163.72 20.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.181 -0.463 . . . . 0.94 110.371 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 75.5 p -74.39 156.6 36.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.97 110.274 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.454 ' O ' HG23 ' A' ' 318' ' ' VAL . 90.5 m-20 -55.5 -40.64 72.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.86 0.362 . . . . 0.6 110.483 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.442 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.0 m-20 -68.61 -51.47 42.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 1.4 111.28 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.425 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 28.6 m-20 -61.01 -36.8 80.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.88 111.684 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.28 -48.94 78.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.4 111.245 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.475 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 6.2 t -73.51 -31.87 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.93 110.771 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.442 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 93.1 mtt180 -55.48 -46.52 76.88 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.03 -0.359 . . . . 1.08 110.03 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.51 -38.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.42 110.276 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.508 ' O ' HG21 ' A' ' 325' ' ' VAL . 40.1 tp -54.61 -50.66 67.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.102 -0.499 . . . . 0.78 110.581 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.475 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 27.9 mtp-105 -61.34 -36.43 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.892 -0.595 . . . . 2.1 110.877 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.96 -46.69 89.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.491 . . . . 1.87 110.016 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.11 -41.71 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.788 -0.642 . . . . 0.58 110.878 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.508 HG21 ' O ' ' A' ' 321' ' ' LEU . 65.1 t -65.53 -15.92 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.282 0.563 . . . . 0.46 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 19.8 m -89.96 0.41 57.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.894 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.23 147.5 26.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 1.16 110.417 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.77 103.8 16.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.761 0.315 . . . . 1.31 111.148 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 176.86 -175.4 47.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.661 -0.78 . . . . 0.66 112.049 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.62 112.05 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.025 2.484 . . . . 0.84 112.077 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.81 121.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.58 110.389 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.34 103.17 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.904 -0.589 . . . . 1.49 110.243 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.8 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.74 111.217 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.6 m -96.78 97.42 9.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.763 -0.828 . . . . 0.89 108.763 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . 0.456 HG13 HD22 ' A' ' 301' ' ' LEU . 26.3 m -100.81 154.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.223 0.535 . . . . 0.88 112.228 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -111.56 110.6 21.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.172 -0.922 . . . . 1.06 109.54 178.782 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.424 ' HZ3' ' CG ' ' A' ' 299' ' ' ASP . 26.3 mtpp . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.083 -0.96 . . . . 0.7 110.129 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.727 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 120.587 0.232 . . . . 0.5 110.556 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.521 ' O ' ' HB2' ' A' ' 261' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.762 -0.637 . . . . 1.0 109.799 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.094 0.473 . . . . 1.7 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.35 115.35 28.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.877 -0.602 . . . . 1.03 110.134 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 37.1 mt -120.88 130.94 74.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 1.1 111.132 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.7 m -104.62 102.66 12.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.704 -0.68 . . . . 1.06 109.434 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . 0.421 ' O ' ' HA ' ' A' ' 332' ' ' SER . 21.5 m -90.42 152.38 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.77 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -113.5 125.15 53.89 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.317 -0.623 . . . . 1.19 109.317 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.33 136.97 52.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 0.72 111.791 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -90.94 117.3 29.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.855 . . . . 0.7 109.971 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.9 mmm -94.16 26.78 3.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.87 111.624 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -99.74 -50.42 4.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.538 -0.541 . . . . 1.27 109.538 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -81.83 -20.6 38.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.495 -0.775 . . . . 1.23 109.992 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -119.74 134.0 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.93 110.033 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -93.17 -8.5 42.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.499 0.555 . . . . 1.35 112.499 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -151.76 170.85 18.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.82 111.116 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 4.4 mt -78.67 -53.82 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.886 -0.597 . . . . 0.43 110.466 -179.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.06 5.73 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.14 112.729 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.9 pt -135.14 152.23 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.525 0.678 . . . . 0.55 111.802 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.91 126.5 47.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.993 -1.003 . . . . 1.57 108.812 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.765 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.0 mm -96.34 114.92 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.65 -0.42 . . . . 0.44 110.461 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.6 t -110.53 106.42 20.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.205 -0.452 . . . . 0.5 110.153 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.96 120.71 5.3 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.734 -0.746 . . . . 0.37 111.813 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.99 103.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.982 -0.377 . . . . 2.46 109.982 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 m -108.43 135.12 50.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 1.34 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.476 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 5.3 t30 -159.54 -157.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 2.95 110.145 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.476 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 12.2 p-10 -55.03 -42.61 72.85 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.933 0.493 . . . . 2.08 111.587 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -18.57 55.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.039 0.447 . . . . 2.98 110.796 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 86.76 -63.65 4.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.828 -0.701 . . . . 1.1 112.028 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -84.4 151.29 24.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.471 . . . . 1.75 110.71 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -165.64 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.72 -0.752 . . . . 1.0 111.997 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 141.47 156.65 6.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.694 -0.765 . . . . 0.38 111.981 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.9 pt -102.37 118.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.51 110.37 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.84 150.48 28.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.865 -0.607 . . . . 1.07 110.777 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.2 mm -76.51 115.5 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.271 -0.422 . . . . 0.57 110.001 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -69.89 -58.82 5.96 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.814 -0.708 . . . . 0.42 112.139 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.47 165.08 36.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.152 -0.314 . . . . 1.26 110.152 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.96 138.88 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.707 -0.479 . . . . 0.87 109.707 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 35.2 mmt -102.39 132.17 48.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.817 0.342 . . . . 0.96 110.675 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -70.07 108.25 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 1.45 110.451 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 136.06 -13.08 4.13 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.382 -0.687 . . . . 0.42 111.382 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.3 170.63 39.3 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.27 111.965 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.15 83.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.53 111.382 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.84 -33.34 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.58 111.132 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.56 -15.35 62.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.5 111.541 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.26 -20.09 25.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.288 -0.415 . . . . 0.55 110.942 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.4 -73.35 0.35 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.55 110.351 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.31 -20.56 30.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.48 -0.867 . . . . 0.39 113.57 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -73.37 -35.79 65.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.743 0.771 . . . . 0.81 111.048 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.9 mt -82.86 137.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.591 -0.522 . . . . 0.74 109.591 179.149 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -135.83 158.65 73.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.44 -0.345 . . . . 0.69 110.369 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.34 112.69 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.505 2.137 . . . . 0.41 111.429 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.92 -21.09 5.02 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.101 -0.571 . . . . 0.37 111.94 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.86 146.67 54.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.758 0.313 . . . . 0.34 110.92 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 59.4 ttp -105.9 132.41 52.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.288 -0.414 . . . . 1.93 110.363 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.46 129.92 34.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.347 -0.388 . . . . 1.16 110.491 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 19.3 mt -104.78 -76.6 0.6 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 1.07 110.221 179.515 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -112.1 128.79 56.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.584 -0.734 . . . . 0.92 110.569 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.99 97.68 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.135 -0.484 . . . . 0.8 110.121 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 57.23 77.22 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.71 111.647 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 75.3 -52.83 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.763 1.023 . . . . 1.11 113.763 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.21 132.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.437 0.637 . . . . 1.02 112.349 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -105.67 132.53 51.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.577 -0.738 . . . . 0.92 109.586 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -99.53 3.7 45.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.845 0.313 . . . . 0.4 111.845 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.53 -22.57 65.26 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.654 0.242 . . . . 1.21 111.654 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -118.06 38.24 3.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.71 110.55 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -138.83 159.34 42.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.94 110.397 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 157.34 37.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.537 -0.301 . . . . 0.97 110.549 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.455 ' O ' HG21 ' A' ' 318' ' ' VAL . 83.1 m-20 -54.78 -48.17 73.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.35 -0.387 . . . . 0.6 111.179 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.21 -50.79 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.849 -0.614 . . . . 1.4 111.386 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -65.05 -33.79 76.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.88 111.469 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.07 83.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.319 -0.401 . . . . 0.4 111.307 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.598 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 2.3 t -71.97 -31.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.607 -0.437 . . . . 0.93 110.917 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -56.25 -54.57 43.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.891 0.377 . . . . 1.08 110.613 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.83 -36.4 77.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.42 110.526 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.458 ' O ' HG21 ' A' ' 325' ' ' VAL . 25.3 tp -56.03 -50.83 69.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.78 110.817 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.598 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 30.8 mtp180 -63.74 -31.96 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.745 -0.661 . . . . 2.1 111.292 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -66.13 -45.17 82.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.029 0.442 . . . . 1.87 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.0 mt -67.08 -41.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.899 -0.591 . . . . 0.58 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG21 ' O ' ' A' ' 321' ' ' LEU . 99.0 t -66.77 -19.48 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.159 0.504 . . . . 0.46 110.992 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 55.3 m -87.25 -5.62 58.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.809 0.337 . . . . 0.44 110.406 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.6 133.69 41.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 1.16 110.393 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.97 130.43 39.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.176 -0.465 . . . . 1.31 110.656 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 146.86 -174.57 26.64 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.83 -0.7 . . . . 0.66 112.286 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 127.67 8.12 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.079 2.519 . . . . 0.84 112.129 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.69 123.92 71.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.103 -0.499 . . . . 0.58 110.564 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 332' ' ' SER . . . . . 0.421 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.9 OUTLIER -105.59 117.25 33.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.825 -0.625 . . . . 1.49 110.335 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 78.3 mt -102.05 120.8 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.07 -0.513 . . . . 0.74 111.002 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.1 m -100.54 103.91 15.25 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.336 -0.616 . . . . 0.89 109.336 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.33 145.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.88 112.023 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -94.79 92.95 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.526 -0.761 . . . . 1.06 109.316 178.753 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.49 -0.766 . . . . 0.7 111.196 -178.447 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.765 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 110.162 -0.311 . . . . 0.5 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.49 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.73 -0.653 . . . . 1.0 110.012 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.991 0.424 . . . . 1.7 110.284 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.34 121.4 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.907 -0.588 . . . . 1.03 110.727 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.9 127.11 67.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.477 -0.328 . . . . 1.1 111.221 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 86.8 m -103.63 118.9 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.157 -0.683 . . . . 1.06 109.157 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.48 143.4 22.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 0.77 111.399 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 t -101.33 137.85 39.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.046 -1.094 . . . . 1.19 108.046 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 85.7 mt -119.15 131.24 55.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.107 0.479 . . . . 0.72 111.668 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.07 108.32 13.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.437 -0.801 . . . . 0.7 110.353 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 95.4 mmm -96.0 13.92 25.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.87 110.981 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -85.27 -40.7 16.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 1.27 109.941 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -93.88 -17.13 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.434 0.635 . . . . 1.23 109.898 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -108.01 161.45 14.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.714 -0.676 . . . . 0.93 110.108 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -124.87 -0.66 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.839 -0.344 . . . . 1.35 111.515 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -159.71 164.04 34.25 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.571 -0.286 . . . . 0.82 110.918 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.7 mt -77.39 -49.22 15.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.863 -0.608 . . . . 0.43 109.711 -179.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 81.27 50.85 4.92 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.68 -0.691 . . . . 0.14 112.339 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -145.56 146.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.517 0.675 . . . . 0.55 111.767 -179.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.29 120.25 38.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.974 . . . . 1.57 108.761 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.722 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.3 mm -88.33 127.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.615 -0.434 . . . . 0.44 110.567 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.81 115.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.331 -0.395 . . . . 0.5 110.714 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.63 111.62 4.29 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.201 -0.759 . . . . 0.37 111.201 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 98.14 5.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 2.46 110.215 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 42.1 m -97.76 87.98 4.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.135 0.493 . . . . 1.34 110.718 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -69.43 -64.85 0.8 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 2.95 111.278 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -135.19 -64.18 0.66 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.023 -0.535 . . . . 2.08 109.752 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.597 ' HD2' ' OD1' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -95.13 -17.76 21.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 2.98 110.467 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 112.23 6.0 24.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.721 -0.752 . . . . 1.1 111.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.597 ' OD1' ' HD2' ' A' ' 273' ' ' ARG . 11.8 p-10 -82.85 67.97 9.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.66 0.743 . . . . 1.75 110.534 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.2 -45.42 0.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.535 -0.757 . . . . 1.0 111.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 117.67 161.15 11.94 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.723 -0.751 . . . . 0.38 112.354 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.86 123.34 58.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.365 0.602 . . . . 0.51 110.601 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.0 159.43 19.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.611 -0.722 . . . . 1.07 110.681 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.62 108.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.379 -0.6 . . . . 0.57 109.379 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -68.57 -58.34 7.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.063 -0.589 . . . . 0.42 112.71 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.63 156.22 39.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.673 0.273 . . . . 1.26 110.545 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.23 134.8 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.87 109.915 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 31.3 mmt -96.38 125.06 40.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.337 -0.392 . . . . 0.96 110.166 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.93 120.75 11.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 1.45 110.364 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.82 -12.56 13.29 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.813 -0.708 . . . . 0.42 111.635 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.48 171.66 47.87 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.712 -0.756 . . . . 0.27 111.641 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.47 80.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.836 0.351 . . . . 0.53 111.382 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.41 -35.12 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.58 110.806 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.58 -11.1 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.5 111.958 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -97.19 -5.43 37.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.775 0.322 . . . . 0.55 110.94 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -95.82 -73.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.55 110.04 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.7 -11.54 42.11 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.556 -0.831 . . . . 0.39 114.174 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -81.2 -29.01 34.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.962 0.881 . . . . 0.81 111.289 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.38 138.06 19.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.603 -0.518 . . . . 0.74 109.603 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.19 158.88 71.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.333 -0.247 . . . . 0.69 110.333 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.3 Cg_exo -59.3 114.07 1.87 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.385 2.057 . . . . 0.41 111.455 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.81 -21.36 5.01 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.995 -0.548 . . . . 0.37 111.954 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -70.2 148.03 49.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.611 0.243 . . . . 0.34 110.425 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 57.6 ttp -105.36 139.67 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 1.93 111.05 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.0 mt -87.16 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.377 -0.374 . . . . 1.16 110.51 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 76.3 mt -115.16 -68.29 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 1.07 110.732 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.454 ' OE1' ' HA ' ' A' ' 306' ' ' ASP . 7.7 tt0 -119.65 133.89 55.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.92 110.258 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.642 ' O ' HG21 ' A' ' 307' ' ' VAL . 69.5 t -127.91 116.15 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.187 -0.461 . . . . 0.8 110.935 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.529 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 1.1 m-20 50.73 46.61 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.876 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.529 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 25.6 m-20 81.27 -13.66 0.89 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.73 1.011 . . . . 1.11 113.73 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.642 HG21 ' O ' ' A' ' 304' ' ' VAL . 2.5 m -90.41 137.01 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.938 -0.705 . . . . 1.02 109.988 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -98.03 134.62 40.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.92 111.649 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.18 -0.34 14.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.4 110.989 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.6 -24.72 64.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.451 0.538 . . . . 1.21 112.451 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -125.71 53.95 1.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.115 0.484 . . . . 1.71 111.407 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 94.6 mtp -142.98 169.02 18.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.138 -0.483 . . . . 0.94 110.139 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.3 p -79.1 159.07 27.66 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.767 -0.457 . . . . 0.97 109.767 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.503 ' O ' HG23 ' A' ' 318' ' ' VAL . 94.1 m-20 -58.05 -42.62 85.82 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.199 0.523 . . . . 0.6 110.217 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.405 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -64.87 -55.13 21.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.209 -0.905 . . . . 1.4 111.263 -179.488 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -58.58 -37.31 75.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.392 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.92 63.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.4 111.692 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -70.4 -30.74 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.839 -0.344 . . . . 0.93 110.97 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.405 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 75.4 mtt180 -57.64 -49.93 74.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.023 0.44 . . . . 1.08 110.182 179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.63 -39.57 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.539 . . . . 0.42 110.128 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.505 ' O ' HG21 ' A' ' 325' ' ' VAL . 23.5 tp -56.27 -52.28 65.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.78 110.501 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.472 ' HA ' HG13 ' B' ' 3' ' ' VAL . 70.6 mtp180 -62.3 -36.33 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.759 -0.655 . . . . 2.1 111.014 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -46.12 87.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.389 -0.369 . . . . 1.87 110.153 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.84 -42.38 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.228 -0.442 . . . . 0.58 110.97 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.505 HG21 ' O ' ' A' ' 321' ' ' LEU . 60.3 t -67.18 -17.02 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 0.46 110.948 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.4 m -86.57 3.79 42.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.44 110.727 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 171.62 7.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.16 110.643 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 138.6 37.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.42 -0.355 . . . . 1.31 111.209 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 132.15 169.42 12.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.699 -0.762 . . . . 0.66 112.312 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.7 140.25 42.45 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.758 2.306 . . . . 0.84 112.118 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 69.2 mt -114.31 128.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.35 -0.386 . . . . 0.58 110.859 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.6 p -101.71 120.24 40.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.012 -0.54 . . . . 1.49 110.003 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.4 mt -113.12 118.74 35.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.385 -0.37 . . . . 0.74 111.53 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 85.6 m -101.94 109.62 21.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.379 -0.6 . . . . 0.89 109.379 178.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.28 155.16 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.34 0.59 . . . . 0.88 112.126 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -107.39 103.36 12.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.202 -0.908 . . . . 1.06 109.336 178.891 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.559 -0.734 . . . . 0.7 110.617 -179.606 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.722 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 120.404 0.145 . . . . 0.5 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.472 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.503 -0.554 . . . . 1.0 109.503 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.92 -0.4 . . . . 1.7 109.92 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.9 mt -122.84 129.73 74.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.83 0.348 . . . . 1.03 110.536 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.09 125.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.369 -0.378 . . . . 1.1 110.829 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.449 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 61.2 m -111.8 111.59 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.29 -0.633 . . . . 1.06 109.29 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.44 153.6 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.77 111.494 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.4 t -106.01 133.69 50.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 1.19 109.472 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.5 mt -109.26 132.37 54.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.026 0.441 . . . . 0.72 111.159 -179.354 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.93 114.21 9.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.7 109.998 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.5 mmm -96.57 21.36 9.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.87 111.203 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -93.39 -50.3 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.224 0.535 . . . . 1.27 109.668 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -83.49 -16.92 43.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.66 . . . . 1.23 110.428 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -119.97 135.62 54.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.071 -0.714 . . . . 0.93 109.071 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -101.97 5.76 40.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.138 0.421 . . . . 1.35 112.138 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.54 166.01 31.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.651 0.263 . . . . 0.82 110.725 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 7.6 mt -78.4 -52.61 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.43 109.843 -179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.73 42.85 5.3 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.995 -0.622 . . . . 0.14 112.56 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.0 pt -143.54 149.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.54 . . . . 0.55 111.635 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.548 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 0.3 OUTLIER -98.22 131.92 44.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 1.57 109.343 178.278 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.662 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 12.3 mm -95.8 104.42 15.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.937 0.399 . . . . 0.44 110.673 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 90.5 t -92.32 108.31 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.884 -0.598 . . . . 0.5 110.157 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.0 106.95 3.48 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.834 -0.698 . . . . 0.37 111.994 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -65.65 104.58 1.06 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.249 0.547 . . . . 2.46 110.386 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 21.2 m -112.43 98.54 7.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.706 -0.679 . . . . 1.34 110.908 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . 0.493 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 6.0 t30 -109.54 -157.59 0.62 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.011 -0.541 . . . . 2.95 109.674 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . 0.493 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 27.5 p-10 -55.11 -37.92 67.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 2.08 111.744 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.481 ' HB3' ' OD1' ' A' ' 275' ' ' ASP . 9.2 ttt180 -89.4 -40.7 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.821 0.343 . . . . 2.98 110.365 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 91.09 -12.74 68.21 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.87 -0.681 . . . . 1.1 113.505 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . 0.481 ' OD1' ' HB3' ' A' ' 273' ' ' ARG . 19.7 p-10 -83.09 40.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.23 0.538 . . . . 1.75 111.324 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -74.6 -37.58 45.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.956 -0.64 . . . . 1.0 112.792 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.43 172.59 32.27 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.552 -0.832 . . . . 0.38 112.112 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.2 pt -106.12 129.14 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.218 0.532 . . . . 0.51 111.272 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -119.47 160.15 22.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.725 -0.671 . . . . 1.07 110.676 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.15 116.03 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.708 -0.678 . . . . 0.57 109.399 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.495 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -75.46 -74.47 0.9 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.42 112.44 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 152.51 50.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.221 -0.289 . . . . 1.26 110.221 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 44.7 mt -105.12 128.3 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.87 110.459 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -95.04 127.24 40.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.989 -0.55 . . . . 0.96 111.032 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -64.25 128.45 35.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.45 110.161 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.34 12.91 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.16 -0.776 . . . . 0.42 111.16 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.24 166.94 51.88 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.776 -0.726 . . . . 0.27 111.926 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.84 -32.33 73.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.738 0.304 . . . . 0.53 111.509 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.22 -40.8 80.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.321 -0.4 . . . . 0.58 110.953 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.42 -13.06 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.208 -0.451 . . . . 0.5 111.081 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.34 -11.04 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.55 111.148 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.484 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 30.6 t70 -96.33 -69.89 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.393 -0.367 . . . . 0.55 110.514 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.3 -13.04 40.17 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.284 -0.96 . . . . 0.39 114.823 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.484 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 19.9 mtm180 -81.1 -33.19 33.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.342 1.071 . . . . 0.81 111.143 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.7 mt -80.43 138.42 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.285 -0.635 . . . . 0.74 109.285 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -141.48 162.01 49.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.351 0.119 . . . . 0.69 110.929 -179.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.495 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 50.4 Cg_exo -56.97 118.38 5.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.335 2.023 . . . . 0.41 111.549 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.74 -26.12 5.73 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.743 -0.742 . . . . 0.37 112.119 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 87.4 m-20 -62.06 145.75 52.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.799 0.333 . . . . 0.34 110.471 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.4 ttp -103.04 135.96 43.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 1.93 110.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.1 121.4 30.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.861 -0.422 . . . . 1.16 109.861 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 85.8 mt -100.01 -68.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.327 0.584 . . . . 1.07 110.07 179.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.53 136.32 54.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.414 -0.812 . . . . 0.92 110.768 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.461 HG13 ' CD1' ' A' ' 321' ' ' LEU . 79.5 t -128.73 107.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.427 -0.583 . . . . 0.8 109.427 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.448 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 0.9 OUTLIER 58.32 62.97 1.84 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.072 -0.513 . . . . 1.71 111.286 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 7.7 m-20 76.51 -44.02 0.47 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.94 1.089 . . . . 1.11 113.94 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 304' ' ' VAL . 35.9 m -71.59 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.265 0.555 . . . . 1.02 111.289 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . 0.438 ' ND2' ' HB2' ' A' ' 310' ' ' GLU . 52.5 t30 -105.02 128.7 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.92 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -101.11 2.86 40.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.409 -0.36 . . . . 0.4 111.712 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . 0.438 ' HB2' ' ND2' ' A' ' 308' ' ' ASN . 2.8 mt-10 -49.29 -41.69 38.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.853 0.686 . . . . 1.21 112.853 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -112.8 39.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.331 . . . . 1.71 111.299 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -121.93 179.67 4.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.761 0.315 . . . . 0.94 110.681 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 89.9 p -88.71 155.66 19.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.805 -0.443 . . . . 0.97 109.805 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.464 ' O ' HG23 ' A' ' 318' ' ' VAL . 97.2 m-20 -58.05 -41.14 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 0.6 110.973 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -50.92 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 1.4 111.802 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.41 -32.52 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.88 111.762 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.23 77.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.337 . . . . 0.4 110.863 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.49 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.8 t -73.58 -31.03 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.93 110.657 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.22 -51.67 65.84 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.502 . . . . 1.08 110.314 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.89 -39.74 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.42 110.37 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.461 ' CD1' HG13 ' A' ' 304' ' ' VAL . 25.5 tp -56.1 -52.53 63.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.78 110.95 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.501 ' HA ' HG12 ' B' ' 3' ' ' VAL . 47.4 mtp180 -62.21 -37.94 87.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 2.1 110.991 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.65 -45.28 94.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.665 0.269 . . . . 1.87 110.421 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.53 -42.79 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.58 110.537 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.454 HG21 ' O ' ' A' ' 321' ' ' LEU . 41.6 t -71.15 -9.92 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.279 0.562 . . . . 0.46 111.043 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -90.21 -9.26 48.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.95 0.405 . . . . 0.44 110.76 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.43 159.48 15.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 1.16 110.618 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.23 116.49 29.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.331 -0.395 . . . . 1.31 110.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 166.05 169.82 30.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.82 -0.705 . . . . 0.66 111.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.05 118.96 5.88 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.603 2.202 . . . . 0.84 111.664 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.22 119.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.032 -0.531 . . . . 0.58 110.954 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 m -97.59 112.17 24.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.797 -0.638 . . . . 1.49 110.022 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.449 ' O ' ' HA ' ' A' ' 251' ' ' THR . 96.6 mt -101.3 121.47 41.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.74 111.819 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 99.4 m -106.26 100.04 9.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.89 108.618 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.3 m -101.95 156.56 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.323 0.583 . . . . 0.88 112.335 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.4 113.29 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 1.06 109.459 178.853 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.5 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.324 -0.846 . . . . 0.7 109.969 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.662 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.548 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 30.1 m95 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 110.672 -0.121 . . . . 0.5 110.672 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.501 HG12 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.594 -0.717 . . . . 1.0 109.697 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.948 -0.39 . . . . 1.7 109.948 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.71 124.44 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 1.03 111.335 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 41.3 mt -120.88 133.22 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.146 -0.479 . . . . 1.1 110.19 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 m -107.36 109.8 21.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.091 -0.504 . . . . 1.06 109.924 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.19 152.61 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.862 0.363 . . . . 0.77 111.101 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 8.8 t -117.91 131.08 56.56 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.94 -0.763 . . . . 1.19 108.94 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 64.9 mt -106.77 140.53 39.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 0.72 111.872 -178.346 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.43 119.89 25.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.7 110.077 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 83.4 mmm -101.0 17.74 21.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.963 0.411 . . . . 0.87 111.33 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -88.35 -50.13 6.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.679 -0.489 . . . . 1.27 109.679 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -93.58 11.77 27.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.441 0.639 . . . . 1.23 109.922 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -133.28 159.0 41.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.93 108.964 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -128.66 0.63 5.49 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.575 -0.45 . . . . 1.35 111.615 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.84 165.5 25.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.603 0.24 . . . . 0.82 110.593 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 8.9 mt -75.36 -54.77 6.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.096 -0.502 . . . . 0.43 109.757 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.1 44.1 5.46 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.894 -0.594 . . . . 0.14 112.269 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.9 pt -143.29 150.4 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.536 . . . . 0.55 111.947 -179.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.545 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.0 OUTLIER -100.21 132.89 45.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.231 -0.895 . . . . 1.57 109.011 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.719 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.9 mm -98.99 117.7 44.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.965 0.412 . . . . 0.44 110.469 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.94 106.64 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.456 -0.338 . . . . 0.5 110.536 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.12 118.15 4.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.37 111.732 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.94 98.86 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 2.46 110.431 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.4 m -96.04 86.03 4.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 1.34 110.947 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.01 -176.14 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.857 -0.611 . . . . 2.95 110.133 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -65.8 -21.41 66.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 2.08 110.232 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -81.49 -8.83 59.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 2.98 110.325 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 90.0 -81.23 1.42 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.778 -0.725 . . . . 1.1 111.842 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.04 155.19 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.965 0.412 . . . . 1.75 110.419 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -162.54 -34.46 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 1.0 111.956 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 130.67 156.9 8.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.726 -0.75 . . . . 0.38 111.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.5 pt -107.72 117.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.154 0.502 . . . . 0.51 110.308 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -108.08 151.11 26.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.777 -0.647 . . . . 1.07 111.152 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.83 117.63 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.222 -0.444 . . . . 0.57 110.045 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . 0.523 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -72.63 -64.27 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.166 -0.54 . . . . 0.42 112.146 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.9 m -149.56 161.37 42.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.843 -0.429 . . . . 1.26 109.843 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 57.2 mt -112.49 128.77 68.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.011 0.434 . . . . 0.87 111.166 -179.441 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.9 mmt -87.31 119.15 27.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.688 -0.687 . . . . 0.96 110.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -62.56 117.61 6.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 1.45 110.142 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 126.14 -18.69 6.53 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.131 -0.788 . . . . 0.42 111.131 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.39 175.0 53.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.972 -0.632 . . . . 0.27 111.995 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.2 -37.23 86.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.799 0.333 . . . . 0.53 111.341 -179.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.94 -37.08 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.58 111.368 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.3 66.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.083 -0.508 . . . . 0.5 111.88 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.28 -14.66 40.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.55 111.197 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.04 -74.57 0.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.441 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.86 -9.89 37.46 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.483 -0.865 . . . . 0.39 114.42 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -88.34 -35.21 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.044 0.922 . . . . 0.81 110.348 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 29.8 mt -81.81 138.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.046 -0.724 . . . . 0.74 109.046 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -144.6 162.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.607 -0.27 . . . . 0.69 110.755 -179.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . 0.523 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 52.2 Cg_exo -55.76 117.47 4.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.598 2.199 . . . . 0.41 111.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.56 -24.9 6.05 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.209 -0.757 . . . . 0.37 111.209 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.66 135.44 55.91 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.712 -0.477 . . . . 0.34 109.712 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 46.3 ttp -97.4 130.86 44.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.728 0.299 . . . . 1.93 110.815 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.8 mt -80.51 125.44 29.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 1.16 110.276 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . 0.426 ' CD1' ' HB1' ' A' ' 336' ' ' ALA . 40.2 mt -105.41 -71.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.19 0.519 . . . . 1.07 110.442 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.07 133.68 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.773 -0.649 . . . . 0.92 110.963 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.07 104.16 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.023 -0.535 . . . . 0.8 110.141 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.45 69.11 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 1.71 111.662 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 74.39 -44.68 0.56 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 1.11 114.103 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.0 m -76.87 127.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.606 0.717 . . . . 1.02 111.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -97.4 130.64 44.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.249 -0.887 . . . . 0.92 110.299 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -100.81 2.35 41.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.794 0.294 . . . . 0.4 111.794 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.08 -27.71 63.9 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.17 0.433 . . . . 1.21 112.17 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -109.22 20.3 18.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.7 0.259 . . . . 1.71 111.7 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.0 mtp -118.41 166.54 12.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.94 111.049 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 10.7 p -75.48 162.63 28.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.97 110.355 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 318' ' ' VAL . 52.5 m-20 -60.97 -43.49 98.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.6 110.697 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.53 -56.71 13.87 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.957 -0.565 . . . . 1.4 111.215 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.411 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 8.8 m-20 -58.78 -36.25 74.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.88 112.346 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.3 -47.73 80.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.4 111.374 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.451 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -73.63 -31.52 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.458 -0.337 . . . . 0.93 111.095 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.411 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 88.5 mtt180 -56.9 -46.92 81.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.86 0.362 . . . . 1.08 110.145 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.29 -38.2 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.42 110.114 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.48 ' O ' HG21 ' A' ' 325' ' ' VAL . 37.4 tp -58.32 -51.36 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.78 110.763 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.484 ' HA ' HG11 ' B' ' 3' ' ' VAL . 52.2 mtp180 -61.59 -31.94 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 2.1 110.706 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.78 -51.29 50.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.465 . . . . 1.87 109.743 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.42 -42.76 88.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.986 -0.552 . . . . 0.58 111.344 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.48 HG21 ' O ' ' A' ' 321' ' ' LEU . 61.6 t -69.12 -13.89 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.072 0.463 . . . . 0.46 111.256 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 75.2 m -87.45 -6.61 58.34 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.148 -0.345 . . . . 0.44 110.538 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.41 139.55 31.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.215 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.62 91.34 4.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.115 0.484 . . . . 1.31 111.693 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.27 172.52 44.89 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.829 -0.7 . . . . 0.66 111.694 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.37 143.94 44.51 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.498 2.132 . . . . 0.84 111.893 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 42.3 mt -122.16 125.59 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.915 0.388 . . . . 0.58 111.496 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m -107.07 120.99 43.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.119 -0.697 . . . . 1.49 109.119 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.6 mt -106.39 129.2 54.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.336 0.588 . . . . 0.74 111.903 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.09 97.3 6.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.491 -0.929 . . . . 0.89 108.491 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.99 152.34 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.398 0.618 . . . . 0.88 112.418 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . 0.426 ' HB1' ' CD1' ' A' ' 302' ' ' LEU . . . -111.15 106.79 15.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.924 . . . . 1.06 109.404 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.312 -0.852 . . . . 0.7 110.103 -179.803 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.719 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.545 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 21.5 m95 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 110.15 -0.315 . . . . 0.5 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.484 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.489 -0.767 . . . . 1.0 110.464 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.713 0.292 . . . . 1.7 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.2 mt -91.34 111.34 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.414 . . . . 1.03 110.496 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.29 131.94 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.007 -0.542 . . . . 1.1 110.053 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' THR . . . . . 0.512 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 5.0 m -121.35 105.46 10.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.036 0.446 . . . . 1.06 110.492 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.54 157.89 6.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.105 -0.498 . . . . 0.77 111.051 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.0 t -109.7 122.55 47.73 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.525 -0.546 . . . . 1.19 109.525 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 53.1 mt -94.48 120.69 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.18 -0.464 . . . . 0.72 111.158 -179.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.51 115.39 18.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.7 110.315 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 85.2 mmm -98.12 19.12 14.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.87 111.039 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -88.66 -52.18 5.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 1.27 109.784 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -92.02 2.03 56.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 1.23 110.001 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -127.71 148.41 50.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.968 -0.56 . . . . 0.93 110.333 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.91 -8.19 14.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.367 -0.379 . . . . 1.35 111.504 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.74 169.51 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.755 0.312 . . . . 0.82 111.194 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.79 -51.63 11.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.365 -0.605 . . . . 0.43 109.365 179.374 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.21 39.28 6.45 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.58 -0.736 . . . . 0.14 112.531 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.7 pt -142.31 149.75 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.309 0.575 . . . . 0.55 111.507 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.435 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 23.3 p -105.26 129.29 53.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.32 -0.855 . . . . 1.57 108.892 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.679 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 11.0 mm -89.43 127.01 42.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.786 0.327 . . . . 0.44 110.524 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 79.3 t -115.57 109.82 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.396 . . . . 0.5 110.129 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.14 145.71 18.69 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.757 -0.735 . . . . 0.37 111.933 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -73.6 114.86 12.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.895 0.379 . . . . 2.46 110.828 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 90.75 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 1.34 110.588 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.94 -158.4 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 2.95 109.674 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.55 -33.91 76.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.293 0.568 . . . . 2.08 109.82 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -112.08 -52.48 2.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.309 -0.86 . . . . 2.98 110.127 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 109.65 52.95 0.6 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.821 -0.704 . . . . 1.1 112.03 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.31 27.75 3.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.174 0.511 . . . . 1.75 110.769 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.93 82.41 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.827 -0.701 . . . . 1.0 112.343 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.64 166.65 16.22 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.066 -0.588 . . . . 0.38 112.277 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.7 pt -110.78 132.88 58.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 0.51 110.552 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 163.79 16.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.534 . . . . 1.07 110.785 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.8 mm -84.04 119.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.57 109.786 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -83.69 -66.28 1.51 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.867 -0.682 . . . . 0.42 112.835 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.3 p -137.93 153.38 49.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.729 0.3 . . . . 1.26 110.959 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 70.8 mt -112.78 133.58 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.87 109.815 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.8 mmt -98.01 127.08 43.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.96 110.848 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.17 117.75 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 1.45 110.459 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.86 -16.6 8.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.821 -0.704 . . . . 0.42 111.946 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.22 168.4 53.12 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.837 -0.696 . . . . 0.27 112.021 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.72 76.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.53 111.301 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.4 -37.43 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.967 -0.56 . . . . 0.58 111.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.28 62.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.5 111.614 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -81.3 -27.88 34.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.342 -0.39 . . . . 0.55 110.939 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.29 -71.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.36 -0.382 . . . . 0.55 110.054 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.08 27.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.083 -1.056 . . . . 0.39 114.168 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -76.26 -23.93 54.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.475 0.637 . . . . 0.81 111.002 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 37.0 mt -88.52 130.06 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.427 -0.583 . . . . 0.74 109.427 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.06 162.64 47.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.725 -0.216 . . . . 0.69 110.553 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 129.75 36.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.322 2.015 . . . . 0.41 111.202 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.55 -17.5 28.23 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.533 -0.841 . . . . 0.37 111.83 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.404 ' CG ' ' HZ3' ' A' ' 337' ' ' LYS . 73.6 m-20 -70.55 141.58 51.86 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.702 -0.481 . . . . 0.34 109.702 179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 41.0 ttp -98.97 132.62 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.451 -0.341 . . . . 1.93 111.093 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . 0.473 HD21 HG13 ' A' ' 335' ' ' VAL . 94.4 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 1.16 110.058 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.1 -60.72 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.537 -0.302 . . . . 1.07 111.281 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -126.91 135.33 50.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.386 -0.37 . . . . 0.92 111.076 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 43.0 t -125.7 92.26 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.376 -0.374 . . . . 0.8 110.305 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.38 79.31 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.835 -0.62 . . . . 1.71 111.312 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.67 -57.43 0.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.978 -1.01 . . . . 1.11 113.416 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.17 130.76 28.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.412 0.625 . . . . 1.02 111.641 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -108.02 135.2 49.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.53 -0.759 . . . . 0.92 111.137 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -113.85 18.7 17.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.4 111.187 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.16 -36.56 75.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.584 -0.28 . . . . 1.21 111.662 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.98 49.28 1.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.26 0.552 . . . . 1.71 110.523 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.81 152.95 48.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.94 110.435 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 155.56 40.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 0.97 110.522 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 95.2 m-20 -49.19 -50.82 36.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.008 0.433 . . . . 0.6 111.306 179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.62 -53.14 61.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.483 -0.781 . . . . 1.4 111.206 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.408 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.8 m-20 -56.3 -40.57 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.882 -0.599 . . . . 0.88 111.714 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.83 81.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.141 -0.481 . . . . 0.4 111.392 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.478 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.9 t -78.04 -29.19 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.9 -0.32 . . . . 0.93 111.176 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.408 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 81.2 mtt180 -55.17 -49.99 70.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 1.08 110.286 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.11 -36.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.093 -0.503 . . . . 0.42 110.655 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . . . . . . . . . 19.6 tp -54.68 -48.29 72.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.995 -0.548 . . . . 0.78 111.801 -179.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.504 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.5 mtp180 -64.48 -30.24 71.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.238 -0.437 . . . . 2.1 111.713 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . 0.405 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 9.3 mm-40 -68.76 -39.38 80.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.087 0.47 . . . . 1.87 109.916 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 62.0 mt -71.13 -43.42 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.837 -0.619 . . . . 0.58 111.085 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.466 HG11 ' HB ' ' B' ' 3' ' ' VAL . 63.7 t -66.65 -19.04 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.169 0.509 . . . . 0.46 111.432 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.4 m -87.64 10.98 16.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.99 0.424 . . . . 0.44 110.853 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.64 152.41 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.377 . . . . 1.16 110.28 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.89 101.06 13.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 1.31 111.635 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.98 39.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.954 -0.641 . . . . 0.66 111.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.5 124.93 11.23 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.327 2.018 . . . . 0.84 112.152 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 78.8 mt -104.74 118.65 52.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.58 110.78 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.19 113.18 25.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.998 -0.546 . . . . 1.49 110.641 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . 0.512 ' O ' ' HA ' ' A' ' 251' ' ' THR . 11.5 mt -96.4 119.39 34.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.159 -0.473 . . . . 0.74 111.194 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 93.68 5.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.89 108.635 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . 0.473 HG13 HD21 ' A' ' 301' ' ' LEU . 21.7 m -97.66 152.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.88 112.278 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.03 95.92 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.399 -0.819 . . . . 1.06 109.078 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HZ3' ' CG ' ' A' ' 299' ' ' ASP . 30.0 mtpp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.285 -0.864 . . . . 0.7 110.256 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.679 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.435 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 25.0 m95 . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 110.089 -0.337 . . . . 0.5 110.089 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.504 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.559 -0.734 . . . . 1.0 110.436 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.831 0.348 . . . . 1.7 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 70.7 mt -93.1 119.38 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 1.03 109.868 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.47 137.71 51.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.202 -0.453 . . . . 1.1 111.264 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.23 122.97 48.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.855 -0.612 . . . . 1.06 110.115 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 33.2 m -114.39 143.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.776 0.322 . . . . 0.77 111.019 -179.868 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.43 107.4 18.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 1.19 110.014 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.16 145.18 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 0.72 111.658 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -99.73 117.95 35.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.794 . . . . 0.7 110.078 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.7 mmm -98.75 26.25 5.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.258 -0.428 . . . . 0.87 111.396 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.99 -53.69 3.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 1.27 109.723 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -83.12 -17.4 43.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.554 -0.748 . . . . 1.23 109.822 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -112.28 145.95 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.832 -0.622 . . . . 0.93 109.959 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -111.12 3.23 18.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.683 -0.235 . . . . 1.35 111.616 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -160.03 165.1 32.55 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.746 0.307 . . . . 0.82 110.734 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.43 110.0 -179.435 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.96 4.26 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.791 -0.641 . . . . 0.14 112.843 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.41 151.65 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.51 0.671 . . . . 0.55 112.073 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.74 119.56 38.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.885 -1.052 . . . . 1.57 109.217 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.682 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 4.7 mm -88.34 107.9 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.892 0.377 . . . . 0.44 110.717 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.86 114.2 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.19 -0.459 . . . . 0.5 110.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.66 113.36 4.46 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.782 -0.723 . . . . 0.37 111.92 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -68.54 101.83 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.193 0.521 . . . . 2.46 110.626 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.59 96.32 4.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.667 -0.697 . . . . 1.34 110.449 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -111.91 -94.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.44 -0.345 . . . . 2.95 111.311 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.53 -37.66 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 2.08 111.468 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -44.45 21.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.202 -0.454 . . . . 2.98 111.15 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 101.44 -47.61 1.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.583 -0.818 . . . . 1.1 111.293 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.9 110.39 21.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.397 0.618 . . . . 1.75 109.908 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.32 -33.35 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.879 -0.677 . . . . 1.0 112.428 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 117.75 159.19 11.25 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.722 -0.751 . . . . 0.38 111.637 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.7 pt -103.59 123.9 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.51 110.565 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 157.05 22.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.704 . . . . 1.07 110.9 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.7 mm -78.28 114.13 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.641 -0.709 . . . . 0.57 109.974 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.91 -57.72 3.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.881 -0.676 . . . . 0.42 112.416 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.9 153.81 35.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.243 -0.281 . . . . 1.26 110.243 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.3 mt -108.88 130.18 62.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.87 110.157 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 39.3 mmt -93.85 122.72 36.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.362 -0.381 . . . . 0.96 110.93 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -61.84 120.21 10.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 1.45 109.764 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.64 -16.19 9.02 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.33 -0.708 . . . . 0.42 111.33 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.2 169.13 45.48 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.443 -0.663 . . . . 0.27 111.443 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.22 74.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.555 0.216 . . . . 0.53 111.546 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 84.1 t -67.87 -37.48 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.58 110.836 -179.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.24 -13.28 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.5 111.249 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.16 -13.72 40.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.507 -0.315 . . . . 0.55 111.048 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.15 -70.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.55 110.534 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.44 42.14 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.386 -0.912 . . . . 0.39 114.276 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.16 -22.77 41.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.864 0.832 . . . . 0.81 111.387 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 54.7 mt -89.97 137.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.226 -0.657 . . . . 0.74 109.226 178.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -140.86 163.34 43.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.752 -0.204 . . . . 0.69 110.864 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.32 121.58 10.3 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.216 1.944 . . . . 0.41 111.368 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.43 8.5 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.849 -0.691 . . . . 0.37 112.173 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.4 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 84.1 m-20 -61.4 139.65 58.16 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.34 110.498 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 36.3 ttp -101.12 130.45 47.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.524 -0.307 . . . . 1.93 110.429 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 31.6 mt -84.73 127.48 34.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.389 . . . . 1.16 110.154 179.611 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 62.4 mt -107.19 -73.55 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.236 0.541 . . . . 1.07 110.391 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -108.07 137.65 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.577 -0.738 . . . . 0.92 110.512 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.0 t -132.45 98.05 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.289 -0.634 . . . . 0.8 109.289 179.065 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.9 m120 59.97 71.94 0.55 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.666 -0.697 . . . . 1.71 111.464 -179.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER 76.69 -51.52 0.58 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.957 1.095 . . . . 1.11 113.957 178.06 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.93 131.66 34.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.571 0.582 . . . . 1.02 112.571 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -101.48 131.39 47.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.44 -0.8 . . . . 0.92 109.235 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.35 5.06 50.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.554 0.576 . . . . 0.4 112.554 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -64.44 -22.16 66.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 1.21 111.699 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -107.44 22.5 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.354 -0.384 . . . . 1.71 111.085 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.21 168.89 16.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 0.94 111.07 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.38 156.14 26.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.863 -0.608 . . . . 0.97 110.404 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 80.7 m-20 -53.22 -50.19 65.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.451 -0.34 . . . . 0.6 111.819 -179.405 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.456 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 10.9 t70 -60.77 -52.77 63.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 1.4 110.901 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.5 -35.56 70.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.933 -0.576 . . . . 0.88 111.123 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.4 111.417 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.47 HG11 ' H21' ' B' ' 1' ' ' PHQ . 1.8 t -70.78 -26.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.845 -0.342 . . . . 0.93 111.285 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.456 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 95.5 mtt180 -56.14 -52.36 64.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.631 -0.507 . . . . 1.08 109.631 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.33 -37.28 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.412 -0.813 . . . . 0.42 110.34 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.419 ' O ' HG21 ' A' ' 325' ' ' VAL . 13.5 tp -54.23 -52.82 60.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.78 110.725 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.46 ' HA ' HG11 ' B' ' 3' ' ' VAL . 33.7 mtp180 -64.03 -33.74 76.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 2.1 111.011 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.83 -41.23 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 1.87 110.412 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.8 mt -69.14 -43.04 81.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.937 -0.574 . . . . 0.58 110.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.419 HG21 ' O ' ' A' ' 321' ' ' LEU . 87.3 t -67.03 -21.98 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.068 0.461 . . . . 0.46 111.165 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -83.97 1.94 41.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.768 0.318 . . . . 0.44 110.954 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.7 141.01 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.16 110.269 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 115.13 21.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 1.31 111.659 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 169.18 -170.92 42.83 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.993 -0.622 . . . . 0.66 112.037 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.24 117.18 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.202 2.602 . . . . 0.84 111.806 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 64.8 mt -98.3 118.12 44.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.58 110.95 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.61 110.13 21.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 1.49 110.295 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.05 124.35 45.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.74 111.379 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.67 99.36 9.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.699 -0.852 . . . . 0.89 108.699 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.6 m -98.88 148.23 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.286 0.565 . . . . 0.88 112.232 -178.103 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -105.12 102.79 12.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.33 -0.85 . . . . 1.06 109.966 179.002 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.4 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 28.2 mtpp . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.349 -0.834 . . . . 0.7 109.856 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.682 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.532 0.206 . . . . 0.5 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.46 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.853 0 N-CA-C 109.369 -0.604 . . . . 1.0 109.369 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 43.2 t30 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.808 0.337 . . . . 1.7 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 91.9 mt -92.12 123.21 44.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 1.03 110.512 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.26 122.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.865 0.364 . . . . 1.1 111.074 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.35 120.35 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 1.06 110.104 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 24.8 m -125.49 144.98 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 0.77 111.785 -179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.0 t -110.99 120.94 44.05 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.582 -0.896 . . . . 1.19 108.582 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 64.7 mt -102.81 135.55 44.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.083 0.468 . . . . 0.72 111.766 -178.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.01 120.17 13.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.277 -0.874 . . . . 0.7 110.371 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 87.8 mmm -102.54 17.46 23.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.165 0.507 . . . . 0.87 110.895 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -88.65 -53.19 4.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.121 0.486 . . . . 1.27 109.801 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -80.48 -31.04 37.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.374 -0.83 . . . . 1.23 110.648 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -92.6 157.71 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.677 -0.49 . . . . 0.93 109.677 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -119.18 -7.76 10.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.915 0.388 . . . . 1.35 110.787 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -156.52 173.26 17.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.036 -0.529 . . . . 0.82 110.279 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 9.0 mt -80.57 -52.93 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.43 110.029 -179.697 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.55 46.27 4.37 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.975 -0.631 . . . . 0.14 112.809 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -145.86 149.58 16.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.113 0.483 . . . . 0.55 111.388 179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' SER . . . . . 0.481 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 5.5 p -99.18 124.62 44.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.473 -0.785 . . . . 1.57 109.159 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.682 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 5.3 mm -89.23 111.02 22.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.04 0.448 . . . . 0.44 110.87 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.7 t -105.94 110.43 31.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.103 -0.498 . . . . 0.5 110.986 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.72 119.36 6.09 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.825 -0.702 . . . . 0.37 111.361 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.91 94.64 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 2.46 110.5 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.9 m -97.79 94.06 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.571 -0.741 . . . . 1.34 110.206 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -97.5 -160.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.836 -0.62 . . . . 2.95 109.359 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.53 -21.73 66.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.106 0.479 . . . . 2.08 110.194 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . 0.414 ' O ' ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -80.18 -17.63 51.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.545 -0.752 . . . . 2.98 110.165 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 89.45 -80.5 1.51 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.918 -0.658 . . . . 1.1 111.694 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.11 146.6 33.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.01 -35.9 0.02 OUTLIER Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.771 -0.728 . . . . 1.0 111.6 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 132.58 154.23 7.52 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.838 -0.696 . . . . 0.38 111.756 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.12 119.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.015 0.436 . . . . 0.51 110.147 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.61 159.54 17.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.783 -0.644 . . . . 1.07 111.18 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.99 112.61 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.564 -0.743 . . . . 0.57 109.397 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.18 -55.38 6.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.397 -0.906 . . . . 0.42 112.267 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.9 p -153.29 156.68 38.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.188 -0.301 . . . . 1.26 110.188 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 35.9 mt -106.71 135.73 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.201 -0.454 . . . . 0.87 110.131 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -97.55 134.65 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.224 -0.444 . . . . 0.96 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -70.25 135.84 49.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 1.45 110.006 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.76 -10.26 64.37 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.824 -0.703 . . . . 0.42 111.907 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.03 176.12 53.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.96 -0.638 . . . . 0.27 112.115 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -68.35 -37.98 81.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.73 0.3 . . . . 0.53 111.094 -179.921 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.3 -33.42 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.048 0.451 . . . . 0.58 111.283 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.13 -21.97 66.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.092 -0.504 . . . . 0.5 111.629 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -84.88 -15.01 46.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.359 -0.382 . . . . 0.55 111.419 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.34 -74.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.55 110.968 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.95 -15.94 47.33 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.604 -0.808 . . . . 0.39 114.085 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -80.29 -29.96 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.651 0.725 . . . . 0.81 110.945 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.8 mt -84.55 137.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.751 -0.462 . . . . 0.74 109.751 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -136.7 164.36 43.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.657 -0.247 . . . . 0.69 110.924 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.7 111.77 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.261 1.974 . . . . 0.41 110.615 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.81 -19.02 5.04 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.485 -0.646 . . . . 0.37 111.485 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . 0.428 ' CG ' ' HZ3' ' A' ' 337' ' ' LYS . 95.4 m-20 -69.06 147.53 51.38 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.044 -0.354 . . . . 0.34 110.044 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 26.7 ttt -103.57 136.97 42.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.695 0.283 . . . . 1.93 110.811 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 19.5 mt -88.59 123.13 32.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 1.16 109.828 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 80.5 mt -102.3 -77.66 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.168 0.509 . . . . 1.07 110.586 179.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -113.0 134.29 54.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.92 111.3 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.32 94.33 2.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.144 -0.48 . . . . 0.8 109.889 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . 0.49 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 60.63 75.98 0.39 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.705 -0.68 . . . . 1.71 111.399 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . 0.49 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 56.5 m-20 76.97 -61.44 0.43 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.903 0.881 . . . . 1.11 112.894 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m -63.36 125.89 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.627 0.727 . . . . 1.02 111.986 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.23 132.95 51.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.249 -0.887 . . . . 0.92 109.925 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -104.35 11.09 35.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.568 -0.287 . . . . 0.4 111.434 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.6 -38.54 66.89 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.952 0.406 . . . . 1.21 111.257 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -123.96 59.17 1.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 1.71 110.867 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 87.2 mtp -140.05 163.84 31.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.94 110.051 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.1 m -69.85 147.29 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.821 -0.437 . . . . 0.97 109.821 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -52.59 -47.07 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.744 0.306 . . . . 0.6 111.096 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -50.3 71.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.4 110.91 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.434 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 1.7 m-20 -61.1 -34.74 75.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.88 111.834 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.98 -49.09 78.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.117 -0.492 . . . . 0.4 111.1 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.76 -28.0 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.529 -0.305 . . . . 0.93 110.905 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.434 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 67.5 mtt180 -54.71 -52.04 63.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 1.08 110.571 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 15.4 t -70.42 -39.58 76.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.42 110.618 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.494 ' O ' HG21 ' A' ' 325' ' ' VAL . 21.7 tp -54.26 -49.24 70.01 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.163 -0.471 . . . . 0.78 111.431 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.518 ' HA ' HG11 ' B' ' 3' ' ' VAL . 14.7 mtp-105 -60.9 -37.49 82.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 2.1 111.654 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.33 -38.02 88.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 1.87 110.779 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.36 -41.64 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.091 -0.504 . . . . 0.58 110.692 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.494 HG21 ' O ' ' A' ' 321' ' ' LEU . 40.5 t -69.83 -19.42 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.044 0.45 . . . . 0.46 111.075 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 22.6 m -91.08 2.01 56.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.053 0.454 . . . . 0.44 110.463 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -106.92 137.78 44.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.164 -0.471 . . . . 1.16 110.572 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.81 99.37 3.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 1.31 111.814 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.59 160.3 24.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.054 -0.593 . . . . 0.66 111.757 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.82 130.32 32.56 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.824 2.349 . . . . 0.84 112.229 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 76.3 mt -112.18 121.13 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.58 111.131 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.5 m -105.99 121.33 43.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.931 -0.577 . . . . 1.49 109.893 178.871 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 36.5 mt -104.08 126.71 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.019 -0.537 . . . . 0.74 111.297 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -106.18 98.65 8.31 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.336 -0.986 . . . . 0.89 108.336 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.12 151.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.414 0.626 . . . . 0.88 112.447 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.47 112.01 23.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.174 -0.921 . . . . 1.06 109.973 179.11 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . 0.428 ' HZ3' ' CG ' ' A' ' 299' ' ' ASP . 25.6 mtpp . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.393 -0.813 . . . . 0.7 109.803 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.682 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . 0.481 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 16.8 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.58 -0.156 . . . . 0.5 110.58 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.518 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.752 -0.642 . . . . 1.0 110.077 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.139 0.495 . . . . 1.7 109.976 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.7 mt -95.58 127.76 47.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.202 -0.453 . . . . 1.03 110.926 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.23 129.38 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.439 -0.346 . . . . 1.1 110.681 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 6.9 m -100.08 110.17 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.149 -0.686 . . . . 1.06 109.149 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.85 154.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.121 0.486 . . . . 0.77 111.385 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.3 t -122.44 126.24 47.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.998 -0.741 . . . . 1.19 108.998 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' LEU . . . . . 0.419 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 66.7 mt -114.21 149.16 36.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.72 111.492 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.8 120.09 34.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.589 -0.732 . . . . 0.7 110.116 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 99.8 mmm -101.1 16.99 23.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.11 0.481 . . . . 0.87 111.223 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.217 -0.66 . . . . 1.27 109.217 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -91.65 -16.32 27.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.478 -0.783 . . . . 1.23 109.9 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -114.39 145.37 41.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.9 -0.591 . . . . 0.93 109.933 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -107.9 -7.94 16.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.742 0.306 . . . . 1.35 111.673 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -151.7 168.91 23.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.492 -0.322 . . . . 0.82 110.932 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 5.8 mt -77.94 -55.17 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.43 109.637 179.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 91.24 43.79 4.56 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.726 -0.67 . . . . 0.14 112.331 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 8.1 pt -139.74 151.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.397 0.617 . . . . 0.55 111.736 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 t -103.1 128.51 49.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.841 -1.072 . . . . 1.57 108.795 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ILE . . . . . 0.66 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.4 mm -97.54 113.87 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.989 0.423 . . . . 0.44 110.744 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.41 114.11 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.342 -0.39 . . . . 0.5 110.101 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.75 108.86 3.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.545 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -87.25 112.33 21.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.749 0.309 . . . . 2.46 110.328 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 41.9 m -117.66 108.69 15.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 1.34 111.018 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -68.68 -55.5 11.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 2.95 110.473 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.09 -49.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.547 -0.297 . . . . 2.08 111.573 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 23.87 8.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 2.98 111.467 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.66 10.9 32.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.342 -0.932 . . . . 1.1 111.483 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.33 116.66 17.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.241 -0.48 . . . . 1.75 110.042 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 164.62 -65.54 0.23 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.616 -0.802 . . . . 1.0 111.964 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 123.0 175.39 14.55 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.766 -0.73 . . . . 0.38 112.127 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -106.08 118.09 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.374 0.607 . . . . 0.51 110.629 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.0 152.73 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.743 -0.662 . . . . 1.07 110.94 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.13 113.36 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.466 . . . . 0.57 110.128 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.33 -60.05 3.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.877 -0.677 . . . . 0.42 112.33 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.07 160.96 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.54 0.209 . . . . 1.26 110.524 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.92 131.98 64.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.778 -0.453 . . . . 0.87 109.778 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.2 mmt -97.99 128.29 44.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.778 0.323 . . . . 0.96 110.759 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -66.45 132.89 49.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.45 110.308 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.86 -12.7 32.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.93 -0.653 . . . . 0.42 111.552 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -87.36 171.82 42.44 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.024 -0.608 . . . . 0.27 111.826 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 288' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.12 -36.65 83.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.53 111.518 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.76 -35.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.58 111.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.79 -14.09 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.5 111.91 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.71 -23.56 25.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 0.55 110.728 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 292' ' ' ASP . . . . . 0.417 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 13.0 t70 -77.98 -68.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.55 110.215 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.46 -20.38 46.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.431 -0.89 . . . . 0.39 113.991 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 294' ' ' ARG . . . . . 0.417 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 72.7 mtm180 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.716 0.758 . . . . 0.81 110.927 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.1 mt -75.62 136.02 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.593 -0.521 . . . . 0.74 109.593 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.42 161.16 64.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.539 -0.3 . . . . 0.69 110.443 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.74 109.41 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.2 1.933 . . . . 0.41 111.041 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 131.86 -15.79 5.1 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.153 -0.546 . . . . 0.37 111.737 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -70.61 149.59 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.241 -0.281 . . . . 0.34 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 27.0 ttp -107.15 135.94 47.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.556 -0.293 . . . . 1.93 110.613 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 mt -89.3 119.22 29.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.135 -0.484 . . . . 1.16 109.829 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 67.2 mt -100.99 -64.33 1.06 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.084 0.469 . . . . 1.07 110.705 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 303' ' ' GLN . . . . . 0.438 ' HG3' ' O ' ' A' ' 307' ' ' VAL . 5.1 tt0 -120.6 133.23 55.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.92 110.815 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 304' ' ' VAL . . . . . 0.425 ' O ' HG21 ' A' ' 307' ' ' VAL . 59.0 t -129.14 104.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.258 -0.428 . . . . 0.8 110.536 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 58.07 70.32 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 1.71 111.483 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.89 -44.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.994 1.109 . . . . 1.11 113.994 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 307' ' ' VAL . . . . . 0.438 ' O ' ' HG3' ' A' ' 303' ' ' GLN . 32.2 m -74.15 139.22 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.354 0.597 . . . . 1.02 111.36 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -111.66 135.64 51.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.69 -0.686 . . . . 0.92 110.379 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -109.26 11.84 25.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.286 . . . . 0.4 111.661 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.98 -29.01 70.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.845 0.313 . . . . 1.21 111.845 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -117.98 36.31 4.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.792 0.33 . . . . 1.71 111.07 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.3 mtp -129.68 153.07 48.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.489 -0.323 . . . . 0.94 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 149.9 49.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.132 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -51.59 -47.67 63.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.443 -0.344 . . . . 0.6 111.602 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 315' ' ' ASP . . . . . 0.465 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.1 OUTLIER -57.8 -50.03 74.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 1.4 111.009 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 316' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 29.8 m-20 -63.75 -37.44 87.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.88 111.815 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.28 -51.09 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.4 111.634 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 318' ' ' VAL . . . . . 0.545 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -72.92 -30.46 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.688 -0.405 . . . . 0.93 110.992 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 319' ' ' ARG . . . . . 0.465 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 80.5 mtt180 -56.11 -46.52 79.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.884 0.373 . . . . 1.08 110.499 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.47 -40.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.42 110.504 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 321' ' ' LEU . . . . . 0.401 ' CD1' HG11 ' A' ' 304' ' ' VAL . 31.5 tp -54.36 -47.77 72.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.12 -0.491 . . . . 0.78 111.417 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 322' ' ' ARG . . . . . 0.545 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 25.6 mtp-105 -64.96 -29.58 70.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.955 -0.566 . . . . 2.1 111.871 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -69.07 -40.42 78.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.153 0.501 . . . . 1.87 110.003 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.66 -44.55 85.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.685 . . . . 0.58 110.718 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 325' ' ' VAL . . . . . 0.428 HG11 ' HB ' ' B' ' 3' ' ' VAL . 40.8 t -69.2 -18.65 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.483 . . . . 0.46 111.594 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -91.75 3.55 54.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.44 110.875 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 148.77 33.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 1.16 110.24 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.0 139.98 36.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.497 -0.32 . . . . 1.31 110.49 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 143.06 -173.62 24.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.662 -0.78 . . . . 0.66 112.308 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.5 117.18 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.424 2.749 . . . . 0.84 112.21 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.6 mt -96.88 119.23 44.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.58 111.258 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.59 115.2 28.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 1.49 110.169 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 49.9 mt -104.45 125.36 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.87 0.367 . . . . 0.74 111.36 -178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 103.05 11.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.563 . . . . 0.89 109.812 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.7 m -103.96 158.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.191 -0.458 . . . . 0.88 111.691 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -118.34 108.72 15.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.488 -0.778 . . . . 1.06 110.195 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.263 -0.875 . . . . 0.7 110.223 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' PHQ . . . . . 0.66 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.377 0.132 . . . . 0.5 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' VAL . . . . . 0.53 HG13 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.727 -0.654 . . . . 1.0 109.997 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.258 -0.275 . . . . 1.26 110.258 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.7 mt -102.64 122.3 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.293 -0.262 . . . . 0.65 110.293 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 27.0 mm -120.13 124.21 72.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 0.55 110.832 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -110.36 111.86 23.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.769 -0.456 . . . . 0.59 109.769 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.87 156.21 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.5 111.434 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -124.85 113.91 18.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.218 -1.03 . . . . 0.79 108.218 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 76.5 mt -97.82 137.97 35.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.622 0.601 . . . . 0.46 112.622 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.16 110.73 14.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.088 -0.96 . . . . 0.65 109.962 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 71.6 mmm -94.87 21.04 8.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.268 -0.424 . . . . 0.63 111.338 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -93.14 -51.06 5.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.21 -0.663 . . . . 1.27 109.21 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -87.24 1.88 51.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.627 -0.715 . . . . 1.06 110.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -128.38 154.96 45.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.878 -0.601 . . . . 0.76 109.464 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -124.89 7.82 8.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 1.09 111.023 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.7 164.7 23.77 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.286 -0.416 . . . . 0.62 110.659 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.1 mt -79.52 -56.38 4.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.469 -0.567 . . . . 0.34 109.469 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.77 43.18 4.25 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.664 -0.698 . . . . 0.14 112.681 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.77 150.34 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.18 112.186 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 22.7 t -98.99 131.36 45.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.751 -1.113 . . . . 1.0 108.198 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.453 HG21 HG22 ' A' ' 318' ' ' VAL . 6.7 mm -98.09 115.79 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.967 0.413 . . . . 0.28 110.752 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 267' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 278' ' ' ILE . 62.1 t -86.84 126.07 40.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.84 88.64 0.86 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.972 -0.632 . . . . 0.37 112.337 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 120.852 0.358 . . . . 1.87 110.266 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 120.953 0.196 . . . . 0.3 112.613 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 278' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 8.3 pt -103.53 123.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.177 0.513 . . . . 0.27 110.432 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.7 156.84 21.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.964 -0.562 . . . . 0.72 111.354 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.97 118.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.24 109.998 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -88.74 -112.69 1.21 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.675 -0.774 . . . . 0.42 111.973 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.62 139.31 31.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.872 0.368 . . . . 0.75 111.445 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.19 132.59 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.16 -0.681 . . . . 0.53 109.16 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 33.9 mmt -95.1 134.83 37.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.517 -0.311 . . . . 0.74 110.994 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.47 133.14 46.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.01 110.199 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.79 -17.81 44.89 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.665 -0.778 . . . . 0.36 111.647 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.6 167.11 54.76 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.019 -0.61 . . . . 0.26 112.131 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.75 -35.25 79.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.723 0.297 . . . . 0.25 111.387 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.67 -42.56 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.26 110.804 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.96 -17.64 64.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.37 111.496 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.66 -21.27 44.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.41 111.135 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.69 -82.21 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.214 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 122.02 -21.45 7.85 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.25 -0.976 . . . . 0.39 113.764 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -66.43 -31.12 71.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.466 0.633 . . . . 0.68 111.277 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 51.3 mt -89.35 132.85 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.337 -0.616 . . . . 0.37 109.337 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.81 165.12 36.23 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.69 110.42 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.51 119.68 7.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.022 1.815 . . . . 0.41 111.47 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 121.99 -21.31 7.9 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.585 -0.817 . . . . 0.29 112.273 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 91.3 m-20 -65.79 141.31 58.35 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.318 -0.253 . . . . 0.34 110.318 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.6 ttp -100.86 132.4 46.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.059 -0.256 . . . . 1.26 110.553 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 34.3 mt -82.09 123.07 28.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.561 -0.29 . . . . 0.48 110.554 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 336' ' ' ALA . 63.9 mt -102.69 -72.54 0.69 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.626 0.726 . . . . 0.53 110.137 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -116.52 134.25 55.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.103 -0.953 . . . . 0.73 110.971 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 321' ' ' LEU . 94.7 t -124.22 96.97 4.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.29 109.34 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.2 t-20 60.47 73.87 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.71 111.461 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.7 m-20 75.86 -50.03 0.61 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.734 1.013 . . . . 1.11 113.734 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.36 130.02 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.57 . . . . 0.71 112.405 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.64 123.14 46.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.74 110.269 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -95.69 6.77 48.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.33 111.598 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.46 -12.36 30.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.319 0.489 . . . . 1.21 112.319 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -126.42 26.89 6.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.218 0.532 . . . . 1.32 110.63 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.2 mtp -125.5 163.02 23.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.259 -0.428 . . . . 0.51 109.987 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 17.9 p -72.08 157.81 37.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.584 0.23 . . . . 0.97 110.646 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 70.4 m-20 -54.94 -43.49 73.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.48 111.168 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -63.84 -52.82 58.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 1.4 110.878 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.99 -39.2 77.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.897 -0.592 . . . . 0.88 111.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.36 -54.33 47.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.2 111.892 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.453 HG22 HG21 ' A' ' 266' ' ' ILE . 3.0 t -70.58 -30.89 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.002 -0.279 . . . . 0.21 111.123 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 58.8 mtt180 -55.77 -52.39 64.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.001 -0.37 . . . . 0.83 110.001 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.27 -37.48 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.17 110.453 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 304' ' ' VAL . 20.7 tp -55.99 -49.33 73.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.073 0.463 . . . . 0.38 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.8 mtp180 -62.34 -35.59 79.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.764 -0.653 . . . . 1.57 111.106 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 17.3 mm-40 -64.84 -36.32 83.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.8 0.333 . . . . 1.87 110.868 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.1 mt -73.61 -40.77 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.416 . . . . 0.29 110.502 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.3 t -70.32 -21.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.24 110.397 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.8 m -90.21 33.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -144.13 170.9 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 1.16 109.704 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.46 149.43 22.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.393 . . . . 0.89 111.503 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.14 158.64 10.17 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.117 -0.563 . . . . 0.45 112.332 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 133.71 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.871 2.381 . . . . 0.58 111.837 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.4 mt -103.5 120.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.967 0.413 . . . . 0.37 111.553 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.86 108.65 20.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.833 -0.621 . . . . 1.09 110.093 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.88 122.97 45.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.268 -0.423 . . . . 0.48 111.652 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.9 m -108.04 104.52 13.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.642 . . . . 0.5 109.265 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.4 153.65 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.33 112.136 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.754 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.53 111.17 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 0.38 110.176 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.432 -0.794 . . . . 0.7 109.347 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 17.4 m95 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 110.147 -0.316 . . . . 0.4 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.741 -0.647 . . . . 0.27 110.458 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.089 0.471 . . . . 1.26 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 83.0 mt -79.76 129.59 37.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.185 -0.461 . . . . 0.65 110.135 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.409 HD12 ' HD3' ' A' ' 337' ' ' LYS . 39.7 mt -128.77 131.83 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.55 110.789 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 m -106.2 112.5 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.585 -0.524 . . . . 0.59 109.585 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.57 150.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.902 0.382 . . . . 0.5 111.045 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -116.78 117.29 29.35 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.79 -0.819 . . . . 0.79 108.79 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 69.9 mt -106.53 152.53 23.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.167 0.508 . . . . 0.46 111.952 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -100.27 126.19 46.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.451 -0.795 . . . . 0.65 110.36 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 79.7 mmm -104.58 22.69 14.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.63 111.752 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -95.46 -52.08 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.386 -0.598 . . . . 1.27 109.386 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -79.81 -26.63 40.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 1.06 109.495 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -110.42 150.7 28.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.76 109.151 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -123.66 12.6 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.461 -0.495 . . . . 1.09 111.105 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -161.24 162.37 31.1 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.077 -0.51 . . . . 0.62 110.099 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.9 mt -77.88 -52.21 9.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.34 110.07 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.91 43.01 6.14 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.85 -0.614 . . . . 0.14 112.394 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 262' ' ' LEU . 9.1 pt -136.94 154.02 30.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.441 0.639 . . . . 0.18 112.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 21.5 t -106.49 121.43 44.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.786 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 9.0 mm -91.25 132.49 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.709 0.29 . . . . 0.28 110.844 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.05 124.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.412 . . . . 0.31 110.032 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.12 113.63 4.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.816 -0.706 . . . . 0.37 112.102 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.87 110.557 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 111.848 -0.501 . . . . 0.3 111.848 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 7.6 pt -100.5 126.4 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.171 0.51 . . . . 0.27 111.103 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 84.9 m-85 -117.68 159.27 23.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 0.72 110.871 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.99 112.14 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.296 -0.631 . . . . 0.24 109.296 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.55 -56.68 3.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.888 -0.672 . . . . 0.42 112.88 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.17 161.41 38.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.627 -0.138 . . . . 0.75 110.627 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 31.1 mt -122.35 131.35 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.53 110.335 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.8 mmt -96.08 115.56 27.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.406 -0.361 . . . . 0.74 110.456 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -64.04 109.77 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.472 . . . . 1.01 110.015 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 142.45 -23.06 2.37 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.877 -0.889 . . . . 0.36 110.877 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.73 177.81 53.88 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.155 -0.545 . . . . 0.26 112.216 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.47 73.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.656 0.243 . . . . 0.25 111.656 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 295' ' ' ILE . 84.7 t -71.11 -41.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.26 111.358 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.7 -18.62 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.37 111.68 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.22 -14.37 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.215 -0.448 . . . . 0.41 111.143 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -88.27 -72.52 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.775 0.321 . . . . 0.55 110.523 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.35 -19.98 26.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.453 -0.879 . . . . 0.39 113.853 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -69.9 -37.49 76.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.418 0.609 . . . . 0.68 110.976 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.464 HD12 HG13 ' A' ' 289' ' ' VAL . 59.6 mt -78.83 135.14 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.743 -0.465 . . . . 0.37 109.743 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.99 161.07 61.8 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.414 . . . . 0.69 110.119 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.21 124.08 15.33 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.195 1.93 . . . . 0.41 111.178 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.14 -16.0 18.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.662 -0.78 . . . . 0.29 111.938 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 90.7 m-20 -67.43 142.79 56.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.813 -0.44 . . . . 0.34 109.813 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 300' ' ' MET . . . . . 0.4 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 28.0 ttt -101.61 136.31 41.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.664 0.268 . . . . 1.26 110.766 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.3 124.99 34.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.373 . . . . 0.48 110.032 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 68.8 mt -105.47 -72.47 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.42 . . . . 0.53 110.453 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.8 135.14 54.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.935 -0.575 . . . . 0.73 110.744 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.33 106.44 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.882 -0.599 . . . . 0.29 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.5 m-20 61.4 62.93 1.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.987 -0.551 . . . . 1.71 111.455 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 29.0 m-20 75.12 -45.94 0.58 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.339 1.237 . . . . 1.11 114.339 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.1 m -71.11 130.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.199 0.523 . . . . 0.71 111.467 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -103.42 140.33 37.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.74 110.319 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.8 5.46 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.321 . . . . 0.33 111.729 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.25 -26.38 66.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.975 0.361 . . . . 1.21 111.975 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -116.74 26.39 9.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.263 0.554 . . . . 1.32 110.904 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 97.3 mtp -118.79 165.77 13.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.314 -0.403 . . . . 0.51 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 27.4 p -75.84 164.8 25.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.97 109.855 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 318' ' ' VAL . 86.7 m-20 -63.78 -36.65 84.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.249 0.547 . . . . 0.48 109.666 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 5.6 t70 -71.29 -53.77 13.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 1.4 110.992 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.24 -35.82 72.28 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.818 -0.628 . . . . 0.88 111.743 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.49 69.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.134 -0.484 . . . . 0.2 112.002 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 314' ' ' ASN . 0.9 OUTLIER -69.82 -29.02 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.926 -0.31 . . . . 0.21 111.003 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 82.8 mtt180 -55.82 -48.06 76.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.281 0.562 . . . . 0.83 110.068 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.3 -41.61 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.17 110.5 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 325' ' ' VAL . 22.6 tp -54.05 -50.2 67.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.38 111.456 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.586 ' HA ' HG11 ' B' ' 3' ' ' VAL . 63.4 mtp180 -62.41 -36.84 83.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.57 111.005 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -63.16 -44.0 96.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 1.87 110.478 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.59 -47.94 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.078 -0.51 . . . . 0.29 111.159 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 321' ' ' LEU . 24.8 t -69.06 -15.19 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.133 0.492 . . . . 0.24 111.347 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 68.8 m -86.06 -5.73 59.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.818 0.342 . . . . 0.44 110.865 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.4 148.72 24.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.236 -0.438 . . . . 1.16 110.528 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 88.21 7.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.066 -0.515 . . . . 0.89 111.356 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -166.26 173.63 41.76 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.959 -0.639 . . . . 0.45 112.187 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.03 141.05 62.45 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.685 2.257 . . . . 0.58 112.371 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 72.2 mt -119.83 123.85 71.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.172 0.51 . . . . 0.37 111.442 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.8 m -112.35 102.61 10.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.554 -0.748 . . . . 1.09 109.435 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.73 121.03 33.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.48 111.801 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.9 m -103.53 98.91 8.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.826 -0.805 . . . . 0.5 108.826 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.42 152.48 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.503 0.557 . . . . 0.33 112.503 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -109.49 108.27 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.38 110.012 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' A' ' 250' ' ' ILE . 24.8 mtpp . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.092 -0.956 . . . . 0.7 109.74 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.9 m95 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.463 0.173 . . . . 0.4 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.848 -0.596 . . . . 0.27 109.69 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.905 -0.406 . . . . 1.26 109.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.15 126.01 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.283 -0.417 . . . . 0.65 110.659 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 23.5 mt -123.46 126.37 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.55 111.484 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 103.57 15.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.27 -0.641 . . . . 0.59 109.27 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 13.4 m -102.15 160.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 0.5 111.509 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.8 t -122.86 142.52 50.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.514 -0.921 . . . . 0.79 108.514 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.564 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.7 mt -123.85 136.36 54.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.209 0.528 . . . . 0.46 112.101 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.45 111.85 14.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.393 -0.821 . . . . 0.65 109.832 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.3 mmm -96.21 17.85 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.63 110.911 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.7 -50.53 6.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.507 0.67 . . . . 1.27 109.229 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -88.95 0.05 56.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.92 -1.036 . . . . 1.06 110.186 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -130.28 133.18 46.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.76 110.276 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.61 15.39 25.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.567 -0.288 . . . . 1.09 110.783 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -166.54 166.64 16.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.24 -0.436 . . . . 0.62 110.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.5 mt -82.77 -52.54 6.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.189 -0.46 . . . . 0.34 109.988 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.74 43.11 5.54 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.891 -0.595 . . . . 0.14 112.98 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.83 150.6 20.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.656 0.741 . . . . 0.18 111.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 12.1 t -100.46 124.51 46.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.874 -1.057 . . . . 1.0 108.691 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 6.5 mm -91.1 114.81 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.28 110.854 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.01 112.31 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.31 110.254 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.15 101.79 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.939 -0.648 . . . . 0.37 112.156 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 110.122 -0.325 . . . . 1.87 110.122 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 111.834 -0.507 . . . . 0.3 111.834 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.5 pt -98.9 123.62 51.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.273 0.559 . . . . 0.27 110.557 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -111.21 156.22 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.716 -0.675 . . . . 0.72 110.604 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.99 118.46 30.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.12 -0.491 . . . . 0.24 109.866 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -89.76 -101.95 1.1 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.519 -0.848 . . . . 0.42 112.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.18 138.88 31.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.663 0.268 . . . . 0.75 111.094 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 69.8 mt -105.28 129.79 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.353 -0.61 . . . . 0.53 109.353 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 26.1 mmt -95.54 123.69 39.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.934 0.397 . . . . 0.74 111.202 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -67.37 122.56 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 1.01 109.809 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 122.73 -20.78 7.68 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.469 -0.652 . . . . 0.36 111.469 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.55 172.65 55.27 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.803 -0.713 . . . . 0.26 112.104 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -36.18 82.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.754 0.312 . . . . 0.25 111.099 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.14 -35.34 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.575 . . . . 0.26 111.115 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.86 -11.52 60.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.37 111.776 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -94.71 -10.17 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.104 0.478 . . . . 0.41 110.462 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.83 -77.12 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.55 110.239 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.0 -16.34 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.653 -0.784 . . . . 0.39 113.699 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -81.39 -36.1 29.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.417 0.608 . . . . 0.68 111.433 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.5 mt -80.04 134.29 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.421 -0.354 . . . . 0.37 110.307 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.51 168.11 16.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.69 110.292 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.75 128.23 25.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.984 1.789 . . . . 0.41 111.49 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.88 -14.6 31.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.821 -0.704 . . . . 0.29 112.299 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.95 141.97 52.95 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.647 -0.501 . . . . 0.34 109.647 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 35.9 ttp -101.36 132.14 47.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.643 0.259 . . . . 1.26 110.859 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.64 120.62 29.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.027 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 336' ' ' ALA . 43.3 mt -101.29 -69.09 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.132 0.492 . . . . 0.53 110.359 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -111.9 133.82 53.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.744 -0.662 . . . . 0.73 110.563 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.8 t -123.64 94.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.964 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.1 t30 58.83 72.9 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.472 -0.786 . . . . 1.71 111.761 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 73.3 m-20 78.3 -48.4 0.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.422 0.897 . . . . 1.11 113.422 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.66 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.229 0.538 . . . . 0.71 111.657 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -103.08 137.51 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.698 -0.683 . . . . 0.74 110.413 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.59 13.0 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.477 -0.329 . . . . 0.33 111.06 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.73 6.11 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.115 0.413 . . . . 1.21 112.115 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.25 33.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.348 0.594 . . . . 1.32 110.068 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.7 mtp -134.31 159.17 41.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.51 110.498 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.06 153.36 43.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.97 110.746 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.1 m-20 -54.18 -46.34 72.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.48 110.961 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.1 t70 -62.06 -48.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.881 -0.599 . . . . 1.4 110.779 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.87 -38.59 76.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.74 -0.664 . . . . 0.88 111.331 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.37 70.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.997 -0.547 . . . . 0.2 111.645 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.3 t -69.88 -27.73 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.956 -0.298 . . . . 0.21 111.298 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 88.3 mtt180 -58.23 -46.06 86.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.447 . . . . 0.83 110.202 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.59 -38.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.83 -0.623 . . . . 0.17 110.109 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.444 ' CD1' HG11 ' A' ' 304' ' ' VAL . 19.0 tp -53.57 -53.25 54.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.87 -0.605 . . . . 0.38 111.34 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.569 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.1 mtp180 -62.09 -34.64 76.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.57 111.338 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 mm-40 -66.84 -40.3 87.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.89 0.376 . . . . 1.87 110.44 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -68.58 -44.64 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.29 110.939 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.9 t -64.74 -21.78 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.16 0.505 . . . . 0.24 111.152 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.5 m -84.69 -0.36 53.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.499 -0.319 . . . . 0.44 110.825 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 327' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 80.4 mm-40 -98.19 163.11 12.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 1.16 110.596 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 15.4 p -99.12 118.68 36.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.224 -0.444 . . . . 0.89 111.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 154.02 165.72 14.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.835 -0.697 . . . . 0.45 111.985 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.92 128.23 14.7 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.337 2.024 . . . . 0.58 111.503 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 34.6 mt -108.22 130.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.922 0.391 . . . . 0.37 111.354 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 18.5 t -104.8 129.73 53.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 1.09 109.258 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.4 mt -114.92 125.76 54.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 0.48 111.287 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -100.65 97.54 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.853 -0.795 . . . . 0.5 108.853 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.3 151.55 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.341 0.591 . . . . 0.33 112.247 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.57 113.07 25.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.234 -0.894 . . . . 0.38 109.146 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.274 -0.869 . . . . 0.7 110.391 -179.535 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.0 m95 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 110.527 -0.175 . . . . 0.4 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.887 -0.577 . . . . 0.27 109.879 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.868 0.366 . . . . 1.26 110.309 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -98.08 129.51 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.359 -0.382 . . . . 0.65 110.436 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.11 128.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.944 0.402 . . . . 0.55 111.152 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.71 119.81 39.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.055 -0.52 . . . . 0.59 109.691 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.95 144.17 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.912 0.387 . . . . 0.5 111.524 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.3 t -107.63 131.59 54.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.426 -0.953 . . . . 0.79 108.426 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.538 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 42.7 mt -114.8 140.17 49.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.46 111.737 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.31 116.79 21.33 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.475 -0.784 . . . . 0.65 110.285 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.6 mmm -98.69 12.62 34.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.63 111.654 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.92 -46.96 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.099 0.476 . . . . 1.27 109.803 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.06 -18.94 29.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 1.06 110.409 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -112.44 137.95 49.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.111 -0.495 . . . . 0.76 109.716 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -102.02 3.52 38.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.022 -0.271 . . . . 1.09 111.572 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -159.72 166.27 30.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.602 0.239 . . . . 0.62 111.05 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 264' ' ' ILE . 6.6 mt -76.04 -53.0 9.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.34 109.735 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.69 40.59 6.27 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 116.049 -0.523 . . . . 0.14 113.052 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 262' ' ' LEU . 6.6 pt -138.07 149.2 24.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.346 0.593 . . . . 0.18 111.623 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.86 129.79 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.284 -0.871 . . . . 1.0 109.264 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.438 HG21 HG22 ' A' ' 318' ' ' VAL . 10.1 mm -93.78 119.76 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.938 0.399 . . . . 0.28 110.483 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.01 113.66 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.369 -0.378 . . . . 0.31 110.583 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.33 124.09 8.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.859 -0.686 . . . . 0.37 111.67 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 1.87 110.783 -179.888 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 112.22 -0.352 . . . . 0.3 112.22 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.4 pt -113.96 130.63 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.27 110.925 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -115.59 163.65 15.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.0 -0.546 . . . . 0.72 110.827 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.34 118.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.059 -0.519 . . . . 0.24 109.883 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.32 -66.94 1.68 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.729 -0.748 . . . . 0.42 112.147 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -145.26 155.62 43.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.537 0.208 . . . . 0.75 110.554 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 296' ' ' GLU . 30.2 mt -106.88 134.33 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.246 -0.434 . . . . 0.53 109.995 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.9 mmt -95.48 122.53 38.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.288 -0.414 . . . . 0.74 110.832 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.88 118.04 5.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 1.01 110.148 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.63 9.05 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.352 -0.699 . . . . 0.36 111.352 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.96 170.62 54.69 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.008 -0.615 . . . . 0.26 112.104 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.7 -36.92 85.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.751 0.31 . . . . 0.25 111.363 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.01 -35.9 71.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.119 -0.492 . . . . 0.26 111.274 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.99 66.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.115 -0.493 . . . . 0.37 111.691 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.2 46.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.41 111.524 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.33 -72.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.799 0.333 . . . . 0.55 110.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.16 -17.8 34.27 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.393 -0.908 . . . . 0.39 114.3 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -73.21 -28.72 62.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.822 0.811 . . . . 0.68 111.278 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.7 mt -88.1 140.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.114 -0.698 . . . . 0.37 109.114 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 296' ' ' GLU . . . . . 0.558 ' HA ' HD11 ' A' ' 283' ' ' ILE . 13.6 pt-20 -148.63 167.67 12.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.579 -0.282 . . . . 0.69 110.242 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.04 133.56 58.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.215 1.943 . . . . 0.41 111.061 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.14 -20.91 32.35 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.29 112.151 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.9 137.87 55.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.925 -0.398 . . . . 0.34 109.925 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.5 ttp -97.5 134.23 41.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.726 0.298 . . . . 1.26 110.729 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.75 124.71 32.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.314 -0.403 . . . . 0.48 109.974 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 336' ' ' ALA . 92.5 mt -105.8 -71.22 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.074 0.464 . . . . 0.53 110.606 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.93 136.96 53.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.73 111.162 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 321' ' ' LEU . 59.7 t -128.02 94.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.29 109.919 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.4 m-20 59.09 75.4 0.4 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.211 -0.45 . . . . 1.71 111.407 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 3.3 m-20 76.72 -58.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.149 0.796 . . . . 1.11 113.149 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.43 121.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.379 0.609 . . . . 0.71 111.898 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -101.15 128.81 47.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.316 -0.856 . . . . 0.74 109.389 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -102.38 20.38 17.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.739 0.304 . . . . 0.33 111.477 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.45 -27.3 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.205 0.446 . . . . 1.21 112.205 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -125.58 37.45 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.633 0.254 . . . . 1.32 111.279 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 86.7 mtp -125.36 168.83 13.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.433 -0.349 . . . . 0.51 110.364 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.9 p -75.33 157.13 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.97 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.6 m-20 -62.27 -33.98 75.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.48 109.799 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -69.53 -54.03 16.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.575 -0.738 . . . . 1.4 111.118 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -59.58 -34.16 72.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.88 111.072 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.34 69.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.984 -0.553 . . . . 0.2 111.031 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.1 t -74.25 -27.96 22.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 121.041 -0.264 . . . . 0.21 110.725 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 66.8 mtt180 -58.35 -51.59 69.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.07 0.462 . . . . 0.83 109.864 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.78 -35.36 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.17 110.517 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.416 HD13 HG21 ' A' ' 304' ' ' VAL . 41.0 tp -54.67 -50.83 67.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.076 -0.511 . . . . 0.38 110.82 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.44 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.7 mtp-105 -61.32 -34.28 74.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.979 -0.555 . . . . 1.57 111.396 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.03 -40.63 96.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 1.87 110.54 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.89 -43.83 76.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.29 110.749 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' B' ' 3' ' ' VAL . 65.4 t -64.93 -32.1 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 0.24 110.753 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 13.7 m -87.31 10.3 17.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.928 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -110.98 151.41 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 1.16 110.081 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.62 134.57 37.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.563 -0.29 . . . . 0.89 110.617 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 135.71 156.14 7.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.852 -0.689 . . . . 0.45 112.339 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.3 139.82 46.87 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.851 2.368 . . . . 0.58 112.044 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.79 126.92 66.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.151 -0.477 . . . . 0.37 111.539 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 108.24 19.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.972 -0.751 . . . . 1.09 108.972 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 99.0 mt -93.65 128.93 40.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.237 -0.438 . . . . 0.48 111.756 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.5 m -108.34 97.39 7.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.442 -0.947 . . . . 0.5 108.442 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.85 159.17 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.33 112.154 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -116.83 116.62 27.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.334 -0.848 . . . . 0.38 109.718 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.488 -0.768 . . . . 0.7 110.271 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 30.4 m95 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 110.243 -0.28 . . . . 0.4 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.523 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.678 -0.677 . . . . 0.27 110.418 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.879 0.371 . . . . 1.26 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 56.0 mt -90.32 111.8 23.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.015 0.436 . . . . 0.65 110.251 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.55 128.73 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.55 110.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 m -98.74 112.35 24.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.59 109.867 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 332' ' ' SER . 6.0 m -100.87 163.34 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.436 -0.347 . . . . 0.5 110.67 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 14.8 t -131.11 134.66 46.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.309 -0.626 . . . . 0.79 109.309 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 72.4 mt -121.96 135.79 54.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.46 111.735 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -85.22 115.62 23.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.459 -0.792 . . . . 0.65 109.973 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.0 mmm -95.8 32.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.952 0.406 . . . . 0.63 111.327 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -102.8 -53.82 2.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.27 109.703 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -70.48 -41.28 72.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.483 -0.562 . . . . 1.06 109.483 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -107.34 157.26 18.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.69 -0.855 . . . . 0.76 108.69 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -124.07 22.56 8.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.625 -0.43 . . . . 1.09 112.03 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.5 158.75 27.01 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.736 0.303 . . . . 0.62 110.778 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 262' ' ' LEU . 5.8 mt -76.35 -56.01 5.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.34 109.734 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.8 42.95 5.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.644 -0.707 . . . . 0.14 112.632 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -143.95 153.84 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.277 0.561 . . . . 0.18 111.866 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.474 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -100.85 131.59 46.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.48 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.5 mm -96.44 110.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.942 0.401 . . . . 0.28 110.385 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.09 110.78 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.504 -0.316 . . . . 0.31 111.486 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.61 113.7 3.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.092 -0.803 . . . . 0.37 111.092 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 120.99 0.424 . . . . 1.87 111.043 -178.801 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.269 -0.332 . . . . 0.3 112.269 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -105.88 129.36 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.031 0.443 . . . . 0.27 110.696 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.45 158.8 23.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 0.72 110.805 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.79 117.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.534 . . . . 0.24 110.393 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.76 -71.42 1.14 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.701 -0.761 . . . . 0.42 112.15 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.0 p -142.58 155.51 44.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.182 -0.303 . . . . 0.75 110.182 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 43.0 mt -106.43 125.53 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.53 110.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.3 mmt -86.36 126.72 34.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.07 -0.513 . . . . 0.74 110.668 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -67.88 110.6 3.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.662 -0.496 . . . . 1.01 109.662 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 132.84 -19.9 4.37 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.885 -0.886 . . . . 0.36 110.885 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.28 54.64 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.713 . . . . 0.26 111.969 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.22 -32.19 73.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.812 0.339 . . . . 0.25 111.0 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.23 -33.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.26 110.734 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.08 -15.7 62.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.273 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.1 -27.79 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 16.5 t70 -76.05 -69.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.55 110.681 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.24 57.32 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.448 -0.882 . . . . 0.39 114.714 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 79.3 mtm180 -82.9 -19.65 36.96 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.019 0.91 . . . . 0.68 111.351 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.1 mt -96.78 138.51 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.206 -0.452 . . . . 0.37 109.959 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.1 157.9 76.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.43 -0.35 . . . . 0.69 110.409 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 297' ' ' PRO . . . . . 0.485 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 33.4 Cg_exo -61.44 94.34 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.611 2.207 . . . . 0.41 111.793 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 150.52 -19.56 1.03 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.963 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -64.06 151.17 43.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.736 0.303 . . . . 0.34 110.842 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 50.6 ttp -104.02 130.1 51.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 1.26 110.683 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.84 115.23 22.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.382 -0.372 . . . . 0.48 110.103 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 51.7 mt -97.9 -73.31 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.27 0.557 . . . . 0.53 110.844 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -115.11 130.74 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.594 -0.73 . . . . 0.73 110.625 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.548 HG13 HD23 ' A' ' 333' ' ' LEU . 96.5 t -126.91 106.44 15.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.201 -0.454 . . . . 0.29 109.972 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 11.4 t-20 61.34 65.98 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 1.5 m-20 74.87 -52.9 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.715 1.006 . . . . 1.11 113.715 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 134.74 29.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.063 0.458 . . . . 0.71 111.542 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -107.32 126.73 52.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.74 110.701 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -96.58 3.79 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.839 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.62 -28.08 65.3 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.828 0.307 . . . . 1.21 111.828 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.75 31.53 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 1.32 110.796 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 89.6 mtp -128.69 154.36 46.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.159 -0.473 . . . . 0.51 110.773 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.95 150.11 48.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.97 110.993 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -51.9 -47.98 64.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.343 . . . . 0.48 111.348 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.42 -46.39 88.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.4 111.672 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.1 m-20 -64.32 -30.72 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.294 -0.412 . . . . 0.88 110.8 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.42 85.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.2 110.786 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 -31.55 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.664 0.268 . . . . 0.21 110.535 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 90.1 mtt180 -56.74 -53.92 52.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.83 110.263 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.8 -37.19 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.17 110.366 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 15.1 tp -55.79 -51.02 68.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.932 -0.577 . . . . 0.38 111.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.43 ' HA ' HG11 ' B' ' 3' ' ' VAL . 36.5 mtp180 -61.83 -35.14 77.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 1.57 111.091 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -64.53 -40.69 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.152 0.501 . . . . 1.87 109.959 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.59 -42.47 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.634 -0.712 . . . . 0.29 110.828 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 321' ' ' LEU . 62.6 t -66.29 -23.95 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.24 110.31 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 6.76 26.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.852 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -105.75 135.54 46.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.349 -0.387 . . . . 1.16 110.002 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 92.18 4.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.438 . . . . 0.89 111.569 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -173.74 171.92 44.86 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.461 -0.656 . . . . 0.45 111.461 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 126.04 13.18 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.361 2.041 . . . . 0.58 111.584 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 58.5 mt -102.95 122.75 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.93 0.395 . . . . 0.37 111.457 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.5 OUTLIER -106.66 121.78 45.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.564 . . . . 1.09 109.615 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.548 HD23 HG13 ' A' ' 304' ' ' VAL . 18.1 mt -108.1 120.95 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.525 . . . . 0.48 110.99 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.82 95.94 7.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.53 0.681 . . . . 0.33 112.399 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -102.52 94.76 5.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.951 -1.022 . . . . 0.38 108.868 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.628 -0.701 . . . . 0.7 110.725 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.474 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 9.8 m95 . . . . . 0 C--O 1.234 0.244 0 N-CA-C 110.366 -0.235 . . . . 0.4 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.434 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.637 -0.696 . . . . 0.27 110.22 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.61 0.243 . . . . 1.26 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 95.1 mt -103.78 127.02 58.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.453 -0.34 . . . . 0.65 110.188 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.21 135.44 59.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.827 0.346 . . . . 0.55 111.358 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 62.9 m -107.01 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.648 -0.501 . . . . 0.59 109.648 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 332' ' ' SER . 4.0 m -102.26 143.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.789 0.328 . . . . 0.5 111.122 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.9 t -114.19 109.78 18.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.79 109.5 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 58.4 mt -100.31 145.27 28.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.46 112.016 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -91.72 119.79 31.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.65 109.732 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 89.5 mmm -99.0 21.52 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.026 0.441 . . . . 0.63 111.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -87.71 -49.91 6.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.768 -0.456 . . . . 1.27 109.768 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.16 -35.81 19.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 1.06 109.355 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -86.87 145.71 26.48 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.695 -0.684 . . . . 0.76 109.464 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.85 -2.33 13.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.545 -0.462 . . . . 1.09 112.024 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -157.58 162.54 38.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.498 0.19 . . . . 0.62 110.677 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.4 mt -77.55 -52.04 9.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.727 -0.472 . . . . 0.34 109.727 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.44 4.61 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.577 -0.738 . . . . 0.14 112.999 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.0 pt -144.84 144.1 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.213 0.53 . . . . 0.18 111.563 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 1.1 p -96.49 126.87 41.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 9.2 mm -91.75 115.84 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.825 0.345 . . . . 0.28 110.776 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.22 119.01 48.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.31 110.251 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.26 122.51 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.002 -0.618 . . . . 0.37 112.072 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 1.87 110.1 179.831 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.192 -0.363 . . . . 0.3 112.192 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.03 128.41 73.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.068 0.461 . . . . 0.27 110.839 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -113.99 157.46 22.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.772 -0.649 . . . . 0.72 110.803 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.59 115.02 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.24 110.014 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.72 -58.16 4.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.42 112.698 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.6 p -151.54 161.97 41.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.187 -0.301 . . . . 0.75 110.187 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.439 HD11 ' HA ' ' A' ' 296' ' ' GLU . 49.0 mt -115.18 134.8 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.53 110.46 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -95.7 125.17 40.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.74 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.05 124.47 20.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.883 -0.599 . . . . 1.01 110.056 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.58 18.12 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.29 -0.724 . . . . 0.36 111.29 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -80.52 166.03 48.88 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.875 -0.679 . . . . 0.26 111.875 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -61.15 -38.83 87.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.662 0.268 . . . . 0.25 111.433 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.69 -31.3 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.26 110.907 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.83 -20.29 61.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.37 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.02 -11.7 43.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.272 -0.422 . . . . 0.41 111.73 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.11 -72.61 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.15 -0.22 . . . . 0.55 111.218 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 113.74 -17.08 20.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.381 -0.914 . . . . 0.39 113.902 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -89.93 -49.32 6.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.32 0.56 . . . . 0.68 111.064 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.24 136.93 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.206 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 296' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' A' ' 283' ' ' ILE . 11.9 pt-20 -143.8 164.2 31.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.69 110.308 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 297' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.5 Cg_exo -60.24 112.54 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.329 2.019 . . . . 0.41 111.27 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 132.45 -19.86 4.48 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.241 -0.744 . . . . 0.29 111.241 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.0 m-20 -70.84 146.14 49.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.732 0.301 . . . . 0.34 110.245 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.1 ttt -103.76 136.44 43.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.309 -0.405 . . . . 1.26 110.656 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 335' ' ' VAL . 18.9 mt -87.99 123.39 32.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.48 110.109 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 336' ' ' ALA . 90.6 mt -106.25 -69.07 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.048 0.451 . . . . 0.53 110.818 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -121.1 124.7 45.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.73 110.484 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.5 t -125.62 101.57 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.29 110.23 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.1 m-20 62.88 65.69 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.998 -0.546 . . . . 1.71 111.244 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.6 m-20 74.69 -43.67 0.53 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.922 1.082 . . . . 1.11 113.922 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 304' ' ' VAL . 33.6 m -69.51 137.47 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 118.261 0.482 . . . . 0.71 111.329 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -111.06 133.16 53.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.771 -0.65 . . . . 0.74 109.645 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.13 12.44 30.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.909 0.337 . . . . 0.33 111.909 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -66.32 -30.56 70.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.723 0.297 . . . . 1.21 111.715 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.56 36.96 4.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 1.32 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 84.1 mtp -125.05 154.96 40.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.324 -0.621 . . . . 0.51 109.324 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 97.0 p -69.17 153.56 43.51 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.147 -0.316 . . . . 0.97 110.147 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -59.6 -26.38 65.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.48 109.842 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -71.48 -56.3 6.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.279 -0.873 . . . . 1.4 110.588 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 10.6 m-20 -63.64 -30.98 72.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.84 -0.618 . . . . 0.88 111.683 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.15 67.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.929 -0.578 . . . . 0.2 112.011 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.33 -27.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.931 -0.308 . . . . 0.21 111.024 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 81.4 mtt180 -58.53 -53.31 59.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.83 110.11 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.6 -40.49 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.871 -0.604 . . . . 0.17 110.274 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.6 tp -55.12 -50.98 67.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.938 -0.574 . . . . 0.38 111.229 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.455 ' HA ' HG11 ' B' ' 3' ' ' VAL . 9.0 mtp180 -61.0 -41.86 97.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.404 . . . . 1.57 111.359 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -61.42 -43.52 98.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.52 0.2 . . . . 1.87 110.55 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.01 -43.25 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.29 110.508 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.3 t -70.01 -19.68 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.277 -0.42 . . . . 0.24 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 66.7 m -77.86 -18.38 56.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.44 110.789 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.09 162.39 12.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.228 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.39 172.07 13.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.359 -0.382 . . . . 0.89 111.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 116.19 168.08 15.04 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.925 -0.655 . . . . 0.45 112.572 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -79.56 104.52 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.699 2.266 . . . . 0.58 111.733 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 50.0 mt -74.06 114.13 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.37 110.691 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 8.1 m -97.31 102.74 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 1.09 109.75 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.89 119.05 37.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.023 -0.535 . . . . 0.48 111.319 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 26.8 m -98.54 101.12 12.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.779 -0.822 . . . . 0.5 108.779 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 301' ' ' LEU . 29.8 m -101.64 156.23 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 0.33 112.204 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.07 111.43 22.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.113 -0.949 . . . . 0.38 109.894 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.7 mtpp . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.511 -0.757 . . . . 0.7 109.796 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.582 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 22.4 m95 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.126 -0.324 . . . . 0.4 110.126 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.71 -0.662 . . . . 0.27 109.973 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.74 0.305 . . . . 1.26 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.61 128.38 49.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.128 -0.323 . . . . 0.65 110.128 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 42.2 mt -126.53 130.51 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.339 . . . . 0.55 111.151 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.8 m -101.62 111.11 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.52 -0.548 . . . . 0.59 109.52 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.91 147.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.688 0.28 . . . . 0.5 111.566 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.2 t -110.16 136.8 48.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.642 -0.503 . . . . 0.79 109.642 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.2 mt -114.71 138.41 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.905 0.383 . . . . 0.46 111.469 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -83.91 117.96 23.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.704 . . . . 0.65 110.155 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 92.2 mmm -98.35 14.05 29.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.374 -0.375 . . . . 0.63 111.584 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.14 -38.39 15.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 1.27 110.342 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 258' ' ' ARG . 25.7 ttt180 -96.34 0.66 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.255 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -131.03 162.52 29.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.76 109.709 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -120.32 -8.23 9.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.827 0.346 . . . . 1.09 111.283 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -154.62 175.95 13.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.509 -0.314 . . . . 0.62 110.707 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.08 -52.46 6.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.34 109.971 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.68 43.18 5.54 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.806 -0.634 . . . . 0.14 112.879 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.02 154.35 31.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.538 0.685 . . . . 0.18 112.37 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.452 ' HB3' ' H ' ' A' ' 282' ' ' SER . 42.5 t -101.8 118.03 36.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.612 -1.176 . . . . 1.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.1 mm -88.63 118.5 34.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.776 0.322 . . . . 0.28 110.138 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.99 109.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.007 0.432 . . . . 0.31 110.759 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.1 124.38 7.54 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.247 -0.741 . . . . 0.37 111.247 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 . . . . . 0 C--N 1.323 -0.543 0 CA-C-O 120.938 0.399 . . . . 1.87 110.635 -179.839 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.305 -0.318 . . . . 0.3 112.305 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.44 114.26 45.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.297 0.57 . . . . 0.27 110.212 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -107.32 154.57 21.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.893 -0.594 . . . . 0.72 110.692 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.23 114.18 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.24 109.782 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.12 -57.7 3.62 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.746 -0.74 . . . . 0.42 112.333 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 282' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 265' ' ' SER . 1.8 p -145.16 158.25 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.144 -0.317 . . . . 0.75 110.144 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 50.4 mt -118.24 131.62 70.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.58 -0.526 . . . . 0.53 109.58 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 34.1 mmt -92.77 124.32 36.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.415 -0.357 . . . . 0.74 110.619 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -58.56 130.18 45.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 1.01 110.997 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.12 -24.55 20.78 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.894 -0.67 . . . . 0.36 112.034 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.19 45.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.058 -0.591 . . . . 0.26 112.424 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.01 -37.32 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.25 111.056 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.457 HG13 HD12 ' A' ' 295' ' ' ILE . 54.8 t -69.54 -39.27 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.26 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.27 -18.15 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.37 111.254 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -85.67 -11.03 54.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.41 110.955 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.49 -67.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.839 -0.43 . . . . 0.55 109.839 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 103.47 -14.96 54.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 0.39 114.435 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -79.96 -33.13 39.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.738 0.769 . . . . 0.68 111.137 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.457 HD12 HG13 ' A' ' 289' ' ' VAL . 63.5 mt -82.57 140.65 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.651 -0.5 . . . . 0.37 109.651 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.13 164.3 32.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.765 -0.198 . . . . 0.69 110.88 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.37 116.94 3.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.41 111.823 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 125.82 -21.81 6.19 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.917 -0.658 . . . . 0.29 111.509 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.5 m-20 -69.44 143.23 53.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 43.7 ttp -103.36 135.3 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.702 0.287 . . . . 1.26 110.813 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 70.4 mt -83.39 123.97 30.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.48 110.182 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 336' ' ' ALA . 46.7 mt -105.15 -72.57 0.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.245 0.545 . . . . 0.53 110.835 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.437 ' H ' ' HB ' ' A' ' 334' ' ' THR . 51.6 tt0 -109.75 135.32 50.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.754 . . . . 0.73 111.034 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 321' ' ' LEU . 67.3 t -131.98 93.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.29 110.149 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 59.21 76.61 0.35 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.798 -0.637 . . . . 1.71 111.737 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.8 OUTLIER 75.21 -53.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.053 -0.976 . . . . 1.11 113.455 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.5 139.66 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.349 0.595 . . . . 0.71 111.864 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.99 130.8 55.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.442 -0.799 . . . . 0.74 110.409 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.482 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 23.7 m-85 -102.02 6.53 41.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.867 0.321 . . . . 0.33 111.867 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.92 -31.61 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 1.21 111.696 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -119.44 53.35 1.04 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.2 0.524 . . . . 1.32 110.301 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 312' ' ' MET . . . . . 0.482 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 84.1 mtp -141.11 160.37 40.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.182 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 148.14 51.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.242 -0.435 . . . . 0.97 110.75 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -49.7 -50.97 41.69 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.484 0.49 . . . . 0.48 111.638 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.22 -47.3 80.22 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.446 . . . . 1.4 111.833 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.58 -35.1 75.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.886 -0.597 . . . . 0.88 111.815 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.02 93.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.452 -0.34 . . . . 0.2 110.865 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.515 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -73.82 -32.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.21 110.623 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -54.98 -50.33 69.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.864 0.364 . . . . 0.83 110.627 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.6 t -70.49 -39.93 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.75 -0.659 . . . . 0.17 110.249 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 325' ' ' VAL . 56.6 tp -55.36 -50.44 69.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.053 -0.521 . . . . 0.38 111.373 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.663 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.0 mtp180 -63.69 -30.13 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 1.57 111.462 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.7 -40.37 80.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.136 0.493 . . . . 1.87 109.804 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.92 -42.67 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.73 . . . . 0.29 111.209 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 321' ' ' LEU . 43.8 t -69.23 -16.94 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.24 110.802 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 23.57 6.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.092 0.473 . . . . 0.44 110.161 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -125.26 -179.31 4.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 1.16 110.102 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.99 146.24 32.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.71 0.29 . . . . 0.89 110.607 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.37 169.59 13.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.707 -0.759 . . . . 0.45 112.269 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 137.09 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 0.58 112.166 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 84.4 mt -115.34 121.57 67.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.142 -0.481 . . . . 0.37 110.414 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.8 m -106.11 121.06 43.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.138 0.494 . . . . 1.09 109.95 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 84.0 mt -105.5 130.52 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.48 111.538 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 2.7 m -104.04 103.23 13.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.28 142.68 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.343 0.592 . . . . 0.33 112.35 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.22 111.95 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.186 -0.916 . . . . 0.38 109.582 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.0 mtpp . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.613 -0.708 . . . . 0.7 109.942 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 28.9 m95 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.547 0.213 . . . . 0.4 110.62 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 119.038 -0.506 . . . . 0.27 109.949 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.917 0.389 . . . . 1.26 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 57.2 mt -92.3 128.78 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.65 110.731 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 33.8 mt -129.67 123.7 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.55 110.875 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.1 m -95.39 102.39 14.19 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.424 -0.584 . . . . 0.59 109.424 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.27 148.4 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.954 0.407 . . . . 0.5 111.751 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -114.87 129.95 56.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.802 -0.814 . . . . 0.79 108.802 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.2 mt -110.89 149.66 30.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.463 . . . . 0.46 111.606 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.27 118.04 30.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.507 -0.77 . . . . 0.65 110.901 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 67.0 mmm -99.46 16.26 23.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.863 -0.608 . . . . 0.63 111.304 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -86.47 -49.41 7.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.35 -0.611 . . . . 1.27 109.35 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -86.44 -22.8 26.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.583 -0.735 . . . . 1.06 110.193 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -106.92 154.76 20.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 0.76 110.472 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.76 -2.39 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.519 0.2 . . . . 1.09 111.304 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -157.56 171.92 19.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.348 . . . . 0.62 110.959 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 7.6 mt -78.21 -51.31 10.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.887 -0.597 . . . . 0.34 110.016 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.05 47.34 5.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.776 -0.647 . . . . 0.14 112.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 262' ' ' LEU . 3.5 pt -142.73 150.45 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.18 112.023 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.26 120.61 40.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.81 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.3 mm -89.56 116.11 30.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.919 0.39 . . . . 0.28 111.036 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.69 118.77 48.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.31 109.877 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.51 127.82 9.36 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.511 -0.852 . . . . 0.37 112.013 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.186 -0.672 . . . . 1.87 109.186 179.114 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.511 -0.236 . . . . 0.3 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.67 138.43 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.898 0.38 . . . . 0.27 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -125.69 158.24 35.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.996 -0.547 . . . . 0.72 110.661 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.3 mm -75.92 109.5 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.067 -0.515 . . . . 0.24 109.698 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.29 -60.13 3.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.754 -0.736 . . . . 0.42 112.273 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 m -145.17 157.97 43.94 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.708 -0.289 . . . . 0.75 110.355 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.2 mt -113.52 130.22 67.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.211 -0.45 . . . . 0.53 110.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.97 119.33 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.74 110.335 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -61.72 116.99 5.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.955 -0.566 . . . . 1.01 110.023 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.1 -17.58 9.12 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.477 -0.649 . . . . 0.36 111.477 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.8 174.03 55.26 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.863 -0.684 . . . . 0.26 111.912 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.93 -36.87 84.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.769 0.318 . . . . 0.25 111.218 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.98 -37.37 77.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.26 111.169 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.41 -17.88 64.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.37 111.828 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.92 -3.66 57.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.828 0.347 . . . . 0.41 111.192 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.63 -80.25 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.745 -0.465 . . . . 0.55 109.745 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 118.33 -21.53 9.97 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.274 -0.965 . . . . 0.39 113.908 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -76.84 -19.59 57.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.568 0.684 . . . . 0.68 111.751 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.8 mt -95.18 136.36 26.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.646 -0.501 . . . . 0.37 109.646 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.63 163.77 47.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.742 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.47 109.04 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.368 2.045 . . . . 0.41 111.452 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.96 -17.14 5.21 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.29 112.09 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 97.7 m-20 -65.11 140.39 58.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.634 0.254 . . . . 0.34 110.348 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.6 ttt -93.76 135.2 35.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.322 . . . . 1.26 111.02 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.6 mt -90.07 118.14 29.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.193 -0.458 . . . . 0.48 109.936 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 336' ' ' ALA . 59.4 mt -103.54 -77.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.098 0.475 . . . . 0.53 110.837 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 308' ' ' ASN . 8.3 tt0 -106.01 134.42 49.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.73 110.996 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 321' ' ' LEU . 84.7 t -131.31 102.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.782 -0.645 . . . . 0.29 109.83 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.2 m-20 58.35 70.53 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.566 -0.743 . . . . 1.71 111.568 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.5 OUTLIER 76.51 -53.36 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.585 0.957 . . . . 1.11 113.585 178.124 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.09 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.71 112.122 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 303' ' ' GLN . 50.0 t30 -103.32 131.39 50.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.521 -0.763 . . . . 0.74 109.782 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -97.17 3.98 51.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.984 0.364 . . . . 0.33 111.984 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.4 -32.8 67.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.965 0.412 . . . . 1.21 111.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -105.78 39.88 1.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.32 111.47 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 34.1 mtp -141.78 165.77 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.514 -0.312 . . . . 0.51 110.263 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.5 p -79.25 162.8 25.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.97 109.899 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 42.7 m-20 -57.26 -40.06 76.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.48 110.037 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 23.9 t0 -63.08 -55.09 28.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.182 -0.917 . . . . 1.4 110.514 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -60.13 -36.18 76.94 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.826 -0.625 . . . . 0.88 111.34 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.29 -56.02 27.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.2 112.157 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.9 t -69.62 -26.71 31.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.963 -0.295 . . . . 0.21 111.358 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 69.4 mtt180 -57.11 -52.28 65.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.83 110.072 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.22 -38.26 74.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.976 -0.556 . . . . 0.17 110.4 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.9 tp -56.09 -51.58 67.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.923 -0.581 . . . . 0.38 110.942 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.678 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.7 mtp180 -61.15 -38.41 86.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.945 -0.571 . . . . 1.57 111.082 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.3 -45.38 88.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.595 -0.275 . . . . 1.87 110.682 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.78 -44.37 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 0.29 110.9 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 321' ' ' LEU . 26.1 t -72.22 -15.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.24 111.424 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 71.7 m -81.74 -16.6 50.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.83 0.348 . . . . 0.44 110.838 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.65 160.7 14.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 1.16 110.357 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 130.82 41.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.97 0.414 . . . . 0.89 111.075 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.31 176.1 27.1 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.523 -0.631 . . . . 0.45 111.523 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.38 135.95 35.46 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.539 2.159 . . . . 0.58 112.151 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.43 129.64 72.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.145 0.497 . . . . 0.37 110.732 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 126.81 52.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.347 -0.842 . . . . 1.09 109.403 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.12 115.91 26.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.48 111.586 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -93.37 90.13 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.599 -0.889 . . . . 0.5 108.599 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.11 146.47 6.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.912 -0.585 . . . . 0.33 111.996 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.539 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.04 107.75 17.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.333 -0.849 . . . . 0.38 110.018 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.429 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 22.7 mtpp . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.432 -0.795 . . . . 0.7 109.692 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.84 -0.6 . . . . 0.27 110.164 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.74 0.305 . . . . 1.26 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.61 122.16 61.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.65 110.629 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 18.3 mt -126.31 131.42 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 88.8 m -104.96 113.24 26.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.943 -0.762 . . . . 0.59 108.943 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 10.2 m -103.56 155.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.283 -0.417 . . . . 0.5 111.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.5 t -108.23 135.35 49.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.05 -0.722 . . . . 0.79 109.05 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.9 mt -119.04 136.14 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.947 0.403 . . . . 0.46 111.524 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -83.46 114.85 21.76 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.547 -0.751 . . . . 0.65 109.924 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 93.8 mmm -98.89 14.77 27.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.63 111.159 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -88.93 -47.54 8.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.27 109.819 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.71 -21.63 32.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 1.06 110.048 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -111.67 159.04 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.76 109.867 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -128.24 14.76 6.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.899 0.38 . . . . 1.09 110.443 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -164.72 169.0 17.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.62 110.163 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.401 HD13 HD11 ' A' ' 264' ' ' ILE . 5.5 mt -81.28 -57.68 3.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.828 0.347 . . . . 0.34 110.27 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.6 36.35 5.89 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.14 112.578 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 262' ' ' LEU . 6.1 pt -137.16 156.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.42 0.629 . . . . 0.18 111.894 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.497 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -102.71 129.15 49.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.006 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.6 mm -97.37 113.33 31.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.28 110.953 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.5 t -114.88 115.24 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.31 110.709 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.64 134.23 12.26 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.97 -0.633 . . . . 0.37 112.393 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 120.623 0.249 . . . . 1.87 110.539 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.679 0 N-CA-C 112.025 -0.43 . . . . 0.3 112.025 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.6 130.44 56.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.174 0.511 . . . . 0.27 111.07 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 279' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 45.4 m-85 -117.71 159.17 23.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.72 110.687 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.0 mm -79.88 120.2 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.919 -0.582 . . . . 0.24 110.227 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.29 -53.41 5.17 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.704 -0.76 . . . . 0.42 112.073 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -155.59 163.76 39.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.49 128.61 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.95 -0.389 . . . . 0.53 109.95 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -90.86 126.45 36.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 0.74 110.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.57 127.57 31.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 1.01 110.03 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 112.4 -14.37 25.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.36 111.572 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.39 175.1 54.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.982 -0.628 . . . . 0.26 111.778 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.85 79.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.69 0.281 . . . . 0.25 111.027 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.22 -36.93 78.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.26 111.054 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.33 -7.27 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.37 111.703 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.91 37.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.327 -0.397 . . . . 0.41 111.155 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -91.8 -80.2 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.55 110.333 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.22 -18.62 9.53 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.521 -0.847 . . . . 0.39 114.024 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -76.69 -33.38 58.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.55 0.675 . . . . 0.68 111.338 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.0 139.43 17.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.173 -0.467 . . . . 0.37 109.892 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.78 160.63 60.21 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.107 -0.331 . . . . 0.69 110.107 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.45 122.97 12.56 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.386 2.057 . . . . 0.41 111.023 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.82 9.82 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.298 -0.721 . . . . 0.29 111.298 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 93.6 m-20 -69.09 144.23 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.666 0.269 . . . . 0.34 110.504 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 300' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 27.3 ttt -100.36 135.38 41.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.381 -0.372 . . . . 1.26 111.1 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.41 123.4 32.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.902 -0.407 . . . . 0.48 109.902 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 336' ' ' ALA . 75.3 mt -102.12 -64.67 1.04 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 0.53 110.887 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -125.11 136.17 53.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.733 -0.667 . . . . 0.73 110.672 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 307' ' ' VAL . 98.5 t -132.66 103.38 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.29 110.134 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.5 m-20 59.81 65.14 1.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 1.71 111.444 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 58.0 m-20 76.31 -51.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.034 0.934 . . . . 1.11 113.451 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 304' ' ' VAL . 0.0 OUTLIER -63.66 124.35 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.387 0.613 . . . . 0.71 111.852 -178.896 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.59 129.61 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.34 -0.845 . . . . 0.74 109.67 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.131 0.419 . . . . 0.33 112.131 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -63.25 -26.19 68.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.643 0.259 . . . . 1.21 111.637 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -117.14 24.37 11.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.68 0.252 . . . . 1.32 111.68 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.8 mtp -122.23 156.49 33.65 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.788 -0.365 . . . . 0.51 111.501 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 144.0 57.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.724 -0.671 . . . . 0.97 110.388 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 318' ' ' VAL . 57.5 m-20 -50.86 -49.05 59.86 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.279 0.362 . . . . 0.48 111.463 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -47.18 85.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.4 111.309 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.21 -29.16 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.509 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.48 81.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.27 -0.423 . . . . 0.2 110.97 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -74.28 -23.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.81 -0.356 . . . . 0.21 110.688 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.08 -45.9 79.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.016 0.436 . . . . 0.83 110.168 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.02 -36.37 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.879 -0.601 . . . . 0.17 110.256 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 304' ' ' VAL . 32.3 tp -56.76 -50.6 71.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.841 -0.618 . . . . 0.38 111.398 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.614 ' HA ' HG11 ' B' ' 3' ' ' VAL . 31.3 mtp180 -61.61 -33.16 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.57 111.258 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.71 -45.46 86.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 1.87 109.948 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.48 -42.78 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.29 111.624 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' B' ' 3' ' ' VAL . 57.5 t -66.32 -26.83 38.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.93 0.395 . . . . 0.24 111.264 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 15.8 m -86.71 -2.21 58.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.253 0.549 . . . . 0.44 110.474 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 163.86 12.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.411 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.13 144.61 25.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.487 -0.324 . . . . 0.89 110.842 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.21 152.8 8.46 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.677 -0.773 . . . . 0.45 111.994 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.36 139.7 72.74 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.947 2.431 . . . . 0.58 112.15 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 57.9 mt -114.52 134.39 57.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.079 -0.51 . . . . 0.37 111.301 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.5 m -108.63 126.16 52.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.59 -0.522 . . . . 1.09 109.59 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 63.8 mt -110.51 118.2 35.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.075 0.398 . . . . 0.48 112.075 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 89.1 m -98.78 100.28 11.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.767 -0.827 . . . . 0.5 108.767 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.92 155.48 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 0.33 112.005 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -113.61 114.89 27.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.263 -0.88 . . . . 0.38 110.111 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.415 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.6 mtpp . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.477 -0.773 . . . . 0.7 109.604 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 58.2 m95 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.368 0.128 . . . . 0.4 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.72 -0.657 . . . . 0.27 109.801 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.26 -0.274 . . . . 1.26 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.36 128.99 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.814 -0.439 . . . . 0.65 109.814 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.36 132.5 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 0.55 110.99 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 13.2 m -109.01 111.4 23.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.414 -0.587 . . . . 0.59 109.414 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.19 149.47 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.5 111.469 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.4 t -115.35 106.84 14.47 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 57.9 mt -87.91 134.96 33.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.46 111.618 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -79.22 115.9 19.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 0.65 110.508 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 60.9 mmm -99.33 19.59 15.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.073 0.463 . . . . 0.63 110.937 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.22 -52.77 4.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.617 -0.512 . . . . 1.27 109.617 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -82.89 -25.67 32.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 1.06 109.62 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -98.86 160.21 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.76 109.561 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -130.21 12.69 5.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.967 0.413 . . . . 1.09 110.562 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -168.6 165.8 12.13 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.791 -0.641 . . . . 0.62 110.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 262' ' ' LEU . 8.0 mt -80.1 -51.51 8.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.639 -0.504 . . . . 0.34 109.639 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.4 43.45 5.55 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.14 112.653 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -144.86 152.16 15.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.489 0.662 . . . . 0.18 111.66 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.426 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 21.5 p -104.22 128.82 52.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.202 -0.908 . . . . 1.0 108.842 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.42 HG13 HD23 ' A' ' 321' ' ' LEU . 7.6 mm -95.26 123.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.899 0.38 . . . . 0.28 110.551 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 63.1 t -104.08 113.43 40.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.419 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.08 105.65 2.8 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.268 -0.733 . . . . 0.37 111.268 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 1.87 110.768 -179.284 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.28 -0.328 . . . . 0.3 112.28 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.83 124.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.045 0.45 . . . . 0.27 110.741 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -116.38 154.95 29.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 0.72 110.536 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 43.7 mm -74.23 114.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.24 109.869 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -72.93 -58.71 4.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.946 -0.645 . . . . 0.42 112.512 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.8 p -152.98 161.36 42.63 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.215 -0.291 . . . . 0.75 110.215 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 41.2 mt -111.02 135.45 50.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.53 110.273 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.0 mmt -98.54 131.61 44.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 0.74 110.152 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -63.85 131.58 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.01 110.668 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.05 50.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.763 -0.732 . . . . 0.36 111.888 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.16 165.22 54.61 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.972 -0.632 . . . . 0.26 112.264 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -31.62 72.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.616 0.246 . . . . 0.25 111.089 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.42 -42.52 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.26 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.03 -17.91 65.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.54 . . . . 0.37 111.214 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.87 55.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 0.41 111.212 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.14 -75.98 0.46 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.515 -0.311 . . . . 0.55 110.755 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.35 -19.96 16.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.374 -0.917 . . . . 0.39 113.813 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -76.88 -27.72 55.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.568 0.684 . . . . 0.68 111.245 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.17 136.99 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.37 109.934 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.04 161.01 62.06 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.407 -0.36 . . . . 0.69 110.543 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.57 114.11 1.99 Allowed 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.266 1.977 . . . . 0.41 110.896 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.27 -20.07 5.33 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.603 -0.599 . . . . 0.29 111.603 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 92.2 m-20 -65.9 143.86 57.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.967 -0.383 . . . . 0.34 109.967 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 39.9 ttp -101.85 135.85 42.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.632 0.254 . . . . 1.26 110.334 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 52.7 mt -86.64 121.02 28.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.48 110.423 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 336' ' ' ALA . 27.7 mt -97.14 -77.88 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.53 110.269 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -114.58 129.43 56.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.636 -0.711 . . . . 0.73 110.404 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.6 t -123.21 97.06 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.367 -0.605 . . . . 0.29 109.367 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 24.5 m120 63.05 72.24 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.641 0.588 . . . . 1.71 111.315 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 21.1 m-20 73.92 -48.12 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.8 1.037 . . . . 1.11 113.8 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.44 125.6 32.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.253 0.549 . . . . 0.71 111.83 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -103.17 123.76 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.627 -0.715 . . . . 0.74 109.744 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.06 8.02 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.441 0.534 . . . . 0.33 112.441 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.16 -22.97 63.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.24 0.459 . . . . 1.21 112.24 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -123.82 37.65 4.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.802 0.334 . . . . 1.32 111.152 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.6 mtp -132.03 164.04 27.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.85 -0.426 . . . . 0.51 109.85 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 p -77.99 155.55 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.286 -0.264 . . . . 0.97 110.286 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 318' ' ' VAL . 93.6 m-20 -52.15 -46.18 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.48 111.086 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -61.28 -51.34 69.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 1.4 111.604 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 7.4 m-20 -64.77 -34.85 79.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.772 0.286 . . . . 0.88 111.772 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.8 81.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.2 110.943 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.5 t -79.47 -24.42 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.776 -0.369 . . . . 0.21 110.885 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.48 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 71.3 mtt180 -57.94 -48.63 79.38 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -73.36 -36.1 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.792 -0.64 . . . . 0.17 110.158 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.9 tp -56.13 -51.23 68.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.881 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.554 ' HA ' HG11 ' B' ' 3' ' ' VAL . 16.6 mtp-105 -62.6 -34.4 76.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 1.57 110.93 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.75 -46.95 83.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.561 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.29 111.125 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 30.8 t -68.74 -12.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.186 0.517 . . . . 0.24 110.951 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -84.6 -4.41 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.85 0.357 . . . . 0.44 110.696 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.75 176.45 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.16 110.132 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 112.89 24.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.89 110.964 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 167.01 169.74 30.99 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.67 -0.776 . . . . 0.45 112.452 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.71 123.13 11.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.62 2.213 . . . . 0.58 111.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 66.3 mt -98.5 114.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.207 -0.451 . . . . 0.37 111.098 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.35 111.18 22.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 1.09 110.123 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.03 120.3 41.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.117 -0.492 . . . . 0.48 111.114 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -105.12 98.65 8.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.136 -0.69 . . . . 0.5 109.136 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.13 149.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.33 111.978 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.77 109.21 19.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.275 -0.875 . . . . 0.38 109.764 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.267 -0.873 . . . . 0.7 109.958 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 18.0 m95 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.425 -0.213 . . . . 0.4 110.425 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.741 -0.647 . . . . 0.27 109.924 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.975 -0.38 . . . . 1.26 109.975 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.0 mt -104.26 130.71 54.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.738 0.304 . . . . 0.65 111.232 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.6 mt -131.62 138.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.55 110.905 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.06 109.91 21.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.118 -0.697 . . . . 0.59 109.118 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.28 158.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.422 . . . . 0.5 111.519 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -123.91 129.35 50.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.893 -0.781 . . . . 0.79 108.893 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.441 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 87.1 mt -112.41 141.39 46.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.46 111.862 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -82.21 107.93 15.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.65 110.628 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 94.0 mmm -93.86 22.48 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.63 110.905 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -94.74 -47.61 6.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.144 -0.688 . . . . 1.27 109.144 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -86.15 -27.7 24.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.288 -0.869 . . . . 1.06 109.55 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -108.76 135.31 50.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.76 109.806 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -102.63 -0.82 31.3 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.028 -0.269 . . . . 1.09 111.398 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -150.26 162.13 41.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.318 . . . . 0.62 110.956 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 264' ' ' ILE . 5.3 mt -75.85 -50.96 13.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.34 109.541 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.23 49.54 4.41 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.659 -0.7 . . . . 0.14 112.589 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.452 HD11 HD13 ' A' ' 262' ' ' LEU . 2.6 pt -145.48 149.71 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.321 0.582 . . . . 0.18 111.722 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.36 121.53 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.871 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.0 mm -88.56 123.3 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.949 0.404 . . . . 0.28 110.623 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.33 113.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.358 -0.383 . . . . 0.31 110.246 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -85.72 103.79 2.78 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.728 -0.749 . . . . 0.37 111.81 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 109.612 -0.514 . . . . 1.87 109.612 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.55 -0.22 . . . . 0.3 112.55 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.34 129.4 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.102 0.477 . . . . 0.27 111.008 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -117.69 162.47 18.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.72 110.771 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.78 113.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.24 109.999 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.37 -65.09 2.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.42 112.478 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.87 152.73 45.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.759 0.314 . . . . 0.75 110.637 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.78 131.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.079 -0.51 . . . . 0.53 109.912 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -92.86 126.2 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.851 0.358 . . . . 0.74 110.642 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -65.3 128.43 35.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 1.01 109.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.21 -12.85 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.968 -0.634 . . . . 0.36 111.519 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.5 171.08 47.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.934 -0.65 . . . . 0.26 111.73 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.55 -37.52 86.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.25 111.259 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.29 -34.2 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.26 111.039 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.67 -20.78 64.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 0.37 111.619 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.7 -6.58 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.457 -0.338 . . . . 0.41 111.057 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.97 -76.4 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.938 -0.393 . . . . 0.55 109.938 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.92 32.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.377 -0.916 . . . . 0.39 114.177 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -76.83 -34.99 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.571 0.685 . . . . 0.68 110.937 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.76 136.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.52 158.65 75.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.522 -0.308 . . . . 0.69 110.697 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.48 99.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.497 2.131 . . . . 0.41 111.434 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 141.66 -15.82 2.66 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.59 -0.604 . . . . 0.29 111.59 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.0 146.41 54.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.732 0.301 . . . . 0.34 110.321 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.3 ttt -99.88 135.27 41.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.266 -0.424 . . . . 1.26 110.75 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 335' ' ' VAL . 30.1 mt -90.82 117.46 29.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.246 -0.434 . . . . 0.48 109.933 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 336' ' ' ALA . 82.5 mt -100.85 -62.83 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.163 0.506 . . . . 0.53 110.735 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -127.33 133.15 50.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.73 110.912 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 321' ' ' LEU . 44.4 t -119.62 87.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.173 -0.467 . . . . 0.29 109.76 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.4 t30 62.96 82.97 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.786 . . . . 1.71 111.437 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 4.6 m-20 74.8 -59.78 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.427 -0.806 . . . . 1.11 113.11 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.0 m -64.34 124.91 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.589 . . . . 0.71 112.456 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.52 130.02 47.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.466 -0.788 . . . . 0.74 109.628 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.421 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 44.0 m-85 -106.89 15.99 24.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.944 0.349 . . . . 0.33 111.944 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -62.64 -32.8 73.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.122 0.415 . . . . 1.21 112.122 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -117.6 35.81 4.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.392 . . . . 1.32 111.209 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 312' ' ' MET . . . . . 0.421 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 95.3 mtp -123.09 167.67 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.02 -0.363 . . . . 0.51 110.02 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 38.9 p -75.96 154.59 35.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.447 -0.342 . . . . 0.97 110.133 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -58.37 -32.67 68.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.48 111.109 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -49.82 19.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.207 -0.452 . . . . 1.4 111.063 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.59 -35.16 77.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.257 -0.429 . . . . 0.88 110.974 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.4 73.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.018 -0.537 . . . . 0.2 111.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.536 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 4.0 t -73.5 -31.96 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.3 . . . . 0.21 110.811 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 78.7 mtt180 -55.45 -50.49 69.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.748 0.309 . . . . 0.83 110.339 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.88 -41.01 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.246 -0.433 . . . . 0.17 110.093 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 304' ' ' VAL . 17.3 tp -52.5 -48.51 65.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.964 -0.562 . . . . 0.38 111.22 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.556 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.3 mtp-105 -62.42 -39.14 92.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.012 -0.54 . . . . 1.57 111.743 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 5.9 mm-40 -65.91 -34.6 78.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.87 110.439 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.3 mt -70.65 -43.93 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.557 . . . . 0.29 110.142 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.8 t -70.78 -18.75 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.246 0.546 . . . . 0.24 110.507 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 56.5 m -87.05 4.77 40.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.037 0.446 . . . . 0.44 110.204 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.35 158.53 18.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 1.16 109.989 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.91 120.48 35.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.662 0.268 . . . . 0.89 111.066 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.59 169.09 19.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.655 -0.783 . . . . 0.45 112.0 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.05 125.4 10.88 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.913 2.408 . . . . 0.58 111.714 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 60.0 mt -100.36 117.69 45.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.922 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 m -90.97 102.23 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.09 110.093 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 24.7 mt -92.93 123.37 36.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.872 0.367 . . . . 0.48 111.886 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.4 m -107.3 99.23 8.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.543 -0.91 . . . . 0.5 108.543 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 301' ' ' LEU . 27.6 m -104.68 155.71 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.33 112.194 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.72 111.06 21.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.227 -0.897 . . . . 0.38 109.829 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.311 -0.852 . . . . 0.7 110.144 -179.346 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 43.4 m95 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 110.665 -0.124 . . . . 0.4 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.679 -0.677 . . . . 0.27 110.003 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.673 0.273 . . . . 1.26 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.45 109.67 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.608 -0.516 . . . . 0.65 109.608 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.63 127.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.799 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -104.21 103.46 13.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.59 110.118 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.38 144.06 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.067 0.46 . . . . 0.5 111.276 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.3 t -114.5 113.68 24.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.087 -0.708 . . . . 0.79 109.087 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.44 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 24.0 mt -95.79 152.74 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.359 0.599 . . . . 0.46 112.038 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.29 122.18 34.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.84 . . . . 0.65 110.017 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 90.7 mmm -102.51 25.07 9.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.63 111.752 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -100.37 -45.38 5.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 258' ' ' ARG . 19.2 ttt180 -92.95 11.43 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.385 0.612 . . . . 1.06 110.178 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.52 155.69 50.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 0.76 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -111.98 -11.94 13.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.627 0.251 . . . . 1.09 110.833 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' B' ' 3' ' ' VAL . 30.0 p90 -157.31 173.07 17.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.542 -0.299 . . . . 0.62 111.066 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.5 mt -75.93 -50.95 13.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.584 . . . . 0.34 109.422 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.9 41.58 5.9 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.517 -0.765 . . . . 0.14 112.823 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.65 146.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.441 0.639 . . . . 0.18 111.767 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.04 115.44 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.704 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.484 HG21 HG22 ' A' ' 318' ' ' VAL . 4.6 mm -85.44 126.65 40.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.28 110.239 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.76 115.84 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.31 110.326 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.32 113.79 4.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.868 -0.682 . . . . 0.37 111.73 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.909 0.385 . . . . 1.87 110.455 -179.837 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 112.116 -0.394 . . . . 0.3 112.116 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.0 pt -102.24 128.85 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.193 0.521 . . . . 0.27 110.809 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -118.19 163.97 15.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.72 111.12 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 280' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 301' ' ' LEU . 46.3 mm -85.74 110.68 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.867 -0.606 . . . . 0.24 109.448 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.79 8.87 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.737 -0.744 . . . . 0.42 112.689 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 163.9 39.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.549 0.214 . . . . 0.75 110.579 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 32.8 mt -114.24 134.32 57.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.53 109.991 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.9 mmt -96.13 128.42 43.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.375 -0.375 . . . . 0.74 110.277 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.26 131.86 49.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.522 . . . . 1.01 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 101.49 -6.85 55.68 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.963 -0.637 . . . . 0.36 112.176 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.15 171.28 46.09 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.872 -0.68 . . . . 0.26 112.419 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -65.52 -35.41 80.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.311 . . . . 0.25 111.057 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.89 -35.63 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.26 110.662 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.57 65.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.37 111.182 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -78.89 -16.61 56.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.41 111.069 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.59 -76.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.641 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.89 -18.35 26.62 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.481 -0.866 . . . . 0.39 114.199 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -69.2 -40.05 78.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.568 0.684 . . . . 0.68 111.468 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.3 137.09 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.739 -0.467 . . . . 0.37 109.739 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -138.87 159.05 68.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.504 -0.316 . . . . 0.69 110.616 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 118.75 5.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.358 2.039 . . . . 0.41 111.629 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 122.12 -19.72 8.18 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.469 -0.653 . . . . 0.29 111.469 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.404 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 84.1 m-20 -65.46 145.49 56.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.656 0.265 . . . . 0.34 110.331 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.3 ttp -101.1 133.84 45.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.443 -0.344 . . . . 1.26 110.516 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.568 HD23 HG12 ' A' ' 335' ' ' VAL . 73.3 mt -88.46 130.19 35.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.48 110.205 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 336' ' ' ALA . 71.4 mt -111.16 -76.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.199 0.523 . . . . 0.53 110.899 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -115.79 140.61 49.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.73 111.136 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 321' ' ' LEU . 87.3 t -134.12 101.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.798 -0.637 . . . . 0.29 109.52 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 7.1 m120 62.3 68.16 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.064 -0.516 . . . . 1.71 111.428 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.93 -51.33 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.251 -0.886 . . . . 1.11 113.373 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.3 m -67.78 130.89 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.27 0.557 . . . . 0.71 111.528 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -105.56 135.61 46.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.421 -0.809 . . . . 0.74 109.767 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 309' ' ' PHE . . . . . 0.404 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 21.9 m-85 -106.2 11.01 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.951 0.352 . . . . 0.33 111.951 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.5 -32.47 71.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.233 0.457 . . . . 1.21 112.233 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -112.33 32.14 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.022 0.439 . . . . 1.32 111.002 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 312' ' ' MET . . . . . 0.404 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 86.5 mtp -123.81 163.72 20.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.181 -0.463 . . . . 0.51 110.371 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 75.5 p -74.39 156.6 36.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.97 110.274 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 90.5 m-20 -55.5 -40.64 72.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.86 0.362 . . . . 0.48 110.483 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.0 m-20 -68.61 -51.47 42.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 1.4 111.28 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 28.6 m-20 -61.01 -36.8 80.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.88 111.684 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.28 -48.94 78.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.2 111.245 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 266' ' ' ILE . 6.2 t -73.51 -31.87 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.21 110.771 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 93.1 mtt180 -55.48 -46.52 76.88 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.03 -0.359 . . . . 0.83 110.03 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.51 -38.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.17 110.276 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 325' ' ' VAL . 40.1 tp -54.61 -50.66 67.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.102 -0.499 . . . . 0.38 110.581 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.9 mtp-105 -61.34 -36.43 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.892 -0.595 . . . . 1.57 110.877 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.96 -46.69 89.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.491 . . . . 1.87 110.016 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.11 -41.71 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.788 -0.642 . . . . 0.29 110.878 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 321' ' ' LEU . 65.1 t -65.53 -15.92 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.282 0.563 . . . . 0.24 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 19.8 m -89.96 0.41 57.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.894 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -103.23 147.5 26.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 1.16 110.417 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.77 103.8 16.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.761 0.315 . . . . 0.89 111.148 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 176.86 -175.4 47.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.661 -0.78 . . . . 0.45 112.049 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.62 112.05 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.025 2.484 . . . . 0.58 112.077 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.81 121.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.37 110.389 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.34 103.17 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.904 -0.589 . . . . 1.09 110.243 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.8 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.48 111.217 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.6 m -96.78 97.42 9.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.763 -0.828 . . . . 0.5 108.763 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.568 HG12 HD23 ' A' ' 301' ' ' LEU . 26.3 m -100.81 154.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.223 0.535 . . . . 0.33 112.228 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.56 110.6 21.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.172 -0.922 . . . . 0.38 109.54 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 26.3 mtpp . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.083 -0.96 . . . . 0.7 110.129 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 120.587 0.232 . . . . 0.4 110.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 261' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.762 -0.637 . . . . 0.27 109.799 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.094 0.473 . . . . 1.26 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.35 115.35 28.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.877 -0.602 . . . . 0.65 110.134 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 337' ' ' LYS . 37.1 mt -120.88 130.94 74.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.55 111.132 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.7 m -104.62 102.66 12.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.704 -0.68 . . . . 0.59 109.434 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 295' ' ' ILE . 21.5 m -90.42 152.38 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.5 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -113.5 125.15 53.89 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.317 -0.623 . . . . 0.79 109.317 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.33 136.97 52.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 0.46 111.791 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -90.94 117.3 29.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.855 . . . . 0.65 109.971 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.9 mmm -94.16 26.78 3.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.63 111.624 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -99.74 -50.42 4.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.538 -0.541 . . . . 1.27 109.538 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -81.83 -20.6 38.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.495 -0.775 . . . . 1.06 109.992 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -119.74 134.0 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.76 110.033 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -93.17 -8.5 42.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.499 0.555 . . . . 1.09 112.499 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -151.76 170.85 18.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.62 111.116 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 262' ' ' LEU . 4.4 mt -78.67 -53.82 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.886 -0.597 . . . . 0.34 110.466 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.06 5.73 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.14 112.729 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.9 pt -135.14 152.23 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.525 0.678 . . . . 0.18 111.802 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.91 126.5 47.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.993 -1.003 . . . . 1.0 108.812 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.0 mm -96.34 114.92 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.65 -0.42 . . . . 0.28 110.461 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.6 t -110.53 106.42 20.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.205 -0.452 . . . . 0.31 110.153 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.96 120.71 5.3 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.734 -0.746 . . . . 0.37 111.813 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.982 -0.377 . . . . 1.87 109.982 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 111.981 -0.448 . . . . 0.3 111.981 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.9 pt -102.37 118.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.27 110.37 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.84 150.48 28.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.865 -0.607 . . . . 0.72 110.777 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.2 mm -76.51 115.5 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.271 -0.422 . . . . 0.24 110.001 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -69.89 -58.82 5.96 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.814 -0.708 . . . . 0.42 112.139 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.47 165.08 36.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.152 -0.314 . . . . 0.75 110.152 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.96 138.88 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.707 -0.479 . . . . 0.53 109.707 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 35.2 mmt -102.39 132.17 48.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.817 0.342 . . . . 0.74 110.675 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -70.07 108.25 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 1.01 110.451 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 136.06 -13.08 4.13 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.382 -0.687 . . . . 0.36 111.382 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.3 170.63 39.3 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.26 111.965 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.15 83.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.25 111.382 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.84 -33.34 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.26 111.132 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.56 -15.35 62.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.37 111.541 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.26 -20.09 25.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.288 -0.415 . . . . 0.41 110.942 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.4 -73.35 0.35 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.55 110.351 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.31 -20.56 30.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.48 -0.867 . . . . 0.39 113.57 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -73.37 -35.79 65.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.743 0.771 . . . . 0.68 111.048 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 252' ' ' VAL . 42.9 mt -82.86 137.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.591 -0.522 . . . . 0.37 109.591 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -135.83 158.65 73.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.44 -0.345 . . . . 0.69 110.369 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.34 112.69 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.505 2.137 . . . . 0.41 111.429 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.92 -21.09 5.02 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.101 -0.571 . . . . 0.29 111.94 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.86 146.67 54.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.758 0.313 . . . . 0.34 110.92 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 59.4 ttp -105.9 132.41 52.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.288 -0.414 . . . . 1.26 110.363 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.46 129.92 34.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.347 -0.388 . . . . 0.48 110.491 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 336' ' ' ALA . 19.3 mt -104.78 -76.6 0.6 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.53 110.221 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.1 128.79 56.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.584 -0.734 . . . . 0.73 110.569 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.99 97.68 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.121 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 57.23 77.22 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.71 111.647 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 75.3 -52.83 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.763 1.023 . . . . 1.11 113.763 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.21 132.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.437 0.637 . . . . 0.71 112.349 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -105.67 132.53 51.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.577 -0.738 . . . . 0.74 109.586 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -99.53 3.7 45.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.845 0.313 . . . . 0.33 111.845 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.53 -22.57 65.26 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.654 0.242 . . . . 1.21 111.654 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -118.06 38.24 3.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.32 110.55 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -138.83 159.34 42.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.51 110.397 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 157.34 37.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.537 -0.301 . . . . 0.97 110.549 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.1 m-20 -54.78 -48.17 73.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.35 -0.387 . . . . 0.48 111.179 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.21 -50.79 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.849 -0.614 . . . . 1.4 111.386 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -65.05 -33.79 76.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.88 111.469 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.07 83.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.307 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 2.3 t -71.97 -31.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.607 -0.437 . . . . 0.21 110.917 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -56.25 -54.57 43.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.891 0.377 . . . . 0.83 110.613 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.83 -36.4 77.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.17 110.526 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.3 tp -56.03 -50.83 69.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.38 110.817 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 30.8 mtp180 -63.74 -31.96 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.57 111.292 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -66.13 -45.17 82.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.029 0.442 . . . . 1.87 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.0 mt -67.08 -41.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.899 -0.591 . . . . 0.29 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 99.0 t -66.77 -19.48 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.159 0.504 . . . . 0.24 110.992 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 55.3 m -87.25 -5.62 58.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.809 0.337 . . . . 0.44 110.406 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -97.6 133.69 41.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 1.16 110.393 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.97 130.43 39.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.176 -0.465 . . . . 0.89 110.656 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 146.86 -174.57 26.64 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.83 -0.7 . . . . 0.45 112.286 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 127.67 8.12 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.079 2.519 . . . . 0.58 112.129 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.69 123.92 71.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.103 -0.499 . . . . 0.37 110.564 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.9 OUTLIER -105.59 117.25 33.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.825 -0.625 . . . . 1.09 110.335 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 78.3 mt -102.05 120.8 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.07 -0.513 . . . . 0.48 111.002 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.1 m -100.54 103.91 15.25 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.336 -0.616 . . . . 0.5 109.336 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.33 145.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.33 112.023 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -94.79 92.95 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.526 -0.761 . . . . 0.38 109.316 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 250' ' ' ILE . 20.3 mtpp . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.49 -0.766 . . . . 0.7 111.196 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 110.162 -0.311 . . . . 0.4 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.73 -0.653 . . . . 0.27 110.012 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.991 0.424 . . . . 1.26 110.284 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.34 121.4 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.907 -0.588 . . . . 0.65 110.727 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.9 127.11 67.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.477 -0.328 . . . . 0.55 111.221 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 86.8 m -103.63 118.9 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.157 -0.683 . . . . 0.59 109.157 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.48 143.4 22.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 0.5 111.399 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 t -101.33 137.85 39.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.046 -1.094 . . . . 0.79 108.046 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 85.7 mt -119.15 131.24 55.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.107 0.479 . . . . 0.46 111.668 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.07 108.32 13.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.437 -0.801 . . . . 0.65 110.353 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 95.4 mmm -96.0 13.92 25.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.63 110.981 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -85.27 -40.7 16.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 1.27 109.941 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -93.88 -17.13 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.434 0.635 . . . . 1.06 109.898 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -108.01 161.45 14.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.714 -0.676 . . . . 0.76 110.108 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -124.87 -0.66 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.839 -0.344 . . . . 1.09 111.515 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -159.71 164.04 34.25 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.571 -0.286 . . . . 0.62 110.918 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.7 mt -77.39 -49.22 15.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.711 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 81.27 50.85 4.92 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.68 -0.691 . . . . 0.14 112.339 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 262' ' ' LEU . 3.7 pt -145.56 146.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.517 0.675 . . . . 0.18 111.767 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.29 120.25 38.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.974 . . . . 1.0 108.761 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.3 mm -88.33 127.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.615 -0.434 . . . . 0.28 110.567 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.81 115.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.331 -0.395 . . . . 0.31 110.714 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.63 111.62 4.29 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.201 -0.759 . . . . 0.37 111.201 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 1.87 110.215 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.354 -0.298 . . . . 0.3 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.86 123.34 58.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.365 0.602 . . . . 0.27 110.601 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.0 159.43 19.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.611 -0.722 . . . . 0.72 110.681 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.62 108.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.379 -0.6 . . . . 0.24 109.379 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -68.57 -58.34 7.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.063 -0.589 . . . . 0.42 112.71 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.63 156.22 39.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.673 0.273 . . . . 0.75 110.545 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.23 134.8 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.53 109.915 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 31.3 mmt -96.38 125.06 40.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.337 -0.392 . . . . 0.74 110.166 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.93 120.75 11.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 1.01 110.364 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.82 -12.56 13.29 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.813 -0.708 . . . . 0.36 111.635 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.48 171.66 47.87 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.712 -0.756 . . . . 0.26 111.641 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.47 80.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.836 0.351 . . . . 0.25 111.382 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.41 -35.12 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.26 110.806 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.58 -11.1 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.37 111.958 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -97.19 -5.43 37.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.775 0.322 . . . . 0.41 110.94 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -95.82 -73.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.55 110.04 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.7 -11.54 42.11 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.556 -0.831 . . . . 0.39 114.174 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -81.2 -29.01 34.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.962 0.881 . . . . 0.68 111.289 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.38 138.06 19.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.603 -0.518 . . . . 0.37 109.603 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.19 158.88 71.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.333 -0.247 . . . . 0.69 110.333 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 297' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.3 Cg_exo -59.3 114.07 1.87 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.385 2.057 . . . . 0.41 111.455 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.81 -21.36 5.01 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.995 -0.548 . . . . 0.29 111.954 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -70.2 148.03 49.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.611 0.243 . . . . 0.34 110.425 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 57.6 ttp -105.36 139.67 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 1.26 111.05 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.0 mt -87.16 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.377 -0.374 . . . . 0.48 110.51 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 336' ' ' ALA . 76.3 mt -115.16 -68.29 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 0.53 110.732 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 306' ' ' ASP . 7.7 tt0 -119.65 133.89 55.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.73 110.258 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.652 ' O ' HG22 ' A' ' 307' ' ' VAL . 69.5 t -127.91 116.15 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.187 -0.461 . . . . 0.29 110.935 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 1.1 m-20 50.73 46.61 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.876 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 25.6 m-20 81.27 -13.66 0.89 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.73 1.011 . . . . 1.11 113.73 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 304' ' ' VAL . 2.5 m -90.41 137.01 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.938 -0.705 . . . . 0.71 109.988 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -98.03 134.62 40.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.74 111.649 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.18 -0.34 14.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.33 110.989 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.6 -24.72 64.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.451 0.538 . . . . 1.21 112.451 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -125.71 53.95 1.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.115 0.484 . . . . 1.32 111.407 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 94.6 mtp -142.98 169.02 18.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.138 -0.483 . . . . 0.51 110.139 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.3 p -79.1 159.07 27.66 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.767 -0.457 . . . . 0.97 109.767 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 94.1 m-20 -58.05 -42.62 85.82 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.199 0.523 . . . . 0.48 110.217 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -55.13 21.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.209 -0.905 . . . . 1.4 111.263 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -58.58 -37.31 75.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.392 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.92 63.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.692 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -70.4 -30.74 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.839 -0.344 . . . . 0.21 110.97 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -57.64 -49.93 74.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.023 0.44 . . . . 0.83 110.182 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.63 -39.57 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.539 . . . . 0.17 110.128 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.5 tp -56.27 -52.28 65.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.38 110.501 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.514 ' HA ' HG11 ' B' ' 3' ' ' VAL . 70.6 mtp180 -62.3 -36.33 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.759 -0.655 . . . . 1.57 111.014 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -46.12 87.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.389 -0.369 . . . . 1.87 110.153 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.84 -42.38 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.97 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 321' ' ' LEU . 60.3 t -67.18 -17.02 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 0.24 110.948 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.4 m -86.57 3.79 42.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.44 110.727 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 171.62 7.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.16 110.643 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 138.6 37.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.42 -0.355 . . . . 0.89 111.209 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 132.15 169.42 12.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.699 -0.762 . . . . 0.45 112.312 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.7 140.25 42.45 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.758 2.306 . . . . 0.58 112.118 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 69.2 mt -114.31 128.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.35 -0.386 . . . . 0.37 110.859 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.6 p -101.71 120.24 40.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.012 -0.54 . . . . 1.09 110.003 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.4 mt -113.12 118.74 35.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.385 -0.37 . . . . 0.48 111.53 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 334' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 251' ' ' THR . 85.6 m -101.94 109.62 21.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.28 155.16 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.34 0.59 . . . . 0.33 112.126 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -107.39 103.36 12.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.202 -0.908 . . . . 0.38 109.336 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.559 -0.734 . . . . 0.7 110.617 -179.606 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 120.404 0.145 . . . . 0.4 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.503 -0.554 . . . . 0.27 109.503 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.92 -0.4 . . . . 1.26 109.92 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.9 mt -122.84 129.73 74.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.83 0.348 . . . . 0.65 110.536 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.09 125.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.369 -0.378 . . . . 0.55 110.829 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 61.2 m -111.8 111.59 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.29 -0.633 . . . . 0.59 109.29 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.44 153.6 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.5 111.494 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.4 t -106.01 133.69 50.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.79 109.472 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.582 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 92.5 mt -109.26 132.37 54.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.026 0.441 . . . . 0.46 111.159 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.93 114.21 9.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.65 109.998 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.5 mmm -96.57 21.36 9.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.63 111.203 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -93.39 -50.3 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.224 0.535 . . . . 1.27 109.668 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -83.49 -16.92 43.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.66 . . . . 1.06 110.428 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -119.97 135.62 54.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.071 -0.714 . . . . 0.76 109.071 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -101.97 5.76 40.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.138 0.421 . . . . 1.09 112.138 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.54 166.01 31.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.651 0.263 . . . . 0.62 110.725 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 262' ' ' LEU . 7.6 mt -78.4 -52.61 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.34 109.843 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.73 42.85 5.3 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.995 -0.622 . . . . 0.14 112.56 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.0 pt -143.54 149.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.54 . . . . 0.18 111.635 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.551 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 0.3 OUTLIER -98.22 131.92 44.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.343 178.278 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.8 104.42 15.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.937 0.399 . . . . 0.28 110.673 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 90.5 t -92.32 108.31 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.884 -0.598 . . . . 0.31 110.157 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.0 106.95 3.48 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.834 -0.698 . . . . 0.37 111.994 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.249 0.547 . . . . 1.87 110.386 -179.552 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 N-CA-C 112.112 -0.395 . . . . 0.3 112.112 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.2 pt -106.12 129.14 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.218 0.532 . . . . 0.27 111.272 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -119.47 160.15 22.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.725 -0.671 . . . . 0.72 110.676 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.15 116.03 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.708 -0.678 . . . . 0.24 109.399 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -75.46 -74.47 0.9 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.42 112.44 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 152.51 50.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.221 -0.289 . . . . 0.75 110.221 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 296' ' ' GLU . 44.7 mt -105.12 128.3 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.53 110.459 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -95.04 127.24 40.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.989 -0.55 . . . . 0.74 111.032 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -64.25 128.45 35.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.01 110.161 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.34 12.91 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.16 -0.776 . . . . 0.36 111.16 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.24 166.94 51.88 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.776 -0.726 . . . . 0.26 111.926 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.84 -32.33 73.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.738 0.304 . . . . 0.25 111.509 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.22 -40.8 80.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.321 -0.4 . . . . 0.26 110.953 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.42 -13.06 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.081 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.34 -11.04 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.41 111.148 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 30.6 t70 -96.33 -69.89 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.393 -0.367 . . . . 0.55 110.514 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.3 -13.04 40.17 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.284 -0.96 . . . . 0.39 114.823 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.481 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 19.9 mtm180 -81.1 -33.19 33.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.342 1.071 . . . . 0.68 111.143 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.7 mt -80.43 138.42 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.285 -0.635 . . . . 0.37 109.285 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 296' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -141.48 162.01 49.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.351 0.119 . . . . 0.69 110.929 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 297' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 50.4 Cg_exo -56.97 118.38 5.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.335 2.023 . . . . 0.41 111.549 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.74 -26.12 5.73 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.743 -0.742 . . . . 0.29 112.119 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 87.4 m-20 -62.06 145.75 52.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.799 0.333 . . . . 0.34 110.471 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.4 ttp -103.04 135.96 43.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 1.26 110.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.1 121.4 30.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.48 109.861 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 336' ' ' ALA . 85.8 mt -100.01 -68.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.327 0.584 . . . . 0.53 110.07 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.53 136.32 54.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.414 -0.812 . . . . 0.73 110.768 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 321' ' ' LEU . 79.5 t -128.73 107.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.427 -0.583 . . . . 0.29 109.427 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 0.9 OUTLIER 58.32 62.97 1.84 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.072 -0.513 . . . . 1.71 111.286 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 7.7 m-20 76.51 -44.02 0.47 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.94 1.089 . . . . 1.11 113.94 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 304' ' ' VAL . 35.9 m -71.59 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.265 0.555 . . . . 0.71 111.289 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 308' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 310' ' ' GLU . 52.5 t30 -105.02 128.7 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.74 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -101.11 2.86 40.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.409 -0.36 . . . . 0.33 111.712 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 310' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' A' ' 308' ' ' ASN . 2.8 mt-10 -49.29 -41.69 38.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.853 0.686 . . . . 1.21 112.853 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -112.8 39.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.331 . . . . 1.32 111.299 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -121.93 179.67 4.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.761 0.315 . . . . 0.51 110.681 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 89.9 p -88.71 155.66 19.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.805 -0.443 . . . . 0.97 109.805 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 318' ' ' VAL . 97.2 m-20 -58.05 -41.14 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 0.48 110.973 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -50.92 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 1.4 111.802 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.41 -32.52 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.88 111.762 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.23 77.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.337 . . . . 0.2 110.863 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -73.58 -31.03 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.21 110.657 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.22 -51.67 65.84 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.502 . . . . 0.83 110.314 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.89 -39.74 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.17 110.37 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.5 tp -56.1 -52.53 63.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.38 110.95 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.545 ' HA ' HG11 ' B' ' 3' ' ' VAL . 47.4 mtp180 -62.21 -37.94 87.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 1.57 110.991 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.65 -45.28 94.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.665 0.269 . . . . 1.87 110.421 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.53 -42.79 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.29 110.537 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 321' ' ' LEU . 41.6 t -71.15 -9.92 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.279 0.562 . . . . 0.24 111.043 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -90.21 -9.26 48.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.95 0.405 . . . . 0.44 110.76 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.43 159.48 15.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 1.16 110.618 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.23 116.49 29.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.331 -0.395 . . . . 0.89 110.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 166.05 169.82 30.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.82 -0.705 . . . . 0.45 111.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.05 118.96 5.88 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.603 2.202 . . . . 0.58 111.664 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.22 119.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.954 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 m -97.59 112.17 24.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.797 -0.638 . . . . 1.09 110.022 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 251' ' ' THR . 96.6 mt -101.3 121.47 41.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.48 111.819 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 99.4 m -106.26 100.04 9.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.5 108.618 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.3 m -101.95 156.56 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.323 0.583 . . . . 0.33 112.335 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.4 113.29 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.38 109.459 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.5 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.324 -0.846 . . . . 0.7 109.969 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 30.1 m95 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 110.672 -0.121 . . . . 0.4 110.672 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.594 -0.717 . . . . 0.27 109.697 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.948 -0.39 . . . . 1.26 109.948 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.71 124.44 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.65 111.335 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 41.3 mt -120.88 133.22 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.19 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 m -107.36 109.8 21.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.091 -0.504 . . . . 0.59 109.924 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.19 152.61 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.862 0.363 . . . . 0.5 111.101 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 8.8 t -117.91 131.08 56.56 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.94 -0.763 . . . . 0.79 108.94 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.452 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.9 mt -106.77 140.53 39.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 0.46 111.872 -178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.43 119.89 25.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.65 110.077 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 83.4 mmm -101.0 17.74 21.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.963 0.411 . . . . 0.63 111.33 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -88.35 -50.13 6.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.679 -0.489 . . . . 1.27 109.679 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -93.58 11.77 27.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.441 0.639 . . . . 1.06 109.922 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -133.28 159.0 41.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.76 108.964 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -128.66 0.63 5.49 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.575 -0.45 . . . . 1.09 111.615 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.84 165.5 25.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.603 0.24 . . . . 0.62 110.593 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.422 HD13 HD11 ' A' ' 264' ' ' ILE . 8.9 mt -75.36 -54.77 6.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.096 -0.502 . . . . 0.34 109.757 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.1 44.1 5.46 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.894 -0.594 . . . . 0.14 112.269 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 262' ' ' LEU . 3.9 pt -143.29 150.4 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.536 . . . . 0.18 111.947 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.0 OUTLIER -100.21 132.89 45.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.011 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 266' ' ' ILE . . . . . 0.403 HG21 HG22 ' A' ' 318' ' ' VAL . 8.9 mm -98.99 117.7 44.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.965 0.412 . . . . 0.28 110.469 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.94 106.64 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.456 -0.338 . . . . 0.31 110.536 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.12 118.15 4.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.37 111.732 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 1.87 110.431 -179.679 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 N-CA-C 111.902 -0.479 . . . . 0.3 111.902 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.5 pt -107.72 117.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.154 0.502 . . . . 0.27 110.308 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -108.08 151.11 26.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.777 -0.647 . . . . 0.72 111.152 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.83 117.63 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.222 -0.444 . . . . 0.24 110.045 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 281' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -72.63 -64.27 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.166 -0.54 . . . . 0.42 112.146 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.9 m -149.56 161.37 42.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.843 -0.429 . . . . 0.75 109.843 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 57.2 mt -112.49 128.77 68.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.011 0.434 . . . . 0.53 111.166 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.9 mmt -87.31 119.15 27.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.688 -0.687 . . . . 0.74 110.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -62.56 117.61 6.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 1.01 110.142 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 126.14 -18.69 6.53 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.131 -0.788 . . . . 0.36 111.131 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.39 175.0 53.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.972 -0.632 . . . . 0.26 111.995 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -64.2 -37.23 86.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.799 0.333 . . . . 0.25 111.341 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.94 -37.08 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.368 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.3 66.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.083 -0.508 . . . . 0.37 111.88 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.28 -14.66 40.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.41 111.197 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.04 -74.57 0.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.441 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.86 -9.89 37.46 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.483 -0.865 . . . . 0.39 114.42 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -88.34 -35.21 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.044 0.922 . . . . 0.68 110.348 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 29.8 mt -81.81 138.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.4 pt-20 -144.6 162.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.607 -0.27 . . . . 0.69 110.755 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 297' ' ' PRO . . . . . 0.525 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 52.2 Cg_exo -55.76 117.47 4.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.598 2.199 . . . . 0.41 111.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.56 -24.9 6.05 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.209 -0.757 . . . . 0.29 111.209 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.66 135.44 55.91 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.712 -0.477 . . . . 0.34 109.712 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 46.3 ttp -97.4 130.86 44.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.728 0.299 . . . . 1.26 110.815 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.8 mt -80.51 125.44 29.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.48 110.276 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 336' ' ' ALA . 40.2 mt -105.41 -71.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.19 0.519 . . . . 0.53 110.442 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.07 133.68 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.773 -0.649 . . . . 0.73 110.963 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.07 104.16 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.023 -0.535 . . . . 0.29 110.141 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.45 69.11 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 1.71 111.662 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 74.39 -44.68 0.56 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 1.11 114.103 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.0 m -76.87 127.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.606 0.717 . . . . 0.71 111.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -97.4 130.64 44.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.249 -0.887 . . . . 0.74 110.299 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -100.81 2.35 41.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.794 0.294 . . . . 0.33 111.794 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.08 -27.71 63.9 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.17 0.433 . . . . 1.21 112.17 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -109.22 20.3 18.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.7 0.259 . . . . 1.32 111.7 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.0 mtp -118.41 166.54 12.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.51 111.049 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 10.7 p -75.48 162.63 28.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.97 110.355 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 318' ' ' VAL . 52.5 m-20 -60.97 -43.49 98.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.48 110.697 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.53 -56.71 13.87 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.957 -0.565 . . . . 1.4 111.215 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 8.8 m-20 -58.78 -36.25 74.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.88 112.346 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.3 -47.73 80.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.2 111.374 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -73.63 -31.52 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.458 -0.337 . . . . 0.21 111.095 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 88.5 mtt180 -56.9 -46.92 81.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.86 0.362 . . . . 0.83 110.145 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.29 -38.2 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.17 110.114 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 37.4 tp -58.32 -51.36 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.38 110.763 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.517 ' HA ' HG11 ' B' ' 3' ' ' VAL . 52.2 mtp180 -61.59 -31.94 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.706 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.78 -51.29 50.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.465 . . . . 1.87 109.743 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.42 -42.76 88.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.986 -0.552 . . . . 0.29 111.344 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 61.6 t -69.12 -13.89 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.072 0.463 . . . . 0.24 111.256 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 75.2 m -87.45 -6.61 58.34 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.148 -0.345 . . . . 0.44 110.538 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.41 139.55 31.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.215 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.62 91.34 4.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.115 0.484 . . . . 0.89 111.693 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.27 172.52 44.89 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.829 -0.7 . . . . 0.45 111.694 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.37 143.94 44.51 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.498 2.132 . . . . 0.58 111.893 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 42.3 mt -122.16 125.59 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.915 0.388 . . . . 0.37 111.496 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m -107.07 120.99 43.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.119 -0.697 . . . . 1.09 109.119 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.6 mt -106.39 129.2 54.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.336 0.588 . . . . 0.48 111.903 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.09 97.3 6.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.491 -0.929 . . . . 0.5 108.491 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.99 152.34 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.398 0.618 . . . . 0.33 112.418 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.856 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.15 106.79 15.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.924 . . . . 0.38 109.404 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.312 -0.852 . . . . 0.7 110.103 -179.803 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 21.5 m95 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 110.15 -0.315 . . . . 0.4 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.489 -0.767 . . . . 0.27 110.464 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.713 0.292 . . . . 1.26 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.2 mt -91.34 111.34 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.496 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.29 131.94 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.007 -0.542 . . . . 0.55 110.053 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 251' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 5.0 m -121.35 105.46 10.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.036 0.446 . . . . 0.59 110.492 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.54 157.89 6.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.105 -0.498 . . . . 0.5 111.051 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.0 t -109.7 122.55 47.73 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.525 -0.546 . . . . 0.79 109.525 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.497 HD13 HD22 ' A' ' 262' ' ' LEU . 53.1 mt -94.48 120.69 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.18 -0.464 . . . . 0.46 111.158 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.51 115.39 18.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.315 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 85.2 mmm -98.12 19.12 14.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.63 111.039 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -88.66 -52.18 5.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 1.27 109.784 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -92.02 2.03 56.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 1.06 110.001 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -127.71 148.41 50.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.968 -0.56 . . . . 0.76 110.333 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.91 -8.19 14.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.367 -0.379 . . . . 1.09 111.504 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.74 169.51 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.755 0.312 . . . . 0.62 111.194 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.497 HD22 HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER -76.79 -51.63 11.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.365 -0.605 . . . . 0.34 109.365 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.21 39.28 6.45 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.58 -0.736 . . . . 0.14 112.531 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.7 pt -142.31 149.75 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.309 0.575 . . . . 0.18 111.507 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.456 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 23.3 p -105.26 129.29 53.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.32 -0.855 . . . . 1.0 108.892 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.0 mm -89.43 127.01 42.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.786 0.327 . . . . 0.28 110.524 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 79.3 t -115.57 109.82 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.396 . . . . 0.31 110.129 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.14 145.71 18.69 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.757 -0.735 . . . . 0.37 111.933 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.895 0.379 . . . . 1.87 110.828 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 112.277 -0.329 . . . . 0.3 112.277 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.7 pt -110.78 132.88 58.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 0.27 110.552 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 163.79 16.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.534 . . . . 0.72 110.785 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.8 mm -84.04 119.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.24 109.786 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -83.69 -66.28 1.51 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.867 -0.682 . . . . 0.42 112.835 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.3 p -137.93 153.38 49.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.729 0.3 . . . . 0.75 110.959 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 70.8 mt -112.78 133.58 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.53 109.815 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.8 mmt -98.01 127.08 43.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.74 110.848 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.17 117.75 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 1.01 110.459 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.86 -16.6 8.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.821 -0.704 . . . . 0.36 111.946 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.22 168.4 53.12 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.837 -0.696 . . . . 0.26 112.021 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.72 76.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.25 111.301 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.4 -37.43 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.967 -0.56 . . . . 0.26 111.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.28 62.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.37 111.614 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -81.3 -27.88 34.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.342 -0.39 . . . . 0.41 110.939 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.29 -71.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.36 -0.382 . . . . 0.55 110.054 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.08 27.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.083 -1.056 . . . . 0.39 114.168 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -76.26 -23.93 54.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.475 0.637 . . . . 0.68 111.002 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 37.0 mt -88.52 130.06 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.427 -0.583 . . . . 0.37 109.427 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.06 162.64 47.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.725 -0.216 . . . . 0.69 110.553 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 129.75 36.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.322 2.015 . . . . 0.41 111.202 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.55 -17.5 28.23 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.533 -0.841 . . . . 0.29 111.83 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.55 141.58 51.86 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.702 -0.481 . . . . 0.34 109.702 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 41.0 ttp -98.97 132.62 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.451 -0.341 . . . . 1.26 111.093 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 335' ' ' VAL . 94.4 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.48 110.058 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.1 -60.72 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.537 -0.302 . . . . 0.53 111.281 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -126.91 135.33 50.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.386 -0.37 . . . . 0.73 111.076 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 321' ' ' LEU . 43.0 t -125.7 92.26 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.376 -0.374 . . . . 0.29 110.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.38 79.31 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.835 -0.62 . . . . 1.71 111.312 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.67 -57.43 0.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.978 -1.01 . . . . 1.11 113.416 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.17 130.76 28.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.412 0.625 . . . . 0.71 111.641 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -108.02 135.2 49.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.53 -0.759 . . . . 0.74 111.137 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -113.85 18.7 17.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.33 111.187 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.16 -36.56 75.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.584 -0.28 . . . . 1.21 111.662 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.98 49.28 1.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.26 0.552 . . . . 1.32 110.523 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.81 152.95 48.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.51 110.435 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 155.56 40.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 0.97 110.522 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -49.19 -50.82 36.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.008 0.433 . . . . 0.48 111.306 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.62 -53.14 61.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.483 -0.781 . . . . 1.4 111.206 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.8 m-20 -56.3 -40.57 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.882 -0.599 . . . . 0.88 111.714 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.83 81.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.141 -0.481 . . . . 0.2 111.392 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.9 t -78.04 -29.19 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.9 -0.32 . . . . 0.21 111.176 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 81.2 mtt180 -55.17 -49.99 70.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.83 110.286 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.11 -36.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.093 -0.503 . . . . 0.17 110.655 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 304' ' ' VAL . 19.6 tp -54.68 -48.29 72.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.995 -0.548 . . . . 0.38 111.801 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.52 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.5 mtp180 -64.48 -30.24 71.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.238 -0.437 . . . . 1.57 111.713 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 323' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 9.3 mm-40 -68.76 -39.38 80.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.087 0.47 . . . . 1.87 109.916 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 62.0 mt -71.13 -43.42 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.837 -0.619 . . . . 0.29 111.085 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.471 HG11 ' HB ' ' B' ' 3' ' ' VAL . 63.7 t -66.65 -19.04 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.169 0.509 . . . . 0.24 111.432 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.4 m -87.64 10.98 16.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.99 0.424 . . . . 0.44 110.853 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -111.64 152.41 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.377 . . . . 1.16 110.28 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.89 101.06 13.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.89 111.635 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.98 39.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.954 -0.641 . . . . 0.45 111.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.5 124.93 11.23 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.327 2.018 . . . . 0.58 112.152 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 78.8 mt -104.74 118.65 52.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.37 110.78 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.19 113.18 25.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.998 -0.546 . . . . 1.09 110.641 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 251' ' ' THR . 11.5 mt -96.4 119.39 34.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.159 -0.473 . . . . 0.48 111.194 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 93.68 5.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.5 108.635 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 301' ' ' LEU . 21.7 m -97.66 152.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.33 112.278 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.03 95.92 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.399 -0.819 . . . . 0.38 109.078 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.285 -0.864 . . . . 0.7 110.256 -179.325 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 25.0 m95 . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 110.089 -0.337 . . . . 0.4 110.089 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.559 -0.734 . . . . 0.27 110.436 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.831 0.348 . . . . 1.26 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 70.7 mt -93.1 119.38 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.65 109.868 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.47 137.71 51.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.202 -0.453 . . . . 0.55 111.264 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.23 122.97 48.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.855 -0.612 . . . . 0.59 110.115 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 295' ' ' ILE . 33.2 m -114.39 143.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.776 0.322 . . . . 0.5 111.019 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.43 107.4 18.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.79 110.014 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.16 145.18 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 0.46 111.658 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -99.73 117.95 35.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.794 . . . . 0.65 110.078 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.7 mmm -98.75 26.25 5.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.258 -0.428 . . . . 0.63 111.396 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.99 -53.69 3.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 1.27 109.723 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -83.12 -17.4 43.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.554 -0.748 . . . . 1.06 109.822 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -112.28 145.95 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.832 -0.622 . . . . 0.76 109.959 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -111.12 3.23 18.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.683 -0.235 . . . . 1.09 111.616 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -160.03 165.1 32.55 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.746 0.307 . . . . 0.62 110.734 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.34 110.0 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.96 4.26 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.791 -0.641 . . . . 0.14 112.843 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.41 151.65 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.51 0.671 . . . . 0.18 112.073 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.74 119.56 38.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.217 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mm -88.34 107.9 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.892 0.377 . . . . 0.28 110.717 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.86 114.2 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.19 -0.459 . . . . 0.31 110.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.66 113.36 4.46 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.782 -0.723 . . . . 0.37 111.92 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.193 0.521 . . . . 1.87 110.626 -179.753 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.791 0 N-CA-C 111.637 -0.585 . . . . 0.3 111.637 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.7 pt -103.59 123.9 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.27 110.565 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 157.05 22.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.704 . . . . 0.72 110.9 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.7 mm -78.28 114.13 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.974 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.91 -57.72 3.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.881 -0.676 . . . . 0.42 112.416 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.9 153.81 35.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.243 -0.281 . . . . 0.75 110.243 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.3 mt -108.88 130.18 62.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.53 110.157 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 39.3 mmt -93.85 122.72 36.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.362 -0.381 . . . . 0.74 110.93 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -61.84 120.21 10.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 1.01 109.764 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.64 -16.19 9.02 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.33 -0.708 . . . . 0.36 111.33 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.2 169.13 45.48 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.443 -0.663 . . . . 0.26 111.443 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.22 74.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.555 0.216 . . . . 0.25 111.546 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 289' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 295' ' ' ILE . 84.1 t -67.87 -37.48 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.26 110.836 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.24 -13.28 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.37 111.249 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.16 -13.72 40.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.507 -0.315 . . . . 0.41 111.048 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.15 -70.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.55 110.534 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.44 42.14 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.386 -0.912 . . . . 0.39 114.276 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.16 -22.77 41.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.864 0.832 . . . . 0.68 111.387 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 295' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 252' ' ' VAL . 54.7 mt -89.97 137.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.226 -0.657 . . . . 0.37 109.226 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -140.86 163.34 43.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.752 -0.204 . . . . 0.69 110.864 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.32 121.58 10.3 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.216 1.944 . . . . 0.41 111.368 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.43 8.5 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.849 -0.691 . . . . 0.29 112.173 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 84.1 m-20 -61.4 139.65 58.16 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.34 110.498 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 36.3 ttp -101.12 130.45 47.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.524 -0.307 . . . . 1.26 110.429 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 301' ' ' LEU . . . . . 0.497 HD23 HG12 ' A' ' 335' ' ' VAL . 31.6 mt -84.73 127.48 34.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.389 . . . . 0.48 110.154 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 336' ' ' ALA . 62.4 mt -107.19 -73.55 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.236 0.541 . . . . 0.53 110.391 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -108.07 137.65 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.577 -0.738 . . . . 0.73 110.512 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 321' ' ' LEU . 93.0 t -132.45 98.05 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.289 -0.634 . . . . 0.29 109.289 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.9 m120 59.97 71.94 0.55 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.666 -0.697 . . . . 1.71 111.464 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.6 OUTLIER 76.69 -51.52 0.58 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.957 1.095 . . . . 1.11 113.957 178.06 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.93 131.66 34.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.571 0.582 . . . . 0.71 112.571 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -101.48 131.39 47.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.44 -0.8 . . . . 0.74 109.235 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.35 5.06 50.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.554 0.576 . . . . 0.33 112.554 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -64.44 -22.16 66.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 1.21 111.699 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -107.44 22.5 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.354 -0.384 . . . . 1.32 111.085 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.21 168.89 16.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 0.51 111.07 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.38 156.14 26.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.863 -0.608 . . . . 0.97 110.404 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 80.7 m-20 -53.22 -50.19 65.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.819 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 10.9 t70 -60.77 -52.77 63.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 1.4 110.901 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.5 -35.56 70.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.933 -0.576 . . . . 0.88 111.123 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.2 111.417 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -70.78 -26.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.845 -0.342 . . . . 0.21 111.285 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 95.5 mtt180 -56.14 -52.36 64.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.631 -0.507 . . . . 0.83 109.631 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.33 -37.28 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.412 -0.813 . . . . 0.17 110.34 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 304' ' ' VAL . 13.5 tp -54.23 -52.82 60.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.725 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HA ' HG11 ' B' ' 3' ' ' VAL . 33.7 mtp180 -64.03 -33.74 76.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.011 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.83 -41.23 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 1.87 110.412 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.8 mt -69.14 -43.04 81.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.937 -0.574 . . . . 0.29 110.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 321' ' ' LEU . 87.3 t -67.03 -21.98 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.068 0.461 . . . . 0.24 111.165 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -83.97 1.94 41.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.768 0.318 . . . . 0.44 110.954 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.7 141.01 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.16 110.269 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 115.13 21.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.89 111.659 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 169.18 -170.92 42.83 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.993 -0.622 . . . . 0.45 112.037 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.24 117.18 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.202 2.602 . . . . 0.58 111.806 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 64.8 mt -98.3 118.12 44.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.95 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.61 110.13 21.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 1.09 110.295 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.05 124.35 45.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.48 111.379 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.67 99.36 9.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.699 -0.852 . . . . 0.5 108.699 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 335' ' ' VAL . . . . . 0.497 HG12 HD23 ' A' ' 301' ' ' LEU . 28.6 m -98.88 148.23 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.286 0.565 . . . . 0.33 112.232 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -105.12 102.79 12.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.33 -0.85 . . . . 0.38 109.966 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 28.2 mtpp . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.349 -0.834 . . . . 0.7 109.856 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.532 0.206 . . . . 0.4 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.853 0 N-CA-C 109.369 -0.604 . . . . 0.27 109.369 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 43.2 t30 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.808 0.337 . . . . 1.26 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 91.9 mt -92.12 123.21 44.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.65 110.512 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.26 122.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.865 0.364 . . . . 0.55 111.074 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.35 120.35 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.59 110.104 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 332' ' ' SER . 24.8 m -125.49 144.98 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 0.5 111.785 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.0 t -110.99 120.94 44.05 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.582 -0.896 . . . . 0.79 108.582 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.43 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.7 mt -102.81 135.55 44.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.083 0.468 . . . . 0.46 111.766 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.01 120.17 13.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.371 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 87.8 mmm -102.54 17.46 23.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.165 0.507 . . . . 0.63 110.895 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -88.65 -53.19 4.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.121 0.486 . . . . 1.27 109.801 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -80.48 -31.04 37.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.374 -0.83 . . . . 1.06 110.648 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -92.6 157.71 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.677 -0.49 . . . . 0.76 109.677 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -119.18 -7.76 10.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.915 0.388 . . . . 1.09 110.787 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -156.52 173.26 17.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.036 -0.529 . . . . 0.62 110.279 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 9.0 mt -80.57 -52.93 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.34 110.029 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.55 46.27 4.37 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.975 -0.631 . . . . 0.14 112.809 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 262' ' ' LEU . 4.7 pt -145.86 149.58 16.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.113 0.483 . . . . 0.18 111.388 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 265' ' ' SER . . . . . 0.495 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 5.5 p -99.18 124.62 44.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.159 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.3 mm -89.23 111.02 22.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.04 0.448 . . . . 0.28 110.87 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.7 t -105.94 110.43 31.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.103 -0.498 . . . . 0.31 110.986 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.72 119.36 6.09 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.825 -0.702 . . . . 0.37 111.361 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 1.87 110.5 -179.677 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.989 0 N-CA-C 111.756 -0.538 . . . . 0.3 111.756 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.12 119.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.015 0.436 . . . . 0.27 110.147 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.61 159.54 17.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.783 -0.644 . . . . 0.72 111.18 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.99 112.61 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.564 -0.743 . . . . 0.24 109.397 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.18 -55.38 6.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.397 -0.906 . . . . 0.42 112.267 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.9 p -153.29 156.68 38.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.188 -0.301 . . . . 0.75 110.188 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 35.9 mt -106.71 135.73 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.201 -0.454 . . . . 0.53 110.131 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -97.55 134.65 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.224 -0.444 . . . . 0.74 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -70.25 135.84 49.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 1.01 110.006 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.76 -10.26 64.37 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.824 -0.703 . . . . 0.36 111.907 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.03 176.12 53.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.96 -0.638 . . . . 0.26 112.115 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -68.35 -37.98 81.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.73 0.3 . . . . 0.25 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.3 -33.42 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.048 0.451 . . . . 0.26 111.283 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.13 -21.97 66.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.092 -0.504 . . . . 0.37 111.629 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -84.88 -15.01 46.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.359 -0.382 . . . . 0.41 111.419 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.34 -74.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.55 110.968 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.95 -15.94 47.33 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.604 -0.808 . . . . 0.39 114.085 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -80.29 -29.96 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.651 0.725 . . . . 0.68 110.945 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.8 mt -84.55 137.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.751 -0.462 . . . . 0.37 109.751 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -136.7 164.36 43.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.657 -0.247 . . . . 0.69 110.924 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.7 111.77 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.261 1.974 . . . . 0.41 110.615 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.81 -19.02 5.04 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.485 -0.646 . . . . 0.29 111.485 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 299' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 95.4 m-20 -69.06 147.53 51.38 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.044 -0.354 . . . . 0.34 110.044 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 26.7 ttt -103.57 136.97 42.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.695 0.283 . . . . 1.26 110.811 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 19.5 mt -88.59 123.13 32.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.48 109.828 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 302' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 336' ' ' ALA . 80.5 mt -102.3 -77.66 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.168 0.509 . . . . 0.53 110.586 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -113.0 134.29 54.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.73 111.3 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.32 94.33 2.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.144 -0.48 . . . . 0.29 109.889 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 305' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 60.63 75.98 0.39 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.705 -0.68 . . . . 1.71 111.399 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 306' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 56.5 m-20 76.97 -61.44 0.43 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.903 0.881 . . . . 1.11 112.894 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m -63.36 125.89 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.627 0.727 . . . . 0.71 111.986 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.23 132.95 51.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.249 -0.887 . . . . 0.74 109.925 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -104.35 11.09 35.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.568 -0.287 . . . . 0.33 111.434 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.6 -38.54 66.89 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.952 0.406 . . . . 1.21 111.257 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -123.96 59.17 1.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 1.32 110.867 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 87.2 mtp -140.05 163.84 31.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.51 110.051 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.1 m -69.85 147.29 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.821 -0.437 . . . . 0.97 109.821 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -52.59 -47.07 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.744 0.306 . . . . 0.48 111.096 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -50.3 71.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.4 110.91 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 1.7 m-20 -61.1 -34.74 75.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.88 111.834 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.98 -49.09 78.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.117 -0.492 . . . . 0.2 111.1 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.76 -28.0 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.529 -0.305 . . . . 0.21 110.905 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 67.5 mtt180 -54.71 -52.04 63.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.83 110.571 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 15.4 t -70.42 -39.58 76.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.17 110.618 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 21.7 tp -54.26 -49.24 70.01 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.163 -0.471 . . . . 0.38 111.431 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.593 ' HA ' HG11 ' B' ' 3' ' ' VAL . 14.7 mtp-105 -60.9 -37.49 82.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 1.57 111.654 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.33 -38.02 88.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 1.87 110.779 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.36 -41.64 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.091 -0.504 . . . . 0.29 110.692 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 40.5 t -69.83 -19.42 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.044 0.45 . . . . 0.24 111.075 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 22.6 m -91.08 2.01 56.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.053 0.454 . . . . 0.44 110.463 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -106.92 137.78 44.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.164 -0.471 . . . . 1.16 110.572 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.81 99.37 3.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 0.89 111.814 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.59 160.3 24.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.054 -0.593 . . . . 0.45 111.757 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.82 130.32 32.56 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.824 2.349 . . . . 0.58 112.229 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 76.3 mt -112.18 121.13 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.37 111.131 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 332' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 9.5 m -105.99 121.33 43.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.931 -0.577 . . . . 1.09 109.893 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 36.5 mt -104.08 126.71 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.297 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -106.18 98.65 8.31 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.336 -0.986 . . . . 0.5 108.336 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.12 151.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.414 0.626 . . . . 0.33 112.447 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 336' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.47 112.01 23.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.174 -0.921 . . . . 0.38 109.973 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 337' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 25.6 mtpp . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.393 -0.813 . . . . 0.7 109.803 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 2' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 16.8 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.58 -0.156 . . . . 0.4 110.58 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.752 -0.642 . . . . 0.27 110.077 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.139 0.495 . . . . 1.26 109.976 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.7 mt -95.58 127.76 47.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.202 -0.453 . . . . 0.65 110.926 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.23 129.38 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.439 -0.346 . . . . 0.55 110.681 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 6.9 m -100.08 110.17 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.149 -0.686 . . . . 0.59 109.149 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.85 154.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.121 0.486 . . . . 0.5 111.385 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.3 t -122.44 126.24 47.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.998 -0.741 . . . . 0.79 108.998 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 66.7 mt -114.21 149.16 36.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.46 111.492 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.8 120.09 34.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.589 -0.732 . . . . 0.65 110.116 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 99.8 mmm -101.1 16.99 23.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.11 0.481 . . . . 0.63 111.223 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.217 -0.66 . . . . 1.27 109.217 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -91.65 -16.32 27.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.478 -0.783 . . . . 1.06 109.9 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -114.39 145.37 41.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.9 -0.591 . . . . 0.76 109.933 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -107.9 -7.94 16.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.742 0.306 . . . . 1.09 111.673 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -151.7 168.91 23.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.492 -0.322 . . . . 0.62 110.932 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.8 mt -77.94 -55.17 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.34 109.637 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 91.24 43.79 4.56 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.726 -0.67 . . . . 0.14 112.331 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 264' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 262' ' ' LEU . 8.1 pt -139.74 151.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.397 0.617 . . . . 0.18 111.736 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 t -103.1 128.51 49.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.795 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.54 113.87 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.989 0.423 . . . . 0.28 110.744 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.41 114.11 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.101 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.75 108.86 3.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.545 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.749 0.309 . . . . 1.87 110.328 -179.73 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.127 -0.389 . . . . 0.3 112.127 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -106.08 118.09 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.374 0.607 . . . . 0.27 110.629 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.0 152.73 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.743 -0.662 . . . . 0.72 110.94 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.13 113.36 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.128 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.33 -60.05 3.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.877 -0.677 . . . . 0.42 112.33 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.07 160.96 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.54 0.209 . . . . 0.75 110.524 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.92 131.98 64.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.778 -0.453 . . . . 0.53 109.778 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.2 mmt -97.99 128.29 44.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.778 0.323 . . . . 0.74 110.759 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -66.45 132.89 49.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.01 110.308 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.86 -12.7 32.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.93 -0.653 . . . . 0.36 111.552 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -87.36 171.82 42.44 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.024 -0.608 . . . . 0.26 111.826 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 288' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.12 -36.65 83.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.25 111.518 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.76 -35.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.26 111.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.79 -14.09 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.37 111.91 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.71 -23.56 25.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 0.41 110.728 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 292' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 13.0 t70 -77.98 -68.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.55 110.215 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.46 -20.38 46.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.431 -0.89 . . . . 0.39 113.991 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 294' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 72.7 mtm180 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.716 0.758 . . . . 0.68 110.927 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.1 mt -75.62 136.02 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.593 -0.521 . . . . 0.37 109.593 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.42 161.16 64.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.539 -0.3 . . . . 0.69 110.443 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.74 109.41 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.2 1.933 . . . . 0.41 111.041 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 131.86 -15.79 5.1 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.153 -0.546 . . . . 0.29 111.737 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -70.61 149.59 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.241 -0.281 . . . . 0.34 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 27.0 ttp -107.15 135.94 47.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.556 -0.293 . . . . 1.26 110.613 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 mt -89.3 119.22 29.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.135 -0.484 . . . . 0.48 109.829 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 67.2 mt -100.99 -64.33 1.06 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.084 0.469 . . . . 0.53 110.705 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 303' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 307' ' ' VAL . 36.5 tt0 -120.6 133.23 55.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.73 110.815 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 304' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.0 t -129.14 104.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.258 -0.428 . . . . 0.29 110.536 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 65.9 t30 58.07 70.32 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 1.71 111.483 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.89 -44.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.994 1.109 . . . . 1.11 113.994 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 307' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 304' ' ' VAL . 32.2 m -74.15 139.22 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.354 0.597 . . . . 0.71 111.36 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -111.66 135.64 51.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.69 -0.686 . . . . 0.74 110.379 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -109.26 11.84 25.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.286 . . . . 0.33 111.661 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.98 -29.01 70.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.845 0.313 . . . . 1.21 111.845 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -117.98 36.31 4.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.792 0.33 . . . . 1.32 111.07 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.3 mtp -129.68 153.07 48.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.489 -0.323 . . . . 0.51 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 149.9 49.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.132 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -51.59 -47.67 63.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.443 -0.344 . . . . 0.48 111.602 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 315' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.1 OUTLIER -57.8 -50.03 74.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 1.4 111.009 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 316' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 29.8 m-20 -63.75 -37.44 87.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.88 111.815 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.28 -51.09 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.2 111.634 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 318' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -72.92 -30.46 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.688 -0.405 . . . . 0.21 110.992 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 319' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 80.5 mtt180 -56.11 -46.52 79.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.884 0.373 . . . . 0.83 110.499 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.47 -40.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.17 110.504 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 31.5 tp -54.36 -47.77 72.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.12 -0.491 . . . . 0.38 111.417 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 322' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 25.6 mtp-105 -64.96 -29.58 70.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.955 -0.566 . . . . 1.57 111.871 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -69.07 -40.42 78.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.153 0.501 . . . . 1.87 110.003 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.66 -44.55 85.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.685 . . . . 0.29 110.718 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 325' ' ' VAL . . . . . 0.456 HG11 ' HB ' ' B' ' 3' ' ' VAL . 40.8 t -69.2 -18.65 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.483 . . . . 0.24 111.594 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -91.75 3.55 54.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.44 110.875 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 148.77 33.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 1.16 110.24 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.0 139.98 36.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.497 -0.32 . . . . 0.89 110.49 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 143.06 -173.62 24.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.662 -0.78 . . . . 0.45 112.308 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.5 117.18 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.424 2.749 . . . . 0.58 112.21 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.6 mt -96.88 119.23 44.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.37 111.258 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.59 115.2 28.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 1.09 110.169 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 333' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 304' ' ' VAL . 49.9 mt -104.45 125.36 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.87 0.367 . . . . 0.48 111.36 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 103.05 11.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.563 . . . . 0.5 109.812 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.7 m -103.96 158.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.191 -0.458 . . . . 0.33 111.691 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -118.34 108.72 15.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.488 -0.778 . . . . 0.38 110.195 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.263 -0.875 . . . . 0.7 110.223 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.377 0.132 . . . . 0.4 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 3' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.727 -0.654 . . . . 0.27 109.997 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.258 -0.275 . . . . 1.26 110.258 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.7 mt -102.64 122.3 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.293 -0.262 . . . . 0.65 110.293 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 27.0 mm -120.13 124.21 72.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 0.55 110.832 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -110.36 111.86 23.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.769 -0.456 . . . . 0.59 109.769 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.87 156.21 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.5 111.434 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -124.85 113.91 18.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.218 -1.03 . . . . 0.79 108.218 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 76.5 mt -97.82 137.97 35.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.622 0.601 . . . . 0.46 112.622 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.16 110.73 14.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.088 -0.96 . . . . 0.65 109.962 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 71.6 mmm -94.87 21.04 8.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.268 -0.424 . . . . 0.63 111.338 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -93.14 -51.06 5.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.21 -0.663 . . . . 1.27 109.21 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -87.24 1.88 51.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.627 -0.715 . . . . 1.06 110.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -128.38 154.96 45.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.878 -0.601 . . . . 0.76 109.464 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -124.89 7.82 8.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 1.09 111.023 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.7 164.7 23.77 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.286 -0.416 . . . . 0.62 110.659 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.1 mt -79.52 -56.38 4.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.469 -0.567 . . . . 0.34 109.469 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.77 43.18 4.25 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.664 -0.698 . . . . 0.14 112.681 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.77 150.34 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.18 112.186 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 22.7 t -98.99 131.36 45.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.751 -1.113 . . . . 1.0 108.198 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.725 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 6.7 mm -98.09 115.79 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.967 0.413 . . . . 0.28 110.752 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 267' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 278' ' ' ILE . 62.1 t -86.84 126.07 40.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.84 88.64 0.86 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.972 -0.632 . . . . 0.37 112.337 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 32.5 tt0 -72.72 118.87 16.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.852 0.358 . . . . 1.87 110.266 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.2 m -129.0 112.82 14.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.341 -0.39 . . . . 1.17 110.916 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -91.76 -152.06 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.97 -0.559 . . . . 2.75 109.937 179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 12.7 p-10 -59.23 -46.35 88.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.292 . . . . 2.08 111.076 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.2 mtm105 -75.78 -55.21 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.126 0.488 . . . . 2.63 110.377 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 137.79 -35.43 2.05 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.607 -0.724 . . . . 0.97 111.913 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.08 92.92 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.819 0.819 . . . . 1.75 110.71 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -113.24 -30.81 2.59 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.501 -0.772 . . . . 0.52 112.091 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.6 158.12 20.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.654 -0.784 . . . . 0.3 112.613 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 278' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 8.3 pt -103.53 123.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.177 0.513 . . . . 0.27 110.432 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.7 156.84 21.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.964 -0.562 . . . . 0.72 111.354 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.97 118.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.24 109.998 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -88.74 -112.69 1.21 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.675 -0.774 . . . . 0.42 111.973 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.62 139.31 31.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.872 0.368 . . . . 0.75 111.445 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.19 132.59 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.16 -0.681 . . . . 0.53 109.16 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 33.9 mmt -95.1 134.83 37.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.517 -0.311 . . . . 0.74 110.994 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.47 133.14 46.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.01 110.199 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.79 -17.81 44.89 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.665 -0.778 . . . . 0.36 111.647 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.6 167.11 54.76 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.019 -0.61 . . . . 0.26 112.131 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.75 -35.25 79.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.723 0.297 . . . . 0.25 111.387 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.67 -42.56 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.26 110.804 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.96 -17.64 64.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.37 111.496 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.66 -21.27 44.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.41 111.135 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.69 -82.21 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.214 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 122.02 -21.45 7.85 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.25 -0.976 . . . . 0.39 113.764 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -66.43 -31.12 71.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.466 0.633 . . . . 0.68 111.277 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 51.3 mt -89.35 132.85 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.337 -0.616 . . . . 0.37 109.337 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.81 165.12 36.23 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.69 110.42 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.51 119.68 7.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.022 1.815 . . . . 0.41 111.47 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 121.99 -21.31 7.9 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.585 -0.817 . . . . 0.29 112.273 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 91.3 m-20 -65.79 141.31 58.35 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.318 -0.253 . . . . 0.34 110.318 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.6 ttp -100.86 132.4 46.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.059 -0.256 . . . . 1.26 110.553 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 34.3 mt -82.09 123.07 28.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.561 -0.29 . . . . 0.48 110.554 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 336' ' ' ALA . 63.9 mt -102.69 -72.54 0.69 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.626 0.726 . . . . 0.53 110.137 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -116.52 134.25 55.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.103 -0.953 . . . . 0.73 110.971 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 321' ' ' LEU . 94.7 t -124.22 96.97 4.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.29 109.34 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.2 t-20 60.47 73.87 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.71 111.461 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.7 m-20 75.86 -50.03 0.61 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.734 1.013 . . . . 1.11 113.734 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.36 130.02 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.57 . . . . 0.71 112.405 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.64 123.14 46.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.74 110.269 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -95.69 6.77 48.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.33 111.598 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.46 -12.36 30.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.319 0.489 . . . . 1.21 112.319 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -126.42 26.89 6.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.218 0.532 . . . . 1.32 110.63 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.2 mtp -125.5 163.02 23.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.259 -0.428 . . . . 0.51 109.987 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 17.9 p -72.08 157.81 37.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.584 0.23 . . . . 0.97 110.646 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 70.4 m-20 -54.94 -43.49 73.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.48 111.168 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -63.84 -52.82 58.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 1.4 110.878 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.99 -39.2 77.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.897 -0.592 . . . . 0.88 111.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.36 -54.33 47.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.2 111.892 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.453 HG22 HG21 ' A' ' 266' ' ' ILE . 3.0 t -70.58 -30.89 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.002 -0.279 . . . . 0.21 111.123 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 58.8 mtt180 -55.77 -52.39 64.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.001 -0.37 . . . . 0.83 110.001 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.27 -37.48 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.17 110.453 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 304' ' ' VAL . 20.7 tp -55.99 -49.33 73.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.073 0.463 . . . . 0.38 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.8 mtp180 -62.34 -35.59 79.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.764 -0.653 . . . . 1.57 111.106 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 17.3 mm-40 -64.84 -36.32 83.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.8 0.333 . . . . 1.87 110.868 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.1 mt -73.61 -40.77 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.416 . . . . 0.29 110.502 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.3 t -70.32 -21.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.24 110.397 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.8 m -90.21 33.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -144.13 170.9 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 1.16 109.704 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.46 149.43 22.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.393 . . . . 0.89 111.503 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.14 158.64 10.17 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.117 -0.563 . . . . 0.45 112.332 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 133.71 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.871 2.381 . . . . 0.58 111.837 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.4 mt -103.5 120.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.967 0.413 . . . . 0.37 111.553 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.86 108.65 20.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.833 -0.621 . . . . 1.09 110.093 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.88 122.97 45.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.268 -0.423 . . . . 0.48 111.652 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.9 m -108.04 104.52 13.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.642 . . . . 0.5 109.265 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.4 153.65 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.33 112.136 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.754 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.53 111.17 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 0.38 110.176 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.432 -0.794 . . . . 0.7 109.347 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.725 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 17.4 m95 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 110.147 -0.316 . . . . 0.4 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.741 -0.647 . . . . 0.27 110.458 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.089 0.471 . . . . 1.26 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 83.0 mt -79.76 129.59 37.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.185 -0.461 . . . . 0.65 110.135 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.409 HD12 ' HD3' ' A' ' 337' ' ' LYS . 39.7 mt -128.77 131.83 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.55 110.789 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 m -106.2 112.5 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.585 -0.524 . . . . 0.59 109.585 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.57 150.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.902 0.382 . . . . 0.5 111.045 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -116.78 117.29 29.35 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.79 -0.819 . . . . 0.79 108.79 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 69.9 mt -106.53 152.53 23.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.167 0.508 . . . . 0.46 111.952 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -100.27 126.19 46.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.451 -0.795 . . . . 0.65 110.36 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 79.7 mmm -104.58 22.69 14.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.63 111.752 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -95.46 -52.08 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.386 -0.598 . . . . 1.27 109.386 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -79.81 -26.63 40.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 1.06 109.495 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -110.42 150.7 28.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.76 109.151 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -123.66 12.6 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.461 -0.495 . . . . 1.09 111.105 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -161.24 162.37 31.1 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.077 -0.51 . . . . 0.62 110.099 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.9 mt -77.88 -52.21 9.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.34 110.07 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.91 43.01 6.14 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.85 -0.614 . . . . 0.14 112.394 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 262' ' ' LEU . 9.1 pt -136.94 154.02 30.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.441 0.639 . . . . 0.18 112.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 21.5 t -106.49 121.43 44.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.786 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.708 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 9.0 mm -91.25 132.49 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.709 0.29 . . . . 0.28 110.844 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.05 124.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.412 . . . . 0.31 110.032 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.12 113.63 4.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.816 -0.706 . . . . 0.37 112.102 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.11 109.15 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.87 110.557 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.3 m -109.4 142.53 40.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.977 -0.556 . . . . 1.17 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -161.8 -170.34 2.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.615 -0.513 . . . . 2.75 109.615 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -56.39 -41.47 76.33 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.347 0.404 . . . . 2.08 110.796 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -40.0 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 2.63 110.36 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 97.47 -46.18 1.68 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.861 -0.685 . . . . 0.97 113.098 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.59 78.16 2.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.742 0.782 . . . . 1.75 111.141 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -95.36 -45.46 3.0 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.716 -0.754 . . . . 0.52 112.3 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 114.19 164.92 15.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.701 -0.761 . . . . 0.3 111.848 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 7.6 pt -100.5 126.4 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.171 0.51 . . . . 0.27 111.103 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 84.9 m-85 -117.68 159.27 23.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 0.72 110.871 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.99 112.14 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.296 -0.631 . . . . 0.24 109.296 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.55 -56.68 3.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.888 -0.672 . . . . 0.42 112.88 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.17 161.41 38.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.627 -0.138 . . . . 0.75 110.627 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 31.1 mt -122.35 131.35 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.53 110.335 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.8 mmt -96.08 115.56 27.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.406 -0.361 . . . . 0.74 110.456 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -64.04 109.77 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.472 . . . . 1.01 110.015 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 142.45 -23.06 2.37 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.877 -0.889 . . . . 0.36 110.877 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.73 177.81 53.88 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.155 -0.545 . . . . 0.26 112.216 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.47 73.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.656 0.243 . . . . 0.25 111.656 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 295' ' ' ILE . 84.7 t -71.11 -41.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.26 111.358 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.7 -18.62 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.37 111.68 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.22 -14.37 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.215 -0.448 . . . . 0.41 111.143 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -88.27 -72.52 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.775 0.321 . . . . 0.55 110.523 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.35 -19.98 26.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.453 -0.879 . . . . 0.39 113.853 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -69.9 -37.49 76.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.418 0.609 . . . . 0.68 110.976 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.464 HD12 HG13 ' A' ' 289' ' ' VAL . 59.6 mt -78.83 135.14 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.743 -0.465 . . . . 0.37 109.743 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.99 161.07 61.8 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.414 . . . . 0.69 110.119 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.21 124.08 15.33 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.195 1.93 . . . . 0.41 111.178 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.14 -16.0 18.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.662 -0.78 . . . . 0.29 111.938 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 90.7 m-20 -67.43 142.79 56.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.813 -0.44 . . . . 0.34 109.813 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 300' ' ' MET . . . . . 0.4 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 28.0 ttt -101.61 136.31 41.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.664 0.268 . . . . 1.26 110.766 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.3 124.99 34.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.373 . . . . 0.48 110.032 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 68.8 mt -105.47 -72.47 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.42 . . . . 0.53 110.453 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.8 135.14 54.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.935 -0.575 . . . . 0.73 110.744 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.33 106.44 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.882 -0.599 . . . . 0.29 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.5 m-20 61.4 62.93 1.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.987 -0.551 . . . . 1.71 111.455 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 29.0 m-20 75.12 -45.94 0.58 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.339 1.237 . . . . 1.11 114.339 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.1 m -71.11 130.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.199 0.523 . . . . 0.71 111.467 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -103.42 140.33 37.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.74 110.319 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.8 5.46 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.321 . . . . 0.33 111.729 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.25 -26.38 66.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.975 0.361 . . . . 1.21 111.975 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -116.74 26.39 9.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.263 0.554 . . . . 1.32 110.904 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 97.3 mtp -118.79 165.77 13.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.314 -0.403 . . . . 0.51 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 27.4 p -75.84 164.8 25.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.97 109.855 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 318' ' ' VAL . 86.7 m-20 -63.78 -36.65 84.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.249 0.547 . . . . 0.48 109.666 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 5.6 t70 -71.29 -53.77 13.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 1.4 110.992 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.24 -35.82 72.28 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.818 -0.628 . . . . 0.88 111.743 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.49 69.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.134 -0.484 . . . . 0.2 112.002 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 314' ' ' ASN . 0.9 OUTLIER -69.82 -29.02 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.926 -0.31 . . . . 0.21 111.003 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 82.8 mtt180 -55.82 -48.06 76.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.281 0.562 . . . . 0.83 110.068 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.3 -41.61 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.17 110.5 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 325' ' ' VAL . 22.6 tp -54.05 -50.2 67.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.38 111.456 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.586 ' HA ' HG11 ' B' ' 3' ' ' VAL . 63.4 mtp180 -62.41 -36.84 83.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.57 111.005 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -63.16 -44.0 96.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 1.87 110.478 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.59 -47.94 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.078 -0.51 . . . . 0.29 111.159 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 321' ' ' LEU . 24.8 t -69.06 -15.19 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.133 0.492 . . . . 0.24 111.347 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 68.8 m -86.06 -5.73 59.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.818 0.342 . . . . 0.44 110.865 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.4 148.72 24.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.236 -0.438 . . . . 1.16 110.528 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 88.21 7.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.066 -0.515 . . . . 0.89 111.356 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -166.26 173.63 41.76 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.959 -0.639 . . . . 0.45 112.187 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.03 141.05 62.45 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.685 2.257 . . . . 0.58 112.371 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 72.2 mt -119.83 123.85 71.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.172 0.51 . . . . 0.37 111.442 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.8 m -112.35 102.61 10.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.554 -0.748 . . . . 1.09 109.435 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.73 121.03 33.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.48 111.801 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.9 m -103.53 98.91 8.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.826 -0.805 . . . . 0.5 108.826 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.42 152.48 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.503 0.557 . . . . 0.33 112.503 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -109.49 108.27 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.38 110.012 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' A' ' 250' ' ' ILE . 24.8 mtpp . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.092 -0.956 . . . . 0.7 109.74 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.708 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.9 m95 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.463 0.173 . . . . 0.4 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.848 -0.596 . . . . 0.27 109.69 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.905 -0.406 . . . . 1.26 109.905 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.15 126.01 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.283 -0.417 . . . . 0.65 110.659 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 23.5 mt -123.46 126.37 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.55 111.484 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 103.57 15.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.27 -0.641 . . . . 0.59 109.27 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 13.4 m -102.15 160.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 0.5 111.509 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.8 t -122.86 142.52 50.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.514 -0.921 . . . . 0.79 108.514 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.564 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.7 mt -123.85 136.36 54.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.209 0.528 . . . . 0.46 112.101 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.45 111.85 14.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.393 -0.821 . . . . 0.65 109.832 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.3 mmm -96.21 17.85 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.63 110.911 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.7 -50.53 6.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.507 0.67 . . . . 1.27 109.229 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -88.95 0.05 56.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.92 -1.036 . . . . 1.06 110.186 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -130.28 133.18 46.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.76 110.276 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.61 15.39 25.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.567 -0.288 . . . . 1.09 110.783 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -166.54 166.64 16.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.24 -0.436 . . . . 0.62 110.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.5 mt -82.77 -52.54 6.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.189 -0.46 . . . . 0.34 109.988 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.74 43.11 5.54 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.891 -0.595 . . . . 0.14 112.98 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.83 150.6 20.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.656 0.741 . . . . 0.18 111.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 12.1 t -100.46 124.51 46.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.874 -1.057 . . . . 1.0 108.691 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.703 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 6.5 mm -91.1 114.81 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.28 110.854 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.01 112.31 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.31 110.254 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.15 101.79 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.939 -0.648 . . . . 0.37 112.156 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 269' ' ' GLN . . . . . 0.433 ' O ' ' HA3' ' A' ' 276' ' ' GLY . 28.3 tt0 -78.5 109.42 12.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.122 -0.325 . . . . 1.87 110.122 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.6 m -111.16 113.11 25.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.465 -0.334 . . . . 1.17 111.082 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -77.57 -163.43 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 2.75 109.992 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.09 -37.49 77.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.732 0.301 . . . . 2.08 111.439 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -78.44 -30.48 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 2.63 110.226 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.51 -7.88 15.65 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.024 -0.83 . . . . 0.97 111.024 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.21 172.49 9.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.15 -0.315 . . . . 1.75 110.15 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 276' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 269' ' ' GLN . . . 159.81 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.68 -0.772 . . . . 0.52 112.195 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 122.96 162.47 11.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.841 -0.695 . . . . 0.3 111.834 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.5 pt -98.9 123.62 51.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.273 0.559 . . . . 0.27 110.557 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -111.21 156.22 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.716 -0.675 . . . . 0.72 110.604 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.99 118.46 30.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.12 -0.491 . . . . 0.24 109.866 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -89.76 -101.95 1.1 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.519 -0.848 . . . . 0.42 112.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.18 138.88 31.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.663 0.268 . . . . 0.75 111.094 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 69.8 mt -105.28 129.79 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.353 -0.61 . . . . 0.53 109.353 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 26.1 mmt -95.54 123.69 39.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.934 0.397 . . . . 0.74 111.202 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -67.37 122.56 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 1.01 109.809 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 122.73 -20.78 7.68 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.469 -0.652 . . . . 0.36 111.469 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.55 172.65 55.27 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.803 -0.713 . . . . 0.26 112.104 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -36.18 82.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.754 0.312 . . . . 0.25 111.099 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.14 -35.34 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.575 . . . . 0.26 111.115 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.86 -11.52 60.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.37 111.776 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -94.71 -10.17 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.104 0.478 . . . . 0.41 110.462 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.83 -77.12 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.55 110.239 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.0 -16.34 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.653 -0.784 . . . . 0.39 113.699 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -81.39 -36.1 29.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.417 0.608 . . . . 0.68 111.433 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.5 mt -80.04 134.29 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.421 -0.354 . . . . 0.37 110.307 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.51 168.11 16.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.69 110.292 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.75 128.23 25.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.984 1.789 . . . . 0.41 111.49 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.88 -14.6 31.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.821 -0.704 . . . . 0.29 112.299 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.95 141.97 52.95 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.647 -0.501 . . . . 0.34 109.647 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 35.9 ttp -101.36 132.14 47.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.643 0.259 . . . . 1.26 110.859 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.64 120.62 29.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.027 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 336' ' ' ALA . 43.3 mt -101.29 -69.09 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.132 0.492 . . . . 0.53 110.359 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -111.9 133.82 53.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.744 -0.662 . . . . 0.73 110.563 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.8 t -123.64 94.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.964 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.1 t30 58.83 72.9 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.472 -0.786 . . . . 1.71 111.761 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 73.3 m-20 78.3 -48.4 0.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.422 0.897 . . . . 1.11 113.422 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.66 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.229 0.538 . . . . 0.71 111.657 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -103.08 137.51 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.698 -0.683 . . . . 0.74 110.413 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.59 13.0 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.477 -0.329 . . . . 0.33 111.06 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.73 6.11 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.115 0.413 . . . . 1.21 112.115 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.25 33.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.348 0.594 . . . . 1.32 110.068 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.7 mtp -134.31 159.17 41.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.51 110.498 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.06 153.36 43.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.97 110.746 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.1 m-20 -54.18 -46.34 72.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.48 110.961 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.1 t70 -62.06 -48.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.881 -0.599 . . . . 1.4 110.779 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.87 -38.59 76.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.74 -0.664 . . . . 0.88 111.331 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.37 70.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.997 -0.547 . . . . 0.2 111.645 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.3 t -69.88 -27.73 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.956 -0.298 . . . . 0.21 111.298 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 88.3 mtt180 -58.23 -46.06 86.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.447 . . . . 0.83 110.202 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.59 -38.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.83 -0.623 . . . . 0.17 110.109 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.444 ' CD1' HG11 ' A' ' 304' ' ' VAL . 19.0 tp -53.57 -53.25 54.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.87 -0.605 . . . . 0.38 111.34 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.569 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.1 mtp180 -62.09 -34.64 76.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.57 111.338 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 mm-40 -66.84 -40.3 87.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.89 0.376 . . . . 1.87 110.44 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -68.58 -44.64 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.29 110.939 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.9 t -64.74 -21.78 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.16 0.505 . . . . 0.24 111.152 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.5 m -84.69 -0.36 53.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.499 -0.319 . . . . 0.44 110.825 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 327' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 80.4 mm-40 -98.19 163.11 12.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 1.16 110.596 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 15.4 p -99.12 118.68 36.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.224 -0.444 . . . . 0.89 111.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 154.02 165.72 14.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.835 -0.697 . . . . 0.45 111.985 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.92 128.23 14.7 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.337 2.024 . . . . 0.58 111.503 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 34.6 mt -108.22 130.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.922 0.391 . . . . 0.37 111.354 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 18.5 t -104.8 129.73 53.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 1.09 109.258 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.4 mt -114.92 125.76 54.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 0.48 111.287 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -100.65 97.54 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.853 -0.795 . . . . 0.5 108.853 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.3 151.55 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.341 0.591 . . . . 0.33 112.247 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.57 113.07 25.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.234 -0.894 . . . . 0.38 109.146 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.274 -0.869 . . . . 0.7 110.391 -179.535 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.703 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.0 m95 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 110.527 -0.175 . . . . 0.4 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.887 -0.577 . . . . 0.27 109.879 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.868 0.366 . . . . 1.26 110.309 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -98.08 129.51 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.359 -0.382 . . . . 0.65 110.436 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.11 128.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.944 0.402 . . . . 0.55 111.152 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.71 119.81 39.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.055 -0.52 . . . . 0.59 109.691 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.95 144.17 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.912 0.387 . . . . 0.5 111.524 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.3 t -107.63 131.59 54.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.426 -0.953 . . . . 0.79 108.426 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.538 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 42.7 mt -114.8 140.17 49.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.46 111.737 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.31 116.79 21.33 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.475 -0.784 . . . . 0.65 110.285 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.6 mmm -98.69 12.62 34.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.63 111.654 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.92 -46.96 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.099 0.476 . . . . 1.27 109.803 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.06 -18.94 29.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 1.06 110.409 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -112.44 137.95 49.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.111 -0.495 . . . . 0.76 109.716 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -102.02 3.52 38.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.022 -0.271 . . . . 1.09 111.572 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -159.72 166.27 30.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.602 0.239 . . . . 0.62 111.05 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 264' ' ' ILE . 6.6 mt -76.04 -53.0 9.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.34 109.735 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.69 40.59 6.27 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 116.049 -0.523 . . . . 0.14 113.052 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 262' ' ' LEU . 6.6 pt -138.07 149.2 24.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.346 0.593 . . . . 0.18 111.623 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.86 129.79 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.284 -0.871 . . . . 1.0 109.264 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.683 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 10.1 mm -93.78 119.76 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.938 0.399 . . . . 0.28 110.483 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.01 113.66 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.369 -0.378 . . . . 0.31 110.583 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.33 124.09 8.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.859 -0.686 . . . . 0.37 111.67 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -86.64 93.15 9.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 1.87 110.783 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.77 109.63 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.17 110.438 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -123.85 -46.48 1.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 2.75 110.692 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.03 -66.13 0.33 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 2.08 110.195 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -50.71 72.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.58 -0.736 . . . . 2.63 110.665 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 99.32 -37.85 3.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.607 -0.806 . . . . 0.97 112.923 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.89 57.43 1.05 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.59 0.709 . . . . 1.75 111.572 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -94.45 -28.19 10.83 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.736 -0.665 . . . . 0.52 111.699 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.55 174.2 32.42 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.896 -0.668 . . . . 0.3 112.22 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.4 pt -113.96 130.63 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.27 110.925 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -115.59 163.65 15.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.0 -0.546 . . . . 0.72 110.827 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.34 118.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.059 -0.519 . . . . 0.24 109.883 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.32 -66.94 1.68 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.729 -0.748 . . . . 0.42 112.147 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -145.26 155.62 43.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.537 0.208 . . . . 0.75 110.554 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 296' ' ' GLU . 30.2 mt -106.88 134.33 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.246 -0.434 . . . . 0.53 109.995 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.9 mmt -95.48 122.53 38.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.288 -0.414 . . . . 0.74 110.832 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.88 118.04 5.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 1.01 110.148 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.63 9.05 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.352 -0.699 . . . . 0.36 111.352 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.96 170.62 54.69 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.008 -0.615 . . . . 0.26 112.104 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.7 -36.92 85.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.751 0.31 . . . . 0.25 111.363 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.01 -35.9 71.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.119 -0.492 . . . . 0.26 111.274 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.99 66.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.115 -0.493 . . . . 0.37 111.691 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.2 46.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.41 111.524 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.33 -72.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.799 0.333 . . . . 0.55 110.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.16 -17.8 34.27 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.393 -0.908 . . . . 0.39 114.3 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -73.21 -28.72 62.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.822 0.811 . . . . 0.68 111.278 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.7 mt -88.1 140.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.114 -0.698 . . . . 0.37 109.114 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 296' ' ' GLU . . . . . 0.558 ' HA ' HD11 ' A' ' 283' ' ' ILE . 13.6 pt-20 -148.63 167.67 12.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.579 -0.282 . . . . 0.69 110.242 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.04 133.56 58.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.215 1.943 . . . . 0.41 111.061 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.14 -20.91 32.35 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.29 112.151 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.9 137.87 55.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.925 -0.398 . . . . 0.34 109.925 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.5 ttp -97.5 134.23 41.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.726 0.298 . . . . 1.26 110.729 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.75 124.71 32.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.314 -0.403 . . . . 0.48 109.974 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 336' ' ' ALA . 92.5 mt -105.8 -71.22 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.074 0.464 . . . . 0.53 110.606 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.93 136.96 53.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.73 111.162 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 321' ' ' LEU . 59.7 t -128.02 94.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.29 109.919 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.4 m-20 59.09 75.4 0.4 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.211 -0.45 . . . . 1.71 111.407 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 3.3 m-20 76.72 -58.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.149 0.796 . . . . 1.11 113.149 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.43 121.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.379 0.609 . . . . 0.71 111.898 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -101.15 128.81 47.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.316 -0.856 . . . . 0.74 109.389 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -102.38 20.38 17.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.739 0.304 . . . . 0.33 111.477 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.45 -27.3 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.205 0.446 . . . . 1.21 112.205 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -125.58 37.45 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.633 0.254 . . . . 1.32 111.279 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 86.7 mtp -125.36 168.83 13.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.433 -0.349 . . . . 0.51 110.364 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.9 p -75.33 157.13 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.97 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.6 m-20 -62.27 -33.98 75.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.48 109.799 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -69.53 -54.03 16.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.575 -0.738 . . . . 1.4 111.118 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -59.58 -34.16 72.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.88 111.072 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.34 69.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.984 -0.553 . . . . 0.2 111.031 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.1 t -74.25 -27.96 22.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 121.041 -0.264 . . . . 0.21 110.725 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 66.8 mtt180 -58.35 -51.59 69.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.07 0.462 . . . . 0.83 109.864 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.78 -35.36 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.17 110.517 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.416 HD13 HG21 ' A' ' 304' ' ' VAL . 41.0 tp -54.67 -50.83 67.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.076 -0.511 . . . . 0.38 110.82 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.44 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.7 mtp-105 -61.32 -34.28 74.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.979 -0.555 . . . . 1.57 111.396 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.03 -40.63 96.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 1.87 110.54 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.89 -43.83 76.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.29 110.749 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' B' ' 3' ' ' VAL . 65.4 t -64.93 -32.1 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 0.24 110.753 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 13.7 m -87.31 10.3 17.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.928 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 20.3 tp60 -110.98 151.41 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 1.16 110.081 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.62 134.57 37.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.563 -0.29 . . . . 0.89 110.617 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 135.71 156.14 7.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.852 -0.689 . . . . 0.45 112.339 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.3 139.82 46.87 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.851 2.368 . . . . 0.58 112.044 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.79 126.92 66.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.151 -0.477 . . . . 0.37 111.539 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 108.24 19.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.972 -0.751 . . . . 1.09 108.972 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 99.0 mt -93.65 128.93 40.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.237 -0.438 . . . . 0.48 111.756 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.5 m -108.34 97.39 7.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.442 -0.947 . . . . 0.5 108.442 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.85 159.17 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.33 112.154 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -116.83 116.62 27.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.334 -0.848 . . . . 0.38 109.718 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.488 -0.768 . . . . 0.7 110.271 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.683 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 30.4 m95 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 110.243 -0.28 . . . . 0.4 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.523 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.678 -0.677 . . . . 0.27 110.418 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.879 0.371 . . . . 1.26 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 56.0 mt -90.32 111.8 23.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.015 0.436 . . . . 0.65 110.251 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.55 128.73 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.55 110.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 m -98.74 112.35 24.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.59 109.867 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 332' ' ' SER . 6.0 m -100.87 163.34 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.436 -0.347 . . . . 0.5 110.67 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 14.8 t -131.11 134.66 46.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.309 -0.626 . . . . 0.79 109.309 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 72.4 mt -121.96 135.79 54.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.46 111.735 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -85.22 115.62 23.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.459 -0.792 . . . . 0.65 109.973 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.0 mmm -95.8 32.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.952 0.406 . . . . 0.63 111.327 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -102.8 -53.82 2.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.27 109.703 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -70.48 -41.28 72.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.483 -0.562 . . . . 1.06 109.483 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -107.34 157.26 18.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.69 -0.855 . . . . 0.76 108.69 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -124.07 22.56 8.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.625 -0.43 . . . . 1.09 112.03 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.5 158.75 27.01 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.736 0.303 . . . . 0.62 110.778 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 262' ' ' LEU . 5.8 mt -76.35 -56.01 5.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.34 109.734 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.8 42.95 5.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.644 -0.707 . . . . 0.14 112.632 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -143.95 153.84 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.277 0.561 . . . . 0.18 111.866 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.474 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -100.85 131.59 46.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.48 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.62 ' HB ' ' H22' ' B' ' 1' ' ' PHQ . 11.5 mm -96.44 110.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.942 0.401 . . . . 0.28 110.385 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.09 110.78 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.504 -0.316 . . . . 0.31 111.486 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.61 113.7 3.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.092 -0.803 . . . . 0.37 111.092 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -77.81 129.72 35.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.99 0.424 . . . . 1.87 111.043 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.3 163.98 15.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.809 -0.632 . . . . 1.17 110.352 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -174.67 -158.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.297 -0.631 . . . . 2.75 109.297 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.05 -31.37 71.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.334 0.588 . . . . 2.08 110.511 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.48 -54.94 4.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.461 -0.791 . . . . 2.63 110.222 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 111.24 -34.37 5.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.772 -0.727 . . . . 0.97 112.075 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -91.91 71.65 5.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.689 0.757 . . . . 1.75 110.667 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -89.44 -17.02 56.19 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.721 -0.672 . . . . 0.52 112.791 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.14 166.86 31.52 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.672 -0.775 . . . . 0.3 112.269 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -105.88 129.36 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.031 0.443 . . . . 0.27 110.696 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.45 158.8 23.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 0.72 110.805 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.79 117.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.534 . . . . 0.24 110.393 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.76 -71.42 1.14 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.701 -0.761 . . . . 0.42 112.15 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.0 p -142.58 155.51 44.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.182 -0.303 . . . . 0.75 110.182 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 43.0 mt -106.43 125.53 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.53 110.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.3 mmt -86.36 126.72 34.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.07 -0.513 . . . . 0.74 110.668 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -67.88 110.6 3.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.662 -0.496 . . . . 1.01 109.662 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 132.84 -19.9 4.37 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.885 -0.886 . . . . 0.36 110.885 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.28 54.64 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.713 . . . . 0.26 111.969 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.22 -32.19 73.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.812 0.339 . . . . 0.25 111.0 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.23 -33.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.26 110.734 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.08 -15.7 62.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.273 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.1 -27.79 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 16.5 t70 -76.05 -69.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.55 110.681 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.24 57.32 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.448 -0.882 . . . . 0.39 114.714 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 79.3 mtm180 -82.9 -19.65 36.96 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.019 0.91 . . . . 0.68 111.351 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.1 mt -96.78 138.51 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.206 -0.452 . . . . 0.37 109.959 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.1 157.9 76.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.43 -0.35 . . . . 0.69 110.409 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.485 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 33.4 Cg_exo -61.44 94.34 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.611 2.207 . . . . 0.41 111.793 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 150.52 -19.56 1.03 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.963 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -64.06 151.17 43.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.736 0.303 . . . . 0.34 110.842 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 50.6 ttp -104.02 130.1 51.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 1.26 110.683 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.84 115.23 22.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.382 -0.372 . . . . 0.48 110.103 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 51.7 mt -97.9 -73.31 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.27 0.557 . . . . 0.53 110.844 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -115.11 130.74 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.594 -0.73 . . . . 0.73 110.625 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.548 HG13 HD23 ' A' ' 333' ' ' LEU . 96.5 t -126.91 106.44 15.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.201 -0.454 . . . . 0.29 109.972 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 11.4 t-20 61.34 65.98 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 1.5 m-20 74.87 -52.9 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.715 1.006 . . . . 1.11 113.715 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 134.74 29.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.063 0.458 . . . . 0.71 111.542 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -107.32 126.73 52.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.74 110.701 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -96.58 3.79 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.839 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.62 -28.08 65.3 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.828 0.307 . . . . 1.21 111.828 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.75 31.53 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 1.32 110.796 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 89.6 mtp -128.69 154.36 46.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.159 -0.473 . . . . 0.51 110.773 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.95 150.11 48.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.97 110.993 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -51.9 -47.98 64.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.343 . . . . 0.48 111.348 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.42 -46.39 88.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.4 111.672 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.1 m-20 -64.32 -30.72 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.294 -0.412 . . . . 0.88 110.8 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.42 85.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.2 110.786 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.421 HG11 ' H21' ' B' ' 1' ' ' PHQ . 1.4 t -72.23 -31.55 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.664 0.268 . . . . 0.21 110.535 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 90.1 mtt180 -56.74 -53.92 52.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.83 110.263 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.8 -37.19 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.17 110.366 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 15.1 tp -55.79 -51.02 68.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.932 -0.577 . . . . 0.38 111.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.43 ' HA ' HG11 ' B' ' 3' ' ' VAL . 36.5 mtp180 -61.83 -35.14 77.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 1.57 111.091 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -64.53 -40.69 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.152 0.501 . . . . 1.87 109.959 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.59 -42.47 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.634 -0.712 . . . . 0.29 110.828 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 321' ' ' LEU . 62.6 t -66.29 -23.95 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.24 110.31 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 6.76 26.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.852 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -105.75 135.54 46.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.349 -0.387 . . . . 1.16 110.002 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 92.18 4.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.438 . . . . 0.89 111.569 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -173.74 171.92 44.86 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.461 -0.656 . . . . 0.45 111.461 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 126.04 13.18 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.361 2.041 . . . . 0.58 111.584 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 58.5 mt -102.95 122.75 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.93 0.395 . . . . 0.37 111.457 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.5 OUTLIER -106.66 121.78 45.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.564 . . . . 1.09 109.615 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.548 HD23 HG13 ' A' ' 304' ' ' VAL . 18.1 mt -108.1 120.95 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.525 . . . . 0.48 110.99 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.82 95.94 7.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.53 0.681 . . . . 0.33 112.399 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -102.52 94.76 5.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.951 -1.022 . . . . 0.38 108.868 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.628 -0.701 . . . . 0.7 110.725 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.62 ' H22' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.474 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 9.8 m95 . . . . . 0 C--O 1.234 0.244 0 N-CA-C 110.366 -0.235 . . . . 0.4 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.434 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.637 -0.696 . . . . 0.27 110.22 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.61 0.243 . . . . 1.26 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 95.1 mt -103.78 127.02 58.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.453 -0.34 . . . . 0.65 110.188 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.21 135.44 59.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.827 0.346 . . . . 0.55 111.358 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 62.9 m -107.01 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.648 -0.501 . . . . 0.59 109.648 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 332' ' ' SER . 4.0 m -102.26 143.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.789 0.328 . . . . 0.5 111.122 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.9 t -114.19 109.78 18.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.79 109.5 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 58.4 mt -100.31 145.27 28.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.46 112.016 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -91.72 119.79 31.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.65 109.732 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 89.5 mmm -99.0 21.52 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.026 0.441 . . . . 0.63 111.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -87.71 -49.91 6.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.768 -0.456 . . . . 1.27 109.768 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.16 -35.81 19.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 1.06 109.355 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -86.87 145.71 26.48 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.695 -0.684 . . . . 0.76 109.464 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.85 -2.33 13.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.545 -0.462 . . . . 1.09 112.024 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -157.58 162.54 38.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.498 0.19 . . . . 0.62 110.677 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.4 mt -77.55 -52.04 9.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.727 -0.472 . . . . 0.34 109.727 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.44 4.61 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.577 -0.738 . . . . 0.14 112.999 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.0 pt -144.84 144.1 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.213 0.53 . . . . 0.18 111.563 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 1.1 p -96.49 126.87 41.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.722 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 9.2 mm -91.75 115.84 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.825 0.345 . . . . 0.28 110.776 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.22 119.01 48.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.31 110.251 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.26 122.51 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.002 -0.618 . . . . 0.37 112.072 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -85.69 89.28 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 1.87 110.1 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.6 m -113.88 80.21 1.35 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.778 -0.646 . . . . 1.17 110.555 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -92.74 -151.31 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 2.75 109.963 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -61.06 -32.38 72.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.163 0.506 . . . . 2.08 110.472 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -69.83 -21.25 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 2.63 110.797 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 88.12 -65.42 3.44 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.313 -0.715 . . . . 0.97 111.313 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -91.48 153.04 20.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.667 -0.494 . . . . 1.75 109.667 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.81 -34.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.608 -0.806 . . . . 0.52 112.365 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 120.25 175.53 15.57 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.425 -0.893 . . . . 0.3 112.192 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.03 128.41 73.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.068 0.461 . . . . 0.27 110.839 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -113.99 157.46 22.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.772 -0.649 . . . . 0.72 110.803 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.59 115.02 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.24 110.014 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.72 -58.16 4.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.42 112.698 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.6 p -151.54 161.97 41.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.187 -0.301 . . . . 0.75 110.187 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.439 HD11 ' HA ' ' A' ' 296' ' ' GLU . 49.0 mt -115.18 134.8 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.53 110.46 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -95.7 125.17 40.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.74 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.05 124.47 20.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.883 -0.599 . . . . 1.01 110.056 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.58 18.12 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.29 -0.724 . . . . 0.36 111.29 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -80.52 166.03 48.88 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.875 -0.679 . . . . 0.26 111.875 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -61.15 -38.83 87.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.662 0.268 . . . . 0.25 111.433 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.69 -31.3 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.26 110.907 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.83 -20.29 61.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.37 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.02 -11.7 43.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.272 -0.422 . . . . 0.41 111.73 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.11 -72.61 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.15 -0.22 . . . . 0.55 111.218 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 113.74 -17.08 20.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.381 -0.914 . . . . 0.39 113.902 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -89.93 -49.32 6.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.32 0.56 . . . . 0.68 111.064 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.24 136.93 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.206 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 296' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' A' ' 283' ' ' ILE . 11.9 pt-20 -143.8 164.2 31.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.69 110.308 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.5 Cg_exo -60.24 112.54 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.329 2.019 . . . . 0.41 111.27 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 132.45 -19.86 4.48 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.241 -0.744 . . . . 0.29 111.241 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.0 m-20 -70.84 146.14 49.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.732 0.301 . . . . 0.34 110.245 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.1 ttt -103.76 136.44 43.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.309 -0.405 . . . . 1.26 110.656 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 335' ' ' VAL . 18.9 mt -87.99 123.39 32.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.48 110.109 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 336' ' ' ALA . 90.6 mt -106.25 -69.07 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.048 0.451 . . . . 0.53 110.818 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -121.1 124.7 45.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.73 110.484 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.5 t -125.62 101.57 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.29 110.23 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.1 m-20 62.88 65.69 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.998 -0.546 . . . . 1.71 111.244 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.6 m-20 74.69 -43.67 0.53 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.922 1.082 . . . . 1.11 113.922 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 304' ' ' VAL . 33.6 m -69.51 137.47 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 118.261 0.482 . . . . 0.71 111.329 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -111.06 133.16 53.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.771 -0.65 . . . . 0.74 109.645 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.13 12.44 30.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.909 0.337 . . . . 0.33 111.909 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -66.32 -30.56 70.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.723 0.297 . . . . 1.21 111.715 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.56 36.96 4.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 1.32 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 84.1 mtp -125.05 154.96 40.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.324 -0.621 . . . . 0.51 109.324 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 97.0 p -69.17 153.56 43.51 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.147 -0.316 . . . . 0.97 110.147 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -59.6 -26.38 65.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.48 109.842 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -71.48 -56.3 6.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.279 -0.873 . . . . 1.4 110.588 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 10.6 m-20 -63.64 -30.98 72.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.84 -0.618 . . . . 0.88 111.683 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.15 67.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.929 -0.578 . . . . 0.2 112.011 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.33 -27.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.931 -0.308 . . . . 0.21 111.024 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 81.4 mtt180 -58.53 -53.31 59.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.83 110.11 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.6 -40.49 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.871 -0.604 . . . . 0.17 110.274 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.6 tp -55.12 -50.98 67.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.938 -0.574 . . . . 0.38 111.229 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.455 ' HA ' HG11 ' B' ' 3' ' ' VAL . 9.0 mtp180 -61.0 -41.86 97.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.404 . . . . 1.57 111.359 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -61.42 -43.52 98.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.52 0.2 . . . . 1.87 110.55 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.01 -43.25 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.29 110.508 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.3 t -70.01 -19.68 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.277 -0.42 . . . . 0.24 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 66.7 m -77.86 -18.38 56.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.44 110.789 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.09 162.39 12.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.228 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.39 172.07 13.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.359 -0.382 . . . . 0.89 111.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 116.19 168.08 15.04 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.925 -0.655 . . . . 0.45 112.572 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -79.56 104.52 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.699 2.266 . . . . 0.58 111.733 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 50.0 mt -74.06 114.13 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.37 110.691 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 8.1 m -97.31 102.74 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 1.09 109.75 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.89 119.05 37.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.023 -0.535 . . . . 0.48 111.319 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 26.8 m -98.54 101.12 12.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.779 -0.822 . . . . 0.5 108.779 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 301' ' ' LEU . 29.8 m -101.64 156.23 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 0.33 112.204 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.07 111.43 22.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.113 -0.949 . . . . 0.38 109.894 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.7 mtpp . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.511 -0.757 . . . . 0.7 109.796 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.722 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.582 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 22.4 m95 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.126 -0.324 . . . . 0.4 110.126 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.71 -0.662 . . . . 0.27 109.973 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.74 0.305 . . . . 1.26 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.61 128.38 49.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.128 -0.323 . . . . 0.65 110.128 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 42.2 mt -126.53 130.51 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.339 . . . . 0.55 111.151 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.8 m -101.62 111.11 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.52 -0.548 . . . . 0.59 109.52 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.91 147.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.688 0.28 . . . . 0.5 111.566 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.2 t -110.16 136.8 48.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.642 -0.503 . . . . 0.79 109.642 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.2 mt -114.71 138.41 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.905 0.383 . . . . 0.46 111.469 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -83.91 117.96 23.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.704 . . . . 0.65 110.155 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 92.2 mmm -98.35 14.05 29.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.374 -0.375 . . . . 0.63 111.584 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.14 -38.39 15.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 1.27 110.342 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 258' ' ' ARG . 25.7 ttt180 -96.34 0.66 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.255 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -131.03 162.52 29.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.76 109.709 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -120.32 -8.23 9.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.827 0.346 . . . . 1.09 111.283 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -154.62 175.95 13.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.509 -0.314 . . . . 0.62 110.707 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.08 -52.46 6.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.34 109.971 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.68 43.18 5.54 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.806 -0.634 . . . . 0.14 112.879 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.02 154.35 31.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.538 0.685 . . . . 0.18 112.37 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.452 ' HB3' ' H ' ' A' ' 282' ' ' SER . 42.5 t -101.8 118.03 36.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.612 -1.176 . . . . 1.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.663 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 11.1 mm -88.63 118.5 34.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.776 0.322 . . . . 0.28 110.138 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.99 109.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.007 0.432 . . . . 0.31 110.759 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.1 124.38 7.54 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.247 -0.741 . . . . 0.37 111.247 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.18 112.39 21.28 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.938 0.399 . . . . 1.87 110.635 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -97.86 93.58 6.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.909 -0.587 . . . . 1.17 110.41 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -86.38 -176.14 5.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 2.75 110.73 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.91 -15.07 63.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.255 0.55 . . . . 2.08 110.002 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -92.97 -3.69 54.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.563 -0.744 . . . . 2.63 110.017 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 88.5 -66.41 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.787 -0.72 . . . . 0.97 112.147 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.86 152.85 29.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.082 0.468 . . . . 1.75 110.642 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.8 -36.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.52 111.829 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 120.67 161.21 11.37 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.642 -0.789 . . . . 0.3 112.305 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.44 114.26 45.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.297 0.57 . . . . 0.27 110.212 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -107.32 154.57 21.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.893 -0.594 . . . . 0.72 110.692 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.23 114.18 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.24 109.782 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.12 -57.7 3.62 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.746 -0.74 . . . . 0.42 112.333 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 282' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 265' ' ' SER . 1.8 p -145.16 158.25 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.144 -0.317 . . . . 0.75 110.144 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 50.4 mt -118.24 131.62 70.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.58 -0.526 . . . . 0.53 109.58 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 34.1 mmt -92.77 124.32 36.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.415 -0.357 . . . . 0.74 110.619 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -58.56 130.18 45.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 1.01 110.997 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.12 -24.55 20.78 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.894 -0.67 . . . . 0.36 112.034 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.19 45.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.058 -0.591 . . . . 0.26 112.424 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.01 -37.32 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.25 111.056 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.457 HG13 HD12 ' A' ' 295' ' ' ILE . 54.8 t -69.54 -39.27 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.26 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.27 -18.15 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.37 111.254 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -85.67 -11.03 54.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.41 110.955 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.49 -67.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.839 -0.43 . . . . 0.55 109.839 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 103.47 -14.96 54.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 0.39 114.435 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -79.96 -33.13 39.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.738 0.769 . . . . 0.68 111.137 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.457 HD12 HG13 ' A' ' 289' ' ' VAL . 63.5 mt -82.57 140.65 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.651 -0.5 . . . . 0.37 109.651 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.13 164.3 32.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.765 -0.198 . . . . 0.69 110.88 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.37 116.94 3.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.41 111.823 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 125.82 -21.81 6.19 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.917 -0.658 . . . . 0.29 111.509 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.5 m-20 -69.44 143.23 53.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 43.7 ttp -103.36 135.3 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.702 0.287 . . . . 1.26 110.813 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 70.4 mt -83.39 123.97 30.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.48 110.182 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 336' ' ' ALA . 46.7 mt -105.15 -72.57 0.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.245 0.545 . . . . 0.53 110.835 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.437 ' H ' ' HB ' ' A' ' 334' ' ' THR . 51.6 tt0 -109.75 135.32 50.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.754 . . . . 0.73 111.034 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 321' ' ' LEU . 67.3 t -131.98 93.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.29 110.149 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 59.21 76.61 0.35 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.798 -0.637 . . . . 1.71 111.737 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.8 OUTLIER 75.21 -53.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.053 -0.976 . . . . 1.11 113.455 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.5 139.66 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.349 0.595 . . . . 0.71 111.864 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.99 130.8 55.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.442 -0.799 . . . . 0.74 110.409 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.482 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 23.7 m-85 -102.02 6.53 41.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.867 0.321 . . . . 0.33 111.867 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.92 -31.61 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 1.21 111.696 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -119.44 53.35 1.04 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.2 0.524 . . . . 1.32 110.301 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 312' ' ' MET . . . . . 0.482 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 84.1 mtp -141.11 160.37 40.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.182 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 148.14 51.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.242 -0.435 . . . . 0.97 110.75 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -49.7 -50.97 41.69 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.484 0.49 . . . . 0.48 111.638 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.22 -47.3 80.22 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.446 . . . . 1.4 111.833 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.58 -35.1 75.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.886 -0.597 . . . . 0.88 111.815 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.02 93.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.452 -0.34 . . . . 0.2 110.865 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.515 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -73.82 -32.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.21 110.623 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -54.98 -50.33 69.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.864 0.364 . . . . 0.83 110.627 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.6 t -70.49 -39.93 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.75 -0.659 . . . . 0.17 110.249 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 325' ' ' VAL . 56.6 tp -55.36 -50.44 69.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.053 -0.521 . . . . 0.38 111.373 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.663 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.0 mtp180 -63.69 -30.13 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 1.57 111.462 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.7 -40.37 80.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.136 0.493 . . . . 1.87 109.804 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.92 -42.67 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.73 . . . . 0.29 111.209 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 321' ' ' LEU . 43.8 t -69.23 -16.94 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.24 110.802 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 23.57 6.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.092 0.473 . . . . 0.44 110.161 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 3.2 tp60 -125.26 -179.31 4.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 1.16 110.102 -179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.99 146.24 32.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.71 0.29 . . . . 0.89 110.607 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.37 169.59 13.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.707 -0.759 . . . . 0.45 112.269 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 137.09 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 0.58 112.166 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 84.4 mt -115.34 121.57 67.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.142 -0.481 . . . . 0.37 110.414 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.8 m -106.11 121.06 43.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.138 0.494 . . . . 1.09 109.95 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 84.0 mt -105.5 130.52 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.48 111.538 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 2.7 m -104.04 103.23 13.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.28 142.68 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.343 0.592 . . . . 0.33 112.35 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.22 111.95 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.186 -0.916 . . . . 0.38 109.582 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.0 mtpp . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.613 -0.708 . . . . 0.7 109.942 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.663 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 28.9 m95 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.547 0.213 . . . . 0.4 110.62 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 119.038 -0.506 . . . . 0.27 109.949 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.917 0.389 . . . . 1.26 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 57.2 mt -92.3 128.78 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.65 110.731 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 33.8 mt -129.67 123.7 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.55 110.875 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.1 m -95.39 102.39 14.19 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.424 -0.584 . . . . 0.59 109.424 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.27 148.4 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.954 0.407 . . . . 0.5 111.751 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -114.87 129.95 56.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.802 -0.814 . . . . 0.79 108.802 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.2 mt -110.89 149.66 30.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.463 . . . . 0.46 111.606 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.27 118.04 30.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.507 -0.77 . . . . 0.65 110.901 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 67.0 mmm -99.46 16.26 23.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.863 -0.608 . . . . 0.63 111.304 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -86.47 -49.41 7.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.35 -0.611 . . . . 1.27 109.35 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -86.44 -22.8 26.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.583 -0.735 . . . . 1.06 110.193 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -106.92 154.76 20.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 0.76 110.472 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.76 -2.39 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.519 0.2 . . . . 1.09 111.304 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -157.56 171.92 19.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.348 . . . . 0.62 110.959 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 7.6 mt -78.21 -51.31 10.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.887 -0.597 . . . . 0.34 110.016 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.05 47.34 5.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.776 -0.647 . . . . 0.14 112.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 262' ' ' LEU . 3.5 pt -142.73 150.45 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.18 112.023 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.26 120.61 40.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.81 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.787 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 5.3 mm -89.56 116.11 30.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.919 0.39 . . . . 0.28 111.036 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.69 118.77 48.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.31 109.877 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.51 127.82 9.36 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.511 -0.852 . . . . 0.37 112.013 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -79.09 69.43 5.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.186 -0.672 . . . . 1.87 109.186 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 274' ' ' GLY . 14.9 m -86.58 92.01 8.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 1.17 111.444 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -99.37 -148.51 0.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.282 -0.872 . . . . 2.75 109.387 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.4 -33.49 67.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.695 0.283 . . . . 2.08 111.297 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -102.71 -52.44 3.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.491 -0.322 . . . . 2.63 111.106 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 270' ' ' SER . . . 95.37 27.03 11.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.541 -0.838 . . . . 0.97 112.314 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -111.03 13.98 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 1.75 110.5 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -67.58 -28.31 73.57 Favored Glycine 0 C--N 1.329 0.184 0 CA-C-N 115.803 -0.635 . . . . 0.52 112.834 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 178.17 25.27 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.502 -0.856 . . . . 0.3 112.511 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.67 138.43 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.898 0.38 . . . . 0.27 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -125.69 158.24 35.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.996 -0.547 . . . . 0.72 110.661 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.3 mm -75.92 109.5 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.067 -0.515 . . . . 0.24 109.698 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.29 -60.13 3.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.754 -0.736 . . . . 0.42 112.273 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 m -145.17 157.97 43.94 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.708 -0.289 . . . . 0.75 110.355 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.2 mt -113.52 130.22 67.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.211 -0.45 . . . . 0.53 110.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.97 119.33 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.74 110.335 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -61.72 116.99 5.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.955 -0.566 . . . . 1.01 110.023 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.1 -17.58 9.12 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.477 -0.649 . . . . 0.36 111.477 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.8 174.03 55.26 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.863 -0.684 . . . . 0.26 111.912 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.93 -36.87 84.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.769 0.318 . . . . 0.25 111.218 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.98 -37.37 77.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.26 111.169 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.41 -17.88 64.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.37 111.828 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.92 -3.66 57.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.828 0.347 . . . . 0.41 111.192 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.63 -80.25 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.745 -0.465 . . . . 0.55 109.745 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 118.33 -21.53 9.97 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.274 -0.965 . . . . 0.39 113.908 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -76.84 -19.59 57.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.568 0.684 . . . . 0.68 111.751 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.8 mt -95.18 136.36 26.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.646 -0.501 . . . . 0.37 109.646 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.63 163.77 47.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.742 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.47 109.04 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.368 2.045 . . . . 0.41 111.452 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.96 -17.14 5.21 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.29 112.09 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 97.7 m-20 -65.11 140.39 58.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.634 0.254 . . . . 0.34 110.348 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.6 ttt -93.76 135.2 35.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.322 . . . . 1.26 111.02 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.6 mt -90.07 118.14 29.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.193 -0.458 . . . . 0.48 109.936 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 336' ' ' ALA . 59.4 mt -103.54 -77.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.098 0.475 . . . . 0.53 110.837 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 308' ' ' ASN . 8.3 tt0 -106.01 134.42 49.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.73 110.996 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 321' ' ' LEU . 84.7 t -131.31 102.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.782 -0.645 . . . . 0.29 109.83 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.2 m-20 58.35 70.53 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.566 -0.743 . . . . 1.71 111.568 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.5 OUTLIER 76.51 -53.36 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.585 0.957 . . . . 1.11 113.585 178.124 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.09 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.71 112.122 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 303' ' ' GLN . 50.0 t30 -103.32 131.39 50.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.521 -0.763 . . . . 0.74 109.782 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -97.17 3.98 51.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.984 0.364 . . . . 0.33 111.984 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.4 -32.8 67.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.965 0.412 . . . . 1.21 111.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -105.78 39.88 1.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.32 111.47 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 34.1 mtp -141.78 165.77 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.514 -0.312 . . . . 0.51 110.263 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.5 p -79.25 162.8 25.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.97 109.899 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 42.7 m-20 -57.26 -40.06 76.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.48 110.037 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 23.9 t0 -63.08 -55.09 28.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.182 -0.917 . . . . 1.4 110.514 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -60.13 -36.18 76.94 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.826 -0.625 . . . . 0.88 111.34 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.29 -56.02 27.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.2 112.157 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.9 t -69.62 -26.71 31.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.963 -0.295 . . . . 0.21 111.358 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 69.4 mtt180 -57.11 -52.28 65.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.83 110.072 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.22 -38.26 74.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.976 -0.556 . . . . 0.17 110.4 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.9 tp -56.09 -51.58 67.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.923 -0.581 . . . . 0.38 110.942 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.678 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.7 mtp180 -61.15 -38.41 86.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.945 -0.571 . . . . 1.57 111.082 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.3 -45.38 88.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.595 -0.275 . . . . 1.87 110.682 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.78 -44.37 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 0.29 110.9 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 321' ' ' LEU . 26.1 t -72.22 -15.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.24 111.424 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 71.7 m -81.74 -16.6 50.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.83 0.348 . . . . 0.44 110.838 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.65 160.7 14.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 1.16 110.357 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 130.82 41.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.97 0.414 . . . . 0.89 111.075 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.31 176.1 27.1 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.523 -0.631 . . . . 0.45 111.523 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.38 135.95 35.46 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.539 2.159 . . . . 0.58 112.151 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.43 129.64 72.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.145 0.497 . . . . 0.37 110.732 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 126.81 52.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.347 -0.842 . . . . 1.09 109.403 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.12 115.91 26.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.48 111.586 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -93.37 90.13 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.599 -0.889 . . . . 0.5 108.599 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.11 146.47 6.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.912 -0.585 . . . . 0.33 111.996 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.539 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.04 107.75 17.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.333 -0.849 . . . . 0.38 110.018 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.429 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 22.7 mtpp . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.432 -0.795 . . . . 0.7 109.692 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.787 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.84 -0.6 . . . . 0.27 110.164 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.74 0.305 . . . . 1.26 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.61 122.16 61.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.65 110.629 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 18.3 mt -126.31 131.42 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 88.8 m -104.96 113.24 26.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.943 -0.762 . . . . 0.59 108.943 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 10.2 m -103.56 155.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.283 -0.417 . . . . 0.5 111.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.5 t -108.23 135.35 49.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.05 -0.722 . . . . 0.79 109.05 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.9 mt -119.04 136.14 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.947 0.403 . . . . 0.46 111.524 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -83.46 114.85 21.76 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.547 -0.751 . . . . 0.65 109.924 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 93.8 mmm -98.89 14.77 27.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.63 111.159 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -88.93 -47.54 8.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.27 109.819 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.71 -21.63 32.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 1.06 110.048 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -111.67 159.04 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.76 109.867 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -128.24 14.76 6.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.899 0.38 . . . . 1.09 110.443 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -164.72 169.0 17.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.62 110.163 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.401 HD13 HD11 ' A' ' 264' ' ' ILE . 5.5 mt -81.28 -57.68 3.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.828 0.347 . . . . 0.34 110.27 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.6 36.35 5.89 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.14 112.578 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 262' ' ' LEU . 6.1 pt -137.16 156.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.42 0.629 . . . . 0.18 111.894 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.497 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -102.71 129.15 49.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.006 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.6 mm -97.37 113.33 31.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.28 110.953 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.5 t -114.88 115.24 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.31 110.709 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.64 134.23 12.26 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.97 -0.633 . . . . 0.37 112.393 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -104.35 156.68 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.623 0.249 . . . . 1.87 110.539 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 275' ' ' ASP . 69.3 m -137.2 121.07 17.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.41 -0.359 . . . . 1.17 110.513 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 -76.15 0.16 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 2.75 110.503 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.29 -16.72 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.06 -0.256 . . . . 2.08 111.551 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 -114.25 11.99 17.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.233 0.539 . . . . 2.63 110.163 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 92.69 -15.08 63.4 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.324 -0.711 . . . . 0.97 111.324 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 270' ' ' SER . 17.2 p-10 -75.05 159.44 31.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.507 . . . . 1.75 110.794 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 163.57 -47.39 0.31 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.893 -0.67 . . . . 0.52 112.156 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.39 172.62 20.8 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.3 112.025 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.6 130.44 56.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.174 0.511 . . . . 0.27 111.07 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 279' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 45.4 m-85 -117.71 159.17 23.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.72 110.687 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.0 mm -79.88 120.2 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.919 -0.582 . . . . 0.24 110.227 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.29 -53.41 5.17 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.704 -0.76 . . . . 0.42 112.073 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -155.59 163.76 39.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.49 128.61 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.95 -0.389 . . . . 0.53 109.95 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -90.86 126.45 36.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 0.74 110.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.57 127.57 31.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 1.01 110.03 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 112.4 -14.37 25.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.36 111.572 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.39 175.1 54.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.982 -0.628 . . . . 0.26 111.778 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.85 79.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.69 0.281 . . . . 0.25 111.027 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.22 -36.93 78.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.26 111.054 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.33 -7.27 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.37 111.703 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.91 37.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.327 -0.397 . . . . 0.41 111.155 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -91.8 -80.2 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.55 110.333 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.22 -18.62 9.53 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.521 -0.847 . . . . 0.39 114.024 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -76.69 -33.38 58.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.55 0.675 . . . . 0.68 111.338 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.0 139.43 17.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.173 -0.467 . . . . 0.37 109.892 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.78 160.63 60.21 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.107 -0.331 . . . . 0.69 110.107 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.45 122.97 12.56 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.386 2.057 . . . . 0.41 111.023 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.82 9.82 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.298 -0.721 . . . . 0.29 111.298 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 93.6 m-20 -69.09 144.23 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.666 0.269 . . . . 0.34 110.504 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 300' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 27.3 ttt -100.36 135.38 41.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.381 -0.372 . . . . 1.26 111.1 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.41 123.4 32.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.902 -0.407 . . . . 0.48 109.902 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 336' ' ' ALA . 75.3 mt -102.12 -64.67 1.04 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 0.53 110.887 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -125.11 136.17 53.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.733 -0.667 . . . . 0.73 110.672 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 307' ' ' VAL . 98.5 t -132.66 103.38 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.29 110.134 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.5 m-20 59.81 65.14 1.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 1.71 111.444 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 58.0 m-20 76.31 -51.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.034 0.934 . . . . 1.11 113.451 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 304' ' ' VAL . 0.0 OUTLIER -63.66 124.35 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.387 0.613 . . . . 0.71 111.852 -178.896 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.59 129.61 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.34 -0.845 . . . . 0.74 109.67 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.131 0.419 . . . . 0.33 112.131 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -63.25 -26.19 68.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.643 0.259 . . . . 1.21 111.637 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -117.14 24.37 11.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.68 0.252 . . . . 1.32 111.68 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.8 mtp -122.23 156.49 33.65 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.788 -0.365 . . . . 0.51 111.501 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 144.0 57.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.724 -0.671 . . . . 0.97 110.388 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 318' ' ' VAL . 57.5 m-20 -50.86 -49.05 59.86 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.279 0.362 . . . . 0.48 111.463 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -47.18 85.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.4 111.309 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.21 -29.16 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.509 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.48 81.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.27 -0.423 . . . . 0.2 110.97 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -74.28 -23.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.81 -0.356 . . . . 0.21 110.688 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.08 -45.9 79.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.016 0.436 . . . . 0.83 110.168 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.02 -36.37 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.879 -0.601 . . . . 0.17 110.256 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 304' ' ' VAL . 32.3 tp -56.76 -50.6 71.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.841 -0.618 . . . . 0.38 111.398 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.614 ' HA ' HG11 ' B' ' 3' ' ' VAL . 31.3 mtp180 -61.61 -33.16 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.57 111.258 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.71 -45.46 86.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 1.87 109.948 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.48 -42.78 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.29 111.624 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' B' ' 3' ' ' VAL . 57.5 t -66.32 -26.83 38.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.93 0.395 . . . . 0.24 111.264 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 15.8 m -86.71 -2.21 58.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.253 0.549 . . . . 0.44 110.474 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 163.86 12.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.411 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.13 144.61 25.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.487 -0.324 . . . . 0.89 110.842 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.21 152.8 8.46 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.677 -0.773 . . . . 0.45 111.994 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.36 139.7 72.74 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.947 2.431 . . . . 0.58 112.15 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 57.9 mt -114.52 134.39 57.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.079 -0.51 . . . . 0.37 111.301 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.5 m -108.63 126.16 52.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.59 -0.522 . . . . 1.09 109.59 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 63.8 mt -110.51 118.2 35.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.075 0.398 . . . . 0.48 112.075 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 89.1 m -98.78 100.28 11.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.767 -0.827 . . . . 0.5 108.767 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.92 155.48 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 0.33 112.005 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -113.61 114.89 27.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.263 -0.88 . . . . 0.38 110.111 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.415 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.6 mtpp . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.477 -0.773 . . . . 0.7 109.604 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.534 ' H22' HG11 ' A' ' 318' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 58.2 m95 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.368 0.128 . . . . 0.4 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.72 -0.657 . . . . 0.27 109.801 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.26 -0.274 . . . . 1.26 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.36 128.99 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.814 -0.439 . . . . 0.65 109.814 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.36 132.5 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 0.55 110.99 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 13.2 m -109.01 111.4 23.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.414 -0.587 . . . . 0.59 109.414 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.19 149.47 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.5 111.469 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.4 t -115.35 106.84 14.47 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 57.9 mt -87.91 134.96 33.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.46 111.618 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -79.22 115.9 19.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 0.65 110.508 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 60.9 mmm -99.33 19.59 15.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.073 0.463 . . . . 0.63 110.937 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.22 -52.77 4.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.617 -0.512 . . . . 1.27 109.617 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -82.89 -25.67 32.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 1.06 109.62 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -98.86 160.21 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.76 109.561 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -130.21 12.69 5.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.967 0.413 . . . . 1.09 110.562 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -168.6 165.8 12.13 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.791 -0.641 . . . . 0.62 110.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 262' ' ' LEU . 8.0 mt -80.1 -51.51 8.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.639 -0.504 . . . . 0.34 109.639 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.4 43.45 5.55 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.14 112.653 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -144.86 152.16 15.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.489 0.662 . . . . 0.18 111.66 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.426 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 21.5 p -104.22 128.82 52.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.202 -0.908 . . . . 1.0 108.842 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.727 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.6 mm -95.26 123.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.899 0.38 . . . . 0.28 110.551 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 63.1 t -104.08 113.43 40.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.419 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.08 105.65 2.8 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.268 -0.733 . . . . 0.37 111.268 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.75 95.95 1.97 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 1.87 110.768 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.1 m -111.91 106.66 15.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.003 -0.544 . . . . 1.17 110.147 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 7.5 t30 -104.92 -149.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.684 -0.689 . . . . 2.75 109.522 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.472 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 18.4 p-10 -56.67 -40.85 76.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 2.08 109.819 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.415 ' HB3' ' OD1' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -83.79 -53.97 5.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 2.63 110.021 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.88 0.09 41.96 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.814 -0.708 . . . . 0.97 112.889 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 273' ' ' ARG . 37.3 p-10 -103.61 43.1 1.11 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.182 0.515 . . . . 1.75 111.173 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -76.13 -28.65 59.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.741 . . . . 0.52 112.605 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.74 173.61 25.71 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 0.3 112.28 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.83 124.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.045 0.45 . . . . 0.27 110.741 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -116.38 154.95 29.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 0.72 110.536 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 43.7 mm -74.23 114.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.24 109.869 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -72.93 -58.71 4.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.946 -0.645 . . . . 0.42 112.512 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.8 p -152.98 161.36 42.63 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.215 -0.291 . . . . 0.75 110.215 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 41.2 mt -111.02 135.45 50.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.53 110.273 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.0 mmt -98.54 131.61 44.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 0.74 110.152 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -63.85 131.58 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.01 110.668 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.05 50.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.763 -0.732 . . . . 0.36 111.888 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.16 165.22 54.61 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.972 -0.632 . . . . 0.26 112.264 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -31.62 72.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.616 0.246 . . . . 0.25 111.089 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.42 -42.52 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.26 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.03 -17.91 65.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.54 . . . . 0.37 111.214 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.87 55.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 0.41 111.212 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.14 -75.98 0.46 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.515 -0.311 . . . . 0.55 110.755 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.35 -19.96 16.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.374 -0.917 . . . . 0.39 113.813 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -76.88 -27.72 55.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.568 0.684 . . . . 0.68 111.245 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.17 136.99 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.37 109.934 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.04 161.01 62.06 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.407 -0.36 . . . . 0.69 110.543 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.57 114.11 1.99 Allowed 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.266 1.977 . . . . 0.41 110.896 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.27 -20.07 5.33 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.603 -0.599 . . . . 0.29 111.603 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 92.2 m-20 -65.9 143.86 57.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.967 -0.383 . . . . 0.34 109.967 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 39.9 ttp -101.85 135.85 42.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.632 0.254 . . . . 1.26 110.334 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 52.7 mt -86.64 121.02 28.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.48 110.423 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 336' ' ' ALA . 27.7 mt -97.14 -77.88 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.53 110.269 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -114.58 129.43 56.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.636 -0.711 . . . . 0.73 110.404 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.6 t -123.21 97.06 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.367 -0.605 . . . . 0.29 109.367 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.422 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 24.5 m120 63.05 72.24 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.641 0.588 . . . . 1.71 111.315 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 21.1 m-20 73.92 -48.12 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.8 1.037 . . . . 1.11 113.8 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.44 125.6 32.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.253 0.549 . . . . 0.71 111.83 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -103.17 123.76 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.627 -0.715 . . . . 0.74 109.744 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.06 8.02 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.441 0.534 . . . . 0.33 112.441 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.16 -22.97 63.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.24 0.459 . . . . 1.21 112.24 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -123.82 37.65 4.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.802 0.334 . . . . 1.32 111.152 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.6 mtp -132.03 164.04 27.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.85 -0.426 . . . . 0.51 109.85 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 p -77.99 155.55 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.286 -0.264 . . . . 0.97 110.286 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 318' ' ' VAL . 93.6 m-20 -52.15 -46.18 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.48 111.086 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -61.28 -51.34 69.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 1.4 111.604 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 7.4 m-20 -64.77 -34.85 79.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.772 0.286 . . . . 0.88 111.772 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.8 81.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.2 110.943 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.5 t -79.47 -24.42 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.776 -0.369 . . . . 0.21 110.885 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.48 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 71.3 mtt180 -57.94 -48.63 79.38 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -73.36 -36.1 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.792 -0.64 . . . . 0.17 110.158 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.9 tp -56.13 -51.23 68.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.881 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.554 ' HA ' HG11 ' B' ' 3' ' ' VAL . 16.6 mtp-105 -62.6 -34.4 76.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 1.57 110.93 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.75 -46.95 83.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.561 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.29 111.125 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 30.8 t -68.74 -12.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.186 0.517 . . . . 0.24 110.951 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -84.6 -4.41 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.85 0.357 . . . . 0.44 110.696 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -102.75 176.45 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.16 110.132 179.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 112.89 24.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.89 110.964 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 167.01 169.74 30.99 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.67 -0.776 . . . . 0.45 112.452 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.71 123.13 11.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.62 2.213 . . . . 0.58 111.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 66.3 mt -98.5 114.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.207 -0.451 . . . . 0.37 111.098 -178.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.35 111.18 22.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 1.09 110.123 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.03 120.3 41.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.117 -0.492 . . . . 0.48 111.114 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -105.12 98.65 8.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.136 -0.69 . . . . 0.5 109.136 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.13 149.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.33 111.978 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.77 109.21 19.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.275 -0.875 . . . . 0.38 109.764 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.267 -0.873 . . . . 0.7 109.958 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.727 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 18.0 m95 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.425 -0.213 . . . . 0.4 110.425 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.741 -0.647 . . . . 0.27 109.924 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.975 -0.38 . . . . 1.26 109.975 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.0 mt -104.26 130.71 54.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.738 0.304 . . . . 0.65 111.232 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.6 mt -131.62 138.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.55 110.905 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.06 109.91 21.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.118 -0.697 . . . . 0.59 109.118 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.28 158.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.422 . . . . 0.5 111.519 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -123.91 129.35 50.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.893 -0.781 . . . . 0.79 108.893 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.441 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 87.1 mt -112.41 141.39 46.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.46 111.862 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -82.21 107.93 15.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.65 110.628 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 94.0 mmm -93.86 22.48 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.63 110.905 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -94.74 -47.61 6.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.144 -0.688 . . . . 1.27 109.144 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -86.15 -27.7 24.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.288 -0.869 . . . . 1.06 109.55 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -108.76 135.31 50.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.76 109.806 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -102.63 -0.82 31.3 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.028 -0.269 . . . . 1.09 111.398 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -150.26 162.13 41.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.318 . . . . 0.62 110.956 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 264' ' ' ILE . 5.3 mt -75.85 -50.96 13.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.34 109.541 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.23 49.54 4.41 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.659 -0.7 . . . . 0.14 112.589 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.452 HD11 HD13 ' A' ' 262' ' ' LEU . 2.6 pt -145.48 149.71 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.321 0.582 . . . . 0.18 111.722 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.36 121.53 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.871 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.712 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.0 mm -88.56 123.3 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.949 0.404 . . . . 0.28 110.623 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.33 113.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.358 -0.383 . . . . 0.31 110.246 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -85.72 103.79 2.78 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.728 -0.749 . . . . 0.37 111.81 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -76.33 108.41 9.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.612 -0.514 . . . . 1.87 109.612 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 270' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 274' ' ' GLY . 19.8 m -108.5 112.2 24.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.196 -0.457 . . . . 1.17 111.106 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -84.39 -150.97 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.05 -0.523 . . . . 2.75 110.587 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.99 -24.3 66.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.478 -0.328 . . . . 2.08 111.654 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -113.45 12.37 18.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.784 0.326 . . . . 2.63 110.591 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 274' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 270' ' ' SER . . . 78.26 8.36 87.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.635 -0.793 . . . . 0.97 112.058 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -93.19 165.39 12.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.72 0.295 . . . . 1.75 110.347 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 151.23 -44.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.867 -0.683 . . . . 0.52 112.054 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.7 170.18 21.01 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.652 -0.785 . . . . 0.3 112.55 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.34 129.4 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.102 0.477 . . . . 0.27 111.008 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -117.69 162.47 18.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.72 110.771 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.78 113.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.24 109.999 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.37 -65.09 2.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.42 112.478 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.87 152.73 45.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.759 0.314 . . . . 0.75 110.637 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.78 131.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.079 -0.51 . . . . 0.53 109.912 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -92.86 126.2 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.851 0.358 . . . . 0.74 110.642 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -65.3 128.43 35.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 1.01 109.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.21 -12.85 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.968 -0.634 . . . . 0.36 111.519 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.5 171.08 47.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.934 -0.65 . . . . 0.26 111.73 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.55 -37.52 86.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.25 111.259 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.29 -34.2 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.26 111.039 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.67 -20.78 64.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 0.37 111.619 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.7 -6.58 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.457 -0.338 . . . . 0.41 111.057 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.97 -76.4 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.938 -0.393 . . . . 0.55 109.938 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.92 32.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.377 -0.916 . . . . 0.39 114.177 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -76.83 -34.99 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.571 0.685 . . . . 0.68 110.937 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.76 136.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.52 158.65 75.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.522 -0.308 . . . . 0.69 110.697 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.48 99.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.497 2.131 . . . . 0.41 111.434 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 141.66 -15.82 2.66 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.59 -0.604 . . . . 0.29 111.59 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.0 146.41 54.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.732 0.301 . . . . 0.34 110.321 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.3 ttt -99.88 135.27 41.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.266 -0.424 . . . . 1.26 110.75 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 335' ' ' VAL . 30.1 mt -90.82 117.46 29.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.246 -0.434 . . . . 0.48 109.933 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 336' ' ' ALA . 82.5 mt -100.85 -62.83 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.163 0.506 . . . . 0.53 110.735 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -127.33 133.15 50.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.73 110.912 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 321' ' ' LEU . 44.4 t -119.62 87.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.173 -0.467 . . . . 0.29 109.76 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.4 t30 62.96 82.97 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.786 . . . . 1.71 111.437 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 4.6 m-20 74.8 -59.78 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.427 -0.806 . . . . 1.11 113.11 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.0 m -64.34 124.91 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.589 . . . . 0.71 112.456 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.52 130.02 47.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.466 -0.788 . . . . 0.74 109.628 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.421 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 44.0 m-85 -106.89 15.99 24.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.944 0.349 . . . . 0.33 111.944 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -62.64 -32.8 73.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.122 0.415 . . . . 1.21 112.122 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -117.6 35.81 4.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.392 . . . . 1.32 111.209 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 312' ' ' MET . . . . . 0.421 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 95.3 mtp -123.09 167.67 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.02 -0.363 . . . . 0.51 110.02 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 38.9 p -75.96 154.59 35.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.447 -0.342 . . . . 0.97 110.133 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -58.37 -32.67 68.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.48 111.109 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -49.82 19.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.207 -0.452 . . . . 1.4 111.063 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.59 -35.16 77.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.257 -0.429 . . . . 0.88 110.974 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.4 73.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.018 -0.537 . . . . 0.2 111.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.536 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 4.0 t -73.5 -31.96 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.3 . . . . 0.21 110.811 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 78.7 mtt180 -55.45 -50.49 69.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.748 0.309 . . . . 0.83 110.339 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.88 -41.01 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.246 -0.433 . . . . 0.17 110.093 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 304' ' ' VAL . 17.3 tp -52.5 -48.51 65.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.964 -0.562 . . . . 0.38 111.22 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.556 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.3 mtp-105 -62.42 -39.14 92.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.012 -0.54 . . . . 1.57 111.743 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 5.9 mm-40 -65.91 -34.6 78.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.87 110.439 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.3 mt -70.65 -43.93 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.557 . . . . 0.29 110.142 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.8 t -70.78 -18.75 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.246 0.546 . . . . 0.24 110.507 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 56.5 m -87.05 4.77 40.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.037 0.446 . . . . 0.44 110.204 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.35 158.53 18.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 1.16 109.989 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.91 120.48 35.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.662 0.268 . . . . 0.89 111.066 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.59 169.09 19.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.655 -0.783 . . . . 0.45 112.0 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.05 125.4 10.88 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.913 2.408 . . . . 0.58 111.714 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 60.0 mt -100.36 117.69 45.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.922 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 m -90.97 102.23 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.09 110.093 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 24.7 mt -92.93 123.37 36.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.872 0.367 . . . . 0.48 111.886 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.4 m -107.3 99.23 8.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.543 -0.91 . . . . 0.5 108.543 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 301' ' ' LEU . 27.6 m -104.68 155.71 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.33 112.194 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.72 111.06 21.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.227 -0.897 . . . . 0.38 109.829 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.311 -0.852 . . . . 0.7 110.144 -179.346 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.712 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 43.4 m95 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 110.665 -0.124 . . . . 0.4 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.679 -0.677 . . . . 0.27 110.003 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.673 0.273 . . . . 1.26 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.45 109.67 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.608 -0.516 . . . . 0.65 109.608 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.63 127.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.799 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -104.21 103.46 13.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.59 110.118 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.38 144.06 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.067 0.46 . . . . 0.5 111.276 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.3 t -114.5 113.68 24.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.087 -0.708 . . . . 0.79 109.087 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.44 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 24.0 mt -95.79 152.74 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.359 0.599 . . . . 0.46 112.038 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.29 122.18 34.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.84 . . . . 0.65 110.017 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 90.7 mmm -102.51 25.07 9.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.63 111.752 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -100.37 -45.38 5.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 258' ' ' ARG . 19.2 ttt180 -92.95 11.43 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.385 0.612 . . . . 1.06 110.178 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.52 155.69 50.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 0.76 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -111.98 -11.94 13.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.627 0.251 . . . . 1.09 110.833 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' B' ' 3' ' ' VAL . 30.0 p90 -157.31 173.07 17.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.542 -0.299 . . . . 0.62 111.066 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.5 mt -75.93 -50.95 13.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.584 . . . . 0.34 109.422 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.9 41.58 5.9 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.517 -0.765 . . . . 0.14 112.823 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.65 146.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.441 0.639 . . . . 0.18 111.767 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.04 115.44 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.704 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.735 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 4.6 mm -85.44 126.65 40.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.28 110.239 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.76 115.84 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.31 110.326 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.32 113.79 4.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.868 -0.682 . . . . 0.37 111.73 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.99 114.32 17.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.909 0.385 . . . . 1.87 110.455 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 51.2 m -119.5 101.54 8.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.079 -0.51 . . . . 1.17 110.196 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -88.34 -146.82 0.15 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.343 -0.39 . . . . 2.75 110.174 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.89 -37.76 88.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 2.08 110.854 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.408 ' HD2' ' OD1' ' A' ' 275' ' ' ASP . 21.2 ttm180 -89.76 -52.3 5.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.6 -0.519 . . . . 2.63 109.6 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.63 -18.35 6.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.497 -0.859 . . . . 0.97 113.159 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 273' ' ' ARG . 31.9 p-10 -85.94 73.45 10.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.651 0.739 . . . . 1.75 111.379 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -101.82 -34.26 4.41 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.745 -0.741 . . . . 0.52 112.118 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.69 165.74 22.54 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.3 112.116 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.0 pt -102.24 128.85 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.193 0.521 . . . . 0.27 110.809 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -118.19 163.97 15.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.72 111.12 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 280' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 301' ' ' LEU . 46.3 mm -85.74 110.68 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.867 -0.606 . . . . 0.24 109.448 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.79 8.87 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.737 -0.744 . . . . 0.42 112.689 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 163.9 39.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.549 0.214 . . . . 0.75 110.579 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 32.8 mt -114.24 134.32 57.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.53 109.991 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.9 mmt -96.13 128.42 43.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.375 -0.375 . . . . 0.74 110.277 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.26 131.86 49.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.522 . . . . 1.01 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 101.49 -6.85 55.68 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.963 -0.637 . . . . 0.36 112.176 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.15 171.28 46.09 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.872 -0.68 . . . . 0.26 112.419 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -65.52 -35.41 80.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.311 . . . . 0.25 111.057 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.89 -35.63 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.26 110.662 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.57 65.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.37 111.182 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -78.89 -16.61 56.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.41 111.069 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.59 -76.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.641 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.89 -18.35 26.62 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.481 -0.866 . . . . 0.39 114.199 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -69.2 -40.05 78.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.568 0.684 . . . . 0.68 111.468 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.3 137.09 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.739 -0.467 . . . . 0.37 109.739 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -138.87 159.05 68.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.504 -0.316 . . . . 0.69 110.616 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 118.75 5.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.358 2.039 . . . . 0.41 111.629 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 122.12 -19.72 8.18 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.469 -0.653 . . . . 0.29 111.469 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.404 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 84.1 m-20 -65.46 145.49 56.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.656 0.265 . . . . 0.34 110.331 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.3 ttp -101.1 133.84 45.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.443 -0.344 . . . . 1.26 110.516 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.568 HD23 HG12 ' A' ' 335' ' ' VAL . 73.3 mt -88.46 130.19 35.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.48 110.205 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 336' ' ' ALA . 71.4 mt -111.16 -76.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.199 0.523 . . . . 0.53 110.899 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 36.2 tt0 -115.79 140.61 49.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.73 111.136 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 321' ' ' LEU . 87.3 t -134.12 101.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.798 -0.637 . . . . 0.29 109.52 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 7.1 m120 62.3 68.16 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.064 -0.516 . . . . 1.71 111.428 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.93 -51.33 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.251 -0.886 . . . . 1.11 113.373 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.3 m -67.78 130.89 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.27 0.557 . . . . 0.71 111.528 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -105.56 135.61 46.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.421 -0.809 . . . . 0.74 109.767 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 309' ' ' PHE . . . . . 0.404 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 21.9 m-85 -106.2 11.01 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.951 0.352 . . . . 0.33 111.951 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.5 -32.47 71.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.233 0.457 . . . . 1.21 112.233 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -112.33 32.14 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.022 0.439 . . . . 1.32 111.002 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 312' ' ' MET . . . . . 0.404 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 86.5 mtp -123.81 163.72 20.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.181 -0.463 . . . . 0.51 110.371 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 75.5 p -74.39 156.6 36.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.97 110.274 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 90.5 m-20 -55.5 -40.64 72.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.86 0.362 . . . . 0.48 110.483 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.0 m-20 -68.61 -51.47 42.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 1.4 111.28 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 28.6 m-20 -61.01 -36.8 80.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.88 111.684 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.28 -48.94 78.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.2 111.245 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 266' ' ' ILE . 6.2 t -73.51 -31.87 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.21 110.771 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 93.1 mtt180 -55.48 -46.52 76.88 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.03 -0.359 . . . . 0.83 110.03 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.51 -38.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.17 110.276 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 325' ' ' VAL . 40.1 tp -54.61 -50.66 67.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.102 -0.499 . . . . 0.38 110.581 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.9 mtp-105 -61.34 -36.43 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.892 -0.595 . . . . 1.57 110.877 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.96 -46.69 89.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.491 . . . . 1.87 110.016 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.11 -41.71 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.788 -0.642 . . . . 0.29 110.878 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 321' ' ' LEU . 65.1 t -65.53 -15.92 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.282 0.563 . . . . 0.24 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 19.8 m -89.96 0.41 57.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.894 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -103.23 147.5 26.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 1.16 110.417 -179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.77 103.8 16.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.761 0.315 . . . . 0.89 111.148 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 176.86 -175.4 47.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.661 -0.78 . . . . 0.45 112.049 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.62 112.05 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.025 2.484 . . . . 0.58 112.077 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.81 121.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.37 110.389 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.34 103.17 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.904 -0.589 . . . . 1.09 110.243 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.8 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.48 111.217 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.6 m -96.78 97.42 9.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.763 -0.828 . . . . 0.5 108.763 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.568 HG12 HD23 ' A' ' 301' ' ' LEU . 26.3 m -100.81 154.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.223 0.535 . . . . 0.33 112.228 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.56 110.6 21.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.172 -0.922 . . . . 0.38 109.54 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 26.3 mtpp . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.083 -0.96 . . . . 0.7 110.129 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.735 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 120.587 0.232 . . . . 0.4 110.556 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 261' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.762 -0.637 . . . . 0.27 109.799 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.094 0.473 . . . . 1.26 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.35 115.35 28.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.877 -0.602 . . . . 0.65 110.134 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 337' ' ' LYS . 37.1 mt -120.88 130.94 74.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.55 111.132 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.7 m -104.62 102.66 12.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.704 -0.68 . . . . 0.59 109.434 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 295' ' ' ILE . 21.5 m -90.42 152.38 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.5 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -113.5 125.15 53.89 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.317 -0.623 . . . . 0.79 109.317 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.33 136.97 52.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 0.46 111.791 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -90.94 117.3 29.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.855 . . . . 0.65 109.971 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.9 mmm -94.16 26.78 3.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.63 111.624 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -99.74 -50.42 4.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.538 -0.541 . . . . 1.27 109.538 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -81.83 -20.6 38.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.495 -0.775 . . . . 1.06 109.992 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -119.74 134.0 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.76 110.033 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -93.17 -8.5 42.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.499 0.555 . . . . 1.09 112.499 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -151.76 170.85 18.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.62 111.116 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 262' ' ' LEU . 4.4 mt -78.67 -53.82 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.886 -0.597 . . . . 0.34 110.466 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.06 5.73 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.14 112.729 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.9 pt -135.14 152.23 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.525 0.678 . . . . 0.18 111.802 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.91 126.5 47.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.993 -1.003 . . . . 1.0 108.812 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.787 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.0 mm -96.34 114.92 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.65 -0.42 . . . . 0.28 110.461 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.6 t -110.53 106.42 20.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.205 -0.452 . . . . 0.31 110.153 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.96 120.71 5.3 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.734 -0.746 . . . . 0.37 111.813 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.99 103.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.982 -0.377 . . . . 1.87 109.982 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 m -108.43 135.12 50.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 1.17 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 271' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 5.3 t30 -159.54 -157.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 2.75 110.145 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 272' ' ' ASP . . . . . 0.488 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 12.2 p-10 -55.03 -42.61 72.85 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.933 0.493 . . . . 2.08 111.587 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -18.57 55.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.039 0.447 . . . . 2.63 110.796 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 86.76 -63.65 4.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.828 -0.701 . . . . 0.97 112.028 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -84.4 151.29 24.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.471 . . . . 1.75 110.71 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -165.64 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.72 -0.752 . . . . 0.52 111.997 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 141.47 156.65 6.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.694 -0.765 . . . . 0.3 111.981 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.9 pt -102.37 118.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.27 110.37 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.84 150.48 28.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.865 -0.607 . . . . 0.72 110.777 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.2 mm -76.51 115.5 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.271 -0.422 . . . . 0.24 110.001 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -69.89 -58.82 5.96 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.814 -0.708 . . . . 0.42 112.139 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.47 165.08 36.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.152 -0.314 . . . . 0.75 110.152 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.96 138.88 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.707 -0.479 . . . . 0.53 109.707 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 35.2 mmt -102.39 132.17 48.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.817 0.342 . . . . 0.74 110.675 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -70.07 108.25 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 1.01 110.451 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 136.06 -13.08 4.13 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.382 -0.687 . . . . 0.36 111.382 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.3 170.63 39.3 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.26 111.965 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.15 83.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.25 111.382 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.84 -33.34 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.26 111.132 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.56 -15.35 62.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.37 111.541 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.26 -20.09 25.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.288 -0.415 . . . . 0.41 110.942 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.4 -73.35 0.35 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.55 110.351 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.31 -20.56 30.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.48 -0.867 . . . . 0.39 113.57 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -73.37 -35.79 65.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.743 0.771 . . . . 0.68 111.048 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 252' ' ' VAL . 42.9 mt -82.86 137.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.591 -0.522 . . . . 0.37 109.591 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -135.83 158.65 73.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.44 -0.345 . . . . 0.69 110.369 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.34 112.69 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.505 2.137 . . . . 0.41 111.429 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.92 -21.09 5.02 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.101 -0.571 . . . . 0.29 111.94 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.86 146.67 54.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.758 0.313 . . . . 0.34 110.92 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 59.4 ttp -105.9 132.41 52.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.288 -0.414 . . . . 1.26 110.363 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.46 129.92 34.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.347 -0.388 . . . . 0.48 110.491 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 336' ' ' ALA . 19.3 mt -104.78 -76.6 0.6 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.53 110.221 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 50.4 tt0 -112.1 128.79 56.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.584 -0.734 . . . . 0.73 110.569 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.99 97.68 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.121 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 57.23 77.22 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.71 111.647 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 75.3 -52.83 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.763 1.023 . . . . 1.11 113.763 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.21 132.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.437 0.637 . . . . 0.71 112.349 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -105.67 132.53 51.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.577 -0.738 . . . . 0.74 109.586 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -99.53 3.7 45.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.845 0.313 . . . . 0.33 111.845 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.53 -22.57 65.26 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.654 0.242 . . . . 1.21 111.654 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -118.06 38.24 3.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.32 110.55 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -138.83 159.34 42.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.51 110.397 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 157.34 37.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.537 -0.301 . . . . 0.97 110.549 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.1 m-20 -54.78 -48.17 73.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.35 -0.387 . . . . 0.48 111.179 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.21 -50.79 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.849 -0.614 . . . . 1.4 111.386 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -65.05 -33.79 76.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.88 111.469 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.07 83.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.307 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 2.3 t -71.97 -31.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.607 -0.437 . . . . 0.21 110.917 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -56.25 -54.57 43.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.891 0.377 . . . . 0.83 110.613 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.83 -36.4 77.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.17 110.526 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.3 tp -56.03 -50.83 69.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.38 110.817 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 30.8 mtp180 -63.74 -31.96 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.57 111.292 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -66.13 -45.17 82.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.029 0.442 . . . . 1.87 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.0 mt -67.08 -41.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.899 -0.591 . . . . 0.29 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 99.0 t -66.77 -19.48 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.159 0.504 . . . . 0.24 110.992 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 55.3 m -87.25 -5.62 58.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.809 0.337 . . . . 0.44 110.406 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.3 tp60 -97.6 133.69 41.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 1.16 110.393 -179.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.97 130.43 39.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.176 -0.465 . . . . 0.89 110.656 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 146.86 -174.57 26.64 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.83 -0.7 . . . . 0.45 112.286 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 127.67 8.12 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.079 2.519 . . . . 0.58 112.129 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.69 123.92 71.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.103 -0.499 . . . . 0.37 110.564 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.9 OUTLIER -105.59 117.25 33.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.825 -0.625 . . . . 1.09 110.335 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 78.3 mt -102.05 120.8 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.07 -0.513 . . . . 0.48 111.002 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.1 m -100.54 103.91 15.25 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.336 -0.616 . . . . 0.5 109.336 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.33 145.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.33 112.023 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -94.79 92.95 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.526 -0.761 . . . . 0.38 109.316 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 250' ' ' ILE . 20.3 mtpp . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.49 -0.766 . . . . 0.7 111.196 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.787 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 110.162 -0.311 . . . . 0.4 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.73 -0.653 . . . . 0.27 110.012 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.991 0.424 . . . . 1.26 110.284 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.34 121.4 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.907 -0.588 . . . . 0.65 110.727 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.9 127.11 67.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.477 -0.328 . . . . 0.55 111.221 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 86.8 m -103.63 118.9 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.157 -0.683 . . . . 0.59 109.157 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.48 143.4 22.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 0.5 111.399 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 t -101.33 137.85 39.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.046 -1.094 . . . . 0.79 108.046 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 85.7 mt -119.15 131.24 55.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.107 0.479 . . . . 0.46 111.668 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.07 108.32 13.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.437 -0.801 . . . . 0.65 110.353 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 95.4 mmm -96.0 13.92 25.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.63 110.981 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -85.27 -40.7 16.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 1.27 109.941 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -93.88 -17.13 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.434 0.635 . . . . 1.06 109.898 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -108.01 161.45 14.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.714 -0.676 . . . . 0.76 110.108 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -124.87 -0.66 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.839 -0.344 . . . . 1.09 111.515 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -159.71 164.04 34.25 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.571 -0.286 . . . . 0.62 110.918 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.7 mt -77.39 -49.22 15.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.711 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 81.27 50.85 4.92 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.68 -0.691 . . . . 0.14 112.339 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 262' ' ' LEU . 3.7 pt -145.56 146.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.517 0.675 . . . . 0.18 111.767 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.29 120.25 38.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.974 . . . . 1.0 108.761 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.746 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.3 mm -88.33 127.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.615 -0.434 . . . . 0.28 110.567 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.81 115.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.331 -0.395 . . . . 0.31 110.714 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.63 111.62 4.29 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.201 -0.759 . . . . 0.37 111.201 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 98.14 5.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 1.87 110.215 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 42.1 m -97.76 87.98 4.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.135 0.493 . . . . 1.17 110.718 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -69.43 -64.85 0.8 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 2.75 111.278 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -135.19 -64.18 0.66 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.023 -0.535 . . . . 2.08 109.752 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.616 ' HD2' ' OD1' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -95.13 -17.76 21.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 2.63 110.467 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 112.23 6.0 24.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.721 -0.752 . . . . 0.97 111.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.616 ' OD1' ' HD2' ' A' ' 273' ' ' ARG . 11.8 p-10 -82.85 67.97 9.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.66 0.743 . . . . 1.75 110.534 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.2 -45.42 0.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.535 -0.757 . . . . 0.52 111.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 117.67 161.15 11.94 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.723 -0.751 . . . . 0.3 112.354 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.86 123.34 58.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.365 0.602 . . . . 0.27 110.601 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.0 159.43 19.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.611 -0.722 . . . . 0.72 110.681 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.62 108.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.379 -0.6 . . . . 0.24 109.379 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -68.57 -58.34 7.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.063 -0.589 . . . . 0.42 112.71 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.63 156.22 39.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.673 0.273 . . . . 0.75 110.545 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.23 134.8 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.53 109.915 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 31.3 mmt -96.38 125.06 40.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.337 -0.392 . . . . 0.74 110.166 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.93 120.75 11.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 1.01 110.364 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.82 -12.56 13.29 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.813 -0.708 . . . . 0.36 111.635 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.48 171.66 47.87 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.712 -0.756 . . . . 0.26 111.641 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.47 80.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.836 0.351 . . . . 0.25 111.382 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.41 -35.12 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.26 110.806 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.58 -11.1 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.37 111.958 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -97.19 -5.43 37.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.775 0.322 . . . . 0.41 110.94 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -95.82 -73.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.55 110.04 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.7 -11.54 42.11 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.556 -0.831 . . . . 0.39 114.174 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -81.2 -29.01 34.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.962 0.881 . . . . 0.68 111.289 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.38 138.06 19.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.603 -0.518 . . . . 0.37 109.603 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.19 158.88 71.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.333 -0.247 . . . . 0.69 110.333 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.3 Cg_exo -59.3 114.07 1.87 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.385 2.057 . . . . 0.41 111.455 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.81 -21.36 5.01 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.995 -0.548 . . . . 0.29 111.954 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -70.2 148.03 49.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.611 0.243 . . . . 0.34 110.425 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 57.6 ttp -105.36 139.67 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 1.26 111.05 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.0 mt -87.16 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.377 -0.374 . . . . 0.48 110.51 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 336' ' ' ALA . 76.3 mt -115.16 -68.29 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 0.53 110.732 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 306' ' ' ASP . 7.7 tt0 -119.65 133.89 55.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.73 110.258 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.652 ' O ' HG22 ' A' ' 307' ' ' VAL . 69.5 t -127.91 116.15 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.187 -0.461 . . . . 0.29 110.935 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 1.1 m-20 50.73 46.61 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.876 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 25.6 m-20 81.27 -13.66 0.89 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.73 1.011 . . . . 1.11 113.73 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 304' ' ' VAL . 2.5 m -90.41 137.01 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.938 -0.705 . . . . 0.71 109.988 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -98.03 134.62 40.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.74 111.649 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.18 -0.34 14.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.33 110.989 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.6 -24.72 64.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.451 0.538 . . . . 1.21 112.451 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -125.71 53.95 1.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.115 0.484 . . . . 1.32 111.407 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 94.6 mtp -142.98 169.02 18.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.138 -0.483 . . . . 0.51 110.139 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.3 p -79.1 159.07 27.66 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.767 -0.457 . . . . 0.97 109.767 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 94.1 m-20 -58.05 -42.62 85.82 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.199 0.523 . . . . 0.48 110.217 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -55.13 21.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.209 -0.905 . . . . 1.4 111.263 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -58.58 -37.31 75.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.392 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.92 63.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.692 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -70.4 -30.74 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.839 -0.344 . . . . 0.21 110.97 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -57.64 -49.93 74.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.023 0.44 . . . . 0.83 110.182 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.63 -39.57 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.539 . . . . 0.17 110.128 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.5 tp -56.27 -52.28 65.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.38 110.501 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.514 ' HA ' HG11 ' B' ' 3' ' ' VAL . 70.6 mtp180 -62.3 -36.33 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.759 -0.655 . . . . 1.57 111.014 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -46.12 87.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.389 -0.369 . . . . 1.87 110.153 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.84 -42.38 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.97 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 321' ' ' LEU . 60.3 t -67.18 -17.02 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 0.24 110.948 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.4 m -86.57 3.79 42.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.44 110.727 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 171.62 7.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.16 110.643 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 138.6 37.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.42 -0.355 . . . . 0.89 111.209 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 132.15 169.42 12.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.699 -0.762 . . . . 0.45 112.312 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.7 140.25 42.45 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.758 2.306 . . . . 0.58 112.118 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 69.2 mt -114.31 128.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.35 -0.386 . . . . 0.37 110.859 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.6 p -101.71 120.24 40.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.012 -0.54 . . . . 1.09 110.003 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.4 mt -113.12 118.74 35.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.385 -0.37 . . . . 0.48 111.53 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 334' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 251' ' ' THR . 85.6 m -101.94 109.62 21.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.28 155.16 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.34 0.59 . . . . 0.33 112.126 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -107.39 103.36 12.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.202 -0.908 . . . . 0.38 109.336 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.559 -0.734 . . . . 0.7 110.617 -179.606 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.746 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 120.404 0.145 . . . . 0.4 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.503 -0.554 . . . . 0.27 109.503 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.92 -0.4 . . . . 1.26 109.92 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.9 mt -122.84 129.73 74.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.83 0.348 . . . . 0.65 110.536 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.09 125.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.369 -0.378 . . . . 0.55 110.829 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 61.2 m -111.8 111.59 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.29 -0.633 . . . . 0.59 109.29 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.44 153.6 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.5 111.494 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.4 t -106.01 133.69 50.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.79 109.472 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.582 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 92.5 mt -109.26 132.37 54.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.026 0.441 . . . . 0.46 111.159 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.93 114.21 9.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.65 109.998 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.5 mmm -96.57 21.36 9.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.63 111.203 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -93.39 -50.3 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.224 0.535 . . . . 1.27 109.668 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -83.49 -16.92 43.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.66 . . . . 1.06 110.428 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -119.97 135.62 54.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.071 -0.714 . . . . 0.76 109.071 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -101.97 5.76 40.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.138 0.421 . . . . 1.09 112.138 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.54 166.01 31.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.651 0.263 . . . . 0.62 110.725 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 262' ' ' LEU . 7.6 mt -78.4 -52.61 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.34 109.843 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.73 42.85 5.3 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.995 -0.622 . . . . 0.14 112.56 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.0 pt -143.54 149.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.54 . . . . 0.18 111.635 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.551 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 0.3 OUTLIER -98.22 131.92 44.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.343 178.278 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.685 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 12.3 mm -95.8 104.42 15.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.937 0.399 . . . . 0.28 110.673 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 90.5 t -92.32 108.31 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.884 -0.598 . . . . 0.31 110.157 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.0 106.95 3.48 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.834 -0.698 . . . . 0.37 111.994 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 61.8 tt0 -65.65 104.58 1.06 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.249 0.547 . . . . 1.87 110.386 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 21.2 m -112.43 98.54 7.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.706 -0.679 . . . . 1.17 110.908 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -109.54 -157.59 0.62 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.011 -0.541 . . . . 2.75 109.674 179.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 27.5 p-10 -55.11 -37.92 67.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 2.08 111.744 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.488 ' HB3' ' OD1' ' A' ' 275' ' ' ASP . 9.2 ttt180 -89.4 -40.7 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.821 0.343 . . . . 2.63 110.365 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 91.09 -12.74 68.21 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.87 -0.681 . . . . 0.97 113.505 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 275' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 273' ' ' ARG . 19.7 p-10 -83.09 40.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.23 0.538 . . . . 1.75 111.324 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -74.6 -37.58 45.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.956 -0.64 . . . . 0.52 112.792 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.43 172.59 32.27 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.552 -0.832 . . . . 0.3 112.112 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.2 pt -106.12 129.14 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.218 0.532 . . . . 0.27 111.272 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -119.47 160.15 22.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.725 -0.671 . . . . 0.72 110.676 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.15 116.03 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.708 -0.678 . . . . 0.24 109.399 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -75.46 -74.47 0.9 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.42 112.44 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 152.51 50.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.221 -0.289 . . . . 0.75 110.221 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 296' ' ' GLU . 44.7 mt -105.12 128.3 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.53 110.459 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -95.04 127.24 40.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.989 -0.55 . . . . 0.74 111.032 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -64.25 128.45 35.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.01 110.161 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.34 12.91 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.16 -0.776 . . . . 0.36 111.16 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.24 166.94 51.88 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.776 -0.726 . . . . 0.26 111.926 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.84 -32.33 73.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.738 0.304 . . . . 0.25 111.509 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.22 -40.8 80.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.321 -0.4 . . . . 0.26 110.953 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.42 -13.06 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.081 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.34 -11.04 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.41 111.148 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 30.6 t70 -96.33 -69.89 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.393 -0.367 . . . . 0.55 110.514 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.3 -13.04 40.17 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.284 -0.96 . . . . 0.39 114.823 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.481 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 19.9 mtm180 -81.1 -33.19 33.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.342 1.071 . . . . 0.68 111.143 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.7 mt -80.43 138.42 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.285 -0.635 . . . . 0.37 109.285 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 296' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -141.48 162.01 49.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.351 0.119 . . . . 0.69 110.929 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 50.4 Cg_exo -56.97 118.38 5.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.335 2.023 . . . . 0.41 111.549 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.74 -26.12 5.73 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.743 -0.742 . . . . 0.29 112.119 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 87.4 m-20 -62.06 145.75 52.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.799 0.333 . . . . 0.34 110.471 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.4 ttp -103.04 135.96 43.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 1.26 110.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.1 121.4 30.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.48 109.861 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 336' ' ' ALA . 85.8 mt -100.01 -68.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.327 0.584 . . . . 0.53 110.07 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.53 136.32 54.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.414 -0.812 . . . . 0.73 110.768 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 321' ' ' LEU . 79.5 t -128.73 107.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.427 -0.583 . . . . 0.29 109.427 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 0.9 OUTLIER 58.32 62.97 1.84 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.072 -0.513 . . . . 1.71 111.286 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 7.7 m-20 76.51 -44.02 0.47 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.94 1.089 . . . . 1.11 113.94 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 304' ' ' VAL . 35.9 m -71.59 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.265 0.555 . . . . 0.71 111.289 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 308' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 310' ' ' GLU . 52.5 t30 -105.02 128.7 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.74 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -101.11 2.86 40.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.409 -0.36 . . . . 0.33 111.712 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 310' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' A' ' 308' ' ' ASN . 2.8 mt-10 -49.29 -41.69 38.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.853 0.686 . . . . 1.21 112.853 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -112.8 39.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.331 . . . . 1.32 111.299 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -121.93 179.67 4.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.761 0.315 . . . . 0.51 110.681 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 89.9 p -88.71 155.66 19.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.805 -0.443 . . . . 0.97 109.805 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 318' ' ' VAL . 97.2 m-20 -58.05 -41.14 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 0.48 110.973 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -50.92 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 1.4 111.802 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.41 -32.52 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.88 111.762 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.23 77.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.337 . . . . 0.2 110.863 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -73.58 -31.03 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.21 110.657 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.22 -51.67 65.84 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.502 . . . . 0.83 110.314 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.89 -39.74 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.17 110.37 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.5 tp -56.1 -52.53 63.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.38 110.95 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.545 ' HA ' HG11 ' B' ' 3' ' ' VAL . 47.4 mtp180 -62.21 -37.94 87.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 1.57 110.991 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.65 -45.28 94.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.665 0.269 . . . . 1.87 110.421 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.53 -42.79 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.29 110.537 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 321' ' ' LEU . 41.6 t -71.15 -9.92 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.279 0.562 . . . . 0.24 111.043 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -90.21 -9.26 48.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.95 0.405 . . . . 0.44 110.76 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.43 159.48 15.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 1.16 110.618 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.23 116.49 29.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.331 -0.395 . . . . 0.89 110.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 166.05 169.82 30.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.82 -0.705 . . . . 0.45 111.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.05 118.96 5.88 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.603 2.202 . . . . 0.58 111.664 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.22 119.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.954 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 m -97.59 112.17 24.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.797 -0.638 . . . . 1.09 110.022 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 251' ' ' THR . 96.6 mt -101.3 121.47 41.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.48 111.819 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 99.4 m -106.26 100.04 9.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.5 108.618 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.3 m -101.95 156.56 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.323 0.583 . . . . 0.33 112.335 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.4 113.29 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.38 109.459 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.5 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.324 -0.846 . . . . 0.7 109.969 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.685 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 30.1 m95 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 110.672 -0.121 . . . . 0.4 110.672 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.594 -0.717 . . . . 0.27 109.697 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.948 -0.39 . . . . 1.26 109.948 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.71 124.44 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.65 111.335 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 41.3 mt -120.88 133.22 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.19 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 m -107.36 109.8 21.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.091 -0.504 . . . . 0.59 109.924 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.19 152.61 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.862 0.363 . . . . 0.5 111.101 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 8.8 t -117.91 131.08 56.56 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.94 -0.763 . . . . 0.79 108.94 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.452 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.9 mt -106.77 140.53 39.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 0.46 111.872 -178.346 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.43 119.89 25.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.65 110.077 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 83.4 mmm -101.0 17.74 21.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.963 0.411 . . . . 0.63 111.33 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -88.35 -50.13 6.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.679 -0.489 . . . . 1.27 109.679 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -93.58 11.77 27.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.441 0.639 . . . . 1.06 109.922 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -133.28 159.0 41.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.76 108.964 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -128.66 0.63 5.49 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.575 -0.45 . . . . 1.09 111.615 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.84 165.5 25.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.603 0.24 . . . . 0.62 110.593 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.422 HD13 HD11 ' A' ' 264' ' ' ILE . 8.9 mt -75.36 -54.77 6.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.096 -0.502 . . . . 0.34 109.757 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.1 44.1 5.46 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.894 -0.594 . . . . 0.14 112.269 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 262' ' ' LEU . 3.9 pt -143.29 150.4 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.536 . . . . 0.18 111.947 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.0 OUTLIER -100.21 132.89 45.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.011 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.742 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.9 mm -98.99 117.7 44.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.965 0.412 . . . . 0.28 110.469 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.94 106.64 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.456 -0.338 . . . . 0.31 110.536 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.12 118.15 4.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.37 111.732 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.94 98.86 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 1.87 110.431 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.4 m -96.04 86.03 4.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 1.17 110.947 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.01 -176.14 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.857 -0.611 . . . . 2.75 110.133 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -65.8 -21.41 66.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 2.08 110.232 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -81.49 -8.83 59.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 2.63 110.325 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 90.0 -81.23 1.42 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.778 -0.725 . . . . 0.97 111.842 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.04 155.19 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.965 0.412 . . . . 1.75 110.419 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -162.54 -34.46 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.52 111.956 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 130.67 156.9 8.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.726 -0.75 . . . . 0.3 111.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.5 pt -107.72 117.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.154 0.502 . . . . 0.27 110.308 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -108.08 151.11 26.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.777 -0.647 . . . . 0.72 111.152 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.83 117.63 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.222 -0.444 . . . . 0.24 110.045 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 281' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -72.63 -64.27 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.166 -0.54 . . . . 0.42 112.146 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.9 m -149.56 161.37 42.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.843 -0.429 . . . . 0.75 109.843 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 57.2 mt -112.49 128.77 68.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.011 0.434 . . . . 0.53 111.166 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.9 mmt -87.31 119.15 27.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.688 -0.687 . . . . 0.74 110.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -62.56 117.61 6.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 1.01 110.142 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 126.14 -18.69 6.53 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.131 -0.788 . . . . 0.36 111.131 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.39 175.0 53.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.972 -0.632 . . . . 0.26 111.995 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -64.2 -37.23 86.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.799 0.333 . . . . 0.25 111.341 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.94 -37.08 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.368 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.3 66.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.083 -0.508 . . . . 0.37 111.88 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.28 -14.66 40.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.41 111.197 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.04 -74.57 0.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.441 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.86 -9.89 37.46 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.483 -0.865 . . . . 0.39 114.42 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -88.34 -35.21 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.044 0.922 . . . . 0.68 110.348 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 29.8 mt -81.81 138.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.4 pt-20 -144.6 162.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.607 -0.27 . . . . 0.69 110.755 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 297' ' ' PRO . . . . . 0.525 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 52.2 Cg_exo -55.76 117.47 4.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.598 2.199 . . . . 0.41 111.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.56 -24.9 6.05 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.209 -0.757 . . . . 0.29 111.209 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.66 135.44 55.91 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.712 -0.477 . . . . 0.34 109.712 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 46.3 ttp -97.4 130.86 44.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.728 0.299 . . . . 1.26 110.815 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.8 mt -80.51 125.44 29.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.48 110.276 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 336' ' ' ALA . 40.2 mt -105.41 -71.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.19 0.519 . . . . 0.53 110.442 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 49.1 tt0 -117.07 133.68 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.773 -0.649 . . . . 0.73 110.963 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.07 104.16 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.023 -0.535 . . . . 0.29 110.141 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.45 69.11 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 1.71 111.662 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 74.39 -44.68 0.56 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 1.11 114.103 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.0 m -76.87 127.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.606 0.717 . . . . 0.71 111.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -97.4 130.64 44.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.249 -0.887 . . . . 0.74 110.299 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -100.81 2.35 41.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.794 0.294 . . . . 0.33 111.794 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.08 -27.71 63.9 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.17 0.433 . . . . 1.21 112.17 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -109.22 20.3 18.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.7 0.259 . . . . 1.32 111.7 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.0 mtp -118.41 166.54 12.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.51 111.049 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 10.7 p -75.48 162.63 28.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.97 110.355 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 318' ' ' VAL . 52.5 m-20 -60.97 -43.49 98.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.48 110.697 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.53 -56.71 13.87 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.957 -0.565 . . . . 1.4 111.215 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 8.8 m-20 -58.78 -36.25 74.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.88 112.346 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.3 -47.73 80.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.2 111.374 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -73.63 -31.52 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.458 -0.337 . . . . 0.21 111.095 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 88.5 mtt180 -56.9 -46.92 81.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.86 0.362 . . . . 0.83 110.145 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.29 -38.2 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.17 110.114 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 37.4 tp -58.32 -51.36 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.38 110.763 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.517 ' HA ' HG11 ' B' ' 3' ' ' VAL . 52.2 mtp180 -61.59 -31.94 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.706 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.78 -51.29 50.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.465 . . . . 1.87 109.743 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.42 -42.76 88.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.986 -0.552 . . . . 0.29 111.344 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 61.6 t -69.12 -13.89 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.072 0.463 . . . . 0.24 111.256 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 75.2 m -87.45 -6.61 58.34 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.148 -0.345 . . . . 0.44 110.538 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.41 139.55 31.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.215 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.62 91.34 4.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.115 0.484 . . . . 0.89 111.693 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.27 172.52 44.89 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.829 -0.7 . . . . 0.45 111.694 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.37 143.94 44.51 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.498 2.132 . . . . 0.58 111.893 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 42.3 mt -122.16 125.59 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.915 0.388 . . . . 0.37 111.496 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m -107.07 120.99 43.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.119 -0.697 . . . . 1.09 109.119 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.6 mt -106.39 129.2 54.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.336 0.588 . . . . 0.48 111.903 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.09 97.3 6.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.491 -0.929 . . . . 0.5 108.491 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.99 152.34 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.398 0.618 . . . . 0.33 112.418 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.856 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.15 106.79 15.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.924 . . . . 0.38 109.404 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.312 -0.852 . . . . 0.7 110.103 -179.803 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.742 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 21.5 m95 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 110.15 -0.315 . . . . 0.4 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.489 -0.767 . . . . 0.27 110.464 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.713 0.292 . . . . 1.26 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.2 mt -91.34 111.34 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.496 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.29 131.94 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.007 -0.542 . . . . 0.55 110.053 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 251' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 5.0 m -121.35 105.46 10.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.036 0.446 . . . . 0.59 110.492 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.54 157.89 6.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.105 -0.498 . . . . 0.5 111.051 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.0 t -109.7 122.55 47.73 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.525 -0.546 . . . . 0.79 109.525 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.497 HD13 HD22 ' A' ' 262' ' ' LEU . 53.1 mt -94.48 120.69 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.18 -0.464 . . . . 0.46 111.158 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.51 115.39 18.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.315 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 85.2 mmm -98.12 19.12 14.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.63 111.039 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -88.66 -52.18 5.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 1.27 109.784 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -92.02 2.03 56.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 1.06 110.001 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -127.71 148.41 50.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.968 -0.56 . . . . 0.76 110.333 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.91 -8.19 14.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.367 -0.379 . . . . 1.09 111.504 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.74 169.51 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.755 0.312 . . . . 0.62 111.194 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.497 HD22 HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER -76.79 -51.63 11.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.365 -0.605 . . . . 0.34 109.365 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.21 39.28 6.45 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.58 -0.736 . . . . 0.14 112.531 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.7 pt -142.31 149.75 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.309 0.575 . . . . 0.18 111.507 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.456 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 23.3 p -105.26 129.29 53.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.32 -0.855 . . . . 1.0 108.892 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.703 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 11.0 mm -89.43 127.01 42.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.786 0.327 . . . . 0.28 110.524 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 79.3 t -115.57 109.82 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.396 . . . . 0.31 110.129 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.14 145.71 18.69 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.757 -0.735 . . . . 0.37 111.933 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -73.6 114.86 12.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.895 0.379 . . . . 1.87 110.828 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 90.75 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 1.17 110.588 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.94 -158.4 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 2.75 109.674 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.55 -33.91 76.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.293 0.568 . . . . 2.08 109.82 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -112.08 -52.48 2.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.309 -0.86 . . . . 2.63 110.127 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 109.65 52.95 0.6 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.821 -0.704 . . . . 0.97 112.03 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.31 27.75 3.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.174 0.511 . . . . 1.75 110.769 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.93 82.41 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.827 -0.701 . . . . 0.52 112.343 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.64 166.65 16.22 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.066 -0.588 . . . . 0.3 112.277 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.7 pt -110.78 132.88 58.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 0.27 110.552 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 163.79 16.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.534 . . . . 0.72 110.785 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.8 mm -84.04 119.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.24 109.786 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -83.69 -66.28 1.51 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.867 -0.682 . . . . 0.42 112.835 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.3 p -137.93 153.38 49.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.729 0.3 . . . . 0.75 110.959 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 70.8 mt -112.78 133.58 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.53 109.815 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.8 mmt -98.01 127.08 43.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.74 110.848 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.17 117.75 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 1.01 110.459 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.86 -16.6 8.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.821 -0.704 . . . . 0.36 111.946 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.22 168.4 53.12 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.837 -0.696 . . . . 0.26 112.021 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.72 76.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.25 111.301 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.4 -37.43 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.967 -0.56 . . . . 0.26 111.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.28 62.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.37 111.614 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -81.3 -27.88 34.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.342 -0.39 . . . . 0.41 110.939 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.29 -71.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.36 -0.382 . . . . 0.55 110.054 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.08 27.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.083 -1.056 . . . . 0.39 114.168 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -76.26 -23.93 54.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.475 0.637 . . . . 0.68 111.002 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 37.0 mt -88.52 130.06 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.427 -0.583 . . . . 0.37 109.427 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.06 162.64 47.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.725 -0.216 . . . . 0.69 110.553 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 129.75 36.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.322 2.015 . . . . 0.41 111.202 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.55 -17.5 28.23 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.533 -0.841 . . . . 0.29 111.83 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.55 141.58 51.86 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.702 -0.481 . . . . 0.34 109.702 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 41.0 ttp -98.97 132.62 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.451 -0.341 . . . . 1.26 111.093 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 335' ' ' VAL . 94.4 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.48 110.058 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.1 -60.72 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.537 -0.302 . . . . 0.53 111.281 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 50.3 tt0 -126.91 135.33 50.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.386 -0.37 . . . . 0.73 111.076 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 321' ' ' LEU . 43.0 t -125.7 92.26 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.376 -0.374 . . . . 0.29 110.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.38 79.31 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.835 -0.62 . . . . 1.71 111.312 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.67 -57.43 0.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.978 -1.01 . . . . 1.11 113.416 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.17 130.76 28.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.412 0.625 . . . . 0.71 111.641 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -108.02 135.2 49.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.53 -0.759 . . . . 0.74 111.137 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -113.85 18.7 17.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.33 111.187 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.16 -36.56 75.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.584 -0.28 . . . . 1.21 111.662 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.98 49.28 1.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.26 0.552 . . . . 1.32 110.523 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.81 152.95 48.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.51 110.435 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 155.56 40.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 0.97 110.522 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -49.19 -50.82 36.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.008 0.433 . . . . 0.48 111.306 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.62 -53.14 61.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.483 -0.781 . . . . 1.4 111.206 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.8 m-20 -56.3 -40.57 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.882 -0.599 . . . . 0.88 111.714 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.83 81.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.141 -0.481 . . . . 0.2 111.392 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.9 t -78.04 -29.19 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.9 -0.32 . . . . 0.21 111.176 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 81.2 mtt180 -55.17 -49.99 70.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.83 110.286 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.11 -36.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.093 -0.503 . . . . 0.17 110.655 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 304' ' ' VAL . 19.6 tp -54.68 -48.29 72.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.995 -0.548 . . . . 0.38 111.801 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.52 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.5 mtp180 -64.48 -30.24 71.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.238 -0.437 . . . . 1.57 111.713 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 323' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 9.3 mm-40 -68.76 -39.38 80.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.087 0.47 . . . . 1.87 109.916 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 62.0 mt -71.13 -43.42 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.837 -0.619 . . . . 0.29 111.085 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.471 HG11 ' HB ' ' B' ' 3' ' ' VAL . 63.7 t -66.65 -19.04 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.169 0.509 . . . . 0.24 111.432 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.4 m -87.64 10.98 16.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.99 0.424 . . . . 0.44 110.853 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.5 tp60 -111.64 152.41 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.377 . . . . 1.16 110.28 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.89 101.06 13.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.89 111.635 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.98 39.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.954 -0.641 . . . . 0.45 111.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.5 124.93 11.23 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.327 2.018 . . . . 0.58 112.152 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 78.8 mt -104.74 118.65 52.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.37 110.78 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.19 113.18 25.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.998 -0.546 . . . . 1.09 110.641 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 251' ' ' THR . 11.5 mt -96.4 119.39 34.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.159 -0.473 . . . . 0.48 111.194 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 93.68 5.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.5 108.635 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 301' ' ' LEU . 21.7 m -97.66 152.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.33 112.278 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.03 95.92 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.399 -0.819 . . . . 0.38 109.078 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.285 -0.864 . . . . 0.7 110.256 -179.325 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.703 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 25.0 m95 . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 110.089 -0.337 . . . . 0.4 110.089 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.559 -0.734 . . . . 0.27 110.436 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.831 0.348 . . . . 1.26 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 70.7 mt -93.1 119.38 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.65 109.868 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.47 137.71 51.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.202 -0.453 . . . . 0.55 111.264 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.23 122.97 48.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.855 -0.612 . . . . 0.59 110.115 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 295' ' ' ILE . 33.2 m -114.39 143.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.776 0.322 . . . . 0.5 111.019 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.43 107.4 18.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.79 110.014 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.16 145.18 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 0.46 111.658 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -99.73 117.95 35.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.794 . . . . 0.65 110.078 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.7 mmm -98.75 26.25 5.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.258 -0.428 . . . . 0.63 111.396 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.99 -53.69 3.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 1.27 109.723 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -83.12 -17.4 43.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.554 -0.748 . . . . 1.06 109.822 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 92.1 m-70 -112.28 145.95 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.832 -0.622 . . . . 0.76 109.959 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -111.12 3.23 18.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.683 -0.235 . . . . 1.09 111.616 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -160.03 165.1 32.55 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.746 0.307 . . . . 0.62 110.734 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.34 110.0 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.96 4.26 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.791 -0.641 . . . . 0.14 112.843 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.41 151.65 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.51 0.671 . . . . 0.18 112.073 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.74 119.56 38.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.217 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.711 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 4.7 mm -88.34 107.9 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.892 0.377 . . . . 0.28 110.717 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.86 114.2 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.19 -0.459 . . . . 0.31 110.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.66 113.36 4.46 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.782 -0.723 . . . . 0.37 111.92 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -68.54 101.83 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.193 0.521 . . . . 1.87 110.626 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.59 96.32 4.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.667 -0.697 . . . . 1.17 110.449 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -111.91 -94.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.44 -0.345 . . . . 2.75 111.311 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.53 -37.66 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 2.08 111.468 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -44.45 21.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.202 -0.454 . . . . 2.63 111.15 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 101.44 -47.61 1.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.583 -0.818 . . . . 0.97 111.293 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.9 110.39 21.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.397 0.618 . . . . 1.75 109.908 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.32 -33.35 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.879 -0.677 . . . . 0.52 112.428 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 117.75 159.19 11.25 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.722 -0.751 . . . . 0.3 111.637 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.7 pt -103.59 123.9 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.27 110.565 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 157.05 22.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.704 . . . . 0.72 110.9 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.7 mm -78.28 114.13 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.974 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.91 -57.72 3.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.881 -0.676 . . . . 0.42 112.416 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.9 153.81 35.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.243 -0.281 . . . . 0.75 110.243 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.3 mt -108.88 130.18 62.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.53 110.157 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 39.3 mmt -93.85 122.72 36.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.362 -0.381 . . . . 0.74 110.93 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -61.84 120.21 10.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 1.01 109.764 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.64 -16.19 9.02 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.33 -0.708 . . . . 0.36 111.33 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.2 169.13 45.48 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.443 -0.663 . . . . 0.26 111.443 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.22 74.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.555 0.216 . . . . 0.25 111.546 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 289' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 295' ' ' ILE . 84.1 t -67.87 -37.48 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.26 110.836 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.24 -13.28 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.37 111.249 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.16 -13.72 40.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.507 -0.315 . . . . 0.41 111.048 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.15 -70.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.55 110.534 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.44 42.14 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.386 -0.912 . . . . 0.39 114.276 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.16 -22.77 41.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.864 0.832 . . . . 0.68 111.387 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 295' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 252' ' ' VAL . 54.7 mt -89.97 137.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.226 -0.657 . . . . 0.37 109.226 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -140.86 163.34 43.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.752 -0.204 . . . . 0.69 110.864 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.32 121.58 10.3 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.216 1.944 . . . . 0.41 111.368 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.43 8.5 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.849 -0.691 . . . . 0.29 112.173 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 84.1 m-20 -61.4 139.65 58.16 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.34 110.498 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 36.3 ttp -101.12 130.45 47.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.524 -0.307 . . . . 1.26 110.429 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 301' ' ' LEU . . . . . 0.497 HD23 HG12 ' A' ' 335' ' ' VAL . 31.6 mt -84.73 127.48 34.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.389 . . . . 0.48 110.154 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 336' ' ' ALA . 62.4 mt -107.19 -73.55 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.236 0.541 . . . . 0.53 110.391 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -108.07 137.65 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.577 -0.738 . . . . 0.73 110.512 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 321' ' ' LEU . 93.0 t -132.45 98.05 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.289 -0.634 . . . . 0.29 109.289 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.9 m120 59.97 71.94 0.55 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.666 -0.697 . . . . 1.71 111.464 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.6 OUTLIER 76.69 -51.52 0.58 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.957 1.095 . . . . 1.11 113.957 178.06 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.93 131.66 34.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.571 0.582 . . . . 0.71 112.571 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -101.48 131.39 47.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.44 -0.8 . . . . 0.74 109.235 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.35 5.06 50.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.554 0.576 . . . . 0.33 112.554 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -64.44 -22.16 66.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 1.21 111.699 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -107.44 22.5 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.354 -0.384 . . . . 1.32 111.085 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.21 168.89 16.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 0.51 111.07 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.38 156.14 26.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.863 -0.608 . . . . 0.97 110.404 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 80.7 m-20 -53.22 -50.19 65.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.819 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 10.9 t70 -60.77 -52.77 63.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 1.4 110.901 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.5 -35.56 70.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.933 -0.576 . . . . 0.88 111.123 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.2 111.417 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -70.78 -26.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.845 -0.342 . . . . 0.21 111.285 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 95.5 mtt180 -56.14 -52.36 64.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.631 -0.507 . . . . 0.83 109.631 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.33 -37.28 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.412 -0.813 . . . . 0.17 110.34 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 304' ' ' VAL . 13.5 tp -54.23 -52.82 60.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.725 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HA ' HG11 ' B' ' 3' ' ' VAL . 33.7 mtp180 -64.03 -33.74 76.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.011 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.83 -41.23 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 1.87 110.412 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.8 mt -69.14 -43.04 81.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.937 -0.574 . . . . 0.29 110.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 321' ' ' LEU . 87.3 t -67.03 -21.98 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.068 0.461 . . . . 0.24 111.165 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -83.97 1.94 41.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.768 0.318 . . . . 0.44 110.954 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.7 141.01 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.16 110.269 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 115.13 21.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.89 111.659 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 169.18 -170.92 42.83 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.993 -0.622 . . . . 0.45 112.037 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.24 117.18 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.202 2.602 . . . . 0.58 111.806 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 64.8 mt -98.3 118.12 44.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.95 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.61 110.13 21.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 1.09 110.295 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.05 124.35 45.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.48 111.379 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.67 99.36 9.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.699 -0.852 . . . . 0.5 108.699 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 335' ' ' VAL . . . . . 0.497 HG12 HD23 ' A' ' 301' ' ' LEU . 28.6 m -98.88 148.23 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.286 0.565 . . . . 0.33 112.232 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -105.12 102.79 12.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.33 -0.85 . . . . 0.38 109.966 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 28.2 mtpp . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.349 -0.834 . . . . 0.7 109.856 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.711 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.532 0.206 . . . . 0.4 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.853 0 N-CA-C 109.369 -0.604 . . . . 0.27 109.369 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 43.2 t30 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.808 0.337 . . . . 1.26 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 91.9 mt -92.12 123.21 44.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.65 110.512 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.26 122.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.865 0.364 . . . . 0.55 111.074 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.35 120.35 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.59 110.104 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 332' ' ' SER . 24.8 m -125.49 144.98 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 0.5 111.785 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.0 t -110.99 120.94 44.05 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.582 -0.896 . . . . 0.79 108.582 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.43 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.7 mt -102.81 135.55 44.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.083 0.468 . . . . 0.46 111.766 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.01 120.17 13.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.371 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 87.8 mmm -102.54 17.46 23.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.165 0.507 . . . . 0.63 110.895 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -88.65 -53.19 4.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.121 0.486 . . . . 1.27 109.801 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -80.48 -31.04 37.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.374 -0.83 . . . . 1.06 110.648 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -92.6 157.71 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.677 -0.49 . . . . 0.76 109.677 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -119.18 -7.76 10.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.915 0.388 . . . . 1.09 110.787 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -156.52 173.26 17.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.036 -0.529 . . . . 0.62 110.279 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 9.0 mt -80.57 -52.93 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.34 110.029 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.55 46.27 4.37 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.975 -0.631 . . . . 0.14 112.809 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 262' ' ' LEU . 4.7 pt -145.86 149.58 16.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.113 0.483 . . . . 0.18 111.388 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 265' ' ' SER . . . . . 0.495 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 5.5 p -99.18 124.62 44.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.159 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.704 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 5.3 mm -89.23 111.02 22.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.04 0.448 . . . . 0.28 110.87 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.7 t -105.94 110.43 31.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.103 -0.498 . . . . 0.31 110.986 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.72 119.36 6.09 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.825 -0.702 . . . . 0.37 111.361 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.91 94.64 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 1.87 110.5 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.9 m -97.79 94.06 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.571 -0.741 . . . . 1.17 110.206 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -97.5 -160.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.836 -0.62 . . . . 2.75 109.359 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.53 -21.73 66.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.106 0.479 . . . . 2.08 110.194 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 273' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -80.18 -17.63 51.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.545 -0.752 . . . . 2.63 110.165 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 89.45 -80.5 1.51 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.918 -0.658 . . . . 0.97 111.694 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.11 146.6 33.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.01 -35.9 0.02 OUTLIER Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.771 -0.728 . . . . 0.52 111.6 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 132.58 154.23 7.52 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.838 -0.696 . . . . 0.3 111.756 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.12 119.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.015 0.436 . . . . 0.27 110.147 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.61 159.54 17.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.783 -0.644 . . . . 0.72 111.18 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.99 112.61 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.564 -0.743 . . . . 0.24 109.397 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.18 -55.38 6.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.397 -0.906 . . . . 0.42 112.267 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.9 p -153.29 156.68 38.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.188 -0.301 . . . . 0.75 110.188 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 35.9 mt -106.71 135.73 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.201 -0.454 . . . . 0.53 110.131 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -97.55 134.65 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.224 -0.444 . . . . 0.74 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -70.25 135.84 49.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 1.01 110.006 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.76 -10.26 64.37 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.824 -0.703 . . . . 0.36 111.907 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.03 176.12 53.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.96 -0.638 . . . . 0.26 112.115 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -68.35 -37.98 81.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.73 0.3 . . . . 0.25 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.3 -33.42 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.048 0.451 . . . . 0.26 111.283 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.13 -21.97 66.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.092 -0.504 . . . . 0.37 111.629 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -84.88 -15.01 46.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.359 -0.382 . . . . 0.41 111.419 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.34 -74.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.55 110.968 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.95 -15.94 47.33 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.604 -0.808 . . . . 0.39 114.085 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -80.29 -29.96 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.651 0.725 . . . . 0.68 110.945 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.8 mt -84.55 137.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.751 -0.462 . . . . 0.37 109.751 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -136.7 164.36 43.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.657 -0.247 . . . . 0.69 110.924 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.7 111.77 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.261 1.974 . . . . 0.41 110.615 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.81 -19.02 5.04 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.485 -0.646 . . . . 0.29 111.485 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 299' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 95.4 m-20 -69.06 147.53 51.38 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.044 -0.354 . . . . 0.34 110.044 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 26.7 ttt -103.57 136.97 42.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.695 0.283 . . . . 1.26 110.811 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 19.5 mt -88.59 123.13 32.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.48 109.828 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 302' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 336' ' ' ALA . 80.5 mt -102.3 -77.66 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.168 0.509 . . . . 0.53 110.586 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -113.0 134.29 54.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.73 111.3 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.32 94.33 2.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.144 -0.48 . . . . 0.29 109.889 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 305' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 60.63 75.98 0.39 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.705 -0.68 . . . . 1.71 111.399 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 306' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 56.5 m-20 76.97 -61.44 0.43 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.903 0.881 . . . . 1.11 112.894 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m -63.36 125.89 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.627 0.727 . . . . 0.71 111.986 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.23 132.95 51.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.249 -0.887 . . . . 0.74 109.925 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -104.35 11.09 35.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.568 -0.287 . . . . 0.33 111.434 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.6 -38.54 66.89 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.952 0.406 . . . . 1.21 111.257 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -123.96 59.17 1.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 1.32 110.867 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 87.2 mtp -140.05 163.84 31.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.51 110.051 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.1 m -69.85 147.29 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.821 -0.437 . . . . 0.97 109.821 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -52.59 -47.07 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.744 0.306 . . . . 0.48 111.096 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -50.3 71.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.4 110.91 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 1.7 m-20 -61.1 -34.74 75.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.88 111.834 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.98 -49.09 78.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.117 -0.492 . . . . 0.2 111.1 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.76 -28.0 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.529 -0.305 . . . . 0.21 110.905 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 67.5 mtt180 -54.71 -52.04 63.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.83 110.571 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 15.4 t -70.42 -39.58 76.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.17 110.618 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 21.7 tp -54.26 -49.24 70.01 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.163 -0.471 . . . . 0.38 111.431 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.593 ' HA ' HG11 ' B' ' 3' ' ' VAL . 14.7 mtp-105 -60.9 -37.49 82.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 1.57 111.654 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.33 -38.02 88.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 1.87 110.779 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.36 -41.64 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.091 -0.504 . . . . 0.29 110.692 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 40.5 t -69.83 -19.42 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.044 0.45 . . . . 0.24 111.075 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 22.6 m -91.08 2.01 56.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.053 0.454 . . . . 0.44 110.463 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -106.92 137.78 44.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.164 -0.471 . . . . 1.16 110.572 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.81 99.37 3.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 0.89 111.814 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.59 160.3 24.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.054 -0.593 . . . . 0.45 111.757 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.82 130.32 32.56 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.824 2.349 . . . . 0.58 112.229 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 76.3 mt -112.18 121.13 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.37 111.131 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 332' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 9.5 m -105.99 121.33 43.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.931 -0.577 . . . . 1.09 109.893 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 36.5 mt -104.08 126.71 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.297 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -106.18 98.65 8.31 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.336 -0.986 . . . . 0.5 108.336 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.12 151.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.414 0.626 . . . . 0.33 112.447 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 336' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.47 112.01 23.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.174 -0.921 . . . . 0.38 109.973 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 337' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 25.6 mtpp . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.393 -0.813 . . . . 0.7 109.803 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.704 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 2' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 16.8 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.58 -0.156 . . . . 0.4 110.58 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.752 -0.642 . . . . 0.27 110.077 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.139 0.495 . . . . 1.26 109.976 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.7 mt -95.58 127.76 47.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.202 -0.453 . . . . 0.65 110.926 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.23 129.38 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.439 -0.346 . . . . 0.55 110.681 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 6.9 m -100.08 110.17 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.149 -0.686 . . . . 0.59 109.149 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.85 154.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.121 0.486 . . . . 0.5 111.385 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.3 t -122.44 126.24 47.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.998 -0.741 . . . . 0.79 108.998 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 66.7 mt -114.21 149.16 36.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.46 111.492 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.8 120.09 34.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.589 -0.732 . . . . 0.65 110.116 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 99.8 mmm -101.1 16.99 23.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.11 0.481 . . . . 0.63 111.223 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.217 -0.66 . . . . 1.27 109.217 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -91.65 -16.32 27.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.478 -0.783 . . . . 1.06 109.9 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -114.39 145.37 41.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.9 -0.591 . . . . 0.76 109.933 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -107.9 -7.94 16.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.742 0.306 . . . . 1.09 111.673 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -151.7 168.91 23.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.492 -0.322 . . . . 0.62 110.932 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 262' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.8 mt -77.94 -55.17 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.34 109.637 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 91.24 43.79 4.56 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.726 -0.67 . . . . 0.14 112.331 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 262' ' ' LEU . 8.1 pt -139.74 151.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.397 0.617 . . . . 0.18 111.736 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 t -103.1 128.51 49.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.795 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ILE . . . . . 0.69 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.4 mm -97.54 113.87 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.989 0.423 . . . . 0.28 110.744 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.41 114.11 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.101 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.75 108.86 3.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.545 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -87.25 112.33 21.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.749 0.309 . . . . 1.87 110.328 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 41.9 m -117.66 108.69 15.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 1.17 111.018 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -68.68 -55.5 11.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 2.75 110.473 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.09 -49.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.547 -0.297 . . . . 2.08 111.573 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 23.87 8.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 2.63 111.467 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.66 10.9 32.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.342 -0.932 . . . . 0.97 111.483 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.33 116.66 17.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.241 -0.48 . . . . 1.75 110.042 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 164.62 -65.54 0.23 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.616 -0.802 . . . . 0.52 111.964 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 123.0 175.39 14.55 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.766 -0.73 . . . . 0.3 112.127 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -106.08 118.09 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.374 0.607 . . . . 0.27 110.629 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.0 152.73 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.743 -0.662 . . . . 0.72 110.94 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.13 113.36 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.128 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.33 -60.05 3.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.877 -0.677 . . . . 0.42 112.33 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.07 160.96 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.54 0.209 . . . . 0.75 110.524 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.92 131.98 64.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.778 -0.453 . . . . 0.53 109.778 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.2 mmt -97.99 128.29 44.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.778 0.323 . . . . 0.74 110.759 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -66.45 132.89 49.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.01 110.308 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.86 -12.7 32.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.93 -0.653 . . . . 0.36 111.552 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -87.36 171.82 42.44 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.024 -0.608 . . . . 0.26 111.826 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 288' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.12 -36.65 83.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.25 111.518 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.76 -35.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.26 111.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.79 -14.09 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.37 111.91 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.71 -23.56 25.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 0.41 110.728 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 292' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 13.0 t70 -77.98 -68.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.55 110.215 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.46 -20.38 46.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.431 -0.89 . . . . 0.39 113.991 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 294' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 72.7 mtm180 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.716 0.758 . . . . 0.68 110.927 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.1 mt -75.62 136.02 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.593 -0.521 . . . . 0.37 109.593 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.42 161.16 64.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.539 -0.3 . . . . 0.69 110.443 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.74 109.41 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.2 1.933 . . . . 0.41 111.041 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 131.86 -15.79 5.1 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.153 -0.546 . . . . 0.29 111.737 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -70.61 149.59 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.241 -0.281 . . . . 0.34 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 27.0 ttp -107.15 135.94 47.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.556 -0.293 . . . . 1.26 110.613 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 mt -89.3 119.22 29.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.135 -0.484 . . . . 0.48 109.829 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 67.2 mt -100.99 -64.33 1.06 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.084 0.469 . . . . 0.53 110.705 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 303' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 307' ' ' VAL . 36.5 tt0 -120.6 133.23 55.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.73 110.815 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 304' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.0 t -129.14 104.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.258 -0.428 . . . . 0.29 110.536 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 65.9 t30 58.07 70.32 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 1.71 111.483 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.89 -44.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.994 1.109 . . . . 1.11 113.994 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 307' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 304' ' ' VAL . 32.2 m -74.15 139.22 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.354 0.597 . . . . 0.71 111.36 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -111.66 135.64 51.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.69 -0.686 . . . . 0.74 110.379 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -109.26 11.84 25.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.286 . . . . 0.33 111.661 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.98 -29.01 70.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.845 0.313 . . . . 1.21 111.845 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -117.98 36.31 4.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.792 0.33 . . . . 1.32 111.07 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.3 mtp -129.68 153.07 48.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.489 -0.323 . . . . 0.51 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 149.9 49.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.132 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -51.59 -47.67 63.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.443 -0.344 . . . . 0.48 111.602 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 315' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.1 OUTLIER -57.8 -50.03 74.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 1.4 111.009 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 316' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 29.8 m-20 -63.75 -37.44 87.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.88 111.815 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.28 -51.09 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.2 111.634 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 318' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -72.92 -30.46 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.688 -0.405 . . . . 0.21 110.992 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 319' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 80.5 mtt180 -56.11 -46.52 79.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.884 0.373 . . . . 0.83 110.499 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.47 -40.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.17 110.504 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 31.5 tp -54.36 -47.77 72.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.12 -0.491 . . . . 0.38 111.417 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 322' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 25.6 mtp-105 -64.96 -29.58 70.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.955 -0.566 . . . . 1.57 111.871 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -69.07 -40.42 78.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.153 0.501 . . . . 1.87 110.003 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.66 -44.55 85.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.685 . . . . 0.29 110.718 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 325' ' ' VAL . . . . . 0.456 HG11 ' HB ' ' B' ' 3' ' ' VAL . 40.8 t -69.2 -18.65 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.483 . . . . 0.24 111.594 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -91.75 3.55 54.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.44 110.875 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 148.77 33.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 1.16 110.24 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.0 139.98 36.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.497 -0.32 . . . . 0.89 110.49 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 143.06 -173.62 24.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.662 -0.78 . . . . 0.45 112.308 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.5 117.18 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.424 2.749 . . . . 0.58 112.21 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.6 mt -96.88 119.23 44.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.37 111.258 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.59 115.2 28.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 1.09 110.169 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 333' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 304' ' ' VAL . 49.9 mt -104.45 125.36 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.87 0.367 . . . . 0.48 111.36 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 103.05 11.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.563 . . . . 0.5 109.812 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.7 m -103.96 158.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.191 -0.458 . . . . 0.33 111.691 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -118.34 108.72 15.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.488 -0.778 . . . . 0.38 110.195 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.263 -0.875 . . . . 0.7 110.223 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 1' ' ' PHQ . . . . . 0.69 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.377 0.132 . . . . 0.4 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 3' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.727 -0.654 . . . . 0.27 109.997 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.258 -0.275 . . . . 1.26 110.258 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.7 mt -102.64 122.3 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.293 -0.262 . . . . 0.65 110.293 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 27.0 mm -120.13 124.21 72.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 0.55 110.832 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -110.36 111.86 23.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.769 -0.456 . . . . 0.59 109.769 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.87 156.21 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.5 111.434 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -124.85 113.91 18.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.218 -1.03 . . . . 0.79 108.218 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 76.5 mt -97.82 137.97 35.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.622 0.601 . . . . 0.46 112.622 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.16 110.73 14.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.088 -0.96 . . . . 0.65 109.962 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 71.6 mmm -94.87 21.04 8.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.268 -0.424 . . . . 0.63 111.338 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -93.14 -51.06 5.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.21 -0.663 . . . . 1.27 109.21 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -87.24 1.88 51.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.627 -0.715 . . . . 1.06 110.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -128.38 154.96 45.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.878 -0.601 . . . . 0.76 109.464 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -124.89 7.82 8.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 1.09 111.023 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.7 164.7 23.77 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.286 -0.416 . . . . 0.62 110.659 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.1 mt -79.52 -56.38 4.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.469 -0.567 . . . . 0.34 109.469 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.77 43.18 4.25 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.664 -0.698 . . . . 0.14 112.681 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.77 150.34 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.18 112.186 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 22.7 t -98.99 131.36 45.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.751 -1.113 . . . . 1.0 108.198 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.453 HG21 HG22 ' A' ' 318' ' ' VAL . 6.7 mm -98.09 115.79 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.967 0.413 . . . . 0.28 110.752 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 278' ' ' ILE . 62.1 t -86.84 126.07 40.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.84 88.64 0.86 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.972 -0.632 . . . . 0.37 112.337 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.326 -0.453 0 CA-C-O 120.852 0.358 . . . . 1.87 110.266 179.914 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.617 0 CA-C-O 120.953 0.196 . . . . 0.3 112.613 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 8.3 pt -103.53 123.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.177 0.513 . . . . 0.27 110.432 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.7 156.84 21.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.964 -0.562 . . . . 0.72 111.354 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.97 118.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.24 109.998 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -88.74 -112.69 1.21 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.675 -0.774 . . . . 0.42 111.973 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.62 139.31 31.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.872 0.368 . . . . 0.75 111.445 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.19 132.59 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.16 -0.681 . . . . 0.53 109.16 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 33.9 mmt -95.1 134.83 37.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.517 -0.311 . . . . 0.74 110.994 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.47 133.14 46.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.01 110.199 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.79 -17.81 44.89 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.665 -0.778 . . . . 0.36 111.647 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.6 167.11 54.76 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.019 -0.61 . . . . 0.26 112.131 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.75 -35.25 79.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.723 0.297 . . . . 0.25 111.387 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.67 -42.56 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.26 110.804 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.96 -17.64 64.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.37 111.496 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.66 -21.27 44.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.41 111.135 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.69 -82.21 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.214 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 122.02 -21.45 7.85 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.25 -0.976 . . . . 0.39 113.764 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -66.43 -31.12 71.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.466 0.633 . . . . 0.68 111.277 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 51.3 mt -89.35 132.85 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.337 -0.616 . . . . 0.37 109.337 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.81 165.12 36.23 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.69 110.42 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.51 119.68 7.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.022 1.815 . . . . 0.41 111.47 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 121.99 -21.31 7.9 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.585 -0.817 . . . . 0.29 112.273 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 91.3 m-20 -65.79 141.31 58.35 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.318 -0.253 . . . . 0.34 110.318 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.6 ttp -100.86 132.4 46.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.059 -0.256 . . . . 1.26 110.553 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 34.3 mt -82.09 123.07 28.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.561 -0.29 . . . . 0.48 110.554 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 336' ' ' ALA . 63.9 mt -102.69 -72.54 0.69 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.626 0.726 . . . . 0.53 110.137 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -116.52 134.25 55.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.103 -0.953 . . . . 0.73 110.971 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 321' ' ' LEU . 94.7 t -124.22 96.97 4.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.29 109.34 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.2 t-20 60.47 73.87 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.71 111.461 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.7 m-20 75.86 -50.03 0.61 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.734 1.013 . . . . 1.11 113.734 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.36 130.02 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.57 . . . . 0.71 112.405 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.64 123.14 46.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.74 110.269 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -95.69 6.77 48.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.33 111.598 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.46 -12.36 30.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.319 0.489 . . . . 1.21 112.319 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -126.42 26.89 6.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.218 0.532 . . . . 1.32 110.63 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.2 mtp -125.5 163.02 23.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.259 -0.428 . . . . 0.51 109.987 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 17.9 p -72.08 157.81 37.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.584 0.23 . . . . 0.97 110.646 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 70.4 m-20 -54.94 -43.49 73.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.48 111.168 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -63.84 -52.82 58.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 1.4 110.878 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.99 -39.2 77.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.897 -0.592 . . . . 0.88 111.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.36 -54.33 47.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.2 111.892 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.453 HG22 HG21 ' A' ' 266' ' ' ILE . 3.0 t -70.58 -30.89 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.002 -0.279 . . . . 0.21 111.123 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 58.8 mtt180 -55.77 -52.39 64.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.001 -0.37 . . . . 0.83 110.001 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.27 -37.48 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.17 110.453 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 304' ' ' VAL . 20.7 tp -55.99 -49.33 73.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.073 0.463 . . . . 0.38 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.8 mtp180 -62.34 -35.59 79.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.764 -0.653 . . . . 1.57 111.106 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 17.3 mm-40 -64.84 -36.32 83.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.8 0.333 . . . . 1.87 110.868 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.1 mt -73.61 -40.77 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.416 . . . . 0.29 110.502 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.3 t -70.32 -21.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.24 110.397 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.8 m -90.21 33.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -144.13 170.9 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 1.16 109.704 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.46 149.43 22.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.393 . . . . 0.89 111.503 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.14 158.64 10.17 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.117 -0.563 . . . . 0.45 112.332 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 133.71 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.871 2.381 . . . . 0.58 111.837 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.4 mt -103.5 120.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.967 0.413 . . . . 0.37 111.553 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.86 108.65 20.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.833 -0.621 . . . . 1.09 110.093 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.88 122.97 45.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.268 -0.423 . . . . 0.48 111.652 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.9 m -108.04 104.52 13.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.642 . . . . 0.5 109.265 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.4 153.65 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.33 112.136 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.754 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.53 111.17 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 0.38 110.176 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.432 -0.794 . . . . 0.7 109.347 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 17.4 m95 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 110.147 -0.316 . . . . 0.4 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.741 -0.647 . . . . 0.27 110.458 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.089 0.471 . . . . 1.26 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 83.0 mt -79.76 129.59 37.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.185 -0.461 . . . . 0.65 110.135 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.409 HD12 ' HD3' ' A' ' 337' ' ' LYS . 39.7 mt -128.77 131.83 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.55 110.789 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 m -106.2 112.5 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.585 -0.524 . . . . 0.59 109.585 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.57 150.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.902 0.382 . . . . 0.5 111.045 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -116.78 117.29 29.35 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.79 -0.819 . . . . 0.79 108.79 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 69.9 mt -106.53 152.53 23.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.167 0.508 . . . . 0.46 111.952 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -100.27 126.19 46.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.451 -0.795 . . . . 0.65 110.36 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 79.7 mmm -104.58 22.69 14.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.63 111.752 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -95.46 -52.08 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.386 -0.598 . . . . 1.27 109.386 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -79.81 -26.63 40.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 1.06 109.495 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -110.42 150.7 28.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.76 109.151 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -123.66 12.6 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.461 -0.495 . . . . 1.09 111.105 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -161.24 162.37 31.1 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.077 -0.51 . . . . 0.62 110.099 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.9 mt -77.88 -52.21 9.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.34 110.07 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.91 43.01 6.14 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.85 -0.614 . . . . 0.14 112.394 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 262' ' ' LEU . 9.1 pt -136.94 154.02 30.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.441 0.639 . . . . 0.18 112.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 21.5 t -106.49 121.43 44.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.786 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 9.0 mm -91.25 132.49 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.709 0.29 . . . . 0.28 110.844 -178.818 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.05 124.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.412 . . . . 0.31 110.032 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.12 113.63 4.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.816 -0.706 . . . . 0.37 112.102 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 . . . . . 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.87 110.557 -179.98 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.599 0 N-CA-C 111.848 -0.501 . . . . 0.3 111.848 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 7.6 pt -100.5 126.4 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.171 0.51 . . . . 0.27 111.103 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 84.9 m-85 -117.68 159.27 23.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 0.72 110.871 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.99 112.14 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.296 -0.631 . . . . 0.24 109.296 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.55 -56.68 3.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.888 -0.672 . . . . 0.42 112.88 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.17 161.41 38.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.627 -0.138 . . . . 0.75 110.627 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 31.1 mt -122.35 131.35 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.53 110.335 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.8 mmt -96.08 115.56 27.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.406 -0.361 . . . . 0.74 110.456 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -64.04 109.77 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.472 . . . . 1.01 110.015 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 142.45 -23.06 2.37 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.877 -0.889 . . . . 0.36 110.877 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.73 177.81 53.88 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.155 -0.545 . . . . 0.26 112.216 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.47 73.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.656 0.243 . . . . 0.25 111.656 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 295' ' ' ILE . 84.7 t -71.11 -41.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.26 111.358 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.7 -18.62 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.37 111.68 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.22 -14.37 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.215 -0.448 . . . . 0.41 111.143 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -88.27 -72.52 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.775 0.321 . . . . 0.55 110.523 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.35 -19.98 26.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.453 -0.879 . . . . 0.39 113.853 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -69.9 -37.49 76.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.418 0.609 . . . . 0.68 110.976 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.464 HD12 HG13 ' A' ' 289' ' ' VAL . 59.6 mt -78.83 135.14 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.743 -0.465 . . . . 0.37 109.743 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.99 161.07 61.8 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.414 . . . . 0.69 110.119 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.21 124.08 15.33 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.195 1.93 . . . . 0.41 111.178 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.14 -16.0 18.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.662 -0.78 . . . . 0.29 111.938 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 90.7 m-20 -67.43 142.79 56.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.813 -0.44 . . . . 0.34 109.813 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . 0.4 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 28.0 ttt -101.61 136.31 41.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.664 0.268 . . . . 1.26 110.766 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.3 124.99 34.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.373 . . . . 0.48 110.032 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 68.8 mt -105.47 -72.47 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.42 . . . . 0.53 110.453 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.8 135.14 54.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.935 -0.575 . . . . 0.73 110.744 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.33 106.44 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.882 -0.599 . . . . 0.29 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.5 m-20 61.4 62.93 1.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.987 -0.551 . . . . 1.71 111.455 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 29.0 m-20 75.12 -45.94 0.58 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.339 1.237 . . . . 1.11 114.339 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.1 m -71.11 130.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.199 0.523 . . . . 0.71 111.467 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -103.42 140.33 37.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.74 110.319 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.8 5.46 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.321 . . . . 0.33 111.729 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.25 -26.38 66.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.975 0.361 . . . . 1.21 111.975 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -116.74 26.39 9.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.263 0.554 . . . . 1.32 110.904 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 97.3 mtp -118.79 165.77 13.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.314 -0.403 . . . . 0.51 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 27.4 p -75.84 164.8 25.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.97 109.855 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 318' ' ' VAL . 86.7 m-20 -63.78 -36.65 84.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.249 0.547 . . . . 0.48 109.666 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 5.6 t70 -71.29 -53.77 13.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 1.4 110.992 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.24 -35.82 72.28 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.818 -0.628 . . . . 0.88 111.743 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.49 69.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.134 -0.484 . . . . 0.2 112.002 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 314' ' ' ASN . 0.9 OUTLIER -69.82 -29.02 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.926 -0.31 . . . . 0.21 111.003 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 82.8 mtt180 -55.82 -48.06 76.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.281 0.562 . . . . 0.83 110.068 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.3 -41.61 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.17 110.5 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 325' ' ' VAL . 22.6 tp -54.05 -50.2 67.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.38 111.456 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.586 ' HA ' HG11 ' B' ' 3' ' ' VAL . 63.4 mtp180 -62.41 -36.84 83.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.57 111.005 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -63.16 -44.0 96.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 1.87 110.478 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.59 -47.94 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.078 -0.51 . . . . 0.29 111.159 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 321' ' ' LEU . 24.8 t -69.06 -15.19 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.133 0.492 . . . . 0.24 111.347 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 68.8 m -86.06 -5.73 59.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.818 0.342 . . . . 0.44 110.865 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.4 148.72 24.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.236 -0.438 . . . . 1.16 110.528 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 88.21 7.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.066 -0.515 . . . . 0.89 111.356 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -166.26 173.63 41.76 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.959 -0.639 . . . . 0.45 112.187 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.03 141.05 62.45 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.685 2.257 . . . . 0.58 112.371 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 72.2 mt -119.83 123.85 71.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.172 0.51 . . . . 0.37 111.442 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.8 m -112.35 102.61 10.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.554 -0.748 . . . . 1.09 109.435 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.73 121.03 33.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.48 111.801 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.9 m -103.53 98.91 8.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.826 -0.805 . . . . 0.5 108.826 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.42 152.48 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.503 0.557 . . . . 0.33 112.503 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -109.49 108.27 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.38 110.012 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' A' ' 250' ' ' ILE . 24.8 mtpp . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.092 -0.956 . . . . 0.7 109.74 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.9 m95 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.463 0.173 . . . . 0.4 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.848 -0.596 . . . . 0.27 109.69 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.905 -0.406 . . . . 1.26 109.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.15 126.01 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.283 -0.417 . . . . 0.65 110.659 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 23.5 mt -123.46 126.37 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.55 111.484 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 103.57 15.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.27 -0.641 . . . . 0.59 109.27 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 13.4 m -102.15 160.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 0.5 111.509 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.8 t -122.86 142.52 50.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.514 -0.921 . . . . 0.79 108.514 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.564 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.7 mt -123.85 136.36 54.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.209 0.528 . . . . 0.46 112.101 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.45 111.85 14.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.393 -0.821 . . . . 0.65 109.832 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.3 mmm -96.21 17.85 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.63 110.911 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.7 -50.53 6.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.507 0.67 . . . . 1.27 109.229 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -88.95 0.05 56.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.92 -1.036 . . . . 1.06 110.186 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -130.28 133.18 46.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.76 110.276 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.61 15.39 25.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.567 -0.288 . . . . 1.09 110.783 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -166.54 166.64 16.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.24 -0.436 . . . . 0.62 110.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.5 mt -82.77 -52.54 6.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.189 -0.46 . . . . 0.34 109.988 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.74 43.11 5.54 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.891 -0.595 . . . . 0.14 112.98 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.83 150.6 20.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.656 0.741 . . . . 0.18 111.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 12.1 t -100.46 124.51 46.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.874 -1.057 . . . . 1.0 108.691 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 6.5 mm -91.1 114.81 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.28 110.854 -178.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.01 112.31 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.31 110.254 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.15 101.79 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.939 -0.648 . . . . 0.37 112.156 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 28.3 tt0 . . . . . 0 C--N 1.325 -0.49 0 N-CA-C 110.122 -0.325 . . . . 1.87 110.122 179.926 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.541 0 N-CA-C 111.834 -0.507 . . . . 0.3 111.834 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.5 pt -98.9 123.62 51.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.273 0.559 . . . . 0.27 110.557 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -111.21 156.22 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.716 -0.675 . . . . 0.72 110.604 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.99 118.46 30.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.12 -0.491 . . . . 0.24 109.866 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -89.76 -101.95 1.1 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.519 -0.848 . . . . 0.42 112.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.18 138.88 31.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.663 0.268 . . . . 0.75 111.094 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 69.8 mt -105.28 129.79 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.353 -0.61 . . . . 0.53 109.353 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 26.1 mmt -95.54 123.69 39.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.934 0.397 . . . . 0.74 111.202 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -67.37 122.56 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 1.01 109.809 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 122.73 -20.78 7.68 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.469 -0.652 . . . . 0.36 111.469 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.55 172.65 55.27 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.803 -0.713 . . . . 0.26 112.104 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -36.18 82.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.754 0.312 . . . . 0.25 111.099 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.14 -35.34 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.575 . . . . 0.26 111.115 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.86 -11.52 60.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.37 111.776 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -94.71 -10.17 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.104 0.478 . . . . 0.41 110.462 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.83 -77.12 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.55 110.239 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.0 -16.34 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.653 -0.784 . . . . 0.39 113.699 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -81.39 -36.1 29.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.417 0.608 . . . . 0.68 111.433 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.5 mt -80.04 134.29 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.421 -0.354 . . . . 0.37 110.307 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.51 168.11 16.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.69 110.292 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.75 128.23 25.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.984 1.789 . . . . 0.41 111.49 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.88 -14.6 31.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.821 -0.704 . . . . 0.29 112.299 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.95 141.97 52.95 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.647 -0.501 . . . . 0.34 109.647 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 35.9 ttp -101.36 132.14 47.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.643 0.259 . . . . 1.26 110.859 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.64 120.62 29.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.027 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 336' ' ' ALA . 43.3 mt -101.29 -69.09 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.132 0.492 . . . . 0.53 110.359 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -111.9 133.82 53.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.744 -0.662 . . . . 0.73 110.563 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.8 t -123.64 94.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.964 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.1 t30 58.83 72.9 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.472 -0.786 . . . . 1.71 111.761 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 73.3 m-20 78.3 -48.4 0.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.422 0.897 . . . . 1.11 113.422 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.66 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.229 0.538 . . . . 0.71 111.657 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -103.08 137.51 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.698 -0.683 . . . . 0.74 110.413 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.59 13.0 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.477 -0.329 . . . . 0.33 111.06 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.73 6.11 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.115 0.413 . . . . 1.21 112.115 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.25 33.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.348 0.594 . . . . 1.32 110.068 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.7 mtp -134.31 159.17 41.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.51 110.498 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.06 153.36 43.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.97 110.746 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.1 m-20 -54.18 -46.34 72.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.48 110.961 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.1 t70 -62.06 -48.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.881 -0.599 . . . . 1.4 110.779 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.87 -38.59 76.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.74 -0.664 . . . . 0.88 111.331 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.37 70.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.997 -0.547 . . . . 0.2 111.645 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.3 t -69.88 -27.73 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.956 -0.298 . . . . 0.21 111.298 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 88.3 mtt180 -58.23 -46.06 86.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.447 . . . . 0.83 110.202 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.59 -38.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.83 -0.623 . . . . 0.17 110.109 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.444 ' CD1' HG11 ' A' ' 304' ' ' VAL . 19.0 tp -53.57 -53.25 54.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.87 -0.605 . . . . 0.38 111.34 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.569 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.1 mtp180 -62.09 -34.64 76.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.57 111.338 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 mm-40 -66.84 -40.3 87.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.89 0.376 . . . . 1.87 110.44 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -68.58 -44.64 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.29 110.939 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.9 t -64.74 -21.78 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.16 0.505 . . . . 0.24 111.152 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.5 m -84.69 -0.36 53.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.499 -0.319 . . . . 0.44 110.825 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 80.4 mm-40 -98.19 163.11 12.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 1.16 110.596 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 15.4 p -99.12 118.68 36.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.224 -0.444 . . . . 0.89 111.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 154.02 165.72 14.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.835 -0.697 . . . . 0.45 111.985 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.92 128.23 14.7 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.337 2.024 . . . . 0.58 111.503 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 34.6 mt -108.22 130.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.922 0.391 . . . . 0.37 111.354 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 18.5 t -104.8 129.73 53.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 1.09 109.258 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.4 mt -114.92 125.76 54.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 0.48 111.287 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -100.65 97.54 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.853 -0.795 . . . . 0.5 108.853 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.3 151.55 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.341 0.591 . . . . 0.33 112.247 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.57 113.07 25.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.234 -0.894 . . . . 0.38 109.146 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.274 -0.869 . . . . 0.7 110.391 -179.535 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.0 m95 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 110.527 -0.175 . . . . 0.4 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.887 -0.577 . . . . 0.27 109.879 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.868 0.366 . . . . 1.26 110.309 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -98.08 129.51 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.359 -0.382 . . . . 0.65 110.436 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.11 128.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.944 0.402 . . . . 0.55 111.152 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.71 119.81 39.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.055 -0.52 . . . . 0.59 109.691 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.95 144.17 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.912 0.387 . . . . 0.5 111.524 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.3 t -107.63 131.59 54.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.426 -0.953 . . . . 0.79 108.426 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.538 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 42.7 mt -114.8 140.17 49.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.46 111.737 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.31 116.79 21.33 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.475 -0.784 . . . . 0.65 110.285 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.6 mmm -98.69 12.62 34.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.63 111.654 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.92 -46.96 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.099 0.476 . . . . 1.27 109.803 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.06 -18.94 29.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 1.06 110.409 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -112.44 137.95 49.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.111 -0.495 . . . . 0.76 109.716 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -102.02 3.52 38.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.022 -0.271 . . . . 1.09 111.572 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -159.72 166.27 30.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.602 0.239 . . . . 0.62 111.05 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 264' ' ' ILE . 6.6 mt -76.04 -53.0 9.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.34 109.735 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.69 40.59 6.27 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 116.049 -0.523 . . . . 0.14 113.052 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 262' ' ' LEU . 6.6 pt -138.07 149.2 24.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.346 0.593 . . . . 0.18 111.623 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.86 129.79 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.284 -0.871 . . . . 1.0 109.264 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.438 HG21 HG22 ' A' ' 318' ' ' VAL . 10.1 mm -93.78 119.76 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.938 0.399 . . . . 0.28 110.483 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.01 113.66 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.369 -0.378 . . . . 0.31 110.583 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.33 124.09 8.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.859 -0.686 . . . . 0.37 111.67 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 1.87 110.783 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.587 0 N-CA-C 112.22 -0.352 . . . . 0.3 112.22 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.4 pt -113.96 130.63 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.27 110.925 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -115.59 163.65 15.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.0 -0.546 . . . . 0.72 110.827 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.34 118.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.059 -0.519 . . . . 0.24 109.883 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.32 -66.94 1.68 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.729 -0.748 . . . . 0.42 112.147 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -145.26 155.62 43.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.537 0.208 . . . . 0.75 110.554 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 296' ' ' GLU . 30.2 mt -106.88 134.33 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.246 -0.434 . . . . 0.53 109.995 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.9 mmt -95.48 122.53 38.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.288 -0.414 . . . . 0.74 110.832 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.88 118.04 5.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 1.01 110.148 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.63 9.05 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.352 -0.699 . . . . 0.36 111.352 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.96 170.62 54.69 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.008 -0.615 . . . . 0.26 112.104 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.7 -36.92 85.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.751 0.31 . . . . 0.25 111.363 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.01 -35.9 71.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.119 -0.492 . . . . 0.26 111.274 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.99 66.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.115 -0.493 . . . . 0.37 111.691 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.2 46.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.41 111.524 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.33 -72.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.799 0.333 . . . . 0.55 110.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.16 -17.8 34.27 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.393 -0.908 . . . . 0.39 114.3 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -73.21 -28.72 62.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.822 0.811 . . . . 0.68 111.278 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.7 mt -88.1 140.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.114 -0.698 . . . . 0.37 109.114 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . 0.558 ' HA ' HD11 ' A' ' 283' ' ' ILE . 13.6 pt-20 -148.63 167.67 12.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.579 -0.282 . . . . 0.69 110.242 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.04 133.56 58.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.215 1.943 . . . . 0.41 111.061 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.14 -20.91 32.35 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.29 112.151 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.9 137.87 55.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.925 -0.398 . . . . 0.34 109.925 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.5 ttp -97.5 134.23 41.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.726 0.298 . . . . 1.26 110.729 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.75 124.71 32.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.314 -0.403 . . . . 0.48 109.974 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 336' ' ' ALA . 92.5 mt -105.8 -71.22 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.074 0.464 . . . . 0.53 110.606 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.93 136.96 53.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.73 111.162 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 321' ' ' LEU . 59.7 t -128.02 94.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.29 109.919 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.4 m-20 59.09 75.4 0.4 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.211 -0.45 . . . . 1.71 111.407 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 3.3 m-20 76.72 -58.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.149 0.796 . . . . 1.11 113.149 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.43 121.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.379 0.609 . . . . 0.71 111.898 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -101.15 128.81 47.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.316 -0.856 . . . . 0.74 109.389 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -102.38 20.38 17.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.739 0.304 . . . . 0.33 111.477 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.45 -27.3 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.205 0.446 . . . . 1.21 112.205 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -125.58 37.45 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.633 0.254 . . . . 1.32 111.279 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 86.7 mtp -125.36 168.83 13.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.433 -0.349 . . . . 0.51 110.364 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.9 p -75.33 157.13 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.97 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.6 m-20 -62.27 -33.98 75.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.48 109.799 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -69.53 -54.03 16.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.575 -0.738 . . . . 1.4 111.118 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -59.58 -34.16 72.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.88 111.072 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.34 69.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.984 -0.553 . . . . 0.2 111.031 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.1 t -74.25 -27.96 22.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 121.041 -0.264 . . . . 0.21 110.725 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 66.8 mtt180 -58.35 -51.59 69.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.07 0.462 . . . . 0.83 109.864 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.78 -35.36 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.17 110.517 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.416 HD13 HG21 ' A' ' 304' ' ' VAL . 41.0 tp -54.67 -50.83 67.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.076 -0.511 . . . . 0.38 110.82 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.44 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.7 mtp-105 -61.32 -34.28 74.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.979 -0.555 . . . . 1.57 111.396 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.03 -40.63 96.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 1.87 110.54 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.89 -43.83 76.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.29 110.749 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' B' ' 3' ' ' VAL . 65.4 t -64.93 -32.1 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 0.24 110.753 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 13.7 m -87.31 10.3 17.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.928 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -110.98 151.41 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 1.16 110.081 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.62 134.57 37.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.563 -0.29 . . . . 0.89 110.617 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 135.71 156.14 7.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.852 -0.689 . . . . 0.45 112.339 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.3 139.82 46.87 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.851 2.368 . . . . 0.58 112.044 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.79 126.92 66.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.151 -0.477 . . . . 0.37 111.539 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 108.24 19.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.972 -0.751 . . . . 1.09 108.972 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 99.0 mt -93.65 128.93 40.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.237 -0.438 . . . . 0.48 111.756 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.5 m -108.34 97.39 7.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.442 -0.947 . . . . 0.5 108.442 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.85 159.17 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.33 112.154 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -116.83 116.62 27.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.334 -0.848 . . . . 0.38 109.718 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.488 -0.768 . . . . 0.7 110.271 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 30.4 m95 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 110.243 -0.28 . . . . 0.4 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.523 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.678 -0.677 . . . . 0.27 110.418 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.879 0.371 . . . . 1.26 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 56.0 mt -90.32 111.8 23.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.015 0.436 . . . . 0.65 110.251 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.55 128.73 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.55 110.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 m -98.74 112.35 24.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.59 109.867 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 332' ' ' SER . 6.0 m -100.87 163.34 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.436 -0.347 . . . . 0.5 110.67 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 14.8 t -131.11 134.66 46.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.309 -0.626 . . . . 0.79 109.309 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 72.4 mt -121.96 135.79 54.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.46 111.735 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -85.22 115.62 23.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.459 -0.792 . . . . 0.65 109.973 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.0 mmm -95.8 32.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.952 0.406 . . . . 0.63 111.327 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -102.8 -53.82 2.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.27 109.703 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -70.48 -41.28 72.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.483 -0.562 . . . . 1.06 109.483 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -107.34 157.26 18.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.69 -0.855 . . . . 0.76 108.69 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -124.07 22.56 8.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.625 -0.43 . . . . 1.09 112.03 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.5 158.75 27.01 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.736 0.303 . . . . 0.62 110.778 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 262' ' ' LEU . 5.8 mt -76.35 -56.01 5.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.34 109.734 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.8 42.95 5.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.644 -0.707 . . . . 0.14 112.632 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -143.95 153.84 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.277 0.561 . . . . 0.18 111.866 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.474 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -100.85 131.59 46.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.48 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.5 mm -96.44 110.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.942 0.401 . . . . 0.28 110.385 -178.865 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.09 110.78 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.504 -0.316 . . . . 0.31 111.486 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.61 113.7 3.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.092 -0.803 . . . . 0.37 111.092 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 120.99 0.424 . . . . 1.87 111.043 -178.801 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.451 0 N-CA-C 112.269 -0.332 . . . . 0.3 112.269 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -105.88 129.36 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.031 0.443 . . . . 0.27 110.696 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.45 158.8 23.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 0.72 110.805 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.79 117.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.534 . . . . 0.24 110.393 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.76 -71.42 1.14 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.701 -0.761 . . . . 0.42 112.15 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.0 p -142.58 155.51 44.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.182 -0.303 . . . . 0.75 110.182 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 43.0 mt -106.43 125.53 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.53 110.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.3 mmt -86.36 126.72 34.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.07 -0.513 . . . . 0.74 110.668 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -67.88 110.6 3.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.662 -0.496 . . . . 1.01 109.662 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 132.84 -19.9 4.37 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.885 -0.886 . . . . 0.36 110.885 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.28 54.64 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.713 . . . . 0.26 111.969 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.22 -32.19 73.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.812 0.339 . . . . 0.25 111.0 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.23 -33.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.26 110.734 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.08 -15.7 62.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.273 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.1 -27.79 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 16.5 t70 -76.05 -69.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.55 110.681 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.24 57.32 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.448 -0.882 . . . . 0.39 114.714 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 79.3 mtm180 -82.9 -19.65 36.96 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.019 0.91 . . . . 0.68 111.351 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.1 mt -96.78 138.51 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.206 -0.452 . . . . 0.37 109.959 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.1 157.9 76.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.43 -0.35 . . . . 0.69 110.409 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . 0.485 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 33.4 Cg_exo -61.44 94.34 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.611 2.207 . . . . 0.41 111.793 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 150.52 -19.56 1.03 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.963 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -64.06 151.17 43.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.736 0.303 . . . . 0.34 110.842 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 50.6 ttp -104.02 130.1 51.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 1.26 110.683 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.84 115.23 22.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.382 -0.372 . . . . 0.48 110.103 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 51.7 mt -97.9 -73.31 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.27 0.557 . . . . 0.53 110.844 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -115.11 130.74 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.594 -0.73 . . . . 0.73 110.625 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.548 HG13 HD23 ' A' ' 333' ' ' LEU . 96.5 t -126.91 106.44 15.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.201 -0.454 . . . . 0.29 109.972 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 11.4 t-20 61.34 65.98 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 1.5 m-20 74.87 -52.9 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.715 1.006 . . . . 1.11 113.715 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 134.74 29.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.063 0.458 . . . . 0.71 111.542 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -107.32 126.73 52.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.74 110.701 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -96.58 3.79 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.839 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.62 -28.08 65.3 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.828 0.307 . . . . 1.21 111.828 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.75 31.53 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 1.32 110.796 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 89.6 mtp -128.69 154.36 46.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.159 -0.473 . . . . 0.51 110.773 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.95 150.11 48.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.97 110.993 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -51.9 -47.98 64.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.343 . . . . 0.48 111.348 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.42 -46.39 88.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.4 111.672 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.1 m-20 -64.32 -30.72 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.294 -0.412 . . . . 0.88 110.8 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.42 85.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.2 110.786 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.4 t -72.23 -31.55 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.664 0.268 . . . . 0.21 110.535 179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 90.1 mtt180 -56.74 -53.92 52.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.83 110.263 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.8 -37.19 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.17 110.366 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 15.1 tp -55.79 -51.02 68.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.932 -0.577 . . . . 0.38 111.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.43 ' HA ' HG11 ' B' ' 3' ' ' VAL . 36.5 mtp180 -61.83 -35.14 77.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 1.57 111.091 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -64.53 -40.69 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.152 0.501 . . . . 1.87 109.959 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.59 -42.47 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.634 -0.712 . . . . 0.29 110.828 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 321' ' ' LEU . 62.6 t -66.29 -23.95 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.24 110.31 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 6.76 26.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.852 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -105.75 135.54 46.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.349 -0.387 . . . . 1.16 110.002 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 92.18 4.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.438 . . . . 0.89 111.569 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -173.74 171.92 44.86 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.461 -0.656 . . . . 0.45 111.461 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 126.04 13.18 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.361 2.041 . . . . 0.58 111.584 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 58.5 mt -102.95 122.75 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.93 0.395 . . . . 0.37 111.457 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.5 OUTLIER -106.66 121.78 45.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.564 . . . . 1.09 109.615 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.548 HD23 HG13 ' A' ' 304' ' ' VAL . 18.1 mt -108.1 120.95 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.525 . . . . 0.48 110.99 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.82 95.94 7.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.53 0.681 . . . . 0.33 112.399 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -102.52 94.76 5.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.951 -1.022 . . . . 0.38 108.868 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.628 -0.701 . . . . 0.7 110.725 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.474 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 9.8 m95 . . . . . 0 C--O 1.234 0.244 0 N-CA-C 110.366 -0.235 . . . . 0.4 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.434 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.637 -0.696 . . . . 0.27 110.22 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.61 0.243 . . . . 1.26 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 95.1 mt -103.78 127.02 58.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.453 -0.34 . . . . 0.65 110.188 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.21 135.44 59.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.827 0.346 . . . . 0.55 111.358 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 62.9 m -107.01 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.648 -0.501 . . . . 0.59 109.648 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 332' ' ' SER . 4.0 m -102.26 143.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.789 0.328 . . . . 0.5 111.122 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.9 t -114.19 109.78 18.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.79 109.5 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 58.4 mt -100.31 145.27 28.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.46 112.016 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -91.72 119.79 31.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.65 109.732 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 89.5 mmm -99.0 21.52 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.026 0.441 . . . . 0.63 111.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -87.71 -49.91 6.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.768 -0.456 . . . . 1.27 109.768 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.16 -35.81 19.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 1.06 109.355 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -86.87 145.71 26.48 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.695 -0.684 . . . . 0.76 109.464 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.85 -2.33 13.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.545 -0.462 . . . . 1.09 112.024 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -157.58 162.54 38.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.498 0.19 . . . . 0.62 110.677 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.4 mt -77.55 -52.04 9.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.727 -0.472 . . . . 0.34 109.727 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.44 4.61 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.577 -0.738 . . . . 0.14 112.999 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.0 pt -144.84 144.1 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.213 0.53 . . . . 0.18 111.563 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 1.1 p -96.49 126.87 41.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 9.2 mm -91.75 115.84 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.825 0.345 . . . . 0.28 110.776 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.22 119.01 48.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.31 110.251 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.26 122.51 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.002 -0.618 . . . . 0.37 112.072 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 1.87 110.1 179.831 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.796 0 N-CA-C 112.192 -0.363 . . . . 0.3 112.192 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.03 128.41 73.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.068 0.461 . . . . 0.27 110.839 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -113.99 157.46 22.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.772 -0.649 . . . . 0.72 110.803 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.59 115.02 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.24 110.014 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.72 -58.16 4.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.42 112.698 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.6 p -151.54 161.97 41.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.187 -0.301 . . . . 0.75 110.187 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.439 HD11 ' HA ' ' A' ' 296' ' ' GLU . 49.0 mt -115.18 134.8 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.53 110.46 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -95.7 125.17 40.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.74 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.05 124.47 20.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.883 -0.599 . . . . 1.01 110.056 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.58 18.12 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.29 -0.724 . . . . 0.36 111.29 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -80.52 166.03 48.88 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.875 -0.679 . . . . 0.26 111.875 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -61.15 -38.83 87.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.662 0.268 . . . . 0.25 111.433 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.69 -31.3 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.26 110.907 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.83 -20.29 61.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.37 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.02 -11.7 43.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.272 -0.422 . . . . 0.41 111.73 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.11 -72.61 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.15 -0.22 . . . . 0.55 111.218 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 113.74 -17.08 20.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.381 -0.914 . . . . 0.39 113.902 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -89.93 -49.32 6.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.32 0.56 . . . . 0.68 111.064 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.24 136.93 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.206 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' A' ' 283' ' ' ILE . 11.9 pt-20 -143.8 164.2 31.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.69 110.308 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.5 Cg_exo -60.24 112.54 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.329 2.019 . . . . 0.41 111.27 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 132.45 -19.86 4.48 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.241 -0.744 . . . . 0.29 111.241 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.0 m-20 -70.84 146.14 49.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.732 0.301 . . . . 0.34 110.245 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.1 ttt -103.76 136.44 43.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.309 -0.405 . . . . 1.26 110.656 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 335' ' ' VAL . 18.9 mt -87.99 123.39 32.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.48 110.109 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 336' ' ' ALA . 90.6 mt -106.25 -69.07 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.048 0.451 . . . . 0.53 110.818 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -121.1 124.7 45.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.73 110.484 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.5 t -125.62 101.57 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.29 110.23 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.1 m-20 62.88 65.69 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.998 -0.546 . . . . 1.71 111.244 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.6 m-20 74.69 -43.67 0.53 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.922 1.082 . . . . 1.11 113.922 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 304' ' ' VAL . 33.6 m -69.51 137.47 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 118.261 0.482 . . . . 0.71 111.329 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -111.06 133.16 53.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.771 -0.65 . . . . 0.74 109.645 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.13 12.44 30.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.909 0.337 . . . . 0.33 111.909 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -66.32 -30.56 70.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.723 0.297 . . . . 1.21 111.715 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.56 36.96 4.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 1.32 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 84.1 mtp -125.05 154.96 40.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.324 -0.621 . . . . 0.51 109.324 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 97.0 p -69.17 153.56 43.51 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.147 -0.316 . . . . 0.97 110.147 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -59.6 -26.38 65.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.48 109.842 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -71.48 -56.3 6.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.279 -0.873 . . . . 1.4 110.588 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 10.6 m-20 -63.64 -30.98 72.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.84 -0.618 . . . . 0.88 111.683 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.15 67.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.929 -0.578 . . . . 0.2 112.011 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.33 -27.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.931 -0.308 . . . . 0.21 111.024 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 81.4 mtt180 -58.53 -53.31 59.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.83 110.11 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.6 -40.49 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.871 -0.604 . . . . 0.17 110.274 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.6 tp -55.12 -50.98 67.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.938 -0.574 . . . . 0.38 111.229 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.455 ' HA ' HG11 ' B' ' 3' ' ' VAL . 9.0 mtp180 -61.0 -41.86 97.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.404 . . . . 1.57 111.359 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -61.42 -43.52 98.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.52 0.2 . . . . 1.87 110.55 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.01 -43.25 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.29 110.508 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.3 t -70.01 -19.68 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.277 -0.42 . . . . 0.24 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 66.7 m -77.86 -18.38 56.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.44 110.789 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.09 162.39 12.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.228 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.39 172.07 13.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.359 -0.382 . . . . 0.89 111.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 116.19 168.08 15.04 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.925 -0.655 . . . . 0.45 112.572 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -79.56 104.52 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.699 2.266 . . . . 0.58 111.733 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 50.0 mt -74.06 114.13 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.37 110.691 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 8.1 m -97.31 102.74 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 1.09 109.75 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.89 119.05 37.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.023 -0.535 . . . . 0.48 111.319 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 26.8 m -98.54 101.12 12.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.779 -0.822 . . . . 0.5 108.779 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 301' ' ' LEU . 29.8 m -101.64 156.23 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 0.33 112.204 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.07 111.43 22.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.113 -0.949 . . . . 0.38 109.894 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.7 mtpp . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.511 -0.757 . . . . 0.7 109.796 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.582 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 22.4 m95 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.126 -0.324 . . . . 0.4 110.126 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.71 -0.662 . . . . 0.27 109.973 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.74 0.305 . . . . 1.26 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.61 128.38 49.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.128 -0.323 . . . . 0.65 110.128 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 42.2 mt -126.53 130.51 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.339 . . . . 0.55 111.151 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.8 m -101.62 111.11 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.52 -0.548 . . . . 0.59 109.52 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.91 147.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.688 0.28 . . . . 0.5 111.566 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.2 t -110.16 136.8 48.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.642 -0.503 . . . . 0.79 109.642 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.2 mt -114.71 138.41 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.905 0.383 . . . . 0.46 111.469 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -83.91 117.96 23.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.704 . . . . 0.65 110.155 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 92.2 mmm -98.35 14.05 29.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.374 -0.375 . . . . 0.63 111.584 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.14 -38.39 15.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 1.27 110.342 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 258' ' ' ARG . 25.7 ttt180 -96.34 0.66 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.255 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -131.03 162.52 29.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.76 109.709 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -120.32 -8.23 9.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.827 0.346 . . . . 1.09 111.283 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -154.62 175.95 13.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.509 -0.314 . . . . 0.62 110.707 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.08 -52.46 6.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.34 109.971 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.68 43.18 5.54 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.806 -0.634 . . . . 0.14 112.879 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.02 154.35 31.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.538 0.685 . . . . 0.18 112.37 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.452 ' HB3' ' H ' ' A' ' 282' ' ' SER . 42.5 t -101.8 118.03 36.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.612 -1.176 . . . . 1.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.1 mm -88.63 118.5 34.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.776 0.322 . . . . 0.28 110.138 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.99 109.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.007 0.432 . . . . 0.31 110.759 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.1 124.38 7.54 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.247 -0.741 . . . . 0.37 111.247 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 . . . . . 0 C--N 1.323 -0.543 0 CA-C-O 120.938 0.399 . . . . 1.87 110.635 -179.839 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.744 0 N-CA-C 112.305 -0.318 . . . . 0.3 112.305 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.44 114.26 45.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.297 0.57 . . . . 0.27 110.212 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -107.32 154.57 21.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.893 -0.594 . . . . 0.72 110.692 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.23 114.18 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.24 109.782 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.12 -57.7 3.62 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.746 -0.74 . . . . 0.42 112.333 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 265' ' ' SER . 1.8 p -145.16 158.25 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.144 -0.317 . . . . 0.75 110.144 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 50.4 mt -118.24 131.62 70.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.58 -0.526 . . . . 0.53 109.58 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 34.1 mmt -92.77 124.32 36.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.415 -0.357 . . . . 0.74 110.619 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -58.56 130.18 45.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 1.01 110.997 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.12 -24.55 20.78 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.894 -0.67 . . . . 0.36 112.034 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.19 45.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.058 -0.591 . . . . 0.26 112.424 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.01 -37.32 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.25 111.056 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.457 HG13 HD12 ' A' ' 295' ' ' ILE . 54.8 t -69.54 -39.27 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.26 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.27 -18.15 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.37 111.254 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -85.67 -11.03 54.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.41 110.955 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.49 -67.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.839 -0.43 . . . . 0.55 109.839 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 103.47 -14.96 54.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 0.39 114.435 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -79.96 -33.13 39.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.738 0.769 . . . . 0.68 111.137 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.457 HD12 HG13 ' A' ' 289' ' ' VAL . 63.5 mt -82.57 140.65 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.651 -0.5 . . . . 0.37 109.651 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.13 164.3 32.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.765 -0.198 . . . . 0.69 110.88 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.37 116.94 3.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.41 111.823 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 125.82 -21.81 6.19 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.917 -0.658 . . . . 0.29 111.509 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.5 m-20 -69.44 143.23 53.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 43.7 ttp -103.36 135.3 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.702 0.287 . . . . 1.26 110.813 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 70.4 mt -83.39 123.97 30.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.48 110.182 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 336' ' ' ALA . 46.7 mt -105.15 -72.57 0.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.245 0.545 . . . . 0.53 110.835 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.437 ' H ' ' HB ' ' A' ' 334' ' ' THR . 8.1 tt0 -109.75 135.32 50.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.754 . . . . 0.73 111.034 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 321' ' ' LEU . 67.3 t -131.98 93.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.29 110.149 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 59.21 76.61 0.35 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.798 -0.637 . . . . 1.71 111.737 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.8 OUTLIER 75.21 -53.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.053 -0.976 . . . . 1.11 113.455 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.5 139.66 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.349 0.595 . . . . 0.71 111.864 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.99 130.8 55.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.442 -0.799 . . . . 0.74 110.409 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.482 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 23.7 m-85 -102.02 6.53 41.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.867 0.321 . . . . 0.33 111.867 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.92 -31.61 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 1.21 111.696 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -119.44 53.35 1.04 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.2 0.524 . . . . 1.32 110.301 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . 0.482 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 84.1 mtp -141.11 160.37 40.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.182 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 148.14 51.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.242 -0.435 . . . . 0.97 110.75 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -49.7 -50.97 41.69 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.484 0.49 . . . . 0.48 111.638 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.22 -47.3 80.22 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.446 . . . . 1.4 111.833 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.58 -35.1 75.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.886 -0.597 . . . . 0.88 111.815 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.02 93.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.452 -0.34 . . . . 0.2 110.865 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.515 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -73.82 -32.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.21 110.623 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -54.98 -50.33 69.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.864 0.364 . . . . 0.83 110.627 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.6 t -70.49 -39.93 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.75 -0.659 . . . . 0.17 110.249 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 325' ' ' VAL . 56.6 tp -55.36 -50.44 69.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.053 -0.521 . . . . 0.38 111.373 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.663 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.0 mtp180 -63.69 -30.13 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 1.57 111.462 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.7 -40.37 80.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.136 0.493 . . . . 1.87 109.804 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.92 -42.67 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.73 . . . . 0.29 111.209 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 321' ' ' LEU . 43.8 t -69.23 -16.94 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.24 110.802 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 23.57 6.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.092 0.473 . . . . 0.44 110.161 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.26 -179.31 4.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 1.16 110.102 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.99 146.24 32.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.71 0.29 . . . . 0.89 110.607 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.37 169.59 13.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.707 -0.759 . . . . 0.45 112.269 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 137.09 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 0.58 112.166 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 84.4 mt -115.34 121.57 67.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.142 -0.481 . . . . 0.37 110.414 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.8 m -106.11 121.06 43.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.138 0.494 . . . . 1.09 109.95 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 84.0 mt -105.5 130.52 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.48 111.538 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 2.7 m -104.04 103.23 13.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.28 142.68 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.343 0.592 . . . . 0.33 112.35 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.22 111.95 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.186 -0.916 . . . . 0.38 109.582 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.0 mtpp . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.613 -0.708 . . . . 0.7 109.942 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 28.9 m95 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.547 0.213 . . . . 0.4 110.62 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 119.038 -0.506 . . . . 0.27 109.949 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.917 0.389 . . . . 1.26 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 57.2 mt -92.3 128.78 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.65 110.731 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 33.8 mt -129.67 123.7 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.55 110.875 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.1 m -95.39 102.39 14.19 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.424 -0.584 . . . . 0.59 109.424 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.27 148.4 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.954 0.407 . . . . 0.5 111.751 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -114.87 129.95 56.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.802 -0.814 . . . . 0.79 108.802 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.2 mt -110.89 149.66 30.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.463 . . . . 0.46 111.606 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.27 118.04 30.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.507 -0.77 . . . . 0.65 110.901 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 67.0 mmm -99.46 16.26 23.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.863 -0.608 . . . . 0.63 111.304 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -86.47 -49.41 7.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.35 -0.611 . . . . 1.27 109.35 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -86.44 -22.8 26.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.583 -0.735 . . . . 1.06 110.193 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -106.92 154.76 20.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 0.76 110.472 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.76 -2.39 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.519 0.2 . . . . 1.09 111.304 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -157.56 171.92 19.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.348 . . . . 0.62 110.959 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 7.6 mt -78.21 -51.31 10.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.887 -0.597 . . . . 0.34 110.016 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.05 47.34 5.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.776 -0.647 . . . . 0.14 112.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 262' ' ' LEU . 3.5 pt -142.73 150.45 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.18 112.023 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.26 120.61 40.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.81 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.3 mm -89.56 116.11 30.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.919 0.39 . . . . 0.28 111.036 -178.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.69 118.77 48.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.31 109.877 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.51 127.82 9.36 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.511 -0.852 . . . . 0.37 112.013 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 . . . . . 0 C--N 1.328 -0.362 0 N-CA-C 109.186 -0.672 . . . . 1.87 109.186 179.114 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.618 0 N-CA-C 112.511 -0.236 . . . . 0.3 112.511 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.67 138.43 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.898 0.38 . . . . 0.27 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -125.69 158.24 35.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.996 -0.547 . . . . 0.72 110.661 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.3 mm -75.92 109.5 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.067 -0.515 . . . . 0.24 109.698 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.29 -60.13 3.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.754 -0.736 . . . . 0.42 112.273 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 m -145.17 157.97 43.94 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.708 -0.289 . . . . 0.75 110.355 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.2 mt -113.52 130.22 67.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.211 -0.45 . . . . 0.53 110.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.97 119.33 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.74 110.335 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -61.72 116.99 5.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.955 -0.566 . . . . 1.01 110.023 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.1 -17.58 9.12 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.477 -0.649 . . . . 0.36 111.477 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.8 174.03 55.26 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.863 -0.684 . . . . 0.26 111.912 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.93 -36.87 84.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.769 0.318 . . . . 0.25 111.218 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.98 -37.37 77.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.26 111.169 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.41 -17.88 64.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.37 111.828 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.92 -3.66 57.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.828 0.347 . . . . 0.41 111.192 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.63 -80.25 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.745 -0.465 . . . . 0.55 109.745 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 118.33 -21.53 9.97 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.274 -0.965 . . . . 0.39 113.908 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -76.84 -19.59 57.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.568 0.684 . . . . 0.68 111.751 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.8 mt -95.18 136.36 26.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.646 -0.501 . . . . 0.37 109.646 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.63 163.77 47.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.742 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.47 109.04 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.368 2.045 . . . . 0.41 111.452 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.96 -17.14 5.21 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.29 112.09 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 97.7 m-20 -65.11 140.39 58.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.634 0.254 . . . . 0.34 110.348 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.6 ttt -93.76 135.2 35.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.322 . . . . 1.26 111.02 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.6 mt -90.07 118.14 29.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.193 -0.458 . . . . 0.48 109.936 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 336' ' ' ALA . 59.4 mt -103.54 -77.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.098 0.475 . . . . 0.53 110.837 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 308' ' ' ASN . 8.3 tt0 -106.01 134.42 49.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.73 110.996 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 321' ' ' LEU . 84.7 t -131.31 102.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.782 -0.645 . . . . 0.29 109.83 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.2 m-20 58.35 70.53 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.566 -0.743 . . . . 1.71 111.568 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.5 OUTLIER 76.51 -53.36 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.585 0.957 . . . . 1.11 113.585 178.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.09 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.71 112.122 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 303' ' ' GLN . 50.0 t30 -103.32 131.39 50.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.521 -0.763 . . . . 0.74 109.782 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -97.17 3.98 51.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.984 0.364 . . . . 0.33 111.984 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.4 -32.8 67.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.965 0.412 . . . . 1.21 111.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -105.78 39.88 1.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.32 111.47 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 34.1 mtp -141.78 165.77 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.514 -0.312 . . . . 0.51 110.263 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.5 p -79.25 162.8 25.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.97 109.899 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 42.7 m-20 -57.26 -40.06 76.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.48 110.037 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 23.9 t0 -63.08 -55.09 28.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.182 -0.917 . . . . 1.4 110.514 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -60.13 -36.18 76.94 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.826 -0.625 . . . . 0.88 111.34 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.29 -56.02 27.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.2 112.157 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.9 t -69.62 -26.71 31.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.963 -0.295 . . . . 0.21 111.358 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 69.4 mtt180 -57.11 -52.28 65.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.83 110.072 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.22 -38.26 74.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.976 -0.556 . . . . 0.17 110.4 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.9 tp -56.09 -51.58 67.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.923 -0.581 . . . . 0.38 110.942 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.678 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.7 mtp180 -61.15 -38.41 86.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.945 -0.571 . . . . 1.57 111.082 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.3 -45.38 88.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.595 -0.275 . . . . 1.87 110.682 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.78 -44.37 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 0.29 110.9 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 321' ' ' LEU . 26.1 t -72.22 -15.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.24 111.424 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 71.7 m -81.74 -16.6 50.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.83 0.348 . . . . 0.44 110.838 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.65 160.7 14.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 1.16 110.357 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 130.82 41.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.97 0.414 . . . . 0.89 111.075 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.31 176.1 27.1 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.523 -0.631 . . . . 0.45 111.523 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.38 135.95 35.46 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.539 2.159 . . . . 0.58 112.151 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.43 129.64 72.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.145 0.497 . . . . 0.37 110.732 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 126.81 52.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.347 -0.842 . . . . 1.09 109.403 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.12 115.91 26.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.48 111.586 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -93.37 90.13 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.599 -0.889 . . . . 0.5 108.599 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.11 146.47 6.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.912 -0.585 . . . . 0.33 111.996 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.539 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.04 107.75 17.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.333 -0.849 . . . . 0.38 110.018 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.429 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 22.7 mtpp . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.432 -0.795 . . . . 0.7 109.692 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.84 -0.6 . . . . 0.27 110.164 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.74 0.305 . . . . 1.26 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.61 122.16 61.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.65 110.629 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 18.3 mt -126.31 131.42 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 88.8 m -104.96 113.24 26.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.943 -0.762 . . . . 0.59 108.943 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 10.2 m -103.56 155.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.283 -0.417 . . . . 0.5 111.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.5 t -108.23 135.35 49.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.05 -0.722 . . . . 0.79 109.05 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.9 mt -119.04 136.14 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.947 0.403 . . . . 0.46 111.524 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -83.46 114.85 21.76 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.547 -0.751 . . . . 0.65 109.924 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 93.8 mmm -98.89 14.77 27.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.63 111.159 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -88.93 -47.54 8.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.27 109.819 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.71 -21.63 32.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 1.06 110.048 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -111.67 159.04 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.76 109.867 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -128.24 14.76 6.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.899 0.38 . . . . 1.09 110.443 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -164.72 169.0 17.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.62 110.163 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.401 HD13 HD11 ' A' ' 264' ' ' ILE . 5.5 mt -81.28 -57.68 3.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.828 0.347 . . . . 0.34 110.27 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.6 36.35 5.89 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.14 112.578 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 262' ' ' LEU . 6.1 pt -137.16 156.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.42 0.629 . . . . 0.18 111.894 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.497 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -102.71 129.15 49.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.006 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.6 mm -97.37 113.33 31.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.28 110.953 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.5 t -114.88 115.24 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.31 110.709 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.64 134.23 12.26 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.97 -0.633 . . . . 0.37 112.393 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 . . . . . 0 C--N 1.324 -0.501 0 CA-C-O 120.623 0.249 . . . . 1.87 110.539 -179.856 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.679 0 N-CA-C 112.025 -0.43 . . . . 0.3 112.025 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.6 130.44 56.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.174 0.511 . . . . 0.27 111.07 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 45.4 m-85 -117.71 159.17 23.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.72 110.687 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.0 mm -79.88 120.2 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.919 -0.582 . . . . 0.24 110.227 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.29 -53.41 5.17 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.704 -0.76 . . . . 0.42 112.073 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -155.59 163.76 39.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.49 128.61 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.95 -0.389 . . . . 0.53 109.95 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -90.86 126.45 36.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 0.74 110.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.57 127.57 31.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 1.01 110.03 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 112.4 -14.37 25.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.36 111.572 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.39 175.1 54.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.982 -0.628 . . . . 0.26 111.778 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.85 79.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.69 0.281 . . . . 0.25 111.027 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.22 -36.93 78.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.26 111.054 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.33 -7.27 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.37 111.703 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.91 37.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.327 -0.397 . . . . 0.41 111.155 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -91.8 -80.2 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.55 110.333 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.22 -18.62 9.53 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.521 -0.847 . . . . 0.39 114.024 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -76.69 -33.38 58.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.55 0.675 . . . . 0.68 111.338 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.0 139.43 17.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.173 -0.467 . . . . 0.37 109.892 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.78 160.63 60.21 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.107 -0.331 . . . . 0.69 110.107 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.45 122.97 12.56 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.386 2.057 . . . . 0.41 111.023 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.82 9.82 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.298 -0.721 . . . . 0.29 111.298 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 93.6 m-20 -69.09 144.23 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.666 0.269 . . . . 0.34 110.504 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 27.3 ttt -100.36 135.38 41.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.381 -0.372 . . . . 1.26 111.1 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.41 123.4 32.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.902 -0.407 . . . . 0.48 109.902 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 336' ' ' ALA . 75.3 mt -102.12 -64.67 1.04 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 0.53 110.887 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -125.11 136.17 53.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.733 -0.667 . . . . 0.73 110.672 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 307' ' ' VAL . 98.5 t -132.66 103.38 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.29 110.134 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.5 m-20 59.81 65.14 1.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 1.71 111.444 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 58.0 m-20 76.31 -51.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.034 0.934 . . . . 1.11 113.451 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 304' ' ' VAL . 0.0 OUTLIER -63.66 124.35 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.387 0.613 . . . . 0.71 111.852 -178.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.59 129.61 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.34 -0.845 . . . . 0.74 109.67 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.131 0.419 . . . . 0.33 112.131 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -63.25 -26.19 68.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.643 0.259 . . . . 1.21 111.637 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -117.14 24.37 11.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.68 0.252 . . . . 1.32 111.68 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.8 mtp -122.23 156.49 33.65 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.788 -0.365 . . . . 0.51 111.501 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 144.0 57.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.724 -0.671 . . . . 0.97 110.388 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 318' ' ' VAL . 57.5 m-20 -50.86 -49.05 59.86 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.279 0.362 . . . . 0.48 111.463 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -47.18 85.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.4 111.309 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.21 -29.16 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.509 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.48 81.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.27 -0.423 . . . . 0.2 110.97 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -74.28 -23.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.81 -0.356 . . . . 0.21 110.688 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.08 -45.9 79.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.016 0.436 . . . . 0.83 110.168 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.02 -36.37 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.879 -0.601 . . . . 0.17 110.256 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 304' ' ' VAL . 32.3 tp -56.76 -50.6 71.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.841 -0.618 . . . . 0.38 111.398 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.614 ' HA ' HG11 ' B' ' 3' ' ' VAL . 31.3 mtp180 -61.61 -33.16 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.57 111.258 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.71 -45.46 86.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 1.87 109.948 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.48 -42.78 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.29 111.624 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' B' ' 3' ' ' VAL . 57.5 t -66.32 -26.83 38.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.93 0.395 . . . . 0.24 111.264 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 15.8 m -86.71 -2.21 58.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.253 0.549 . . . . 0.44 110.474 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 163.86 12.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.411 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.13 144.61 25.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.487 -0.324 . . . . 0.89 110.842 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.21 152.8 8.46 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.677 -0.773 . . . . 0.45 111.994 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.36 139.7 72.74 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.947 2.431 . . . . 0.58 112.15 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 57.9 mt -114.52 134.39 57.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.079 -0.51 . . . . 0.37 111.301 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.5 m -108.63 126.16 52.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.59 -0.522 . . . . 1.09 109.59 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 63.8 mt -110.51 118.2 35.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.075 0.398 . . . . 0.48 112.075 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 89.1 m -98.78 100.28 11.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.767 -0.827 . . . . 0.5 108.767 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.92 155.48 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 0.33 112.005 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -113.61 114.89 27.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.263 -0.88 . . . . 0.38 110.111 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.415 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.6 mtpp . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.477 -0.773 . . . . 0.7 109.604 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 58.2 m95 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.368 0.128 . . . . 0.4 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.72 -0.657 . . . . 0.27 109.801 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.26 -0.274 . . . . 1.26 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.36 128.99 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.814 -0.439 . . . . 0.65 109.814 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.36 132.5 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 0.55 110.99 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 13.2 m -109.01 111.4 23.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.414 -0.587 . . . . 0.59 109.414 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.19 149.47 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.5 111.469 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.4 t -115.35 106.84 14.47 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 57.9 mt -87.91 134.96 33.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.46 111.618 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -79.22 115.9 19.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 0.65 110.508 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 60.9 mmm -99.33 19.59 15.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.073 0.463 . . . . 0.63 110.937 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.22 -52.77 4.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.617 -0.512 . . . . 1.27 109.617 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -82.89 -25.67 32.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 1.06 109.62 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -98.86 160.21 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.76 109.561 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -130.21 12.69 5.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.967 0.413 . . . . 1.09 110.562 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -168.6 165.8 12.13 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.791 -0.641 . . . . 0.62 110.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 262' ' ' LEU . 8.0 mt -80.1 -51.51 8.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.639 -0.504 . . . . 0.34 109.639 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.4 43.45 5.55 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.14 112.653 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -144.86 152.16 15.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.489 0.662 . . . . 0.18 111.66 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.426 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 21.5 p -104.22 128.82 52.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.202 -0.908 . . . . 1.0 108.842 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.42 HG13 HD23 ' A' ' 321' ' ' LEU . 7.6 mm -95.26 123.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.899 0.38 . . . . 0.28 110.551 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 63.1 t -104.08 113.43 40.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.419 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.08 105.65 2.8 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.268 -0.733 . . . . 0.37 111.268 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 . . . . . 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 1.87 110.768 -179.284 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.545 0 N-CA-C 112.28 -0.328 . . . . 0.3 112.28 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.83 124.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.045 0.45 . . . . 0.27 110.741 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -116.38 154.95 29.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 0.72 110.536 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 43.7 mm -74.23 114.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.24 109.869 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -72.93 -58.71 4.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.946 -0.645 . . . . 0.42 112.512 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.8 p -152.98 161.36 42.63 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.215 -0.291 . . . . 0.75 110.215 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 41.2 mt -111.02 135.45 50.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.53 110.273 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.0 mmt -98.54 131.61 44.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 0.74 110.152 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -63.85 131.58 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.01 110.668 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.05 50.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.763 -0.732 . . . . 0.36 111.888 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.16 165.22 54.61 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.972 -0.632 . . . . 0.26 112.264 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -31.62 72.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.616 0.246 . . . . 0.25 111.089 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.42 -42.52 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.26 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.03 -17.91 65.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.54 . . . . 0.37 111.214 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.87 55.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 0.41 111.212 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.14 -75.98 0.46 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.515 -0.311 . . . . 0.55 110.755 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.35 -19.96 16.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.374 -0.917 . . . . 0.39 113.813 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -76.88 -27.72 55.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.568 0.684 . . . . 0.68 111.245 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.17 136.99 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.37 109.934 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.04 161.01 62.06 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.407 -0.36 . . . . 0.69 110.543 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.57 114.11 1.99 Allowed 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.266 1.977 . . . . 0.41 110.896 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.27 -20.07 5.33 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.603 -0.599 . . . . 0.29 111.603 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 92.2 m-20 -65.9 143.86 57.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.967 -0.383 . . . . 0.34 109.967 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 39.9 ttp -101.85 135.85 42.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.632 0.254 . . . . 1.26 110.334 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 52.7 mt -86.64 121.02 28.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.48 110.423 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 336' ' ' ALA . 27.7 mt -97.14 -77.88 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.53 110.269 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -114.58 129.43 56.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.636 -0.711 . . . . 0.73 110.404 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.6 t -123.21 97.06 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.367 -0.605 . . . . 0.29 109.367 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.59 HD21 HG23 ' A' ' 331' ' ' ILE . 61.6 m-80 63.05 72.24 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.641 0.588 . . . . 1.71 111.315 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 21.1 m-20 73.92 -48.12 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.8 1.037 . . . . 1.11 113.8 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.44 125.6 32.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.253 0.549 . . . . 0.71 111.83 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -103.17 123.76 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.627 -0.715 . . . . 0.74 109.744 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.06 8.02 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.441 0.534 . . . . 0.33 112.441 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.16 -22.97 63.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.24 0.459 . . . . 1.21 112.24 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -123.82 37.65 4.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.802 0.334 . . . . 1.32 111.152 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.6 mtp -132.03 164.04 27.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.85 -0.426 . . . . 0.51 109.85 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 p -77.99 155.55 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.286 -0.264 . . . . 0.97 110.286 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 318' ' ' VAL . 93.6 m-20 -52.15 -46.18 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.48 111.086 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -61.28 -51.34 69.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 1.4 111.604 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 7.4 m-20 -64.77 -34.85 79.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.772 0.286 . . . . 0.88 111.772 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.8 81.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.2 110.943 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.5 t -79.47 -24.42 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.776 -0.369 . . . . 0.21 110.885 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.48 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 71.3 mtt180 -57.94 -48.63 79.38 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -73.36 -36.1 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.792 -0.64 . . . . 0.17 110.158 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.9 tp -56.13 -51.23 68.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.881 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.554 ' HA ' HG11 ' B' ' 3' ' ' VAL . 16.6 mtp-105 -62.6 -34.4 76.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 1.57 110.93 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.75 -46.95 83.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.561 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.29 111.125 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 30.8 t -68.74 -12.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.186 0.517 . . . . 0.24 110.951 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -84.6 -4.41 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.85 0.357 . . . . 0.44 110.696 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 176.45 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.16 110.132 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 112.89 24.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.89 110.964 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 167.01 169.74 30.99 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.67 -0.776 . . . . 0.45 112.452 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.71 123.13 11.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.62 2.213 . . . . 0.58 111.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . 0.59 HG23 HD21 ' A' ' 305' ' ' ASN . 66.3 mt -98.5 114.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.207 -0.451 . . . . 0.37 111.098 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.35 111.18 22.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 1.09 110.123 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.03 120.3 41.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.117 -0.492 . . . . 0.48 111.114 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -105.12 98.65 8.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.136 -0.69 . . . . 0.5 109.136 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.13 149.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.33 111.978 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.77 109.21 19.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.275 -0.875 . . . . 0.38 109.764 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.267 -0.873 . . . . 0.7 109.958 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 18.0 m95 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.425 -0.213 . . . . 0.4 110.425 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.741 -0.647 . . . . 0.27 109.924 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.975 -0.38 . . . . 1.26 109.975 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.0 mt -104.26 130.71 54.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.738 0.304 . . . . 0.65 111.232 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.6 mt -131.62 138.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.55 110.905 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.06 109.91 21.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.118 -0.697 . . . . 0.59 109.118 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.28 158.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.422 . . . . 0.5 111.519 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -123.91 129.35 50.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.893 -0.781 . . . . 0.79 108.893 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.441 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 87.1 mt -112.41 141.39 46.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.46 111.862 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -82.21 107.93 15.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.65 110.628 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 94.0 mmm -93.86 22.48 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.63 110.905 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -94.74 -47.61 6.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.144 -0.688 . . . . 1.27 109.144 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -86.15 -27.7 24.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.288 -0.869 . . . . 1.06 109.55 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -108.76 135.31 50.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.76 109.806 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -102.63 -0.82 31.3 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.028 -0.269 . . . . 1.09 111.398 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -150.26 162.13 41.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.318 . . . . 0.62 110.956 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 264' ' ' ILE . 5.3 mt -75.85 -50.96 13.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.34 109.541 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.23 49.54 4.41 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.659 -0.7 . . . . 0.14 112.589 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.452 HD11 HD13 ' A' ' 262' ' ' LEU . 2.6 pt -145.48 149.71 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.321 0.582 . . . . 0.18 111.722 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.36 121.53 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.871 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.0 mm -88.56 123.3 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.949 0.404 . . . . 0.28 110.623 -179.168 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.33 113.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.358 -0.383 . . . . 0.31 110.246 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -85.72 103.79 2.78 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.728 -0.749 . . . . 0.37 111.81 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 . . . . . 0 C--N 1.323 -0.579 0 N-CA-C 109.612 -0.514 . . . . 1.87 109.612 179.828 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.741 0 N-CA-C 112.55 -0.22 . . . . 0.3 112.55 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.34 129.4 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.102 0.477 . . . . 0.27 111.008 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -117.69 162.47 18.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.72 110.771 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.78 113.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.24 109.999 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.37 -65.09 2.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.42 112.478 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.87 152.73 45.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.759 0.314 . . . . 0.75 110.637 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.78 131.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.079 -0.51 . . . . 0.53 109.912 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -92.86 126.2 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.851 0.358 . . . . 0.74 110.642 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -65.3 128.43 35.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 1.01 109.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.21 -12.85 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.968 -0.634 . . . . 0.36 111.519 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.5 171.08 47.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.934 -0.65 . . . . 0.26 111.73 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.55 -37.52 86.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.25 111.259 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.29 -34.2 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.26 111.039 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.67 -20.78 64.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 0.37 111.619 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.7 -6.58 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.457 -0.338 . . . . 0.41 111.057 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.97 -76.4 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.938 -0.393 . . . . 0.55 109.938 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.92 32.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.377 -0.916 . . . . 0.39 114.177 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -76.83 -34.99 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.571 0.685 . . . . 0.68 110.937 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.76 136.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.52 158.65 75.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.522 -0.308 . . . . 0.69 110.697 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.48 99.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.497 2.131 . . . . 0.41 111.434 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 141.66 -15.82 2.66 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.59 -0.604 . . . . 0.29 111.59 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.0 146.41 54.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.732 0.301 . . . . 0.34 110.321 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.3 ttt -99.88 135.27 41.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.266 -0.424 . . . . 1.26 110.75 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 335' ' ' VAL . 30.1 mt -90.82 117.46 29.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.246 -0.434 . . . . 0.48 109.933 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 336' ' ' ALA . 82.5 mt -100.85 -62.83 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.163 0.506 . . . . 0.53 110.735 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -127.33 133.15 50.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.73 110.912 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 321' ' ' LEU . 44.4 t -119.62 87.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.173 -0.467 . . . . 0.29 109.76 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.4 t30 62.96 82.97 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.786 . . . . 1.71 111.437 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 4.6 m-20 74.8 -59.78 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.427 -0.806 . . . . 1.11 113.11 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.0 m -64.34 124.91 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.589 . . . . 0.71 112.456 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.52 130.02 47.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.466 -0.788 . . . . 0.74 109.628 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.421 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 44.0 m-85 -106.89 15.99 24.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.944 0.349 . . . . 0.33 111.944 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -62.64 -32.8 73.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.122 0.415 . . . . 1.21 112.122 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -117.6 35.81 4.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.392 . . . . 1.32 111.209 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . 0.421 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 95.3 mtp -123.09 167.67 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.02 -0.363 . . . . 0.51 110.02 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 38.9 p -75.96 154.59 35.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.447 -0.342 . . . . 0.97 110.133 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -58.37 -32.67 68.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.48 111.109 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -49.82 19.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.207 -0.452 . . . . 1.4 111.063 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.59 -35.16 77.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.257 -0.429 . . . . 0.88 110.974 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.4 73.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.018 -0.537 . . . . 0.2 111.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.536 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 4.0 t -73.5 -31.96 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.3 . . . . 0.21 110.811 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 78.7 mtt180 -55.45 -50.49 69.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.748 0.309 . . . . 0.83 110.339 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.88 -41.01 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.246 -0.433 . . . . 0.17 110.093 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 304' ' ' VAL . 17.3 tp -52.5 -48.51 65.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.964 -0.562 . . . . 0.38 111.22 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.556 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.3 mtp-105 -62.42 -39.14 92.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.012 -0.54 . . . . 1.57 111.743 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 5.9 mm-40 -65.91 -34.6 78.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.87 110.439 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.3 mt -70.65 -43.93 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.557 . . . . 0.29 110.142 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.8 t -70.78 -18.75 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.246 0.546 . . . . 0.24 110.507 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 56.5 m -87.05 4.77 40.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.037 0.446 . . . . 0.44 110.204 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.35 158.53 18.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 1.16 109.989 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.91 120.48 35.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.662 0.268 . . . . 0.89 111.066 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.59 169.09 19.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.655 -0.783 . . . . 0.45 112.0 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.05 125.4 10.88 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.913 2.408 . . . . 0.58 111.714 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 60.0 mt -100.36 117.69 45.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.922 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 m -90.97 102.23 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.09 110.093 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 24.7 mt -92.93 123.37 36.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.872 0.367 . . . . 0.48 111.886 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.4 m -107.3 99.23 8.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.543 -0.91 . . . . 0.5 108.543 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 301' ' ' LEU . 27.6 m -104.68 155.71 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.33 112.194 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.72 111.06 21.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.227 -0.897 . . . . 0.38 109.829 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.311 -0.852 . . . . 0.7 110.144 -179.346 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 43.4 m95 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 110.665 -0.124 . . . . 0.4 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.679 -0.677 . . . . 0.27 110.003 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.673 0.273 . . . . 1.26 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.45 109.67 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.608 -0.516 . . . . 0.65 109.608 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.63 127.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.799 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -104.21 103.46 13.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.59 110.118 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.38 144.06 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.067 0.46 . . . . 0.5 111.276 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.3 t -114.5 113.68 24.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.087 -0.708 . . . . 0.79 109.087 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.44 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 24.0 mt -95.79 152.74 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.359 0.599 . . . . 0.46 112.038 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.29 122.18 34.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.84 . . . . 0.65 110.017 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 90.7 mmm -102.51 25.07 9.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.63 111.752 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -100.37 -45.38 5.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 258' ' ' ARG . 19.2 ttt180 -92.95 11.43 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.385 0.612 . . . . 1.06 110.178 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.52 155.69 50.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 0.76 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -111.98 -11.94 13.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.627 0.251 . . . . 1.09 110.833 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' B' ' 3' ' ' VAL . 30.0 p90 -157.31 173.07 17.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.542 -0.299 . . . . 0.62 111.066 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.5 mt -75.93 -50.95 13.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.584 . . . . 0.34 109.422 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.9 41.58 5.9 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.517 -0.765 . . . . 0.14 112.823 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.65 146.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.441 0.639 . . . . 0.18 111.767 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.04 115.44 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.704 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.484 HG21 HG22 ' A' ' 318' ' ' VAL . 4.6 mm -85.44 126.65 40.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.28 110.239 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.76 115.84 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.31 110.326 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.32 113.79 4.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.868 -0.682 . . . . 0.37 111.73 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 . . . . . 0 C--N 1.323 -0.572 0 CA-C-O 120.909 0.385 . . . . 1.87 110.455 -179.837 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.551 0 N-CA-C 112.116 -0.394 . . . . 0.3 112.116 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.0 pt -102.24 128.85 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.193 0.521 . . . . 0.27 110.809 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -118.19 163.97 15.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.72 111.12 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 301' ' ' LEU . 46.3 mm -85.74 110.68 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.867 -0.606 . . . . 0.24 109.448 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.79 8.87 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.737 -0.744 . . . . 0.42 112.689 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 163.9 39.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.549 0.214 . . . . 0.75 110.579 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 32.8 mt -114.24 134.32 57.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.53 109.991 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.9 mmt -96.13 128.42 43.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.375 -0.375 . . . . 0.74 110.277 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.26 131.86 49.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.522 . . . . 1.01 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 101.49 -6.85 55.68 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.963 -0.637 . . . . 0.36 112.176 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.15 171.28 46.09 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.872 -0.68 . . . . 0.26 112.419 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -65.52 -35.41 80.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.311 . . . . 0.25 111.057 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.89 -35.63 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.26 110.662 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.57 65.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.37 111.182 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -78.89 -16.61 56.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.41 111.069 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.59 -76.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.641 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.89 -18.35 26.62 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.481 -0.866 . . . . 0.39 114.199 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -69.2 -40.05 78.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.568 0.684 . . . . 0.68 111.468 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.3 137.09 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.739 -0.467 . . . . 0.37 109.739 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -138.87 159.05 68.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.504 -0.316 . . . . 0.69 110.616 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 118.75 5.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.358 2.039 . . . . 0.41 111.629 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 122.12 -19.72 8.18 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.469 -0.653 . . . . 0.29 111.469 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.404 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 84.1 m-20 -65.46 145.49 56.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.656 0.265 . . . . 0.34 110.331 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.3 ttp -101.1 133.84 45.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.443 -0.344 . . . . 1.26 110.516 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.568 HD23 HG12 ' A' ' 335' ' ' VAL . 73.3 mt -88.46 130.19 35.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.48 110.205 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 336' ' ' ALA . 71.4 mt -111.16 -76.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.199 0.523 . . . . 0.53 110.899 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -115.79 140.61 49.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.73 111.136 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 321' ' ' LEU . 87.3 t -134.12 101.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.798 -0.637 . . . . 0.29 109.52 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 7.1 m120 62.3 68.16 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.064 -0.516 . . . . 1.71 111.428 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.93 -51.33 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.251 -0.886 . . . . 1.11 113.373 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.3 m -67.78 130.89 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.27 0.557 . . . . 0.71 111.528 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -105.56 135.61 46.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.421 -0.809 . . . . 0.74 109.767 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . 0.404 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 21.9 m-85 -106.2 11.01 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.951 0.352 . . . . 0.33 111.951 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.5 -32.47 71.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.233 0.457 . . . . 1.21 112.233 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -112.33 32.14 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.022 0.439 . . . . 1.32 111.002 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . 0.404 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 86.5 mtp -123.81 163.72 20.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.181 -0.463 . . . . 0.51 110.371 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 75.5 p -74.39 156.6 36.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.97 110.274 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 90.5 m-20 -55.5 -40.64 72.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.86 0.362 . . . . 0.48 110.483 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.0 m-20 -68.61 -51.47 42.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 1.4 111.28 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 28.6 m-20 -61.01 -36.8 80.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.88 111.684 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.28 -48.94 78.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.2 111.245 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 266' ' ' ILE . 6.2 t -73.51 -31.87 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.21 110.771 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 93.1 mtt180 -55.48 -46.52 76.88 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.03 -0.359 . . . . 0.83 110.03 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.51 -38.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.17 110.276 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 325' ' ' VAL . 40.1 tp -54.61 -50.66 67.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.102 -0.499 . . . . 0.38 110.581 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.9 mtp-105 -61.34 -36.43 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.892 -0.595 . . . . 1.57 110.877 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.96 -46.69 89.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.491 . . . . 1.87 110.016 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.11 -41.71 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.788 -0.642 . . . . 0.29 110.878 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 321' ' ' LEU . 65.1 t -65.53 -15.92 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.282 0.563 . . . . 0.24 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 19.8 m -89.96 0.41 57.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.894 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.23 147.5 26.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 1.16 110.417 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.77 103.8 16.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.761 0.315 . . . . 0.89 111.148 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 176.86 -175.4 47.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.661 -0.78 . . . . 0.45 112.049 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.62 112.05 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.025 2.484 . . . . 0.58 112.077 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.81 121.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.37 110.389 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.34 103.17 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.904 -0.589 . . . . 1.09 110.243 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.8 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.48 111.217 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.6 m -96.78 97.42 9.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.763 -0.828 . . . . 0.5 108.763 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.568 HG12 HD23 ' A' ' 301' ' ' LEU . 26.3 m -100.81 154.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.223 0.535 . . . . 0.33 112.228 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.56 110.6 21.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.172 -0.922 . . . . 0.38 109.54 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 26.3 mtpp . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.083 -0.96 . . . . 0.7 110.129 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 120.587 0.232 . . . . 0.4 110.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 261' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.762 -0.637 . . . . 0.27 109.799 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.094 0.473 . . . . 1.26 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.35 115.35 28.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.877 -0.602 . . . . 0.65 110.134 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 337' ' ' LYS . 37.1 mt -120.88 130.94 74.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.55 111.132 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.7 m -104.62 102.66 12.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.704 -0.68 . . . . 0.59 109.434 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 295' ' ' ILE . 21.5 m -90.42 152.38 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.5 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -113.5 125.15 53.89 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.317 -0.623 . . . . 0.79 109.317 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.33 136.97 52.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 0.46 111.791 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -90.94 117.3 29.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.855 . . . . 0.65 109.971 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.9 mmm -94.16 26.78 3.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.63 111.624 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -99.74 -50.42 4.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.538 -0.541 . . . . 1.27 109.538 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -81.83 -20.6 38.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.495 -0.775 . . . . 1.06 109.992 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -119.74 134.0 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.76 110.033 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -93.17 -8.5 42.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.499 0.555 . . . . 1.09 112.499 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -151.76 170.85 18.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.62 111.116 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 262' ' ' LEU . 4.4 mt -78.67 -53.82 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.886 -0.597 . . . . 0.34 110.466 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.06 5.73 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.14 112.729 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.9 pt -135.14 152.23 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.525 0.678 . . . . 0.18 111.802 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.91 126.5 47.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.993 -1.003 . . . . 1.0 108.812 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 7.0 mm -96.34 114.92 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.65 -0.42 . . . . 0.28 110.461 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.6 t -110.53 106.42 20.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.205 -0.452 . . . . 0.31 110.153 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.96 120.71 5.3 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.734 -0.746 . . . . 0.37 111.813 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 . . . . . 0 C--N 1.326 -0.422 0 N-CA-C 109.982 -0.377 . . . . 1.87 109.982 179.836 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.705 0 N-CA-C 111.981 -0.448 . . . . 0.3 111.981 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.9 pt -102.37 118.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.27 110.37 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.84 150.48 28.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.865 -0.607 . . . . 0.72 110.777 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.2 mm -76.51 115.5 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.271 -0.422 . . . . 0.24 110.001 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -69.89 -58.82 5.96 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.814 -0.708 . . . . 0.42 112.139 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.47 165.08 36.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.152 -0.314 . . . . 0.75 110.152 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.96 138.88 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.707 -0.479 . . . . 0.53 109.707 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 35.2 mmt -102.39 132.17 48.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.817 0.342 . . . . 0.74 110.675 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -70.07 108.25 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 1.01 110.451 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 136.06 -13.08 4.13 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.382 -0.687 . . . . 0.36 111.382 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.3 170.63 39.3 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.26 111.965 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.15 83.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.25 111.382 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.84 -33.34 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.26 111.132 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.56 -15.35 62.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.37 111.541 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.26 -20.09 25.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.288 -0.415 . . . . 0.41 110.942 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.4 -73.35 0.35 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.55 110.351 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.31 -20.56 30.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.48 -0.867 . . . . 0.39 113.57 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -73.37 -35.79 65.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.743 0.771 . . . . 0.68 111.048 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 252' ' ' VAL . 42.9 mt -82.86 137.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.591 -0.522 . . . . 0.37 109.591 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -135.83 158.65 73.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.44 -0.345 . . . . 0.69 110.369 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.34 112.69 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.505 2.137 . . . . 0.41 111.429 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.92 -21.09 5.02 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.101 -0.571 . . . . 0.29 111.94 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.86 146.67 54.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.758 0.313 . . . . 0.34 110.92 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 59.4 ttp -105.9 132.41 52.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.288 -0.414 . . . . 1.26 110.363 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.46 129.92 34.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.347 -0.388 . . . . 0.48 110.491 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 336' ' ' ALA . 19.3 mt -104.78 -76.6 0.6 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.53 110.221 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -112.1 128.79 56.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.584 -0.734 . . . . 0.73 110.569 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.99 97.68 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.121 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 57.23 77.22 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.71 111.647 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 75.3 -52.83 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.763 1.023 . . . . 1.11 113.763 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.21 132.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.437 0.637 . . . . 0.71 112.349 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -105.67 132.53 51.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.577 -0.738 . . . . 0.74 109.586 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -99.53 3.7 45.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.845 0.313 . . . . 0.33 111.845 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.53 -22.57 65.26 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.654 0.242 . . . . 1.21 111.654 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -118.06 38.24 3.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.32 110.55 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -138.83 159.34 42.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.51 110.397 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 157.34 37.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.537 -0.301 . . . . 0.97 110.549 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.1 m-20 -54.78 -48.17 73.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.35 -0.387 . . . . 0.48 111.179 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.21 -50.79 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.849 -0.614 . . . . 1.4 111.386 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -65.05 -33.79 76.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.88 111.469 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.07 83.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.307 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 2.3 t -71.97 -31.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.607 -0.437 . . . . 0.21 110.917 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -56.25 -54.57 43.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.891 0.377 . . . . 0.83 110.613 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.83 -36.4 77.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.17 110.526 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.3 tp -56.03 -50.83 69.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.38 110.817 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 30.8 mtp180 -63.74 -31.96 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.57 111.292 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -66.13 -45.17 82.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.029 0.442 . . . . 1.87 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.0 mt -67.08 -41.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.899 -0.591 . . . . 0.29 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 99.0 t -66.77 -19.48 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.159 0.504 . . . . 0.24 110.992 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 55.3 m -87.25 -5.62 58.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.809 0.337 . . . . 0.44 110.406 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.6 133.69 41.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 1.16 110.393 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.97 130.43 39.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.176 -0.465 . . . . 0.89 110.656 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 146.86 -174.57 26.64 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.83 -0.7 . . . . 0.45 112.286 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 127.67 8.12 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.079 2.519 . . . . 0.58 112.129 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.69 123.92 71.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.103 -0.499 . . . . 0.37 110.564 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.9 OUTLIER -105.59 117.25 33.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.825 -0.625 . . . . 1.09 110.335 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 78.3 mt -102.05 120.8 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.07 -0.513 . . . . 0.48 111.002 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.1 m -100.54 103.91 15.25 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.336 -0.616 . . . . 0.5 109.336 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.33 145.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.33 112.023 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -94.79 92.95 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.526 -0.761 . . . . 0.38 109.316 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 250' ' ' ILE . 20.3 mtpp . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.49 -0.766 . . . . 0.7 111.196 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 110.162 -0.311 . . . . 0.4 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.73 -0.653 . . . . 0.27 110.012 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.991 0.424 . . . . 1.26 110.284 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.34 121.4 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.907 -0.588 . . . . 0.65 110.727 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.9 127.11 67.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.477 -0.328 . . . . 0.55 111.221 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 86.8 m -103.63 118.9 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.157 -0.683 . . . . 0.59 109.157 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.48 143.4 22.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 0.5 111.399 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 t -101.33 137.85 39.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.046 -1.094 . . . . 0.79 108.046 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 85.7 mt -119.15 131.24 55.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.107 0.479 . . . . 0.46 111.668 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.07 108.32 13.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.437 -0.801 . . . . 0.65 110.353 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 95.4 mmm -96.0 13.92 25.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.63 110.981 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -85.27 -40.7 16.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 1.27 109.941 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -93.88 -17.13 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.434 0.635 . . . . 1.06 109.898 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -108.01 161.45 14.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.714 -0.676 . . . . 0.76 110.108 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -124.87 -0.66 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.839 -0.344 . . . . 1.09 111.515 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -159.71 164.04 34.25 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.571 -0.286 . . . . 0.62 110.918 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.7 mt -77.39 -49.22 15.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.711 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 81.27 50.85 4.92 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.68 -0.691 . . . . 0.14 112.339 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 262' ' ' LEU . 3.7 pt -145.56 146.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.517 0.675 . . . . 0.18 111.767 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.29 120.25 38.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.974 . . . . 1.0 108.761 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.3 mm -88.33 127.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.615 -0.434 . . . . 0.28 110.567 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.81 115.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.331 -0.395 . . . . 0.31 110.714 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.63 111.62 4.29 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.201 -0.759 . . . . 0.37 111.201 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 1.87 110.215 -179.532 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.571 0 N-CA-C 112.354 -0.298 . . . . 0.3 112.354 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.86 123.34 58.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.365 0.602 . . . . 0.27 110.601 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.0 159.43 19.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.611 -0.722 . . . . 0.72 110.681 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.62 108.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.379 -0.6 . . . . 0.24 109.379 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -68.57 -58.34 7.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.063 -0.589 . . . . 0.42 112.71 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.63 156.22 39.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.673 0.273 . . . . 0.75 110.545 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.23 134.8 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.53 109.915 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 31.3 mmt -96.38 125.06 40.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.337 -0.392 . . . . 0.74 110.166 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.93 120.75 11.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 1.01 110.364 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.82 -12.56 13.29 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.813 -0.708 . . . . 0.36 111.635 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.48 171.66 47.87 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.712 -0.756 . . . . 0.26 111.641 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.47 80.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.836 0.351 . . . . 0.25 111.382 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.41 -35.12 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.26 110.806 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.58 -11.1 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.37 111.958 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -97.19 -5.43 37.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.775 0.322 . . . . 0.41 110.94 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -95.82 -73.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.55 110.04 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.7 -11.54 42.11 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.556 -0.831 . . . . 0.39 114.174 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -81.2 -29.01 34.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.962 0.881 . . . . 0.68 111.289 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.38 138.06 19.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.603 -0.518 . . . . 0.37 109.603 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.19 158.88 71.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.333 -0.247 . . . . 0.69 110.333 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.3 Cg_exo -59.3 114.07 1.87 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.385 2.057 . . . . 0.41 111.455 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.81 -21.36 5.01 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.995 -0.548 . . . . 0.29 111.954 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -70.2 148.03 49.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.611 0.243 . . . . 0.34 110.425 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 57.6 ttp -105.36 139.67 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 1.26 111.05 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.0 mt -87.16 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.377 -0.374 . . . . 0.48 110.51 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 336' ' ' ALA . 76.3 mt -115.16 -68.29 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 0.53 110.732 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 306' ' ' ASP . 7.7 tt0 -119.65 133.89 55.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.73 110.258 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.652 ' O ' HG22 ' A' ' 307' ' ' VAL . 69.5 t -127.91 116.15 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.187 -0.461 . . . . 0.29 110.935 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 1.1 m-20 50.73 46.61 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.876 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 25.6 m-20 81.27 -13.66 0.89 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.73 1.011 . . . . 1.11 113.73 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 304' ' ' VAL . 2.5 m -90.41 137.01 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.938 -0.705 . . . . 0.71 109.988 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -98.03 134.62 40.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.74 111.649 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.18 -0.34 14.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.33 110.989 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.6 -24.72 64.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.451 0.538 . . . . 1.21 112.451 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -125.71 53.95 1.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.115 0.484 . . . . 1.32 111.407 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 94.6 mtp -142.98 169.02 18.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.138 -0.483 . . . . 0.51 110.139 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.3 p -79.1 159.07 27.66 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.767 -0.457 . . . . 0.97 109.767 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 94.1 m-20 -58.05 -42.62 85.82 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.199 0.523 . . . . 0.48 110.217 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -55.13 21.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.209 -0.905 . . . . 1.4 111.263 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -58.58 -37.31 75.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.392 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.92 63.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.692 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -70.4 -30.74 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.839 -0.344 . . . . 0.21 110.97 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -57.64 -49.93 74.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.023 0.44 . . . . 0.83 110.182 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.63 -39.57 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.539 . . . . 0.17 110.128 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.5 tp -56.27 -52.28 65.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.38 110.501 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.514 ' HA ' HG11 ' B' ' 3' ' ' VAL . 70.6 mtp180 -62.3 -36.33 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.759 -0.655 . . . . 1.57 111.014 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -46.12 87.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.389 -0.369 . . . . 1.87 110.153 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.84 -42.38 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.97 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 321' ' ' LEU . 60.3 t -67.18 -17.02 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 0.24 110.948 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.4 m -86.57 3.79 42.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.44 110.727 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 171.62 7.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.16 110.643 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 138.6 37.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.42 -0.355 . . . . 0.89 111.209 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 132.15 169.42 12.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.699 -0.762 . . . . 0.45 112.312 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.7 140.25 42.45 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.758 2.306 . . . . 0.58 112.118 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 69.2 mt -114.31 128.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.35 -0.386 . . . . 0.37 110.859 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.6 p -101.71 120.24 40.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.012 -0.54 . . . . 1.09 110.003 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.4 mt -113.12 118.74 35.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.385 -0.37 . . . . 0.48 111.53 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 251' ' ' THR . 85.6 m -101.94 109.62 21.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.28 155.16 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.34 0.59 . . . . 0.33 112.126 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -107.39 103.36 12.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.202 -0.908 . . . . 0.38 109.336 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.559 -0.734 . . . . 0.7 110.617 -179.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 120.404 0.145 . . . . 0.4 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.503 -0.554 . . . . 0.27 109.503 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.92 -0.4 . . . . 1.26 109.92 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.9 mt -122.84 129.73 74.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.83 0.348 . . . . 0.65 110.536 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.09 125.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.369 -0.378 . . . . 0.55 110.829 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 61.2 m -111.8 111.59 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.29 -0.633 . . . . 0.59 109.29 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.44 153.6 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.5 111.494 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.4 t -106.01 133.69 50.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.79 109.472 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.582 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 92.5 mt -109.26 132.37 54.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.026 0.441 . . . . 0.46 111.159 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.93 114.21 9.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.65 109.998 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.5 mmm -96.57 21.36 9.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.63 111.203 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -93.39 -50.3 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.224 0.535 . . . . 1.27 109.668 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -83.49 -16.92 43.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.66 . . . . 1.06 110.428 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -119.97 135.62 54.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.071 -0.714 . . . . 0.76 109.071 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -101.97 5.76 40.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.138 0.421 . . . . 1.09 112.138 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.54 166.01 31.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.651 0.263 . . . . 0.62 110.725 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 262' ' ' LEU . 7.6 mt -78.4 -52.61 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.34 109.843 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.73 42.85 5.3 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.995 -0.622 . . . . 0.14 112.56 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.0 pt -143.54 149.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.54 . . . . 0.18 111.635 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.551 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 0.3 OUTLIER -98.22 131.92 44.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.343 178.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 12.3 mm -95.8 104.42 15.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.937 0.399 . . . . 0.28 110.673 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 90.5 t -92.32 108.31 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.884 -0.598 . . . . 0.31 110.157 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.0 106.95 3.48 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.834 -0.698 . . . . 0.37 111.994 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 . . . . . 0 C--O 1.235 0.337 0 CA-C-O 121.249 0.547 . . . . 1.87 110.386 -179.552 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.69 0 N-CA-C 112.112 -0.395 . . . . 0.3 112.112 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.2 pt -106.12 129.14 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.218 0.532 . . . . 0.27 111.272 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -119.47 160.15 22.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.725 -0.671 . . . . 0.72 110.676 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.15 116.03 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.708 -0.678 . . . . 0.24 109.399 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -75.46 -74.47 0.9 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.42 112.44 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 152.51 50.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.221 -0.289 . . . . 0.75 110.221 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 296' ' ' GLU . 44.7 mt -105.12 128.3 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.53 110.459 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -95.04 127.24 40.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.989 -0.55 . . . . 0.74 111.032 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -64.25 128.45 35.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.01 110.161 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.34 12.91 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.16 -0.776 . . . . 0.36 111.16 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.24 166.94 51.88 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.776 -0.726 . . . . 0.26 111.926 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.84 -32.33 73.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.738 0.304 . . . . 0.25 111.509 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.22 -40.8 80.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.321 -0.4 . . . . 0.26 110.953 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.42 -13.06 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.081 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.34 -11.04 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.41 111.148 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 30.6 t70 -96.33 -69.89 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.393 -0.367 . . . . 0.55 110.514 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.3 -13.04 40.17 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.284 -0.96 . . . . 0.39 114.823 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.481 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 19.9 mtm180 -81.1 -33.19 33.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.342 1.071 . . . . 0.68 111.143 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.7 mt -80.43 138.42 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.285 -0.635 . . . . 0.37 109.285 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -141.48 162.01 49.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.351 0.119 . . . . 0.69 110.929 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 50.4 Cg_exo -56.97 118.38 5.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.335 2.023 . . . . 0.41 111.549 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.74 -26.12 5.73 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.743 -0.742 . . . . 0.29 112.119 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 87.4 m-20 -62.06 145.75 52.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.799 0.333 . . . . 0.34 110.471 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.4 ttp -103.04 135.96 43.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 1.26 110.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.1 121.4 30.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.48 109.861 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 336' ' ' ALA . 85.8 mt -100.01 -68.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.327 0.584 . . . . 0.53 110.07 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.53 136.32 54.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.414 -0.812 . . . . 0.73 110.768 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 321' ' ' LEU . 79.5 t -128.73 107.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.427 -0.583 . . . . 0.29 109.427 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 0.9 OUTLIER 58.32 62.97 1.84 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.072 -0.513 . . . . 1.71 111.286 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 7.7 m-20 76.51 -44.02 0.47 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.94 1.089 . . . . 1.11 113.94 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 304' ' ' VAL . 35.9 m -71.59 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.265 0.555 . . . . 0.71 111.289 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 310' ' ' GLU . 52.5 t30 -105.02 128.7 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.74 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -101.11 2.86 40.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.409 -0.36 . . . . 0.33 111.712 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' A' ' 308' ' ' ASN . 2.8 mt-10 -49.29 -41.69 38.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.853 0.686 . . . . 1.21 112.853 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -112.8 39.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.331 . . . . 1.32 111.299 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -121.93 179.67 4.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.761 0.315 . . . . 0.51 110.681 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 89.9 p -88.71 155.66 19.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.805 -0.443 . . . . 0.97 109.805 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 318' ' ' VAL . 97.2 m-20 -58.05 -41.14 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 0.48 110.973 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -50.92 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 1.4 111.802 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.41 -32.52 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.88 111.762 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.23 77.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.337 . . . . 0.2 110.863 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -73.58 -31.03 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.21 110.657 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.22 -51.67 65.84 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.502 . . . . 0.83 110.314 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.89 -39.74 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.17 110.37 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.5 tp -56.1 -52.53 63.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.38 110.95 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.545 ' HA ' HG11 ' B' ' 3' ' ' VAL . 47.4 mtp180 -62.21 -37.94 87.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 1.57 110.991 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.65 -45.28 94.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.665 0.269 . . . . 1.87 110.421 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.53 -42.79 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.29 110.537 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 321' ' ' LEU . 41.6 t -71.15 -9.92 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.279 0.562 . . . . 0.24 111.043 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -90.21 -9.26 48.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.95 0.405 . . . . 0.44 110.76 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.43 159.48 15.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 1.16 110.618 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.23 116.49 29.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.331 -0.395 . . . . 0.89 110.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 166.05 169.82 30.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.82 -0.705 . . . . 0.45 111.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.05 118.96 5.88 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.603 2.202 . . . . 0.58 111.664 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.22 119.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.954 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 m -97.59 112.17 24.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.797 -0.638 . . . . 1.09 110.022 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 251' ' ' THR . 96.6 mt -101.3 121.47 41.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.48 111.819 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 99.4 m -106.26 100.04 9.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.5 108.618 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.3 m -101.95 156.56 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.323 0.583 . . . . 0.33 112.335 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.4 113.29 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.38 109.459 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.5 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.324 -0.846 . . . . 0.7 109.969 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 30.1 m95 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 110.672 -0.121 . . . . 0.4 110.672 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.594 -0.717 . . . . 0.27 109.697 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.948 -0.39 . . . . 1.26 109.948 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.71 124.44 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.65 111.335 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 41.3 mt -120.88 133.22 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.19 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 m -107.36 109.8 21.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.091 -0.504 . . . . 0.59 109.924 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.19 152.61 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.862 0.363 . . . . 0.5 111.101 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 8.8 t -117.91 131.08 56.56 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.94 -0.763 . . . . 0.79 108.94 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.452 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.9 mt -106.77 140.53 39.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 0.46 111.872 -178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.43 119.89 25.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.65 110.077 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 83.4 mmm -101.0 17.74 21.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.963 0.411 . . . . 0.63 111.33 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -88.35 -50.13 6.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.679 -0.489 . . . . 1.27 109.679 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -93.58 11.77 27.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.441 0.639 . . . . 1.06 109.922 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -133.28 159.0 41.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.76 108.964 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -128.66 0.63 5.49 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.575 -0.45 . . . . 1.09 111.615 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.84 165.5 25.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.603 0.24 . . . . 0.62 110.593 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.422 HD13 HD11 ' A' ' 264' ' ' ILE . 8.9 mt -75.36 -54.77 6.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.096 -0.502 . . . . 0.34 109.757 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.1 44.1 5.46 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.894 -0.594 . . . . 0.14 112.269 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 262' ' ' LEU . 3.9 pt -143.29 150.4 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.536 . . . . 0.18 111.947 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.0 OUTLIER -100.21 132.89 45.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.011 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . 0.403 HG21 HG22 ' A' ' 318' ' ' VAL . 8.9 mm -98.99 117.7 44.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.965 0.412 . . . . 0.28 110.469 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.94 106.64 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.456 -0.338 . . . . 0.31 110.536 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.12 118.15 4.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.37 111.732 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 . . . . . 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 1.87 110.431 -179.679 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.698 0 N-CA-C 111.902 -0.479 . . . . 0.3 111.902 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.5 pt -107.72 117.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.154 0.502 . . . . 0.27 110.308 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -108.08 151.11 26.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.777 -0.647 . . . . 0.72 111.152 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.83 117.63 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.222 -0.444 . . . . 0.24 110.045 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -72.63 -64.27 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.166 -0.54 . . . . 0.42 112.146 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.9 m -149.56 161.37 42.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.843 -0.429 . . . . 0.75 109.843 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 57.2 mt -112.49 128.77 68.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.011 0.434 . . . . 0.53 111.166 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.9 mmt -87.31 119.15 27.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.688 -0.687 . . . . 0.74 110.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -62.56 117.61 6.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 1.01 110.142 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 126.14 -18.69 6.53 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.131 -0.788 . . . . 0.36 111.131 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.39 175.0 53.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.972 -0.632 . . . . 0.26 111.995 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -64.2 -37.23 86.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.799 0.333 . . . . 0.25 111.341 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.94 -37.08 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.368 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.3 66.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.083 -0.508 . . . . 0.37 111.88 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.28 -14.66 40.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.41 111.197 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.04 -74.57 0.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.441 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.86 -9.89 37.46 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.483 -0.865 . . . . 0.39 114.42 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -88.34 -35.21 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.044 0.922 . . . . 0.68 110.348 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 29.8 mt -81.81 138.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.4 pt-20 -144.6 162.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.607 -0.27 . . . . 0.69 110.755 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . 0.525 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 52.2 Cg_exo -55.76 117.47 4.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.598 2.199 . . . . 0.41 111.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.56 -24.9 6.05 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.209 -0.757 . . . . 0.29 111.209 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.66 135.44 55.91 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.712 -0.477 . . . . 0.34 109.712 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 46.3 ttp -97.4 130.86 44.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.728 0.299 . . . . 1.26 110.815 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.8 mt -80.51 125.44 29.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.48 110.276 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 336' ' ' ALA . 40.2 mt -105.41 -71.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.19 0.519 . . . . 0.53 110.442 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.07 133.68 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.773 -0.649 . . . . 0.73 110.963 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.07 104.16 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.023 -0.535 . . . . 0.29 110.141 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.45 69.11 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 1.71 111.662 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 74.39 -44.68 0.56 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 1.11 114.103 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.0 m -76.87 127.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.606 0.717 . . . . 0.71 111.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -97.4 130.64 44.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.249 -0.887 . . . . 0.74 110.299 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -100.81 2.35 41.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.794 0.294 . . . . 0.33 111.794 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.08 -27.71 63.9 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.17 0.433 . . . . 1.21 112.17 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -109.22 20.3 18.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.7 0.259 . . . . 1.32 111.7 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.0 mtp -118.41 166.54 12.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.51 111.049 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 10.7 p -75.48 162.63 28.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.97 110.355 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 318' ' ' VAL . 52.5 m-20 -60.97 -43.49 98.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.48 110.697 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.53 -56.71 13.87 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.957 -0.565 . . . . 1.4 111.215 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 8.8 m-20 -58.78 -36.25 74.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.88 112.346 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.3 -47.73 80.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.2 111.374 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -73.63 -31.52 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.458 -0.337 . . . . 0.21 111.095 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 88.5 mtt180 -56.9 -46.92 81.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.86 0.362 . . . . 0.83 110.145 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.29 -38.2 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.17 110.114 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 37.4 tp -58.32 -51.36 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.38 110.763 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.517 ' HA ' HG11 ' B' ' 3' ' ' VAL . 52.2 mtp180 -61.59 -31.94 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.706 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.78 -51.29 50.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.465 . . . . 1.87 109.743 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.42 -42.76 88.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.986 -0.552 . . . . 0.29 111.344 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 61.6 t -69.12 -13.89 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.072 0.463 . . . . 0.24 111.256 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 75.2 m -87.45 -6.61 58.34 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.148 -0.345 . . . . 0.44 110.538 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.41 139.55 31.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.215 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.62 91.34 4.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.115 0.484 . . . . 0.89 111.693 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.27 172.52 44.89 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.829 -0.7 . . . . 0.45 111.694 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.37 143.94 44.51 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.498 2.132 . . . . 0.58 111.893 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 42.3 mt -122.16 125.59 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.915 0.388 . . . . 0.37 111.496 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m -107.07 120.99 43.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.119 -0.697 . . . . 1.09 109.119 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.6 mt -106.39 129.2 54.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.336 0.588 . . . . 0.48 111.903 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.09 97.3 6.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.491 -0.929 . . . . 0.5 108.491 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.99 152.34 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.398 0.618 . . . . 0.33 112.418 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.856 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.15 106.79 15.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.924 . . . . 0.38 109.404 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.312 -0.852 . . . . 0.7 110.103 -179.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 21.5 m95 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 110.15 -0.315 . . . . 0.4 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.489 -0.767 . . . . 0.27 110.464 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.713 0.292 . . . . 1.26 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.2 mt -91.34 111.34 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.496 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.29 131.94 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.007 -0.542 . . . . 0.55 110.053 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 5.0 m -121.35 105.46 10.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.036 0.446 . . . . 0.59 110.492 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.54 157.89 6.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.105 -0.498 . . . . 0.5 111.051 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.0 t -109.7 122.55 47.73 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.525 -0.546 . . . . 0.79 109.525 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.497 HD13 HD22 ' A' ' 262' ' ' LEU . 53.1 mt -94.48 120.69 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.18 -0.464 . . . . 0.46 111.158 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.51 115.39 18.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.315 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 85.2 mmm -98.12 19.12 14.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.63 111.039 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -88.66 -52.18 5.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 1.27 109.784 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -92.02 2.03 56.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 1.06 110.001 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -127.71 148.41 50.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.968 -0.56 . . . . 0.76 110.333 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.91 -8.19 14.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.367 -0.379 . . . . 1.09 111.504 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.74 169.51 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.755 0.312 . . . . 0.62 111.194 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.497 HD22 HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER -76.79 -51.63 11.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.365 -0.605 . . . . 0.34 109.365 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.21 39.28 6.45 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.58 -0.736 . . . . 0.14 112.531 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.7 pt -142.31 149.75 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.309 0.575 . . . . 0.18 111.507 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.456 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 23.3 p -105.26 129.29 53.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.32 -0.855 . . . . 1.0 108.892 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 11.0 mm -89.43 127.01 42.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.786 0.327 . . . . 0.28 110.524 -178.822 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 79.3 t -115.57 109.82 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.396 . . . . 0.31 110.129 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.14 145.71 18.69 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.757 -0.735 . . . . 0.37 111.933 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 . . . . . 0 C--N 1.326 -0.431 0 CA-C-O 120.895 0.379 . . . . 1.87 110.828 -179.948 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.448 -0.564 0 N-CA-C 112.277 -0.329 . . . . 0.3 112.277 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.7 pt -110.78 132.88 58.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 0.27 110.552 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 163.79 16.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.534 . . . . 0.72 110.785 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.8 mm -84.04 119.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.24 109.786 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -83.69 -66.28 1.51 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.867 -0.682 . . . . 0.42 112.835 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.3 p -137.93 153.38 49.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.729 0.3 . . . . 0.75 110.959 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 70.8 mt -112.78 133.58 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.53 109.815 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.8 mmt -98.01 127.08 43.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.74 110.848 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.17 117.75 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 1.01 110.459 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.86 -16.6 8.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.821 -0.704 . . . . 0.36 111.946 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.22 168.4 53.12 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.837 -0.696 . . . . 0.26 112.021 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.72 76.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.25 111.301 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.4 -37.43 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.967 -0.56 . . . . 0.26 111.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.28 62.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.37 111.614 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -81.3 -27.88 34.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.342 -0.39 . . . . 0.41 110.939 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.29 -71.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.36 -0.382 . . . . 0.55 110.054 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.08 27.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.083 -1.056 . . . . 0.39 114.168 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -76.26 -23.93 54.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.475 0.637 . . . . 0.68 111.002 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 37.0 mt -88.52 130.06 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.427 -0.583 . . . . 0.37 109.427 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.06 162.64 47.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.725 -0.216 . . . . 0.69 110.553 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 129.75 36.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.322 2.015 . . . . 0.41 111.202 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.55 -17.5 28.23 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.533 -0.841 . . . . 0.29 111.83 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.55 141.58 51.86 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.702 -0.481 . . . . 0.34 109.702 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 41.0 ttp -98.97 132.62 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.451 -0.341 . . . . 1.26 111.093 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 335' ' ' VAL . 94.4 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.48 110.058 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.1 -60.72 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.537 -0.302 . . . . 0.53 111.281 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -126.91 135.33 50.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.386 -0.37 . . . . 0.73 111.076 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 321' ' ' LEU . 43.0 t -125.7 92.26 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.376 -0.374 . . . . 0.29 110.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.38 79.31 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.835 -0.62 . . . . 1.71 111.312 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.67 -57.43 0.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.978 -1.01 . . . . 1.11 113.416 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.17 130.76 28.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.412 0.625 . . . . 0.71 111.641 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -108.02 135.2 49.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.53 -0.759 . . . . 0.74 111.137 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -113.85 18.7 17.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.33 111.187 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.16 -36.56 75.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.584 -0.28 . . . . 1.21 111.662 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.98 49.28 1.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.26 0.552 . . . . 1.32 110.523 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.81 152.95 48.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.51 110.435 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 155.56 40.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 0.97 110.522 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -49.19 -50.82 36.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.008 0.433 . . . . 0.48 111.306 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.62 -53.14 61.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.483 -0.781 . . . . 1.4 111.206 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.8 m-20 -56.3 -40.57 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.882 -0.599 . . . . 0.88 111.714 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.83 81.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.141 -0.481 . . . . 0.2 111.392 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.9 t -78.04 -29.19 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.9 -0.32 . . . . 0.21 111.176 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 81.2 mtt180 -55.17 -49.99 70.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.83 110.286 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.11 -36.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.093 -0.503 . . . . 0.17 110.655 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 304' ' ' VAL . 19.6 tp -54.68 -48.29 72.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.995 -0.548 . . . . 0.38 111.801 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.52 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.5 mtp180 -64.48 -30.24 71.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.238 -0.437 . . . . 1.57 111.713 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 9.3 mm-40 -68.76 -39.38 80.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.087 0.47 . . . . 1.87 109.916 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 62.0 mt -71.13 -43.42 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.837 -0.619 . . . . 0.29 111.085 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.471 HG11 ' HB ' ' B' ' 3' ' ' VAL . 63.7 t -66.65 -19.04 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.169 0.509 . . . . 0.24 111.432 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.4 m -87.64 10.98 16.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.99 0.424 . . . . 0.44 110.853 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.64 152.41 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.377 . . . . 1.16 110.28 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.89 101.06 13.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.89 111.635 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.98 39.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.954 -0.641 . . . . 0.45 111.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.5 124.93 11.23 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.327 2.018 . . . . 0.58 112.152 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 78.8 mt -104.74 118.65 52.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.37 110.78 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.19 113.18 25.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.998 -0.546 . . . . 1.09 110.641 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 251' ' ' THR . 11.5 mt -96.4 119.39 34.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.159 -0.473 . . . . 0.48 111.194 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 93.68 5.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.5 108.635 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 301' ' ' LEU . 21.7 m -97.66 152.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.33 112.278 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.03 95.92 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.399 -0.819 . . . . 0.38 109.078 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.285 -0.864 . . . . 0.7 110.256 -179.325 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 25.0 m95 . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 110.089 -0.337 . . . . 0.4 110.089 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.559 -0.734 . . . . 0.27 110.436 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.831 0.348 . . . . 1.26 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 70.7 mt -93.1 119.38 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.65 109.868 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.47 137.71 51.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.202 -0.453 . . . . 0.55 111.264 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.23 122.97 48.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.855 -0.612 . . . . 0.59 110.115 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 295' ' ' ILE . 33.2 m -114.39 143.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.776 0.322 . . . . 0.5 111.019 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.43 107.4 18.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.79 110.014 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.16 145.18 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 0.46 111.658 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -99.73 117.95 35.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.794 . . . . 0.65 110.078 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.7 mmm -98.75 26.25 5.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.258 -0.428 . . . . 0.63 111.396 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.99 -53.69 3.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 1.27 109.723 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -83.12 -17.4 43.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.554 -0.748 . . . . 1.06 109.822 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -112.28 145.95 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.832 -0.622 . . . . 0.76 109.959 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -111.12 3.23 18.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.683 -0.235 . . . . 1.09 111.616 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -160.03 165.1 32.55 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.746 0.307 . . . . 0.62 110.734 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.34 110.0 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.96 4.26 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.791 -0.641 . . . . 0.14 112.843 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.41 151.65 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.51 0.671 . . . . 0.18 112.073 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.74 119.56 38.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.217 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 4.7 mm -88.34 107.9 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.892 0.377 . . . . 0.28 110.717 -178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.86 114.2 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.19 -0.459 . . . . 0.31 110.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.66 113.36 4.46 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.782 -0.723 . . . . 0.37 111.92 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 . . . . . 0 C--N 1.325 -0.481 0 CA-C-O 121.193 0.521 . . . . 1.87 110.626 -179.753 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.444 -0.791 0 N-CA-C 111.637 -0.585 . . . . 0.3 111.637 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.7 pt -103.59 123.9 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.27 110.565 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 157.05 22.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.704 . . . . 0.72 110.9 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.7 mm -78.28 114.13 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.974 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.91 -57.72 3.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.881 -0.676 . . . . 0.42 112.416 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.9 153.81 35.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.243 -0.281 . . . . 0.75 110.243 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.3 mt -108.88 130.18 62.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.53 110.157 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 39.3 mmt -93.85 122.72 36.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.362 -0.381 . . . . 0.74 110.93 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -61.84 120.21 10.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 1.01 109.764 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.64 -16.19 9.02 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.33 -0.708 . . . . 0.36 111.33 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.2 169.13 45.48 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.443 -0.663 . . . . 0.26 111.443 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.22 74.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.555 0.216 . . . . 0.25 111.546 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 295' ' ' ILE . 84.1 t -67.87 -37.48 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.26 110.836 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.24 -13.28 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.37 111.249 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.16 -13.72 40.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.507 -0.315 . . . . 0.41 111.048 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.15 -70.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.55 110.534 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.44 42.14 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.386 -0.912 . . . . 0.39 114.276 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.16 -22.77 41.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.864 0.832 . . . . 0.68 111.387 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 252' ' ' VAL . 54.7 mt -89.97 137.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.226 -0.657 . . . . 0.37 109.226 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -140.86 163.34 43.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.752 -0.204 . . . . 0.69 110.864 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.32 121.58 10.3 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.216 1.944 . . . . 0.41 111.368 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.43 8.5 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.849 -0.691 . . . . 0.29 112.173 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 84.1 m-20 -61.4 139.65 58.16 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.34 110.498 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 36.3 ttp -101.12 130.45 47.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.524 -0.307 . . . . 1.26 110.429 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . 0.497 HD23 HG12 ' A' ' 335' ' ' VAL . 31.6 mt -84.73 127.48 34.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.389 . . . . 0.48 110.154 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 336' ' ' ALA . 62.4 mt -107.19 -73.55 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.236 0.541 . . . . 0.53 110.391 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -108.07 137.65 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.577 -0.738 . . . . 0.73 110.512 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 321' ' ' LEU . 93.0 t -132.45 98.05 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.289 -0.634 . . . . 0.29 109.289 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.9 m120 59.97 71.94 0.55 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.666 -0.697 . . . . 1.71 111.464 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.6 OUTLIER 76.69 -51.52 0.58 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.957 1.095 . . . . 1.11 113.957 178.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.93 131.66 34.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.571 0.582 . . . . 0.71 112.571 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -101.48 131.39 47.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.44 -0.8 . . . . 0.74 109.235 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.35 5.06 50.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.554 0.576 . . . . 0.33 112.554 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -64.44 -22.16 66.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 1.21 111.699 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -107.44 22.5 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.354 -0.384 . . . . 1.32 111.085 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.21 168.89 16.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 0.51 111.07 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.38 156.14 26.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.863 -0.608 . . . . 0.97 110.404 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 80.7 m-20 -53.22 -50.19 65.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.819 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 10.9 t70 -60.77 -52.77 63.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 1.4 110.901 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.5 -35.56 70.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.933 -0.576 . . . . 0.88 111.123 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.2 111.417 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -70.78 -26.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.845 -0.342 . . . . 0.21 111.285 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 95.5 mtt180 -56.14 -52.36 64.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.631 -0.507 . . . . 0.83 109.631 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.33 -37.28 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.412 -0.813 . . . . 0.17 110.34 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 304' ' ' VAL . 13.5 tp -54.23 -52.82 60.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.725 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HA ' HG11 ' B' ' 3' ' ' VAL . 33.7 mtp180 -64.03 -33.74 76.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.011 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.83 -41.23 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 1.87 110.412 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.8 mt -69.14 -43.04 81.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.937 -0.574 . . . . 0.29 110.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 321' ' ' LEU . 87.3 t -67.03 -21.98 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.068 0.461 . . . . 0.24 111.165 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -83.97 1.94 41.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.768 0.318 . . . . 0.44 110.954 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.7 141.01 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.16 110.269 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 115.13 21.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.89 111.659 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 169.18 -170.92 42.83 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.993 -0.622 . . . . 0.45 112.037 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.24 117.18 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.202 2.602 . . . . 0.58 111.806 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 64.8 mt -98.3 118.12 44.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.95 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.61 110.13 21.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 1.09 110.295 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.05 124.35 45.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.48 111.379 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.67 99.36 9.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.699 -0.852 . . . . 0.5 108.699 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . 0.497 HG12 HD23 ' A' ' 301' ' ' LEU . 28.6 m -98.88 148.23 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.286 0.565 . . . . 0.33 112.232 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -105.12 102.79 12.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.33 -0.85 . . . . 0.38 109.966 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 28.2 mtpp . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.349 -0.834 . . . . 0.7 109.856 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.532 0.206 . . . . 0.4 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.853 0 N-CA-C 109.369 -0.604 . . . . 0.27 109.369 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 43.2 t30 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.808 0.337 . . . . 1.26 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 91.9 mt -92.12 123.21 44.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.65 110.512 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.26 122.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.865 0.364 . . . . 0.55 111.074 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.35 120.35 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.59 110.104 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 332' ' ' SER . 24.8 m -125.49 144.98 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 0.5 111.785 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.0 t -110.99 120.94 44.05 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.582 -0.896 . . . . 0.79 108.582 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.43 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.7 mt -102.81 135.55 44.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.083 0.468 . . . . 0.46 111.766 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.01 120.17 13.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.371 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 87.8 mmm -102.54 17.46 23.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.165 0.507 . . . . 0.63 110.895 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -88.65 -53.19 4.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.121 0.486 . . . . 1.27 109.801 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -80.48 -31.04 37.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.374 -0.83 . . . . 1.06 110.648 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -92.6 157.71 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.677 -0.49 . . . . 0.76 109.677 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -119.18 -7.76 10.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.915 0.388 . . . . 1.09 110.787 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -156.52 173.26 17.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.036 -0.529 . . . . 0.62 110.279 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 9.0 mt -80.57 -52.93 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.34 110.029 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.55 46.27 4.37 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.975 -0.631 . . . . 0.14 112.809 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 262' ' ' LEU . 4.7 pt -145.86 149.58 16.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.113 0.483 . . . . 0.18 111.388 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . 0.495 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 5.5 p -99.18 124.62 44.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.159 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.3 mm -89.23 111.02 22.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.04 0.448 . . . . 0.28 110.87 -178.759 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.7 t -105.94 110.43 31.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.103 -0.498 . . . . 0.31 110.986 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.72 119.36 6.09 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.825 -0.702 . . . . 0.37 111.361 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 . . . . . 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 1.87 110.5 -179.677 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.441 -0.989 0 N-CA-C 111.756 -0.538 . . . . 0.3 111.756 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.12 119.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.015 0.436 . . . . 0.27 110.147 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.61 159.54 17.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.783 -0.644 . . . . 0.72 111.18 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.99 112.61 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.564 -0.743 . . . . 0.24 109.397 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.18 -55.38 6.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.397 -0.906 . . . . 0.42 112.267 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.9 p -153.29 156.68 38.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.188 -0.301 . . . . 0.75 110.188 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 35.9 mt -106.71 135.73 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.201 -0.454 . . . . 0.53 110.131 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -97.55 134.65 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.224 -0.444 . . . . 0.74 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -70.25 135.84 49.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 1.01 110.006 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.76 -10.26 64.37 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.824 -0.703 . . . . 0.36 111.907 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.03 176.12 53.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.96 -0.638 . . . . 0.26 112.115 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -68.35 -37.98 81.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.73 0.3 . . . . 0.25 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.3 -33.42 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.048 0.451 . . . . 0.26 111.283 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.13 -21.97 66.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.092 -0.504 . . . . 0.37 111.629 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -84.88 -15.01 46.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.359 -0.382 . . . . 0.41 111.419 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.34 -74.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.55 110.968 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.95 -15.94 47.33 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.604 -0.808 . . . . 0.39 114.085 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -80.29 -29.96 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.651 0.725 . . . . 0.68 110.945 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.8 mt -84.55 137.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.751 -0.462 . . . . 0.37 109.751 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -136.7 164.36 43.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.657 -0.247 . . . . 0.69 110.924 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.7 111.77 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.261 1.974 . . . . 0.41 110.615 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.81 -19.02 5.04 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.485 -0.646 . . . . 0.29 111.485 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 95.4 m-20 -69.06 147.53 51.38 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.044 -0.354 . . . . 0.34 110.044 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 26.7 ttt -103.57 136.97 42.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.695 0.283 . . . . 1.26 110.811 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 19.5 mt -88.59 123.13 32.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.48 109.828 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 336' ' ' ALA . 80.5 mt -102.3 -77.66 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.168 0.509 . . . . 0.53 110.586 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -113.0 134.29 54.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.73 111.3 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.32 94.33 2.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.144 -0.48 . . . . 0.29 109.889 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 60.63 75.98 0.39 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.705 -0.68 . . . . 1.71 111.399 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 56.5 m-20 76.97 -61.44 0.43 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.903 0.881 . . . . 1.11 112.894 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m -63.36 125.89 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.627 0.727 . . . . 0.71 111.986 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.23 132.95 51.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.249 -0.887 . . . . 0.74 109.925 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -104.35 11.09 35.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.568 -0.287 . . . . 0.33 111.434 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.6 -38.54 66.89 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.952 0.406 . . . . 1.21 111.257 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -123.96 59.17 1.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 1.32 110.867 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 87.2 mtp -140.05 163.84 31.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.51 110.051 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.1 m -69.85 147.29 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.821 -0.437 . . . . 0.97 109.821 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -52.59 -47.07 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.744 0.306 . . . . 0.48 111.096 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -50.3 71.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.4 110.91 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 1.7 m-20 -61.1 -34.74 75.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.88 111.834 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.98 -49.09 78.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.117 -0.492 . . . . 0.2 111.1 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.76 -28.0 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.529 -0.305 . . . . 0.21 110.905 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 67.5 mtt180 -54.71 -52.04 63.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.83 110.571 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 15.4 t -70.42 -39.58 76.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.17 110.618 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 21.7 tp -54.26 -49.24 70.01 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.163 -0.471 . . . . 0.38 111.431 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.593 ' HA ' HG11 ' B' ' 3' ' ' VAL . 14.7 mtp-105 -60.9 -37.49 82.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 1.57 111.654 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.33 -38.02 88.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 1.87 110.779 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.36 -41.64 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.091 -0.504 . . . . 0.29 110.692 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 40.5 t -69.83 -19.42 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.044 0.45 . . . . 0.24 111.075 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 22.6 m -91.08 2.01 56.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.053 0.454 . . . . 0.44 110.463 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -106.92 137.78 44.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.164 -0.471 . . . . 1.16 110.572 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.81 99.37 3.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 0.89 111.814 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.59 160.3 24.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.054 -0.593 . . . . 0.45 111.757 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.82 130.32 32.56 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.824 2.349 . . . . 0.58 112.229 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 76.3 mt -112.18 121.13 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.37 111.131 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 9.5 m -105.99 121.33 43.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.931 -0.577 . . . . 1.09 109.893 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 36.5 mt -104.08 126.71 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.297 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -106.18 98.65 8.31 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.336 -0.986 . . . . 0.5 108.336 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.12 151.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.414 0.626 . . . . 0.33 112.447 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.47 112.01 23.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.174 -0.921 . . . . 0.38 109.973 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 25.6 mtpp . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.393 -0.813 . . . . 0.7 109.803 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 16.8 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.58 -0.156 . . . . 0.4 110.58 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.752 -0.642 . . . . 0.27 110.077 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.139 0.495 . . . . 1.26 109.976 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.7 mt -95.58 127.76 47.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.202 -0.453 . . . . 0.65 110.926 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.23 129.38 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.439 -0.346 . . . . 0.55 110.681 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 6.9 m -100.08 110.17 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.149 -0.686 . . . . 0.59 109.149 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.85 154.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.121 0.486 . . . . 0.5 111.385 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.3 t -122.44 126.24 47.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.998 -0.741 . . . . 0.79 108.998 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 66.7 mt -114.21 149.16 36.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.46 111.492 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.8 120.09 34.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.589 -0.732 . . . . 0.65 110.116 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 99.8 mmm -101.1 16.99 23.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.11 0.481 . . . . 0.63 111.223 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.217 -0.66 . . . . 1.27 109.217 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -91.65 -16.32 27.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.478 -0.783 . . . . 1.06 109.9 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -114.39 145.37 41.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.9 -0.591 . . . . 0.76 109.933 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -107.9 -7.94 16.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.742 0.306 . . . . 1.09 111.673 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -151.7 168.91 23.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.492 -0.322 . . . . 0.62 110.932 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.8 mt -77.94 -55.17 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.34 109.637 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 91.24 43.79 4.56 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.726 -0.67 . . . . 0.14 112.331 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 264' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 262' ' ' LEU . 8.1 pt -139.74 151.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.397 0.617 . . . . 0.18 111.736 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 t -103.1 128.51 49.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.795 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 8.4 mm -97.54 113.87 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.989 0.423 . . . . 0.28 110.744 -179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.41 114.11 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.101 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.75 108.86 3.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.545 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 . . . . . 0 C--N 1.325 -0.467 0 CA-C-O 120.749 0.309 . . . . 1.87 110.328 -179.73 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.446 -0.658 0 N-CA-C 112.127 -0.389 . . . . 0.3 112.127 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -106.08 118.09 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.374 0.607 . . . . 0.27 110.629 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.0 152.73 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.743 -0.662 . . . . 0.72 110.94 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.13 113.36 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.128 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.33 -60.05 3.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.877 -0.677 . . . . 0.42 112.33 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.07 160.96 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.54 0.209 . . . . 0.75 110.524 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.92 131.98 64.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.778 -0.453 . . . . 0.53 109.778 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.2 mmt -97.99 128.29 44.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.778 0.323 . . . . 0.74 110.759 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -66.45 132.89 49.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.01 110.308 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.86 -12.7 32.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.93 -0.653 . . . . 0.36 111.552 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -87.36 171.82 42.44 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.024 -0.608 . . . . 0.26 111.826 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 288' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.12 -36.65 83.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.25 111.518 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.76 -35.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.26 111.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.79 -14.09 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.37 111.91 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.71 -23.56 25.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 0.41 110.728 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 292' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 13.0 t70 -77.98 -68.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.55 110.215 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.46 -20.38 46.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.431 -0.89 . . . . 0.39 113.991 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 294' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 72.7 mtm180 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.716 0.758 . . . . 0.68 110.927 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.1 mt -75.62 136.02 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.593 -0.521 . . . . 0.37 109.593 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.42 161.16 64.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.539 -0.3 . . . . 0.69 110.443 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.74 109.41 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.2 1.933 . . . . 0.41 111.041 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 131.86 -15.79 5.1 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.153 -0.546 . . . . 0.29 111.737 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -70.61 149.59 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.241 -0.281 . . . . 0.34 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 27.0 ttp -107.15 135.94 47.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.556 -0.293 . . . . 1.26 110.613 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 mt -89.3 119.22 29.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.135 -0.484 . . . . 0.48 109.829 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 67.2 mt -100.99 -64.33 1.06 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.084 0.469 . . . . 0.53 110.705 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 303' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 307' ' ' VAL . 5.1 tt0 -120.6 133.23 55.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.73 110.815 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 304' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.0 t -129.14 104.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.258 -0.428 . . . . 0.29 110.536 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 58.07 70.32 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 1.71 111.483 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.89 -44.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.994 1.109 . . . . 1.11 113.994 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 307' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 304' ' ' VAL . 32.2 m -74.15 139.22 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.354 0.597 . . . . 0.71 111.36 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -111.66 135.64 51.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.69 -0.686 . . . . 0.74 110.379 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -109.26 11.84 25.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.286 . . . . 0.33 111.661 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.98 -29.01 70.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.845 0.313 . . . . 1.21 111.845 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -117.98 36.31 4.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.792 0.33 . . . . 1.32 111.07 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.3 mtp -129.68 153.07 48.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.489 -0.323 . . . . 0.51 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 149.9 49.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.132 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -51.59 -47.67 63.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.443 -0.344 . . . . 0.48 111.602 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 315' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.1 OUTLIER -57.8 -50.03 74.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 1.4 111.009 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 316' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 29.8 m-20 -63.75 -37.44 87.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.88 111.815 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.28 -51.09 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.2 111.634 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 318' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -72.92 -30.46 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.688 -0.405 . . . . 0.21 110.992 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 319' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 80.5 mtt180 -56.11 -46.52 79.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.884 0.373 . . . . 0.83 110.499 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.47 -40.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.17 110.504 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 31.5 tp -54.36 -47.77 72.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.12 -0.491 . . . . 0.38 111.417 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 322' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 25.6 mtp-105 -64.96 -29.58 70.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.955 -0.566 . . . . 1.57 111.871 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -69.07 -40.42 78.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.153 0.501 . . . . 1.87 110.003 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.66 -44.55 85.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.685 . . . . 0.29 110.718 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 325' ' ' VAL . . . . . 0.456 HG11 ' HB ' ' B' ' 3' ' ' VAL . 40.8 t -69.2 -18.65 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.483 . . . . 0.24 111.594 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -91.75 3.55 54.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.44 110.875 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 148.77 33.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 1.16 110.24 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.0 139.98 36.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.497 -0.32 . . . . 0.89 110.49 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 143.06 -173.62 24.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.662 -0.78 . . . . 0.45 112.308 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.5 117.18 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.424 2.749 . . . . 0.58 112.21 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.6 mt -96.88 119.23 44.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.37 111.258 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.59 115.2 28.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 1.09 110.169 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 333' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 304' ' ' VAL . 49.9 mt -104.45 125.36 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.87 0.367 . . . . 0.48 111.36 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 103.05 11.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.563 . . . . 0.5 109.812 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.7 m -103.96 158.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.191 -0.458 . . . . 0.33 111.691 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -118.34 108.72 15.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.488 -0.778 . . . . 0.38 110.195 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.263 -0.875 . . . . 0.7 110.223 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.377 0.132 . . . . 0.4 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.727 -0.654 . . . . 0.27 109.997 178.214 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 . . . . . 0 N--CA 1.482 1.149 0 N-CA-C 110.258 -0.275 . . . . 1.26 110.258 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 35.7 mt -102.64 122.3 54.83 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 110.293 -0.262 . . . . 0.65 110.293 -179.769 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 27.0 mm -120.13 124.21 72.22 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 CA-C-O 120.875 0.369 . . . . 0.55 110.832 -179.7 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -110.36 111.86 23.42 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.769 -0.456 . . . . 0.59 109.769 178.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.1 m -109.87 156.21 10.82 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.097 0.475 . . . . 0.5 111.434 -179.243 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.8 t -124.85 113.91 18.52 Favored 'General case' 0 C--N 1.319 -0.723 0 N-CA-C 108.218 -1.03 . . . . 0.79 108.218 178.509 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.528 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 76.5 mt -97.82 137.97 35.88 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 112.622 0.601 . . . . 0.46 112.622 -177.39 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 25.0 t-20 -79.16 110.73 14.69 Favored 'General case' 0 C--O 1.236 0.377 0 CA-C-N 115.088 -0.96 . . . . 0.65 109.962 179.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 71.6 mmm -94.87 21.04 8.0 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.268 -0.424 . . . . 0.63 111.338 -179.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 38.3 mm-40 -93.14 -51.06 5.21 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 109.21 -0.663 . . . . 1.27 109.21 178.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 19.3 ttt180 -87.24 1.88 51.79 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 115.627 -0.715 . . . . 1.06 110.256 179.515 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 45.4 m80 -128.38 154.96 45.45 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.878 -0.601 . . . . 0.76 109.464 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -124.89 7.82 8.08 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.724 0.297 . . . . 1.09 111.023 -179.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.1 p90 -163.7 164.7 23.77 Favored 'General case' 0 C--O 1.236 0.387 0 CA-C-N 116.286 -0.416 . . . . 0.62 110.659 -179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.427 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.1 mt -79.52 -56.38 4.36 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 109.469 -0.567 . . . . 0.34 109.469 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.77 43.18 4.25 Favored Glycine 0 N--CA 1.444 -0.771 0 CA-C-N 115.664 -0.698 . . . . 0.14 112.681 178.758 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.9 pt -141.77 150.34 19.42 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.578 0.704 . . . . 0.18 112.186 -179.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 22.7 t -98.99 131.36 45.09 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 114.751 -1.113 . . . . 1.0 108.198 177.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.725 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 6.7 mm -98.09 115.79 39.12 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-O 120.967 0.413 . . . . 0.28 110.752 -179.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . 0.473 ' O ' ' HA ' ' A' ' 278' ' ' ILE . 62.1 t -86.84 126.07 40.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.952 -0.567 . . . . 0.31 110.641 -179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.84 88.64 0.86 Allowed Glycine 0 N--CA 1.449 -0.436 0 C-N-CA 120.972 -0.632 . . . . 0.37 112.337 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -72.72 118.87 16.18 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 120.852 0.358 . . . . 1.87 110.266 179.914 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.2 m -129.0 112.82 14.44 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 116.341 -0.39 . . . . 1.17 110.916 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.5 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 6.6 t30 -91.76 -152.06 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.97 -0.559 . . . . 2.75 109.937 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.5 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 12.7 p-10 -59.23 -46.35 88.71 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.712 0.292 . . . . 2.08 111.076 179.828 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.2 mtm105 -75.78 -55.21 5.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 121.126 0.488 . . . . 2.63 110.377 179.344 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 137.79 -35.43 2.05 Favored Glycine 0 N--CA 1.445 -0.745 0 CA-C-N 115.607 -0.724 . . . . 0.97 111.913 -179.887 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.1 p-10 -75.08 92.92 2.69 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.819 0.819 . . . . 1.75 110.71 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -113.24 -30.81 2.59 Favored Glycine 0 N--CA 1.448 -0.516 0 CA-C-N 115.501 -0.772 . . . . 0.52 112.091 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 107.6 158.12 20.39 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.654 -0.784 . . . . 0.3 112.613 179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . 0.473 ' HA ' ' O ' ' A' ' 267' ' ' VAL . 8.3 pt -103.53 123.72 57.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-O 121.177 0.513 . . . . 0.27 110.432 179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 93.3 m-85 -111.7 156.84 21.25 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 115.964 -0.562 . . . . 0.72 111.354 -178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -79.97 118.31 27.32 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 115.717 -0.674 . . . . 0.24 109.998 178.678 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -88.74 -112.69 1.21 Allowed Glycine 0 N--CA 1.446 -0.665 0 C-N-CA 120.675 -0.774 . . . . 0.42 111.973 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -85.62 139.31 31.51 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.872 0.368 . . . . 0.75 111.445 -179.914 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 52.7 mt -102.19 132.59 47.89 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 N-CA-C 109.16 -0.681 . . . . 0.53 109.16 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 33.9 mmt -95.1 134.83 37.38 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.517 -0.311 . . . . 0.74 110.994 -179.1 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.6 tptp -70.47 133.14 46.55 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.077 -0.51 . . . . 1.01 110.199 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 104.79 -17.81 44.89 Favored Glycine 0 N--CA 1.446 -0.672 0 C-N-CA 120.665 -0.778 . . . . 0.36 111.647 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.6 167.11 54.76 Favored Glycine 0 N--CA 1.443 -0.842 0 C-N-CA 121.019 -0.61 . . . . 0.26 112.131 179.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.528 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.75 -35.25 79.96 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 120.723 0.297 . . . . 0.25 111.387 -179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.67 -42.56 83.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.26 110.804 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.96 -17.64 64.5 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.19 -0.459 . . . . 0.37 111.496 -179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.66 -21.27 44.99 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.239 -0.437 . . . . 0.41 111.135 179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -89.69 -82.21 0.27 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.214 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 122.02 -21.45 7.85 Favored Glycine 0 N--CA 1.449 -0.488 0 C-N-CA 120.25 -0.976 . . . . 0.39 113.764 179.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 70.6 mtm180 -66.43 -31.12 71.67 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 117.466 0.633 . . . . 0.68 111.277 -179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 51.3 mt -89.35 132.85 33.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 109.337 -0.616 . . . . 0.37 109.337 178.822 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -137.81 165.12 36.23 Favored Pre-proline 0 C--N 1.322 -0.61 0 CA-C-N 116.544 -0.298 . . . . 0.69 110.42 -178.878 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_exo -56.51 119.68 7.06 Favored 'Trans proline' 0 C--N 1.347 0.482 0 C-N-CA 122.022 1.815 . . . . 0.41 111.47 179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 121.99 -21.31 7.9 Favored Glycine 0 N--CA 1.448 -0.547 0 C-N-CA 120.585 -0.817 . . . . 0.29 112.273 -179.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.492 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 91.3 m-20 -65.79 141.31 58.35 Favored 'General case' 0 N--CA 1.464 0.259 0 N-CA-C 110.318 -0.253 . . . . 0.34 110.318 179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.6 ttp -100.86 132.4 46.28 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 121.059 -0.256 . . . . 1.26 110.553 179.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 34.3 mt -82.09 123.07 28.62 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 116.561 -0.29 . . . . 0.48 110.554 179.923 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.754 HD11 ' HB2' ' A' ' 336' ' ' ALA . 63.9 mt -102.69 -72.54 0.69 Allowed 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.626 0.726 . . . . 0.53 110.137 179.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -116.52 134.25 55.07 Favored 'General case' 0 C--N 1.321 -0.644 0 CA-C-N 115.103 -0.953 . . . . 0.73 110.971 -179.036 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.467 HG21 HD13 ' A' ' 321' ' ' LEU . 94.7 t -124.22 96.97 4.19 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.682 0 CA-C-N 115.589 -0.732 . . . . 0.29 109.34 178.754 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.461 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.2 t-20 60.47 73.87 0.47 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.473 -0.785 . . . . 1.71 111.461 -179.805 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.461 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.7 m-20 75.86 -50.03 0.61 Allowed 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 113.734 1.013 . . . . 1.11 113.734 178.216 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -73.36 130.02 35.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.296 0.57 . . . . 0.71 112.405 -178.868 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 44.0 t30 -103.64 123.14 46.43 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.474 -0.785 . . . . 0.74 110.269 179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 17.4 m-85 -95.69 6.77 48.11 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.333 -0.394 . . . . 0.33 111.598 -178.516 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -63.46 -12.36 30.84 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 112.319 0.489 . . . . 1.21 112.319 -178.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 62.9 t30 -126.42 26.89 6.28 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 121.218 0.532 . . . . 1.32 110.63 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.2 mtp -125.5 163.02 23.58 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.259 -0.428 . . . . 0.51 109.987 -179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 17.9 p -72.08 157.81 37.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 120.584 0.23 . . . . 0.97 110.646 -179.992 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 70.4 m-20 -54.94 -43.49 73.43 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.204 -0.453 . . . . 0.48 111.168 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 37.3 m-20 -63.84 -52.82 58.38 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.019 -0.537 . . . . 1.4 110.878 -179.832 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 67.0 m-20 -57.99 -39.2 77.63 Favored 'General case' 0 N--CA 1.462 0.174 0 CA-C-N 115.897 -0.592 . . . . 0.88 111.204 -179.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.36 -54.33 47.99 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.958 -0.565 . . . . 0.2 111.892 -179.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.453 HG22 HG21 ' A' ' 266' ' ' ILE . 3.0 t -70.58 -30.89 44.36 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 121.002 -0.279 . . . . 0.21 111.123 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.547 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 58.8 mtt180 -55.77 -52.39 64.11 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.001 -0.37 . . . . 0.83 110.001 179.045 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.4 t -69.27 -37.48 76.03 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.079 -0.51 . . . . 0.17 110.453 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.467 HD13 HG21 ' A' ' 304' ' ' VAL . 20.7 tp -55.99 -49.33 73.93 Favored 'General case' 0 C--N 1.332 -0.158 0 CA-C-O 121.073 0.463 . . . . 0.38 110.629 179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.566 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.8 mtp180 -62.34 -35.59 79.57 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.764 -0.653 . . . . 1.57 111.106 -179.518 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.547 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 17.3 mm-40 -64.84 -36.32 83.95 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.8 0.333 . . . . 1.87 110.868 179.634 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.1 mt -73.61 -40.77 55.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.975 0.416 . . . . 0.29 110.502 179.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.45 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.3 t -70.32 -21.6 23.46 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.312 0.577 . . . . 0.24 110.397 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 29.8 m -90.21 33.17 0.89 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.032 -0.531 . . . . 0.44 110.234 178.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.2 tp-100 -144.13 170.9 15.07 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 116.101 -0.5 . . . . 1.16 109.704 179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -97.46 149.43 22.17 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-O 120.924 0.393 . . . . 0.89 111.503 -179.695 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.14 158.64 10.17 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 121.117 -0.563 . . . . 0.45 112.332 179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.7 Cg_endo -65.5 133.71 35.66 Favored 'Trans proline' 0 C--N 1.343 0.237 0 C-N-CA 122.871 2.381 . . . . 0.58 111.837 179.791 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.4 mt -103.5 120.15 53.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.458 0 CA-C-O 120.967 0.413 . . . . 0.37 111.553 -178.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -92.86 108.65 20.16 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 115.833 -0.621 . . . . 1.09 110.093 178.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.3 mt -102.88 122.97 45.64 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.268 -0.423 . . . . 0.48 111.652 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.9 m -108.04 104.52 13.97 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 109.265 -0.642 . . . . 0.5 109.265 178.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.0 m -106.4 153.65 7.66 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 CA-C-O 121.355 0.598 . . . . 0.33 112.136 -178.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.754 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.53 111.17 22.89 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 0.38 110.176 179.051 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.492 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.247 0.929 0 CA-C-O 118.432 -0.794 . . . . 0.7 109.347 179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.725 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 17.4 m95 . . . . . 0 N--CA 1.465 0.285 0 N-CA-C 110.147 -0.316 . . . . 0.4 110.147 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.566 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.118 0 CA-C-O 118.741 -0.647 . . . . 0.27 110.458 179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.5 t30 . . . . . 0 N--CA 1.478 0.937 0 CA-C-O 121.089 0.471 . . . . 1.26 110.481 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 83.0 mt -79.76 129.59 37.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 116.185 -0.461 . . . . 0.65 110.135 179.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.409 HD12 ' HD3' ' A' ' 337' ' ' LYS . 39.7 mt -128.77 131.83 68.13 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-O 120.903 0.382 . . . . 0.55 110.789 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.3 m -106.2 112.5 25.55 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 109.585 -0.524 . . . . 0.59 109.585 178.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.4 m -103.57 150.28 7.05 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-O 120.902 0.382 . . . . 0.5 111.045 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.6 t -116.78 117.29 29.35 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.79 -0.819 . . . . 0.79 108.79 179.206 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 69.9 mt -106.53 152.53 23.56 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-O 121.167 0.508 . . . . 0.46 111.952 -178.406 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.7 t-20 -100.27 126.19 46.56 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.451 -0.795 . . . . 0.65 110.36 -179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 79.7 mmm -104.58 22.69 14.56 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.895 0.378 . . . . 0.63 111.752 -178.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 50.0 mm-40 -95.46 -52.08 4.29 Favored 'General case' 0 C--N 1.325 -0.464 0 N-CA-C 109.386 -0.598 . . . . 1.27 109.386 178.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 46.2 ttt180 -79.81 -26.63 40.46 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.814 -0.63 . . . . 1.06 109.495 178.857 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 50.4 m80 -110.42 150.7 28.46 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.586 -0.734 . . . . 0.76 109.151 179.321 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 32.2 m-70 -123.66 12.6 9.26 Favored 'General case' 0 C--N 1.321 -0.663 0 C-N-CA 120.461 -0.495 . . . . 1.09 111.105 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.2 p90 -161.24 162.37 31.1 Favored 'General case' 0 C--O 1.237 0.43 0 CA-C-N 116.077 -0.51 . . . . 0.62 110.099 179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.423 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.9 mt -77.88 -52.21 9.23 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.074 -0.512 . . . . 0.34 110.07 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.91 43.01 6.14 Favored Glycine 0 N--CA 1.446 -0.686 0 CA-C-N 115.85 -0.614 . . . . 0.14 112.394 179.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.423 HG12 ' HB3' ' A' ' 262' ' ' LEU . 9.1 pt -136.94 154.02 30.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.435 0 CA-C-O 121.441 0.639 . . . . 0.18 112.073 -179.791 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 21.5 t -106.49 121.43 44.26 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 114.93 -1.032 . . . . 1.0 108.786 178.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.708 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 9.0 mm -91.25 132.49 35.62 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 120.709 0.29 . . . . 0.28 110.844 -178.818 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 88.9 t -117.05 124.34 72.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-N 116.295 -0.412 . . . . 0.31 110.032 179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.12 113.63 4.58 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.816 -0.706 . . . . 0.37 112.102 179.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 5.1 tp-100 -67.11 109.15 2.91 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 121.095 0.474 . . . . 1.87 110.557 -179.98 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 5.3 m -109.4 142.53 40.22 Favored 'General case' 0 C--N 1.321 -0.673 0 CA-C-N 115.977 -0.556 . . . . 1.17 110.046 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -161.8 -170.34 2.53 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 109.615 -0.513 . . . . 2.75 109.615 -179.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 16.1 p-10 -56.39 -41.47 76.33 Favored 'General case' 0 C--N 1.327 -0.394 0 O-C-N 123.347 0.404 . . . . 2.08 110.796 179.448 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -74.11 -40.0 62.98 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.119 0.485 . . . . 2.63 110.36 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 97.47 -46.18 1.68 Allowed Glycine 0 N--CA 1.447 -0.597 0 C-N-CA 120.861 -0.685 . . . . 0.97 113.098 179.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 9.7 p-10 -75.59 78.16 2.59 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.742 0.782 . . . . 1.75 111.141 -179.721 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -95.36 -45.46 3.0 Favored Glycine 0 N--CA 1.445 -0.742 0 C-N-CA 120.716 -0.754 . . . . 0.52 112.3 179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 114.19 164.92 15.28 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.701 -0.761 . . . . 0.3 111.848 179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 7.6 pt -100.5 126.4 54.11 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-O 121.171 0.51 . . . . 0.27 111.103 -179.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.4 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 84.9 m-85 -117.68 159.27 23.25 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 115.662 -0.699 . . . . 0.72 110.871 -179.55 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.7 mm -82.99 112.14 20.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.296 -0.631 . . . . 0.24 109.296 178.425 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.55 -56.68 3.54 Favored Glycine 0 N--CA 1.449 -0.448 0 C-N-CA 120.888 -0.672 . . . . 0.42 112.88 -179.124 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -142.17 161.41 38.09 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 110.627 -0.138 . . . . 0.75 110.627 -179.376 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 31.1 mt -122.35 131.35 73.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.416 -0.356 . . . . 0.53 110.335 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.8 mmt -96.08 115.56 27.61 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.406 -0.361 . . . . 0.74 110.456 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.9 tptp -64.04 109.77 1.92 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-O 121.092 0.472 . . . . 1.01 110.015 179.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 142.45 -23.06 2.37 Favored Glycine 0 N--CA 1.446 -0.664 0 N-CA-C 110.877 -0.889 . . . . 0.36 110.877 -179.136 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.73 177.81 53.88 Favored Glycine 0 N--CA 1.445 -0.755 0 C-N-CA 121.155 -0.545 . . . . 0.26 112.216 179.267 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -67.04 -32.47 73.69 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 111.656 0.243 . . . . 0.25 111.656 -179.399 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.464 HG13 HD12 ' A' ' 295' ' ' ILE . 84.7 t -71.11 -41.14 75.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.916 0.389 . . . . 0.26 111.358 -179.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.7 -18.62 65.47 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.089 -0.505 . . . . 0.37 111.68 -179.361 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.22 -14.37 53.42 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.215 -0.448 . . . . 0.41 111.143 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -88.27 -72.52 0.53 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.775 0.321 . . . . 0.55 110.523 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.35 -19.98 26.16 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.453 -0.879 . . . . 0.39 113.853 178.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.2 mtm180 -69.9 -37.49 76.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 117.418 0.609 . . . . 0.68 110.976 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.464 HD12 HG13 ' A' ' 289' ' ' VAL . 59.6 mt -78.83 135.14 26.46 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 109.743 -0.465 . . . . 0.37 109.743 179.401 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -137.99 161.07 61.8 Favored Pre-proline 0 C--N 1.32 -0.685 0 CA-C-N 116.288 -0.414 . . . . 0.69 110.119 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.4 Cg_exo -57.21 124.08 15.33 Favored 'Trans proline' 0 C--N 1.346 0.419 0 C-N-CA 122.195 1.93 . . . . 0.41 111.178 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 115.14 -16.0 18.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.662 -0.78 . . . . 0.29 111.938 -179.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.401 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 90.7 m-20 -67.43 142.79 56.57 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.813 -0.44 . . . . 0.34 109.813 179.248 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . 0.4 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 28.0 ttt -101.61 136.31 41.67 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-O 120.664 0.268 . . . . 1.26 110.766 -179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 43.1 mt -88.3 124.99 34.44 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.378 -0.373 . . . . 0.48 110.032 179.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 68.8 mt -105.47 -72.47 0.71 Allowed 'General case' 0 C--N 1.326 -0.441 0 CA-C-O 120.983 0.42 . . . . 0.53 110.453 -179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.0 tt0 -122.8 135.14 54.44 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.935 -0.575 . . . . 0.73 110.744 -179.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 46.2 t -132.33 106.44 10.9 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 115.882 -0.599 . . . . 0.29 109.7 179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.42 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.5 m-20 61.4 62.93 1.27 Allowed 'General case' 0 C--O 1.236 0.372 0 CA-C-N 115.987 -0.551 . . . . 1.71 111.455 -179.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.42 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 29.0 m-20 75.12 -45.94 0.58 Allowed 'General case' 0 N--CA 1.469 0.498 0 N-CA-C 114.339 1.237 . . . . 1.11 114.339 177.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.1 m -71.11 130.97 34.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.438 0 CA-C-O 121.199 0.523 . . . . 0.71 111.467 -179.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 37.5 t-20 -103.42 140.33 37.61 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.66 -0.7 . . . . 0.74 110.319 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 33.3 m-85 -111.8 5.46 19.07 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.495 -0.321 . . . . 0.33 111.729 -179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -60.25 -26.38 66.4 Favored 'General case' 0 N--CA 1.468 0.454 0 N-CA-C 111.975 0.361 . . . . 1.21 111.975 -179.614 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -116.74 26.39 9.87 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.263 0.554 . . . . 1.32 110.904 -179.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 97.3 mtp -118.79 165.77 13.62 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-N 116.314 -0.403 . . . . 0.51 110.594 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 27.4 p -75.84 164.8 25.86 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 109.855 -0.424 . . . . 0.97 109.855 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.466 ' O ' HG23 ' A' ' 318' ' ' VAL . 86.7 m-20 -63.78 -36.65 84.6 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 121.249 0.547 . . . . 0.48 109.666 179.591 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.486 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 5.6 t70 -71.29 -53.77 13.14 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.242 -0.89 . . . . 1.4 110.992 -179.426 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -58.24 -35.82 72.28 Favored 'General case' 0 N--CA 1.465 0.311 0 CA-C-N 115.818 -0.628 . . . . 0.88 111.743 -179.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.4 -51.49 69.62 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.134 -0.484 . . . . 0.2 112.002 -179.509 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 314' ' ' ASN . 0.9 OUTLIER -69.82 -29.02 39.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 C-N-CA 120.926 -0.31 . . . . 0.21 111.003 -179.174 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.486 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 82.8 mtt180 -55.82 -48.06 76.1 Favored 'General case' 0 N--CA 1.466 0.335 0 CA-C-O 121.281 0.562 . . . . 0.83 110.068 179.249 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.5 t -75.3 -41.61 43.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-N 115.682 -0.69 . . . . 0.17 110.5 179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.405 ' O ' HG23 ' A' ' 325' ' ' VAL . 22.6 tp -54.05 -50.2 67.25 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-N 116.042 -0.526 . . . . 0.38 111.456 -179.694 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.586 ' HA ' HG11 ' B' ' 3' ' ' VAL . 63.4 mtp180 -62.41 -36.84 83.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.152 -0.477 . . . . 1.57 111.005 -179.214 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 22.5 mm-40 -63.16 -44.0 96.7 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.729 0.3 . . . . 1.87 110.478 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.6 mt -61.59 -47.94 91.05 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.078 -0.51 . . . . 0.29 111.159 179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.405 HG23 ' O ' ' A' ' 321' ' ' LEU . 24.8 t -69.06 -15.19 19.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 CA-C-O 121.133 0.492 . . . . 0.24 111.347 -179.227 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 68.8 m -86.06 -5.73 59.16 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.818 0.342 . . . . 0.44 110.865 179.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 2.6 mp0 -100.4 148.72 24.42 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 116.236 -0.438 . . . . 1.16 110.528 -179.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -87.64 88.21 7.6 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.066 -0.515 . . . . 0.89 111.356 -179.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -166.26 173.63 41.76 Favored Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.959 -0.639 . . . . 0.45 112.187 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.03 141.05 62.45 Favored 'Trans proline' 0 C--O 1.234 0.282 0 C-N-CA 122.685 2.257 . . . . 0.58 112.371 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 72.2 mt -119.83 123.85 71.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-O 121.172 0.51 . . . . 0.37 111.442 -179.457 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 2.8 m -112.35 102.61 10.74 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.554 -0.748 . . . . 1.09 109.435 178.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 12.4 mt -92.73 121.03 33.72 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.018 -0.537 . . . . 0.48 111.801 -178.587 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.9 m -103.53 98.91 8.72 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 108.826 -0.805 . . . . 0.5 108.826 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 36.0 m -100.42 152.48 4.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 112.503 0.557 . . . . 0.33 112.503 -177.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -109.49 108.27 18.7 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.452 -0.794 . . . . 0.38 110.012 178.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.409 ' HD3' HD12 ' A' ' 250' ' ' ILE . 24.8 mtpp . . . . . 0 C--O 1.247 0.942 0 CA-C-O 118.092 -0.956 . . . . 0.7 109.74 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.708 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 39.9 m95 . . . . . 0 C--O 1.233 0.233 0 CA-C-O 120.463 0.173 . . . . 0.4 110.55 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.586 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.848 -0.596 . . . . 0.27 109.69 178.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 . . . . . 0 N--CA 1.48 1.054 0 N-CA-C 109.905 -0.406 . . . . 1.26 109.905 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.0 mt -96.15 126.01 48.86 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 CA-C-N 116.283 -0.417 . . . . 0.65 110.659 -179.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 23.5 mt -123.46 126.37 73.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-O 120.936 0.398 . . . . 0.55 111.484 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -98.39 103.57 15.53 Favored 'General case' 0 C--N 1.324 -0.516 0 N-CA-C 109.27 -0.641 . . . . 0.59 109.27 178.283 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 13.4 m -102.15 160.55 4.08 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.724 0 CA-C-O 121.061 0.458 . . . . 0.5 111.509 -178.638 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.8 t -122.86 142.52 50.69 Favored 'General case' 0 C--N 1.321 -0.672 0 N-CA-C 108.514 -0.921 . . . . 0.79 108.514 178.698 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.564 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.7 mt -123.85 136.36 54.32 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.209 0.528 . . . . 0.46 112.101 -178.489 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -78.45 111.85 14.9 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.393 -0.821 . . . . 0.65 109.832 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.3 mmm -96.21 17.85 14.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.955 0.407 . . . . 0.63 110.911 -179.711 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 20.1 mm-40 -87.7 -50.53 6.42 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-O 121.507 0.67 . . . . 1.27 109.229 178.767 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 47.2 ttt180 -88.95 0.05 56.97 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 114.92 -1.036 . . . . 1.06 110.186 179.515 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.2 m80 -130.28 133.18 46.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.354 -0.384 . . . . 0.76 110.276 -179.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 96.4 m-70 -106.61 15.39 25.83 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 116.567 -0.288 . . . . 1.09 110.783 179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -166.54 166.64 16.1 Favored 'General case' 0 C--O 1.237 0.446 0 CA-C-N 116.24 -0.436 . . . . 0.62 110.471 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.422 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.5 mt -82.77 -52.54 6.66 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.189 -0.46 . . . . 0.34 109.988 -179.599 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.74 43.11 5.54 Favored Glycine 0 N--CA 1.448 -0.544 0 CA-C-N 115.891 -0.595 . . . . 0.14 112.98 178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 3.7 pt -140.83 150.6 20.5 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 CA-C-O 121.656 0.741 . . . . 0.18 111.829 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 12.1 t -100.46 124.51 46.08 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-N 114.874 -1.057 . . . . 1.0 108.691 178.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.703 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 6.5 mm -91.1 114.81 29.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.881 0.372 . . . . 0.28 110.854 -178.686 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.0 t -100.01 112.31 32.16 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-N 116.087 -0.506 . . . . 0.31 110.254 179.74 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -88.15 101.79 2.76 Favored Glycine 0 N--CA 1.447 -0.61 0 C-N-CA 120.939 -0.648 . . . . 0.37 112.156 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . 0.433 ' O ' ' HA3' ' A' ' 276' ' ' GLY . 28.3 tt0 -78.5 109.42 12.66 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 110.122 -0.325 . . . . 1.87 110.122 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 8.6 m -111.16 113.11 25.39 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.465 -0.334 . . . . 1.17 111.082 -179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 46.8 t30 -77.57 -163.43 0.39 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 2.75 109.992 179.158 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -59.09 -37.49 77.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.732 0.301 . . . . 2.08 111.439 -179.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 18.7 mtt85 -78.44 -30.48 47.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.193 0.52 . . . . 2.63 110.226 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 117.51 -7.88 15.65 Favored Glycine 0 N--CA 1.449 -0.435 0 N-CA-C 111.024 -0.83 . . . . 0.97 111.024 -178.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.1 p-10 -89.21 172.49 9.03 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 110.15 -0.315 . . . . 1.75 110.15 179.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . 0.433 ' HA3' ' O ' ' A' ' 269' ' ' GLN . . . 159.81 -57.47 0.32 Allowed Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.68 -0.772 . . . . 0.52 112.195 179.797 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 122.96 162.47 11.52 Favored Glycine 0 N--CA 1.448 -0.541 0 C-N-CA 120.841 -0.695 . . . . 0.3 111.834 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.5 pt -98.9 123.62 51.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-O 121.273 0.559 . . . . 0.27 110.557 179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 79.5 m-85 -111.21 156.22 21.77 Favored 'General case' 0 C--N 1.32 -0.716 0 CA-C-N 115.716 -0.675 . . . . 0.72 110.604 -179.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.2 mm -82.99 118.46 30.71 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.647 0 CA-C-N 116.12 -0.491 . . . . 0.24 109.866 179.187 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -89.76 -101.95 1.1 Allowed Glycine 0 N--CA 1.444 -0.802 0 C-N-CA 120.519 -0.848 . . . . 0.42 112.154 -179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -88.18 138.88 31.05 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-O 120.663 0.268 . . . . 0.75 111.094 -179.568 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 69.8 mt -105.28 129.79 57.53 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.353 -0.61 . . . . 0.53 109.353 178.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 26.1 mmt -95.54 123.69 39.2 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.934 0.397 . . . . 0.74 111.202 -179.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 21.9 tptp -67.37 122.56 18.19 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.987 -0.551 . . . . 1.01 109.809 179.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 122.73 -20.78 7.68 Favored Glycine 0 N--CA 1.447 -0.578 0 N-CA-C 111.469 -0.652 . . . . 0.36 111.469 -179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.55 172.65 55.27 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.803 -0.713 . . . . 0.26 112.104 179.642 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.564 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -36.18 82.46 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-O 120.754 0.312 . . . . 0.25 111.099 -179.661 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 62.9 t -67.14 -35.34 74.02 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.934 -0.575 . . . . 0.26 111.115 -179.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.86 -11.52 60.62 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.088 -0.506 . . . . 0.37 111.776 -179.27 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -94.71 -10.17 32.51 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 121.104 0.478 . . . . 0.41 110.462 179.407 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.1 t70 -86.83 -77.12 0.33 Allowed 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.7 -0.682 . . . . 0.55 110.239 -179.795 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.0 -16.34 20.61 Favored Glycine 0 N--CA 1.45 -0.378 0 C-N-CA 120.653 -0.784 . . . . 0.39 113.699 179.009 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 46.5 mtm180 -81.39 -36.1 29.95 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 117.417 0.608 . . . . 0.68 111.433 -179.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.5 mt -80.04 134.29 27.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.421 -0.354 . . . . 0.37 110.307 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -139.51 168.11 16.37 Favored Pre-proline 0 C--N 1.324 -0.543 0 CA-C-N 116.215 -0.448 . . . . 0.69 110.292 -179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 38.9 Cg_exo -60.75 128.23 25.02 Favored 'Trans proline' 0 C--N 1.347 0.456 0 C-N-CA 121.984 1.789 . . . . 0.41 111.49 178.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 109.88 -14.6 31.69 Favored Glycine 0 N--CA 1.448 -0.5 0 C-N-CA 120.821 -0.704 . . . . 0.29 112.299 -179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.4 m-20 -69.95 141.97 52.95 Favored 'General case' 0 CA--C 1.521 -0.147 0 N-CA-C 109.647 -0.501 . . . . 0.34 109.647 179.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 35.9 ttp -101.36 132.14 47.08 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-O 120.643 0.259 . . . . 1.26 110.859 -179.687 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 11.1 mt -87.64 120.62 29.14 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.393 -0.367 . . . . 0.48 110.027 179.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.578 HD11 ' HB2' ' A' ' 336' ' ' ALA . 43.3 mt -101.29 -69.09 0.79 Allowed 'General case' 0 C--N 1.321 -0.663 0 CA-C-O 121.132 0.492 . . . . 0.53 110.359 179.835 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -111.9 133.82 53.85 Favored 'General case' 0 C--N 1.322 -0.612 0 CA-C-N 115.744 -0.662 . . . . 0.73 110.563 -179.089 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.444 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.8 t -123.64 94.06 2.69 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 116.014 -0.539 . . . . 0.29 109.964 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.463 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.1 t30 58.83 72.9 0.5 Allowed 'General case' 0 C--N 1.323 -0.554 0 CA-C-N 115.472 -0.786 . . . . 1.71 111.761 179.853 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.463 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 73.3 m-20 78.3 -48.4 0.46 Allowed 'General case' 0 N--CA 1.472 0.663 0 N-CA-C 113.422 0.897 . . . . 1.11 113.422 177.819 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 18.8 m -75.66 131.04 35.65 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 121.229 0.538 . . . . 0.71 111.657 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 36.2 t-20 -103.08 137.51 41.16 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.698 -0.683 . . . . 0.74 110.413 -179.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 29.4 m-85 -108.59 13.0 25.57 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.477 -0.329 . . . . 0.33 111.06 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -68.73 6.11 0.93 Allowed 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 112.115 0.413 . . . . 1.21 112.115 -179.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -150.25 33.72 0.65 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-O 121.348 0.594 . . . . 1.32 110.068 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.7 mtp -134.31 159.17 41.81 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.053 -0.521 . . . . 0.51 110.498 -179.91 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -68.06 153.36 43.9 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.34 -0.391 . . . . 0.97 110.746 -179.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.1 m-20 -54.18 -46.34 72.35 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.036 -0.529 . . . . 0.48 110.961 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.436 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.1 t70 -62.06 -48.61 79.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.881 -0.599 . . . . 1.4 110.779 179.971 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 20.7 m-20 -57.87 -38.59 76.02 Favored 'General case' 0 N--CA 1.466 0.352 0 CA-C-N 115.74 -0.664 . . . . 0.88 111.331 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.65 -51.37 70.21 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.997 -0.547 . . . . 0.2 111.645 -179.647 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.41 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.3 t -69.88 -27.73 34.13 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.205 0 C-N-CA 120.956 -0.298 . . . . 0.21 111.298 -179.327 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.436 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 88.3 mtt180 -58.23 -46.06 86.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.04 0.447 . . . . 0.83 110.202 179.096 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 21.1 t -77.59 -38.56 26.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 CA-C-N 115.83 -0.623 . . . . 0.17 110.109 179.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.444 ' CD1' HG11 ' A' ' 304' ' ' VAL . 19.0 tp -53.57 -53.25 54.32 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-N 115.87 -0.605 . . . . 0.38 111.34 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.569 ' HA ' HG11 ' B' ' 3' ' ' VAL . 42.1 mtp180 -62.09 -34.64 76.69 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.214 -0.448 . . . . 1.57 111.338 -178.894 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.494 ' O ' ' HG2' ' A' ' 327' ' ' GLN . 13.2 mm-40 -66.84 -40.3 87.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.89 0.376 . . . . 1.87 110.44 179.256 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -68.58 -44.64 82.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.88 -0.6 . . . . 0.29 110.939 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.427 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.9 t -64.74 -21.78 30.02 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.384 0 CA-C-O 121.16 0.505 . . . . 0.24 111.152 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.5 m -84.69 -0.36 53.27 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.499 -0.319 . . . . 0.44 110.825 179.485 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 323' ' ' GLU . 80.4 mm-40 -98.19 163.11 12.87 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.835 0.35 . . . . 1.16 110.596 -179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 15.4 p -99.12 118.68 36.39 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.224 -0.444 . . . . 0.89 111.074 -179.713 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 154.02 165.72 14.08 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 120.835 -0.697 . . . . 0.45 111.985 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.92 128.23 14.7 Favored 'Trans proline' 0 C--O 1.233 0.239 0 C-N-CA 122.337 2.024 . . . . 0.58 111.503 179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 34.6 mt -108.22 130.22 61.17 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-O 120.922 0.391 . . . . 0.37 111.354 -179.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 18.5 t -104.8 129.73 53.02 Favored 'General case' 0 C--N 1.324 -0.522 0 N-CA-C 109.258 -0.645 . . . . 1.09 109.258 178.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.4 mt -114.92 125.76 54.0 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.974 0.416 . . . . 0.48 111.287 -179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -100.65 97.54 8.2 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 108.853 -0.795 . . . . 0.5 108.853 178.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 27.5 m -100.3 151.55 5.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-O 121.341 0.591 . . . . 0.33 112.247 -177.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.578 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.57 113.07 25.23 Favored 'General case' 0 C--N 1.322 -0.597 0 CA-C-N 115.234 -0.894 . . . . 0.38 109.146 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.252 1.199 0 CA-C-O 118.274 -0.869 . . . . 0.7 110.391 -179.535 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.703 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 25.0 m95 . . . . . 0 C--O 1.236 0.354 0 N-CA-C 110.527 -0.175 . . . . 0.4 110.527 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.569 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.899 0 CA-C-O 118.887 -0.577 . . . . 0.27 109.879 178.387 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 . . . . . 0 N--CA 1.479 1.0 0 CA-C-O 120.868 0.366 . . . . 1.26 110.309 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 61.9 mt -98.08 129.51 48.2 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.359 -0.382 . . . . 0.65 110.436 -179.786 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 53.2 mt -127.11 128.68 70.71 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-O 120.944 0.402 . . . . 0.55 111.152 -179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -104.71 119.81 39.87 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.055 -0.52 . . . . 0.59 109.691 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 28.6 m -121.95 144.17 32.09 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 CA-C-O 120.912 0.387 . . . . 0.5 111.524 -179.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 15.3 t -107.63 131.59 54.21 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 108.426 -0.953 . . . . 0.79 108.426 178.206 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.538 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 42.7 mt -114.8 140.17 49.14 Favored 'General case' 0 C--N 1.321 -0.664 0 CA-C-O 121.014 0.435 . . . . 0.46 111.737 -178.234 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -81.31 116.79 21.33 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.475 -0.784 . . . . 0.65 110.285 179.525 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.6 mmm -98.69 12.62 34.88 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.843 -0.617 . . . . 0.63 111.654 -179.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.0 mm-40 -85.92 -46.96 10.08 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.099 0.476 . . . . 1.27 109.803 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 67.4 ttt180 -87.06 -18.94 29.38 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.378 0.609 . . . . 1.06 110.409 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 53.0 m80 -112.44 137.95 49.89 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.111 -0.495 . . . . 0.76 109.716 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.8 m-70 -102.02 3.52 38.91 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 121.022 -0.271 . . . . 1.09 111.572 -178.796 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 5.3 p90 -159.72 166.27 30.85 Favored 'General case' 0 C--O 1.236 0.383 0 CA-C-O 120.602 0.239 . . . . 0.62 111.05 -179.054 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.469 HD13 HD11 ' A' ' 264' ' ' ILE . 6.6 mt -76.04 -53.0 9.02 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.041 -0.527 . . . . 0.34 109.735 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.69 40.59 6.27 Favored Glycine 0 N--CA 1.445 -0.709 0 CA-C-N 116.049 -0.523 . . . . 0.14 113.052 178.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.469 HD11 HD13 ' A' ' 262' ' ' LEU . 6.6 pt -138.07 149.2 24.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-O 121.346 0.593 . . . . 0.18 111.623 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.86 129.79 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.284 -0.871 . . . . 1.0 109.264 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.683 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 10.1 mm -93.78 119.76 42.12 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 120.938 0.399 . . . . 0.28 110.483 -179.377 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 60.2 t -106.01 113.66 43.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 116.369 -0.378 . . . . 0.31 110.583 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.33 124.09 8.02 Favored Glycine 0 N--CA 1.45 -0.373 0 C-N-CA 120.859 -0.686 . . . . 0.37 111.67 179.681 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -86.64 93.15 9.14 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.945 0.403 . . . . 1.87 110.783 -179.888 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -124.77 109.63 13.32 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.969 -0.56 . . . . 1.17 110.438 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.3 t30 -123.85 -46.48 1.97 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 121.012 0.434 . . . . 2.75 110.692 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -145.03 -66.13 0.33 Allowed 'General case' 0 C--N 1.324 -0.516 0 CA-C-N 115.809 -0.632 . . . . 2.08 110.195 -179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -60.78 -50.71 72.35 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.58 -0.736 . . . . 2.63 110.665 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 99.32 -37.85 3.35 Favored Glycine 0 N--CA 1.445 -0.716 0 C-N-CA 120.607 -0.806 . . . . 0.97 112.923 179.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -75.89 57.43 1.05 Allowed 'General case' 0 N--CA 1.465 0.311 0 CA-C-O 121.59 0.709 . . . . 1.75 111.572 -179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -94.45 -28.19 10.83 Favored Glycine 0 N--CA 1.447 -0.629 0 CA-C-N 115.736 -0.665 . . . . 0.52 111.699 179.628 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.55 174.2 32.42 Favored Glycine 0 N--CA 1.447 -0.587 0 C-N-CA 120.896 -0.668 . . . . 0.3 112.22 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.4 pt -113.96 130.63 67.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.987 0.422 . . . . 0.27 110.925 -179.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -115.59 163.65 15.47 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.0 -0.546 . . . . 0.72 110.827 -179.347 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 46.2 mm -84.34 118.44 31.58 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 116.059 -0.519 . . . . 0.24 109.883 178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -78.32 -66.94 1.68 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.729 -0.748 . . . . 0.42 112.147 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -145.26 155.62 43.34 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 120.537 0.208 . . . . 0.75 110.554 179.633 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.558 HD11 ' HA ' ' A' ' 296' ' ' GLU . 30.2 mt -106.88 134.33 48.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 CA-C-N 116.246 -0.434 . . . . 0.53 109.995 179.835 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.9 mmt -95.48 122.53 38.31 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.288 -0.414 . . . . 0.74 110.832 -179.735 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.9 tptp -58.88 118.04 5.32 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.824 -0.625 . . . . 1.01 110.148 179.695 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 120.57 -19.63 9.05 Favored Glycine 0 N--CA 1.449 -0.443 0 N-CA-C 111.352 -0.699 . . . . 0.36 111.352 -178.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.96 170.62 54.69 Favored Glycine 0 N--CA 1.447 -0.573 0 C-N-CA 121.008 -0.615 . . . . 0.26 112.104 179.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.538 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -63.7 -36.92 85.45 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 120.751 0.31 . . . . 0.25 111.363 -179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 52.7 t -69.01 -35.9 71.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.119 -0.492 . . . . 0.26 111.274 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.56 -22.99 66.75 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.115 -0.493 . . . . 0.37 111.691 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -79.86 -20.2 46.51 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.469 -0.332 . . . . 0.41 111.524 -179.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 11.8 t70 -86.33 -72.81 0.48 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-O 120.799 0.333 . . . . 0.55 110.136 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.16 -17.8 34.27 Favored Glycine 0 CA--C 1.521 0.432 0 C-N-CA 120.393 -0.908 . . . . 0.39 114.3 178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.5 mtm180 -73.21 -28.72 62.34 Favored 'General case' 0 C--O 1.235 0.315 0 CA-C-N 117.822 0.811 . . . . 0.68 111.278 -179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.7 mt -88.1 140.55 15.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.471 0 N-CA-C 109.114 -0.698 . . . . 0.37 109.114 178.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . 0.558 ' HA ' HD11 ' A' ' 283' ' ' ILE . 13.6 pt-20 -148.63 167.67 12.67 Favored Pre-proline 0 C--N 1.321 -0.645 0 CA-C-N 116.579 -0.282 . . . . 0.69 110.242 -179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.04 133.56 58.78 Favored 'Trans proline' 0 C--N 1.346 0.444 0 C-N-CA 122.215 1.943 . . . . 0.41 111.061 178.247 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 107.14 -20.91 32.35 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.752 -0.737 . . . . 0.29 112.151 -179.835 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 99.2 m-20 -67.9 137.87 55.58 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.925 -0.398 . . . . 0.34 109.925 179.655 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 48.5 ttp -97.5 134.23 41.01 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-O 120.726 0.298 . . . . 1.26 110.729 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 22.7 mt -85.75 124.71 32.56 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-N 116.314 -0.403 . . . . 0.48 109.974 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.496 HD11 ' HB2' ' A' ' 336' ' ' ALA . 92.5 mt -105.8 -71.22 0.75 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.074 0.464 . . . . 0.53 110.606 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.3 tt0 -117.93 136.96 53.15 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.819 -0.628 . . . . 0.73 111.162 -178.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.416 HG21 HD13 ' A' ' 321' ' ' LEU . 59.7 t -128.02 94.69 2.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.614 -0.721 . . . . 0.29 109.919 179.371 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.489 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.4 m-20 59.09 75.4 0.4 Allowed 'General case' 0 C--O 1.236 0.382 0 CA-C-N 116.211 -0.45 . . . . 1.71 111.407 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.489 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 3.3 m-20 76.72 -58.85 0.51 Allowed 'General case' 0 N--CA 1.47 0.565 0 N-CA-C 113.149 0.796 . . . . 1.11 113.149 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -64.43 121.43 13.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.398 0 CA-C-O 121.379 0.609 . . . . 0.71 111.898 -178.339 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 53.2 t30 -101.15 128.81 47.08 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.316 -0.856 . . . . 0.74 109.389 179.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 49.9 m-85 -102.38 20.38 17.03 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.739 0.304 . . . . 0.33 111.477 -178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -63.45 -27.3 69.19 Favored 'General case' 0 C--N 1.326 -0.438 0 N-CA-C 112.205 0.446 . . . . 1.21 112.205 -179.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 61.8 m-80 -125.58 37.45 4.36 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-O 120.633 0.254 . . . . 1.32 111.279 -179.413 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 86.7 mtp -125.36 168.83 13.0 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.433 -0.349 . . . . 0.51 110.364 179.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 79.9 p -75.33 157.13 34.77 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.698 0.285 . . . . 0.97 110.887 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.488 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.6 m-20 -62.27 -33.98 75.67 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.182 0.515 . . . . 0.48 109.799 179.43 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.414 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.7 OUTLIER -69.53 -54.03 16.15 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.575 -0.738 . . . . 1.4 111.118 179.816 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -59.58 -34.16 72.37 Favored 'General case' 0 CA--C 1.519 -0.243 0 CA-C-N 116.144 -0.48 . . . . 0.88 111.072 -179.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.6 -51.34 69.88 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.984 -0.553 . . . . 0.2 111.031 179.58 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.488 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.1 t -74.25 -27.96 22.42 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 121.041 -0.264 . . . . 0.21 110.725 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.414 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 66.8 mtt180 -58.35 -51.59 69.18 Favored 'General case' 0 N--CA 1.464 0.239 0 CA-C-O 121.07 0.462 . . . . 0.83 109.864 178.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.9 t -73.78 -35.36 43.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.915 -0.584 . . . . 0.17 110.517 179.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.416 HD13 HG21 ' A' ' 304' ' ' VAL . 41.0 tp -54.67 -50.83 67.28 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.076 -0.511 . . . . 0.38 110.82 179.698 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.44 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.7 mtp-105 -61.32 -34.28 74.98 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.979 -0.555 . . . . 1.57 111.396 -179.365 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 57.2 mm-40 -64.03 -40.63 96.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.863 0.363 . . . . 1.87 110.54 179.266 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 37.1 mt -70.89 -43.83 76.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.009 -0.541 . . . . 0.29 110.749 179.683 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.523 HG11 ' HB ' ' B' ' 3' ' ' VAL . 65.4 t -64.93 -32.1 56.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-O 121.047 0.451 . . . . 0.24 110.753 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 13.7 m -87.31 10.3 17.66 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 116.316 -0.402 . . . . 0.44 110.928 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.2 tp-100 -110.98 151.41 27.98 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.09 -0.504 . . . . 1.16 110.081 179.77 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.62 134.57 37.16 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.563 -0.29 . . . . 0.89 110.617 179.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 135.71 156.14 7.47 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.852 -0.689 . . . . 0.45 112.339 179.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 37.7 Cg_endo -68.3 139.82 46.87 Favored 'Trans proline' 0 C--N 1.345 0.374 0 C-N-CA 122.851 2.368 . . . . 0.58 112.044 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 68.9 mt -109.79 126.92 66.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 116.151 -0.477 . . . . 0.37 111.539 -179.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 9.8 m -107.6 108.24 19.42 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.972 -0.751 . . . . 1.09 108.972 178.68 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 99.0 mt -93.65 128.93 40.06 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 116.237 -0.438 . . . . 0.48 111.756 -178.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 2.5 m -108.34 97.39 7.08 Favored 'General case' 0 C--N 1.322 -0.612 0 N-CA-C 108.442 -0.947 . . . . 0.5 108.442 177.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 33.8 m -103.85 159.17 5.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-O 121.138 0.494 . . . . 0.33 112.154 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.496 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -116.83 116.62 27.8 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.334 -0.848 . . . . 0.38 109.718 179.13 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.7 mtpp . . . . . 0 C--O 1.253 1.26 0 CA-C-O 118.488 -0.768 . . . . 0.7 110.271 -179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.683 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 30.4 m95 . . . . . 0 C--O 1.234 0.249 0 N-CA-C 110.243 -0.28 . . . . 0.4 110.243 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.523 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.678 -0.677 . . . . 0.27 110.418 179.697 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 . . . . . 0 N--CA 1.48 1.054 0 CA-C-O 120.879 0.371 . . . . 1.26 110.274 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 56.0 mt -90.32 111.8 23.91 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.725 0 CA-C-O 121.015 0.436 . . . . 0.65 110.251 179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 69.9 mt -118.55 128.73 75.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 CA-C-N 115.935 -0.575 . . . . 0.55 110.419 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 2.0 m -98.74 112.35 24.45 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-N 116.273 -0.422 . . . . 0.59 109.867 179.184 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 332' ' ' SER . 6.0 m -100.87 163.34 3.09 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 CA-C-N 116.436 -0.347 . . . . 0.5 110.67 -179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 14.8 t -131.11 134.66 46.78 Favored 'General case' 0 C--N 1.32 -0.713 0 N-CA-C 109.309 -0.626 . . . . 0.79 109.309 179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.403 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 72.4 mt -121.96 135.79 54.88 Favored 'General case' 0 C--N 1.321 -0.658 0 CA-C-O 121.086 0.469 . . . . 0.46 111.735 -179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -85.22 115.62 23.1 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 115.459 -0.792 . . . . 0.65 109.973 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.0 mmm -95.8 32.0 1.96 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.952 0.406 . . . . 0.63 111.327 -179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 13.3 mm-40 -102.8 -53.82 2.77 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.938 -0.574 . . . . 1.27 109.703 178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.6 ttt180 -70.48 -41.28 72.93 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.483 -0.562 . . . . 1.06 109.483 179.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 27.7 m80 -107.34 157.26 18.09 Favored 'General case' 0 C--N 1.326 -0.45 0 N-CA-C 108.69 -0.855 . . . . 0.76 108.69 178.957 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.9 m-70 -124.07 22.56 8.7 Favored 'General case' 0 C--N 1.323 -0.579 0 C-N-CA 120.625 -0.43 . . . . 1.09 112.03 -179.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 34.2 p90 -161.5 158.75 27.01 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 120.736 0.303 . . . . 0.62 110.778 179.391 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.401 ' HA ' HD23 ' A' ' 262' ' ' LEU . 5.8 mt -76.35 -56.01 5.03 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.904 -0.589 . . . . 0.34 109.734 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.8 42.95 5.25 Favored Glycine 0 N--CA 1.445 -0.733 0 CA-C-N 115.644 -0.707 . . . . 0.14 112.632 179.007 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -143.95 153.84 15.71 Favored 'Isoleucine or valine' 0 C--O 1.237 0.409 0 CA-C-O 121.277 0.561 . . . . 0.18 111.866 179.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.474 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -100.85 131.59 46.66 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.185 -0.916 . . . . 1.0 109.48 178.668 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.62 ' HB ' ' H22' ' B' ' 1' ' ' PHQ . 11.5 mm -96.44 110.02 23.94 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 CA-C-O 120.942 0.401 . . . . 0.28 110.385 -178.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 62.1 t -98.09 110.78 26.38 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 CA-C-N 116.504 -0.316 . . . . 0.31 111.486 -179.11 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -86.61 113.7 3.95 Favored Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 111.092 -0.803 . . . . 0.37 111.092 178.686 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 4.9 tp-100 -77.81 129.72 35.79 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.99 0.424 . . . . 1.87 111.043 -178.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -117.3 163.98 15.52 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.809 -0.632 . . . . 1.17 110.352 -179.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 21.2 t30 -174.67 -158.77 0.08 Allowed 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.297 -0.631 . . . . 2.75 109.297 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.1 p-10 -61.05 -31.37 71.02 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 121.334 0.588 . . . . 2.08 110.511 179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -84.48 -54.94 4.41 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.461 -0.791 . . . . 2.63 110.222 179.34 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 111.24 -34.37 5.34 Favored Glycine 0 N--CA 1.447 -0.578 0 C-N-CA 120.772 -0.727 . . . . 0.97 112.075 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 20.7 p-10 -91.91 71.65 5.62 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.689 0.757 . . . . 1.75 110.667 -179.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -89.44 -17.02 56.19 Favored Glycine 0 N--CA 1.452 -0.253 0 CA-C-N 115.721 -0.672 . . . . 0.52 112.791 -179.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.14 166.86 31.52 Favored Glycine 0 N--CA 1.449 -0.451 0 C-N-CA 120.672 -0.775 . . . . 0.3 112.269 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -105.88 129.36 59.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-O 121.031 0.443 . . . . 0.27 110.696 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.7 m-85 -117.45 158.8 23.86 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.898 -0.592 . . . . 0.72 110.805 -179.161 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.1 mm -76.79 117.46 21.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-N 116.026 -0.534 . . . . 0.24 110.393 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.485 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.76 -71.42 1.14 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.701 -0.761 . . . . 0.42 112.15 179.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 8.0 p -142.58 155.51 44.99 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 110.182 -0.303 . . . . 0.75 110.182 179.342 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 43.0 mt -106.43 125.53 62.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 116.279 -0.419 . . . . 0.53 110.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.3 mmt -86.36 126.72 34.55 Favored 'General case' 0 C--N 1.321 -0.639 0 CA-C-N 116.07 -0.513 . . . . 0.74 110.668 -179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.5 tptp -67.88 110.6 3.92 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.662 -0.496 . . . . 1.01 109.662 179.289 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 132.84 -19.9 4.37 Favored Glycine 0 N--CA 1.444 -0.827 0 N-CA-C 110.885 -0.886 . . . . 0.36 110.885 -178.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.88 170.28 54.64 Favored Glycine 0 N--CA 1.446 -0.66 0 C-N-CA 120.804 -0.713 . . . . 0.26 111.969 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.403 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.22 -32.19 73.46 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 120.812 0.339 . . . . 0.25 111.0 -179.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 47.5 t -66.23 -33.6 64.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.29 -0.414 . . . . 0.26 110.734 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -72.08 -15.7 62.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.108 -0.496 . . . . 0.37 111.273 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.1 -27.79 24.45 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.157 -0.474 . . . . 0.41 110.831 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.432 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 16.5 t70 -76.05 -69.97 0.47 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.214 -0.448 . . . . 0.55 110.681 -179.714 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.12 -8.24 57.32 Favored Glycine 0 CA--C 1.522 0.522 0 C-N-CA 120.448 -0.882 . . . . 0.39 114.714 178.364 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.432 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 79.3 mtm180 -82.9 -19.65 36.96 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.019 0.91 . . . . 0.68 111.351 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.1 mt -96.78 138.51 21.68 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.206 -0.452 . . . . 0.37 109.959 179.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -132.1 157.9 76.98 Favored Pre-proline 0 C--N 1.324 -0.502 0 CA-C-N 116.43 -0.35 . . . . 0.69 110.409 -179.557 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.485 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 33.4 Cg_exo -61.44 94.34 0.12 Allowed 'Trans proline' 0 C--O 1.236 0.419 0 C-N-CA 122.611 2.207 . . . . 0.41 111.793 179.089 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 150.52 -19.56 1.03 Allowed Glycine 0 N--CA 1.447 -0.602 0 CA-C-N 115.726 -0.67 . . . . 0.29 111.963 -179.481 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -64.06 151.17 43.77 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-O 120.736 0.303 . . . . 0.34 110.842 179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 50.6 ttp -104.02 130.1 51.67 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.344 -0.389 . . . . 1.26 110.683 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 38.0 mt -84.84 115.23 22.64 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.382 -0.372 . . . . 0.48 110.103 179.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.649 HD11 ' HB2' ' A' ' 336' ' ' ALA . 51.7 mt -97.9 -73.31 0.62 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.27 0.557 . . . . 0.53 110.844 179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.9 tt0 -115.11 130.74 57.0 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.594 -0.73 . . . . 0.73 110.625 -179.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.548 HG13 HD23 ' A' ' 333' ' ' LEU . 96.5 t -126.91 106.44 15.49 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 116.201 -0.454 . . . . 0.29 109.972 179.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 11.4 t-20 61.34 65.98 0.92 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.014 -0.539 . . . . 1.71 110.904 -179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 1.5 m-20 74.87 -52.9 0.68 Allowed 'General case' 0 N--CA 1.472 0.633 0 N-CA-C 113.715 1.006 . . . . 1.11 113.715 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 19.0 m -65.23 134.74 29.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.334 0 CA-C-O 121.063 0.458 . . . . 0.71 111.542 -179.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.2 t30 -107.32 126.73 52.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.038 -0.528 . . . . 0.74 110.701 -179.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -96.58 3.79 52.38 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.241 -0.436 . . . . 0.33 111.839 -178.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.9 mt-10 -58.62 -28.08 65.3 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 111.828 0.307 . . . . 1.21 111.828 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -115.75 31.53 6.66 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-O 120.999 0.428 . . . . 1.32 110.796 179.948 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 89.6 mtp -128.69 154.36 46.38 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.159 -0.473 . . . . 0.51 110.773 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.95 150.11 48.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.209 -0.45 . . . . 0.97 110.993 179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 97.5 m-20 -51.9 -47.98 64.35 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.444 -0.343 . . . . 0.48 111.348 -179.572 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -62.42 -46.39 88.78 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.189 -0.46 . . . . 1.4 111.672 -179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.533 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.1 m-20 -64.32 -30.72 71.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.294 -0.412 . . . . 0.88 110.8 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -61.85 -47.42 85.11 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.99 -0.55 . . . . 0.2 110.786 179.263 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.421 HG11 ' H21' ' B' ' 1' ' ' PHQ . 1.4 t -72.23 -31.55 39.65 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.274 0 CA-C-O 120.664 0.268 . . . . 0.21 110.535 179.939 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.533 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 90.1 mtt180 -56.74 -53.92 52.17 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.092 -0.504 . . . . 0.83 110.263 179.334 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 27.2 t -69.8 -37.19 72.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.081 -0.509 . . . . 0.17 110.366 179.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 15.1 tp -55.79 -51.02 68.87 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.932 -0.577 . . . . 0.38 111.17 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.43 ' HA ' HG11 ' B' ' 3' ' ' VAL . 36.5 mtp180 -61.83 -35.14 77.38 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.257 -0.429 . . . . 1.57 111.091 -179.11 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 62.7 mm-40 -64.53 -40.69 96.07 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 121.152 0.501 . . . . 1.87 109.959 178.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 92.0 mt -69.59 -42.47 80.61 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 115.634 -0.712 . . . . 0.29 110.828 179.806 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 321' ' ' LEU . 62.6 t -66.29 -23.95 32.64 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-O 121.262 0.553 . . . . 0.24 110.31 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -85.76 6.76 26.44 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.935 -0.575 . . . . 0.44 110.852 179.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 tp-100 -105.75 135.54 46.99 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 116.349 -0.387 . . . . 1.16 110.002 179.708 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -78.66 92.18 4.72 Favored 'General case' 0 C--N 1.322 -0.595 0 CA-C-N 116.235 -0.438 . . . . 0.89 111.569 -179.715 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -173.74 171.92 44.86 Favored Glycine 0 N--CA 1.448 -0.519 0 N-CA-C 111.461 -0.656 . . . . 0.45 111.461 179.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_endo -69.21 126.04 13.18 Favored 'Trans proline' 0 C--O 1.234 0.297 0 C-N-CA 122.361 2.041 . . . . 0.58 111.584 179.445 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 58.5 mt -102.95 122.75 55.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 CA-C-O 120.93 0.395 . . . . 0.37 111.457 -178.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.488 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.5 OUTLIER -106.66 121.78 45.03 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.958 -0.564 . . . . 1.09 109.615 178.552 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.548 HD23 HG13 ' A' ' 304' ' ' VAL . 18.1 mt -108.1 120.95 43.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 116.044 -0.525 . . . . 0.48 110.99 -179.397 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.82 95.94 7.25 Favored 'General case' 0 C--N 1.321 -0.656 0 N-CA-C 108.627 -0.879 . . . . 0.5 108.627 178.604 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 12.5 m -99.54 149.87 5.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 CA-C-O 121.53 0.681 . . . . 0.33 112.399 -177.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.649 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -102.52 94.76 5.83 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-N 114.951 -1.022 . . . . 0.38 108.868 178.295 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 26.6 mtpp . . . . . 0 C--O 1.251 1.177 0 CA-C-O 118.628 -0.701 . . . . 0.7 110.725 -179.221 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.62 ' H22' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.474 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 9.8 m95 . . . . . 0 C--O 1.234 0.244 0 N-CA-C 110.366 -0.235 . . . . 0.4 110.366 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.434 ' HB ' HG11 ' A' ' 325' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.029 0 CA-C-O 118.637 -0.696 . . . . 0.27 110.22 179.225 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 52.1 t30 . . . . . 0 N--CA 1.482 1.125 0 CA-C-O 120.61 0.243 . . . . 1.26 110.417 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 95.1 mt -103.78 127.02 58.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.453 -0.34 . . . . 0.65 110.188 -179.88 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 3.4 mp -131.21 135.44 59.65 Favored 'Isoleucine or valine' 0 C--O 1.233 0.218 0 CA-C-O 120.827 0.346 . . . . 0.55 111.358 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 62.9 m -107.01 115.89 30.97 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.648 -0.501 . . . . 0.59 109.648 178.356 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.53 ' O ' ' HA ' ' A' ' 332' ' ' SER . 4.0 m -102.26 143.98 14.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 120.789 0.328 . . . . 0.5 111.122 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.9 t -114.19 109.78 18.93 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.342 0.591 . . . . 0.79 109.5 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.4 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 58.4 mt -100.31 145.27 28.33 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.207 0.527 . . . . 0.46 112.016 -178.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.2 t-20 -91.72 119.79 31.88 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.402 -0.817 . . . . 0.65 109.732 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 89.5 mmm -99.0 21.52 11.56 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 121.026 0.441 . . . . 0.63 111.75 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 44.0 mm-40 -87.71 -49.91 6.83 Favored 'General case' 0 C--N 1.323 -0.563 0 N-CA-C 109.768 -0.456 . . . . 1.27 109.768 178.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 44.2 ttt180 -86.16 -35.81 19.91 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.794 -0.639 . . . . 1.06 109.355 178.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.0 m80 -86.87 145.71 26.48 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 115.695 -0.684 . . . . 0.76 109.464 179.796 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 76.0 m-70 -113.85 -2.33 13.66 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.545 -0.462 . . . . 1.09 112.024 -179.263 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 28.3 p90 -157.58 162.54 38.76 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-O 120.498 0.19 . . . . 0.62 110.677 179.83 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.49 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.4 mt -77.55 -52.04 9.7 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 109.727 -0.472 . . . . 0.34 109.727 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.12 48.44 4.61 Favored Glycine 0 N--CA 1.445 -0.76 0 CA-C-N 115.577 -0.738 . . . . 0.14 112.999 179.052 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 7.0 pt -144.84 144.1 22.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 CA-C-O 121.213 0.53 . . . . 0.18 111.563 -179.974 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.582 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 1.1 p -96.49 126.87 41.98 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 109.208 -0.664 . . . . 1.0 109.208 178.097 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.722 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 9.2 mm -91.75 115.84 31.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 CA-C-O 120.825 0.345 . . . . 0.28 110.776 -179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 55.9 t -101.22 119.01 48.8 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 CA-C-N 116.206 -0.452 . . . . 0.31 110.251 179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -92.26 122.51 6.88 Favored Glycine 0 N--CA 1.448 -0.507 0 C-N-CA 121.002 -0.618 . . . . 0.37 112.072 -179.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -85.69 89.28 7.7 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-O 121.287 0.565 . . . . 1.87 110.1 179.831 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.6 m -113.88 80.21 1.35 Allowed 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.778 -0.646 . . . . 1.17 110.555 -179.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -92.74 -151.31 0.29 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 2.75 109.963 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 16.8 p-10 -61.06 -32.38 72.01 Favored 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 121.163 0.506 . . . . 2.08 110.472 179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.402 ' O ' ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -69.83 -21.25 63.39 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.715 -0.675 . . . . 2.63 110.797 179.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 88.12 -65.42 3.44 Favored Glycine 0 N--CA 1.448 -0.535 0 N-CA-C 111.313 -0.715 . . . . 0.97 111.313 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -91.48 153.04 20.09 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 109.667 -0.494 . . . . 1.75 109.667 179.327 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -166.81 -34.66 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.429 0 C-N-CA 120.608 -0.806 . . . . 0.52 112.365 -179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 120.25 175.53 15.57 Favored Glycine 0 N--CA 1.444 -0.796 0 C-N-CA 120.425 -0.893 . . . . 0.3 112.192 179.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 9.9 pt -116.03 128.41 73.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.545 0 CA-C-O 121.068 0.461 . . . . 0.27 110.839 -179.687 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 81.5 m-85 -113.99 157.46 22.44 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.772 -0.649 . . . . 0.72 110.803 -179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.0 mm -80.59 115.02 22.41 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.159 -0.473 . . . . 0.24 110.014 178.777 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.5 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -74.72 -58.16 4.23 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.79 -0.719 . . . . 0.42 112.698 -179.718 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.6 p -151.54 161.97 41.76 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 110.187 -0.301 . . . . 0.75 110.187 -179.919 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.439 HD11 ' HA ' ' A' ' 296' ' ' GLU . 49.0 mt -115.18 134.8 57.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-O 120.735 0.302 . . . . 0.53 110.46 -179.836 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -95.7 125.17 40.1 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.16 -0.473 . . . . 0.74 110.894 -179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.5 tptp -62.05 124.47 20.91 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.883 -0.599 . . . . 1.01 110.056 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 114.64 -17.58 18.12 Favored Glycine 0 N--CA 1.45 -0.389 0 N-CA-C 111.29 -0.724 . . . . 0.36 111.29 -179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -80.52 166.03 48.88 Favored Glycine 0 N--CA 1.444 -0.776 0 C-N-CA 120.875 -0.679 . . . . 0.26 111.875 179.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.4 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -61.15 -38.83 87.83 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-O 120.662 0.268 . . . . 0.25 111.433 -179.772 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 48.5 t -66.69 -31.3 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.859 0.361 . . . . 0.26 110.907 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.83 -20.29 61.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 0.37 111.162 -179.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.02 -11.7 43.46 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.272 -0.422 . . . . 0.41 111.73 -179.463 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -77.11 -72.61 0.34 Allowed 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 121.15 -0.22 . . . . 0.55 111.218 -179.598 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 113.74 -17.08 20.8 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.381 -0.914 . . . . 0.39 113.902 178.767 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 73.6 mtm180 -89.93 -49.32 6.67 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 117.32 0.56 . . . . 0.68 111.064 -179.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 35.9 mt -68.24 136.93 25.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.206 179.697 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . 0.439 ' HA ' HD11 ' A' ' 283' ' ' ILE . 11.9 pt-20 -143.8 164.2 31.43 Favored Pre-proline 0 C--N 1.322 -0.595 0 CA-C-N 115.934 -0.576 . . . . 0.69 110.308 -179.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.5 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.5 Cg_exo -60.24 112.54 1.34 Allowed 'Trans proline' 0 C--N 1.345 0.344 0 C-N-CA 122.329 2.019 . . . . 0.41 111.27 178.349 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 132.45 -19.86 4.48 Favored Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 111.241 -0.744 . . . . 0.29 111.241 -178.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.437 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.0 m-20 -70.84 146.14 49.85 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.732 0.301 . . . . 0.34 110.245 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.1 ttt -103.76 136.44 43.44 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 116.309 -0.405 . . . . 1.26 110.656 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.444 HD23 HG12 ' A' ' 335' ' ' VAL . 18.9 mt -87.99 123.39 32.66 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.246 -0.434 . . . . 0.48 110.109 179.752 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.562 HD11 ' HB2' ' A' ' 336' ' ' ALA . 90.6 mt -106.25 -69.07 0.84 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.048 0.451 . . . . 0.53 110.818 179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.2 tt0 -121.1 124.7 45.42 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.776 -0.647 . . . . 0.73 110.484 -179.068 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.482 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.5 t -125.62 101.57 8.63 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.39 -0.368 . . . . 0.29 110.23 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.404 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.1 m-20 62.88 65.69 0.79 Allowed 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.998 -0.546 . . . . 1.71 111.244 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 2.6 m-20 74.69 -43.67 0.53 Allowed 'General case' 0 N--CA 1.473 0.69 0 N-CA-C 113.922 1.082 . . . . 1.11 113.922 178.191 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.482 HG22 ' O ' ' A' ' 304' ' ' VAL . 33.6 m -69.51 137.47 24.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 118.261 0.482 . . . . 0.71 111.329 -178.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -111.06 133.16 53.66 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.771 -0.65 . . . . 0.74 109.645 -179.718 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 31.8 m-85 -106.13 12.44 30.24 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 111.909 0.337 . . . . 0.33 111.909 -178.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -66.32 -30.56 70.99 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.723 0.297 . . . . 1.21 111.715 -179.446 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 18.5 m-80 -122.56 36.96 4.51 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 121.119 0.485 . . . . 1.32 110.816 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 84.1 mtp -125.05 154.96 40.51 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 109.324 -0.621 . . . . 0.51 109.324 178.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 97.0 p -69.17 153.56 43.51 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 110.147 -0.316 . . . . 0.97 110.147 179.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -59.6 -26.38 65.4 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.163 0.506 . . . . 0.48 109.842 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.478 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -71.48 -56.3 6.18 Favored 'General case' 0 C--N 1.332 -0.179 0 CA-C-N 115.279 -0.873 . . . . 1.4 110.588 179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.427 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 10.6 m-20 -63.64 -30.98 72.02 Favored 'General case' 0 N--CA 1.464 0.243 0 CA-C-N 115.84 -0.618 . . . . 0.88 111.683 -178.723 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.36 -51.15 67.74 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.929 -0.578 . . . . 0.2 112.011 -179.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 1.7 t -75.33 -27.27 19.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 C-N-CA 120.931 -0.308 . . . . 0.21 111.024 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.478 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 81.4 mtt180 -58.53 -53.31 59.79 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.904 0.383 . . . . 0.83 110.11 179.4 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.3 t -66.6 -40.49 86.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.871 -0.604 . . . . 0.17 110.274 179.5 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.448 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.6 tp -55.12 -50.98 67.88 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.938 -0.574 . . . . 0.38 111.229 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.455 ' HA ' HG11 ' B' ' 3' ' ' VAL . 9.0 mtp180 -61.0 -41.86 97.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.31 -0.404 . . . . 1.57 111.359 -178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 19.0 mm-40 -61.42 -43.52 98.73 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.52 0.2 . . . . 1.87 110.55 179.607 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 83.4 mt -64.01 -43.25 97.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.866 0.365 . . . . 0.29 110.508 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.448 HG23 ' O ' ' A' ' 321' ' ' LEU . 59.3 t -70.01 -19.68 22.7 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 CA-C-N 116.277 -0.42 . . . . 0.24 111.045 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 66.7 m -77.86 -18.38 56.31 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.854 0.359 . . . . 0.44 110.789 179.378 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.1 mp0 -102.09 162.39 12.95 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-N 116.172 -0.467 . . . . 1.16 110.228 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.39 172.07 13.99 Favored 'General case' 0 C--N 1.322 -0.624 0 CA-C-N 116.359 -0.382 . . . . 0.89 111.745 -179.59 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 116.19 168.08 15.04 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.925 -0.655 . . . . 0.45 112.572 179.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -79.56 104.52 1.73 Allowed 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 122.699 2.266 . . . . 0.58 111.733 179.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 50.0 mt -74.06 114.13 13.31 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.654 0 CA-C-N 116.048 -0.524 . . . . 0.37 110.691 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.53 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 8.1 m -97.31 102.74 14.58 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.833 -0.621 . . . . 1.09 109.75 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 1.3 mp -98.89 119.05 37.0 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 116.023 -0.535 . . . . 0.48 111.319 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 26.8 m -98.54 101.12 12.46 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 108.779 -0.822 . . . . 0.5 108.779 178.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.444 HG12 HD23 ' A' ' 301' ' ' LEU . 29.8 m -101.64 156.23 4.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.528 0 CA-C-N 115.924 -0.58 . . . . 0.33 112.204 -178.302 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.562 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.07 111.43 22.79 Favored 'General case' 0 C--N 1.322 -0.621 0 CA-C-N 115.113 -0.949 . . . . 0.38 109.894 179.091 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.437 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.7 mtpp . . . . . 0 C--O 1.252 1.229 0 CA-C-O 118.511 -0.757 . . . . 0.7 109.796 179.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.722 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.582 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 22.4 m95 . . . . . 0 N--CA 1.462 0.165 0 N-CA-C 110.126 -0.324 . . . . 0.4 110.126 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.455 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.71 -0.662 . . . . 0.27 109.973 178.519 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 47.0 t30 . . . . . 0 N--CA 1.478 0.975 0 CA-C-O 120.74 0.305 . . . . 1.26 110.518 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 69.5 mt -97.61 128.38 49.0 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.527 0 N-CA-C 110.128 -0.323 . . . . 0.65 110.128 179.71 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 42.2 mt -126.53 130.51 71.76 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 120.813 0.339 . . . . 0.55 111.151 -179.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.8 m -101.62 111.11 23.25 Favored 'General case' 0 C--N 1.325 -0.478 0 N-CA-C 109.52 -0.548 . . . . 0.59 109.52 178.612 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 34.4 m -114.91 147.93 18.0 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-O 120.688 0.28 . . . . 0.5 111.566 -178.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 11.2 t -110.16 136.8 48.82 Favored 'General case' 0 C--N 1.324 -0.51 0 N-CA-C 109.642 -0.503 . . . . 0.79 109.642 178.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.2 mt -114.71 138.41 50.75 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-O 120.905 0.383 . . . . 0.46 111.469 -178.917 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -83.91 117.96 23.68 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.65 -0.704 . . . . 0.65 110.155 179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 92.2 mmm -98.35 14.05 29.37 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.374 -0.375 . . . . 0.63 111.584 -178.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 18.3 mm-40 -88.14 -38.39 15.39 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-O 121.286 0.565 . . . . 1.27 110.342 179.522 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.419 HH11 ' HD3' ' A' ' 258' ' ' ARG . 25.7 ttt180 -96.34 0.66 51.03 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.575 -0.739 . . . . 1.06 110.255 179.656 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -131.03 162.52 29.62 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 115.771 -0.65 . . . . 0.76 109.709 -179.834 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 33.4 m-70 -120.32 -8.23 9.67 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 120.827 0.346 . . . . 1.09 111.283 179.798 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 33.3 p90 -154.62 175.95 13.02 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.509 -0.314 . . . . 0.62 110.707 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . . . . . . . . . 6.5 mt -82.08 -52.46 6.99 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.187 -0.46 . . . . 0.34 109.971 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.68 43.18 5.54 Favored Glycine 0 N--CA 1.449 -0.45 0 CA-C-N 115.806 -0.634 . . . . 0.14 112.879 179.176 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.4 pt -137.02 154.35 31.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.521 0 CA-C-O 121.538 0.685 . . . . 0.18 112.37 -179.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.452 ' HB3' ' H ' ' A' ' 282' ' ' SER . 42.5 t -101.8 118.03 36.09 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 114.612 -1.176 . . . . 1.0 109.043 178.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.663 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 11.1 mm -88.63 118.5 34.2 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-O 120.776 0.322 . . . . 0.28 110.138 -179.571 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 92.6 t -111.99 109.77 29.74 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.629 0 CA-C-O 121.007 0.432 . . . . 0.31 110.759 -179.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -91.1 124.38 7.54 Favored Glycine 0 N--CA 1.446 -0.688 0 N-CA-C 111.247 -0.741 . . . . 0.37 111.247 179.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.1 tt0 -86.18 112.39 21.28 Favored 'General case' 0 C--N 1.323 -0.543 0 CA-C-O 120.938 0.399 . . . . 1.87 110.635 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.1 m -97.86 93.58 6.43 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.909 -0.587 . . . . 1.17 110.41 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -86.38 -176.14 5.76 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.208 -0.451 . . . . 2.75 110.73 -179.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 2.7 p-10 -67.91 -15.07 63.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.255 0.55 . . . . 2.08 110.002 179.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 10.3 ttt180 -92.97 -3.69 54.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.563 -0.744 . . . . 2.63 110.017 179.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 88.5 -66.41 3.2 Favored Glycine 0 N--CA 1.448 -0.516 0 C-N-CA 120.787 -0.72 . . . . 0.97 112.147 -179.627 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -79.86 152.85 29.45 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 121.082 0.468 . . . . 1.75 110.642 -179.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -159.8 -36.96 0.02 OUTLIER Glycine 0 N--CA 1.449 -0.437 0 CA-C-N 115.812 -0.631 . . . . 0.52 111.829 -179.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 120.67 161.21 11.37 Favored Glycine 0 N--CA 1.445 -0.744 0 C-N-CA 120.642 -0.789 . . . . 0.3 112.305 179.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.0 pt -106.44 114.26 45.19 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-O 121.297 0.57 . . . . 0.27 110.212 179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 26.9 m-85 -107.32 154.57 21.08 Favored 'General case' 0 C--N 1.32 -0.698 0 CA-C-N 115.893 -0.594 . . . . 0.72 110.692 -178.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.6 mm -79.23 114.18 19.63 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 109.782 -0.451 . . . . 0.24 109.782 179.197 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.12 -57.7 3.62 Favored Glycine 0 N--CA 1.448 -0.539 0 C-N-CA 120.746 -0.74 . . . . 0.42 112.333 -179.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . 0.452 ' H ' ' HB3' ' A' ' 265' ' ' SER . 1.8 p -145.16 158.25 43.87 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 110.144 -0.317 . . . . 0.75 110.144 -179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 50.4 mt -118.24 131.62 70.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 N-CA-C 109.58 -0.526 . . . . 0.53 109.58 179.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 34.1 mmt -92.77 124.32 36.69 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.415 -0.357 . . . . 0.74 110.619 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 27.9 tptp -58.56 130.18 45.61 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.989 -0.551 . . . . 1.01 110.997 179.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.12 -24.55 20.78 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.894 -0.67 . . . . 0.36 112.034 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -69.38 168.19 45.92 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 121.058 -0.591 . . . . 0.26 112.424 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.01 -37.32 84.43 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 120.908 0.385 . . . . 0.25 111.056 -179.842 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.457 HG13 HD12 ' A' ' 295' ' ' ILE . 54.8 t -69.54 -39.27 78.26 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.101 -0.5 . . . . 0.26 110.781 -179.934 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.27 -18.15 64.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.833 -0.621 . . . . 0.37 111.254 -179.499 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -85.67 -11.03 54.79 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.056 -0.52 . . . . 0.41 110.955 179.724 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -88.49 -67.76 0.81 Allowed 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.839 -0.43 . . . . 0.55 109.839 179.266 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 103.47 -14.96 54.06 Favored Glycine 0 N--CA 1.45 -0.428 0 C-N-CA 120.587 -0.816 . . . . 0.39 114.435 177.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 54.1 mtm180 -79.96 -33.13 39.78 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 117.738 0.769 . . . . 0.68 111.137 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.457 HD12 HG13 ' A' ' 289' ' ' VAL . 63.5 mt -82.57 140.65 16.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 N-CA-C 109.651 -0.5 . . . . 0.37 109.651 179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -143.13 164.3 32.49 Favored Pre-proline 0 C--N 1.327 -0.38 0 CA-C-N 116.765 -0.198 . . . . 0.69 110.88 -179.464 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 39.0 Cg_exo -58.37 116.94 3.6 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.611 2.207 . . . . 0.41 111.823 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 125.82 -21.81 6.19 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.917 -0.658 . . . . 0.29 111.509 -179.37 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.461 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 88.5 m-20 -69.44 143.23 53.63 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.768 -0.456 . . . . 0.34 109.768 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 43.7 ttp -103.36 135.3 45.24 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 120.702 0.287 . . . . 1.26 110.813 -179.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 70.4 mt -83.39 123.97 30.19 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.226 -0.443 . . . . 0.48 110.182 179.528 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.688 HD11 ' HB2' ' A' ' 336' ' ' ALA . 46.7 mt -105.15 -72.57 0.71 Allowed 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 121.245 0.545 . . . . 0.53 110.835 -179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.437 ' H ' ' HB ' ' A' ' 334' ' ' THR . 8.1 tt0 -109.75 135.32 50.86 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.542 -0.754 . . . . 0.73 111.034 -178.515 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.408 HG21 HD13 ' A' ' 321' ' ' LEU . 67.3 t -131.98 93.66 1.76 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.415 0 CA-C-N 115.942 -0.572 . . . . 0.29 110.149 179.555 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.438 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 59.21 76.61 0.35 Allowed 'General case' 0 C--O 1.237 0.423 0 CA-C-N 115.798 -0.637 . . . . 1.71 111.737 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.438 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.8 OUTLIER 75.21 -53.37 0.66 Allowed 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.053 -0.976 . . . . 1.11 113.455 178.423 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 16.8 m -70.5 139.66 19.71 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-O 121.349 0.595 . . . . 0.71 111.864 -178.687 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 64.1 t30 -111.99 130.8 55.74 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.442 -0.799 . . . . 0.74 110.409 -179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.482 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 23.7 m-85 -102.02 6.53 41.16 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 111.867 0.321 . . . . 0.33 111.867 -179.075 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -59.92 -31.61 70.0 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.746 0.308 . . . . 1.21 111.696 -179.664 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -119.44 53.35 1.04 Allowed 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.2 0.524 . . . . 1.32 110.301 179.746 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . 0.482 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 84.1 mtp -141.11 160.37 40.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.95 -0.568 . . . . 0.51 110.182 179.52 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -68.38 148.14 51.11 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 116.242 -0.435 . . . . 0.97 110.75 179.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 98.7 m-20 -49.7 -50.97 41.69 Favored 'General case' 0 N--CA 1.469 0.491 0 O-C-N 123.484 0.49 . . . . 0.48 111.638 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -64.22 -47.3 80.22 Favored 'General case' 0 N--CA 1.464 0.27 0 CA-C-N 116.22 -0.446 . . . . 1.4 111.833 -179.223 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 39.5 m-20 -60.58 -35.1 75.25 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 115.886 -0.597 . . . . 0.88 111.815 -178.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.89 -45.02 93.83 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.452 -0.34 . . . . 0.2 110.865 179.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.515 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -73.82 -32.61 34.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-N 116.412 -0.358 . . . . 0.21 110.623 -179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 61.2 mtt180 -54.98 -50.33 69.21 Favored 'General case' 0 C--O 1.234 0.268 0 CA-C-O 120.864 0.364 . . . . 0.83 110.627 179.718 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.6 t -70.49 -39.93 76.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.455 0 CA-C-N 115.75 -0.659 . . . . 0.17 110.249 179.574 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.471 ' O ' HG23 ' A' ' 325' ' ' VAL . 56.6 tp -55.36 -50.44 69.68 Favored 'General case' 0 C--N 1.333 -0.141 0 CA-C-N 116.053 -0.521 . . . . 0.38 111.373 179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.663 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.0 mtp180 -63.69 -30.13 71.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.025 -0.534 . . . . 1.57 111.462 -178.665 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 58.7 mm-40 -68.7 -40.37 80.04 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 121.136 0.493 . . . . 1.87 109.804 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 71.2 mt -68.92 -42.67 82.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.595 -0.73 . . . . 0.29 111.209 179.84 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.471 HG23 ' O ' ' A' ' 321' ' ' LEU . 43.8 t -69.23 -16.94 21.28 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.395 0 CA-C-O 121.158 0.504 . . . . 0.24 110.802 -179.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 47.6 m -96.67 23.57 6.85 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.092 0.473 . . . . 0.44 110.161 179.038 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -125.26 -179.31 4.53 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.887 -0.597 . . . . 1.16 110.102 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -107.99 146.24 32.76 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-O 120.71 0.29 . . . . 0.89 110.607 179.473 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.37 169.59 13.09 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.707 -0.759 . . . . 0.45 112.269 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 58.0 Cg_endo -73.97 137.09 23.71 Favored 'Trans proline' 0 N--CA 1.462 -0.337 0 C-N-CA 122.69 2.26 . . . . 0.58 112.166 179.809 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 84.4 mt -115.34 121.57 67.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.563 0 CA-C-N 116.142 -0.481 . . . . 0.37 110.414 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 10.8 m -106.11 121.06 43.38 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-O 121.138 0.494 . . . . 1.09 109.95 179.413 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 84.0 mt -105.5 130.52 53.55 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.898 -0.592 . . . . 0.48 111.538 -178.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.437 ' HB ' ' H ' ' A' ' 303' ' ' GLN . 2.7 m -104.04 103.23 13.02 Favored 'General case' 0 C--N 1.321 -0.658 0 N-CA-C 108.802 -0.814 . . . . 0.5 108.802 177.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.5 m -102.28 142.68 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-O 121.343 0.592 . . . . 0.33 112.35 -178.303 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.688 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -108.22 111.95 24.19 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.186 -0.916 . . . . 0.38 109.582 178.819 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.461 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.0 mtpp . . . . . 0 C--O 1.251 1.144 0 CA-C-O 118.613 -0.708 . . . . 0.7 109.942 -179.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.663 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 28.9 m95 . . . . . 0 N--CA 1.463 0.204 0 CA-C-O 120.547 0.213 . . . . 0.4 110.62 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.663 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.1 OUTLIER . . . . . 0 C--O 1.245 0.841 0 CA-C-O 119.038 -0.506 . . . . 0.27 109.949 178.766 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 44.4 t-20 . . . . . 0 N--CA 1.481 1.076 0 CA-C-O 120.917 0.389 . . . . 1.26 109.959 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 57.2 mt -92.3 128.78 43.7 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.588 0 CA-C-N 116.435 -0.348 . . . . 0.65 110.731 -179.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 33.8 mt -129.67 123.7 57.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 CA-C-N 116.2 -0.455 . . . . 0.55 110.875 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 3.1 m -95.39 102.39 14.19 Favored 'General case' 0 C--N 1.322 -0.62 0 N-CA-C 109.424 -0.584 . . . . 0.59 109.424 178.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 25.0 m -100.27 148.4 6.77 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 CA-C-O 120.954 0.407 . . . . 0.5 111.751 -178.963 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -114.87 129.95 56.8 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 108.802 -0.814 . . . . 0.79 108.802 178.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.471 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 80.2 mt -110.89 149.66 30.3 Favored 'General case' 0 C--N 1.321 -0.637 0 CA-C-O 121.071 0.463 . . . . 0.46 111.606 -178.484 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 26.2 t-20 -93.27 118.04 30.79 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.507 -0.77 . . . . 0.65 110.901 -179.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 67.0 mmm -99.46 16.26 23.77 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.863 -0.608 . . . . 0.63 111.304 -179.902 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 57.5 mm-40 -86.47 -49.41 7.61 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.35 -0.611 . . . . 1.27 109.35 178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 69.4 ttt180 -86.44 -22.8 26.31 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.583 -0.735 . . . . 1.06 110.193 179.429 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.2 m80 -106.92 154.76 20.58 Favored 'General case' 0 C--N 1.325 -0.462 0 CA-C-N 115.998 -0.546 . . . . 0.76 110.472 -179.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -115.76 -2.39 12.42 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.519 0.2 . . . . 1.09 111.304 -179.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 30.6 p90 -157.56 171.92 19.49 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.832 0.348 . . . . 0.62 110.959 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 7.6 mt -78.21 -51.31 10.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.887 -0.597 . . . . 0.34 110.016 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 86.05 47.34 5.03 Favored Glycine 0 N--CA 1.447 -0.618 0 CA-C-N 115.776 -0.647 . . . . 0.14 112.708 179.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.429 HD11 HD13 ' A' ' 262' ' ' LEU . 3.5 pt -142.73 150.45 18.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.486 0.66 . . . . 0.18 112.023 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -100.26 120.61 40.18 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 114.991 -1.004 . . . . 1.0 108.81 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.787 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 5.3 mm -89.56 116.11 30.42 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.598 0 CA-C-O 120.919 0.39 . . . . 0.28 111.036 -178.518 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 68.9 t -101.69 118.77 48.97 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.496 0 CA-C-N 116.094 -0.503 . . . . 0.31 109.877 179.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -98.51 127.82 9.36 Favored Glycine 0 N--CA 1.444 -0.813 0 C-N-CA 120.511 -0.852 . . . . 0.37 112.013 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 3.0 tp-100 -79.09 69.43 5.27 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.186 -0.672 . . . . 1.87 109.186 179.114 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.4 ' HA ' ' HA2' ' A' ' 274' ' ' GLY . 14.9 m -86.58 92.01 8.76 Favored 'General case' 0 C--N 1.323 -0.575 0 CA-C-N 115.61 -0.723 . . . . 1.17 111.444 -179.014 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 29.0 p-10 -99.37 -148.51 0.35 Allowed 'General case' 0 C--N 1.321 -0.645 0 CA-C-N 115.282 -0.872 . . . . 2.75 109.387 178.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 28.3 t70 -57.4 -33.49 67.9 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.695 0.283 . . . . 2.08 111.297 179.81 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 22.7 ttm180 -102.71 -52.44 3.08 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.491 -0.322 . . . . 2.63 111.106 -179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.4 ' HA2' ' HA ' ' A' ' 270' ' ' SER . . . 95.37 27.03 11.13 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.541 -0.838 . . . . 0.97 112.314 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -111.03 13.98 21.97 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.017 0.437 . . . . 1.75 110.5 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -67.58 -28.31 73.57 Favored Glycine 0 C--N 1.329 0.184 0 CA-C-N 115.803 -0.635 . . . . 0.52 112.834 -179.605 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 104.21 178.17 25.27 Favored Glycine 0 N--CA 1.447 -0.618 0 C-N-CA 120.502 -0.856 . . . . 0.3 112.511 179.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.2 pt -113.67 138.43 43.41 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 CA-C-O 120.898 0.38 . . . . 0.27 110.894 -179.734 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 48.6 m-85 -125.69 158.24 35.3 Favored 'General case' 0 C--N 1.324 -0.504 0 CA-C-N 115.996 -0.547 . . . . 0.72 110.661 -179.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 32.3 mm -75.92 109.5 9.69 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-N 116.067 -0.515 . . . . 0.24 109.698 178.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.29 -60.13 3.92 Favored Glycine 0 N--CA 1.45 -0.433 0 C-N-CA 120.754 -0.736 . . . . 0.42 112.273 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 30.7 m -145.17 157.97 43.94 Favored 'General case' 0 C--N 1.321 -0.671 0 O-C-N 122.708 -0.289 . . . . 0.75 110.355 179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 49.2 mt -113.52 130.22 67.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 CA-C-N 116.211 -0.45 . . . . 0.53 110.137 179.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.8 mmt -87.97 119.33 28.22 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.237 -0.438 . . . . 0.74 110.335 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -61.72 116.99 5.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.955 -0.566 . . . . 1.01 110.023 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.1 -17.58 9.12 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 111.477 -0.649 . . . . 0.36 111.477 -179.074 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -78.8 174.03 55.26 Favored Glycine 0 N--CA 1.446 -0.685 0 C-N-CA 120.863 -0.684 . . . . 0.26 111.912 179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.471 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.93 -36.87 84.83 Favored 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.769 0.318 . . . . 0.25 111.218 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 86.6 t -68.98 -37.37 77.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.101 -0.499 . . . . 0.26 111.169 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.41 -17.88 64.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.243 -0.435 . . . . 0.37 111.828 -179.196 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -89.92 -3.66 57.93 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.828 0.347 . . . . 0.41 111.192 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.7 t70 -94.63 -80.25 0.41 Allowed 'General case' 0 C--N 1.326 -0.452 0 N-CA-C 109.745 -0.465 . . . . 0.55 109.745 179.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 118.33 -21.53 9.97 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.274 -0.965 . . . . 0.39 113.908 179.021 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -76.84 -19.59 57.34 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 117.568 0.684 . . . . 0.68 111.751 -179.241 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 68.8 mt -95.18 136.36 26.46 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 N-CA-C 109.646 -0.501 . . . . 0.37 109.646 179.236 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -136.63 163.77 47.36 Favored Pre-proline 0 C--N 1.323 -0.559 0 CA-C-N 116.439 -0.346 . . . . 0.69 110.742 -179.343 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_exo -62.47 109.04 0.78 Allowed 'Trans proline' 0 C--N 1.347 0.448 0 C-N-CA 122.368 2.045 . . . . 0.41 111.452 179.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.96 -17.14 5.21 Favored Glycine 0 N--CA 1.446 -0.693 0 CA-C-N 115.799 -0.637 . . . . 0.29 112.09 -179.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.429 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 97.7 m-20 -65.11 140.39 58.8 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.634 0.254 . . . . 0.34 110.348 179.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.6 ttt -93.76 135.2 35.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.775 0.322 . . . . 1.26 111.02 -179.913 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 25.6 mt -90.07 118.14 29.39 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.193 -0.458 . . . . 0.48 109.936 179.347 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.539 HD11 ' HB2' ' A' ' 336' ' ' ALA . 59.4 mt -103.54 -77.12 0.57 Allowed 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 121.098 0.475 . . . . 0.53 110.837 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 308' ' ' ASN . 8.3 tt0 -106.01 134.42 49.17 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.81 -0.632 . . . . 0.73 110.996 -178.864 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.436 HG21 HD13 ' A' ' 321' ' ' LEU . 84.7 t -131.31 102.21 5.99 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 115.782 -0.645 . . . . 0.29 109.83 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 3.2 m-20 58.35 70.53 0.64 Allowed 'General case' 0 C--O 1.236 0.376 0 CA-C-N 115.566 -0.743 . . . . 1.71 111.568 -179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.5 OUTLIER 76.51 -53.36 0.59 Allowed 'General case' 0 N--CA 1.469 0.512 0 N-CA-C 113.585 0.957 . . . . 1.11 113.585 178.124 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.6 m -72.09 133.02 32.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 121.27 0.557 . . . . 0.71 112.122 -178.405 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.409 ' HA ' ' HA ' ' A' ' 303' ' ' GLN . 50.0 t30 -103.32 131.39 50.43 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.521 -0.763 . . . . 0.74 109.782 179.804 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 -97.17 3.98 51.33 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 111.984 0.364 . . . . 0.33 111.984 -178.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -57.4 -32.8 67.2 Favored 'General case' 0 N--CA 1.466 0.372 0 CA-C-O 120.965 0.412 . . . . 1.21 111.69 179.803 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 49.2 m-80 -105.78 39.88 1.68 Allowed 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.094 -0.503 . . . . 1.32 111.47 -179.053 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 34.1 mtp -141.78 165.77 26.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.514 -0.312 . . . . 0.51 110.263 179.726 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 77.5 p -79.25 162.8 25.44 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 109.899 -0.408 . . . . 0.97 109.899 179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 42.7 m-20 -57.26 -40.06 76.88 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.068 0.461 . . . . 0.48 110.037 179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.461 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 23.9 t0 -63.08 -55.09 28.41 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 115.182 -0.917 . . . . 1.4 110.514 -179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 69.9 m-20 -60.13 -36.18 76.94 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 115.826 -0.625 . . . . 0.88 111.34 -179.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.29 -56.02 27.45 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 115.98 -0.555 . . . . 0.2 112.157 -179.231 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.9 t -69.62 -26.71 31.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 C-N-CA 120.963 -0.295 . . . . 0.21 111.358 -178.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.461 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 69.4 mtt180 -57.11 -52.28 65.92 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.867 0.365 . . . . 0.83 110.072 179.214 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.7 t -70.22 -38.26 74.01 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 115.976 -0.556 . . . . 0.17 110.4 179.788 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.458 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.9 tp -56.09 -51.58 67.36 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 115.923 -0.581 . . . . 0.38 110.942 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.678 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.7 mtp180 -61.15 -38.41 86.33 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.945 -0.571 . . . . 1.57 111.082 -179.2 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 59.3 mm-40 -64.3 -45.38 88.21 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.595 -0.275 . . . . 1.87 110.682 179.49 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 94.5 mt -59.78 -44.37 93.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.436 -0.347 . . . . 0.29 110.9 -179.761 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.458 HG23 ' O ' ' A' ' 321' ' ' LEU . 26.1 t -72.22 -15.21 17.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 121.129 0.49 . . . . 0.24 111.424 -179.398 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 71.7 m -81.74 -16.6 50.56 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-O 120.83 0.348 . . . . 0.44 110.838 179.368 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -97.65 160.7 14.16 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.303 -0.408 . . . . 1.16 110.357 179.807 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -94.7 130.82 41.04 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-O 120.97 0.414 . . . . 0.89 111.075 -179.851 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.31 176.1 27.1 Favored Glycine 0 N--CA 1.45 -0.406 0 N-CA-C 111.523 -0.631 . . . . 0.45 111.523 179.741 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 40.4 Cg_endo -68.38 135.95 35.46 Favored 'Trans proline' 0 C--O 1.236 0.391 0 C-N-CA 122.539 2.159 . . . . 0.58 112.151 179.746 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 77.1 mt -116.43 129.64 72.56 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.145 0.497 . . . . 0.37 110.732 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -119.26 126.81 52.37 Favored 'General case' 0 C--N 1.322 -0.598 0 CA-C-N 115.347 -0.842 . . . . 1.09 109.403 179.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 83.8 mt -116.12 115.91 26.9 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 120.802 0.334 . . . . 0.48 111.586 -178.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -93.37 90.13 6.63 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.599 -0.889 . . . . 0.5 108.599 177.578 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 15.2 m -92.11 146.47 6.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 115.912 -0.585 . . . . 0.33 111.996 -178.31 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.539 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.04 107.75 17.26 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.333 -0.849 . . . . 0.38 110.018 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.429 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 22.7 mtpp . . . . . 0 C--O 1.248 0.997 0 CA-C-O 118.432 -0.795 . . . . 0.7 109.692 179.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.787 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.463 0.223 0 N-CA-C 109.881 -0.414 . . . . 0.4 109.881 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.678 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.914 0 CA-C-O 118.84 -0.6 . . . . 0.27 110.164 178.568 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 18.3 t-20 . . . . . 0 N--CA 1.479 0.986 0 CA-C-O 120.74 0.305 . . . . 1.26 110.239 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 87.5 mt -107.61 122.16 61.5 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.504 0 CA-C-O 120.909 0.385 . . . . 0.65 110.629 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 18.3 mt -126.31 131.42 71.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 CA-C-N 116.263 -0.426 . . . . 0.55 111.478 -179.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 88.8 m -104.96 113.24 26.72 Favored 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 108.943 -0.762 . . . . 0.59 108.943 177.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 10.2 m -103.56 155.55 5.52 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.613 0 CA-C-N 116.283 -0.417 . . . . 0.5 111.857 -178.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.5 t -108.23 135.35 49.7 Favored 'General case' 0 C--N 1.323 -0.568 0 N-CA-C 109.05 -0.722 . . . . 0.79 109.05 178.326 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 84.9 mt -119.04 136.14 54.28 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 120.947 0.403 . . . . 0.46 111.524 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.2 t-20 -83.46 114.85 21.76 Favored 'General case' 0 C--O 1.237 0.444 0 CA-C-N 115.547 -0.751 . . . . 0.65 109.924 179.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 93.8 mmm -98.89 14.77 27.78 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.036 -0.529 . . . . 0.63 111.159 -179.26 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 62.8 mm-40 -88.93 -47.54 8.08 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 116.023 -0.535 . . . . 1.27 109.819 178.871 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.3 ttt180 -83.71 -21.63 32.26 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.855 -0.611 . . . . 1.06 110.048 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.9 m80 -111.67 159.04 18.59 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.139 -0.482 . . . . 0.76 109.867 -179.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 90.6 m-70 -128.24 14.76 6.71 Favored 'General case' 0 C--N 1.322 -0.603 0 CA-C-O 120.899 0.38 . . . . 1.09 110.443 179.721 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 12.9 p90 -164.72 169.0 17.37 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.074 -0.512 . . . . 0.62 110.163 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.401 HD13 HD11 ' A' ' 264' ' ' ILE . 5.5 mt -81.28 -57.68 3.39 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 120.828 0.347 . . . . 0.34 110.27 -179.846 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 93.6 36.35 5.89 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.95 -0.643 . . . . 0.14 112.578 179.212 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.401 HD11 HD13 ' A' ' 262' ' ' LEU . 6.1 pt -137.16 156.1 33.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.42 0.629 . . . . 0.18 111.894 -179.782 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.497 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.1 OUTLIER -102.71 129.15 49.24 Favored 'General case' 0 C--N 1.322 -0.608 0 CA-C-N 114.993 -1.003 . . . . 1.0 110.006 179.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . . . . . . . . . 5.6 mm -97.37 113.33 31.51 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-N 116.186 -0.461 . . . . 0.28 110.953 -179.245 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 24.5 t -114.88 115.24 48.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.279 -0.419 . . . . 0.31 110.709 -179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.64 134.23 12.26 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.97 -0.633 . . . . 0.37 112.393 179.907 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -104.35 156.68 17.72 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-O 120.623 0.249 . . . . 1.87 110.539 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 275' ' ' ASP . 69.3 m -137.2 121.07 17.55 Favored 'General case' 0 N--CA 1.451 -0.386 0 CA-C-N 116.41 -0.359 . . . . 1.17 110.513 179.294 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.4 t30 -75.66 -76.15 0.16 Allowed 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.3 -0.409 . . . . 2.75 110.503 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -145.29 -16.72 0.49 Allowed 'General case' 0 C--N 1.328 -0.339 0 C-N-CA 121.06 -0.256 . . . . 2.08 111.551 179.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 3.3 mtm105 -114.25 11.99 17.57 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.233 0.539 . . . . 2.63 110.163 178.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 92.69 -15.08 63.4 Favored Glycine 0 N--CA 1.451 -0.342 0 N-CA-C 111.324 -0.711 . . . . 0.97 111.324 -179.122 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.489 ' O ' ' HA ' ' A' ' 270' ' ' SER . 17.2 p-10 -75.05 159.44 31.71 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.186 -0.507 . . . . 1.75 110.794 -179.595 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 163.57 -47.39 0.31 Allowed Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.893 -0.67 . . . . 0.52 112.156 -179.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 109.39 172.62 20.8 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.548 -0.834 . . . . 0.3 112.025 179.811 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -105.6 130.44 56.99 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 CA-C-O 121.174 0.511 . . . . 0.27 111.07 -179.759 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . 0.456 ' CE2' ' HB2' ' A' ' 300' ' ' MET . 45.4 m-85 -117.71 159.17 23.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.768 -0.651 . . . . 0.72 110.687 -179.369 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 49.0 mm -79.88 120.2 30.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 115.919 -0.582 . . . . 0.24 110.227 179.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -77.29 -53.41 5.17 Favored Glycine 0 N--CA 1.454 -0.122 0 C-N-CA 120.704 -0.76 . . . . 0.42 112.073 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.6 p -155.59 163.76 39.53 Favored 'General case' 0 C--N 1.319 -0.751 0 N-CA-C 109.841 -0.429 . . . . 0.75 109.841 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.4 mt -117.49 128.61 74.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 N-CA-C 109.95 -0.389 . . . . 0.53 109.95 179.694 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -90.86 126.45 36.04 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 116.265 -0.425 . . . . 0.74 110.813 -179.441 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.8 tptp -63.57 127.57 31.93 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.18 -0.464 . . . . 1.01 110.03 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 112.4 -14.37 25.35 Favored Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 120.657 -0.782 . . . . 0.36 111.572 -179.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -81.39 175.1 54.51 Favored Glycine 0 N--CA 1.447 -0.581 0 C-N-CA 120.982 -0.628 . . . . 0.26 111.778 179.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -69.05 -38.85 79.35 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.69 0.281 . . . . 0.25 111.027 -179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.22 -36.93 78.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 CA-C-N 116.039 -0.528 . . . . 0.26 111.054 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.33 -7.27 46.0 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.073 -0.512 . . . . 0.37 111.703 -179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -91.09 -11.91 37.22 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 116.327 -0.397 . . . . 0.41 111.155 -179.893 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.8 t70 -91.8 -80.2 0.36 Allowed 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.404 -0.362 . . . . 0.55 110.333 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 120.22 -18.62 9.53 Favored Glycine 0 CA--C 1.519 0.317 0 C-N-CA 120.521 -0.847 . . . . 0.39 114.024 179.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -76.69 -33.38 58.23 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 117.55 0.675 . . . . 0.68 111.338 -179.472 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.4 mt -83.0 139.43 17.77 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 CA-C-N 116.173 -0.467 . . . . 0.37 109.892 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -139.78 160.63 60.21 Favored Pre-proline 0 C--N 1.325 -0.492 0 N-CA-C 110.107 -0.331 . . . . 0.69 110.107 -179.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 49.0 Cg_exo -58.45 122.97 12.56 Favored 'Trans proline' 0 C--O 1.235 0.34 0 C-N-CA 122.386 2.057 . . . . 0.41 111.023 178.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 120.07 -17.82 9.82 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.298 -0.721 . . . . 0.29 111.298 -178.775 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.415 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 93.6 m-20 -69.09 144.23 53.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.666 0.269 . . . . 0.34 110.504 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . 0.456 ' HB2' ' CE2' ' A' ' 279' ' ' TYR . 27.3 ttt -100.36 135.38 41.89 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.381 -0.372 . . . . 1.26 111.1 -179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 36.8 mt -87.41 123.4 32.31 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 109.902 -0.407 . . . . 0.48 109.902 179.238 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.631 HD11 ' HB2' ' A' ' 336' ' ' ALA . 75.3 mt -102.12 -64.67 1.04 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.263 0.554 . . . . 0.53 110.887 -179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.3 tt0 -125.11 136.17 53.38 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.733 -0.667 . . . . 0.73 110.672 -179.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.468 ' O ' HG23 ' A' ' 307' ' ' VAL . 98.5 t -132.66 103.38 6.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.206 -0.452 . . . . 0.29 110.134 179.416 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.442 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 8.5 m-20 59.81 65.14 1.17 Allowed 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.318 -0.401 . . . . 1.71 111.444 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.442 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 58.0 m-20 76.31 -51.16 0.6 Allowed 'General case' 0 N--CA 1.474 0.759 0 C-N-CA 124.034 0.934 . . . . 1.11 113.451 178.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.468 HG23 ' O ' ' A' ' 304' ' ' VAL . 0.0 OUTLIER -63.66 124.35 18.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-O 121.387 0.613 . . . . 0.71 111.852 -178.896 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 67.0 t30 -99.59 129.61 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.34 -0.845 . . . . 0.74 109.67 179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.0 m-85 -108.63 12.67 25.74 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 112.131 0.419 . . . . 0.33 112.131 -178.248 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -63.25 -26.19 68.67 Favored 'General case' 0 N--CA 1.465 0.32 0 CA-C-O 120.643 0.259 . . . . 1.21 111.637 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 94.6 m-20 -117.14 24.37 11.22 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 111.68 0.252 . . . . 1.32 111.68 -179.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 79.8 mtp -122.23 156.49 33.65 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.788 -0.365 . . . . 0.51 111.501 -179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.24 144.0 57.47 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.724 -0.671 . . . . 0.97 110.388 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.472 ' O ' HG23 ' A' ' 318' ' ' VAL . 57.5 m-20 -50.86 -49.05 59.86 Favored 'General case' 0 N--CA 1.468 0.433 0 O-C-N 123.279 0.362 . . . . 0.48 111.463 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -58.73 -47.18 85.5 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.104 -0.498 . . . . 1.4 111.309 -179.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 65.8 m-20 -69.21 -29.16 67.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.901 -0.59 . . . . 0.88 111.509 -179.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -63.4 -47.48 81.83 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 116.27 -0.423 . . . . 0.2 110.97 179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.546 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -74.28 -23.77 18.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.81 -0.356 . . . . 0.21 110.688 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 33.0 mtt180 -56.08 -45.9 79.21 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-O 121.016 0.436 . . . . 0.83 110.168 178.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -77.02 -36.37 24.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 115.879 -0.601 . . . . 0.17 110.256 179.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.457 ' CD1' HG11 ' A' ' 304' ' ' VAL . 32.3 tp -56.76 -50.6 71.79 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.841 -0.618 . . . . 0.38 111.398 -179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.614 ' HA ' HG11 ' B' ' 3' ' ' VAL . 31.3 mtp180 -61.61 -33.16 73.44 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.34 -0.391 . . . . 1.57 111.258 -179.03 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -64.71 -45.46 86.45 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 121.122 0.487 . . . . 1.87 109.948 178.889 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 68.0 mt -67.48 -42.78 87.43 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.387 0 CA-C-N 115.564 -0.744 . . . . 0.29 111.624 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.489 HG11 ' HB ' ' B' ' 3' ' ' VAL . 57.5 t -66.32 -26.83 38.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-O 120.93 0.395 . . . . 0.24 111.264 -179.239 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 15.8 m -86.71 -2.21 58.35 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-O 121.253 0.549 . . . . 0.44 110.474 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -98.05 163.86 12.58 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.783 -0.644 . . . . 1.16 110.411 -179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -91.13 144.61 25.45 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.487 -0.324 . . . . 0.89 110.842 179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 124.21 152.8 8.46 Favored Glycine 0 N--CA 1.445 -0.738 0 C-N-CA 120.677 -0.773 . . . . 0.45 111.994 -179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -63.36 139.7 72.74 Favored 'Trans proline' 0 C--O 1.237 0.444 0 C-N-CA 122.947 2.431 . . . . 0.58 112.15 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 57.9 mt -114.52 134.39 57.65 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 CA-C-N 116.079 -0.51 . . . . 0.37 111.301 -178.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 6.5 m -108.63 126.16 52.66 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.59 -0.522 . . . . 1.09 109.59 178.667 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 63.8 mt -110.51 118.2 35.59 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 112.075 0.398 . . . . 0.48 112.075 -178.792 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 89.1 m -98.78 100.28 11.47 Favored 'General case' 0 C--N 1.326 -0.454 0 N-CA-C 108.767 -0.827 . . . . 0.5 108.767 177.929 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 28.0 m -104.92 155.48 6.22 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 CA-C-O 121.287 0.565 . . . . 0.33 112.005 -178.264 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.631 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -113.61 114.89 27.07 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.263 -0.88 . . . . 0.38 110.111 179.319 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.415 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 23.6 mtpp . . . . . 0 C--O 1.247 0.954 0 CA-C-O 118.477 -0.773 . . . . 0.7 109.604 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.534 ' H22' HG11 ' A' ' 318' ' ' VAL . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.497 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 58.2 m95 . . . . . 0 N--CA 1.465 0.288 0 CA-C-O 120.368 0.128 . . . . 0.4 110.873 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.614 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.72 -0.657 . . . . 0.27 109.801 177.315 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 41.4 t-20 . . . . . 0 N--CA 1.481 1.123 0 N-CA-C 110.26 -0.274 . . . . 1.26 110.26 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 72.3 mt -92.36 128.99 43.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 N-CA-C 109.814 -0.439 . . . . 0.65 109.814 179.261 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.3 mt -126.36 132.5 70.31 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.78 0.324 . . . . 0.55 110.99 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 13.2 m -109.01 111.4 23.03 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.414 -0.587 . . . . 0.59 109.414 178.656 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 29.6 m -111.19 149.47 13.93 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-O 120.863 0.363 . . . . 0.5 111.469 -179.083 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 2.4 t -115.35 106.84 14.47 Favored 'General case' 0 C--N 1.325 -0.499 0 N-CA-C 109.148 -0.686 . . . . 0.79 109.148 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.459 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 57.9 mt -87.91 134.96 33.6 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.874 -0.603 . . . . 0.46 111.618 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -79.22 115.9 19.16 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.313 -0.858 . . . . 0.65 110.508 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 60.9 mmm -99.33 19.59 15.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.073 0.463 . . . . 0.63 110.937 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -89.22 -52.77 4.89 Favored 'General case' 0 C--N 1.324 -0.526 0 N-CA-C 109.617 -0.512 . . . . 1.27 109.617 179.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 58.9 ttt180 -82.89 -25.67 32.28 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.727 -0.669 . . . . 1.06 109.62 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 56.8 m80 -98.86 160.21 14.42 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.918 -0.583 . . . . 0.76 109.561 179.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 99.6 m-70 -130.21 12.69 5.59 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-O 120.967 0.413 . . . . 1.09 110.562 -179.79 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 22.4 p90 -168.6 165.8 12.13 Favored 'General case' 0 C--O 1.236 0.385 0 CA-C-N 115.791 -0.641 . . . . 0.62 110.135 -179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.433 HD23 ' HA ' ' A' ' 262' ' ' LEU . 8.0 mt -80.1 -51.51 8.92 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 109.639 -0.504 . . . . 0.34 109.639 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.4 43.45 5.55 Favored Glycine 0 N--CA 1.443 -0.853 0 CA-C-N 115.736 -0.665 . . . . 0.14 112.653 179.124 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.7 pt -144.86 152.16 15.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 CA-C-O 121.489 0.662 . . . . 0.18 111.66 179.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.426 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 21.5 p -104.22 128.82 52.0 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 115.202 -0.908 . . . . 1.0 108.842 178.211 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.727 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.6 mm -95.26 123.41 47.39 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.835 0 CA-C-O 120.899 0.38 . . . . 0.28 110.551 -178.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 63.1 t -104.08 113.43 40.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.419 179.818 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -84.08 105.65 2.8 Favored Glycine 0 N--CA 1.446 -0.637 0 N-CA-C 111.268 -0.733 . . . . 0.37 111.268 179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.9 tp-100 -72.75 95.95 1.97 Allowed 'General case' 0 C--N 1.326 -0.452 0 CA-C-O 121.099 0.476 . . . . 1.87 110.768 -179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 20.1 m -111.91 106.66 15.43 Favored 'General case' 0 C--N 1.32 -0.676 0 CA-C-N 116.003 -0.544 . . . . 1.17 110.147 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.472 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 7.5 t30 -104.92 -149.77 0.42 Allowed 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.684 -0.689 . . . . 2.75 109.522 179.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.472 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 18.4 p-10 -56.67 -40.85 76.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.101 0.477 . . . . 2.08 109.819 178.752 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.415 ' HB3' ' OD1' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -83.79 -53.97 5.23 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.676 -0.693 . . . . 2.63 110.021 178.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.88 0.09 41.96 Favored Glycine 0 C--N 1.331 0.259 0 C-N-CA 120.814 -0.708 . . . . 0.97 112.889 179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.415 ' OD1' ' HB3' ' A' ' 273' ' ' ARG . 37.3 p-10 -103.61 43.1 1.11 Allowed 'General case' 0 C--N 1.32 -0.682 0 CA-C-O 121.182 0.515 . . . . 1.75 111.173 -179.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -76.13 -28.65 59.94 Favored Glycine 0 N--CA 1.449 -0.438 0 C-N-CA 120.743 -0.741 . . . . 0.52 112.605 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 103.74 173.61 25.71 Favored Glycine 0 N--CA 1.448 -0.545 0 C-N-CA 120.759 -0.734 . . . . 0.3 112.28 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 13.5 pt -105.83 124.48 60.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-O 121.045 0.45 . . . . 0.27 110.741 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 59.4 m-85 -116.38 154.95 29.35 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.944 -0.571 . . . . 0.72 110.536 -179.303 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 43.7 mm -74.23 114.33 13.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 115.98 -0.555 . . . . 0.24 109.869 178.922 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -72.93 -58.71 4.66 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.946 -0.645 . . . . 0.42 112.512 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 1.8 p -152.98 161.36 42.63 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 110.215 -0.291 . . . . 0.75 110.215 179.803 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 41.2 mt -111.02 135.45 50.13 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.242 -0.436 . . . . 0.53 110.273 -179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.0 mmt -98.54 131.61 44.63 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 116.186 -0.461 . . . . 0.74 110.152 179.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.3 tptp -63.85 131.58 48.19 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 115.996 -0.547 . . . . 1.01 110.668 -179.657 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 103.71 -17.05 50.67 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.763 -0.732 . . . . 0.36 111.888 -179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -75.16 165.22 54.61 Favored Glycine 0 N--CA 1.444 -0.826 0 C-N-CA 120.972 -0.632 . . . . 0.26 112.264 179.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.459 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.88 -31.62 72.7 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-O 120.616 0.246 . . . . 0.25 111.089 -179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 98.1 t -70.42 -42.52 78.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.424 . . . . 0.26 110.791 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.03 -17.91 65.0 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.011 -0.54 . . . . 0.37 111.214 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -83.03 -13.87 55.03 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.153 -0.476 . . . . 0.41 111.212 179.562 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -91.14 -75.98 0.46 Allowed 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 116.515 -0.311 . . . . 0.55 110.755 -179.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 114.35 -19.96 16.57 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.374 -0.917 . . . . 0.39 113.813 178.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 50.5 mtm180 -76.88 -27.72 55.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 117.568 0.684 . . . . 0.68 111.245 -179.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.5 mt -88.17 136.99 21.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.573 0 CA-C-N 116.229 -0.441 . . . . 0.37 109.934 179.432 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -138.04 161.01 62.06 Favored Pre-proline 0 C--N 1.323 -0.574 0 CA-C-N 116.407 -0.36 . . . . 0.69 110.543 -179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_exo -60.57 114.11 1.99 Allowed 'Trans proline' 0 C--O 1.235 0.337 0 C-N-CA 122.266 1.977 . . . . 0.41 110.896 178.538 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.27 -20.07 5.33 Favored Glycine 0 N--CA 1.449 -0.47 0 N-CA-C 111.603 -0.599 . . . . 0.29 111.603 -179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.453 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 92.2 m-20 -65.9 143.86 57.16 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.967 -0.383 . . . . 0.34 109.967 179.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 39.9 ttp -101.85 135.85 42.7 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.632 0.254 . . . . 1.26 110.334 179.831 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 52.7 mt -86.64 121.02 28.58 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 116.389 -0.369 . . . . 0.48 110.423 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.751 HD11 ' HB2' ' A' ' 336' ' ' ALA . 27.7 mt -97.14 -77.88 0.48 Allowed 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 121.192 0.52 . . . . 0.53 110.269 179.734 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 3.1 tt0 -114.58 129.43 56.67 Favored 'General case' 0 N--CA 1.449 -0.486 0 CA-C-N 115.636 -0.711 . . . . 0.73 110.404 -179.451 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.427 HG11 ' CD1' ' A' ' 321' ' ' LEU . 90.6 t -123.21 97.06 4.4 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.763 0 N-CA-C 109.367 -0.605 . . . . 0.29 109.367 178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.59 HD21 HG23 ' A' ' 331' ' ' ILE . 61.6 m-80 63.05 72.24 0.49 Allowed 'General case' 0 C--N 1.328 -0.35 0 O-C-N 123.641 0.588 . . . . 1.71 111.315 -179.666 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 21.1 m-20 73.92 -48.12 0.66 Allowed 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.8 1.037 . . . . 1.11 113.8 177.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.4 m -73.44 125.6 32.72 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-O 121.253 0.549 . . . . 0.71 111.83 -178.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -103.17 123.76 47.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.627 -0.715 . . . . 0.74 109.744 179.708 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 25.5 m-85 -91.06 8.02 37.57 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 112.441 0.534 . . . . 0.33 112.441 -177.784 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 17.7 mt-10 -60.16 -22.97 63.55 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 112.24 0.459 . . . . 1.21 112.24 -179.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 59.8 m-80 -123.82 37.65 4.36 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-O 120.802 0.334 . . . . 1.32 111.152 -179.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.6 mtp -132.03 164.04 27.09 Favored 'General case' 0 C--N 1.328 -0.351 0 N-CA-C 109.85 -0.426 . . . . 0.51 109.85 179.256 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 3.5 p -77.99 155.55 30.68 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 110.286 -0.264 . . . . 0.97 110.286 179.746 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.428 ' O ' HG23 ' A' ' 318' ' ' VAL . 93.6 m-20 -52.15 -46.18 65.35 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.253 -0.431 . . . . 0.48 111.086 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.422 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 1.8 m-20 -61.28 -51.34 69.32 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.841 -0.618 . . . . 1.4 111.604 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.48 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 7.4 m-20 -64.77 -34.85 79.32 Favored 'General case' 0 C--N 1.328 -0.341 0 N-CA-C 111.772 0.286 . . . . 0.88 111.772 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -56.91 -46.8 81.73 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.263 -0.426 . . . . 0.2 110.943 179.767 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.5 t -79.47 -24.42 12.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 C-N-CA 120.776 -0.369 . . . . 0.21 110.885 -179.807 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.48 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 71.3 mtt180 -57.94 -48.63 79.38 Favored 'General case' 0 C--N 1.333 -0.15 0 N-CA-C 109.437 -0.579 . . . . 0.83 109.437 178.466 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 23.2 t -73.36 -36.1 47.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 115.792 -0.64 . . . . 0.17 110.158 179.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 20.9 tp -56.13 -51.23 68.69 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 116.066 -0.516 . . . . 0.38 110.881 179.819 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.554 ' HA ' HG11 ' B' ' 3' ' ' VAL . 16.6 mtp-105 -62.6 -34.4 76.94 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.122 -0.49 . . . . 1.57 110.93 -179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.5 mm-40 -63.75 -46.95 83.01 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.091 -0.504 . . . . 1.87 110.561 179.34 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 89.2 mt -63.59 -44.37 98.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.1 -0.5 . . . . 0.29 111.125 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 30.8 t -68.74 -12.09 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.452 0 CA-C-O 121.186 0.517 . . . . 0.24 110.951 -179.69 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -84.6 -4.41 58.97 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.85 0.357 . . . . 0.44 110.696 179.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -102.75 176.45 5.15 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.468 -0.333 . . . . 1.16 110.132 179.671 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.91 112.89 24.68 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.837 0.351 . . . . 0.89 110.964 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 167.01 169.74 30.99 Favored Glycine 0 N--CA 1.448 -0.566 0 C-N-CA 120.67 -0.776 . . . . 0.45 112.452 179.575 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -63.71 123.13 11.5 Favored 'Trans proline' 0 C--O 1.235 0.35 0 C-N-CA 122.62 2.213 . . . . 0.58 111.642 179.51 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . 0.59 HG23 HD21 ' A' ' 305' ' ' ASN . 66.3 mt -98.5 114.65 36.68 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 CA-C-N 116.207 -0.451 . . . . 0.37 111.098 -178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -90.35 111.18 22.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.999 -0.546 . . . . 1.09 110.123 179.188 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 92.8 mt -105.03 120.3 41.15 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 116.117 -0.492 . . . . 0.48 111.114 -179.409 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.5 m -105.12 98.65 8.32 Favored 'General case' 0 C--N 1.322 -0.618 0 N-CA-C 109.136 -0.69 . . . . 0.5 109.136 178.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.8 m -101.13 149.97 6.07 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-O 121.3 0.571 . . . . 0.33 111.978 -178.446 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.751 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -110.77 109.21 19.34 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.275 -0.875 . . . . 0.38 109.764 179.076 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.453 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 24.5 mtpp . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.267 -0.873 . . . . 0.7 109.958 179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.727 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.426 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 18.0 m95 . . . . . 0 C--O 1.234 0.278 0 N-CA-C 110.425 -0.213 . . . . 0.4 110.425 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.554 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.972 0 CA-C-O 118.741 -0.647 . . . . 0.27 109.924 178.655 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.975 -0.38 . . . . 1.26 109.975 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 29.0 mt -104.26 130.71 54.57 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.599 0 CA-C-O 120.738 0.304 . . . . 0.65 111.232 -178.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 50.6 mt -131.62 138.08 53.75 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.27 -0.423 . . . . 0.55 110.905 179.798 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.06 109.91 21.47 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.118 -0.697 . . . . 0.59 109.118 178.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 32.6 m -107.28 158.88 7.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.601 0 CA-C-O 120.985 0.422 . . . . 0.5 111.519 -178.805 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.2 t -123.91 129.35 50.84 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 108.893 -0.781 . . . . 0.79 108.893 179.023 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.441 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 87.1 mt -112.41 141.39 46.2 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-O 121.074 0.464 . . . . 0.46 111.862 -178.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.1 t-20 -82.21 107.93 15.27 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.413 -0.812 . . . . 0.65 110.628 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 94.0 mmm -93.86 22.48 5.6 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 116.054 -0.521 . . . . 0.63 110.905 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -94.74 -47.61 6.41 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 109.144 -0.688 . . . . 1.27 109.144 178.586 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 78.0 ttt180 -86.15 -27.7 24.44 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.288 -0.869 . . . . 1.06 109.55 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.8 m80 -108.76 135.31 50.19 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.668 -0.696 . . . . 0.76 109.806 -179.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 30.3 m-70 -102.63 -0.82 31.3 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 121.028 -0.269 . . . . 1.09 111.398 -179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 13.4 p90 -150.26 162.13 41.09 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.767 0.318 . . . . 0.62 110.956 -179.628 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.452 HD13 HD11 ' A' ' 264' ' ' ILE . 5.3 mt -75.85 -50.96 13.62 Favored 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.818 -0.628 . . . . 0.34 109.541 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 85.23 49.54 4.41 Favored Glycine 0 N--CA 1.446 -0.697 0 CA-C-N 115.659 -0.7 . . . . 0.14 112.589 179.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.452 HD11 HD13 ' A' ' 262' ' ' LEU . 2.6 pt -145.48 149.71 16.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 CA-C-O 121.321 0.582 . . . . 0.18 111.722 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -100.36 121.53 41.66 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 115.052 -0.976 . . . . 1.0 108.871 178.404 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.712 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.0 mm -88.56 123.3 40.86 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.783 0 CA-C-O 120.949 0.404 . . . . 0.28 110.623 -179.168 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.2 t -105.33 113.87 43.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.358 -0.383 . . . . 0.31 110.246 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -85.72 103.79 2.78 Favored Glycine 0 N--CA 1.443 -0.844 0 C-N-CA 120.728 -0.749 . . . . 0.37 111.81 179.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -76.33 108.41 9.26 Favored 'General case' 0 C--N 1.323 -0.579 0 N-CA-C 109.612 -0.514 . . . . 1.87 109.612 179.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . 0.454 ' HB3' ' HA2' ' A' ' 274' ' ' GLY . 19.8 m -108.5 112.2 24.47 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.196 -0.457 . . . . 1.17 111.106 -178.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -84.39 -150.97 0.12 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 116.05 -0.523 . . . . 2.75 110.587 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 9.4 p-10 -65.99 -24.3 66.75 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.478 -0.328 . . . . 2.08 111.654 -179.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -113.45 12.37 18.67 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.784 0.326 . . . . 2.63 110.591 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . 0.454 ' HA2' ' HB3' ' A' ' 270' ' ' SER . . . 78.26 8.36 87.51 Favored Glycine 0 C--N 1.33 0.213 0 C-N-CA 120.635 -0.793 . . . . 0.97 112.058 -179.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 14.7 p-10 -93.19 165.39 12.84 Favored 'General case' 0 C--N 1.322 -0.62 0 CA-C-O 120.72 0.295 . . . . 1.75 110.347 -179.783 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 151.23 -44.42 0.67 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.867 -0.683 . . . . 0.52 112.054 -179.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 108.7 170.18 21.01 Favored Glycine 0 N--CA 1.445 -0.741 0 C-N-CA 120.652 -0.785 . . . . 0.3 112.55 179.528 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.4 pt -101.34 129.4 52.48 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-O 121.102 0.477 . . . . 0.27 111.008 -179.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 62.1 m-85 -117.69 162.47 18.0 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.928 -0.578 . . . . 0.72 110.771 -179.261 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 37.2 mm -84.78 113.29 23.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 CA-C-N 116.261 -0.427 . . . . 0.24 109.999 178.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.37 -65.09 2.06 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.818 -0.706 . . . . 0.42 112.478 -179.92 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -140.87 152.73 45.32 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 120.759 0.314 . . . . 0.75 110.637 179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 60.2 mt -104.78 131.41 53.92 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 CA-C-N 116.079 -0.51 . . . . 0.53 109.912 179.657 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.5 mmt -92.86 126.2 37.83 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-O 120.851 0.358 . . . . 0.74 110.642 -179.645 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 16.4 tptp -65.3 128.43 35.8 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.829 -0.623 . . . . 1.01 109.86 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.21 -12.85 33.88 Favored Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.968 -0.634 . . . . 0.36 111.519 -179.013 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.5 171.08 47.19 Favored Glycine 0 N--CA 1.446 -0.695 0 C-N-CA 120.934 -0.65 . . . . 0.26 111.73 179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.441 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.55 -37.52 86.47 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 120.657 0.265 . . . . 0.25 111.259 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 53.1 t -67.29 -34.2 67.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.983 0.421 . . . . 0.26 111.039 -179.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.67 -20.78 64.46 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.235 -0.439 . . . . 0.37 111.619 -179.581 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -90.7 -6.58 54.3 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.457 -0.338 . . . . 0.41 111.057 -179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.0 t70 -90.97 -76.4 0.44 Allowed 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.938 -0.393 . . . . 0.55 109.938 179.814 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.19 -16.92 32.21 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.377 -0.916 . . . . 0.39 114.177 178.573 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 22.8 mtm180 -76.83 -34.99 57.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.571 0.685 . . . . 0.68 110.937 -179.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 65.7 mt -81.76 136.31 23.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 N-CA-C 109.678 -0.49 . . . . 0.37 109.678 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.8 pt-20 -133.52 158.65 75.1 Favored Pre-proline 0 C--N 1.324 -0.505 0 CA-C-N 116.522 -0.308 . . . . 0.69 110.697 -179.602 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_exo -60.48 99.93 0.15 Allowed 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.497 2.131 . . . . 0.41 111.434 178.653 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 141.66 -15.82 2.66 Favored Glycine 0 N--CA 1.445 -0.756 0 N-CA-C 111.59 -0.604 . . . . 0.29 111.59 -179.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 81.2 m-20 -67.0 146.41 54.39 Favored 'General case' 0 C--O 1.234 0.259 0 CA-C-O 120.732 0.301 . . . . 0.34 110.321 179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 28.3 ttt -99.88 135.27 41.55 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 116.266 -0.424 . . . . 1.26 110.75 -179.646 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.451 HD23 HG12 ' A' ' 335' ' ' VAL . 30.1 mt -90.82 117.46 29.46 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.246 -0.434 . . . . 0.48 109.933 179.571 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.466 HD11 ' HB2' ' A' ' 336' ' ' ALA . 82.5 mt -100.85 -62.83 1.19 Allowed 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.163 0.506 . . . . 0.53 110.735 -179.77 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -127.33 133.15 50.13 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.787 -0.642 . . . . 0.73 110.912 -179.284 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.499 HG11 ' CD1' ' A' ' 321' ' ' LEU . 44.4 t -119.62 87.71 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.321 -0.659 0 CA-C-N 116.173 -0.467 . . . . 0.29 109.76 178.737 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.452 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.4 t30 62.96 82.97 0.17 Allowed 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.47 -0.786 . . . . 1.71 111.437 -179.739 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.452 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 4.6 m-20 74.8 -59.78 0.54 Allowed 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 115.427 -0.806 . . . . 1.11 113.11 178.538 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 5.0 m -64.34 124.91 20.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-O 121.338 0.589 . . . . 0.71 112.456 -178.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 65.2 t30 -101.52 130.02 47.71 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.466 -0.788 . . . . 0.74 109.628 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.421 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 44.0 m-85 -106.89 15.99 24.82 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 111.944 0.349 . . . . 0.33 111.944 -178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 66.2 mt-10 -62.64 -32.8 73.91 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 112.122 0.415 . . . . 1.21 112.122 -179.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 48.7 m-80 -117.6 35.81 4.54 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.922 0.392 . . . . 1.32 111.209 -179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . 0.421 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 95.3 mtp -123.09 167.67 13.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 110.02 -0.363 . . . . 0.51 110.02 179.72 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 38.9 p -75.96 154.59 35.77 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 116.447 -0.342 . . . . 0.97 110.133 -179.678 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.443 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -58.37 -32.67 68.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.319 -0.401 . . . . 0.48 111.109 179.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -74.69 -49.82 19.85 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.207 -0.452 . . . . 1.4 111.063 -179.544 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -61.59 -35.16 77.06 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.257 -0.429 . . . . 0.88 110.974 -179.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.85 -50.4 73.44 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.018 -0.537 . . . . 0.2 111.258 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.536 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 4.0 t -73.5 -31.96 34.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.541 -0.3 . . . . 0.21 110.811 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.466 ' O ' ' HG2' ' A' ' 323' ' ' GLU . 78.7 mtt180 -55.45 -50.49 69.7 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-O 120.748 0.309 . . . . 0.83 110.339 179.42 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 37.0 t -69.88 -41.01 79.51 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 CA-C-N 116.246 -0.433 . . . . 0.17 110.093 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.499 ' CD1' HG11 ' A' ' 304' ' ' VAL . 17.3 tp -52.5 -48.51 65.95 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 115.964 -0.562 . . . . 0.38 111.22 179.651 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.556 ' HA ' HG11 ' B' ' 3' ' ' VAL . 18.3 mtp-105 -62.42 -39.14 92.31 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 116.012 -0.54 . . . . 1.57 111.743 -179.161 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.466 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 5.9 mm-40 -65.91 -34.6 78.5 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-O 120.914 0.387 . . . . 1.87 110.439 179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 80.3 mt -70.65 -43.93 77.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 115.976 -0.557 . . . . 0.29 110.142 179.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.444 HG23 ' O ' ' A' ' 321' ' ' LEU . 47.8 t -70.78 -18.75 21.12 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-O 121.246 0.546 . . . . 0.24 110.507 179.742 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 56.5 m -87.05 4.77 40.66 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 121.037 0.446 . . . . 0.44 110.204 178.571 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -110.35 158.53 18.34 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.976 -0.556 . . . . 1.16 109.989 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.91 120.48 35.18 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-O 120.662 0.268 . . . . 0.89 111.066 -179.741 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 155.59 169.09 19.58 Favored Glycine 0 N--CA 1.449 -0.456 0 C-N-CA 120.655 -0.783 . . . . 0.45 112.0 179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 8.3 Cg_exo -72.05 125.4 10.88 Favored 'Trans proline' 0 C--N 1.343 0.27 0 C-N-CA 122.913 2.408 . . . . 0.58 111.714 179.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 60.0 mt -100.36 117.69 45.94 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.282 -0.417 . . . . 0.37 110.922 -179.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.4 m -90.97 102.23 15.0 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.08 -0.509 . . . . 1.09 110.093 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 24.7 mt -92.93 123.37 36.14 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 120.872 0.367 . . . . 0.48 111.886 -178.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.4 m -107.3 99.23 8.78 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 108.543 -0.91 . . . . 0.5 108.543 178.18 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.451 HG12 HD23 ' A' ' 301' ' ' LEU . 27.6 m -104.68 155.71 6.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.507 0 CA-C-O 121.329 0.585 . . . . 0.33 112.194 -177.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.466 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.72 111.06 21.58 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.227 -0.897 . . . . 0.38 109.829 178.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 25.3 mtpp . . . . . 0 C--O 1.251 1.176 0 CA-C-O 118.311 -0.852 . . . . 0.7 110.144 -179.346 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.712 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 43.4 m95 . . . . . 0 C--O 1.234 0.286 0 N-CA-C 110.665 -0.124 . . . . 0.4 110.665 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.556 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.019 0 CA-C-O 118.679 -0.677 . . . . 0.27 110.003 178.041 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 23.4 t-20 . . . . . 0 N--CA 1.48 1.06 0 CA-C-O 120.673 0.273 . . . . 1.26 110.713 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 58.3 mt -106.45 109.67 28.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.513 0 N-CA-C 109.608 -0.516 . . . . 0.65 109.608 179.255 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 63.0 mt -113.63 127.74 70.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.623 0 CA-C-N 116.362 -0.381 . . . . 0.55 110.799 -179.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.5 m -104.21 103.46 13.23 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.931 -0.577 . . . . 0.59 110.118 179.536 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 17.8 m -98.38 144.06 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-O 121.067 0.46 . . . . 0.5 111.276 -178.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 1.3 t -114.5 113.68 24.76 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 109.087 -0.708 . . . . 0.79 109.087 178.58 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.44 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 24.0 mt -95.79 152.74 18.21 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-O 121.359 0.599 . . . . 0.46 112.038 -178.056 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -92.29 122.18 34.5 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 115.351 -0.84 . . . . 0.65 110.017 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 90.7 mmm -102.51 25.07 9.49 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.994 0.426 . . . . 0.63 111.752 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 65.4 mm-40 -100.37 -45.38 5.6 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 109.75 -0.463 . . . . 1.27 109.75 179.017 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . 0.405 HH11 ' HD3' ' A' ' 258' ' ' ARG . 19.2 ttt180 -92.95 11.43 27.37 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.385 0.612 . . . . 1.06 110.178 179.26 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 40.3 m80 -135.52 155.69 50.08 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.165 -0.68 . . . . 0.76 109.165 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 98.3 m-70 -111.98 -11.94 13.79 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-O 120.627 0.251 . . . . 1.09 110.833 -179.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . 0.533 ' HB2' ' O ' ' B' ' 3' ' ' VAL . 30.0 p90 -157.31 173.07 17.5 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.542 -0.299 . . . . 0.62 111.066 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 262' ' ' LEU . 6.5 mt -75.93 -50.95 13.54 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.422 -0.584 . . . . 0.34 109.422 179.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.9 41.58 5.9 Favored Glycine 0 N--CA 1.445 -0.71 0 CA-C-N 115.517 -0.765 . . . . 0.14 112.823 179.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 4.5 pt -136.65 146.23 28.98 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.664 0 CA-C-O 121.441 0.639 . . . . 0.18 111.767 179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -97.04 115.44 27.47 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.0 -1.0 . . . . 1.0 108.704 178.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.735 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 4.6 mm -85.44 126.65 40.42 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.739 0 CA-C-O 121.013 0.435 . . . . 0.28 110.239 -179.332 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 95.7 t -115.76 115.84 50.53 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.259 -0.428 . . . . 0.31 110.326 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -93.32 113.79 4.56 Favored Glycine 0 N--CA 1.446 -0.659 0 C-N-CA 120.868 -0.682 . . . . 0.37 111.73 179.892 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 6.4 tp-100 -78.99 114.32 17.84 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 120.909 0.385 . . . . 1.87 110.455 -179.837 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 51.2 m -119.5 101.54 8.01 Favored 'General case' 0 C--N 1.319 -0.733 0 CA-C-N 116.079 -0.51 . . . . 1.17 110.196 179.867 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 14.6 t30 -88.34 -146.82 0.15 Allowed 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 116.343 -0.39 . . . . 2.75 110.174 179.805 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -62.89 -37.76 88.19 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-O 120.839 0.352 . . . . 2.08 110.854 179.776 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.408 ' HD2' ' OD1' ' A' ' 275' ' ' ASP . 21.2 ttm180 -89.76 -52.3 5.06 Favored 'General case' 0 C--N 1.327 -0.392 0 N-CA-C 109.6 -0.519 . . . . 2.63 109.6 178.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 125.63 -18.35 6.78 Favored Glycine 0 C--N 1.331 0.297 0 C-N-CA 120.497 -0.859 . . . . 0.97 113.159 178.811 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.408 ' OD1' ' HD2' ' A' ' 273' ' ' ARG . 31.9 p-10 -85.94 73.45 10.32 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-O 121.651 0.739 . . . . 1.75 111.379 -179.419 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -101.82 -34.26 4.41 Favored Glycine 0 N--CA 1.447 -0.614 0 C-N-CA 120.745 -0.741 . . . . 0.52 112.118 179.521 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 106.69 165.74 22.54 Favored Glycine 0 N--CA 1.448 -0.551 0 C-N-CA 120.925 -0.655 . . . . 0.3 112.116 179.576 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.0 pt -102.24 128.85 54.5 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.488 0 CA-C-O 121.193 0.521 . . . . 0.27 110.809 179.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 92.4 m-85 -118.19 163.97 15.86 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.801 -0.636 . . . . 0.72 111.12 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . 0.443 HD11 HD21 ' A' ' 301' ' ' LEU . 46.3 mm -85.74 110.68 19.98 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 115.867 -0.606 . . . . 0.24 109.448 178.257 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.81 -51.79 8.87 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.737 -0.744 . . . . 0.42 112.689 -179.469 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -156.15 163.9 39.05 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 120.549 0.214 . . . . 0.75 110.579 -179.556 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 32.8 mt -114.24 134.32 57.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.233 -0.44 . . . . 0.53 109.991 179.645 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.9 mmt -96.13 128.42 43.02 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 116.375 -0.375 . . . . 0.74 110.277 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 18.6 tptp -63.26 131.86 49.77 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.053 -0.522 . . . . 1.01 110.22 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 101.49 -6.85 55.68 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.963 -0.637 . . . . 0.36 112.176 -179.406 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -85.15 171.28 46.09 Favored Glycine 0 N--CA 1.449 -0.471 0 C-N-CA 120.872 -0.68 . . . . 0.26 112.419 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.44 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -65.52 -35.41 80.78 Favored 'General case' 0 C--N 1.327 -0.412 0 CA-C-O 120.752 0.311 . . . . 0.25 111.057 179.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 83.4 t -71.89 -35.63 55.23 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-N 116.07 -0.514 . . . . 0.26 110.662 179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -67.28 -24.57 65.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.827 -0.624 . . . . 0.37 111.182 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -78.89 -16.61 56.81 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 116.158 -0.474 . . . . 0.41 111.069 179.715 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 13.4 t70 -89.59 -76.19 0.42 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.641 -179.772 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 110.89 -18.35 26.62 Favored Glycine 0 CA--C 1.52 0.363 0 C-N-CA 120.481 -0.866 . . . . 0.39 114.199 178.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 45.3 mtm180 -69.2 -40.05 78.27 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-N 117.568 0.684 . . . . 0.68 111.468 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 61.2 mt -80.3 137.09 22.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.548 0 N-CA-C 109.739 -0.467 . . . . 0.37 109.739 179.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -138.87 159.05 68.67 Favored Pre-proline 0 C--N 1.325 -0.457 0 CA-C-N 116.504 -0.316 . . . . 0.69 110.616 -179.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 52.1 Cg_exo -55.24 118.75 5.52 Favored 'Trans proline' 0 C--N 1.348 0.515 0 C-N-CA 122.358 2.039 . . . . 0.41 111.629 178.876 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 122.12 -19.72 8.18 Favored Glycine 0 N--CA 1.446 -0.662 0 N-CA-C 111.469 -0.653 . . . . 0.29 111.469 -178.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.404 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 84.1 m-20 -65.46 145.49 56.06 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.656 0.265 . . . . 0.34 110.331 179.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.3 ttp -101.1 133.84 45.02 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.443 -0.344 . . . . 1.26 110.516 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.568 HD23 HG12 ' A' ' 335' ' ' VAL . 73.3 mt -88.46 130.19 35.26 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.362 -0.381 . . . . 0.48 110.205 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.604 HD11 ' HB2' ' A' ' 336' ' ' ALA . 71.4 mt -111.16 -76.52 0.6 Allowed 'General case' 0 C--N 1.323 -0.565 0 CA-C-O 121.199 0.523 . . . . 0.53 110.899 179.898 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.8 tt0 -115.79 140.61 49.05 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.648 -0.705 . . . . 0.73 111.136 -178.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.457 HG21 HD13 ' A' ' 321' ' ' LEU . 87.3 t -134.12 101.3 3.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-N 115.798 -0.637 . . . . 0.29 109.52 179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 7.1 m120 62.3 68.16 0.68 Allowed 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.064 -0.516 . . . . 1.71 111.428 -179.46 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 74.93 -51.33 0.67 Allowed 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 115.251 -0.886 . . . . 1.11 113.373 178.3 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 17.3 m -67.78 130.89 33.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 CA-C-O 121.27 0.557 . . . . 0.71 111.528 -178.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 58.7 t30 -105.56 135.61 46.65 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.421 -0.809 . . . . 0.74 109.767 -179.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . 0.404 ' HD1' ' SD ' ' A' ' 312' ' ' MET . 21.9 m-85 -106.2 11.01 31.7 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 111.951 0.352 . . . . 0.33 111.951 -178.496 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 37.7 mt-10 -60.5 -32.47 71.47 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 112.233 0.457 . . . . 1.21 112.233 -179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 51.8 m-80 -112.33 32.14 5.78 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 121.022 0.439 . . . . 1.32 111.002 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . 0.404 ' SD ' ' HD1' ' A' ' 309' ' ' PHE . 86.5 mtp -123.81 163.72 20.63 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-N 116.181 -0.463 . . . . 0.51 110.371 179.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 75.5 p -74.39 156.6 36.87 Favored 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.349 -0.387 . . . . 0.97 110.274 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 90.5 m-20 -55.5 -40.64 72.01 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-O 120.86 0.362 . . . . 0.48 110.483 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.435 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 2.0 m-20 -68.61 -51.47 42.02 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.764 -0.653 . . . . 1.4 111.28 -179.661 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.441 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 28.6 m-20 -61.01 -36.8 80.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.373 -0.376 . . . . 0.88 111.684 -179.144 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.28 -48.94 78.86 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.214 -0.448 . . . . 0.2 111.245 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.484 HG22 HG21 ' A' ' 266' ' ' ILE . 6.2 t -73.51 -31.87 34.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 C-N-CA 121.071 -0.252 . . . . 0.21 110.771 -179.595 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.441 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 93.1 mtt180 -55.48 -46.52 76.88 Favored 'General case' 0 N--CA 1.462 0.125 0 N-CA-C 110.03 -0.359 . . . . 0.83 110.03 179.016 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 45.2 t -73.51 -38.36 52.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.903 -0.589 . . . . 0.17 110.276 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.511 ' O ' HG23 ' A' ' 325' ' ' VAL . 40.1 tp -54.61 -50.66 67.54 Favored 'General case' 0 CA--C 1.521 -0.148 0 CA-C-N 116.102 -0.499 . . . . 0.38 110.581 179.366 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.496 ' HA ' HG11 ' B' ' 3' ' ' VAL . 27.9 mtp-105 -61.34 -36.43 80.15 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.892 -0.595 . . . . 1.57 110.877 -179.68 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.1 mm-40 -60.96 -46.69 89.71 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 121.132 0.491 . . . . 1.87 110.016 178.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 57.6 mt -65.11 -41.71 92.54 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 115.788 -0.642 . . . . 0.29 110.878 179.857 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 321' ' ' LEU . 65.1 t -65.53 -15.92 19.44 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 CA-C-O 121.282 0.563 . . . . 0.24 111.055 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 19.8 m -89.96 0.41 57.1 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.469 -0.332 . . . . 0.44 110.894 179.054 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -103.23 147.5 26.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.86 0.362 . . . . 1.16 110.417 -179.529 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -88.77 103.8 16.3 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-O 120.761 0.315 . . . . 0.89 111.148 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 176.86 -175.4 47.62 Favored Glycine 0 N--CA 1.448 -0.553 0 C-N-CA 120.661 -0.78 . . . . 0.45 112.049 179.598 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -79.62 112.05 2.88 Favored 'Trans proline' 0 N--CA 1.46 -0.464 0 C-N-CA 123.025 2.484 . . . . 0.58 112.077 179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.2 mt -84.81 121.71 37.21 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-N 116.316 -0.402 . . . . 0.37 110.389 179.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -103.34 103.17 13.15 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.904 -0.589 . . . . 1.09 110.243 -179.858 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 96.7 mt -93.8 111.81 23.57 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.994 -0.548 . . . . 0.48 111.217 -179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.6 m -96.78 97.42 9.31 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 108.763 -0.828 . . . . 0.5 108.763 178.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.568 HG12 HD23 ' A' ' 301' ' ' LEU . 26.3 m -100.81 154.08 4.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.223 0.535 . . . . 0.33 112.228 -178.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.604 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.56 110.6 21.09 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.172 -0.922 . . . . 0.38 109.54 178.782 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 26.3 mtpp . . . . . 0 C--O 1.246 0.92 0 CA-C-O 118.083 -0.96 . . . . 0.7 110.129 -179.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.735 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 11.1 m95 . . . . . 0 C--O 1.235 0.327 0 CA-C-O 120.587 0.232 . . . . 0.4 110.556 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.533 ' O ' ' HB2' ' A' ' 261' ' ' PHE . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.886 0 CA-C-O 118.762 -0.637 . . . . 0.27 109.799 178.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 39.1 t-20 . . . . . 0 N--CA 1.48 1.03 0 CA-C-O 121.094 0.473 . . . . 1.26 109.876 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 71.7 mt -89.35 115.35 28.89 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.747 0 CA-C-N 115.877 -0.602 . . . . 0.65 110.134 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . 0.436 HD12 ' HD3' ' A' ' 337' ' ' LYS . 37.1 mt -120.88 130.94 74.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-O 121.076 0.465 . . . . 0.55 111.132 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 10.7 m -104.62 102.66 12.25 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.704 -0.68 . . . . 0.59 109.434 178.828 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.491 HG21 HD11 ' A' ' 295' ' ' ILE . 21.5 m -90.42 152.38 3.35 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 CA-C-O 120.972 0.415 . . . . 0.5 111.413 -178.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 5.5 t -113.5 125.15 53.89 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.317 -0.623 . . . . 0.79 109.317 179.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 92.3 mt -115.33 136.97 52.54 Favored 'General case' 0 C--N 1.323 -0.559 0 CA-C-O 121.041 0.448 . . . . 0.46 111.791 -178.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 13.8 t-20 -90.94 117.3 29.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.32 -0.855 . . . . 0.65 109.971 179.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.9 mmm -94.16 26.78 3.13 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.226 -0.443 . . . . 0.63 111.624 -179.401 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 43.9 mm-40 -99.74 -50.42 4.05 Favored 'General case' 0 C--N 1.327 -0.409 0 N-CA-C 109.538 -0.541 . . . . 1.27 109.538 178.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 72.0 ttt180 -81.83 -20.6 38.69 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-N 115.495 -0.775 . . . . 1.06 109.992 179.524 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 46.5 m80 -119.74 134.0 55.4 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.7 -0.682 . . . . 0.76 110.033 179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 62.7 m-70 -93.17 -8.5 42.31 Favored 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 112.499 0.555 . . . . 1.09 112.499 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 45.9 p90 -151.76 170.85 18.76 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.757 0.313 . . . . 0.62 111.116 -179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.407 HD23 ' HA ' ' A' ' 262' ' ' LEU . 4.4 mt -78.67 -53.82 6.76 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.886 -0.597 . . . . 0.34 110.466 -179.307 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.88 41.06 5.73 Favored Glycine 0 N--CA 1.448 -0.533 0 CA-C-N 115.97 -0.559 . . . . 0.14 112.729 179.059 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 9.9 pt -135.14 152.23 32.08 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.525 0.678 . . . . 0.18 111.802 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -100.91 126.5 47.55 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 114.993 -1.003 . . . . 1.0 108.812 178.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.787 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 7.0 mm -96.34 114.92 34.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.735 0 C-N-CA 120.65 -0.42 . . . . 0.28 110.461 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 98.6 t -110.53 106.42 20.71 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-N 116.205 -0.452 . . . . 0.31 110.153 179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -83.96 120.71 5.3 Favored Glycine 0 N--CA 1.446 -0.681 0 C-N-CA 120.734 -0.746 . . . . 0.37 111.813 179.837 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 29.9 tt0 -63.99 103.54 0.6 Allowed 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 109.982 -0.377 . . . . 1.87 109.982 179.836 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 1.2 m -108.43 135.12 50.25 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 116.038 -0.528 . . . . 1.17 110.198 -179.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.488 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 5.3 t30 -159.54 -157.28 0.57 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 116.307 -0.406 . . . . 2.75 110.145 -179.603 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.488 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 12.2 p-10 -55.03 -42.61 72.85 Favored 'General case' 0 N--CA 1.466 0.349 0 C-N-CA 122.933 0.493 . . . . 2.08 111.587 179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.96 -18.57 55.86 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-O 121.039 0.447 . . . . 2.63 110.796 -179.829 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 86.76 -63.65 4.05 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.828 -0.701 . . . . 0.97 112.028 -179.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 7.6 p-10 -84.4 151.29 24.78 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.088 0.471 . . . . 1.75 110.71 -179.764 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -165.64 -39.52 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 120.72 -0.752 . . . . 0.52 111.997 179.886 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 141.47 156.65 6.88 Favored Glycine 0 N--CA 1.445 -0.705 0 C-N-CA 120.694 -0.765 . . . . 0.3 111.981 179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 10.9 pt -102.37 118.98 50.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-O 121.171 0.51 . . . . 0.27 110.37 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 94.0 m-85 -109.84 150.48 28.33 Favored 'General case' 0 C--N 1.322 -0.6 0 CA-C-N 115.865 -0.607 . . . . 0.72 110.777 -179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.2 mm -76.51 115.5 18.27 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 116.271 -0.422 . . . . 0.24 110.001 178.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -69.89 -58.82 5.96 Favored Glycine 0 N--CA 1.449 -0.498 0 C-N-CA 120.814 -0.708 . . . . 0.42 112.139 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -153.47 165.08 36.95 Favored 'General case' 0 C--N 1.321 -0.643 0 N-CA-C 110.152 -0.314 . . . . 0.75 110.152 -179.744 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 56.0 mt -114.96 138.88 43.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 109.707 -0.479 . . . . 0.53 109.707 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 35.2 mmt -102.39 132.17 48.56 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.817 0.342 . . . . 0.74 110.675 -179.67 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.7 tptp -70.07 108.25 4.0 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 116.075 -0.511 . . . . 1.01 110.451 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 136.06 -13.08 4.13 Favored Glycine 0 N--CA 1.447 -0.624 0 N-CA-C 111.382 -0.687 . . . . 0.36 111.382 -179.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -88.3 170.63 39.3 Favored Glycine 0 N--CA 1.448 -0.549 0 C-N-CA 120.856 -0.688 . . . . 0.26 111.965 179.358 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -64.75 -36.15 83.36 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-O 120.703 0.287 . . . . 0.25 111.382 -179.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 58.0 t -65.84 -33.34 62.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-O 120.866 0.365 . . . . 0.26 111.132 -179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -71.56 -15.35 62.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.167 -0.469 . . . . 0.37 111.541 -179.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.26 -20.09 25.93 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 116.288 -0.415 . . . . 0.41 110.942 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -79.4 -73.35 0.35 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.259 -0.428 . . . . 0.55 110.351 -179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 108.31 -20.56 30.25 Favored Glycine 0 N--CA 1.449 -0.481 0 C-N-CA 120.48 -0.867 . . . . 0.39 113.57 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.8 mtm180 -73.37 -35.79 65.99 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 117.743 0.771 . . . . 0.68 111.048 -179.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.491 HD11 HG21 ' A' ' 252' ' ' VAL . 42.9 mt -82.86 137.76 20.47 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.562 0 N-CA-C 109.591 -0.522 . . . . 0.37 109.591 179.149 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 13.8 pt-20 -135.83 158.65 73.62 Favored Pre-proline 0 C--N 1.322 -0.617 0 CA-C-N 116.44 -0.345 . . . . 0.69 110.369 -179.865 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 42.9 Cg_exo -56.34 112.69 1.16 Allowed 'Trans proline' 0 C--N 1.348 0.551 0 C-N-CA 122.505 2.137 . . . . 0.41 111.429 179.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.92 -21.09 5.02 Favored Glycine 0 N--CA 1.447 -0.63 0 C-N-CA 121.101 -0.571 . . . . 0.29 111.94 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 48.2 m-20 -64.86 146.67 54.57 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.758 0.313 . . . . 0.34 110.92 179.973 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 59.4 ttp -105.9 132.41 52.03 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.288 -0.414 . . . . 1.26 110.363 179.854 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 23.2 mt -84.46 129.92 34.81 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 116.347 -0.388 . . . . 0.48 110.491 179.881 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.532 HD11 ' HB2' ' A' ' 336' ' ' ALA . 19.3 mt -104.78 -76.6 0.6 Allowed 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.213 0.53 . . . . 0.53 110.221 179.515 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.4 tt0 -112.1 128.79 56.31 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 115.584 -0.734 . . . . 0.73 110.569 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 97.9 t -121.99 97.68 5.13 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 116.135 -0.484 . . . . 0.29 110.121 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 57.23 77.22 0.28 Allowed 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.799 -0.637 . . . . 1.71 111.647 -179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER 75.3 -52.83 0.66 Allowed 'General case' 0 N--CA 1.471 0.592 0 N-CA-C 113.763 1.023 . . . . 1.11 113.763 178.004 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 20.2 m -75.21 132.98 32.38 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-O 121.437 0.637 . . . . 0.71 112.349 -178.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 46.2 t-20 -105.67 132.53 51.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.577 -0.738 . . . . 0.74 109.586 179.369 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 22.7 m-85 -99.53 3.7 45.63 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 111.845 0.313 . . . . 0.33 111.845 -178.683 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 38.8 mt-10 -61.53 -22.57 65.26 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 111.654 0.242 . . . . 1.21 111.654 179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -118.06 38.24 3.74 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 120.796 0.332 . . . . 1.32 110.55 -179.79 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -138.83 159.34 42.35 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.253 -0.43 . . . . 0.51 110.397 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.05 157.34 37.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.537 -0.301 . . . . 0.97 110.549 -179.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.49 ' O ' HG23 ' A' ' 318' ' ' VAL . 83.1 m-20 -54.78 -48.17 73.02 Favored 'General case' 0 N--CA 1.464 0.258 0 CA-C-N 116.35 -0.387 . . . . 0.48 111.179 -179.524 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -59.21 -50.79 72.67 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.849 -0.614 . . . . 1.4 111.386 -179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 9.3 m-20 -65.05 -33.79 76.89 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.927 -0.579 . . . . 0.88 111.469 -178.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -60.24 -48.07 83.3 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.319 -0.401 . . . . 0.2 111.307 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.596 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 2.3 t -71.97 -31.3 40.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 C-N-CA 120.607 -0.437 . . . . 0.21 110.917 -179.56 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 77.7 mtt180 -56.25 -54.57 43.76 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.891 0.377 . . . . 0.83 110.613 179.619 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 40.8 t -66.83 -36.4 77.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.164 -0.471 . . . . 0.17 110.526 179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.3 tp -56.03 -50.83 69.83 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.161 -0.472 . . . . 0.38 110.817 179.59 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.596 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 30.8 mtp180 -63.74 -31.96 73.31 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.745 -0.661 . . . . 1.57 111.292 -178.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 32.9 mm-40 -66.13 -45.17 82.01 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 121.029 0.442 . . . . 1.87 110.147 178.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 70.0 mt -67.08 -41.84 87.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.899 -0.591 . . . . 0.29 111.019 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 99.0 t -66.77 -19.48 25.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 CA-C-O 121.159 0.504 . . . . 0.24 110.992 -179.966 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 55.3 m -87.25 -5.62 58.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.809 0.337 . . . . 0.44 110.406 179.139 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.6 133.69 41.81 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.174 -0.467 . . . . 1.16 110.393 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -73.97 130.43 39.85 Favored 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 116.176 -0.465 . . . . 0.89 110.656 179.615 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 146.86 -174.57 26.64 Favored Glycine 0 N--CA 1.447 -0.617 0 C-N-CA 120.83 -0.7 . . . . 0.45 112.286 179.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 5.6 Cg_exo -78.67 127.67 8.12 Favored 'Trans proline' 0 C--O 1.238 0.476 0 C-N-CA 123.079 2.519 . . . . 0.58 112.129 179.666 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 61.2 mt -115.69 123.92 71.59 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-N 116.103 -0.499 . . . . 0.37 110.564 179.92 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.438 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 0.9 OUTLIER -105.59 117.25 33.54 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 115.825 -0.625 . . . . 1.09 110.335 179.817 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 78.3 mt -102.05 120.8 41.01 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-N 116.07 -0.513 . . . . 0.48 111.002 -179.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 3.1 m -100.54 103.91 15.25 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 109.336 -0.616 . . . . 0.5 109.336 178.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 3.6 m -106.33 145.17 14.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.511 0 CA-C-O 121.026 0.441 . . . . 0.33 112.023 -178.581 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.532 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -94.79 92.95 7.21 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.526 -0.761 . . . . 0.38 109.316 178.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.436 ' HD3' HD12 ' A' ' 250' ' ' ILE . 20.3 mtpp . . . . . 0 C--O 1.245 0.825 0 CA-C-O 118.49 -0.766 . . . . 0.7 111.196 -178.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.787 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 14.3 m95 . . . . . 0 C--O 1.236 0.361 0 N-CA-C 110.162 -0.311 . . . . 0.4 110.162 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.51 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.027 0 CA-C-O 118.73 -0.653 . . . . 0.27 110.012 178.858 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 6.9 t-20 . . . . . 0 N--CA 1.477 0.895 0 CA-C-O 120.991 0.424 . . . . 1.26 110.284 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 63.7 mt -77.34 121.4 29.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 115.907 -0.588 . . . . 0.65 110.727 179.826 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 48.5 mt -127.9 127.11 67.72 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.461 0 CA-C-N 116.477 -0.328 . . . . 0.55 111.221 -179.545 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 334' ' ' THR . 86.8 m -103.63 118.9 37.79 Favored 'General case' 0 C--N 1.325 -0.49 0 N-CA-C 109.157 -0.683 . . . . 0.59 109.157 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 9.3 m -112.48 143.4 22.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-O 121.099 0.476 . . . . 0.5 111.399 -178.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.9 t -101.33 137.85 39.13 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 108.046 -1.094 . . . . 0.79 108.046 177.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 85.7 mt -119.15 131.24 55.86 Favored 'General case' 0 C--N 1.318 -0.783 0 CA-C-O 121.107 0.479 . . . . 0.46 111.668 -179.194 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.5 t-20 -80.07 108.32 13.57 Favored 'General case' 0 C--N 1.323 -0.552 0 CA-C-N 115.437 -0.801 . . . . 0.65 110.353 179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 95.4 mmm -96.0 13.92 25.39 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.826 -0.625 . . . . 0.63 110.981 -179.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 66.6 mm-40 -85.27 -40.7 16.3 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 121.145 0.498 . . . . 1.27 109.941 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 29.0 ttt180 -93.88 -17.13 23.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.434 0.635 . . . . 1.06 109.898 178.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 33.9 m80 -108.01 161.45 14.94 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.714 -0.676 . . . . 0.76 110.108 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.0 m-70 -124.87 -0.66 7.92 Favored 'General case' 0 C--N 1.324 -0.531 0 C-N-CA 120.839 -0.344 . . . . 1.09 111.515 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 38.2 p90 -159.71 164.04 34.25 Favored 'General case' 0 C--O 1.237 0.403 0 CA-C-N 116.571 -0.286 . . . . 0.62 110.918 179.949 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.412 ' HB3' HG12 ' A' ' 264' ' ' ILE . 5.7 mt -77.39 -49.22 15.33 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 115.863 -0.608 . . . . 0.34 109.711 -179.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 81.27 50.85 4.92 Favored Glycine 0 N--CA 1.444 -0.781 0 CA-C-N 115.68 -0.691 . . . . 0.14 112.339 179.423 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.412 HG12 ' HB3' ' A' ' 262' ' ' LEU . 3.7 pt -145.56 146.98 19.03 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 121.517 0.675 . . . . 0.18 111.767 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -98.29 120.25 38.37 Favored 'General case' 0 C--N 1.321 -0.638 0 CA-C-N 115.057 -0.974 . . . . 1.0 108.761 178.245 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.746 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.3 mm -88.33 127.39 41.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.733 0 C-N-CA 120.615 -0.434 . . . . 0.28 110.567 -179.125 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 56.0 t -106.81 115.59 48.66 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 CA-C-N 116.331 -0.395 . . . . 0.31 110.714 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -97.63 111.62 4.29 Favored Glycine 0 N--CA 1.443 -0.845 0 N-CA-C 111.201 -0.759 . . . . 0.37 111.201 179.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.28 98.14 5.08 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 121.087 0.47 . . . . 1.87 110.215 -179.532 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 42.1 m -97.76 87.98 4.18 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-O 121.135 0.493 . . . . 1.17 110.718 -179.475 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 2.1 p30 -69.43 -64.85 0.8 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.388 -0.824 . . . . 2.75 111.278 -179.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.0 t70 -135.19 -64.18 0.66 Allowed 'General case' 0 C--N 1.319 -0.755 0 CA-C-N 116.023 -0.535 . . . . 2.08 109.752 179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.616 ' HD2' ' OD1' ' A' ' 275' ' ' ASP . 0.0 OUTLIER -95.13 -17.76 21.53 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.964 -0.562 . . . . 2.63 110.467 -179.983 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 112.23 6.0 24.37 Favored Glycine 0 N--CA 1.447 -0.606 0 C-N-CA 120.721 -0.752 . . . . 0.97 111.907 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.616 ' OD1' ' HD2' ' A' ' 273' ' ' ARG . 11.8 p-10 -82.85 67.97 9.15 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.66 0.743 . . . . 1.75 110.534 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -123.2 -45.42 0.29 Allowed Glycine 0 N--CA 1.448 -0.555 0 CA-C-N 115.535 -0.757 . . . . 0.52 111.916 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 117.67 161.15 11.94 Favored Glycine 0 N--CA 1.447 -0.571 0 C-N-CA 120.723 -0.751 . . . . 0.3 112.354 179.82 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 14.3 pt -104.86 123.34 58.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.478 0 CA-C-O 121.365 0.602 . . . . 0.27 110.601 179.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 70.8 m-85 -113.0 159.43 19.13 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.611 -0.722 . . . . 0.72 110.681 -179.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -82.62 108.08 15.11 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.578 0 N-CA-C 109.379 -0.6 . . . . 0.24 109.379 178.327 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.505 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -68.57 -58.34 7.17 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 121.063 -0.589 . . . . 0.42 112.71 -179.182 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -151.63 156.22 39.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 120.673 0.273 . . . . 0.75 110.545 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 40.7 mt -107.23 134.8 47.85 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 CA-C-N 116.058 -0.519 . . . . 0.53 109.915 179.743 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 31.3 mmt -96.38 125.06 40.61 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 116.337 -0.392 . . . . 0.74 110.166 179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 23.6 tptp -62.93 120.75 11.96 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.232 -0.44 . . . . 1.01 110.364 -179.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 117.82 -12.56 13.29 Favored Glycine 0 N--CA 1.448 -0.563 0 C-N-CA 120.813 -0.708 . . . . 0.36 111.635 -179.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.48 171.66 47.87 Favored Glycine 0 N--CA 1.446 -0.678 0 C-N-CA 120.712 -0.756 . . . . 0.26 111.641 179.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.12 -35.47 80.39 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 120.836 0.351 . . . . 0.25 111.382 -179.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 61.2 t -69.41 -35.12 65.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.037 -0.529 . . . . 0.26 110.806 -179.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.58 -11.1 60.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.995 -0.548 . . . . 0.37 111.958 -179.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -97.19 -5.43 37.06 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.775 0.322 . . . . 0.41 110.94 179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -95.82 -73.03 0.61 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 0.55 110.04 179.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.7 -11.54 42.11 Favored Glycine 0 CA--C 1.52 0.368 0 C-N-CA 120.556 -0.831 . . . . 0.39 114.174 178.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 80.5 mtm180 -81.2 -29.01 34.69 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 117.962 0.881 . . . . 0.68 111.289 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 55.9 mt -88.38 138.06 19.9 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 N-CA-C 109.603 -0.518 . . . . 0.37 109.603 179.186 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 11.4 pt-20 -137.19 158.88 71.68 Favored Pre-proline 0 C--N 1.325 -0.478 0 N-CA-C 110.333 -0.247 . . . . 0.69 110.333 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.505 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 32.3 Cg_exo -59.3 114.07 1.87 Allowed 'Trans proline' 0 C--O 1.236 0.393 0 C-N-CA 122.385 2.057 . . . . 0.41 111.455 179.035 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 129.81 -21.36 5.01 Favored Glycine 0 N--CA 1.444 -0.806 0 CA-C-N 115.995 -0.548 . . . . 0.29 111.954 -179.207 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 82.7 m-20 -70.2 148.03 49.1 Favored 'General case' 0 N--CA 1.464 0.242 0 CA-C-O 120.611 0.243 . . . . 0.34 110.425 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 57.6 ttp -105.36 139.67 39.65 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.518 -0.31 . . . . 1.26 111.05 -179.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 14.0 mt -87.16 138.17 31.72 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.377 -0.374 . . . . 0.48 110.51 179.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.628 HD11 ' HB2' ' A' ' 336' ' ' ALA . 76.3 mt -115.16 -68.29 0.93 Allowed 'General case' 0 C--N 1.325 -0.461 0 CA-C-O 120.924 0.392 . . . . 0.53 110.732 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.475 ' OE1' ' HA ' ' A' ' 306' ' ' ASP . 7.7 tt0 -119.65 133.89 55.45 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.295 -0.411 . . . . 0.73 110.258 -179.776 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.652 ' O ' HG22 ' A' ' 307' ' ' VAL . 69.5 t -127.91 116.15 41.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 CA-C-N 116.187 -0.461 . . . . 0.29 110.935 -179.887 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.527 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 1.1 m-20 50.73 46.61 25.68 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.97 -0.559 . . . . 1.71 111.876 179.507 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.527 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 25.6 m-20 81.27 -13.66 0.89 Allowed 'General case' 0 N--CA 1.474 0.733 0 N-CA-C 113.73 1.011 . . . . 1.11 113.73 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.652 HG22 ' O ' ' A' ' 304' ' ' VAL . 2.5 m -90.41 137.01 22.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 C-N-CA 119.938 -0.705 . . . . 0.71 109.988 179.416 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 55.3 t30 -98.03 134.62 40.87 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.138 -0.483 . . . . 0.74 111.649 -178.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -113.18 -0.34 14.67 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.302 -0.408 . . . . 0.33 110.989 179.647 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 41.0 mt-10 -59.6 -24.72 64.03 Favored 'General case' 0 N--CA 1.465 0.285 0 N-CA-C 112.451 0.538 . . . . 1.21 112.451 -179.208 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -125.71 53.95 1.53 Allowed 'General case' 0 C--N 1.325 -0.486 0 CA-C-O 121.115 0.484 . . . . 1.32 111.407 -179.282 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 94.6 mtp -142.98 169.02 18.35 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.138 -0.483 . . . . 0.51 110.139 179.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 51.3 p -79.1 159.07 27.66 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 109.767 -0.457 . . . . 0.97 109.767 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.509 ' O ' HG23 ' A' ' 318' ' ' VAL . 94.1 m-20 -58.05 -42.62 85.82 Favored 'General case' 0 N--CA 1.464 0.227 0 CA-C-O 121.199 0.523 . . . . 0.48 110.217 179.657 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.87 -55.13 21.26 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.209 -0.905 . . . . 1.4 111.263 -179.488 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 21.2 m-20 -58.58 -37.31 75.52 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.169 -0.468 . . . . 0.88 111.392 -179.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -58.53 -52.92 63.6 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.155 -0.475 . . . . 0.2 111.692 -179.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.509 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -70.4 -30.74 44.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.839 -0.344 . . . . 0.21 110.97 -179.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 75.4 mtt180 -57.64 -49.93 74.84 Favored 'General case' 0 C--N 1.332 -0.17 0 CA-C-O 121.023 0.44 . . . . 0.83 110.182 179.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 76.0 t -67.63 -39.57 82.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.396 0 CA-C-N 116.013 -0.539 . . . . 0.17 110.128 179.405 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.513 ' O ' HG23 ' A' ' 325' ' ' VAL . 23.5 tp -56.27 -52.28 65.05 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.014 -0.539 . . . . 0.38 110.501 179.623 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.514 ' HA ' HG11 ' B' ' 3' ' ' VAL . 70.6 mtp180 -62.3 -36.33 81.81 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.759 -0.655 . . . . 1.57 111.014 -179.408 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -63.6 -46.12 87.24 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.389 -0.369 . . . . 1.87 110.153 179.288 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 74.8 mt -64.84 -42.38 94.72 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 CA-C-N 116.228 -0.442 . . . . 0.29 110.97 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.513 HG23 ' O ' ' A' ' 321' ' ' LEU . 60.3 t -67.18 -17.02 22.04 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 CA-C-O 121.037 0.446 . . . . 0.24 110.948 -179.784 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 48.4 m -86.57 3.79 42.82 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.78 0.324 . . . . 0.44 110.727 179.566 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -107.21 171.62 7.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.839 0.352 . . . . 1.16 110.643 179.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -100.35 138.6 37.2 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 116.42 -0.355 . . . . 0.89 111.209 -179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 132.15 169.42 12.3 Favored Glycine 0 N--CA 1.448 -0.512 0 C-N-CA 120.699 -0.762 . . . . 0.45 112.312 179.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 41.7 Cg_endo -69.7 140.25 42.45 Favored 'Trans proline' 0 C--O 1.236 0.386 0 C-N-CA 122.758 2.306 . . . . 0.58 112.118 179.462 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 69.2 mt -114.31 128.06 71.49 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-N 116.35 -0.386 . . . . 0.37 110.859 -179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.6 p -101.71 120.24 40.04 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.012 -0.54 . . . . 1.09 110.003 179.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.4 mt -113.12 118.74 35.59 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 116.385 -0.37 . . . . 0.48 111.53 -179.076 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . 0.404 ' HA ' ' HA ' ' A' ' 251' ' ' THR . 85.6 m -101.94 109.62 21.4 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 109.379 -0.6 . . . . 0.5 109.379 178.36 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 21.3 m -113.28 155.16 14.55 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-O 121.34 0.59 . . . . 0.33 112.126 -178.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.628 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -107.39 103.36 12.68 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 115.202 -0.908 . . . . 0.38 109.336 178.891 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 27.3 mtpp . . . . . 0 C--O 1.249 1.06 0 CA-C-O 118.559 -0.734 . . . . 0.7 110.617 -179.606 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.746 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 42.6 m95 . . . . . 0 CA--C 1.519 -0.221 0 CA-C-O 120.404 0.145 . . . . 0.4 111.092 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.514 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.247 0.946 0 N-CA-C 109.503 -0.554 . . . . 0.27 109.503 177.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 . . . . . 0 N--CA 1.476 0.875 0 N-CA-C 109.92 -0.4 . . . . 1.26 109.92 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 82.9 mt -122.84 129.73 74.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.592 0 CA-C-O 120.83 0.348 . . . . 0.65 110.536 -179.999 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 51.6 mt -130.09 125.72 60.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 116.369 -0.378 . . . . 0.55 110.829 -179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.444 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 61.2 m -111.8 111.59 22.67 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 109.29 -0.633 . . . . 0.59 109.29 178.179 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 15.7 m -122.44 153.6 27.09 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 CA-C-O 120.971 0.415 . . . . 0.5 111.494 -179.406 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 9.4 t -106.01 133.69 50.32 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 115.948 -0.569 . . . . 0.79 109.472 179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.582 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 92.5 mt -109.26 132.37 54.19 Favored 'General case' 0 C--N 1.318 -0.789 0 CA-C-O 121.026 0.441 . . . . 0.46 111.159 -179.354 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 17.9 t-20 -71.93 114.21 9.78 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.664 -0.698 . . . . 0.65 109.998 179.29 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 97.5 mmm -96.57 21.36 9.39 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-O 121.117 0.484 . . . . 0.63 111.203 -179.583 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 55.4 mm-40 -93.39 -50.3 5.52 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-O 121.224 0.535 . . . . 1.27 109.668 178.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 66.9 ttt180 -83.49 -16.92 43.77 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.749 -0.66 . . . . 1.06 110.428 -179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 13.6 m80 -119.97 135.62 54.84 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 109.071 -0.714 . . . . 0.76 109.071 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 91.6 m-70 -101.97 5.76 40.91 Favored 'General case' 0 C--N 1.323 -0.565 0 N-CA-C 112.138 0.421 . . . . 1.09 112.138 -178.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 23.3 p90 -159.54 166.01 31.72 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.651 0.263 . . . . 0.62 110.725 -179.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.421 ' HA ' HD23 ' A' ' 262' ' ' LEU . 7.6 mt -78.4 -52.61 8.32 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 116.05 -0.523 . . . . 0.34 109.843 -179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.73 42.85 5.3 Favored Glycine 0 N--CA 1.446 -0.646 0 C-N-CA 120.995 -0.622 . . . . 0.14 112.56 178.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 6.0 pt -143.54 149.25 18.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 121.233 0.54 . . . . 0.18 111.635 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.551 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 0.3 OUTLIER -98.22 131.92 44.16 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.138 -0.937 . . . . 1.0 109.343 178.278 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.685 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 12.3 mm -95.8 104.42 15.82 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.784 0 CA-C-O 120.937 0.399 . . . . 0.28 110.673 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 90.5 t -92.32 108.31 20.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 CA-C-N 115.884 -0.598 . . . . 0.31 110.157 179.906 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -95.0 106.95 3.48 Favored Glycine 0 N--CA 1.449 -0.491 0 C-N-CA 120.834 -0.698 . . . . 0.37 111.994 -179.912 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -65.65 104.58 1.06 Allowed 'General case' 0 C--O 1.235 0.337 0 CA-C-O 121.249 0.547 . . . . 1.87 110.386 -179.552 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 21.2 m -112.43 98.54 7.34 Favored 'General case' 0 C--N 1.324 -0.528 0 CA-C-N 115.706 -0.679 . . . . 1.17 110.908 -179.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . 0.521 ' ND2' ' H ' ' A' ' 272' ' ' ASP . 6.0 t30 -109.54 -157.59 0.62 Allowed 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 116.011 -0.541 . . . . 2.75 109.674 179.668 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . 0.521 ' H ' ' ND2' ' A' ' 271' ' ' ASN . 27.5 p-10 -55.11 -37.92 67.48 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 122.792 0.437 . . . . 2.08 111.744 179.827 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.488 ' HB3' ' OD1' ' A' ' 275' ' ' ASP . 9.2 ttt180 -89.4 -40.7 12.56 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.821 0.343 . . . . 2.63 110.365 179.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 91.09 -12.74 68.21 Favored Glycine 0 CA--C 1.52 0.35 0 C-N-CA 120.87 -0.681 . . . . 0.97 113.505 178.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . 0.488 ' OD1' ' HB3' ' A' ' 273' ' ' ARG . 19.7 p-10 -83.09 40.22 0.69 Allowed 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 121.23 0.538 . . . . 1.75 111.324 -179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -74.6 -37.58 45.78 Favored Glycine 0 N--CA 1.448 -0.533 0 C-N-CA 120.956 -0.64 . . . . 0.52 112.792 -179.494 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 98.43 172.59 32.27 Favored Glycine 0 N--CA 1.446 -0.69 0 C-N-CA 120.552 -0.832 . . . . 0.3 112.112 179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 21.2 pt -106.12 129.14 59.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-O 121.218 0.532 . . . . 0.27 111.272 -179.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 46.8 m-85 -119.47 160.15 22.9 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.725 -0.671 . . . . 0.72 110.676 -179.73 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 50.5 mm -79.15 116.03 22.42 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 CA-C-N 115.708 -0.678 . . . . 0.24 109.399 178.458 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.496 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -75.46 -74.47 0.9 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.82 -0.705 . . . . 0.42 112.44 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -136.27 152.51 50.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 110.221 -0.289 . . . . 0.75 110.221 179.913 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.447 HD11 ' HA ' ' A' ' 296' ' ' GLU . 44.7 mt -105.12 128.3 59.07 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.304 -0.407 . . . . 0.53 110.459 -179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -95.04 127.24 40.94 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.989 -0.55 . . . . 0.74 111.032 -179.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 4.3 tppp? -64.25 128.45 35.85 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.305 -0.407 . . . . 1.01 110.161 179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 115.5 -21.34 12.91 Favored Glycine 0 N--CA 1.448 -0.548 0 N-CA-C 111.16 -0.776 . . . . 0.36 111.16 -179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.24 166.94 51.88 Favored Glycine 0 N--CA 1.446 -0.679 0 C-N-CA 120.776 -0.726 . . . . 0.26 111.926 179.516 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -62.84 -32.33 73.53 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-O 120.738 0.304 . . . . 0.25 111.509 -179.796 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 96.2 t -69.22 -40.8 80.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-N 116.321 -0.4 . . . . 0.26 110.953 -179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -69.42 -13.06 62.16 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.208 -0.451 . . . . 0.37 111.081 -179.708 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.34 -11.04 50.6 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.994 -0.548 . . . . 0.41 111.148 -179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.481 ' OD2' ' HB2' ' A' ' 294' ' ' ARG . 30.6 t70 -96.33 -69.89 0.74 Allowed 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.393 -0.367 . . . . 0.55 110.514 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.3 -13.04 40.17 Favored Glycine 0 CA--C 1.522 0.513 0 C-N-CA 120.284 -0.96 . . . . 0.39 114.823 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.481 ' HB2' ' OD2' ' A' ' 292' ' ' ASP . 19.9 mtm180 -81.1 -33.19 33.47 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 118.342 1.071 . . . . 0.68 111.143 -179.627 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 45.7 mt -80.43 138.42 19.8 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.626 0 N-CA-C 109.285 -0.635 . . . . 0.37 109.285 178.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . 0.447 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.6 pt-20 -141.48 162.01 49.43 Favored Pre-proline 0 C--N 1.325 -0.493 0 CA-C-O 120.351 0.119 . . . . 0.69 110.929 -179.197 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.496 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 50.4 Cg_exo -56.97 118.38 5.24 Favored 'Trans proline' 0 C--N 1.347 0.457 0 C-N-CA 122.335 2.023 . . . . 0.41 111.549 178.547 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.74 -26.12 5.73 Favored Glycine 0 N--CA 1.445 -0.736 0 C-N-CA 120.743 -0.742 . . . . 0.29 112.119 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.439 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 87.4 m-20 -62.06 145.75 52.3 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-O 120.799 0.333 . . . . 0.34 110.471 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 42.4 ttp -103.04 135.96 43.74 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.306 -0.406 . . . . 1.26 110.617 -179.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 50.0 mt -88.1 121.4 30.46 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 109.861 -0.422 . . . . 0.48 109.861 179.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.558 HD11 ' HB2' ' A' ' 336' ' ' ALA . 85.8 mt -100.01 -68.15 0.82 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 121.327 0.584 . . . . 0.53 110.07 179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 8.1 tt0 -121.53 136.32 54.96 Favored 'General case' 0 C--N 1.321 -0.668 0 CA-C-N 115.414 -0.812 . . . . 0.73 110.768 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.466 HG21 HD13 ' A' ' 321' ' ' LEU . 79.5 t -128.73 107.67 16.12 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.648 0 N-CA-C 109.427 -0.583 . . . . 0.29 109.427 178.641 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.45 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 0.9 OUTLIER 58.32 62.97 1.84 Allowed 'General case' 0 C--N 1.323 -0.572 0 CA-C-N 116.072 -0.513 . . . . 1.71 111.286 -179.351 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.45 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 7.7 m-20 76.51 -44.02 0.47 Allowed 'General case' 0 N--CA 1.475 0.781 0 N-CA-C 113.94 1.089 . . . . 1.11 113.94 177.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.413 HG22 ' O ' ' A' ' 304' ' ' VAL . 35.9 m -71.59 132.71 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.355 0 CA-C-O 121.265 0.555 . . . . 0.71 111.289 -178.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . 0.451 ' ND2' ' HB2' ' A' ' 310' ' ' GLU . 52.5 t30 -105.02 128.7 53.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 115.839 -0.619 . . . . 0.74 110.656 -179.311 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.0 m-85 -101.11 2.86 40.7 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.409 -0.36 . . . . 0.33 111.712 -178.834 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . 0.451 ' HB2' ' ND2' ' A' ' 308' ' ' ASN . 2.8 mt-10 -49.29 -41.69 38.95 Favored 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 112.853 0.686 . . . . 1.21 112.853 -179.266 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 9.8 m-20 -112.8 39.42 2.52 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-O 120.794 0.331 . . . . 1.32 111.299 -178.281 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 85.2 mtp -121.93 179.67 4.43 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.761 0.315 . . . . 0.51 110.681 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 89.9 p -88.71 155.66 19.45 Favored 'General case' 0 C--N 1.324 -0.528 0 N-CA-C 109.805 -0.443 . . . . 0.97 109.805 179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.493 ' O ' HG23 ' A' ' 318' ' ' VAL . 97.2 m-20 -58.05 -41.14 82.65 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.966 0.412 . . . . 0.48 110.973 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -66.43 -50.92 61.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.723 -0.671 . . . . 1.4 111.802 -179.17 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 24.5 m-20 -66.41 -32.52 73.95 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.366 -0.379 . . . . 0.88 111.762 -178.408 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.69 -49.23 77.21 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 120.807 0.337 . . . . 0.2 110.863 179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -73.58 -31.03 31.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.369 -0.378 . . . . 0.21 110.657 -179.808 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . . . . . . . . . 70.9 mtt180 -55.22 -51.67 65.84 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.153 0.502 . . . . 0.83 110.314 179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 36.7 t -69.89 -39.74 78.0 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 115.769 -0.651 . . . . 0.17 110.37 179.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.473 ' O ' HG23 ' A' ' 325' ' ' VAL . 25.5 tp -56.1 -52.53 63.99 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.093 0.473 . . . . 0.38 110.95 179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.545 ' HA ' HG11 ' B' ' 3' ' ' VAL . 47.4 mtp180 -62.21 -37.94 87.27 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.829 -0.623 . . . . 1.57 110.991 -179.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 4.7 mm-40 -61.65 -45.28 94.73 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.665 0.269 . . . . 1.87 110.421 179.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.7 mt -62.53 -42.79 97.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.329 -0.396 . . . . 0.29 110.537 179.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.473 HG23 ' O ' ' A' ' 321' ' ' LEU . 41.6 t -71.15 -9.92 13.37 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.521 0 CA-C-O 121.279 0.562 . . . . 0.24 111.043 179.976 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.3 m -90.21 -9.26 48.76 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.95 0.405 . . . . 0.44 110.76 179.005 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -101.43 159.48 15.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.413 -0.358 . . . . 1.16 110.618 179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -92.23 116.49 29.0 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-N 116.331 -0.395 . . . . 0.89 110.991 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 166.05 169.82 30.17 Favored Glycine 0 N--CA 1.447 -0.598 0 C-N-CA 120.82 -0.705 . . . . 0.45 111.794 179.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 51.7 Cg_endo -72.05 118.96 5.88 Favored 'Trans proline' 0 C--O 1.236 0.412 0 C-N-CA 122.603 2.202 . . . . 0.58 111.664 179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 80.6 mt -92.22 119.09 39.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 116.032 -0.531 . . . . 0.37 110.954 -179.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 1.2 m -97.59 112.17 24.15 Favored 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.797 -0.638 . . . . 1.09 110.022 179.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.444 ' O ' ' HA ' ' A' ' 251' ' ' THR . 96.6 mt -101.3 121.47 41.94 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 116.254 -0.43 . . . . 0.48 111.819 -178.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 99.4 m -106.26 100.04 9.6 Favored 'General case' 0 C--N 1.323 -0.544 0 N-CA-C 108.618 -0.882 . . . . 0.5 108.618 177.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 29.3 m -101.95 156.56 4.68 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.417 0 CA-C-O 121.323 0.583 . . . . 0.33 112.335 -178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.558 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.4 113.29 25.42 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.044 -0.98 . . . . 0.38 109.459 178.853 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.439 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 29.5 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.324 -0.846 . . . . 0.7 109.969 -179.315 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.685 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.551 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 30.1 m95 . . . . . 0 C--O 1.236 0.363 0 N-CA-C 110.672 -0.121 . . . . 0.4 110.672 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.545 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.246 0.907 0 CA-C-O 118.594 -0.717 . . . . 0.27 109.697 177.648 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 28.4 t-20 . . . . . 0 N--CA 1.48 1.044 0 N-CA-C 109.948 -0.39 . . . . 1.26 109.948 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 51.1 mt -92.71 124.44 45.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 CA-C-N 116.408 -0.36 . . . . 0.65 111.335 -179.131 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 41.3 mt -120.88 133.22 68.25 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 CA-C-N 116.146 -0.479 . . . . 0.55 110.19 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 1.4 m -107.36 109.8 21.63 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 116.091 -0.504 . . . . 0.59 109.924 179.152 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 18.1 m -116.19 152.61 17.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 CA-C-O 120.862 0.363 . . . . 0.5 111.101 -179.062 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 8.8 t -117.91 131.08 56.56 Favored 'General case' 0 C--N 1.319 -0.73 0 N-CA-C 108.94 -0.763 . . . . 0.79 108.94 178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.452 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.9 mt -106.77 140.53 39.47 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-O 121.189 0.519 . . . . 0.46 111.872 -178.346 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -83.43 119.89 25.22 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-N 115.312 -0.858 . . . . 0.65 110.077 179.594 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 83.4 mmm -101.0 17.74 21.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.963 0.411 . . . . 0.63 111.33 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 64.5 mm-40 -88.35 -50.13 6.52 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 109.679 -0.489 . . . . 1.27 109.679 179.312 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 9.2 ttp180 -93.58 11.77 27.61 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.441 0.639 . . . . 1.06 109.922 179.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 39.0 m80 -133.28 159.0 41.52 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.445 -0.798 . . . . 0.76 108.964 179.516 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 57.8 m-70 -128.66 0.63 5.49 Favored 'General case' 0 C--N 1.323 -0.584 0 C-N-CA 120.575 -0.45 . . . . 1.09 111.615 -179.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 10.6 p90 -162.84 165.5 25.24 Favored 'General case' 0 C--O 1.238 0.455 0 CA-C-O 120.603 0.24 . . . . 0.62 110.593 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.422 HD13 HD11 ' A' ' 264' ' ' ILE . 8.9 mt -75.36 -54.77 6.51 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 116.096 -0.502 . . . . 0.34 109.757 -179.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 88.1 44.1 5.46 Favored Glycine 0 N--CA 1.444 -0.817 0 CA-C-N 115.894 -0.594 . . . . 0.14 112.269 179.137 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.422 HD11 HD13 ' A' ' 262' ' ' LEU . 3.9 pt -143.29 150.4 17.61 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.506 0 CA-C-O 121.225 0.536 . . . . 0.18 111.947 -179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.55 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 0.0 OUTLIER -100.21 132.89 45.32 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.231 -0.895 . . . . 1.0 109.011 178.352 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.742 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.9 mm -98.99 117.7 44.49 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.816 0 CA-C-O 120.965 0.412 . . . . 0.28 110.469 -179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 86.1 t -105.94 106.64 20.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.456 -0.338 . . . . 0.31 110.536 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -87.12 118.15 4.88 Favored Glycine 0 N--CA 1.448 -0.515 0 C-N-CA 120.806 -0.711 . . . . 0.37 111.732 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 52.4 tt0 -64.94 98.86 0.31 Allowed 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 120.921 0.391 . . . . 1.87 110.431 -179.679 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 2.4 m -96.04 86.03 4.19 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.965 -0.561 . . . . 1.17 110.947 -178.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.01 -176.14 3.46 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.857 -0.611 . . . . 2.75 110.133 179.947 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 11.6 p-10 -65.8 -21.41 66.49 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.15 0.5 . . . . 2.08 110.232 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 2.1 tmt_? -81.49 -8.83 59.78 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.635 -0.711 . . . . 2.63 110.325 179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 90.0 -81.23 1.42 Allowed Glycine 0 N--CA 1.449 -0.462 0 C-N-CA 120.778 -0.725 . . . . 0.97 111.842 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.8 p-10 -80.04 155.19 27.7 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.965 0.412 . . . . 1.75 110.419 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -162.54 -34.46 0.02 OUTLIER Glycine 0 N--CA 1.448 -0.519 0 C-N-CA 120.86 -0.686 . . . . 0.52 111.956 -179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 130.67 156.9 8.75 Favored Glycine 0 N--CA 1.446 -0.698 0 C-N-CA 120.726 -0.75 . . . . 0.3 111.902 179.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.5 pt -107.72 117.33 53.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.615 0 CA-C-O 121.154 0.502 . . . . 0.27 110.308 179.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 33.0 m-85 -108.08 151.11 26.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.777 -0.647 . . . . 0.72 111.152 -178.772 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.1 mm -73.83 117.63 18.02 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.645 0 CA-C-N 116.222 -0.444 . . . . 0.24 110.045 178.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . 0.525 ' O ' ' HB3' ' A' ' 297' ' ' PRO . . . -72.63 -64.27 2.64 Favored Glycine 0 N--CA 1.448 -0.505 0 C-N-CA 121.166 -0.54 . . . . 0.42 112.146 -179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 70.9 m -149.56 161.37 42.28 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 109.843 -0.429 . . . . 0.75 109.843 179.574 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . 0.43 HD11 ' HA ' ' A' ' 296' ' ' GLU . 57.2 mt -112.49 128.77 68.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.011 0.434 . . . . 0.53 111.166 -179.441 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 19.9 mmt -87.31 119.15 27.27 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.688 -0.687 . . . . 0.74 110.101 179.67 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.7 tptp -62.56 117.61 6.46 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.297 -0.41 . . . . 1.01 110.142 179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 126.14 -18.69 6.53 Favored Glycine 0 N--CA 1.45 -0.424 0 N-CA-C 111.131 -0.788 . . . . 0.36 111.131 -178.897 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.39 175.0 53.58 Favored Glycine 0 N--CA 1.447 -0.601 0 C-N-CA 120.972 -0.632 . . . . 0.26 111.995 179.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.452 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -64.2 -37.23 86.72 Favored 'General case' 0 C--N 1.325 -0.47 0 CA-C-O 120.799 0.333 . . . . 0.25 111.341 -179.767 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 56.4 t -67.94 -37.08 77.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.231 -0.44 . . . . 0.26 111.368 -179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -66.88 -21.3 66.01 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.083 -0.508 . . . . 0.37 111.88 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -87.28 -14.66 40.32 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 120.836 0.351 . . . . 0.41 111.197 -179.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 14.9 t70 -81.04 -74.57 0.32 Allowed 'General case' 0 C--N 1.327 -0.413 0 CA-C-N 116.224 -0.444 . . . . 0.55 110.441 -179.942 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 107.86 -9.89 37.46 Favored Glycine 0 CA--C 1.521 0.423 0 C-N-CA 120.483 -0.865 . . . . 0.39 114.42 178.507 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 56.3 mtm180 -88.34 -35.21 17.31 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 118.044 0.922 . . . . 0.68 110.348 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 29.8 mt -81.81 138.28 19.79 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 N-CA-C 109.046 -0.724 . . . . 0.37 109.046 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . 0.43 ' HA ' HD11 ' A' ' 283' ' ' ILE . 10.4 pt-20 -144.6 162.72 37.73 Favored Pre-proline 0 C--N 1.325 -0.469 0 CA-C-N 116.607 -0.27 . . . . 0.69 110.755 -179.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . 0.525 ' HB3' ' O ' ' A' ' 281' ' ' GLY . 52.2 Cg_exo -55.76 117.47 4.1 Favored 'Trans proline' 0 C--N 1.349 0.565 0 C-N-CA 122.598 2.199 . . . . 0.41 111.241 178.942 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 124.56 -24.9 6.05 Favored Glycine 0 N--CA 1.445 -0.755 0 N-CA-C 111.209 -0.757 . . . . 0.29 111.209 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 -64.66 135.44 55.91 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 109.712 -0.477 . . . . 0.34 109.712 179.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 46.3 ttp -97.4 130.86 44.49 Favored 'General case' 0 C--N 1.321 -0.654 0 CA-C-O 120.728 0.299 . . . . 1.26 110.815 -179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 21.8 mt -80.51 125.44 29.97 Favored 'General case' 0 C--N 1.325 -0.476 0 CA-C-N 116.056 -0.52 . . . . 0.48 110.276 179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.856 HD11 ' HB2' ' A' ' 336' ' ' ALA . 40.2 mt -105.41 -71.87 0.73 Allowed 'General case' 0 C--N 1.324 -0.533 0 CA-C-O 121.19 0.519 . . . . 0.53 110.442 179.831 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 7.9 tt0 -117.07 133.68 55.7 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-N 115.773 -0.649 . . . . 0.73 110.963 -178.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 93.7 t -128.07 104.16 11.37 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 CA-C-N 116.023 -0.535 . . . . 0.29 110.141 179.754 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 59.45 69.11 0.74 Allowed 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.948 -0.569 . . . . 1.71 111.662 179.842 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 74.39 -44.68 0.56 Allowed 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 114.103 1.149 . . . . 1.11 114.103 177.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 7.0 m -76.87 127.58 37.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-O 121.606 0.717 . . . . 0.71 111.834 -179.027 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.7 t30 -97.4 130.64 44.51 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 115.249 -0.887 . . . . 0.74 110.299 -179.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -100.81 2.35 41.04 Favored 'General case' 0 C--N 1.327 -0.397 0 N-CA-C 111.794 0.294 . . . . 0.33 111.794 -178.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -58.08 -27.71 63.9 Favored 'General case' 0 N--CA 1.466 0.361 0 N-CA-C 112.17 0.433 . . . . 1.21 112.17 -179.405 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -109.22 20.3 18.47 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 111.7 0.259 . . . . 1.32 111.7 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 95.0 mtp -118.41 166.54 12.54 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 120.815 0.341 . . . . 0.51 111.049 -179.365 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 10.7 p -75.48 162.63 28.17 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.073 -0.512 . . . . 0.97 110.355 -179.837 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 318' ' ' VAL . 52.5 m-20 -60.97 -43.49 98.7 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 0.48 110.697 -179.442 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 18.8 m-20 -63.53 -56.71 13.87 Favored 'General case' 0 C--O 1.234 0.243 0 CA-C-N 115.957 -0.565 . . . . 1.4 111.215 -179.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.42 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 8.8 m-20 -58.78 -36.25 74.11 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.901 -0.591 . . . . 0.88 112.346 -178.383 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.3 -47.73 80.74 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.842 0.353 . . . . 0.2 111.374 -179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.461 HG23 ' O ' ' A' ' 314' ' ' ASN . 2.8 t -73.63 -31.52 32.52 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.458 -0.337 . . . . 0.21 111.095 -179.518 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.42 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 88.5 mtt180 -56.9 -46.92 81.61 Favored 'General case' 0 C--O 1.233 0.231 0 CA-C-O 120.86 0.362 . . . . 0.83 110.145 179.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 38.8 t -71.29 -38.2 68.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.979 -0.555 . . . . 0.17 110.114 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.469 ' O ' HG23 ' A' ' 325' ' ' VAL . 37.4 tp -58.32 -51.36 70.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.937 -0.574 . . . . 0.38 110.763 179.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.517 ' HA ' HG11 ' B' ' 3' ' ' VAL . 52.2 mtp180 -61.59 -31.94 72.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.171 -0.468 . . . . 1.57 110.706 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 3.0 mm-40 -67.78 -51.29 50.55 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.743 -0.465 . . . . 1.87 109.743 178.848 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.3 mt -59.42 -42.76 88.68 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.195 0 CA-C-N 115.986 -0.552 . . . . 0.29 111.344 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 321' ' ' LEU . 61.6 t -69.12 -13.89 17.82 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.35 0 CA-C-O 121.072 0.463 . . . . 0.24 111.256 -179.391 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 75.2 m -87.45 -6.61 58.34 Favored 'General case' 0 C--N 1.327 -0.376 0 O-C-N 122.148 -0.345 . . . . 0.44 110.538 179.135 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 1.8 mp0 -95.41 139.55 31.54 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.245 -0.434 . . . . 1.16 110.215 179.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -77.62 91.34 4.0 Favored 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.115 0.484 . . . . 0.89 111.693 -179.595 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . -172.27 172.52 44.89 Favored Glycine 0 N--CA 1.446 -0.639 0 C-N-CA 120.829 -0.7 . . . . 0.45 111.694 179.533 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -71.37 143.94 44.51 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.498 2.132 . . . . 0.58 111.893 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 42.3 mt -122.16 125.59 73.17 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.477 0 CA-C-O 120.915 0.388 . . . . 0.37 111.496 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 3.9 m -107.07 120.99 43.58 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.119 -0.697 . . . . 1.09 109.119 178.42 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 77.6 mt -106.39 129.2 54.43 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-O 121.336 0.588 . . . . 0.48 111.903 -178.225 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.09 97.3 6.94 Favored 'General case' 0 C--N 1.322 -0.609 0 N-CA-C 108.491 -0.929 . . . . 0.5 108.491 178.122 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 18.4 m -102.99 152.34 5.9 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.519 0 CA-C-O 121.398 0.618 . . . . 0.33 112.418 -177.832 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.856 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -111.15 106.79 15.92 Favored 'General case' 0 C--N 1.322 -0.616 0 CA-C-N 115.166 -0.924 . . . . 0.38 109.404 179.042 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 28.1 mtpp . . . . . 0 C--O 1.251 1.132 0 CA-C-O 118.312 -0.852 . . . . 0.7 110.103 -179.803 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.742 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.55 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 21.5 m95 . . . . . 0 N--CA 1.465 0.314 0 N-CA-C 110.15 -0.315 . . . . 0.4 110.15 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.517 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.249 1.064 0 CA-C-O 118.489 -0.767 . . . . 0.27 110.464 178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 40.4 t-20 . . . . . 0 N--CA 1.481 1.089 0 CA-C-O 120.713 0.292 . . . . 1.26 110.322 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 66.2 mt -91.34 111.34 23.71 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.402 0 CA-C-N 116.288 -0.414 . . . . 0.65 110.496 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 38.1 mm -113.29 131.94 63.57 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.007 -0.542 . . . . 0.55 110.053 -179.848 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . 0.519 ' HA ' ' O ' ' A' ' 333' ' ' LEU . 5.0 m -121.35 105.46 10.55 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-O 121.036 0.446 . . . . 0.59 110.492 179.79 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.7 m -105.54 157.89 6.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.644 0 CA-C-N 116.105 -0.498 . . . . 0.5 111.051 -179.347 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 4.0 t -109.7 122.55 47.73 Favored 'General case' 0 C--N 1.322 -0.611 0 N-CA-C 109.525 -0.546 . . . . 0.79 109.525 178.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.497 HD13 HD22 ' A' ' 262' ' ' LEU . 53.1 mt -94.48 120.69 35.11 Favored 'General case' 0 C--N 1.32 -0.695 0 CA-C-N 116.18 -0.464 . . . . 0.46 111.158 -179.199 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -78.51 115.39 18.19 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.735 -0.666 . . . . 0.65 110.315 179.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 85.2 mmm -98.12 19.12 14.65 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 116.112 -0.495 . . . . 0.63 111.039 -179.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -88.66 -52.18 5.28 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 121.131 0.491 . . . . 1.27 109.784 179.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 42.4 ttt180 -92.02 2.03 56.82 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-N 115.785 -0.643 . . . . 1.06 110.001 179.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 54.7 m80 -127.71 148.41 50.41 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 115.968 -0.56 . . . . 0.76 110.333 -179.807 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 3.6 m-70 -110.91 -8.19 14.51 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 116.367 -0.379 . . . . 1.09 111.504 -179.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 29.1 p90 -153.74 169.51 23.15 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.755 0.312 . . . . 0.62 111.194 -178.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.497 HD22 HD13 ' A' ' 254' ' ' LEU . 0.6 OUTLIER -76.79 -51.63 11.02 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.365 -0.605 . . . . 0.34 109.365 179.374 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.21 39.28 6.45 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.58 -0.736 . . . . 0.14 112.531 179.007 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.7 pt -142.31 149.75 19.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 121.309 0.575 . . . . 0.18 111.507 -179.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.456 ' HB3' ' CE2' ' B' ' 2' ' ' TRP . 23.3 p -105.26 129.29 53.65 Favored 'General case' 0 C--N 1.318 -0.774 0 CA-C-N 115.32 -0.855 . . . . 1.0 108.892 177.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.703 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 11.0 mm -89.43 127.01 42.36 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-O 120.786 0.327 . . . . 0.28 110.524 -178.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 79.3 t -115.57 109.82 29.63 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.33 -0.396 . . . . 0.31 110.129 179.727 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.14 145.71 18.69 Favored Glycine 0 N--CA 1.448 -0.511 0 C-N-CA 120.757 -0.735 . . . . 0.37 111.933 179.865 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 30.8 mm-40 -73.6 114.86 12.34 Favored 'General case' 0 C--N 1.326 -0.431 0 CA-C-O 120.895 0.379 . . . . 1.87 110.828 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -86.9 90.75 8.44 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 116.084 -0.507 . . . . 1.17 110.588 179.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 1.7 m120 -105.94 -158.4 0.66 Allowed 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.994 -0.548 . . . . 2.75 109.674 179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -63.55 -33.91 76.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.293 0.568 . . . . 2.08 109.82 178.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 49.1 ttp180 -112.08 -52.48 2.78 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.309 -0.86 . . . . 2.63 110.127 179.418 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 109.65 52.95 0.6 Allowed Glycine 0 N--CA 1.45 -0.426 0 C-N-CA 120.821 -0.704 . . . . 0.97 112.03 179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 10.1 p-10 -136.31 27.75 3.12 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-O 121.174 0.511 . . . . 1.75 110.769 -179.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -75.36 -13.93 82.41 Favored Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.827 -0.701 . . . . 0.52 112.343 179.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 113.64 166.65 16.22 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 121.066 -0.588 . . . . 0.3 112.277 179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 8.7 pt -110.78 132.88 58.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.009 0.433 . . . . 0.27 110.552 179.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 47.0 m-85 -118.72 163.79 16.32 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-N 116.026 -0.534 . . . . 0.72 110.785 -179.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 48.8 mm -84.04 119.98 34.12 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.535 0 CA-C-N 115.792 -0.64 . . . . 0.24 109.786 178.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -83.69 -66.28 1.51 Allowed Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.867 -0.682 . . . . 0.42 112.835 -179.451 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 4.3 p -137.93 153.38 49.5 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-O 120.729 0.3 . . . . 0.75 110.959 -179.742 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 70.8 mt -112.78 133.58 58.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 115.936 -0.575 . . . . 0.53 109.815 179.804 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 37.8 mmt -98.01 127.08 43.74 Favored 'General case' 0 C--N 1.322 -0.628 0 CA-C-N 115.996 -0.547 . . . . 0.74 110.848 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 28.5 tptp -62.17 117.75 6.46 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.819 -0.628 . . . . 1.01 110.459 179.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.86 -16.6 8.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.821 -0.704 . . . . 0.36 111.946 -179.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -79.22 168.4 53.12 Favored Glycine 0 N--CA 1.449 -0.493 0 C-N-CA 120.837 -0.696 . . . . 0.26 112.021 179.489 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -63.89 -33.72 76.33 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.872 0.367 . . . . 0.25 111.301 -179.772 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 92.4 t -67.4 -37.43 78.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.967 -0.56 . . . . 0.26 111.196 -179.764 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.42 -15.28 62.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.275 -0.421 . . . . 0.37 111.614 -179.51 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -81.3 -27.88 34.87 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.342 -0.39 . . . . 0.41 110.939 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -79.29 -71.77 0.43 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.36 -0.382 . . . . 0.55 110.054 -179.897 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 109.67 -20.08 27.66 Favored Glycine 0 N--CA 1.449 -0.465 0 C-N-CA 120.083 -1.056 . . . . 0.39 114.168 178.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 62.8 mtm180 -76.26 -23.93 54.48 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 117.475 0.637 . . . . 0.68 111.002 -179.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 37.0 mt -88.52 130.06 38.63 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.427 -0.583 . . . . 0.37 109.427 178.685 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -141.06 162.64 47.05 Favored Pre-proline 0 C--N 1.323 -0.585 0 CA-C-N 116.725 -0.216 . . . . 0.69 110.553 -179.321 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.26 129.75 36.92 Favored 'Trans proline' 0 C--N 1.346 0.42 0 C-N-CA 122.322 2.015 . . . . 0.41 111.202 178.82 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 110.55 -17.5 28.23 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 120.533 -0.841 . . . . 0.29 111.83 -179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 73.6 m-20 -70.55 141.58 51.86 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.702 -0.481 . . . . 0.34 109.702 179.269 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 41.0 ttp -98.97 132.62 44.14 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 116.451 -0.341 . . . . 1.26 111.093 -179.31 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.484 HD23 HG12 ' A' ' 335' ' ' VAL . 94.4 mt -88.5 130.34 35.24 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.197 -0.456 . . . . 0.48 110.058 179.64 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 42.1 mt -115.1 -60.72 1.85 Allowed 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.537 -0.302 . . . . 0.53 111.281 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 9.0 tt0 -126.91 135.33 50.78 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 116.386 -0.37 . . . . 0.73 111.076 -178.48 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.444 HG21 HD13 ' A' ' 321' ' ' LEU . 43.0 t -125.7 92.26 2.0 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 CA-C-N 116.376 -0.374 . . . . 0.29 110.305 179.997 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 59.38 79.31 0.23 Allowed 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.835 -0.62 . . . . 1.71 111.312 -179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 74.67 -57.43 0.61 Allowed 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.978 -1.01 . . . . 1.11 113.416 178.757 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 33.5 m -63.17 130.76 28.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.367 0 CA-C-O 121.412 0.625 . . . . 0.71 111.641 -178.561 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 61.0 t30 -108.02 135.2 49.78 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.53 -0.759 . . . . 0.74 111.137 -178.835 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 41.5 m-85 -113.85 18.7 17.18 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.116 -0.493 . . . . 0.33 111.187 -179.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 29.4 mt-10 -59.16 -36.56 75.5 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 116.584 -0.28 . . . . 1.21 111.662 -179.618 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -120.98 49.28 1.5 Allowed 'General case' 0 C--N 1.321 -0.659 0 CA-C-O 121.26 0.552 . . . . 1.32 110.523 179.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -129.81 152.95 48.74 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.904 -0.589 . . . . 0.51 110.435 179.758 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -69.68 155.56 40.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.526 -0.306 . . . . 0.97 110.522 -179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.421 ' O ' HG23 ' A' ' 318' ' ' VAL . 95.2 m-20 -49.19 -50.82 36.26 Favored 'General case' 0 N--CA 1.471 0.605 0 CA-C-O 121.008 0.433 . . . . 0.48 111.306 179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 14.2 m-20 -57.62 -53.14 61.52 Favored 'General case' 0 CA--C 1.518 -0.281 0 CA-C-N 115.483 -0.781 . . . . 1.4 111.206 -179.499 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.428 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 51.8 m-20 -56.3 -40.57 74.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.882 -0.599 . . . . 0.88 111.714 -178.672 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.7 -47.83 81.27 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 116.141 -0.481 . . . . 0.2 111.392 -179.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.486 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.9 t -78.04 -29.19 15.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 C-N-CA 120.9 -0.32 . . . . 0.21 111.176 -179.633 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.428 ' HD2' ' HA ' ' A' ' 316' ' ' ASP . 81.2 mtt180 -55.17 -49.99 70.46 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.398 -0.364 . . . . 0.83 110.286 179.498 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 16.0 t -76.11 -36.5 31.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-N 116.093 -0.503 . . . . 0.17 110.655 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.444 HD13 HG21 ' A' ' 304' ' ' VAL . 19.6 tp -54.68 -48.29 72.57 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-N 115.995 -0.548 . . . . 0.38 111.801 -179.581 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.52 ' HA ' HG11 ' B' ' 3' ' ' VAL . 22.5 mtp180 -64.48 -30.24 71.27 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 116.238 -0.437 . . . . 1.57 111.713 -178.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . 0.42 ' HG2' ' O ' ' A' ' 319' ' ' ARG . 9.3 mm-40 -68.76 -39.38 80.3 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-O 121.087 0.47 . . . . 1.87 109.916 179.266 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 62.0 mt -71.13 -43.42 75.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 115.837 -0.619 . . . . 0.29 111.085 -179.86 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.471 HG11 ' HB ' ' B' ' 3' ' ' VAL . 63.7 t -66.65 -19.04 25.1 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 CA-C-O 121.169 0.509 . . . . 0.24 111.432 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 50.4 m -87.64 10.98 16.28 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 120.99 0.424 . . . . 0.44 110.853 178.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -111.64 152.41 27.69 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.372 -0.377 . . . . 1.16 110.28 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -92.89 101.06 13.41 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-O 120.862 0.363 . . . . 0.89 111.635 -179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 175.51 171.98 39.95 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.954 -0.641 . . . . 0.45 111.786 179.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 49.6 Cg_endo -70.5 124.93 11.23 Favored 'Trans proline' 0 C--O 1.234 0.308 0 C-N-CA 122.327 2.018 . . . . 0.58 112.152 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 78.8 mt -104.74 118.65 52.44 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.605 0 CA-C-N 116.216 -0.447 . . . . 0.37 110.78 -179.646 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -93.19 113.18 25.34 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 115.998 -0.546 . . . . 1.09 110.641 179.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.519 ' O ' ' HA ' ' A' ' 251' ' ' THR . 11.5 mt -96.4 119.39 34.8 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 116.159 -0.473 . . . . 0.48 111.194 -179.752 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -102.65 93.68 5.24 Favored 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.635 -0.876 . . . . 0.5 108.635 178.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.484 HG12 HD23 ' A' ' 301' ' ' LEU . 21.7 m -97.66 152.94 3.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 115.66 -0.7 . . . . 0.33 112.278 -177.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -112.03 95.92 5.75 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.399 -0.819 . . . . 0.38 109.078 178.341 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 30.0 mtpp . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.285 -0.864 . . . . 0.7 110.256 -179.325 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.703 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.456 ' CE2' ' HB3' ' A' ' 265' ' ' SER . 25.0 m95 . . . . . 0 N--CA 1.464 0.275 0 N-CA-C 110.089 -0.337 . . . . 0.4 110.089 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.52 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.248 1.014 0 CA-C-O 118.559 -0.734 . . . . 0.27 110.436 178.399 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 59.2 t30 . . . . . 0 N--CA 1.479 1.021 0 CA-C-O 120.831 0.348 . . . . 1.26 110.42 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 70.7 mt -93.1 119.38 40.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.539 0 CA-C-N 116.191 -0.459 . . . . 0.65 109.868 179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 79.2 mt -118.47 137.71 51.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.403 0 CA-C-N 116.202 -0.453 . . . . 0.55 111.264 -178.537 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -108.23 122.97 48.03 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 115.855 -0.612 . . . . 0.59 110.115 179.252 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.464 HG21 HD11 ' A' ' 295' ' ' ILE . 33.2 m -114.39 143.28 24.46 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 CA-C-O 120.776 0.322 . . . . 0.5 111.019 -179.868 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.43 107.4 18.39 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.878 -0.601 . . . . 0.79 110.014 179.407 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.16 145.18 24.71 Favored 'General case' 0 C--N 1.322 -0.591 0 CA-C-O 121.12 0.486 . . . . 0.46 111.658 -178.789 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 22.8 t-20 -99.73 117.95 35.17 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.452 -0.794 . . . . 0.65 110.078 179.612 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 98.7 mmm -98.75 26.25 5.83 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 116.258 -0.428 . . . . 0.63 111.396 -179.582 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 16.7 mm-40 -95.99 -53.69 3.58 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 109.723 -0.473 . . . . 1.27 109.723 179.067 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 57.2 ttt180 -83.12 -17.4 43.18 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.554 -0.748 . . . . 1.06 109.822 179.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 49.1 m80 -112.28 145.95 39.07 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.832 -0.622 . . . . 0.76 109.959 -179.825 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 35.5 m-70 -111.12 3.23 18.38 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.683 -0.235 . . . . 1.09 111.616 -179.282 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 24.3 p90 -160.03 165.1 32.55 Favored 'General case' 0 C--O 1.237 0.42 0 CA-C-O 120.746 0.307 . . . . 0.62 110.734 179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.419 HD22 ' HA ' ' A' ' 262' ' ' LEU . 0.0 OUTLIER -78.73 -54.58 5.95 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.8 -0.636 . . . . 0.34 110.0 -179.435 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 92.92 42.96 4.26 Favored Glycine 0 N--CA 1.447 -0.582 0 CA-C-N 115.791 -0.641 . . . . 0.14 112.843 179.01 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . . . . . . . . . 5.6 pt -140.41 151.65 21.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.516 0 CA-C-O 121.51 0.671 . . . . 0.18 112.073 -179.995 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -101.74 119.56 38.97 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 114.885 -1.052 . . . . 1.0 109.217 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.711 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 4.7 mm -88.34 107.9 18.11 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.707 0 CA-C-O 120.892 0.377 . . . . 0.28 110.717 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 42.6 t -103.86 114.2 42.83 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 CA-C-N 116.19 -0.459 . . . . 0.31 110.482 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -103.66 113.36 4.46 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.782 -0.723 . . . . 0.37 111.92 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 19.4 mt-30 -68.54 101.83 1.34 Allowed 'General case' 0 C--N 1.325 -0.481 0 CA-C-O 121.193 0.521 . . . . 1.87 110.626 -179.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -126.59 96.32 4.63 Favored 'General case' 0 C--N 1.324 -0.535 0 CA-C-N 115.667 -0.697 . . . . 1.17 110.449 -179.382 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 59.5 t30 -111.91 -94.99 0.44 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 116.44 -0.345 . . . . 2.75 111.311 -179.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -96.53 -37.66 10.31 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.969 0.414 . . . . 2.08 111.468 -178.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.15 -44.45 21.93 Favored 'General case' 0 C--N 1.324 -0.502 0 CA-C-N 116.202 -0.454 . . . . 2.63 111.15 -179.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 101.44 -47.61 1.18 Allowed Glycine 0 N--CA 1.444 -0.795 0 C-N-CA 120.583 -0.818 . . . . 0.97 111.293 -179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 12.6 p-10 -90.9 110.39 21.63 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.397 0.618 . . . . 1.75 109.908 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -134.32 -33.35 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.879 -0.677 . . . . 0.52 112.428 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 117.75 159.19 11.25 Favored Glycine 0 N--CA 1.444 -0.791 0 C-N-CA 120.722 -0.751 . . . . 0.3 111.637 -179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 11.7 pt -103.59 123.9 57.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.211 0.529 . . . . 0.27 110.565 -179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -113.61 157.05 22.6 Favored 'General case' 0 C--N 1.323 -0.558 0 CA-C-N 115.65 -0.704 . . . . 0.72 110.9 -179.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.7 mm -78.28 114.13 18.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.482 0 CA-C-N 115.641 -0.709 . . . . 0.24 109.974 179.047 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -76.91 -57.72 3.67 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.881 -0.676 . . . . 0.42 112.416 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -150.9 153.81 35.99 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 110.243 -0.281 . . . . 0.75 110.243 179.775 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.3 mt -108.88 130.18 62.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 CA-C-N 116.337 -0.392 . . . . 0.53 110.157 179.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 39.3 mmt -93.85 122.72 36.62 Favored 'General case' 0 C--N 1.32 -0.7 0 CA-C-N 116.362 -0.381 . . . . 0.74 110.93 -179.5 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 26.7 tptp -61.84 120.21 10.28 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.143 -0.48 . . . . 1.01 109.764 179.793 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 121.64 -16.19 9.02 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 111.33 -0.708 . . . . 0.36 111.33 -179.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -84.2 169.13 45.48 Favored Glycine 0 N--CA 1.446 -0.639 0 N-CA-C 111.443 -0.663 . . . . 0.26 111.443 179.255 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . . . . . . . . . . . -62.68 -33.22 74.64 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.555 0.216 . . . . 0.25 111.546 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . 0.421 HG13 HD12 ' A' ' 295' ' ' ILE . 84.1 t -67.87 -37.48 78.5 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-O 120.908 0.385 . . . . 0.26 110.836 -179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -70.24 -13.28 62.1 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.963 -0.562 . . . . 0.37 111.249 -179.534 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -88.16 -13.72 40.5 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 116.507 -0.315 . . . . 0.41 111.048 179.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 18.4 t70 -91.15 -70.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.621 -0.263 . . . . 0.55 110.534 -179.886 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 106.48 -15.44 42.14 Favored Glycine 0 CA--C 1.52 0.372 0 C-N-CA 120.386 -0.912 . . . . 0.39 114.276 178.476 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 77.2 mtm180 -80.16 -22.77 41.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 117.864 0.832 . . . . 0.68 111.387 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . 0.464 HD11 HG21 ' A' ' 252' ' ' VAL . 54.7 mt -89.97 137.5 21.33 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.226 -0.657 . . . . 0.37 109.226 178.92 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -140.86 163.34 43.36 Favored Pre-proline 0 C--N 1.325 -0.486 0 CA-C-N 116.752 -0.204 . . . . 0.69 110.864 -179.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 41.3 Cg_exo -57.32 121.58 10.3 Favored 'Trans proline' 0 C--N 1.349 0.575 0 C-N-CA 122.216 1.944 . . . . 0.41 111.368 178.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 119.42 -23.43 8.5 Favored Glycine 0 N--CA 1.447 -0.604 0 C-N-CA 120.849 -0.691 . . . . 0.29 112.173 -179.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.404 ' OD1' ' HG2' ' A' ' 337' ' ' LYS . 84.1 m-20 -61.4 139.65 58.16 Favored 'General case' 0 N--CA 1.464 0.238 0 CA-C-O 120.584 0.23 . . . . 0.34 110.498 179.805 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 36.3 ttp -101.12 130.45 47.18 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-N 116.524 -0.307 . . . . 1.26 110.429 179.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . 0.497 HD23 HG12 ' A' ' 335' ' ' VAL . 31.6 mt -84.73 127.48 34.13 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.343 -0.389 . . . . 0.48 110.154 179.611 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.645 HD11 ' HB2' ' A' ' 336' ' ' ALA . 62.4 mt -107.19 -73.55 0.68 Allowed 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.236 0.541 . . . . 0.53 110.391 179.864 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 4.6 tt0 -108.07 137.65 45.69 Favored 'General case' 0 C--N 1.322 -0.614 0 CA-C-N 115.577 -0.738 . . . . 0.73 110.512 -179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.429 HG21 HD13 ' A' ' 321' ' ' LEU . 93.0 t -132.45 98.05 2.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 N-CA-C 109.289 -0.634 . . . . 0.29 109.289 179.065 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.413 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 5.9 m120 59.97 71.94 0.55 Allowed 'General case' 0 C--O 1.237 0.396 0 CA-C-N 115.666 -0.697 . . . . 1.71 111.464 -179.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.413 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 0.6 OUTLIER 76.69 -51.52 0.58 Allowed 'General case' 0 N--CA 1.468 0.442 0 N-CA-C 113.957 1.095 . . . . 1.11 113.957 178.06 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 2.7 m -73.93 131.66 34.59 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.498 0 N-CA-C 112.571 0.582 . . . . 0.71 112.571 -178.236 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 59.4 t30 -101.48 131.39 47.64 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.44 -0.8 . . . . 0.74 109.235 179.278 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 30.5 m-85 -97.35 5.06 50.46 Favored 'General case' 0 C--N 1.325 -0.486 0 N-CA-C 112.554 0.576 . . . . 0.33 112.554 -177.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 50.4 mt-10 -64.44 -22.16 66.88 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.776 0.322 . . . . 1.21 111.699 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 4.4 m-20 -107.44 22.5 15.88 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 116.354 -0.384 . . . . 1.32 111.085 -179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 81.9 mtp -130.21 168.89 16.13 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 120.791 0.329 . . . . 0.51 111.07 -179.322 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.38 156.14 26.83 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 115.863 -0.608 . . . . 0.97 110.404 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . 0.449 ' O ' HG23 ' A' ' 318' ' ' VAL . 80.7 m-20 -53.22 -50.19 65.22 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.451 -0.34 . . . . 0.48 111.819 -179.405 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.462 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 10.9 t70 -60.77 -52.77 63.68 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.346 -0.388 . . . . 1.4 110.901 -179.266 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -57.5 -35.56 70.38 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.933 -0.576 . . . . 0.88 111.123 -179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -59.56 -49.71 76.73 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.13 -0.486 . . . . 0.2 111.417 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.449 HG23 ' O ' ' A' ' 314' ' ' ASN . 1.8 t -70.78 -26.72 28.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 C-N-CA 120.845 -0.342 . . . . 0.21 111.285 -179.375 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.462 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 95.5 mtt180 -56.14 -52.36 64.64 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.631 -0.507 . . . . 0.83 109.631 179.105 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 6.0 t -71.33 -37.28 64.77 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 115.412 -0.813 . . . . 0.17 110.34 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.429 HD13 HG21 ' A' ' 304' ' ' VAL . 13.5 tp -54.23 -52.82 60.09 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.95 -0.568 . . . . 0.38 110.725 179.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.474 ' HA ' HG11 ' B' ' 3' ' ' VAL . 33.7 mtp180 -64.03 -33.74 76.44 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.092 -0.504 . . . . 1.57 111.011 -179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -65.83 -41.23 92.05 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.026 0.441 . . . . 1.87 110.412 179.176 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 98.8 mt -69.14 -43.04 81.91 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.937 -0.574 . . . . 0.29 110.588 179.576 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 321' ' ' LEU . 87.3 t -67.03 -21.98 28.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-O 121.068 0.461 . . . . 0.24 111.165 -179.629 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 57.9 m -83.97 1.94 41.21 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.768 0.318 . . . . 0.44 110.954 179.466 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.7 141.01 39.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.276 -0.42 . . . . 1.16 110.269 179.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 7.1 p -82.28 115.13 21.21 Favored 'General case' 0 C--N 1.322 -0.611 0 CA-C-O 120.986 0.422 . . . . 0.89 111.659 -179.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 169.18 -170.92 42.83 Favored Glycine 0 N--CA 1.447 -0.628 0 C-N-CA 120.993 -0.622 . . . . 0.45 112.037 179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 1.2 Cg_endo -83.24 117.18 2.46 Favored 'Trans proline' 0 N--CA 1.456 -0.702 0 C-N-CA 123.202 2.602 . . . . 0.58 111.806 179.509 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 64.8 mt -98.3 118.12 44.3 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-N 116.239 -0.437 . . . . 0.37 110.95 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -102.61 110.13 21.97 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.827 -0.624 . . . . 1.09 110.295 179.662 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 93.1 mt -100.05 124.35 45.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.091 -0.504 . . . . 0.48 111.379 -179.652 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -104.67 99.36 9.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 108.699 -0.852 . . . . 0.5 108.699 178.076 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . 0.497 HG12 HD23 ' A' ' 301' ' ' LEU . 28.6 m -98.88 148.23 6.3 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-O 121.286 0.565 . . . . 0.33 112.232 -178.103 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.645 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -105.12 102.79 12.26 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.33 -0.85 . . . . 0.38 109.966 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.404 ' HG2' ' OD1' ' A' ' 299' ' ' ASP . 28.2 mtpp . . . . . 0 C--O 1.246 0.912 0 CA-C-O 118.349 -0.834 . . . . 0.7 109.856 -179.792 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.711 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 9.6 m95 . . . . . 0 N--CA 1.466 0.356 0 CA-C-O 120.532 0.206 . . . . 0.4 110.668 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.474 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.853 0 N-CA-C 109.369 -0.604 . . . . 0.27 109.369 178.045 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 43.2 t30 . . . . . 0 N--CA 1.48 1.043 0 CA-C-O 120.808 0.337 . . . . 1.26 110.614 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 91.9 mt -92.12 123.21 44.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.379 -0.373 . . . . 0.65 110.512 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 55.5 mt -123.26 122.2 64.75 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.503 0 CA-C-O 120.865 0.364 . . . . 0.55 111.074 -179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -103.35 120.35 40.62 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 115.996 -0.547 . . . . 0.59 110.104 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . 0.407 ' O ' ' HA ' ' A' ' 332' ' ' SER . 24.8 m -125.49 144.98 33.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.443 0 CA-C-O 120.824 0.345 . . . . 0.5 111.785 -179.273 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.0 t -110.99 120.94 44.05 Favored 'General case' 0 C--N 1.324 -0.508 0 N-CA-C 108.582 -0.896 . . . . 0.79 108.582 178.256 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.43 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 64.7 mt -102.81 135.55 44.26 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-O 121.083 0.468 . . . . 0.46 111.766 -178.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.3 t-20 -68.01 120.17 13.82 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.277 -0.874 . . . . 0.65 110.371 179.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 87.8 mmm -102.54 17.46 23.62 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-O 121.165 0.507 . . . . 0.63 110.895 -179.614 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -88.65 -53.19 4.76 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-O 121.121 0.486 . . . . 1.27 109.801 179.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 63.2 ttt180 -80.48 -31.04 37.4 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 115.374 -0.83 . . . . 1.06 110.648 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 36.2 m80 -92.6 157.71 16.36 Favored 'General case' 0 C--N 1.325 -0.479 0 N-CA-C 109.677 -0.49 . . . . 0.76 109.677 179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 77.3 m-70 -119.18 -7.76 10.25 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 120.915 0.388 . . . . 1.09 110.787 -179.631 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 43.1 p90 -156.52 173.26 17.17 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 116.036 -0.529 . . . . 0.62 110.279 179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.436 HD23 ' HA ' ' A' ' 262' ' ' LEU . 9.0 mt -80.57 -52.93 7.03 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.249 -0.432 . . . . 0.34 110.029 -179.697 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 89.55 46.27 4.37 Favored Glycine 0 N--CA 1.445 -0.722 0 C-N-CA 120.975 -0.631 . . . . 0.14 112.809 178.915 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.417 HD11 HD13 ' A' ' 262' ' ' LEU . 4.7 pt -145.86 149.58 16.25 Favored 'Isoleucine or valine' 0 C--O 1.238 0.486 0 CA-C-O 121.113 0.483 . . . . 0.18 111.388 179.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . 0.495 ' HB3' ' CZ2' ' B' ' 2' ' ' TRP . 5.5 p -99.18 124.62 44.37 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-N 115.473 -0.785 . . . . 1.0 109.159 178.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.704 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 5.3 mm -89.23 111.02 22.27 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 CA-C-O 121.04 0.448 . . . . 0.28 110.87 -178.759 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 91.7 t -105.94 110.43 31.29 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.525 0 CA-C-N 116.103 -0.498 . . . . 0.31 110.986 -179.771 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -94.72 119.36 6.09 Favored Glycine 0 N--CA 1.446 -0.644 0 C-N-CA 120.825 -0.702 . . . . 0.37 111.361 179.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -72.91 94.64 1.86 Allowed 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.146 0.498 . . . . 1.87 110.5 -179.677 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 3.9 m -97.79 94.06 6.72 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.571 -0.741 . . . . 1.17 110.206 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 7.7 t-20 -97.5 -160.13 0.78 Allowed 'General case' 0 C--N 1.322 -0.602 0 CA-C-N 115.836 -0.62 . . . . 2.75 109.359 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.3 p-10 -66.53 -21.73 66.16 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-O 121.106 0.479 . . . . 2.08 110.194 179.191 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . 0.426 ' O ' ' HD3' ' A' ' 273' ' ' ARG . 0.0 OUTLIER -80.18 -17.63 51.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.545 -0.752 . . . . 2.63 110.165 179.276 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 89.45 -80.5 1.51 Allowed Glycine 0 N--CA 1.447 -0.616 0 C-N-CA 120.918 -0.658 . . . . 0.97 111.694 -179.384 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -79.11 146.6 33.11 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.643 -0.503 . . . . 1.75 109.643 179.408 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . -155.01 -35.9 0.02 OUTLIER Glycine 0 C--N 1.315 -0.59 0 C-N-CA 120.771 -0.728 . . . . 0.52 111.6 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 132.58 154.23 7.52 Favored Glycine 0 N--CA 1.441 -0.989 0 C-N-CA 120.838 -0.696 . . . . 0.3 111.756 179.928 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 6.3 pt -102.12 119.93 51.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 CA-C-O 121.015 0.436 . . . . 0.27 110.147 179.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 75.0 m-85 -109.61 159.54 17.02 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.783 -0.644 . . . . 0.72 111.18 -178.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.1 mm -79.99 112.61 18.23 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.585 0 CA-C-N 115.564 -0.743 . . . . 0.24 109.397 178.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.18 -55.38 6.29 Favored Glycine 0 N--CA 1.45 -0.37 0 C-N-CA 120.397 -0.906 . . . . 0.42 112.267 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 3.9 p -153.29 156.68 38.86 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 110.188 -0.301 . . . . 0.75 110.188 179.79 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 35.9 mt -106.71 135.73 44.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.589 0 CA-C-N 116.201 -0.454 . . . . 0.53 110.131 179.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 36.0 mmt -97.55 134.65 40.49 Favored 'General case' 0 C--N 1.321 -0.634 0 CA-C-N 116.224 -0.444 . . . . 0.74 110.329 179.987 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 36.0 tptt -70.25 135.84 49.35 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.124 -0.489 . . . . 1.01 110.006 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 97.76 -10.26 64.37 Favored Glycine 0 N--CA 1.449 -0.494 0 C-N-CA 120.824 -0.703 . . . . 0.36 111.907 -179.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -82.03 176.12 53.9 Favored Glycine 0 N--CA 1.446 -0.691 0 C-N-CA 120.96 -0.638 . . . . 0.26 112.115 179.433 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.43 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -68.35 -37.98 81.03 Favored 'General case' 0 C--N 1.321 -0.642 0 CA-C-O 120.73 0.3 . . . . 0.25 111.094 -179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 59.2 t -68.3 -33.42 60.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 121.048 0.451 . . . . 0.26 111.283 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -65.13 -21.97 66.87 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.092 -0.504 . . . . 0.37 111.629 -179.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -84.88 -15.01 46.07 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.359 -0.382 . . . . 0.41 111.419 -179.71 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . . . . . . . . . 12.9 t70 -85.34 -74.22 0.41 Allowed 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.548 -0.296 . . . . 0.55 110.968 -179.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 104.95 -15.94 47.33 Favored Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.604 -0.808 . . . . 0.39 114.085 178.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . . . . . . . . . 55.8 mtm180 -80.29 -29.96 38.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 117.651 0.725 . . . . 0.68 110.945 -179.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 42.8 mt -84.55 137.68 20.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 N-CA-C 109.751 -0.462 . . . . 0.37 109.751 179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -136.7 164.36 43.05 Favored Pre-proline 0 C--N 1.324 -0.53 0 CA-C-N 116.657 -0.247 . . . . 0.69 110.924 -178.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_exo -62.7 111.77 1.44 Allowed 'Trans proline' 0 C--N 1.346 0.442 0 C-N-CA 122.261 1.974 . . . . 0.41 110.615 177.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 130.81 -19.02 5.04 Favored Glycine 0 N--CA 1.446 -0.665 0 N-CA-C 111.485 -0.646 . . . . 0.29 111.485 -179.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . 0.425 ' CG ' ' HZ2' ' A' ' 337' ' ' LYS . 95.4 m-20 -69.06 147.53 51.38 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 110.044 -0.354 . . . . 0.34 110.044 179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 26.7 ttt -103.57 136.97 42.3 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-O 120.695 0.283 . . . . 1.26 110.811 -179.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 19.5 mt -88.59 123.13 32.77 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-N 116.191 -0.459 . . . . 0.48 109.828 179.248 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 336' ' ' ALA . 80.5 mt -102.3 -77.66 0.55 Allowed 'General case' 0 C--N 1.322 -0.605 0 CA-C-O 121.168 0.509 . . . . 0.53 110.586 179.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -113.0 134.29 54.58 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.897 -0.592 . . . . 0.73 111.3 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . . . . . . . . . 48.2 t -127.32 94.33 2.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 CA-C-N 116.144 -0.48 . . . . 0.29 109.889 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . 0.487 ' O ' ' HB2' ' A' ' 306' ' ' ASP . 4.0 m-20 60.63 75.98 0.39 Allowed 'General case' 0 C--O 1.237 0.404 0 CA-C-N 115.705 -0.68 . . . . 1.71 111.399 -179.65 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . 0.487 ' HB2' ' O ' ' A' ' 305' ' ' ASN . 56.5 m-20 76.97 -61.44 0.43 Allowed 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 123.903 0.881 . . . . 1.11 112.894 178.857 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . . . . . . . . . 15.4 m -63.36 125.89 20.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.627 0.727 . . . . 0.71 111.986 -178.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 42.0 t-20 -106.23 132.95 51.67 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 115.249 -0.887 . . . . 0.74 109.925 -179.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -104.35 11.09 35.1 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 116.568 -0.287 . . . . 0.33 111.434 -179.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -54.6 -38.54 66.89 Favored 'General case' 0 N--CA 1.465 0.318 0 CA-C-O 120.952 0.406 . . . . 1.21 111.257 179.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 24.6 m-80 -123.96 59.17 1.15 Allowed 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.072 0.463 . . . . 1.32 110.867 -179.213 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 87.2 mtp -140.05 163.84 31.64 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 115.856 -0.611 . . . . 0.51 110.051 179.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 1.1 m -69.85 147.29 50.53 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.821 -0.437 . . . . 0.97 109.821 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -52.59 -47.07 67.13 Favored 'General case' 0 N--CA 1.465 0.319 0 CA-C-O 120.744 0.306 . . . . 0.48 111.096 -179.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.05 -50.3 71.17 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.021 -0.536 . . . . 1.4 110.91 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.452 ' OD1' ' HD2' ' A' ' 319' ' ' ARG . 1.7 m-20 -61.1 -34.74 75.42 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.77 -0.65 . . . . 0.88 111.834 -179.016 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -57.98 -49.09 78.02 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.117 -0.492 . . . . 0.2 111.1 179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . . . . . . . . . 2.4 t -75.76 -28.0 19.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.529 -0.305 . . . . 0.21 110.905 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.452 ' HD2' ' OD1' ' A' ' 316' ' ' ASP . 67.5 mtt180 -54.71 -52.04 63.68 Favored 'General case' 0 C--O 1.233 0.193 0 CA-C-O 120.907 0.384 . . . . 0.83 110.571 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 15.4 t -70.42 -39.58 76.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.42 0 CA-C-N 115.864 -0.607 . . . . 0.17 110.618 -179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.502 ' O ' HG23 ' A' ' 325' ' ' VAL . 21.7 tp -54.26 -49.24 70.01 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 116.163 -0.471 . . . . 0.38 111.431 -179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.593 ' HA ' HG11 ' B' ' 3' ' ' VAL . 14.7 mtp-105 -60.9 -37.49 82.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.124 -0.489 . . . . 1.57 111.654 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 27.9 mt-10 -65.33 -38.02 88.85 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-O 120.897 0.379 . . . . 1.87 110.779 179.819 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 86.7 mt -69.36 -41.64 80.92 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 116.091 -0.504 . . . . 0.29 110.692 179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 321' ' ' LEU . 40.5 t -69.83 -19.42 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 CA-C-O 121.044 0.45 . . . . 0.24 111.075 179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 22.6 m -91.08 2.01 56.65 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-O 121.053 0.454 . . . . 0.44 110.463 179.354 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 4.7 tp-100 -106.92 137.78 44.34 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.164 -0.471 . . . . 1.16 110.572 -179.766 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -74.81 99.37 3.74 Favored 'General case' 0 C--N 1.325 -0.472 0 CA-C-N 116.089 -0.505 . . . . 0.89 111.814 -179.389 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 177.59 160.3 24.02 Favored Glycine 0 N--CA 1.447 -0.586 0 C-N-CA 121.054 -0.593 . . . . 0.45 111.757 179.464 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 33.5 Cg_exo -60.82 130.32 32.56 Favored 'Trans proline' 0 C--N 1.345 0.362 0 C-N-CA 122.824 2.349 . . . . 0.58 112.229 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 76.3 mt -112.18 121.13 64.03 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 CA-C-N 116.204 -0.453 . . . . 0.37 111.131 -179.53 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . 0.407 ' HA ' ' O ' ' A' ' 252' ' ' VAL . 9.5 m -105.99 121.33 43.88 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.931 -0.577 . . . . 1.09 109.893 178.871 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . . . . . . . . . 36.5 mt -104.08 126.71 51.41 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 116.019 -0.537 . . . . 0.48 111.297 -178.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 1.3 m -106.18 98.65 8.31 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.336 -0.986 . . . . 0.5 108.336 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 35.7 m -100.12 151.68 4.98 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.487 0 CA-C-O 121.414 0.626 . . . . 0.33 112.447 -177.992 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . 0.56 ' HB2' HD11 ' A' ' 302' ' ' LEU . . . -112.47 112.01 23.25 Favored 'General case' 0 C--N 1.323 -0.55 0 CA-C-N 115.174 -0.921 . . . . 0.38 109.973 179.11 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . 0.425 ' HZ2' ' CG ' ' A' ' 299' ' ' ASP . 25.6 mtpp . . . . . 0 C--O 1.247 0.943 0 CA-C-O 118.393 -0.813 . . . . 0.7 109.803 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.704 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . 0.495 ' CZ2' ' HB3' ' A' ' 265' ' ' SER . 16.8 m95 . . . . . 0 C--O 1.236 0.36 0 N-CA-C 110.58 -0.156 . . . . 0.4 110.58 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.593 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.245 0.832 0 CA-C-O 118.752 -0.642 . . . . 0.27 110.077 178.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' ASN . . . . . . . . . . . . . 24.5 t-20 . . . . . 0 N--CA 1.481 1.119 0 CA-C-O 121.139 0.495 . . . . 1.26 109.976 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ILE . . . . . . . . . . . . . 37.7 mt -95.58 127.76 47.33 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.202 -0.453 . . . . 0.65 110.926 -179.136 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' ILE . . . . . . . . . . . . . 68.9 mt -132.23 129.38 59.79 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-N 116.439 -0.346 . . . . 0.55 110.681 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' THR . . . . . . . . . . . . . 6.9 m -100.08 110.17 22.47 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 109.149 -0.686 . . . . 0.59 109.149 178.425 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' VAL . . . . . . . . . . . . . 12.8 m -99.85 154.3 4.32 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.603 0 CA-C-O 121.121 0.486 . . . . 0.5 111.385 -178.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' THR . . . . . . . . . . . . . 3.3 t -122.44 126.24 47.5 Favored 'General case' 0 C--N 1.321 -0.634 0 N-CA-C 108.998 -0.741 . . . . 0.79 108.998 179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' LEU . . . . . 0.578 ' HB3' ' HB1' ' A' ' 288' ' ' ALA . 66.7 mt -114.21 149.16 36.21 Favored 'General case' 0 C--N 1.324 -0.538 0 CA-C-O 121.044 0.45 . . . . 0.46 111.492 -178.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ASN . . . . . . . . . . . . . 21.7 t-20 -94.8 120.09 34.45 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.589 -0.732 . . . . 0.65 110.116 179.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' MET . . . . . . . . . . . . . 99.8 mmm -101.1 16.99 23.59 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.11 0.481 . . . . 0.63 111.223 -179.287 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLU . . . . . . . . . . . . . 36.6 mm-40 -89.64 -43.36 10.8 Favored 'General case' 0 C--N 1.322 -0.592 0 N-CA-C 109.217 -0.66 . . . . 1.27 109.217 179.056 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ARG . . . . . . . . . . . . . 20.8 ttt180 -91.65 -16.32 27.21 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.478 -0.783 . . . . 1.06 109.9 178.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' HIS . . . . . . . . . . . . . 44.0 m80 -114.39 145.37 41.92 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-N 115.9 -0.591 . . . . 0.76 109.933 -179.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -107.9 -7.94 16.1 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 120.742 0.306 . . . . 1.09 111.673 -179.107 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -151.7 168.91 23.54 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 116.492 -0.322 . . . . 0.62 110.932 -179.465 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' LEU . . . . . 0.491 HD23 ' HA ' ' A' ' 262' ' ' LEU . 5.8 mt -77.94 -55.17 5.52 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.949 -0.569 . . . . 0.34 109.637 179.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . . . . . . . . . . . 91.24 43.79 4.56 Favored Glycine 0 N--CA 1.445 -0.762 0 CA-C-N 115.726 -0.67 . . . . 0.14 112.331 179.052 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ILE . . . . . 0.409 HG12 ' HB3' ' A' ' 262' ' ' LEU . 8.1 pt -139.74 151.6 22.31 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-O 121.397 0.617 . . . . 0.18 111.736 -179.948 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' SER . . . . . . . . . . . . . 17.6 t -103.1 128.51 49.97 Favored 'General case' 0 C--N 1.321 -0.666 0 CA-C-N 114.841 -1.072 . . . . 1.0 108.795 178.307 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ILE . . . . . 0.69 ' HB ' ' H21' ' B' ' 1' ' ' PHQ . 8.4 mm -97.54 113.87 33.17 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 CA-C-O 120.989 0.423 . . . . 0.28 110.744 -179.01 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' VAL . . . . . . . . . . . . . 59.3 t -97.41 114.11 33.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.683 0 CA-C-N 116.342 -0.39 . . . . 0.31 110.101 179.451 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' GLY . . . . . . . . . . . . . . . -89.75 108.86 3.55 Favored Glycine 0 N--CA 1.447 -0.605 0 C-N-CA 120.771 -0.728 . . . . 0.37 111.545 179.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 269' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -87.25 112.33 21.91 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 120.749 0.309 . . . . 1.87 110.328 -179.73 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 270' ' ' SER . . . . . . . . . . . . . 41.9 m -117.66 108.69 15.74 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 116.138 -0.483 . . . . 1.17 111.018 -179.877 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 271' ' ' ASN . . . . . . . . . . . . . 60.4 t30 -68.68 -55.5 11.21 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.965 -0.561 . . . . 2.75 110.473 179.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 272' ' ' ASP . . . . . . . . . . . . . 7.1 t70 -137.09 -49.42 0.62 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.547 -0.297 . . . . 2.08 111.573 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 273' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -124.17 23.87 8.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.856 0.36 . . . . 2.63 111.467 -178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 274' ' ' GLY . . . . . . . . . . . . . . . 104.66 10.9 32.03 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.342 -0.932 . . . . 0.97 111.483 -179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 275' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -76.33 116.66 17.23 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-N 115.241 -0.48 . . . . 1.75 110.042 179.593 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 276' ' ' GLY . . . . . . . . . . . . . . . 164.62 -65.54 0.23 Allowed Glycine 0 N--CA 1.445 -0.737 0 C-N-CA 120.616 -0.802 . . . . 0.52 111.964 179.644 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 277' ' ' GLY . . . . . . . . . . . . . . . 123.0 175.39 14.55 Favored Glycine 0 N--CA 1.446 -0.658 0 C-N-CA 120.766 -0.73 . . . . 0.3 112.127 179.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 278' ' ' ILE . . . . . . . . . . . . . 12.4 pt -106.08 118.09 53.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.374 0.607 . . . . 0.27 110.629 -179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 279' ' ' TYR . . . . . . . . . . . . . 80.8 m-85 -112.0 152.73 27.79 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.743 -0.662 . . . . 0.72 110.94 -179.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 280' ' ' ILE . . . . . . . . . . . . . 47.8 mm -76.13 113.36 14.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-N 116.176 -0.466 . . . . 0.24 110.128 179.117 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 281' ' ' GLY . . . . . . . . . . . . . . . -73.33 -60.05 3.95 Favored Glycine 0 N--CA 1.45 -0.43 0 C-N-CA 120.877 -0.677 . . . . 0.42 112.33 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 282' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.07 160.96 42.33 Favored 'General case' 0 C--N 1.324 -0.523 0 CA-C-O 120.54 0.209 . . . . 0.75 110.524 -179.711 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 283' ' ' ILE . . . . . . . . . . . . . 54.7 mt -113.92 131.98 64.23 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 109.778 -0.453 . . . . 0.53 109.778 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 284' ' ' MET . . . . . . . . . . . . . 38.2 mmt -97.99 128.29 44.45 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-O 120.778 0.323 . . . . 0.74 110.759 -179.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 285' ' ' LYS . . . . . . . . . . . . . 24.8 tptp -66.45 132.89 49.27 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.175 -0.466 . . . . 1.01 110.308 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 286' ' ' GLY . . . . . . . . . . . . . . . 109.86 -12.7 32.18 Favored Glycine 0 N--CA 1.449 -0.48 0 C-N-CA 120.93 -0.653 . . . . 0.36 111.552 -179.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 287' ' ' GLY . . . . . . . . . . . . . . . -87.36 171.82 42.44 Favored Glycine 0 N--CA 1.445 -0.766 0 C-N-CA 121.024 -0.608 . . . . 0.26 111.826 179.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 288' ' ' ALA . . . . . 0.578 ' HB1' ' HB3' ' A' ' 254' ' ' LEU . . . -66.12 -36.65 83.71 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.793 0.33 . . . . 0.25 111.518 -179.698 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 289' ' ' VAL . . . . . . . . . . . . . 60.7 t -65.76 -35.51 75.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.32 -0.4 . . . . 0.26 111.289 -179.308 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 290' ' ' ALA . . . . . . . . . . . . . . . -68.79 -14.09 62.81 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.993 -0.549 . . . . 0.37 111.91 -179.363 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 291' ' ' ALA . . . . . . . . . . . . . . . -86.71 -23.56 25.5 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-O 120.887 0.375 . . . . 0.41 110.728 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 292' ' ' ASP . . . . . 0.411 ' OD1' ' HB2' ' A' ' 294' ' ' ARG . 13.0 t70 -77.98 -68.25 0.65 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.227 -0.442 . . . . 0.55 110.215 179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 293' ' ' GLY . . . . . . . . . . . . . . . 101.46 -20.38 46.96 Favored Glycine 0 N--CA 1.448 -0.546 0 C-N-CA 120.431 -0.89 . . . . 0.39 113.991 178.707 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 294' ' ' ARG . . . . . 0.411 ' HB2' ' OD1' ' A' ' 292' ' ' ASP . 72.7 mtm180 -71.52 -38.64 71.09 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 117.716 0.758 . . . . 0.68 110.927 -179.673 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 295' ' ' ILE . . . . . . . . . . . . . 53.1 mt -75.62 136.02 25.83 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 109.593 -0.521 . . . . 0.37 109.593 179.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 296' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -135.42 161.16 64.87 Favored Pre-proline 0 C--N 1.321 -0.633 0 CA-C-N 116.539 -0.3 . . . . 0.69 110.443 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 297' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -59.74 109.41 0.58 Allowed 'Trans proline' 0 C--N 1.347 0.46 0 C-N-CA 122.2 1.933 . . . . 0.41 111.041 178.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 298' ' ' GLY . . . . . . . . . . . . . . . 131.86 -15.79 5.1 Favored Glycine 0 N--CA 1.446 -0.67 0 C-N-CA 121.153 -0.546 . . . . 0.29 111.737 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 299' ' ' ASP . . . . . . . . . . . . . 96.7 m-20 -70.61 149.59 46.91 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.241 -0.281 . . . . 0.34 110.241 179.326 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 300' ' ' MET . . . . . . . . . . . . . 27.0 ttp -107.15 135.94 47.84 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 116.556 -0.293 . . . . 1.26 110.613 179.637 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 301' ' ' LEU . . . . . . . . . . . . . 16.6 mt -89.3 119.22 29.58 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.135 -0.484 . . . . 0.48 109.829 179.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 302' ' ' LEU . . . . . . . . . . . . . 67.2 mt -100.99 -64.33 1.06 Allowed 'General case' 0 C--N 1.323 -0.585 0 CA-C-O 121.084 0.469 . . . . 0.53 110.705 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 303' ' ' GLN . . . . . 0.444 ' HG3' ' O ' ' A' ' 307' ' ' VAL . 5.1 tt0 -120.6 133.23 55.4 Favored 'General case' 0 C--N 1.325 -0.478 0 CA-C-N 115.828 -0.624 . . . . 0.73 110.815 -178.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 304' ' ' VAL . . . . . 0.446 ' O ' HG22 ' A' ' 307' ' ' VAL . 59.0 t -129.14 104.68 11.55 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.619 0 CA-C-N 116.258 -0.428 . . . . 0.29 110.536 179.844 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 305' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 58.07 70.32 0.66 Allowed 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.272 -0.422 . . . . 1.71 111.483 179.739 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 306' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER 72.89 -44.57 0.6 Allowed 'General case' 0 N--CA 1.471 0.619 0 N-CA-C 113.994 1.109 . . . . 1.11 113.994 178.125 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 307' ' ' VAL . . . . . 0.446 HG22 ' O ' ' A' ' 304' ' ' VAL . 32.2 m -74.15 139.22 19.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 CA-C-O 121.354 0.597 . . . . 0.71 111.36 -179.237 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 308' ' ' ASN . . . . . . . . . . . . . 60.3 t30 -111.66 135.64 51.97 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.69 -0.686 . . . . 0.74 110.379 -178.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 309' ' ' PHE . . . . . . . . . . . . . 40.6 m-85 -109.26 11.84 25.17 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.57 -0.286 . . . . 0.33 111.661 -178.972 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 310' ' ' GLU . . . . . . . . . . . . . 49.7 mt-10 -62.98 -29.01 70.49 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 111.845 0.313 . . . . 1.21 111.845 -179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 311' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -117.98 36.31 4.38 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-O 120.792 0.33 . . . . 1.32 111.07 -179.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 312' ' ' MET . . . . . . . . . . . . . 93.3 mtp -129.68 153.07 48.5 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.489 -0.323 . . . . 0.51 110.671 179.922 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 313' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -65.86 149.9 49.45 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.964 -0.562 . . . . 0.97 111.132 179.951 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 314' ' ' ASN . . . . . . . . . . . . . 88.9 m-20 -51.59 -47.67 63.46 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.443 -0.344 . . . . 0.48 111.602 -179.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 315' ' ' ASP . . . . . 0.458 ' O ' ' HG3' ' A' ' 319' ' ' ARG . 0.1 OUTLIER -57.8 -50.03 74.64 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.041 -0.527 . . . . 1.4 111.009 179.937 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 316' ' ' ASP . . . . . 0.438 ' HA ' ' HD2' ' A' ' 319' ' ' ARG . 29.8 m-20 -63.75 -37.44 87.35 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.753 -0.658 . . . . 0.88 111.815 -178.922 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 317' ' ' ALA . . . . . . . . . . . . . . . -55.28 -51.09 67.78 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.261 -0.427 . . . . 0.2 111.634 -179.431 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 318' ' ' VAL . . . . . 0.549 ' O ' ' HG3' ' A' ' 322' ' ' ARG . 1.5 t -72.92 -30.46 32.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.688 -0.405 . . . . 0.21 110.992 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 319' ' ' ARG . . . . . 0.458 ' HG3' ' O ' ' A' ' 315' ' ' ASP . 80.5 mtt180 -56.11 -46.52 79.08 Favored 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.884 0.373 . . . . 0.83 110.499 179.666 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 320' ' ' VAL . . . . . . . . . . . . . 25.9 t -75.47 -40.45 41.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.999 -0.546 . . . . 0.17 110.504 179.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 321' ' ' LEU . . . . . 0.456 ' O ' HG23 ' A' ' 325' ' ' VAL . 31.5 tp -54.36 -47.77 72.24 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.12 -0.491 . . . . 0.38 111.417 -179.765 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 322' ' ' ARG . . . . . 0.549 ' HG3' ' O ' ' A' ' 318' ' ' VAL . 25.6 mtp-105 -64.96 -29.58 70.52 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.955 -0.566 . . . . 1.57 111.871 -178.707 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 323' ' ' GLU . . . . . . . . . . . . . 40.6 mm-40 -69.07 -40.42 78.48 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-O 121.153 0.501 . . . . 1.87 110.003 179.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 324' ' ' ILE . . . . . . . . . . . . . 63.0 mt -67.66 -44.55 85.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 CA-C-N 115.692 -0.685 . . . . 0.29 110.718 179.859 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 325' ' ' VAL . . . . . 0.456 HG11 ' HB ' ' B' ' 3' ' ' VAL . 40.8 t -69.2 -18.65 22.92 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-O 121.115 0.483 . . . . 0.24 111.594 -179.245 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 326' ' ' SER . . . . . . . . . . . . . 49.4 m -91.75 3.55 54.86 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-O 120.954 0.407 . . . . 0.44 110.875 179.335 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 327' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.18 148.77 33.33 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 116.15 -0.477 . . . . 1.16 110.24 179.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 328' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.0 139.98 36.76 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 116.497 -0.32 . . . . 0.89 110.49 -179.702 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 329' ' ' GLY . . . . . . . . . . . . . . . 143.06 -173.62 24.06 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.662 -0.78 . . . . 0.45 112.308 179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 330' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -89.5 117.18 0.74 Allowed 'Trans proline' 0 N--CA 1.459 -0.556 0 C-N-CA 123.424 2.749 . . . . 0.58 112.21 179.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 331' ' ' ILE . . . . . . . . . . . . . 56.6 mt -96.88 119.23 44.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 CA-C-N 116.367 -0.379 . . . . 0.37 111.258 -179.581 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 332' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -99.59 115.2 28.86 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.931 -0.577 . . . . 1.09 110.169 178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 333' ' ' LEU . . . . . 0.419 HD23 HG13 ' A' ' 304' ' ' VAL . 49.9 mt -104.45 125.36 50.57 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 120.87 0.367 . . . . 0.48 111.36 -178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 334' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -109.08 103.05 11.98 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.96 -0.563 . . . . 0.5 109.812 179.216 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 335' ' ' VAL . . . . . . . . . . . . . 16.7 m -103.96 158.43 5.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.541 0 CA-C-N 116.191 -0.458 . . . . 0.33 111.691 -178.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 336' ' ' ALA . . . . . . . . . . . . . . . -118.34 108.72 15.43 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 115.488 -0.778 . . . . 0.38 110.195 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 337' ' ' LYS . . . . . . . . . . . . . 23.6 mtpp . . . . . 0 C--O 1.251 1.14 0 CA-C-O 118.263 -0.875 . . . . 0.7 110.223 -179.545 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' PHQ . . . . . 0.69 ' H21' ' HB ' ' A' ' 266' ' ' ILE . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' TRP . . . . . . . . . . . . . 47.7 m95 . . . . . 0 N--CA 1.466 0.332 0 CA-C-O 120.377 0.132 . . . . 0.4 110.878 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' VAL . . . . . 0.538 HG11 ' HA ' ' A' ' 322' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.089 0 CA-C-O 118.727 -0.654 . . . . 0.27 109.997 178.214 . . . . . . . . 2 2 . 1 stop_ save_